PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mukhamedova, M; Wrapp, D; Shen, CH; Gilman, MSA; Ruckwardt, TJ; Schramm, CA; Ault, L; Chang, LR; Derrien-Colemyn, A; Lucas, SAM; Ransier, A; Darko, S; Phung, E; Wang, LS; Zhang, Y; Rush, SA; Madan, B; Stewart-Jones, GBE; Costner, PJ; Holman, LA; Hickman, SP; Berkowitz, NM; Doria-Rose, NA; Morabito, KM; DeKosky, BJ; Gaudinski, MR; Chen, GL; Crank, MC; Misasi, J; Sullivan, NJ; Douek, DC; Kwong, PD; Graham, BS; McLellan, JS; Mascola, JR				Mukhamedova, Maryam; Wrapp, Daniel; Shen, Chen-Hsiang; Gilman, Morgan S. A.; Ruckwardt, Tracy J.; Schramm, Chaim A.; Ault, Larissa; Chang, Lauren; Derrien-Colemyn, Alexandrine; Lucas, Sarah A. M.; Ransier, Amy; Darko, Samuel; Phung, Emily; Wang, Lingshu; Zhang, Yi; Rush, Scott A.; Madan, Bharat; Stewart-Jones, Guillaume B. E.; Costner, Pamela J.; Holman, LaSonji A.; Hickman, Somia P.; Berkowitz, Nina M.; Doria-Rose, Nicole A.; Morabito, Kaitlyn M.; DeKosky, Brandon J.; Gaudinski, Martin R.; Chen, Grace L.; Crank, Michelle C.; Misasi, John; Sullivan, Nancy J.; Douek, Daniel C.; Kwong, Peter D.; Graham, Barney S.; McLellan, Jason S.; Mascola, John R.			Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses	IMMUNITY			English	Article							GRAPHICAL USER-INTERFACE; CRYO-EM; DESIGN; NEUTRALIZATION; PHENIX; HEAVY	An effective vaccine for respiratory syncytial virus (RSV) is an unrealized public health goal. A single dose of the prefusion-stabilized fusion (F) glycoprotein subunit vaccine (DS-Cav1) substantially increases serum-neutralizing activity in healthy adults. We sought to determine whether DS-Cav1 vaccination induces a repertoire mirroring the pre-existing diversity from natural infection or whether antibody lineages targeting specific epitopes predominate. We evaluated RSV F-specific B cell responses before and after vaccination in six participants using complementary B cell sequencing methodologies and identified 555 clonal lineages. DS-Cav1-induced lineages recognized the prefusion conformation of F (pre-F) and were genetically diverse. Expressed antibodies recognized all six antigenic sites on the pre-F trimer. We identified 34 public clono-types, and structural analysis of two antibodies from a predominant clonotype revealed a common mode of recognition. Thus, vaccination with DS-Cav1 generates a diverse polyclonal response targeting the antigenic sites on pre-F, supporting the development and advanced testing of pre-F-based vaccines against RSV.	[Mukhamedova, Maryam; Shen, Chen-Hsiang; Ruckwardt, Tracy J.; Schramm, Chaim A.; Ault, Larissa; Chang, Lauren; Derrien-Colemyn, Alexandrine; Lucas, Sarah A. M.; Ransier, Amy; Darko, Samuel; Phung, Emily; Wang, Lingshu; Zhang, Yi; Stewart-Jones, Guillaume B. E.; Costner, Pamela J.; Holman, LaSonji A.; Hickman, Somia P.; Berkowitz, Nina M.; Doria-Rose, Nicole A.; Morabito, Kaitlyn M.; Gaudinski, Martin R.; Chen, Grace L.; Crank, Michelle C.; Misasi, John; Sullivan, Nancy J.; Douek, Daniel C.; Kwong, Peter D.; Graham, Barney S.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Mukhamedova, Maryam] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Phung, Emily] George Washington Univ, Inst Biomed Sci, Washington, DC 20052 USA; [Wrapp, Daniel; Gilman, Morgan S. A.; Rush, Scott A.; McLellan, Jason S.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Madan, Bharat; DeKosky, Brandon J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [DeKosky, Brandon J.] Univ Kansas, Dept Chem Engn, Lawrence, KS 66045 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; George Washington University; University of Texas System; University of Texas Austin; University of Kansas; University of Kansas	Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmascola@nih.gov	Madan, Bharat/AAR-2965-2021; Wrapp, Daniel/HCH-3481-2022	Madan, Bharat/0000-0002-7376-9991; Wrapp, Daniel/0000-0002-0538-9647; Ault, Larissa/0000-0001-5463-0401; Chang, Lauren/0000-0002-3287-3987; Wang, Lingshu/0000-0002-8404-4910; Rush, Scott/0000-0002-9601-5068; Gaudinski, Martin/0000-0002-3743-5281	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health	We thank Richard Nguyen and David Ambrozak for assistance with flow cytometry. We also thank the members of the Humoral Immunology Section, Viral Pathogenesis Laboratories, and the ImmunoTechnology Section, Vaccine Research Center, especially Azad Kumar for producing and providing pre-and post-F proteins and Deepika Nair for helping produce RSV F antigenic site mutants. We also thank Yuliya I. Petrova and Rosemarie Mason for helpful comments and guidance and Man Chen for running some of the serum neutralization assays. In addition, we thank Yaroslav Tsybovsky for informative nsEM structures. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health. We also thank the volunteers who participated in the VRC 317 clinical trial.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Avnir Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20842; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Briney B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23901; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Crank MC, 2019, SCIENCE, V365, P505, DOI 10.1126/science.aav9033; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879; Gilman MSA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005035; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goodwin E, 2018, IMMUNITY, V48, P339, DOI 10.1016/j.immuni.2018.01.005; Graham BS, 2017, CURR OPIN VIROL, V23, P107, DOI 10.1016/j.coviro.2017.03.012; Griffin MP, 2020, NEW ENGL J MED, V383, P698; Hotard AL, 2012, VIROLOGY, V434, P129, DOI 10.1016/j.virol.2012.09.022; Joyce M Gordon, 2019, Pathog Immun, V4, P294, DOI 10.20411/pai.v4i2.338; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kong R, 2019, CELL, V178, P567, DOI 10.1016/j.cell.2019.06.030; Kong R, 2012, J VIROL, V86, P12115, DOI 10.1128/JVI.01632-12; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Liaw A, 2018, RANDOMFOREST; Lu B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40387-y; Mas V, 2018, VACCINE, V36, P6660, DOI 10.1016/j.vaccine.2018.09.056; Mason RD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005537; Mazur NI, 2018, LANCET INFECT DIS, V18, pE295, DOI 10.1016/S1473-3099(18)30292-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDaniel JR, 2016, NAT PROTOC, V11, P429, DOI 10.1038/nprot.2016.024; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mousa JJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.271; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Powell HR, 2017, NAT PROTOC, V12, P1310, DOI 10.1038/nprot.2017.037; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Ruckwardt TJ, 2019, IMMUNITY, V51, P429, DOI 10.1016/j.immuni.2019.08.007; Schramm CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00372; Sethna Z, 2019, BIOINFORMATICS, V35, P2974, DOI 10.1093/bioinformatics/btz035; Sharma A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-233; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12137-1; Wang B, 2018, NAT BIOTECHNOL, V36, P152, DOI 10.1038/nbt.4052; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao X, 2019, MABS-AUSTIN, V11, P1415, DOI 10.1080/19420862.2019.1654304; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	52	10	10	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					769	+		10.1016/j.immuni.2021.03.004	http://dx.doi.org/10.1016/j.immuni.2021.03.004		APR 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33823129	Bronze, Green Accepted			2022-12-18	WOS:000640102800016
J	Shannon, JP; Vrba, SM; Reynoso, GV; Wynne-Jones, E; Kamenyeva, O; Malo, CS; Cherry, CR; McManus, DT; Hickman, HD				Shannon, John P.; Vrba, Sophia M.; Reynoso, Glennys, V; Wynne-Jones, Erica; Kamenyeva, Olena; Malo, Courtney S.; Cherry, Christian R.; McManus, Daniel T.; Hickman, Heather D.			Group 1 innate lymphoid-cell-derived interferon-gamma maintains anti-viral vigilance in the mucosal epithelium	IMMUNITY			English	Article							NK CELLS; T-CELLS; ANIMAL-MODELS; MIGRATION; PAPILLOMAVIRUS; TRANSMISSION; ACTIVATION; RESPONSES; SMALLPOX; BET	The oropharyngeal mucosa serves as a perpetual pathogen entry point and a critical site for viral replication and spread. Here, we demonstrate that type 1 innate lymphoid cells (ILC1s) were the major immune force providing early protection during acute oral mucosal viral infection. Using intravital microscopy, we show that ILC1s populated and patrolled the uninfected labial mucosa. ILC1s produced interferon-gamma (IFN-gamma) in the absence of infection, leading to the upregulation of key antiviral genes, which were downregulated in uninfected animals upon genetic ablation of ILC1s or antibody-based neutralization of IFN-gamma. Thus, tonic IFN-gamma production generates increased oral mucosal viral resistance even before infection. Our results demonstrate barrier-tissue protection through tissue surveillance in the absence of rearranged-antigen receptors and the induction of an antiviral state during homeostasis. This aspect of ILC1 biology raises the possibility that these cells do not share true functional redundancy with other tissue-resident lymphocytes.	[Shannon, John P.; Vrba, Sophia M.; Reynoso, Glennys, V; Wynne-Jones, Erica; Malo, Courtney S.; Cherry, Christian R.; McManus, Daniel T.; Hickman, Heather D.] NIAID, Viral Immun & Pathogenesis Unit, Lab Clin Immunol & Microbiol, NIH, Bethesda, MD 20892 USA; [Kamenyeva, Olena] NIAID, Biol Imaging Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hickman, HD (corresponding author), NIAID, Viral Immun & Pathogenesis Unit, Lab Clin Immunol & Microbiol, NIH, Bethesda, MD 20892 USA.	hhickman@mail.nih.gov		Shannon, John/0000-0002-8722-2209	Intramural Research Program of the NIAID, NIH	Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIAID, NIH. Graphical abstract was drawn by Ethan Tyler, NIH Medical Arts Branch. We thank Dr. Jinfang (Jeff) Zhu for kindly sharing T-bet-ZsGreen reporter mice, Dr. KPJM van Gisbergen for helpful comments regarding NAD<SUP>+</SUP> depletion of tissue-resident cells, and Drs. Eric Vivier and Ron Germain for helpful discussions on this study.	Adams NM, 2018, IMMUNOL REV, V286, P23, DOI 10.1111/imr.12710; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Baron S, 2003, J DENT RES, V82, P252, DOI 10.1177/154405910308200401; Berman TA, 2017, CANCER-AM CANCER SOC, V123, P2219, DOI 10.1002/cncr.30588; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Brown JL, 2018, J DENT RES, V97, P1399, DOI 10.1177/0022034518782141; Chapman JL, 2010, VET PATHOL, V47, P852, DOI 10.1177/0300985810378649; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Cush SS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005493; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Dutzan N, 2017, IMMUNITY, V46, P133, DOI 10.1016/j.immuni.2016.12.010; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Edelblum KL, 2012, P NATL ACAD SCI USA, V109, P7097, DOI 10.1073/pnas.1112519109; Farlik M, 2012, MOL CELL BIOL, V32, P1032, DOI 10.1128/MCB.06021-11; Fenner F., 1988, SMALLPOX ITS ERADICA, P1460; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hernaez B., 2018, FRESEARCH, V7, pF1000; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004; Huang N., 2020, INTEGRATED SINGLE CE; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Kawabe T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9304; Khairallah C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02636; Klose CSN, 2019, CURR OPIN IMMUNOL, V56, P94, DOI 10.1016/j.coi.2018.11.002; Koksal AC, 2011, J BIOL CHEM, V286, P14373, DOI 10.1074/jbc.M111.226357; Kollias CM, 2015, J NEUROVIROL, V21, P8, DOI 10.1007/s13365-014-0302-2; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Mann BA, 2008, J INTERF CYTOK RES, V28, P367, DOI 10.1089/jir.2007.0113; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; McBride AA, 2017, BIOL CHEM, V398, P919, DOI 10.1515/hsz-2017-0113; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; O'Sullivan TE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02235; Park E, 2019, ELIFE, V8, DOI 10.7554/eLife.47605; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Schaupp L, 2020, CELL, V181, P1080, DOI 10.1016/j.cell.2020.04.022; Shannon JP, 2019, METHODS MOL BIOL, V2023, P301, DOI 10.1007/978-1-4939-9593-6_19; Sheppard S, 2013, BLOOD, V121, P5025, DOI 10.1182/blood-2012-12-471607; Slifka MK, 2004, DERMATOL CLIN, V22, P263, DOI 10.1016/j.det.2004.03.002; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Stark R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau1022; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Thier K, 2017, J VIROL, V91, DOI 10.1128/JVI.01295-17; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; van Konijnenburg DPH, 2017, CELL, V171, P783, DOI 10.1016/j.cell.2017.08.046; Vashist N, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.00505, 10.3389/fiimmu.2018.00505]; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Victorino F, 2015, J IMMUNOL, V195, P4973, DOI 10.4049/jimmunol.1500651; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	62	10	10	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					276	+		10.1016/j.immuni.2020.12.004	http://dx.doi.org/10.1016/j.immuni.2020.12.004		FEB 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33434494	Green Accepted, Bronze			2022-12-18	WOS:000627407700012
J	Lin, YR; Parks, KR; Weidle, C; Naidu, AS; Khechaduri, A; Riker, AO; Takushi, B; Chun, JH; Borst, AJ; Veesler, D; Stuart, A; Agrawal, P; Gray, M; Pancera, M; Huang, PS; Stamatatos, L				Lin, Yu-Ru; Parks, K. Rachael; Weidle, Connor; Naidu, Anika S.; Khechaduri, Arineh; Riker, Andrew O.; Takushi, Brittany; Chun, Jung-Ho; Borst, Andrew J.; Veesler, David; Stuart, Andrew; Agrawal, Parul; Gray, Matthew; Pancera, Marie; Huang, Po-Ssu; Stamatatos, Leonidas			HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors	IMMUNITY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; AFFINITY MATURATION; GERMINAL-CENTERS; IDENTIFICATION; SEQUENCE; POTENT; IG; RESPONSES; FEATURES; PATHWAY	Activating precursor B cell receptors of HIV-1 broadly neutralizing antibodies requires specifically designed immunogens. Here, we compared the abilities of three such germline-targeting immunogens against the VRC01-class receptors to activate the targeted B cells in transgenic mice expressing the germline VH of the VRC01 antibody but diverse mouse light chains. lmmunogen-specific VRC01 -like B cells were isolated at different time points after immunization, their VH and VL genes were sequenced, and the corresponding antibodies characterized, VRC01 B cell sub-populations with distinct cross-reactivity properties were activated by each immunogen, and these differences correlated with distinct biophysical and biochemical features of the germline-targeting immunogens. Our study indicates that the design of effective immunogens to activate B cell receptors leading to protective HIV-1 antibodies will require a better understanding of how the biophysical properties of the epitope and its surrounding surface on the germline-targeting immunogen influence its interaction with the available receptor variants in vivo.	[Lin, Yu-Ru; Parks, K. Rachael; Weidle, Connor; Khechaduri, Arineh; Riker, Andrew O.; Takushi, Brittany; Stuart, Andrew; Agrawal, Parul; Gray, Matthew; Pancera, Marie; Stamatatos, Leonidas] Fred Hutchinson Canc Res Ctr, Vaccines & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Parks, K. Rachael; Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Naidu, Anika S.; Huang, Po-Ssu] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chun, Jung-Ho; Borst, Andrew J.; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Pancera, Marie] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Weidle, Connor] Omeros, Waterfront Res Ctr, 201 Elliott Ave W, Seattle, WA 98119 USA; [Naidu, Anika S.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Stanford University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University	Pancera, M; Stamatatos, L (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccines & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Stamatatos, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Huang, PS (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Pancera, M (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mpancera@fredhutch.org; possu@stanford.edu; lstamata@fredhutch.org	Veesler, David/HCH-3986-2022	Borst, Andrew/0000-0003-4297-7824; Huang, Possu/0000-0002-7948-2895	NIH/NIAID [R01 AI104384, P01 AI138212]; Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC0205CH11231]; United States Department of Energy, Office of Science, Office of Advanced Scientific Computing Research, Scientific Discovery through Advanced Computing (SciDAC) program; Stanford's Bio-X Interdisciplinary Initiatives Seed Grants Program; James B. Pendleton Charitable Trust of the Formulatrix robotic instrumentation; National Institute of General Medical Sciences	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Advanced Scientific Computing Research, Scientific Discovery through Advanced Computing (SciDAC) program; Stanford's Bio-X Interdisciplinary Initiatives Seed Grants Program; James B. Pendleton Charitable Trust of the Formulatrix robotic instrumentation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH/NIAID grants R01 AI104384 and P01 AI138212. X-ray diffraction data were collected at the Berkeley Center for Structural Biology beamline 5.0.1, which is supported in part by the National Institute of General Medical Sciences. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the United States Department of Energy under contract DE-AC0205CH11231. P.-S.H. is supported by the United States Department of Energy, Office of Science, Office of Advanced Scientific Computing Research, Scientific Discovery through Advanced Computing (SciDAC) program and Stanford's Bio-X Interdisciplinary Initiatives Seed Grants Program. We thank the James B. Pendleton Charitable Trust for the support of the Formulatrix robotic instrumentation. We would also like to thank Cassie Brian from the Baker lab at the University of Washington for her help with the yeast display experiments.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; [Anonymous], 2017, QDOAS VERSION 32 SO; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Borst AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37688; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI 10.1007/978-3-540-35306-5_10; Chen F, 2019, CURR OPIN VIROL, V34, P149, DOI 10.1016/j.coviro.2019.02.004; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escolano A, 2019, NATURE, V570, P468, DOI 10.1038/s41586-019-1250-z; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381; Hofmeyer T, 2013, J MOL BIOL, V425, P1302, DOI 10.1016/j.jmb.2012.12.017; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; Medina-Ramirez M, 2017, J EXP MED, V214, P2573, DOI 10.1084/jem.20161160; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PageS H., 2018, BIOSTRINGS EFFICIENT; Parks KR, 2019, CELL REP, V29, P3060, DOI 10.1016/j.celrep.2019.10.071; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; R Core Team, 2018, R R PROJ STAT COMP; Sangesland M, 2019, IMMUNITY, V51, P735, DOI 10.1016/j.immuni.2019.09.001; Scharf L, 2016, ELIFE, V5, DOI 10.7554/eLife.13783; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Silva M, 2017, CELL REP, V21, P3672, DOI 10.1016/j.celrep.2017.12.014; Snijder J, 2018, IMMUNITY, V48, P799, DOI 10.1016/j.immuni.2018.03.026; Steichen JM, 2019, SCIENCE, V366, P1216, DOI 10.1126/science.aax4380; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Umotoy J, 2019, IMMUNITY, V51, P141, DOI 10.1016/j.immuni.2019.06.004; Veesler D, 2014, P NATL ACAD SCI USA, V111, P8815, DOI 10.1073/pnas.1404575111; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Williams WB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01336-3; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	66	10	10	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					840	+		10.1016/j.immuni.2020.09.007	http://dx.doi.org/10.1016/j.immuni.2020.09.007			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053332	Green Accepted, Bronze			2022-12-18	WOS:000581062800015
J	Buchholz, VR; Busch, DH				Buchholz, Veit R.; Busch, Dirk H.			Back to the Future: Effector Fate during T Cell Exhaustion	IMMUNITY			English	Editorial Material								Exhausted CD8(+) T cells adopt a functionally attenuated state but still confer a certain degree of pathogen control. Chen et al. (2019), Hudson et al. (2019), and Zander et al. (2019) assign the lasting maintenance of this restrained pathogen control to an equilibrium of effector-like, transitory, terminal, and memory-like exhausted T cells.	[Buchholz, Veit R.; Busch, Dirk H.] TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Busch, Dirk H.] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany	Technical University of Munich; German Center for Infection Research	Buchholz, VR; Busch, DH (corresponding author), TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Busch, DH (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.	veit.buchholz@tum.de; dirk.busch@tum.de	Buchholz, Veit R./AAF-6966-2021	Buchholz, Veit R./0000-0003-0441-3913				Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Lin WHW, 2016, CELL REP, V17, P1773, DOI 10.1016/j.celrep.2016.10.032; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009	12	10	10	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					970	972		10.1016/j.immuni.2019.11.007	http://dx.doi.org/10.1016/j.immuni.2019.11.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31851902	Bronze			2022-12-18	WOS:000503162900002
J	Sundararaman, SK; Barbie, DA				Sundararaman, Shriram K.; Barbie, David A.			Tumor cGAMP Awakens the Natural Killers	IMMUNITY			English	Editorial Material							MELANOMA	Type I interferon (IFN) production within the tumor microenvironment is important in shaping the immune response to the tumor. In this issue of Immunity, Marcus et al. (2018) reveal that tumor cells produce 2'3'-cGAMP, which activates the STING pathway in non-tumor cells and leads to type I IFN production and the priming of natural killer cells for tumor rejection.	[Sundararaman, Shriram K.; Barbie, David A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Barbie, DA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	dbarbie@partners.org		Sundararaman, Shriram/0000-0002-6686-6945	Bristol-Myers Squibb; Novartis; NATIONAL CANCER INSTITUTE [R01CA190394] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	D.A.B. is a consultant for N-of-One and has received honoraria from Loxo Oncology and Madalon Consulting and research grants from Bristol-Myers Squibb and Novartis.	Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Ng KW, 2018, TRENDS IMMUNOL, V39, P44, DOI 10.1016/j.it.2017.07.013; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Xia TL, 2016, CANCER RES, V76, P6747, DOI 10.1158/0008-5472.CAN-16-1404; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	10	10	11	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					585	587		10.1016/j.immuni.2018.10.001	http://dx.doi.org/10.1016/j.immuni.2018.10.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332624	Green Accepted, Bronze			2022-12-18	WOS:000447386700004
J	Harris, NL; Loke, P				Harris, Nicola L.; Loke, P'ng			Recent Advances in Type-2-Cell-Mediated Immunity: Insights from Helminth Infection (vol 47, pg 1024, 2017)	IMMUNITY			English	Correction												nicola.harris@epfl.ch	harris, nicola/E-5342-2019	harris, nicola/0000-0003-2922-0210				Harris NL, 2017, IMMUNITY, V47, P1024, DOI 10.1016/j.immuni.2017.11.015	1	10	10	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					396	396		10.1016/j.immuni.2018.02.011	http://dx.doi.org/10.1016/j.immuni.2018.02.011			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466760	Bronze			2022-12-18	WOS:000425507800022
J	Vandenabeele, P; Riquet, F; Cappe, B				Vandenabeele, Peter; Riquet, Franck; Cappe, Benjamin			Necroptosis: (Last) Message in a Bubble	IMMUNITY			English	Editorial Material							CELL-DEATH; MLKL; MEMBRANE	RIPK3 kinase-mediated phosphorylation of MLKL pseudokinase is the execution event of necroptosis. Two independent reports-in Immunity (Yoon et al., 2017) and Cell (Gong et al., 2017)-reveal that MLKL affects homeostatic membrane trafficking and necroptosis-enhanced bubble formation involving interaction with the ESCRT machinery.	[Vandenabeele, Peter; Riquet, Franck; Cappe, Benjamin] VIB, Inflammat Res Ctr, Mol Signaling & Cell Death Unit, Ghent, Belgium; [Vandenabeele, Peter; Riquet, Franck; Cappe, Benjamin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Methusalem Program, Ghent, Belgium; [Riquet, Franck] Univ Lille 1, CNRS, UMR 8576, Unite Glycobiol Struct & Fonct, Villeneuve Dascq, France	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Vandenabeele, P (corresponding author), VIB, Inflammat Res Ctr, Mol Signaling & Cell Death Unit, Ghent, Belgium.; Vandenabeele, P (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.; Vandenabeele, P (corresponding author), Univ Ghent, Methusalem Program, Ghent, Belgium.	peter.vandenabeele@irc.vib-ugent.be	Vandenabeele, Peter/C-8597-2009; CAPPE, Benjamin/ABG-5598-2020; Vandenabeele, Peter/AAD-5793-2022	CAPPE, Benjamin/0000-0002-8162-9788; Vandenabeele, Peter/0000-0002-6669-8822				Christ L, 2017, TRENDS BIOCHEM SCI, V42, P42, DOI 10.1016/j.tibs.2016.08.016; Dondelinger Y, 2016, TRENDS CELL BIOL, V26, P721, DOI 10.1016/j.tcb.2016.06.004; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Petrie EJ, 2017, IMMUNOL CELL BIOL, V95, P152, DOI 10.1038/icb.2016.125; Romero M, 2017, CELL DEATH DIFFER, V24, P798, DOI 10.1038/cdd.2017.11; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Yoon S, 2017, IMMUNITY, V47, P51, DOI 10.1016/j.immuni.2017.06.001; Zargarian S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002711	9	10	11	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					1	3		10.1016/j.immuni.2017.07.002	http://dx.doi.org/10.1016/j.immuni.2017.07.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723543	Bronze			2022-12-18	WOS:000405712800001
J	Ost, KS; Round, JL				Ost, Kyla S.; Round, June L.			A Few Good Commensals: Gut Microbes Use IFN-gamma to Fight Salmonella	IMMUNITY			English	Editorial Material							BACTERIA; INFECTION	Whereas strong evidence supports the notion that the microbiota promotes immune system maturation in multiple tissues, the identity of the specific microbes that elicit protective immunity to different infections is less clear. In a recent issue of Cell Host & Microbe, Thiemann et al. (2017) report the identification of specific gut bacteria that protect from Salmonella infection by priming host IFN-gamma responses.	[Ost, Kyla S.; Round, June L.] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Round, JL (corresponding author), Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA.	june.round@path.utah.edu		Ost, Kyla/0000-0003-4101-2836				Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kubinak JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9642; MUOTIALA A, 1990, MICROB PATHOGENESIS, V8, P135, DOI 10.1016/0882-4010(90)90077-4; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Thiemann S, 2017, CELL HOST MICROBE, V21, P682, DOI 10.1016/j.chom.2017.05.005	10	10	11	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					977	979		10.1016/j.immuni.2017.06.010	http://dx.doi.org/10.1016/j.immuni.2017.06.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636967	Bronze			2022-12-18	WOS:000403665900010
J	Mjosberg, J; Mazzurana, L				Mjosberg, Jenny; Mazzurana, Luca			ILC-poiesis: Making Tissue ILCs from Blood	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; DIFFERENTIATION; PRECURSORS; SUBSETS		[Mjosberg, Jenny; Mazzurana, Luca] Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, S-17177 Stockholm, Sweden; [Mjosberg, Jenny] Linkoping Univ, Dept Clin & Expt Med, S-58183 Linkoping, Sweden	Karolinska Institutet; Linkoping University	Mjosberg, J (corresponding author), Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, S-17177 Stockholm, Sweden.; Mjosberg, J (corresponding author), Linkoping Univ, Dept Clin & Expt Med, S-58183 Linkoping, Sweden.	jenny.mjosberg@ki.se		Mjosberg, Jenny/0000-0002-1119-0976				Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365	9	10	10	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					344	346		10.1016/j.immuni.2017.03.002	http://dx.doi.org/10.1016/j.immuni.2017.03.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329700	Bronze			2022-12-18	WOS:000396818100007
J	Ealey, KN; Koyasu, S				Ealey, Kafi N.; Koyasu, Shigeo			How Many Subsets of Innate Lymphoid Cells Do We Need?	IMMUNITY			English	Editorial Material							INFLAMMATION	Innate lymphoid cells (ILCs) are composed of three main subsets. In this issue of Immunity, Simoni et al. (2017) show using mass-cytometry that human ILCs are highly heterogeneous between individuals and tissues and lack a previously proposed helper-type ILC1 population.	[Ealey, Kafi N.] RIKEN Ctr Integrat Med Sci, Lab Innate Immune Syst, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Koyasu, Shigeo] RIKEN Ctr Integrat Med Sci, Lab Immune Cell Syst, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	RIKEN; RIKEN	Koyasu, S (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Immune Cell Syst, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	shigeo.koyasu@riken.jp	Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038				Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Morita H, 2016, J ALLERGY CLIN IMMUN, V138, P1253, DOI 10.1016/j.jaci.2016.09.011; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553	10	10	10	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					10	13		10.1016/j.immuni.2016.12.018	http://dx.doi.org/10.1016/j.immuni.2016.12.018			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28099859	Bronze			2022-12-18	WOS:000392918300005
J	Weitz, TM; Town, T				Weitz, Tara M.; Town, Terrence			Amyloid Cascade into Clarity	IMMUNITY			English	Editorial Material							ALZHEIMER-LIKE PATHOLOGY; A-BETA; PLAQUES; DISEASE; MEMORY		[Weitz, Tara M.; Town, Terrence] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, 1501 San Pablo St,Room 321, Los Angeles, CA 90089 USA	University of Southern California	Town, T (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, 1501 San Pablo St,Room 321, Los Angeles, CA 90089 USA.	ttown@usc.edu						Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; Gate D, 2010, J NEURAL TRANSM, V117, P961, DOI 10.1007/s00702-010-0422-7; Guillot-Sestier MV, 2015, NEURON, V85, P534, DOI 10.1016/j.neuron.2014.12.068; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WISNIEWSKI HM, 1991, ACTA NEUROPATHOL, V81, P588, DOI 10.1007/BF00310142	10	10	10	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					717	718		10.1016/j.immuni.2016.10.006	http://dx.doi.org/10.1016/j.immuni.2016.10.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760336	Bronze			2022-12-18	WOS:000389473200006
J	Tinoco, R; Carrette, F; Barraza, ML; Otero, DC; Magana, J; Bosenberg, MW; Swain, SL; Bradley, LM				Tinoco, Roberto; Carrette, Florent; Barraza, Monique L.; Otero, Dennis C.; Magana, Jonathan; Bosenberg, Marcus W.; Swain, Susan L.; Bradley, Linda M.			PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion (vol 44, pg 1190, 2016)	IMMUNITY			English	Correction												lbradley@sbpdiscovery.org		Tinoco, Roberto/0000-0001-5420-9692				Tinoco R, 2016, IMMUNITY, V44, P1190, DOI 10.1016/j.immuni.2016.04.015	1	10	10	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1470	1470		10.1016/j.immuni.2016.05.011	http://dx.doi.org/10.1016/j.immuni.2016.05.011			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332735	Bronze			2022-12-18	WOS:000378341200023
J	Karst, SM				Karst, Stephanie M.			Viral Safeguard: The Enteric Virome Protects against Gut Inflammation	IMMUNITY			English	Editorial Material							COMMENSAL BACTERIA; DISEASE	In this issue of Immunity, Kweon and colleagues (2016) report a novel antiviral cocktail approach to specifically reduce the virome component of the intestinal microbiota. Using this strategy, they generate compelling evidence that the virome provides protection from gut inflammatory conditions.	[Karst, Stephanie M.] Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Coll Med, 1600 SW Archer Rd, Gainesville, FL 32610 USA		Karst, SM (corresponding author), Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Coll Med, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	skarst@ufl.edu						Alard P., 2011, CLOSED SECT, V2, P180; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Ogilvie LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00918; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wang WW, 2015, INFLAMM BOWEL DIS, V21, P1419, DOI 10.1097/MIB.0000000000000344; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009	10	10	10	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					715	718		10.1016/j.immuni.2016.04.004	http://dx.doi.org/10.1016/j.immuni.2016.04.004			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096311	Bronze			2022-12-18	WOS:000374444300002
J	Kashem, SW; Riedl, MS; Yao, C; Honda, CN; Vulchanova, L; Kaplan, DH				Kashem, Sakeen W.; Riedl, Maureen S.; Yao, Chen; Honda, Christopher N.; Vulchanova, Lucy; Kaplan, Daniel H.			Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b(+) Dermal Dendritic Cells and Drive Protective Cutaneous Immunity (vol 43, pg 515, 2015)	IMMUNITY			English	Correction												dankaplan@pitt.edu		Vulchanova, Lucy/0000-0002-6577-4467				Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016	1	10	10	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					830	830		10.1016/j.immuni.2015.09.015	http://dx.doi.org/10.1016/j.immuni.2015.09.015			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED		Bronze			2022-12-18	WOS:000363478700023
J	Oh, SA; Li, MO				Oh, Soyoung A.; Li, Ming O.			TETs Link Hydrogen Sulfide to Immune Tolerance	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; FOXP3 LOCUS; DEMETHYLATION	Demethylation of the Foxp3 locus maintains gene expression and Treg cell stability. Yang et al. (2015) show that the gasotransmitter hydrogen sulfide co-operates with growth factor TGF-beta and interleukin-2 to activate Tet-mediated DNA demethylation of Foxp3 to promote immune tolerance.	[Oh, Soyoung A.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.	lim@mskcc.org		li, ming/0000-0002-1383-0535				Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Wang LQ, 2013, MOL CELL BIOL, V33, P4106, DOI 10.1128/MCB.00144-13; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Yang RL, 2015, IMMUNITY, V43, P251, DOI 10.1016/j.immuni.2015.07.017; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	9	10	11	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					211	213		10.1016/j.immuni.2015.08.001	http://dx.doi.org/10.1016/j.immuni.2015.08.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287675	Bronze			2022-12-18	WOS:000360101200001
J	Papayannopoulos, V				Papayannopoulos, Venizelos			Sweet NETs, Bitter Wounds	IMMUNITY			English	Editorial Material							NEUTROPHIL EXTRACELLULAR TRAPS; IMMUNITY; INNATE	What causes slow wound healing rates in diabetes is poorly understood. Wong et al. (2015) report that an increase in the deployment of neutrophil extracellular traps associated with hyperglycemia slows down wound healing.	Francis Crick Inst, Mill Hill Labs, London NW7 1AA, England	Francis Crick Institute	Papayannopoulos, V (corresponding author), Francis Crick Inst, Mill Hill Labs, London NW7 1AA, England.	veni.p@crick.ac.uk		Papayannopoulos, Venizelos/0000-0002-3741-8190	The Francis Crick Institute [10129] Funding Source: researchfish	The Francis Crick Institute		Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Etulain J, 2015, BLOOD, V126, P242, DOI 10.1182/blood-2015-01-624023; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887	10	10	11	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					223	225		10.1016/j.immuni.2015.08.002	http://dx.doi.org/10.1016/j.immuni.2015.08.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287680	Bronze			2022-12-18	WOS:000360101200006
J	Bengsch, B; Wherry, EJ				Bengsch, Bertram; Wherry, E. John			The Importance of Cooperation: Partnerless NFAT Induces T Cell Exhaustion	IMMUNITY			English	Editorial Material							CHRONIC VIRAL-INFECTION; TRANSCRIPTION FACTOR; PD-1	Downstream of costimulatory pathways, complexes of transcription factors NFAT and AP-1 promote effector T cell differentiation. In this issue of Immunity, Martinez et al. report that monomeric NFAT binding in the absence of a transcriptional partner induces a gene expression program involved in T cell exhaustion.	[Bengsch, Bertram; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Inst Immunol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Bengsch, Bertram/ABF-2142-2020; Wherry, John/ABI-1280-2020	Bengsch, Bertram/0000-0003-2552-740X; 				Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Kahan SM, 2015, VIROLOGY; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Vezys V, 2011, J IMMUNOL, V187, P1634, DOI 10.4049/jimmunol.1100077	10	10	12	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					203	205		10.1016/j.immuni.2015.01.023	http://dx.doi.org/10.1016/j.immuni.2015.01.023			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692694	Bronze			2022-12-18	WOS:000349916400002
J	Colucci, F				Colucci, Francesco			An Oral Commensal Associates with Disease: Chicken, Egg, or Red Herring?	IMMUNITY			English	Editorial Material							FUSOBACTERIUM-NUCLEATUM	Fusobacterium nucleatum might be the cause or consequence of disease in many tissues in and outside the mouth. In this issue of Immunity, Gur et al. (2015) suggest a new mechanism by which this oral commensal might help cancer cells escape host immunity.	[Colucci, Francesco] Univ Cambridge, Ctr Trophoblast Res, Natl Inst Hlth, Cambridge Biomed Res Ctr,Rosie Hosp, Cambridge CB2 0SW, England; [Colucci, Francesco] Univ Cambridge, Dept Obstet & Gynaecol, Sch Clin Med, Natl Inst Hlth,Res Cambridge Biomed Res Ctr,Rosie, Cambridge CB2 0SW, England	University of Cambridge; University of Cambridge	Colucci, F (corresponding author), Univ Cambridge, Ctr Trophoblast Res, Natl Inst Hlth, Cambridge Biomed Res Ctr,Rosie Hosp, Box 223,Robinson Way, Cambridge CB2 0SW, England.	fc287@medschl.cam.ac.uk	Colucci, Francesco/F-2844-2010	Colucci, Francesco/0000-0001-5193-6376				Chaushu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002601; de Andrade LF, 2014, IMMUNOL CELL BIOL, V92, P237, DOI 10.1038/icb.2013.95; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; STARNES CO, 1992, NATURE, V357, P11, DOI 10.1038/357011a0	9	10	10	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					208	210		10.1016/j.immuni.2015.01.024	http://dx.doi.org/10.1016/j.immuni.2015.01.024			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692696	Bronze			2022-12-18	WOS:000349916400004
J	Uhm, M; Saltiel, AR				Uhm, Maeran; Saltiel, Alan R.			White, Brown, and Beige; Type 2 Immunity Gets Hot	IMMUNITY			English	Editorial Material							EOSINOPHILS; OBESITY	The biogenesis of beige fat is poorly understood. In recent issues of Nature and Cell, Brestoff et al. (2014) and Lee et al. (2015) demonstrate that resident innate lymphoid cells in subcutaneous fat generate and activate beige adipocytes, producing thermogenesis.	[Uhm, Maeran; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@umich.edu	Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828				Brestoff JR, 2014, NATURE; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112	12	10	10	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					15	17		10.1016/j.immuni.2015.01.001	http://dx.doi.org/10.1016/j.immuni.2015.01.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607455	Bronze			2022-12-18	WOS:000348197500007
J	Laurence, A; Belkaid, Y; O'Shea, JJ				Laurence, Arian; Belkaid, Yasmine; O'Shea, John J.			A Degrading View of Regulatory T Cells	IMMUNITY			English	Editorial Material							IN-VIVO; PLASTICITY; STABILITY	Studies by van Loosdregt et al. and Chen et al. in this issue of Immunity provide evidence for previously unrecognized players that regulate FOXP3 degradation. These are interesting developments that point to unappreciated mechanisms by which inflammatory signals can impact expression of FOXP3 and possibly the stability of Treg cell phenotypes.	[Laurence, Arian; Belkaid, Yasmine; O'Shea, John J.] NIAMSD, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	O'Shea, JJ (corresponding author), NIAMSD, Bethesda, MD 20892 USA.	osheaj@arb.niams.nih.gov	Laurence, Arian/A-8770-2009	Laurence, Arian/0000-0003-0942-8292; Belkaid, Yasmine/0000-0001-9962-3571	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	11	10	14	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					201	203		10.1016/j.immuni.2013.08.017	http://dx.doi.org/10.1016/j.immuni.2013.08.017			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973216	Bronze			2022-12-18	WOS:000330948800002
J	Di Paolo, NC; Shayakhmetov, DM				Di Paolo, Nelson C.; Shayakhmetov, Dmitry M.			Interleukin-1 Receptor 2 Keeps the Lid on Interleukin-1 alpha	IMMUNITY			English	Editorial Material							IDENTIFICATION; IL-1-ALPHA; PROTEASE; ENZYME	The molecular mechanisms that regulate functional activation of IL-1 alpha remain elusive. In this issue of Immunity, Zheng et al. (2013) describe a molecular system implicating interleukin-1 receptor-2 (IL-1R2) as a principal cytosolic factor that controls functional IL-1 alpha activation during necrosis.	[Di Paolo, Nelson C.; Shayakhmetov, Dmitry M.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shayakhmetov, DM (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	dshax@uw.edu			NATIONAL CANCER INSTITUTE [R01CA141439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065429] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA141439] Funding Source: Medline; NIAID NIH HHS [R01 AI065429] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Kawaguchi Y, 2006, P NATL ACAD SCI USA, V103, P14501, DOI 10.1073/pnas.0603545103; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	10	10	10	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					203	205		10.1016/j.immuni.2013.02.001	http://dx.doi.org/10.1016/j.immuni.2013.02.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23438818	Green Accepted, Bronze			2022-12-18	WOS:000330940800002
J	Matloubian, M; Cyster, JG				Matloubian, Mehrdad; Cyster, Jason G.			Th1 Cell Induction in Lymph Nodes According to a Red-Blue Chemokine Map	IMMUNITY			English	Editorial Material							RECEPTOR CXCR3; T-CELLS; GENERATION; EFFECTOR	Lymph nodes are compartmentalized organs but whether this feature has a role in T cell differentiation has been unclear. In this issue, Groom et al. (2012) reveal that spatially separated expression of two CXCR3 ligands guides Th1 cell development.	[Matloubian, Mehrdad] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Matloubian, Mehrdad] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Matloubian, M (corresponding author), Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.	mehrdad.matloubian@ucsf.edu; jason.cyster@ucsf.edu			Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI045073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015	9	10	10	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 14	2012	37	6					954	956		10.1016/j.immuni.2012.11.007	http://dx.doi.org/10.1016/j.immuni.2012.11.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23244716	Green Accepted, Bronze			2022-12-18	WOS:000312575000004
J	Levy, DE; Marie, IJ				Levy, David E.; Marie, Isabelle J.			STATus Report on Tetramers	IMMUNITY			English	Editorial Material							LOCUS	STAT proteins bind DNA as dimers to regulate gene expression. Cooperative recruitment of pairs of dimers (tetramers) to adjacent DNA sites has also been documented. In this issue, Lin et al. (2012) examined tetramer function in vivo and showed that STAT5 tetramers function primarily as transcriptional activators.	[Levy, David E.; Marie, Isabelle J.] NYU, Sch Med, Dept Pathol, Mol Oncol & Immunol Program, New York, NY 10128 USA; [Levy, David E.; Marie, Isabelle J.] NYU, Sch Med, Dept Microbiol, New York, NY 10128 USA	New York University; New York University	Levy, DE (corresponding author), NYU, Sch Med, Dept Pathol, Mol Oncol & Immunol Program, New York, NY 10128 USA.	david.levy@nyumc.org	Levy, David/AAG-6202-2019; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; Marie, Isabelle/0000-0002-3091-7624	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI028900] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Lee JE, 2012, AM J PHYSIOL-CELL PH, V302, pC804, DOI 10.1152/ajpcell.00379.2011; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995	10	10	10	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 20	2012	36	4					553	555		10.1016/j.immuni.2012.04.003	http://dx.doi.org/10.1016/j.immuni.2012.04.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22520849	Bronze			2022-12-18	WOS:000303223900006
J	Hamann, A				Hamann, Alf			Regulatory T Cells Stay on Course	IMMUNITY			English	Editorial Material							IN-VIVO; EXPRESSION; MEMORY	Regulatory T (Treg) cells are thought to be susceptible to conversion into effector T cells. In this issue of Immunity, Miyao et al. (2012) provide evidence that the apparent plasticity of murine Foxp3(+) Treg cells is largely restricted to a defined subset of poorly committed Foxp3(+) cells.	[Hamann, Alf] Charite, D-10117 Berlin, Germany; [Hamann, Alf] Deutsch Rheuma Forschungszentrum Berlin, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ)	Hamann, A (corresponding author), Charite, D-10117 Berlin, Germany.	hamann@drfz.de		Hamann, Alf/0000-0003-1518-5717				Dong J, 2007, J IMMUNOL, V179, P2389, DOI 10.4049/jimmunol.179.4.2389; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Klein L, 2011, SEMIN IMMUNOL, V23, P401, DOI 10.1016/j.smim.2011.06.003; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	10	10	10	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					161	163		10.1016/j.immuni.2012.02.004	http://dx.doi.org/10.1016/j.immuni.2012.02.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22365661	Bronze			2022-12-18	WOS:000300812400004
J	Galluzzi, L; Kroemer, G				Galluzzi, Lorenzo; Kroemer, Guido			Necroptosis Turns TNF Lethal	IMMUNITY			English	Editorial Material									[Galluzzi, Lorenzo; Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Galluzzi, Lorenzo; Kroemer, Guido] Inst Gustave Roussy, F-94805 Villejuif, France; [Galluzzi, Lorenzo] Univ Paris 11, F-94805 Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, F-75006 Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, F-75908 Paris, France; [Kroemer, Guido] Univ Paris 04, F-75270 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Kroemer, G (corresponding author), INSERM, U848, F-94805 Villejuif, France.	kroemer@orange.fr	Galluzzi, Lorenzo/K-2709-2012; Galluzzi, Lorenzo/AAG-6294-2019; Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/AAG-6432-2019	Galluzzi, Lorenzo/0000-0003-2257-8500; KROEMER, Guido/0000-0002-9334-4405; 				Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	10	10	10	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 23	2011	35	6					849	851		10.1016/j.immuni.2011.12.004	http://dx.doi.org/10.1016/j.immuni.2011.12.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195740	Bronze			2022-12-18	WOS:000298777300003
J	Parvatiyar, K; Cheng, GH				Parvatiyar, Kislay; Cheng, Genhong			NOD So Fast: NLRX1 Puts the Brake on Inflammation	IMMUNITY			English	Editorial Material							NF-KAPPA-B; ACTIVATION; POLYUBIQUITINATION; IMMUNITY; NEMO	In this issue of Immunity, Allen et al. (2011) and Xia et al. (2011) provide in vivo and biochemical evidence that NLRX1, a member of the nucleotide binding domain and leucine-rich-repeat-containing protein family, functions as a negative regulator of RIG-I and Toll-like receptors.	[Parvatiyar, Kislay; Cheng, Genhong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cheng, GH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	gcheng@mednet.ucla.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069120, R01AI056154] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI069120, R01 AI056154] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; REBSAMEN M, 2011, CELL DEATH IN PRESS; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	10	10	10	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					821	822		10.1016/j.immuni.2011.06.006	http://dx.doi.org/10.1016/j.immuni.2011.06.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703534	Green Accepted, Bronze			2022-12-18	WOS:000292349700001
J	McElrath, MJ				McElrath, M. Juliana			Standing Guard at the Mucosa	IMMUNITY			English	Editorial Material							VACCINATION; ANTIBODIES; INFECTION; VACCINES	Most successful vaccines elicit antibodies that protect against infection. In this issue of Immunity, Bomsel et al. (2011) show in the rhesus macaque model that vaccine-induced mucosal antibodies, rather than circulating neutralizing antibodies, may be critical components for protective immunity against HIV-1.	[McElrath, M. Juliana] Univ Washington, Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McElrath, MJ (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.	jmcelrat@fhcrc.org						Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Hudgens MG, 2009, J INFECT DIS, V200, P609, DOI 10.1086/600891; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Zhao J, 2009, J VIROL, V83, P4102, DOI 10.1128/JVI.02173-08	9	10	11	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 25	2011	34	2					146	148		10.1016/j.immuni.2011.02.014	http://dx.doi.org/10.1016/j.immuni.2011.02.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349427	Bronze			2022-12-18	WOS:000287989500005
J	Murphy, PM				Murphy, Philip M.			Double Duty for CCL21 in Dendritic Cell Trafficking	IMMUNITY			English	Editorial Material							MIGRATION	Mechanisms controlling leukocyte adhesion, propulsion and directional migration have not been fully integrated. In this issue of Immunity, Schumann et al. (2010) propose that DCs swarm to T cell zones using immobilized CCL21 for adhesive random migration and soluble CCL21 for steering.	NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Murphy, PM (corresponding author), NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pmm@nih.gov			Intramural NIH HHS [ZIA AI000615-21] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Murphy PM, 2000, PHARMACOL REV, V52, P145; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9	9	10	10	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 28	2010	32	5					590	592		10.1016/j.immuni.2010.05.004	http://dx.doi.org/10.1016/j.immuni.2010.05.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20510869	Green Accepted, Bronze			2022-12-18	WOS:000278280500005
J	O'Brien, R; Jin, NY; Huang, YF; Aydintug, MK; Roark, C; Born, W				O'Brien, Rebecca; Jin, Niyun; Huang, Yafei; Aydintug, M. Kemal; Roark, Christina; Born, Willi			Characteristics of IL-17-Producing gamma delta T Cells	IMMUNITY			English	Letter							EXPRESSION; DIVERSITY; GENES		[O'Brien, Rebecca; Jin, Niyun; Huang, Yafei; Aydintug, M. Kemal; Roark, Christina; Born, Willi] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Roark, Christina] Beacon Biotechnol, Aurora, CO 80045 USA	National Jewish Health	O'Brien, R (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	obrienr@njhealth.org						Cheng L, 2008, J NEUROIMMUNOL, V203, P3, DOI 10.1016/j.jneuroim.2008.06.007; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; O'Brien RL, 2007, IMMUNOL REV, V215, P77, DOI 10.1111/j.1600-065X.2006.00477.x; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001	8	10	10	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 29	2010	32	1					1	1		10.1016/j.immuni.2010.01.006	http://dx.doi.org/10.1016/j.immuni.2010.01.006			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20152161	Bronze			2022-12-18	WOS:000274119900001
J	Mazmanian, SK				Mazmanian, Sarkis K.			Gut Immune Balance Is as Easy as S-F-B	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; SYSTEM; DIFFERENTIATION; RESPONSES; BACTERIA; T(H)17	Microbes appear to modulate homeostatic plasticity of T helper and T regulatory cells. In this issue of Immunity, Gaboriau-Routhiau et al. (2009) now reveal that segmented filamentous bacteria uniquely coordinate the intestinal T cell profile. The potential implications of this process to various immune functions are discussed.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Mazmanian, SK (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	sarkis@caltech.edu		Mazmanian, Sarkis/0000-0003-2713-1513	NIDDK NIH HHS [R01 DK078938-01A2, R01 DK078938] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078938] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chow J, 2009, CELL HOST MICROBE, V5, P8, DOI 10.1016/j.chom.2008.12.006; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Talham GL, 1999, INFECT IMMUN, V67, P1992	10	10	13	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 16	2009	31	4					536	538		10.1016/j.immuni.2009.09.005	http://dx.doi.org/10.1016/j.immuni.2009.09.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833084	Bronze			2022-12-18	WOS:000271403900005
J	Yokoyama, WM				Yokoyama, Wayne M.			Inhibitory Receptors Signal Activation	IMMUNITY			English	Editorial Material							TOLERANCE; FAMILY; CELLS		Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA.	yokoyama@im.wustl.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Sun JC, 2008, J EXP MED, V205, P1819, DOI 10.1084/jem.20072448; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Yokoyama W.M., 2008, FUNDAMENTAL IMMUNOLO, P483	9	10	10	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					515	517		10.1016/j.immuni.2008.09.009	http://dx.doi.org/10.1016/j.immuni.2008.09.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18957262	Bronze			2022-12-18	WOS:000260316700004
J	Wherry, EJ; Ha, SJ; Kaech, SM; Haining, WN; Sarkar, S; Kalia, V; Subramaniam, S; Blattman, JN; Barber, DL; Ahmed, R				Wherry, E. John; Ha, Sang-Jun; Kaech, Susan M.; Haining, W. Nicholas; Sarkar, Surojit; Kalia, Vandana; Subramaniam, Shruti; Blattman, Joseph N.; Barber, Daniel L.; Ahmed, Rafi			Molecular signature of CD8(+) T cell exhaustion during chronic viral infection (vol 27, pg 670, 2007)	IMMUNITY			English	Correction												jwherry@wistar.org; ra@microbio.emory.edu	Wherry, John/ABI-1280-2020					Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	1	10	10	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					824	824		10.1016/j.immuni.2007.11.006	http://dx.doi.org/10.1016/j.immuni.2007.11.006			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA		Bronze			2022-12-18	WOS:000251269000015
J	Filippi, CM; von Herrath, MG				Filippi, Christophe M.; von Herrath, Matthias G.			Islet beta-cell death - Fuel to sustain autoimmunity?	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS	Under what context do dying P-cells enhance the autoimmune process in type 1 diabetes? Kim et al. (2007) find that secondary necrosis of beta-cells can prime the autoimmune response via uptake by and activation of antigen-presenting cells through Toll-like receptor2.	La Jolla Allergy & Immunol Inst, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Filippi, CM (corresponding author), La Jolla Allergy & Immunol Inst, 9420 Athena Circle, La Jolla, CA 92037 USA.	christophe@liai.org; matthias@liai.org						Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Christen U, 2001, J IMMUNOL, V166, P7023, DOI 10.4049/jimmunol.166.12.7023; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zheng Y, 2007, ANN NY ACAD SCI, V1103, P45, DOI 10.1196/annals.1394.014	10	10	11	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2007	27	2					183	185		10.1016/j.immuni.2007.08.002	http://dx.doi.org/10.1016/j.immuni.2007.08.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723211	Bronze			2022-12-18	WOS:000249056300004
J	Rammensee, HG				Rammensee, Hans-Georg			Peptides made to order	IMMUNITY			English	Editorial Material							CLASS-I MOLECULES; TRIMS PRECURSORS; AMINOPEPTIDASE; ERAP1; ER		Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Rammensee, HG (corresponding author), Univ Tubingen, Dept Immunol, Morgenstelle 1, D-72076 Tubingen, Germany.							Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; PARNER E, 1998, ANNU REV IMMUNOL, V16, P323; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Stevanovic S, 2005, TRANSPL IMMUNOL, V14, P171, DOI 10.1016/j.trim.2005.03.018; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103	10	10	11	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					693	695		10.1016/j.immuni.2006.10.008	http://dx.doi.org/10.1016/j.immuni.2006.10.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17098199	Bronze			2022-12-18	WOS:000242063100002
J	Kupfer, A				Kupfer, Abraham			Signaling in the immunological synapse: Defining the optimal size	IMMUNITY			English	Editorial Material							T-CELL-ACTIVATION	In this issue of Immunity, Varma et al. (2006) report that in the synapses between T cells and planar bilayers, T cell receptor (TCR) proximal signaling takes place in peripheral TCR-microclusters that form continually and that TCR signaling ceases when they fuse with the central supramolecular activation cluster.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Immunol, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Kupfer, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 733 N Broadway,BRB Room 623, Baltimore, MD 21205 USA.							Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; von Essen M, 2006, J IMMUNOL, V176, P7502, DOI 10.4049/jimmunol.176.12.7502; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	10	10	11	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2006	25	1					11	13		10.1016/j.immuni.2006.07.005	http://dx.doi.org/10.1016/j.immuni.2006.07.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860751	Bronze			2022-12-18	WOS:000239713000004
J	Kapsenberg, M				Kapsenberg, M			Tweaking of memory T helper 2 cells by TSLP	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; EPITHELIAL-CELLS; INDUCE	Thymic stromal lymphopoietin conditions dendritic cells to support homeostatic proliferation of central memory T cells. In this issue of Immunity, Wang et al. (2006) show that these dendritic cells are critical in maintaining T helper 2 central memory cells and impart them with expression of unique proallergic molecules.	Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kapsenberg, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.							Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183	9	10	10	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2006	24	6					673	675		10.1016/j.immuni.2006.06.004	http://dx.doi.org/10.1016/j.immuni.2006.06.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782024	Bronze			2022-12-18	WOS:000238592200006
J	Pillai, S				Pillai, S			Two lymphoid roads diverge - but does antigen bade B cells to take the road less traveled?	IMMUNITY			English	Editorial Material							POSITIVE SELECTION; IMMUNOGLOBULIN; LYMPHOCYTES	The contribution of a self-antigen to marginal-zone B lymphocytes is described in this issue (Wen et al., 2005). Other interpretations of these important findings are considered here.	Massachusetts Gen Hosp, Ctr Canc Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University	Pillai, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Cambridge, MA 02139 USA.							Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; Wen LJ, 2005, IMMUNITY, V23, P297, DOI 10.1016/j.immuni.2005.08.007	9	10	10	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2005	23	3					242	244		10.1016/j.immuni.2005.09.001	http://dx.doi.org/10.1016/j.immuni.2005.09.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169496	Bronze			2022-12-18	WOS:000232382500002
J	Yokoyama, WM				Yokoyama, WM			Betting on NKT and NK cells	IMMUNITY			English	Editorial Material							RUNX1 BINDING-SITE; SUSCEPTIBILITY	Natural killer T (NKT) cells, as their name implies, constitutively express markers and receptors first identified on bona fide natural killer (NK) cells, supporting a potential relationship between NKT and NK cells. In this issue of Immunity, Townsend et al. further define this relationship in terms of the transcription factor, T-bet.	Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, Box 8045,660 S Euclid Ave, St Louis, MO 63110 USA.							Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; TOKUHIRO S, 2003, NAT GENET, V20, P477; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711	11	10	10	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2004	20	4					363	365		10.1016/S1074-7613(04)00085-8	http://dx.doi.org/10.1016/S1074-7613(04)00085-8			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084266	Bronze			2022-12-18	WOS:000221442800003
J	Clark, EA; Craxton, A				Clark, EA; Craxton, A			A CD40 bridge between innate and adaptive immunity	IMMUNITY			English	Editorial Material							B-CELLS; HUMORAL IMMUNITY; HYPER-IGM; EXPRESSION; COMPLEMENT		Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Clark, EA (corresponding author), Univ Washington, Dept Microbiol, Box 357242, Seattle, WA 98195 USA.			Clark, Edward A/0000-0001-8061-5475				Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Brodeur SR, 2003, IMMUNITY, V18, P837, DOI 10.1016/S1074-7613(03)00149-3; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Erickson LD, 2002, J CLIN INVEST, V109, P613, DOI 10.1172/JCI200214110; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Imai S, 2001, J BIOL CHEM, V276, P46118, DOI 10.1074/jbc.M104581200; Kutukculer N, 2003, J PEDIATR-US, V142, P194, DOI 10.1067/mpd.2003.41; Lindahl G, 2000, CURR OPIN IMMUNOL, V12, P44, DOI 10.1016/S0952-7915(99)00049-7; MOFFAT GJ, 1992, BIOCHEMISTRY-US, V31, P12376, DOI 10.1021/bi00164a012; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; Vinuesa CG, 2003, EUR J IMMUNOL, V33, P297, DOI 10.1002/immu.200310003; VYTHDREESE FA, 1995, EUR J IMMUNOL, V25, P3023, DOI 10.1002/eji.1830251106; Wang YF, 2001, IMMUNITY, V15, P971, DOI 10.1016/S1074-7613(01)00242-4; Yasui T, 2002, INT IMMUNOL, V14, P319, DOI 10.1093/intimm/14.3.319	17	10	12	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2003	18	6					724	725		10.1016/S1074-7613(03)00146-8	http://dx.doi.org/10.1016/S1074-7613(03)00146-8			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818154	Bronze			2022-12-18	WOS:000183767700003
J	Madrenas, J				Madrenas, J			A SLAT in the Th2 signalosome	IMMUNITY			English	Article							T-CELL ACTIVATION; RECEPTOR LIGATION; GENE-PRODUCT; SAP; DIFFERENTIATION; POLARIZATION; INTERPLAY; ABSENCE; COMPLEX; SWAP-70	There is abundant information on the distinguishing features of TCR-mediated signaling in Th1 and Th2 cells. However, the primary signals that determine the commitment and differentiation of naive T cells toward those T helper subsets, especially prior to the contribution of polarizing cytokines, remain elusive. This mini-review discusses the potential contribution of SLAT in favoring differentiation along the Th2 lineage and how this may bring us closer to a framework model for Th1/Th2 differentiation.	Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Madrenas, J (corresponding author), Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada.		Madrenas, Quim/P-5008-2019					Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Boutin Y, 1997, J IMMUNOL, V159, P5802; Castro AG, 1999, J IMMUNOL, V163, P5860; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chau LA, 1999, J IMMUNOL, V163, P1853; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Fields PE, 2001, NAT IMMUNOL, V2, P382, DOI 10.1038/87679; Fowell DJ, 1997, IMMUNITY, V6, P559, DOI 10.1016/S1074-7613(00)80344-1; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Kaga S, 1998, J IMMUNOL, V160, P4182; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Leitenberg D, 2001, SEMIN IMMUNOL, V13, P129, DOI 10.1006/smim.2000.0304; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nichols KE, 2001, NAT IMMUNOL, V2, P665, DOI 10.1038/90595; Noble A, 2001, EUR J IMMUNOL, V31, P2227, DOI 10.1002/1521-4141(200107)31:7<2227::AID-IMMU2227>3.0.CO;2-C; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shan XC, 2001, MOL CELL BIOL, V21, P7137, DOI 10.1128/MCB.21.21.7137-7149.2001; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125	27	10	10	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2003	18	4					459	461		10.1016/S1074-7613(03)00089-X	http://dx.doi.org/10.1016/S1074-7613(03)00089-X			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705849	Bronze			2022-12-18	WOS:000182353900002
J	Moody, DB; Porcelli, SA				Moody, DB; Porcelli, SA			CD1 trafficking: Invariant chain gives a new twist to the tale	IMMUNITY			English	Article							DIFFERENT INTRACELLULAR COMPARTMENTS; ANTIGEN-PRESENTING MOLECULES; T-CELLS; STRUCTURAL REQUIREMENTS; CYTOPLASMIC TAIL; DENDRITIC CELLS; LIPID ANTIGENS; NKT CELLS; RECOGNITION; GLYCOLIPIDS	The CD1 family of MHC class I-related proteins present foreign and self-lipid antigens for specific recognition by T cells. Based on previous experience with MHC class I and II molecules, it seems likely that a thorough knowledge of the intracellular trafficking and localization of CD1 proteins will be essential to fully understand their functions in antigen presentation and immune responses. Two studies in this issue of Immunity take a detailed look at factors affecting the localization of mouse CD1 proteins to the endocytic system of antigen-presenting cells. Their results provide intriguing evidence for the involvement of two critical components of the MHC class II endosomal processing pathway, cathepsin S and the invariant chain, in the normal functioning of CD1.	Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Moody, DB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Smith Bldg Room 514,1 Jimmy Fund Way, Boston, MA 02115 USA.							Angenieux C, 2000, J BIOL CHEM, V275, P37757, DOI 10.1074/jbc.M007082200; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Cresswell P, 2000, TRAFFIC, V1, P301, DOI 10.1034/j.1600-0854.2000.010402.x; Geuze HJ, 1998, IMMUNOL TODAY, V19, P282, DOI 10.1016/S0167-5699(98)01269-9; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; MARTIN LH, 1986, P NATL ACAD SCI USA, V83, P9154, DOI 10.1073/pnas.83.23.9154; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Riese RJ, 2001, IMMUNITY, V15, P909, DOI 10.1016/S1074-7613(01)00247-3; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Schaible UE, 2000, J IMMUNOL, V164, P4843, DOI 10.4049/jimmunol.164.9.4843; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; Shinkai K, 2000, J EXP MED, V191, P907, DOI 10.1084/jem.191.6.907; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	26	10	12	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					861	865		10.1016/S1074-7613(01)00250-3	http://dx.doi.org/10.1016/S1074-7613(01)00250-3			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754808	Bronze			2022-12-18	WOS:000172961400001
J	Wang, ZJ; Muecksch, F; Cho, A; Gaebler, C; Hoffmann, HH; Ramos, V; Zong, S; Cipolla, M; Johnson, B; Schmidt, F; DaSilva, J; Bednarski, E; Ben Tanfous, T; Raspe, R; Yao, KH; Lee, YE; Chen, T; Turroja, M; Milard, KG; Dizon, J; Kaczynska, A; Gazumyan, A; Oliveira, TY; Rice, CM; Caskey, M; Bieniasz, PD; Hatziioannou, T; Barnes, CO; Nussenzweig, MC				Wang, Zijun; Muecksch, Frauke; Cho, Alice; Gaebler, Christian; Hoffmann, Hans-Heinrich; Ramos, Victor; Zong, Shuai; Cipolla, Melissa; Johnson, Briana; Schmidt, Fabian; DaSilva, Justin; Bednarski, Eva; Ben Tanfous, Tarek; Raspe, Raphael; Yao, Kaihui; Lee, Yu E.; Chen, Teresia; Turroja, Martina; Milard, Katrina G.; Dizon, Juan; Kaczynska, Anna; Gazumyan, Anna; Oliveira, Thiago Y.; Rice, Charles M.; Caskey, Marina; Bieniasz, Paul D.; Hatziioannou, Theodora; Barnes, Christopher O.; Nussenzweig, Michel C.			Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins	IMMUNITY			English	Article							GERMINAL CENTER; ANTIBODIES; VACCINATION; VISUALIZATION; RBD	SARS-CoV-2 infection or vaccination produces neutralizing antibody responses that contribute to better clinical outcomes. The receptor-binding domain (RBD) and the N-terminal domain (NTD) of the spike trimer (S) constitute the two major neutralizing targets for antibodies. Here, we use NTD-specific probes to capture anti-NTD memory B cells in a longitudinal cohort of infected individuals, some of whom were vaccinated. We found 6 complementation groups of neutralizing antibodies. 58% targeted epitopes outside the NTD super site, 58% neutralized either Gamma or Omicron, and 14% were broad neutralizers that also neutralized Omicron. Structural characterization revealed that broadly active antibodies targeted three epitopes outside the NTD supersite including a class that recognized both the NTD and SD2 domain. Rapid recruitment of memory B cells producing these antibodies into the plasma cell compartment upon re-infection likely contributes to the relatively benign course of subsequent infections with SARS-CoV-2 variants, including Omicron.	[Wang, Zijun; Cho, Alice; Gaebler, Christian; Ramos, Victor; Zong, Shuai; Cipolla, Melissa; Johnson, Briana; Ben Tanfous, Tarek; Raspe, Raphael; Yao, Kaihui; Turroja, Martina; Milard, Katrina G.; Dizon, Juan; Kaczynska, Anna; Gazumyan, Anna; Oliveira, Thiago Y.; Caskey, Marina; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Muecksch, Frauke; Schmidt, Fabian; DaSilva, Justin; Bednarski, Eva; Bieniasz, Paul D.; Hatziioannou, Theodora] Rockefeller Univ, Lab Retrovirol, New York, NY 10065 USA; [Hoffmann, Hans-Heinrich; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Lee, Yu E.; Chen, Teresia; Barnes, Christopher O.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Bieniasz, Paul D.; Nussenzweig, Michel C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Barnes, Christopher O.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	Rockefeller University; Rockefeller University; Rockefeller University; Stanford University; Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Bieniasz, PD; Hatziioannou, T (corresponding author), Rockefeller Univ, Lab Retrovirol, New York, NY 10065 USA.; Barnes, CO (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Bieniasz, PD; Nussenzweig, MC (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Barnes, CO (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	pbieniasz@rockefeller.edu; thatziio@rockefeller.edu; cobarnes@stanford.edu; nussen@rockefeller.edu	Oliveira, Thiago Y/HGA-3848-2022; Gaebler, Christian/GWZ-2628-2022; Wang, Zhiquan/HHS-6768-2022	Oliveira, Thiago Y/0000-0002-2654-0879; Gaebler, Christian/0000-0001-7295-8128; Chen, Teresia/0000-0002-5606-9803; Raspe, Raphael/0000-0003-3409-4968	NIH [P01-AI138398-S1, 2U19AI111825, R37-AI64003, R01AI78788]; Howard Hughes Medical Institute Hanna Gray Fellowship; Shapiro-Silverberg Fund for the Advancement of Translational Research; National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award program) [UL1 TR001866]; Robert S. Wennett Post-Doctoral Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Hanna Gray Fellowship; Shapiro-Silverberg Fund for the Advancement of Translational Research; National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award program); Robert S. Wennett Post-Doctoral Fellowship	We thank all study participants who devoted time to our research, The Rockefeller University Hospital nursing staff, and Clinical Research Support Office. Thanks to all members of the M.C. N. laboratory for helpful discussions, Ma~sa Jankovic for laboratory support, and Kristie Gordon for technical assistance with cell-sorting experiments. We thank the laboratory of Dr. Pamela Bjorkman at the California Institute of Technology (Caltech) for SARSCoV-2 spike expression constructs. We thank Dr. Jost Vielmetter and other members of the Protein Expression Center in the Beckman Institute at Caltech for expression assistance. Cryo-EM data for this work was collected at the Stanford-SLAC cryo-EM center with support from Dr. Elizabeth Montabana and the Evelyn Gruss Lipper cryo-EM resource center (Rockefeller University) with support from Mark Ebrahim, Johanna Sotiris, and Honkit Ng. This work was supported by NIH grants P01-AI138398-S1 and 2U19AI111825 to M.C.N., R37-AI64003 to P.D.B., and R01AI78788 to T.H. C.O.B. is supported by the Howard Hughes Medical Institute Hanna Gray Fellowship and is a Chan Zuckerberg Biohub investigator. C.G. was supported by the Robert S. Wennett Post-Doctoral Fellowship and the Shapiro-Silverberg Fund for the Advancement of Translational Research. C.G. and Z.W. were supported in part by the National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award program, grant UL1 TR001866). P. D.B. and M.C.N. are Howard Hughes Medical Institute Investigators. This article is subject to HHMI's Open Access to Publications policy. HHMI lab heads have previously granted a nonexclusive CC BY 4.0 license to the public and a sublicensable license to HHMI in their research articles. Pursuant to those licenses, the author-accepted manuscript of this article can be made freely available under a CC BY 4.0 license immediately upon publication.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amanat F, 2021, CELL, V184, P3936, DOI 10.1016/j.cell.2021.06.005; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Bell JM, 2016, METHODS, V100, P25, DOI 10.1016/j.ymeth.2016.02.018; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Callaway E, 2021, NATURE, V600, P21, DOI 10.1038/d41586-021-03552-w; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1101/2021.12.12.472269, 10.1038/s41586-021-04386-2]; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1002/nla.2362, 10.1038/s41586-021-04385-3]; Cerutti G, 2021, CELL REP, V37, DOI [10.1101/2021.06.29.450397, 10.1016/j.celrep.2021.109928]; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Cho A, 2021, NATURE, V600, P517, DOI 10.1038/s41586-021-04060-7; Dejnirattisai W, 2022, CELL, V185, P467, DOI 10.1016/j.cell.2021.12.046; DeWitt WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160853; Dougan M, 2021, NEW ENGL J MED, V385, P1382, DOI 10.1056/NEJMoa2102685; Dussupt V, 2021, NAT IMMUNOL, V22, P1503, DOI 10.1038/s41590-021-01068-z; Elsner RA, 2020, IMMUNITY, V53, P1136, DOI 10.1016/j.immuni.2020.11.006; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644, 10.1101/2021.02.26.21252554, 10.1126/science.abh2644Article]; Fernandez-Leiro R, 2017, ACTA CRYSTALLOGR D, V73, P496, DOI 10.1107/S2059798316019276; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gruell H, 2022, NAT MED, V28, P477, DOI 10.1038/s41591-021-01676-0; Guo YC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02365; Gupta A, 2021, NEW ENGL J MED, V385, P1941, DOI 10.1056/NEJMoa2107934; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; GUY HR, 1985, BIOPHYS J, V47, P61, DOI 10.1016/S0006-3495(85)83877-7; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Haslwanter D, 2021, MBIO, V12, DOI 10.1128/mBio.02473-21; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li DP, 2021, CELL, V184, P4203, DOI 10.1016/j.cell.2021.06.021; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu YF, 2021, CELL, V184, P3452, DOI 10.1016/j.cell.2021.05.032; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCallum M, 2021, SCIENCE, V374, P1621, DOI [10.1126/science.abl8506, 10.1101/2021.08.11.455956]; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Muecksch F, 2021, IMMUNITY, V54, P1853, DOI 10.1016/j.immuni.2021.07.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rossler A, 2022, NEW ENGL J MED, V386, P698, DOI 10.1056/NEJMc2119236; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Rosa A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg7607; Schmidt F, 2022, NEW ENGL J MED, V386, P599, DOI 10.1056/NEJMc2119641; Schmidt F, 2021, NATURE, V600, P512, DOI 10.1038/s41586-021-04005-0; Schmidt F, 2020, J EXP MED, V217, DOI 10.1084/jem.20201181; Schmitz A.J., 2021, IMMUNITY, V54, DOI [10.1016, DOI 10.1016/j.immuni.2021.08.013]; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Suryadevara N, 2021, CELL, V184, P2316, DOI 10.1016/j.cell.2021.03.029; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Tong P, 2021, CELL, V184, P4969, DOI [10.1016/j.cell.2021.07.025, 10.1101/2021.03.10.434840]; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Viant C, 2021, J EXP MED, V218, DOI 10.1084/jem.20202489; Viant C, 2020, CELL, V183, P1298, DOI 10.1016/j.cell.2020.09.063; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Voss WN, 2021, SCIENCE, V372, P1108, DOI 10.1126/science.abg5268; Wang DX, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02904-w; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312; Wu M, 2022, LANCET, V399, P715, DOI 10.1016/S0140-6736(22)00092-7; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhang J, 2021, SCIENCE, V374, P1353, DOI [10.1101/2021.08.17.456689, 10.1126/science.abl9463]; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	79	9	9	8	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					998	+		10.1016/j.immuni.2022.04.003	http://dx.doi.org/10.1016/j.immuni.2022.04.003			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35447092	Green Published, hybrid			2022-12-18	WOS:000823293900010
J	Zhao, M; Ren, KQ; Xiong, XW; Xin, Y; Zou, YJ; Maynard, JC; Kim, A; Battist, AP; Koneripalli, N; Wang, YS; Chen, QY; Xin, RY; Yang, CY; Huang, R; Yu, JH; Huang, Z; Zhang, ZD; Wang, HG; Wang, DY; Xiao, YH; Salgado, OC; Jarjour, NN; Hogquist, KA; Revelo, XS; Burlingame, AL; Gao, X; von Moltke, J; Lin, ZY; Ruan, HB				Zhao, Ming; Ren, Kaiqun; Xiong, Xiwen; Xin, Yue; Zou, Yujie; Maynard, Jason C.; Kim, Angela; Battist, Alexander P.; Koneripalli, Navya; Wang, Yusu; Chen, Qianyue; Xin, Ruyue; Yang, Chenyan; Huang, Rong; Yu, Jiahui; Huang, Zan; Zhang, Zengdi; Wang, Haiguang; Wang, Daoyuan; Xiao, Yihui; Salgado, Oscar C.; Jarjour, Nicholas N.; Hogquist, Kristin A.; Revelo, Xavier S.; Burlingame, Alma L.; Gao, Xiang; von Moltke, Jakob; Lin, Zhaoyu; Ruan, Hai-Bin			Epithelial STAT6 O-GlcNAcylation drives a concerted anti-helminth alarmin response dependent on tuft cell hyperplasia and Gasdermin C	IMMUNITY			English	Article							TYPE-2 IMMUNITY; IL-33; TRANSFERASE; MECHANISMS; ASTHMA; PHOSPHORYLATION; INTERLEUKIN-4; TRANSCRIPTION; CHROMOSOME; INTERACTS	The epithelium is an integral component of mucosal barrier and host immunity. Following helminth infection, the intestinal epithelial cells secrete "alarmin"cytokines, such as interleukin-25 (IL-25) and IL-33, to initiate the type 2 immune responses for helminth expulsion and tolerance. However, it is unknown how helminth infection and the resulting cytokine milieu drive epithelial remodeling and orchestrate alarmin secretion. Here, we report that epithelial O-linked N-Acetylglucosamine (O-GlcNAc) protein modification was induced upon helminth infections. By modifying and activating the transcription factor STAT6, O-GlcNAc transferase promoted the transcription of lineage-defining Pou2f3 in tuft cell differentiation and IL-25 production. Meanwhile, STAT6 O-GlcNAcylation activated the expression of Gsdmc family genes. The membrane pore formed by GSDMC facilitated the unconventional secretion of IL-33. GSDMC-mediated IL-33 secretion was indispensable for effective anti-helminth immunity and contributed to induced intestinal inflammation. Protein O-GlcNAcylation can be harnessed for future treatment of type 2 inflammation-associated human diseases.	[Zhao, Ming; Ren, Kaiqun; Kim, Angela; Battist, Alexander P.; Koneripalli, Navya; Huang, Zan; Zhang, Zengdi; Wang, Haiguang; Revelo, Xavier S.; Ruan, Hai-Bin] Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Ren, Kaiqun; Wang, Daoyuan; Xiao, Yihui] Hunan Normal Univ, Coll Med, Changsha, Hunan, Peoples R China; [Xiong, Xiwen; Xin, Yue; Yang, Chenyan; Huang, Rong; Yu, Jiahui] Xinxiang Med Univ, Sch Forens Med, Xinxiang, Henan, Peoples R China; [Zou, Yujie; Wang, Yusu; Chen, Qianyue; Xin, Ruyue; Gao, Xiang; Lin, Zhaoyu] Nanjing Univ, Nanjing Drum Tower Hosp, Sch Med,State Key Lab Pharmaceut Biotechnol,MOE K, Natl Resource Ctr Mutant Mice China,Model Anim Re, Nanjing, Peoples R China; [Maynard, Jason C.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Salgado, Oscar C.; Jarjour, Nicholas N.; Hogquist, Kristin A.; Revelo, Xavier S.; Ruan, Hai-Bin] Univ Minnesota, Ctr Immunol, Med Sch, Minneapolis, MN 55455 USA; [Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [von Moltke, Jakob] Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA	University of Minnesota System; University of Minnesota Twin Cities; Hunan Normal University; Xinxiang Medical University; Nanjing University; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	Ruan, HB (corresponding author), Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.; Lin, ZY (corresponding author), Nanjing Univ, Nanjing Drum Tower Hosp, Sch Med,State Key Lab Pharmaceut Biotechnol,MOE K, Natl Resource Ctr Mutant Mice China,Model Anim Re, Nanjing, Peoples R China.; Ruan, HB (corresponding author), Univ Minnesota, Ctr Immunol, Med Sch, Minneapolis, MN 55455 USA.	linzy@nju.edu.cn; hruan@umn.edu	Xiong, Xiwen/GSN-0686-2022	Ruan, Hai-Bin/0000-0002-3858-1272; Kim, Angela/0000-0001-9835-7363; Battist, Alexander/0000-0003-0384-3639; Jarjour, Nicholas/0000-0001-9400-4448; Zhao, Ming/0000-0001-8882-6533; Revelo, Xavier/0000-0002-2754-509X	National Institute of Health [R21 AI140109, R56 AI162791, R01 AI139420]; National Natural Sci-ence Foundation of China [U1904132]; Program for Science & Technology Innovation Talents in Higher Education of Henan Province, China [20HAS-TIT046]; Natural Science Foundation of Hunan Province, China [2015JJ6072, 2020JJ4441]; Research Foundation of Education Bureau of Hunan Province, China [20A304]; Ministry of Science and Technol-ogy of China [2018YFA0801100]; Ministry of Science and Technology of China [2021YFF0702100]; National Natural Science Foundation of China [31971056]; Miriam and Sheldon G. Adelson Medical Research Foundation; American Heart Association Postdoc-toral Fellowship; Damon Runyon Cancer Research Foundation Fellowship [DRG-2427-21]; NIH [R01 DK122056, 1DP2AI136596]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Sci-ence Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Science & Technology Innovation Talents in Higher Education of Henan Province, China; Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Research Foundation of Education Bureau of Hunan Province, China; Ministry of Science and Technol-ogy of China(Ministry of Science and Technology, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Miriam and Sheldon G. Adelson Medical Research Foundation; American Heart Association Postdoc-toral Fellowship(American Heart Association); Damon Runyon Cancer Research Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Timothy C. Wang, Dr. Xiaoyong Yang, and Dr. Fred D. Finkelman for providing Dclk1-CreER mice, Rosa26-LSL-rOGT/mOGA mice, and Il4ra-/-mice, respectively. We thank Dr. Reinhard Hinterleitner of University of Pitts-burg for providing DNA extracted from cecum of Tritrichomonas colonized mice. This work was supported by National Institute of Health (R21 AI140109, R56 AI162791, and R01 AI139420) to H.-B.R.; National Natural Sci-ence Foundation of China (U1904132) and Program for Science & Technology Innovation Talents in Higher Education of Henan Province, China (20HAS-TIT046) to X.X.; Natural Science Foundation of Hunan Province, China (2015JJ6072 and 2020JJ4441) and Research Foundation of Education Bureau of Hunan Province, China (20A304) to K.R.; Ministry of Science and Technol-ogy of China (2018YFA0801100) to L.Z.; Ministry of Science and Technology of China (2021YFF0702100) and National Natural Science Foundation of China (31971056) to X.G.; NIH R01 DK122056 to X.S.R.; NIH 1DP2AI136596 to J.v.M.; and the Miriam and Sheldon G. Adelson Medical Research Foundation grant to A.L.B. H.W and N.N.J. received American Heart Association Postdoc-toral Fellowship and Damon Runyon Cancer Research Foundation Fellowship (DRG-2427-21) , respectively.	Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Bach JF, 2018, NAT REV IMMUNOL, V18, P105, DOI 10.1038/nri.2017.111; Bamias G, 2015, CURR OPIN GASTROEN, V31, P471, DOI 10.1097/MOG.0000000000000212; Banerjee A, 2020, GASTROENTEROLOGY, V159, DOI 10.1053/j.gastro.2020.08.029; Billipp TE, 2021, CURR OPIN IMMUNOL, V68, P98, DOI 10.1016/j.coi.2020.09.006; Bjerknes M, 2012, DEV BIOL, V362, P194, DOI 10.1016/j.ydbio.2011.12.009; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Bulek K, 2020, J CLIN INVEST, V130, P4218, DOI 10.1172/JCI138103; Camberis M., 2003, CURR PROTOC IMMUNOL, V55, DOI DOI 10.1002/0471142735.IM1912S55; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Chang YH, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00648-9; Chao KL, 2017, P NATL ACAD SCI USA, V114, pE1128, DOI 10.1073/pnas.1616783114; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Das S, 2017, ADV IMMUNOL, V135, P1, DOI 10.1016/bs.ai.2017.06.001; Das S, 2016, P NATL ACAD SCI USA, V113, P13132, DOI 10.1073/pnas.1610433113; Diefenbach A, 2020, IMMUNITY, V52, P452, DOI 10.1016/j.immuni.2020.02.016; Ferrer-Font L, 2020, ELIFE, V9, DOI 10.7554/eLife.51678; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Harnik Y, 2021, NAT METAB, V3, P1680, DOI 10.1038/s42255-021-00504-6; Harris NL, 2017, IMMUNITY, V47, P1024, DOI 10.1016/j.immuni.2017.11.015; Hodzic Z, 2017, CYTOKINE, V100, P1, DOI 10.1016/j.cyto.2017.06.017; Hou JW, 2020, NAT CELL BIOL, V22, P1264, DOI 10.1038/s41556-020-0575-z; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hung LY, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc6259; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Kamal M, 2002, PARASITOLOGY, V125, P275, DOI [10.1017/S0031182002002068, 10.1017/s0031182002002068]; Khan WI, 2001, PARASITE IMMUNOL, V23, P39, DOI 10.1046/j.1365-3024.2001.00353.x; Koo Bon-Kyoung, 2013, Curr Protoc Stem Cell Biol, V27, DOI 10.1002/9780470151808.sc05a06s27; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Liu B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08300-3; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Ma CM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6717; Mahe Maxime M, 2013, Curr Protoc Mouse Biol, V3, P217, DOI 10.1002/9780470942390.mo130179; Maiti NR, 2005, J INTERF CYTOK RES, V25, P553, DOI 10.1089/jir.2005.25.553; Martinez MR, 2017, BIOCHEM SOC T, V45, P237, DOI 10.1042/BST20160153; McGinty JW, 2020, IMMUNITY, V52, P528, DOI 10.1016/j.immuni.2020.02.005; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Morita H, 2017, J ALLERGY CLIN IMMUN, V140, P381, DOI 10.1016/j.jaci.2017.03.042; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; O'Grady SM, 2013, J PHYSIOL-LONDON, V591, P4595, DOI 10.1113/jphysiol.2013.254649; Oliphant CJ, 2011, IMMUNOLOGY, V134, P378, DOI 10.1111/j.1365-2567.2011.03499.x; Pastille E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006649; Qin W, 2017, P NATL ACAD SCI USA, V114, pE6749, DOI 10.1073/pnas.1702688114; Rana N, 2022, CELL, V185, P283, DOI 10.1016/j.cell.2021.12.024; Ribet D, 2010, CELL, V143, P694, DOI 10.1016/j.cell.2010.11.019; Ruan HB, 2017, GENE DEV, V31, P1655, DOI 10.1101/gad.305441.117; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schneider C, 2019, NAT REV IMMUNOL, V19, P584, DOI 10.1038/s41577-019-0176-x; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Schubart C, 2019, MUCOSAL IMMUNOL, V12, P413, DOI 10.1038/s41385-018-0107-3; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Smallwood TB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00453; Srisomboon Y, 2020, J PHYSIOL-LONDON, V598, P1829, DOI 10.1113/JP279379; Stockinger S, 2014, J INNATE IMMUN, V6, P530, DOI 10.1159/000357644; Su C, 2018, MUCOSAL IMMUNOL, V11, P144, DOI 10.1038/mi.2017.20; Ting HA, 2019, J IMMUNOL, V202, P1321, DOI 10.4049/jimmunol.1801069; Uchida M, 2017, ALLERGY, V72, P1521, DOI 10.1111/all.13158; Varyani F, 2017, AM J PHYSIOL-GASTR L, V312, pG537, DOI 10.1152/ajpgi.00024.2017; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Williams MA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01091; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Xi RH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026307118; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yang YF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13914-8; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Zhang JY, 2021, CELL RES, V31, P980, DOI 10.1038/s41422-021-00506-9; Zhao M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108013; Zhao M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708736; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	86	9	9	12	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					623	+		10.1016/j.immuni.2022.03.009	http://dx.doi.org/10.1016/j.immuni.2022.03.009			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35385697				2022-12-18	WOS:000788864600009
J	Simpson, DS; Pang, JY; Weir, A; Kong, IY; Fritsch, M; Rashidi, M; Cooney, JP; Davidson, KC; Speir, M; Djajawi, TM; Hughes, S; Mackiewicz, L; Dayton, M; Anderton, H; Doerflinger, M; Deng, YX; Huang, AS; Conos, SA; Tye, H; Chow, SH; Rahman, A; Norton, RS; Naderer, T; Nicholson, SE; Burgio, G; Man, SM; Groom, JR; Herold, MJ; Hawkins, ED; Lawlor, KE; Strasser, A; Silke, J; Pellegrini, M; Kashkar, H; Feltham, R; Vince, JE				Simpson, Daniel S.; Pang, Jiyi; Weir, Ashley; Kong, Isabella Y.; Fritsch, Melanie; Rashidi, Maryam; Cooney, James P.; Davidson, Kathryn C.; Speir, Mary; Djajawi, Tirta M.; Hughes, Sebastian; Mackiewicz, Liana; Dayton, Merle; Anderton, Holly; Doerflinger, Marcel; Deng, Yexuan; Huang, Allan Shuai; Conos, Stephanie A.; Tye, Hazel; Chow, Seong H.; Rahman, Arfatur; Norton, Raymond S.; Naderer, Thomas; Nicholson, Sandra E.; Burgio, Gaetan; Man, Si Ming; Groom, Joanna R.; Herold, Marco J.; Hawkins, Edwin D.; Lawlor, Kate E.; Strasser, Andreas; Silke, John; Pellegrini, Marc; Kashkar, Hamid; Feltham, Rebecca; Vince, James E.			Interferon-g primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway	IMMUNITY			English	Article							NITRIC-OXIDE SYNTHASE; NLRP3 INFLAMMASOME ACTIVATION; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; INDUCED APOPTOSIS; S-NITROSYLATION; SIGNALING PATHWAYS; TOXOPLASMA-GONDII; MOLECULAR SWITCH; MICE LACKING	Cell death plays an important role during pathogen infections. Here, we report that interferon-g (IFNg) sensitizes macrophages to Toll-like receptor (TLR)-induced death that requires macrophage-intrinsic death ligands and caspase-8 enzymatic activity, which trigger the mitochondrial apoptotic effectors, BAX and BAK. The pro-apoptotic caspase-8 substrate BID was dispensable for BAX and BAK activation. Instead, caspase-8 reduced pro-survival BCL-2 transcription and increased inducible nitric oxide synthase (iNOS), thus facilitating BAX and BAK signaling. IFNg-primed, TLR-induced macrophage killing required iNOS, which licensed apoptotic caspase-8 activity and reduced the BAX and BAK inhibitors, A1 and MCL-1. The deletion of iNOS or caspase-8 limited SARS-CoV-2-induced disease in mice, while caspase-8 caused lethality independent of iNOS in a model of hemophagocytic lymphohistiocytosis. These findings reveal that iNOS selectively licenses programmed cell death, which may explain how nitric oxide impacts disease severity in SARS-CoV-2 infection and other iNOS-associated inflammatory conditions.	[Simpson, Daniel S.; Pang, Jiyi; Weir, Ashley; Kong, Isabella Y.; Rashidi, Maryam; Cooney, James P.; Davidson, Kathryn C.; Hughes, Sebastian; Mackiewicz, Liana; Dayton, Merle; Anderton, Holly; Doerflinger, Marcel; Deng, Yexuan; Huang, Allan Shuai; Nicholson, Sandra E.; Groom, Joanna R.; Herold, Marco J.; Hawkins, Edwin D.; Strasser, Andreas; Silke, John; Pellegrini, Marc; Feltham, Rebecca; Vince, James E.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Simpson, Daniel S.; Pang, Jiyi; Weir, Ashley; Kong, Isabella Y.; Rashidi, Maryam; Cooney, James P.; Davidson, Kathryn C.; Hughes, Sebastian; Anderton, Holly; Doerflinger, Marcel; Deng, Yexuan; Huang, Allan Shuai; Nicholson, Sandra E.; Groom, Joanna R.; Herold, Marco J.; Hawkins, Edwin D.; Strasser, Andreas; Silke, John; Pellegrini, Marc; Feltham, Rebecca; Vince, James E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Pang, Jiyi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Fritsch, Melanie; Kashkar, Hamid] Univ Cologne, Ctr Mol Med Cologne, Inst Mol Immunol, D-50931 Cologne, Germany; [Fritsch, Melanie; Kashkar, Hamid] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Speir, Mary; Djajawi, Tirta M.; Conos, Stephanie A.; Tye, Hazel; Lawlor, Kate E.] Monash Univ, Ctr Innate Immun & Infect Dis, Hudson Inst Med Res, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia; [Chow, Seong H.; Naderer, Thomas] Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Rahman, Arfatur; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Norton, Raymond S.] Monash Univ, ARC Ctr Fragment Based Design, Parkville, Vic 3052, Australia; [Burgio, Gaetan; Man, Si Ming] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia	Walter & Eliza Hall Institute; University of Melbourne; Nankai University; University of Cologne; University of Cologne; Hudson Institute of Medical Research; Monash University; Monash University; Monash University; Monash University; Australian National University; John Curtin School of Medical Research	Feltham, R; Vince, JE (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Feltham, R; Vince, JE (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	feltham.r@wehi.edu.au; vince@wehi.edu.au	Rahman, Arfatur/AAC-1482-2022; Silke, John/B-7622-2008	Rahman, Arfatur/0000-0001-8749-0337; Silke, John/0000-0002-7611-5774; Kong, Isabella/0000-0002-7480-4525; Cooney, James/0000-0003-3680-4644; Feltham, Rebecca/0000-0001-8376-6869; Simpson, Daniel/0000-0002-6248-427X; Djajawi, Tirta/0000-0003-3527-1276; Weir, Ashley/0000-0002-3072-2616	National Health and Medical Research Council (NHMRC) of Australia [1145788, 1101405, 1162765, 1165591, 1143105, 1183848, 1137989, 1183070, 1181089, 1182649, 1194144, 1175011, 1107149, 1195038, 101671]; German Research Foundation [SFB1403, 414786233, 1141466, 1020363, 1144014, 1159488]; Leukemia and Lymphoma Society [LLS SCOR7015-18]; Australian Research Council (ARC) [FT190100266, FT170100313]; Monash Graduate Scholarship (CF-MGS) from Monash University; NHMRC [1156095]; National Collaborative Research Infrastructure Strategy (NCRIS) via Phenom-ics Australia; Walter and Eliza Hall Institute of Medical Research; Galbraith Family Charitable Trust; Australian Government Independent Research Institute Infrastructure Support Scheme; Victorian State Government Operational Infrastructure Support Scheme, Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); German Research Foundation(German Research Foundation (DFG)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Australian Research Council (ARC)(Australian Research Council); Monash Graduate Scholarship (CF-MGS) from Monash University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Collaborative Research Infrastructure Strategy (NCRIS) via Phenom-ics Australia; Walter and Eliza Hall Institute of Medical Research; Galbraith Family Charitable Trust; Australian Government Independent Research Institute Infrastructure Support Scheme(Australian Government); Victorian State Government Operational Infrastructure Support Scheme, Australia	We thank Associate Professor G. Dewson for valuable experimental advice and critical reading of the manuscript and Dr. P. Bouillet for kind donation of Pmaip1<SUP>-/-</SUP> and Bid<SUP>-/-</SUP>mice. We gratefully acknowledge grant support from the National Health and Medical Research Council (NHMRC) of Australia (proj-ect grants: 1145788 to J.E.V., K.E.L.; 1101405 to J.E.V.; 1162765 to K.E.L.; 1165591 to E.D.H.; 1143105 to M.J.H. and A.S.; 1183848 to T.N; 1137989 to J.R.G; ideas grants: 1183070 to J.E.V.; 1181089 to K.E.L.; 1182649 to J.R.G; investigator grants: 1194144 to H.A.; 1175011 to M.P.; 1107149 & 1195038 to J.S.; program grant 101671 to A.S.) , the German Research Foun-dation (SFB1403, project no. 414786233 to H.K.) , fellowships (1141466 to J.E.V.; 1020363 to A.S.; 1144014 to S.A.C.; 1159488 to E.D.H.) , and the Leu-kemia and Lymphoma Society (LLS SCOR 7015-18 to A.S., M.J.H., and J.S.) . K.E.L. and T.F are Australian Research Council (ARC) Future Fellows (FT190100266 to K.E.L and FT170100313 to T.N.) . A.R. is supported by the Co-Funded Monash Graduate Scholarship (CF-MGS) from Monash University. M.J.H. is an NHMRC Senior Research Fellow (1156095) . G.B. is funded by the National Collaborative Research Infrastructure Strategy (NCRIS) via Phenom-ics Australia. D.S.S. is supported by a philanthropic PhD scholarship from the Walter and Eliza Hall Institute of Medical Research. R.F. is supported by the Galbraith Family Charitable Trust. This work was also supported by opera-tional infrastructure grants through the Australian Government Independent Research Institute Infrastructure Support Scheme and the Victorian State Gov-ernment Operational Infrastructure Support Scheme, Australia.	Alehashemi S., 2020, Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18; Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; [Anonymous], Immunol. Rev., DOI 10.1016/j.immuni.2009.09.002; Baker PJ, 2018, METHODS MOL BIOL, V1714, P41, DOI 10.1007/978-1-4939-7519-8_3; Bossaller L., 2012, J. Immunol; Brumatti G, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3099; Chauhan D, 2018, CELL REP, V25, P2354, DOI 10.1016/j.celrep.2018.10.087; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chow SH, 2016, CELL MICROBIOL, V18, P466, DOI 10.1111/cmi.12573; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; De Nardo D, 2018, METHODS MOL BIOL, V1784, P35, DOI 10.1007/978-1-4939-7837-3_4; DeLaney A.A., 2019, Proc. Natl. Acad. Sci; Dhillon SS, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.17; Doerflinger M, 2020, IMMUNITY, V53, P533, DOI 10.1016/j.immuni.2020.07.004; Drutman SB, 2020, NEW ENGL J MED, V382, P437, DOI 10.1056/NEJMoa1910640; Dubey M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.248; Ebert G, 2020, CELL REP, V30, P4343, DOI 10.1016/j.celrep.2020.03.032; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Feltham R, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2016.83; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Fritsch M, 2019, NATURE, V575, P683, DOI 10.1038/s41586-019-1770-6; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Gitlin AD, 2020, NATURE, V587, P275, DOI 10.1038/s41586-020-2796-5; Gross TJ, 2014, J IMMUNOL, V192, P2326, DOI 10.4049/jimmunol.1301758; Gurung P., 2014, J. Immunol., V192; Hague S, 2004, NEUROLOGY, V62, P635, DOI 10.1212/01.WNL.0000110191.38152.29; Han H., 2018, Nucleic Acids Research, V46; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Henry CM, 2017, MOL CELL, V65, P715, DOI 10.1016/j.molcel.2017.01.022; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Hierholzer J. C., 1996, P25, DOI 10.1016/B978-012465330-6/50003-8; Hildebrand JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16819-z; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Ivashkiv LB, 2018, NAT REV IMMUNOL, V18, P545, DOI 10.1038/s41577-018-0029-z; Jaco I, 2017, MOL CELL, V66, P698, DOI 10.1016/j.molcel.2017.05.003; Janssen R, 2002, J IMMUNOL, V169, P3900, DOI 10.4049/jimmunol.169.7.3900; Jiang SH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10242-9; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8515; Karki Rajendra, 2021, Cell, V184, P149, DOI [10.1101/2020.10.29.361048, 10.1016/j.cell.2020.11.025]; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kayagaki N, 2021, NATURE, V591, P131, DOI 10.1038/s41586-021-03218-7; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kiang JG, 2008, MOL PHARMACOL, V73, P738, DOI 10.1124/mol.107.041079; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kreuz S., 2004, J. Cell Biol; Lalaoui N, 2020, NATURE, V577, P103, DOI 10.1038/s41586-019-1828-5; Lang MJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.519; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lauffer F, 2018, J INVEST DERMATOL, V138, P1785, DOI 10.1016/j.jid.2018.02.034; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawlor KE, 2017, CELL REP, V20, P668, DOI 10.1016/j.celrep.2017.06.073; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Leon-Bollotte L, 2011, GASTROENTEROLOGY, V140, P2009, DOI 10.1053/j.gastro.2011.02.053; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li S., 2020, Signal Transduct. Target. Ther., V5, P235, DOI 10.1038/s41392-020-00334-0; Li XL, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-018-1102-z; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locatelli F, 2020, NEW ENGL J MED, V382, P1811, DOI 10.1056/NEJMoa1911326; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Marsden VS, 2004, J CELL BIOL, V165, P775, DOI 10.1083/jcb.200312030; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Metzakopian E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01766-5; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Murphy MP, 1999, BBA-BIOENERGETICS, V1411, P401, DOI 10.1016/S0005-2728(99)00029-8; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Newton K., 2004, Mol. Cell. Biol., V24; Newton K, 2019, NATURE, V575, P679, DOI 10.1038/s41586-019-1752-8; Newton K, 2019, NATURE, V574, P428, DOI 10.1038/s41586-019-1548-x; Niedelman W, 2013, INFECT IMMUN, V81, P4341, DOI 10.1128/IAI.00416-13; O'Brien AR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39142-0; Okada S, 1998, J IMMUNOL, V160, P2590; Orzalli MH, 2021, IMMUNITY, V54, P1447, DOI 10.1016/j.immuni.2021.04.012; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Peschon JJ, 1998, J IMMUNOL, V160, P943; Philip NH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005910; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguez D.A., 2016, The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis; Romagny S, 2018, CANCER RES, V78, P1948, DOI 10.1158/0008-5472.CAN-17-2078; Salaun B, 2007, EUR J IMMUNOL, V37, P3311, DOI 10.1002/eji.200737744; SCHNEEMANN M, 1993, J INFECT DIS, V167, P1358, DOI 10.1093/infdis/167.6.1358; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Sedger LM, 1999, J IMMUNOL, V163, P920; Seminara AR, 2007, CELL CYCLE, V6, P1772, DOI 10.4161/cc.6.14.4438; Sennlaub F, 2002, J NEUROSCI, V22, P3987, DOI 10.1523/JNEUROSCI.22-10-03987.2002; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Snyder CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007059; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Speir M, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.34, 10.1038/nmicrobiol.2015.34]; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki T, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007299; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Talbott SJ, 2014, CELL CYCLE, V13, P1948, DOI 10.4161/cc.28898; Tanzer MC, 2017, CELL DEATH DIFFER, V24, P481, DOI 10.1038/cdd.2016.147; Taraborrelli L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06155-8; Taylor EL, 2003, CELL DEATH DIFFER, V10, P418, DOI 10.1038/sj.cdd.4401152; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; Trovoada MD, 2014, INFECT IMMUN, V82, P1287, DOI 10.1128/IAI.01070-13; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vandenabeele P., 2016, J. Clin. Invest., V126; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2018, CELL REP, V25, P2339, DOI 10.1016/j.celrep.2018.10.103; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang A, 2019, P NATL ACAD SCI USA, V116, P2200, DOI 10.1073/pnas.1820704116; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Weir A, 2021, CURR OPIN IMMUNOL, V68, P83, DOI 10.1016/j.coi.2020.09.008; Wickham H., 2009, ggplot2, DOI 10.1007/978-0-387-98141-3; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Woo M, 1999, J IMMUNOL, V163, P4909; Wu WW, 2015, APOPTOSIS, V20, P491, DOI 10.1007/s10495-015-1087-3; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu XL, 1998, CANCER RES, V58, P2832; Yang C, 2020, J LEUKOCYTE BIOL, V107, P273, DOI 10.1002/JLB.4MA1019-152R; Yang GX, 2002, STEM CELLS, V20, P241, DOI 10.1634/stemcells.20-3-241; Young Rachel, 2018, Immunohorizons, V2, P27, DOI 10.4049/immunohorizons.1700073; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	136	9	9	12	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					423	+		10.1016/j.immuni.2022.01.003	http://dx.doi.org/10.1016/j.immuni.2022.01.003			29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35139355	Green Published, Bronze			2022-12-18	WOS:000791044400009
J	Cautivo, KM; Matatia, PR; Lizama, CO; Mroz, NM; Dahlgren, MW; Yu, XF; Sbierski-Kind, J; Taruselli, MT; Brooks, JF; Wade-Vallance, A; Caryotakis, SE; Chang, AA; Liang, HE; Zikherman, J; Locksley, RM; Molofsky, AB				Cautivo, Kelly M.; Matatia, Peri R.; Lizama, Carlos O.; Mroz, Nicholas M.; Dahlgren, Madelene W.; Yu, Xiaofei; Sbierski-Kind, Julia; Taruselli, Marcela T.; Brooks, Jeremy F.; Wade-Vallance, Adam; Caryotakis, Sofia E.; Chang, Anthony A.; Liang, Hong-Erh; Zikherman, Julie; Locksley, Richard M.; Molofsky, Ari B.			Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation	IMMUNITY			English	Article							IFN-GAMMA; RESIDENT MEMORY; T-CELLS; LISTERIA-MONOCYTOGENES; TISSUE-REPAIR; INNATE; MICE; RECEPTOR; RESPONSES; LUNG	Allergic immunity is orchestrated by group 2 innate lymphoid cells (ILC2s) and type 2 helper T (Th2) cells prominently arrayed at epithelial-and microbial-rich barriers. However, ILC2s and Th2 cells are also present in fibroblast-rich niches within the adventitial layer of larger vessels and similar boundary structures in sterile deep tissues, and it remains unclear whether they undergo dynamic repositioning during immune perturbations. Here, we used thick-section quantitative imaging to show that allergic inflammation drives invasion of lung and liver non-adventitial parenchyma by ILC2s and Th2 cells. However, during concurrent type 1 and type 2 mixed inflammation, IFNg from broadly distributed type 1 lymphocytes directly blocked both ILC2 parenchymal trafficking and subsequent cell survival. ILC2 and Th2 cell confinement to adventitia limited mortality by the type 1 pathogen Listeria monocytogenes. Our results suggest that the topography of tissue lymphocyte subsets is tightly regulated to promote appropriately timed and balanced immunity.	[Cautivo, Kelly M.; Matatia, Peri R.; Mroz, Nicholas M.; Dahlgren, Madelene W.; Yu, Xiaofei; Sbierski-Kind, Julia; Taruselli, Marcela T.; Chang, Anthony A.; Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lizama, Carlos O.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Molofsky, Ari B.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Mroz, Nicholas M.; Wade-Vallance, Adam; Caryotakis, Sofia E.; Chang, Anthony A.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Brooks, Jeremy F.; Liang, Hong-Erh; Zikherman, Julie; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Molofsky, AB (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Molofsky, AB (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.	ari.molofsky@ucsf.edu		Wade-Vallance, Adam Kevin/0000-0002-6863-1461; Lizama, Carlos/0000-0002-0471-8525; Mroz, Nicholas/0000-0002-4781-8518; Yu, Xiaofei/0000-0002-3863-9040; Taruselli, Marcela/0000-0002-7965-4335	UCSF Parnassus Flow Core RRID [SCR_018206]; DRC Center Grant NIH [P30 DK063720]; NHLBI [NIH R01HL142701, R56HL142701]; NIH [R01AI26918]; HHMI; NLHBI [NIH R01HL142701, R56HL142701]; NIDDK [K08DK101604]; Larry L. Hillblom Foundation Grant; Nina Ireland Program for Lung Health; Sandler Asthma Basic Research Center (SABRE); UCSF Liver Center; RAP grant; PBBR grant	UCSF Parnassus Flow Core RRID; DRC Center Grant NIH; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NLHBI; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Larry L. Hillblom Foundation Grant; Nina Ireland Program for Lung Health; Sandler Asthma Basic Research Center (SABRE); UCSF Liver Center; RAP grant; PBBR grant	We thank the UCSF Parnassus Flow Core RRID:SCR_018206 and DRC Center Grant NIH P30 DK063720 and UCSF Biological Imaging and Development Core (BIDC) for instruments and services; Tien Peng, Anna V. Molofsky, and Michael Rosenblum (comments and discussion) ; and Jorge Ortiz-Carpena and Sepideh Farhat (technical assistance) ; K.M.C. is supported by the NHLBI (NIH R01HL142701 and R56HL142701) . R.M.L. is supported by NIH R01AI26918 and HHMI. A.B.M. is supported by the NLHBI (NIH R01HL142701 and R56HL142701) , NIDDK (K08DK101604) , Larry L. Hillblom Foundation Grant, Nina Ireland Program for Lung Health, Sandler Asthma Basic Research Center (SABRE) , and the UCSF Liver Center, RAP and PBBR grants.	Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Buechler MB, 2021, NATURE, V593, P575, DOI 10.1038/s41586-021-03549-5; Cameron GJM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00826; Campbell L, 2019, J EXP MED, V216, P2714, DOI 10.1084/jem.20180610; Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847; Cautivo KM, 2020, CURR OPIN IMMUNOL, V64, P34, DOI 10.1016/j.coi.2020.03.005; Cautivo KM, 2016, MOL METAB, V5, P491, DOI 10.1016/j.molmet.2016.05.004; Cautivo KM, 2016, EUR J IMMUNOL, V46, P1315, DOI 10.1002/eji.201545562; Chang Timothy T, 2002, Am J Clin Dermatol, V3, P175, DOI 10.2165/00128071-200203030-00004; Chavez-Arroyo A, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13175; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Corren J, 2019, NAT IMMUNOL, V20, P1603, DOI 10.1038/s41590-019-0524-9; Coyle AJ, 1996, J IMMUNOL, V156, P2680; Dahlgren MW, 2019, TRENDS IMMUNOL, V40, P877, DOI 10.1016/j.it.2019.08.002; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; Dahlgren MW, 2018, CURR OPIN IMMUNOL, V54, P13, DOI 10.1016/j.coi.2018.05.008; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Dutton EE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8082; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Germain RN, 2019, CURR OPIN IMMUNOL, V56, P76, DOI 10.1016/j.coi.2018.11.001; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Ghaedi M, 2020, J EXP MED, V217, DOI 10.1084/jem.20182293; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Gola A, 2021, NATURE, V589, P131, DOI 10.1038/s41586-020-2977-2; HAAKFRENDSCHO M, 1992, J IMMUNOL, V148, P3978; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Han HW, 2017, IMMUNOL REV, V278, P116, DOI 10.1111/imr.12546; Han MY, 2017, AM J RESP CELL MOL, V56, P242, DOI 10.1165/rcmb.2016-0056OC; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Klicznik MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav8995; Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee SH, 2013, J IMMUNOL, V191, P4223, DOI 10.4049/jimmunol.1300910; Li WZ, 2017, P NATL ACAD SCI USA, V114, pE7321, DOI 10.1073/pnas.1708981114; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Mack MR, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay1005; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MAGGI E, 1992, J IMMUNOL, V148, P2142; Mahlakoiv T, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax0416; Marsland BJ, 2004, P NATL ACAD SCI USA, V101, P6116, DOI 10.1073/pnas.0401582101; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; Molofsky AB, 2015, IMMUNITY, V42, P1005, DOI 10.1016/j.immuni.2015.06.006; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nguyen PT, 2020, CELL, V182, P388, DOI 10.1016/j.cell.2020.05.050; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Puttur F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7638; Radoshevich L, 2018, NAT REV MICROBIOL, V16, P32, DOI 10.1038/nrmicro.2017.126; Rana BMJ, 2019, J EXP MED, V216, P1999, DOI 10.1084/jem.20190689; Reinhardt RL, 2015, J IMMUNOL, V194, P2358, DOI 10.4049/jimmunol.1401992; REINHOLD U, 1993, J AM ACAD DERMATOL, V29, P58, DOI 10.1016/0190-9622(93)70152-J; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Ruterbusch M, 2020, ANNU REV IMMUNOL, V38, P705, DOI 10.1146/annurev-immunol-103019-085803; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schuijs MJ, 2020, NAT IMMUNOL, V21, P998, DOI 10.1038/s41590-020-0745-y; Schuijs MJ, 2018, ANN NY ACAD SCI, V1417, P87, DOI 10.1111/nyas.13604; Sonnenberg GE, 2019, NAT REV IMMUNOL, V19, P599, DOI 10.1038/s41577-019-0194-8; Spallanzani RG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw3658; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Stier MT, 2017, J IMMUNOL, V199, P510, DOI 10.4049/jimmunol.1601984; Stolley JM, 2020, J EXP MED, V217, DOI 10.1084/jem.20192197; Tang JY, 2013, EUR J IMMUNOL, V43, P1407, DOI 10.1002/eji.201243119; Tibbitt CA, 2019, IMMUNITY, V51, P169, DOI 10.1016/j.immuni.2019.05.014; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; Woytschak J, 2016, IMMUNITY, V45, P172, DOI 10.1016/j.immuni.2016.06.025; Zeis P, 2020, IMMUNITY, V53, P775, DOI 10.1016/j.immuni.2020.09.002; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	92	9	9	5	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					254	+		10.1016/j.immuni.2021.12.014	http://dx.doi.org/10.1016/j.immuni.2021.12.014			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35139352				2022-12-18	WOS:000754308000011
J	Fang, Y; Liu, ZZ; Qiu, Y; Kong, J; Fu, YH; Liu, YJ; Wang, C; Quan, J; Wang, Q; Xu, W; Yin, L; Cui, J; Xu, Y; Curry, S; Jiang, SB; Lu, L; Zhou, X				Fang, Yuan; Liu, Zezhong; Qiu, Yang; Kong, Jing; Fu, Yuhong; Liu, Yujie; Wang, Chong; Quan, Jia; Wang, Qian; Xu, Wei; Yin, Lei; Cui, Jie; Xu, Yi; Curry, Stephen; Jiang, Shibo; Lu, Lu; Zhou, Xi			Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivo	IMMUNITY			English	Article							ANTIVIRAL IMMUNITY; SWISS-MODEL; INTERFERENCE; DOMAIN; DICER; REPLICATION; CELLS; SIRNA; ACTS	RNA interference (RNAi) is the major antiviral mechanism in plants and invertebrates, but the absence of detectable viral (v)siRNAs in mammalian cells upon viral infection has questioned the functional relevance of this pathway in mammalian immunity. We designed a series of peptides specifically targeting enterovirus A71 (EV-A71)-encoded protein 3A, a viral suppressor of RNAi (VSR). These peptides abrogated the VSR function of EV-A71 in infected cells and resulted in the accumulation of vsiRNAs and reduced viral replication. These vsiRNAs were functional, as evidenced by RISC-loading and silencing of target RNAs. The effects of VSR-targeting peptides (VTPs) on infection with EV-A71 as well as another enterovirus, Coxsackievirus-A16, were ablated upon deletion of Dicer1 or AGO2, core components of the RNAi pathway. In vivo, VTP treatment protected mice against lethal EV-A71 challenge, with detectable vsiRNAs. Our findings provide evidence for the functional relevance of RNAi in mammalian immunity and present a therapeutic strategy for infectious disease.	[Fang, Yuan; Liu, Yujie; Quan, Jia; Yin, Lei] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Fang, Yuan; Qiu, Yang; Kong, Jing; Liu, Yujie; Wang, Chong; Quan, Jia; Zhou, Xi] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Liu, Zezhong; Fu, Yuhong; Wang, Qian; Xu, Wei; Jiang, Shibo; Lu, Lu] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China; [Liu, Zezhong; Fu, Yuhong; Wang, Qian; Xu, Wei; Jiang, Shibo; Lu, Lu] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai Inst Infect Dis & Biosecur, Shanghai 200032, Peoples R China; [Wang, Chong; Xu, Yi] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, Guangzhou 510120, Peoples R China; [Cui, Jie] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Curry, Stephen] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Fudan University; Fudan University; Guangzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Imperial College London	Zhou, X (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.; Lu, L (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China.; Lu, L (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai Inst Infect Dis & Biosecur, Shanghai 200032, Peoples R China.	lul@fudan.edu.cn; zhouxi@wh.iov.cn	lu, lu/HGA-0894-2022; Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135; Cui, Jie/0000-0001-8176-9951; yin, lei/0000-0001-5203-2766; Zhou, Xi/0000-0002-3846-5079	National Natural Science Foundation of China (NSFC) [31970169]; Strategic Priority Research Program of CAS [XDB29010300]; National Mega-Projects of China [2018ZX10301403]; NSFC [81822045, 81630090, 81873964]; Newton Advanced Fellowship from the Academy of Medical Sciences, UK [NAF005\1002]; CAS Pioneer Hundred Talents Program; CAS Youth Innovation Promotion Association [2020332]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of CAS; National Mega-Projects of China; NSFC(National Natural Science Foundation of China (NSFC)); Newton Advanced Fellowship from the Academy of Medical Sciences, UK; CAS Pioneer Hundred Talents Program; CAS Youth Innovation Promotion Association	We thank Drs. B.R. Cullen, C.-F. Qin, and J. Zhan for critical reagents. We thank J. Xu, A. Wang, and P. Yu at Wuhan Institute of Virology and Q. Wang at the sharing platform for large-scale instrument of Fudan University for technical support. This work was supported by National Natural Science Foundation of China (NSFC) (31970169 to X.Z.), the Strategic Priority Research Program of CAS (XDB29010300 to X.Z.), National Mega-Projects of China for Major Infectious Diseases (2018ZX10301403 to L.L.), NSFC (81822045 to L.L., 81630090 to S.J., and 81873964 to Y.Q.), and Newton Advanced Fellowship from the Academy of Medical Sciences, UK (NAF005\1002 to X.Z. and S.C.). J.C. is supported by the CAS Pioneer Hundred Talents Program. Y.Q. is supported by the CAS Youth Innovation Promotion Association (2020332).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Baggen J, 2018, NAT REV MICROBIOL, V16, P368, DOI 10.1038/s41579-018-0005-4; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Beydoun T, 2015, J OCUL PHARMACOL TH, V31, P93, DOI 10.1089/jop.2013.0247; Bode SA, 2017, CHEMBIOCHEM, V18, P185, DOI 10.1002/cbic.201600614; Bogerd HP, 2014, RNA, V20, P923, DOI 10.1261/rna.044545.114; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen X, 2010, J BIOL CHEM, V285, P25506, DOI 10.1074/jbc.M110.101170; Cui L, 2015, J VIROL, V89, P9029, DOI 10.1128/JVI.01331-15; Cullen BR, 2017, IMMUNITY, V46, P970, DOI 10.1016/j.immuni.2017.05.004; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; Deloche C, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.20; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Gao QQ, 2015, ANTIMICROB AGENTS CH, V59, P2654, DOI 10.1128/AAC.05108-14; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Guo ZX, 2019, NAT REV IMMUNOL, V19, P31, DOI 10.1038/s41577-018-0071-x; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Han QX, 2020, MBIO, V11, DOI 10.1128/mBio.03278-19; Han QX, 2017, NATL SCI REV, V4, P667, DOI 10.1093/nsr/nwx085; He QQ, 2018, J VIROL, V92, DOI 10.1128/JVI.02251-17; Karjee S, 2010, J VIROL, V84, P10395, DOI 10.1128/JVI.00748-10; Kennedy EM, 2015, P NATL ACAD SCI USA, V112, pE6945, DOI 10.1073/pnas.1513421112; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Li H, 2019, BIOMED PHARMACOTHER, V116, DOI 10.1016/j.biopha.2019.108976; Li Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.250; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Lu B, 2017, CELL HOST MICROBE, V22, P86, DOI 10.1016/j.chom.2017.06.013; Lu YF, 2016, VIROLOGY, V496, P28, DOI 10.1016/j.virol.2016.05.013; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Maillard PV, 2019, EMBO J, V38, DOI 10.15252/embj.2018100941; Mathur K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38065; Mu JF, 2020, SCI CHINA LIFE SCI, V63, P1413, DOI 10.1007/s11427-020-1692-1; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pallansch, 2007, FIELDS VIROLOGY, P839; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Poirier EZ, 2021, SCIENCE, V373, P231, DOI 10.1126/science.abg2264; Qian Q, 2020, J VIROL, V94, DOI 10.1128/JVI.01233-19; Qiu Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax7989; Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006; Ren PJ, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.60; Ren YJ, 2016, J BIOL CHEM, V291, P13206, DOI 10.1074/jbc.M116.718080; Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shahrudin S, 2021, SCIENCE, V373, P160, DOI 10.1126/science.abj5673; Shu T, 2020, VIROL SIN, V35, P321, DOI 10.1007/s12250-020-00242-1; Strauss DM, 2003, J MOL BIOL, V330, P225, DOI 10.1016/S0022-2836(03)00577-1; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Wang HQ, 2019, VIROL SIN, V34, P9, DOI 10.1007/s12250-018-0071-9; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Wu YL, 2020, CELL HOST MICROBE, V27, P891, DOI 10.1016/j.chom.2020.04.023; Xi JM, 2019, VIROL SIN, V34, P66, DOI 10.1007/s12250-019-00089-1; Xia S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4580; Xiao X, 2017, J VIROL, V91, DOI 10.1128/JVI.00791-17; Xie XP, 2019, CELL RES, V29, P261, DOI 10.1038/s41422-019-0158-3; Xu JY, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020154; Xu YP, 2019, CELL RES, V29, P265, DOI 10.1038/s41422-019-0152-9; Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672; Zeng JX, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.628887; Zeng JX, 2020, CELL STEM CELL, V27, P618, DOI 10.1016/j.stem.2020.07.012; Zhang M, 2016, CELL RES, V26, P1302, DOI 10.1038/cr.2016.125; Zhang XN, 2013, ANTIVIR RES, V97, P264, DOI 10.1016/j.antiviral.2012.12.029; Zhao H, 2013, APPL MICROBIOL BIOT, V97, P10445, DOI 10.1007/s00253-013-5257-3; Zhou H, 2020, VIROL SIN, V35, P436, DOI 10.1007/s12250-019-00182-5; Zhu Y, 2007, CHEM BIOL DRUG DES, V70, P311, DOI 10.1111/j.1747-0285.2007.00564.x	74	9	9	10	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2231	+		10.1016/j.immuni.2021.08.027	http://dx.doi.org/10.1016/j.immuni.2021.08.027		OCT 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34555337	Bronze, Green Submitted			2022-12-18	WOS:000706854100012
J	Flommersfeld, S; Bottcher, JP; Ersching, J; Flossdorf, M; Meiser, P; Pachmayr, LO; Leube, J; Hensel, I; Jarosch, S; Zhang, Q; Chaudhry, MZ; Andrae, I; Schiemann, M; Busch, DH; Cicin-Sain, L; Sun, JC; Gasteiger, G; Victora, GD; Hofer, T; Buchholz, VR; Grassmann, S				Flommersfeld, Sophie; Bottcher, Jan P.; Ersching, Jonatan; Flossdorf, Michael; Meiser, Philippa; Pachmayr, Ludwig O.; Leube, Justin; Hensel, Inge; Jarosch, Sebastian; Zhang, Qin; Chaudhry, M. Zeeshan; Andrae, Immanuel; Schiemann, Matthias; Busch, Dirk H.; Cicin-Sain, Luka; Sun, Joseph C.; Gasteiger, Georg; Victora, Gabriel D.; Hoefer, Thomas; Buchholz, Veit R.; Grassmann, Simon			Fate mapping of single NK cells identifies a type 1 innate lymphoid-like lineage that bridges innate and adaptive recognition of viral infection	IMMUNITY			English	Article							DENDRITIC CELLS; MOUSE CYTOMEGALOVIRUS; RECEPTOR; MEMORY; EXPRESSION; CONVERSION; REVEALS; ANTIGEN; SUBSET; LIGAND	Upon viral infection, natural killer (NK) cells expressing certain germline-encoded receptors are selected, expanded, and maintained in an adaptive-like manner. Currently, these are thought to differentiate along a common pathway. However, by fate mapping of single NK cells upon murine cytomegalovirus (MCMV) infection, we identified two distinct NK cell lineages that contributed to adaptive-like responses. One was equivalent to conventional NK (cNK) cells while the other was transcriptionally similar to type 1 innate lymphoid cells (ILC1s). ILC1-like NK cells showed splenic residency and strong cytokine production but also recognized and killed MCMV-infected cells, guided by activating receptor Ly49H. Moreover, they induced clustering of conventional type 1 dendritic cells and facilitated antigen-specific T cell priming early during MCMV infection, which depended on Ly49H and the NK cell-intrinsic expression of transcription factor Batf3. Thereby, ILC1-like NK cells bridge innate and adaptive viral recognition and unite critical features of cNK cells and ILC1s.	[Flommersfeld, Sophie; Flossdorf, Michael; Pachmayr, Ludwig O.; Leube, Justin; Hensel, Inge; Jarosch, Sebastian; Andrae, Immanuel; Schiemann, Matthias; Busch, Dirk H.; Buchholz, Veit R.; Grassmann, Simon] Tech Univ Munich TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Bottcher, Jan P.; Meiser, Philippa] Tech Univ Munich TUM, Sch Med, Inst Mol Immunol & Expt Oncol, Klinikum Rechts Isar, Munich, Germany; [Ersching, Jonatan; Victora, Gabriel D.] Rockefeller Univ, Lab Lymphocyte Dynam, New York, NY 10065 USA; [Zhang, Qin; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, Heidelberg, Germany; [Zhang, Qin; Hoefer, Thomas] Heidelberg Univ, BioQuant Ctr, Heidelberg, Germany; [Chaudhry, M. Zeeshan; Cicin-Sain, Luka] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Busch, Dirk H.; Buchholz, Veit R.] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Sun, Joseph C.; Grassmann, Simon] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Gasteiger, Georg] Wurzburg Inst Syst Immunol, Wurzburg, Germany; [Gasteiger, Georg] Julius Maximilians Univ Wurzburg, Max Planck Res Grp, Wurzburg, Germany	Technical University of Munich; Technical University of Munich; Rockefeller University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Memorial Sloan Kettering Cancer Center; Max Planck Society; University of Wurzburg	Buchholz, VR; Grassmann, S (corresponding author), Tech Univ Munich TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Buchholz, VR (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.; Grassmann, S (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.	veit.buchholz@tum.de; simon.grassmann@tum.de	Chaudhry, M. Zeeshan/AAJ-8203-2021	Chaudhry, M. Zeeshan/0000-0002-1372-4257; Gasteiger, Georg/0000-0001-6986-127X; Jarosch, Sebastian/0000-0002-2908-8590	European Research Council [949719]; Else Kroner-Fresenius-Stiftung (EKFS) [2019_A91]; German Research Foundation (DFG) [1054 (210592381)]; International Junior Research Group [N-LW-2016-370]; Elite Network of Bavaria; Bavarian State Ministry of Science and the Arts; DFG [424926990, 179 (031L0170A)]; BMBF project [01ZX1505]; BMBF project TIDY [031L0170A]; Helmholtz association project [PIE-008]	European Research Council(European Research Council (ERC)European Commission); Else Kroner-Fresenius-Stiftung (EKFS); German Research Foundation (DFG)(German Research Foundation (DFG)); International Junior Research Group; Elite Network of Bavaria; Bavarian State Ministry of Science and the Arts; DFG(German Research Foundation (DFG)); BMBF project(Federal Ministry of Education & Research (BMBF)); BMBF project TIDY(Federal Ministry of Education & Research (BMBF)); Helmholtz association project	This work was supported by the European Research Council starting grant (949719 -SCIMAP) to V.R.B.; the Else Kroner-Fresenius-Stiftung (EKFS 2019_A91) to V.R.B.; the German Research Foundation (DFG) -SFB 1054 (210592381) to V.R.B. and D.H.B.; an International Junior Research Group grant (N-LW-2016-370) from the Elite Network of Bavaria, Bavarian State Ministry of Science and the Arts to J.P.B.; the DFG -(424926990) to J.P.B.; the BMBF project Quan-T cell (e:Med initiative on Systems Medicine, FKZ 01ZX1505) to M.F.; the BMBF project TIDY (Computational Life Sciences, FKZ 031L0170A) to T.H.; the Helmholtz association project (PIE-008) to L.C.S.; and the DFG -TRR 179 (031L0170A) to M.S. In memoriam of J.E. who was a Cancer Research Institute/Hearst Foundation postdoctoral fellow and died in October 2020.	Adams NM, 2020, NAT REV IMMUNOL, V20, P694, DOI 10.1038/s41577-020-0307-4; Adams NM, 2019, IMMUNITY, V50, P1381, DOI 10.1016/j.immuni.2019.04.009; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Busche A, 2013, J IMMUNOL, V190, P2767, DOI 10.4049/jimmunol.1200966; Cella M, 2019, NAT IMMUNOL, V20, P980, DOI 10.1038/s41590-019-0425-y; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Chaudhry MZ, 2020, P NATL ACAD SCI USA, V117, P12961, DOI 10.1073/pnas.1914667117; COLEMAN DL, 1969, AM J PHYSIOL, V217, P1298; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Erick TK, 2016, J IMMUNOL, V197, P2485, DOI 10.4049/jimmunol.1601099; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Grassmann S, 2020, NAT IMMUNOL, V21, P1563, DOI 10.1038/s41590-020-00807-y; Grassmann S, 2019, IMMUNITY, V50, P1391, DOI 10.1016/j.immuni.2019.04.015; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Harmon C, 2016, EUR J IMMUNOL, V46, P2111, DOI 10.1002/eji.201646559; Harris RBS, 1997, AM J PHYSIOL-REG I, V272, pR1809; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jeevan-Raj B, 2017, CELL REP, V20, P613, DOI 10.1016/j.celrep.2017.06.071; Kamimura Y, 2015, CELL REP, V10, P280, DOI 10.1016/j.celrep.2014.12.025; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Melsen JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00262; Mitrovic M, 2012, J VIROL, V86, P2165, DOI 10.1128/JVI.06042-11; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Redeker A, 2014, EUR J IMMUNOL, V44, P1046, DOI 10.1002/eji.201343946; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Takeuchi A, 2009, J IMMUNOL, V183, P4220, DOI 10.4049/jimmunol.0901248; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Wu CF, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9781	48	9	9	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2288	+		10.1016/j.immuni.2021.08.002	http://dx.doi.org/10.1016/j.immuni.2021.08.002		OCT 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34437840	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-18	WOS:000706854100016
J	Trindade, BC; Ceglia, S; Berthelette, A; Raso, F; Howley, K; Muppidi, JR; Reboldi, A				Trindade, Bruno C.; Ceglia, Simona; Berthelette, Alyssa; Raso, Fiona; Howley, Kelsey; Muppidi, Jagan R.; Reboldi, Andrea			The cholesterol metabolite 25-hydroxycholesterol restrains the transcriptional regulator SREBP2 and limits intestinal IgA plasma cell differentiation	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; CENTER B-CELLS; DENDRITIC CELLS; T-CELLS; MACROPHAGES; OBESITY; ENTRY; INFLAMMATION; HOMEOSTASIS; GENERATION	Diets high in cholesterol alter intestinal immunity. Here, we examined how the cholesterol metabolite 25-hydroxycholesterol (25-HC) impacts the intestinal B cell response. Mice lacking cholesterol 25-hydroxylase (CH25H), the enzyme generating 25-HC, had higher frequencies of immunoglobulin A (IgA)-secreting antigen-specific B cells upon immunization or infection. 25-HC did not affect class-switch recombination but rather restrained plasma cell (PC) differentiation. 25-HC was produced by follicular dendritic cells and increased in response to dietary cholesterol. Mechanistically, 25-HC restricted activation of the sterolsensing transcription factor SREBP2, thereby regulating B cell cholesterol biosynthesis. Ectopic expression of SREBP2 in germinal center B cells induced rapid PC differentiation, whereas SREBP2 deficiency reduced PC output in vitro and in vivo. High-cholesterol diet impaired, whereas Ch25h deficiency enhanced, the IgA response against Salmonella and the resulting protection from systemic bacterial dissemination. Thus, a 25-HC-SREBP2 axis shapes the humoral response at the intestinal barrier, providing insight into the effect of high dietary cholesterol in intestinal immunity.	[Trindade, Bruno C.; Ceglia, Simona; Berthelette, Alyssa; Raso, Fiona; Howley, Kelsey; Reboldi, Andrea] Univ Massachusetts, Chan Med Sch, Dept Pathol, Worcester, MA 01605 USA; [Muppidi, Jagan R.] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Trindade, Bruno C.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Michigan System; University of Michigan	Reboldi, A (corresponding author), Univ Massachusetts, Chan Med Sch, Dept Pathol, Worcester, MA 01605 USA.	andrea.reboldi@umassmed.edu		Ceglia, Simona/0000-0002-5315-9387; Trindade, Bruno/0000-0002-7339-9003; Reboldi, Andrea/0000-0003-1137-6292; Muppidi, Jagan/0000-0002-2639-4226	Kenneth Rainin Foundation Innovator Award; Charles H. Hood Foundation Child Health Research Awards Program; NIH [T32 AI132152, T32 AI007349]; Intramural Research Program of the National Institutes of Health; Center for Cancer Research, National Cancer Institute	Kenneth Rainin Foundation Innovator Award; Charles H. Hood Foundation Child Health Research Awards Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Michael Gallagher and Leslie Berg for the help with the nuclear isolation and staining, Grant Weaver and Lawrence Stern for the help with the generation of LTbR-Fc, Garnett Kelsoe for generously allowing use of NB21 cells, and Joonsoo Kang for the critical reading of the manuscript. This work was supported by the Kenneth Rainin Foundation Innovator Award (to A.R.), Charles H. Hood Foundation Child Health Research Awards Program (to A.R.), and NIH training grants T32 AI132152 and T32 AI007349 (to F.R.). J.R.M. is supported by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute. We acknowledge the University of Massachusetts Flow Cytometry Core Facility for access to sorting services.	Baptista AP, 2019, IMMUNITY, V50, P1188, DOI 10.1016/j.immuni.2019.04.001; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chu C, 2018, CELL REP, V23, P3750, DOI 10.1016/j.celrep.2018.05.099; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Emgard J, 2018, IMMUNITY, V48, P120, DOI 10.1016/j.immuni.2017.11.020; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gallagher Michael P, 2018, Immunohorizons, V2, P208, DOI 10.4049/immunohorizons.1800032; Garidou L, 2015, CELL METAB, V22, P100, DOI 10.1016/j.cmet.2015.06.001; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Hand TW, 2021, ANNU REV IMMUNOL, V39, P695, DOI 10.1146/annurev-immunol-102119-074236; Holmes AB, 2020, J EXP MED, V217, DOI 10.1084/jem.20200483; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lu E, 2019, NATURE, V567, P244, DOI 10.1038/s41586-019-1003-z; Luck H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11370-y; Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; Melo-Gonzalez F, 2019, J EXP MED, V216, P728, DOI 10.1084/jem.20180871; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Moor K, 2016, NAT PROTOC, V11, P1531, DOI 10.1038/nprot.2016.091; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Muhomah TA, 2019, BIOSCI MICROB FOOD H, V38, P55, DOI 10.12938/bmfh.18-027; Muppidi JR, 2015, J EXP MED, V212, P2213, DOI 10.1084/jem.20151250; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Petta I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00439; Pikor NB, 2021, J IMMUNOL, V206, P257, DOI 10.4049/jimmunol.2000914; Radtke D, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03106; Reboldi A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4822; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rong SX, 2017, J LIPID RES, V58, P1988, DOI 10.1194/jlr.M077610; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Stewart I, 2018, IMMUNITY, V49, P477, DOI 10.1016/j.immuni.2018.08.025; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015	56	9	9	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2273	+		10.1016/j.immuni.2021.09.004	http://dx.doi.org/10.1016/j.immuni.2021.09.004		OCT 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644558	Green Accepted, Bronze			2022-12-18	WOS:000706854100015
J	Medina, CB; Chiu, YH; Stremska, ME; Lucas, CD; Poon, I; Tung, KS; Elliott, MR; Desai, B; Lorenz, UM; Bayliss, DA; Ravichandran, KS				Medina, Christopher B.; Chiu, Yu-Hsin; Stremska, Marta E.; Lucas, Christopher D.; Poon, Ivan; Tung, Kenneth S.; Elliott, Michael R.; Desai, Bimal; Lorenz, Ulrike M.; Bayliss, Douglas A.; Ravichandran, Kodi S.			Pannexin 1 channels facilitate communication between T cells to restrict the severity of airway inflammation	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; EXTRACELLULAR ATP; CD39; ASTHMA; DIFFERENTIATION; EXPRESSION; CD73	Allergic airway inflammation is driven by type-2 CD4(+) T cell inflammatory responses. We uncover an immunoregulatory role for the nucleotide release channel, Panx1, in T cell crosstalk during airway disease. Inverse correlations between Panx1 and asthmatics and our mouse models revealed the necessity, specificity, and sufficiency of Panx1 in T cells to restrict inflammation. Global Panx1(-/-) mice experienced exacerbated airway inflammation, and T-cell-specific deletion phenocopied Panx1(-/-) mice. A transgenic designed to re-express Panx1 in T cells reversed disease severity in global Panx1(-/-) mice. Panx1 activation occurred in pro-inflammatory T effector (Teff) and inhibitory T regulatory (Treg) cells and mediated the extracellular-nucleotide-based Treg-Teff crosstalk required for suppression of Teff cell proliferation. Mechanistic studies identified a Salt-inducible kinase-dependent phosphorylation of Panx1 serine 205 important for channel activation. A genetically targeted mouse expressing non-phosphorylatable Panx1S205A phenocopied the exacerbated inflammation in Panx1(-/-) mice. These data identify Panx1-dependent Treg:Teff cell communication in restricting airway disease.	[Medina, Christopher B.; Lucas, Christopher D.; Elliott, Michael R.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Medina, Christopher B.; Stremska, Marta E.; Tung, Kenneth S.; Elliott, Michael R.; Lorenz, Ulrike M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Medina, Christopher B.; Stremska, Marta E.; Tung, Kenneth S.; Elliott, Michael R.; Lorenz, Ulrike M.; Ravichandran, Kodi S.] Univ Virginia, Dept Immunol, Charlottesville, VA 22908 USA; [Medina, Christopher B.; Stremska, Marta E.; Tung, Kenneth S.; Elliott, Michael R.; Lorenz, Ulrike M.; Ravichandran, Kodi S.] Univ Virginia, Dept Canc Biol, Charlottesville, VA 22908 USA; [Chiu, Yu-Hsin; Desai, Bimal; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Tung, Kenneth S.; Lorenz, Ulrike M.; Ravichandran, Kodi S.] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Chiu, Yu-Hsin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30071, Taiwan; [Chiu, Yu-Hsin] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu 30071, Taiwan; [Poon, Ivan] La Trobe Univ, Dept Biochem & Genet, Melbourne, Vic 3083, Australia; [Ravichandran, Kodi S.] Univ Ghent, VIB UGent Inflammat Res Ctr, B-9000 Ghent, Belgium; [Ravichandran, Kodi S.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; National Tsing Hua University; National Tsing Hua University; La Trobe University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Ravichandran, KS (corresponding author), Univ Virginia, Dept Canc Biol, Charlottesville, VA 22908 USA.; Ravichandran, KS (corresponding author), Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA.; Ravichandran, KS (corresponding author), Univ Ghent, VIB UGent Inflammat Res Ctr, B-9000 Ghent, Belgium.; Ravichandran, KS (corresponding author), Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium.	ravi@virginia.edu		Poon, Ivan/0000-0002-9119-7173; Medina, Christopher/0000-0001-7441-9232; Lucas, Christopher/0000-0002-7523-0295	NHLBI [P01HL120840]; NIGMS [R35GM122542]; Center for Cell Clearance, University of Virginia School of Medicine; FWO, Belgium; FWO [3083753-DECODE]; NIAID [R21 AI139967, R21 AI135455]; NIH T32 Pharmacology Training Grant [T32GM007055]; Wellcome Trust [206566/Z/17/Z]; Ministry of Science and Technology Taiwan [108-2320-B-007-007-MY2]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Center for Cell Clearance, University of Virginia School of Medicine; FWO, Belgium(FWO); FWO(FWO); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH T32 Pharmacology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank members of the Ravichandran laboratory, members of the Pannexin Interest Group at UVA for numerous discussions and critical reading of the manuscript, and Dr. Wenhao Xu for help in developing transgenic and genetically targeted mice. This work is supported by grants to K.S.R. from NHLBI (P01HL120840); NIGMS R35GM122542; the Center for Cell Clearance, University of Virginia School of Medicine; the Odysseus Award from the FWO, Belgium; EOS Grant from the FWO (3083753-DECODE); and the NHLBI (P01HL120840) and NIAID (R21 AI139967 and R21 AI135455) to U.M.L. Additional support was received through the NIH T32 Pharmacology Training Grant (T32GM007055) (C.B.M). C.D.L. was supported by The Wellcome Trust (206566/Z/17/Z). Y.C. was supported by the Ministry of Science and Technology Taiwan (108-2320-B-007-007-MY2). C.D.L. current affiliation is University of Edinburgh Center for Inflammation Research, Queen's Medical Research Institute, Edinburgh BioQuarter.	Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Arias-Calderon M, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0087-5; Billaud M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005824; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cheng LE, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016352; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dubyak GR, 2019, METHOD ENZYMOL, V629, P81, DOI 10.1016/bs.mie.2019.10.006; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Gandhi VD, 2013, CURR ALLERGY ASTHM R, V13, P262, DOI 10.1007/s11882-013-0349-9; Gold M, 2015, METHODS MOL BIOL, V1220, P503, DOI 10.1007/978-1-4939-1568-2_31; He NH, 2017, P NATL ACAD SCI USA, V114, P12542, DOI 10.1073/pnas.1715363114; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Holtzman MJ, 2014, NAT REV IMMUNOL, V14, P686, DOI 10.1038/nri3739; Idzko M, 2013, ALLERGY, V68, P472, DOI 10.1111/all.12119; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jankowski J, 2018, J AM SOC NEPHROL, V29, P1887, DOI 10.1681/ASN.2017121306; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kaur M, 2015, EUR RESPIR REV, V24, P510, DOI 10.1183/16000617.0030-2015; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lazar Z, 2010, CHEST, V138, P536, DOI 10.1378/chest.10-0085; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; Medina CB, 2020, NATURE, V580, P130, DOI 10.1038/s41586-020-2121-3; Michalski K, 2020, ELIFE, V9, DOI 10.7554/eLife.54670; Morioka S, 2018, NATURE, V563, P714, DOI 10.1038/s41586-018-0735-5; Morita H, 2016, J ALLERGY CLIN IMMUN, V138, P1253, DOI 10.1016/j.jaci.2016.09.011; Nixon M, 2016, MOL METAB, V5, P34, DOI 10.1016/j.molmet.2015.10.004; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Raedler D, 2015, J ALLERGY CLIN IMMUN, V135, P81, DOI 10.1016/j.jaci.2014.07.046; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Scanlon ST, 2012, CURR OPIN IMMUNOL, V24, P707, DOI 10.1016/j.coi.2012.08.009; Sharma AK, 2018, AM J PHYSIOL-LUNG C, V315, pL301, DOI 10.1152/ajplung.00004.2018; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sun ZC, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00265-w; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Umetsu DT, 2006, IMMUNOL REV, V212, P238, DOI 10.1111/j.0105-2896.2006.00413.x; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Velasquez S, 2016, J IMMUNOL, V196, P4338, DOI 10.4049/jimmunol.1502440; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Wei R, 2015, NEUROSCIENCE, V301, P168, DOI 10.1016/j.neuroscience.2015.05.070; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamaguchi H, 2014, ELIFE, V3, DOI 10.7554/eLife.02172; Yang FC, 2013, J BIOL CHEM, V288, P6227, DOI 10.1074/jbc.M112.431239	49	9	9	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1715	+		10.1016/j.immuni.2021.06.014	http://dx.doi.org/10.1016/j.immuni.2021.06.014		AUG 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34283971	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000684589700011
J	Zhang, WJ; Zhangyuan, G; Wang, F; Jin, KP; Shen, HY; Zhang, LS; Yuan, X; Wang, JC; Zhang, HT; Yu, WW; Huang, RY; Xu, XL; Yin, Y; Zhong, GS; Lin, AN; Sun, BC				Zhang, Wenjie; Zhangyuan, Guangyan; Wang, Fei; Jin, Kangpeng; Shen, Haiyuan; Zhang, Liansheng; Yuan, Xiang; Wang, Jincheng; Zhang, Haitian; Yu, Weiwei; Huang, Ruyi; Xu, Xiaoliang; Yin, Yin; Zhong, Guisheng; Lin, Anning; Sun, Beicheng			The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation	IMMUNITY			English	Article							NF-KAPPA-B; ASTROCYTE ELEVATED GENE-1; HEPATOCELLULAR-CARCINOMA; CANCER; PROGRESSION; PATHWAY; CELLS; MYC; HEPATOCARCINOGENESIS; STEATOHEPATITIS	Chronic inflammation plays a central role in hepatocellular carcinoma (HCC), but the contribution of hepatocytes to tumor-associated inflammation is not clear. Here, we report that the zinc finger transcription factor Miz1 restricted hepatocyte-driven inflammation to suppress HCC, independently of its transcriptional activity. Miz1 was downregulated in HCC mouse models and a substantial fraction of HCC patients. Hepatocyte-specific Miz1 deletion in mice generated a distinct sub-group of hepatocytes that produced pro-inflammatory cytokines and chemokines, which skewed the polarization of the tumor-infiltrating macrophages toward pro-inflammatory phenotypes to promote HCC. Mechanistically, Miz1 sequestrated the oncoprotein metadherin (MTDH), preventing MTDH from promoting transcription factor nuclear factor kappa B (NF-kappa B) activation. A distinct sub-group of pro-inflammatory cytokine-producing hepatocytes was also seen in a subset of HCC patients. In addition, Miz1 expression inversely correated with disease recurrence and poor prognosis in HCC patients. Our findings identify Miz1 as a tumor suppressor that prevents hepatocytes from driving inflammation in HCC.	[Zhang, Wenjie; Zhangyuan, Guangyan; Wang, Fei; Jin, Kangpeng; Shen, Haiyuan; Wang, Jincheng; Zhang, Haitian; Yu, Weiwei; Huang, Ruyi; Xu, Xiaoliang; Yin, Yin; Sun, Beicheng] Nanjing Univ Med Sch, Dept Hepatobiliary Surg, Affiliated Drum Tower Hosp, Nanjing 210008, Peoples R China; [Zhang, Wenjie; Zhangyuan, Guangyan; Wang, Fei; Jin, Kangpeng; Shen, Haiyuan; Wang, Jincheng; Zhang, Haitian; Yu, Weiwei; Huang, Ruyi; Xu, Xiaoliang; Yin, Yin; Sun, Beicheng] Nanjing Med Univ, Liver Transplantat Ctr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Liansheng; Yuan, Xiang] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Zhang, Liansheng; Yuan, Xiang; Lin, Anning] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Zhong, Guisheng] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Lin, Anning] Nanjing Univ, Inst Modern Biol, Nanjing 20018, Peoples R China	Nanjing University; Nanjing Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chicago; ShanghaiTech University; Nanjing University	Sun, BC (corresponding author), Nanjing Univ Med Sch, Dept Hepatobiliary Surg, Affiliated Drum Tower Hosp, Nanjing 210008, Peoples R China.; Sun, BC (corresponding author), Nanjing Med Univ, Liver Transplantat Ctr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.; Lin, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	anninglin@nju.edu.cn; sunbc@nju.edu.cn	shen, haiyuan/GQQ-6063-2022; Yu, Wei/GZL-3831-2022	shen, haiyuan/0000-0003-3520-8402; Zhangyuan, Guangyan/0000-0002-6298-8304; Zhang, Liansheng/0000-0001-6444-6421; Yin, Yin/0000-0001-8113-4278; Sun, Beicheng/0000-0002-8657-7024; Wang, Jincheng/0000-0001-9345-2388	National Key Research and Development Program of China [2016YFC0905900, 91329301]; State Key Program of National Natural Science Foundation [81930086, 31430026]; National Institutes of Health [GM103868, GMR35122457]; National Natural Science Foundation of China [81702344]	National Key Research and Development Program of China; State Key Program of National Natural Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Research and Development Program of China (2016YFC0905900 to B.S.; 91329301 to A.L.), the State Key Program of National Natural Science Foundation (81930086 to B.S.; 31430026 to A.L.), National Institutes of Health grants (GM103868 and GMR35122457 to A.L.), and The National Natural Science Foundation of China (81702344 to W.Z.).	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basu S, 2009, P NATL ACAD SCI USA, V106, P1433, DOI 10.1073/pnas.0804863106; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Brown ZJ, 2018, NAT REV GASTRO HEPAT, V15, P536, DOI 10.1038/s41575-018-0033-6; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Do-Umehara HC, 2013, NAT IMMUNOL, V14, P461, DOI 10.1038/ni.2566; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Gebhardt A, 2007, J CELL SCI, V120, P2586, DOI 10.1242/jcs.007104; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Honnemann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034885; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; Jin Y, 2014, TUMOR BIOL, V35, P9905, DOI 10.1007/s13277-014-2279-0; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Krishnan RK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7658; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Lan T, 2018, HEPATOLOGY, V68, P1070, DOI 10.1002/hep.29885; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; Li WY, 2015, J CLIN INVEST, V125, P4239, DOI 10.1172/JCI81203; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Liu J, 2012, P NATL ACAD SCI USA, V109, P191, DOI 10.1073/pnas.1105176108; Liu J, 2009, P NATL ACAD SCI USA, V106, P18279, DOI 10.1073/pnas.0906328106; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Ma LC, 2019, CANCER CELL, V36, P418, DOI 10.1016/j.ccell.2019.08.007; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mould KJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126556; Oakley F, 2009, GASTROENTEROLOGY, V136, P2334, DOI 10.1053/j.gastro.2009.02.081; Park SY, 2016, ONCOL REP, V36, P2641, DOI 10.3892/or.2016.5106; Peter S, 2014, EMBO MOL MED, V6, P1525, DOI 10.15252/emmm.201403927; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ringelhan M, 2018, NAT IMMUNOL, V19, P222, DOI 10.1038/s41590-018-0044-z; Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200; Robertson CL, 2018, CANCER RES, V78, P6436, DOI 10.1158/0008-5472.CAN-18-0659; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Saba I, 2011, BLOOD, V117, P3370, DOI 10.1182/blood-2010-09-310680; Saelens W, 2019, NAT BIOTECHNOL, V37, P547, DOI 10.1038/s41587-019-0071-9; Saito M, 2009, P NATL ACAD SCI USA, V106, P11294, DOI 10.1073/pnas.0903854106; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Srivastava J, 2012, HEPATOLOGY, V56, P1782, DOI 10.1002/hep.25868; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Tacke F, 2017, J HEPATOL, V66, P1300, DOI 10.1016/j.jhep.2017.02.026; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; vanRooijen N, 1997, J LEUKOCYTE BIOL, V62, P702, DOI 10.1002/jlb.62.6.702; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Weston CJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00893; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang Y, 2010, P NATL ACAD SCI USA, V107, P13444, DOI 10.1073/pnas.0913690107; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Zhang JQ, 2019, HEPATOLOGY, V69, P1549, DOI 10.1002/hep.30153; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang Q, 2019, GUT, V68, P2019, DOI 10.1136/gutjnl-2019-318912; Zhang WJ, 2015, ONCOTARGET, V6, P9420, DOI 10.18632/oncotarget.3353; Zhu K, 2011, CLIN CANCER RES, V17, P7294, DOI 10.1158/1078-0432.CCR-11-1327	76	9	10	10	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1168	+		10.1016/j.immuni.2021.04.027	http://dx.doi.org/10.1016/j.immuni.2021.04.027		JUN 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34038747	Bronze			2022-12-18	WOS:000659882900010
J	Clement, CC; Nanaware, PP; Yamazaki, T; Negroni, MP; Ramesh, K; Morozova, K; Thangaswamy, S; Graves, A; Kim, HJ; Li, TWX; Vigano', M; Soni, RK; Gadina, M; Tse, HY; Galluzzi, L; Roche, PA; Denzin, LK; Stern, LJ; Santambrogio, L				Clement, Cristina C.; Nanaware, Padma P.; Yamazaki, Takahiro; Negroni, Maria Pia; Ramesh, Karthik; Morozova, Kateryna; Thangaswamy, Sangeetha; Graves, Austin; Kim, Hei Jung; Li, Tsai Wanxia; Vigano', Marco; Soni, Rajesh K.; Gadina, Massimo; Tse, Harley Y.; Galluzzi, Lorenzo; Roche, Paul A.; Denzin, Lisa K.; Stern, Lawrence J.; Santambrogio, Laura			Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery	IMMUNITY			English	Article							GLYCATION END-PRODUCTS; OXIDATIVE STRESS; HLA-DM; NONENZYMATIC GLYCATION; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; T-CELLS; CARDIOVASCULAR-DISEASE; MASS-SPECTROMETRY; GLYOXALASE-I	Hyperglycemia and hyperlipidemia are often observed in individuals with type II diabetes (T2D) and related mouse models. One dysmetabolic biochemical consequence is the non-enzymatic reaction between sugars, lipids, and proteins, favoring protein glycation, glycoxidation, and lipoxidation. Here, we identified oxidative alterations in key components of the major histocompatibility complex (MHC) class II molecule antigen processing and presentation machinery in vivo under conditions of hyperglycemia-induced metabolic stress. These modifications were linked to epitope-specific changes in endosomal processing efficiency, MHC class II-peptide binding, and DM editing activity. Moreover, we observed some quantitative and qualitative changes in the MHC class II immunopeptidome of Ob/Ob mice on a high-fat diet compared with controls, including changes in the presentation of an apolipoprotein B100 peptide associated previously with T2D and metabolic syndrome-related clinical complications. These findings highlight a link between glycation reactions and altered MHC class II antigen presentation that may contribute to T2D complications.	[Clement, Cristina C.; Yamazaki, Takahiro; Morozova, Kateryna; Thangaswamy, Sangeetha; Galluzzi, Lorenzo; Santambrogio, Laura] Weill Cornell Med, Dept Radiat Oncol, New York, NY 10065 USA; [Nanaware, Padma P.; Negroni, Maria Pia; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Ramesh, Karthik; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Immunol & Microbiol Program, Worcester, MA 01605 USA; [Graves, Austin; Denzin, Lisa K.] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA; [Kim, Hei Jung; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Li, Tsai Wanxia; Gadina, Massimo] NIAMSD, Translat Immunol Sect, NIH, Bethesda, MD 20892 USA; [Vigano', Marco] Galeazzi Orthoped Inst Care & Sci Res, Orthoped Biotechnol Lab, Milan, Italy; [Soni, Rajesh K.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Prote & Macromol Crystallog Shared Resource, Irving Med Ctr, New York, NY USA; [Tse, Harley Y.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Dept Microbiol & Immunol, Detroit, MI USA; [Galluzzi, Lorenzo; Santambrogio, Laura] Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Galluzzi, Lorenzo; Santambrogio, Laura] Caryl & Israel Englander Inst Precis Med, New York, NY 10065 USA	Cornell University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Columbia University; NewYork-Presbyterian Hospital; Wayne State University	Santambrogio, L (corresponding author), Weill Cornell Med, Dept Radiat Oncol, New York, NY 10065 USA.; Stern, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.; Stern, LJ (corresponding author), Univ Massachusetts, Sch Med, Immunol & Microbiol Program, Worcester, MA 01605 USA.; Santambrogio, L (corresponding author), Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Santambrogio, L (corresponding author), Caryl & Israel Englander Inst Precis Med, New York, NY 10065 USA.	lawrence.stern@umassmed.edu; las4011@med.cornell.edu	Clement, Cristina/ABG-4525-2021	Clement, Cristina/0000-0003-1464-407X	NIH [AI146180, AI137198]; Barile Children's Medical Research Trust; Robert Wood Johnson Foundation [67038]; Intramural Research Program of the National Institutes of Health; PHS [R01AI117535]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barile Children's Medical Research Trust; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service)	The work was supported by NIH AI146180 and NIH AI137198 (to L.S. and L.J.S.), PHS R01AI117535, The Barile Children's Medical Research Trust and the Robert Wood Johnson Foundation (67038 to the Child Health Institute of New Jersey) (to L.K.D.), and the Intramural Research Program of the National Institutes of Health (to P.A.R.).	Adamopoulos C, 2016, CELL MOL LIFE SCI, V73, P1685, DOI 10.1007/s00018-015-2091-z; Ahmad S, 2014, GLYCOBIOLOGY, V24, P281, DOI 10.1093/glycob/cwt109; Al Maruf A, 2015, CHEM-BIOL INTERACT, V234, P96, DOI 10.1016/j.cbi.2014.11.007; Andreatta M, 2017, NUCLEIC ACIDS RES, V45, pW458, DOI 10.1093/nar/gkx248; Andriani GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35218; Araki E, 2010, J DIABETES INVEST, V1, P90, DOI 10.1111/j.2040-1124.2010.00013.x; Arena S, 2014, MASS SPECTROM REV, V33, P49, DOI 10.1002/mas.21378; Backos DS, 2013, NEUROCHEM RES, V38, P1838, DOI 10.1007/s11064-013-1090-4; Bansal S, 2012, MOL CELL BIOCHEM, V361, P289, DOI 10.1007/s11010-011-1114-9; Bavkar LN, 2019, MOL CELL BIOCHEM, V459, P61, DOI 10.1007/s11010-019-03550-7; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bo JS, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2029854; Bonnefont-Rousselot D, 2003, METABOLISM, V52, P586, DOI 10.1053/meta.2003.50093; Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097; Brownlee M, 2000, METABOLISM, V49, P9, DOI 10.1016/S0026-0495(00)80078-5; BROWNLEE M, 1995, CLIN INVEST MED, V18, P275; BROWNLEE M, 1994, DIABETES, V43, P836, DOI 10.2337/diab.43.6.836; Busch R, 1998, J IMMUNOL, V160, P734; Butterfield DA, 2014, MASS SPECTROM REV, V33, P277, DOI 10.1002/mas.21374; Cannizzo ES, 2012, CELL REP, V2, P136, DOI 10.1016/j.celrep.2012.06.005; Carven GJ, 2005, BIOCHEMISTRY-US, V44, P13625, DOI 10.1021/bi050972p; Clement CC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85633; Clement CC, 2016, J BIOL CHEM, V291, P5576, DOI 10.1074/jbc.M115.655738; Collins BC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00249-5; Colombo S, 2019, FREE RADICAL BIO MED, V144, P144, DOI 10.1016/j.freeradbiomed.2019.05.025; Dobi A, 2019, FREE RADICAL RES, V53, P150, DOI 10.1080/10715762.2018.1529866; Fallas JL, 2007, J IMMUNOL, V178, P1488, DOI 10.4049/jimmunol.178.3.1488; Fujita T, 1998, J BIOCHEM-TOKYO, V124, P1237, DOI 10.1093/oxfordjournals.jbchem.a022243; GAMMON G, 1987, IMMUNOL REV, V98, P53; GE FX, 2017, ONCOTARGET, V8, DOI DOI 10.3390/F8100355; Greifenhagen U, 2016, ANAL BIOANAL CHEM, V408, P5557, DOI 10.1007/s00216-016-9651-4; Hanssen NMJ, 2014, EUR HEART J, V35, P1137, DOI 10.1093/eurheartj/eht402; Haskins K, 2011, CURR OPIN IMMUNOL, V23, P739, DOI 10.1016/j.coi.2011.08.004; Jahouh F, 2012, RAPID COMMUN MASS SP, V26, P749, DOI 10.1002/rcm.6166; Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889; Jiang X, 2015, APOPTOSIS, V20, P1033, DOI 10.1007/s10495-015-1130-4; LANDAIS D, 1986, J IMMUNOL, V137, P3002; Lapolla A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/412103; Li YM, 1996, P NATL ACAD SCI USA, V93, P3902, DOI 10.1073/pnas.93.9.3902; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Liu BF, 1999, DIABETES, V48, P2074, DOI 10.2337/diabetes.48.10.2074; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Liu JH, 2009, FEBS J, V276, P4598, DOI 10.1111/j.1742-4658.2009.07165.x; Ma H, 2009, J CELL MOL MED, V13, P1751, DOI 10.1111/j.1582-4934.2008.00547.x; Matsui T, 2010, PHARMACOL RES, V61, P34, DOI 10.1016/j.phrs.2009.07.004; Miksik I, 1997, J CHROMATOGR B, V699, P311; MOREL PA, 1988, P NATL ACAD SCI USA, V85, P8111, DOI 10.1073/pnas.85.21.8111; MULLARKEY CJ, 1990, BIOCHEM BIOPH RES CO, V173, P932, DOI 10.1016/S0006-291X(05)80875-7; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; Nobecourt E, 2008, DIABETOLOGIA, V51, P1008, DOI 10.1007/s00125-008-0986-z; Nobecourt E, 2010, ARTERIOSCL THROM VAS, V30, P766, DOI 10.1161/ATVBAHA.109.201715; Painter Corrie A, 2011, Curr Top Biochem Res, V13, P39; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Passarelli M, 2005, DIABETES, V54, P2198, DOI 10.2337/diabetes.54.7.2198; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Rybstein MD, 2018, NAT CELL BIOL, V20, P243, DOI 10.1038/s41556-018-0042-2; Sadowska-Bartosz I, 2015, CHEM-BIOL INTERACT, V240, P154, DOI 10.1016/j.cbi.2015.07.006; Saleh J, 2015, WORLD J CARDIOL, V7, P449, DOI 10.4330/wjc.v7.i8.449; Scharf B, 2013, CHEM BIOL, V20, P922, DOI 10.1016/j.chembiol.2013.06.006; Schmidt R, 2015, J MASS SPECTROM, V50, P613, DOI 10.1002/jms.3569; Shaw MK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00095; Shimada S, 2005, DIABETES RES CLIN PR, V69, P272, DOI 10.1016/j.diabres.2005.01.007; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Sima AV, 2010, J CELL MOL MED, V14, P2790, DOI 10.1111/j.1582-4934.2009.00933.x; Singer SM, 1998, DIABETES, V47, P1570, DOI 10.2337/diabetes.47.10.1570; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Son S, 2017, J BIOL CHEM, V292, P20437, DOI 10.1074/jbc.M117.806307; Soro-Paavonen A, 2006, CURR MED CHEM, V13, P1777, DOI 10.2174/092986706777452515; Spiller S, 2017, PROTEIN PEPTIDE LETT, V24, P887, DOI 10.2174/0929866524666170202124120; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Uchiki T, 2012, AGING CELL, V11, P1, DOI 10.1111/j.1474-9726.2011.00752.x; Utz PJ, 1997, J EXP MED, V185, P843, DOI 10.1084/jem.185.5.843; van Stipdonk MJB, 1998, INT IMMUNOL, V10, P943, DOI 10.1093/intimm/10.7.943; Wan XX, 2020, NAT IMMUNOL, V21, P455, DOI 10.1038/s41590-020-0623-7; Warnecke A, 2017, NEUROMOL MED, V19, P463, DOI 10.1007/s12017-017-8461-y; Wei Q, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-13; Wiik AS, 2010, AUTOIMMUN REV, V10, P90, DOI 10.1016/j.autrev.2010.08.009; Wong RKM, 2002, DIABETES, V51, P2846, DOI 10.2337/diabetes.51.9.2846; Yamagishi S, 2017, J DIABETES, V9, P141, DOI 10.1111/1753-0407.12475; Yan H, 1997, BIOCHEM J, V328, P599, DOI 10.1042/bj3280599; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yin L, 2014, CURR PROTOC IMMUNOL, V106, P5; Zakliczynski M, 2009, TRANSPL P, V41, P3185, DOI 10.1016/j.transproceed.2009.07.069; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0; Zavala-Ruiz Z, 2004, CHEM BIOL, V11, P1395, DOI 10.1016/j.chembiol.2004.08.007; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	88	9	9	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					721	+		10.1016/j.immuni.2021.02.019	http://dx.doi.org/10.1016/j.immuni.2021.02.019		APR 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33725478	Bronze, Green Accepted			2022-12-18	WOS:000640102800013
J	Chu, T; Zehn, D				Chu, Talyn; Zehn, Dietmar			Charting the Roadmap of T Cell Exhaustion	IMMUNITY			English	Editorial Material								Exposure to chronic infection or malignant tumors triggers the differentiation of functionally impaired, so-called exhausted T cells. In this issue of Immunity, Beltra et al. reveal a multi-step developmental process that defines how T cells transition from proliferating progenitors into terminally differentiated exhausted T cells.	[Chu, Talyn; Zehn, Dietmar] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany	Technical University of Munich	Zehn, D (corresponding author), Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany.	dietmar.zehn@tum.de		Zehn, Dietmar/0000-0003-1393-8527				Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050	10	9	9	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					724	726		10.1016/j.immuni.2020.04.019	http://dx.doi.org/10.1016/j.immuni.2020.04.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433943	Bronze			2022-12-18	WOS:000535371100003
J	Gorman, J; Mason, RD; Nettey, L; Cavett, N; Chuang, GY; Peng, D; Tsybovsky, Y; Verardi, R; Nguyen, R; Ambrozak, D; Biris, K; LaBranche, CC; Ramesh, A; Schramm, CA; Zhou, J; Bailer, RT; Kepler, TB; Montefiori, DC; Shapiro, L; Douek, DC; Mascola, JR; Roederer, M; Kwong, PD				Gorman, Jason; Mason, Rosemarie D.; Nettey, Leonard; Cavett, Nicole; Chuang, Gwo-Yu; Peng, Dongjun; Tsybovsky, Yaroslav; Verardi, Raffaello; Nguyen, Richard; Ambrozak, David; Biris, Kristin; LaBranche, Celia C.; Ramesh, Akshaya; Schramm, Chaim A.; Zhou, Jing; Bailer, Robert T.; Kepler, Thomas B.; Montefiori, David C.; Shapiro, Lawrence; Douek, Daniel C.; Mascola, John R.; Roederer, Mario; Kwong, Peter D.			Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields	IMMUNITY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; ENVELOPE; GP120	HIV- and SIV-envelope (Env) trimers are both extensively glycosylated, and antibodies identified to date have been unable to fully neutralize SIVmac239. Here, we report the isolation, structure, and glycan interactions of antibody ITS90.03, a monoclonal antibody that completely neutralized the highly neutralization-resistant isolate, SIVmac239. The co-crystal structure of a fully glycosylated SIVmac239-gp120 core in complex with rhesus CD4 and the antigen-binding fragment of ITS90.03 at 2.5-angstrom resolution revealed that ITS90 recognized an epitope comprised of 45% glycan. SIV-gp120 core, rhesus CD4, and their complex could each be aligned structurally to their human counterparts. The structure revealed that glycans masked most of the SIV Env protein surface, with ITS90 targeting a glycan hole, which is occupied in similar to 83% of SIV strains by glycan N238. Overall, the SIV glycan shield appears to functionally resemble its HIV counterpart in coverage of spike, shielding from antibody, and modulation of receptor accessibility.	[Gorman, Jason; Mason, Rosemarie D.; Nettey, Leonard; Cavett, Nicole; Chuang, Gwo-Yu; Peng, Dongjun; Verardi, Raffaello; Nguyen, Richard; Ambrozak, David; Biris, Kristin; Schramm, Chaim A.; Zhou, Jing; Bailer, Robert T.; Shapiro, Lawrence; Douek, Daniel C.; Mascola, John R.; Roederer, Mario; Kwong, Peter D.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Tsybovsky, Yaroslav] Leidos Biomed Res Inc, Electron Microscopy Lab, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Ramesh, Akshaya; Kepler, Thomas B.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; Boston University; Columbia University	Roederer, M; Kwong, PD (corresponding author), NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA.	roederer@nih.gov; pdkwong@nih.go	Ramesh, Akshaya/GWR-3496-2022; Shapiro, Lawrence/AAE-7172-2019; Roederer, Mario/G-1887-2011; Mascola, John/AAI-7193-2021; Gorman, Jason/AGG-9417-2022		Intramural Research Programs of the Vaccine Research Center; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]	Intramural Research Programs of the Vaccine Research Center; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE))	We thank J. Stuckey for assistance with figures and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center for discussions or comments on the manuscript. We thank the Vaccine Research Center NHP Immunogenicity Core for providing NHP plasma and PBMC samples. Support for this work was provided by the Intramural Research Programs of the Vaccine Research Center and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Andrabi R, 2019, CELL REP, V27, P2426, DOI 10.1016/j.celrep.2019.04.082; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; Chuang GY, 2019, STRUCTURE, V27, P196, DOI 10.1016/j.str.2018.10.007; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; Davenport YW, 2016, J VIROL, V90, P2112, DOI 10.1128/JVI.02678-15; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hu GQ, 2017, J VIROL, V91, DOI 10.1128/JVI.00134-17; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Humes D, 2012, J VIROL, V86, P12472, DOI 10.1128/JVI.02176-12; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mason RD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005537; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Perfetto Stephen P, 2010, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0934s53; Roederer M, 2014, NATURE, V505, P502, DOI 10.1038/nature12893; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	33	9	9	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					724	+		10.1016/j.immuni.2019.09.007	http://dx.doi.org/10.1016/j.immuni.2019.09.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31586542	Bronze			2022-12-18	WOS:000490141700017
J	Petzold, T; Massberg, S				Petzold, Tobias; Massberg, Steffen			Thrombin: A Gas Pedal Driving Innate Immunity	IMMUNITY			English	Editorial Material							THROMBOPOIESIS	Hemostasis and immunity were long considered entirely separate entities. In this issue of Immunity, Burzyn-ski et al. (2019) find that thrombin, the key enzyme within the coagulation cascade, activates IL-1 alpha, a central pleiotropic pro-inflammatory cytokine, to promote wound healing and platelet production following ecto-derm injury.	[Petzold, Tobias; Massberg, Steffen] Klinikum Univ Munchen, Med Klin & Poliklin 1, Munich, Germany; [Petzold, Tobias; Massberg, Steffen] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Massberg, S (corresponding author), Klinikum Univ Munchen, Med Klin & Poliklin 1, Munich, Germany.; Massberg, S (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany.	steffen.massberg@med.uni-muenchen.de	Massberg, Steffen/AAN-6054-2021					Burzynski LC, 2019, IMMUNITY, V50, P1033, DOI 10.1016/j.immuni.2019.03.003; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Feldmeyer L, 2010, EUR J CELL BIOL, V89, P638, DOI 10.1016/j.ejcb.2010.04.008; Gaertner F, 2017, CELL, V171, P1368, DOI 10.1016/j.cell.2017.11.001; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Nishimura S, 2015, J CELL BIOL, V209, P453, DOI 10.1083/jcb.201410052; Zhang L, 2012, J EXP MED, V209, P2165, DOI 10.1084/jem.20121090	9	9	9	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1024	1026		10.1016/j.immuni.2019.03.006	http://dx.doi.org/10.1016/j.immuni.2019.03.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995493	Bronze			2022-12-18	WOS:000464660800017
J	Conche, C; Greten, FR				Conche, Claire; Greten, Florian R.			Fungi Enter the Stage of Colon Carcinogenesis	IMMUNITY			English	Editorial Material								The significant contribution of intestinal bacteria for the pathogenesis of colorectal cancer is widely accepted by now. In this issue of Immunity, two articles by Malik et al. (2018) and Wang et al. (2018) highlight the role of commensal fungi, which so far have been underestimated.	[Conche, Claire; Greten, Florian R.] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, D-60596 Frankfurt, Germany		Greten, FR (corresponding author), Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, D-60596 Frankfurt, Germany.	greten@gsh.uni-frankfurt.de	Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080				Bergmann H, 2017, EUR J IMMUNOL, V47, P1342, DOI 10.1002/eji.201646765; Corvilain E, 2018, J CLIN IMMUNOL, V38, P656, DOI 10.1007/s10875-018-0539-2; Drummond RA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01836; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Malik A, 2018, IMMUNITY, V49, P515, DOI 10.1016/j.immuni.2018.08.024; Wang TT, 2018, IMMUNITY, V49, P504, DOI 10.1016/j.immuni.2018.08.018; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	7	9	10	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					384	386		10.1016/j.immuni.2018.09.002	http://dx.doi.org/10.1016/j.immuni.2018.09.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30231977	Bronze			2022-12-18	WOS:000444909600004
J	Allen, JE; Ruckerl, D				Allen, Judith E.; Ruckerl, Dominik			The Silent Undertakers: Macrophages Programmed for Efferocytosis	IMMUNITY			English	Editorial Material							RESIDENT MACROPHAGES; APOPTOTIC CELLS; MONOCYTES	Two recent Immunity papers provide new insight into efferocytosis by tissue-resident macrophages. Baratin et al. (2017) identify a resident macrophage population in the T cell zone of lymph nodes responsible for the silent uptake of vast numbers of apoptotic cells. Roberts et al. (2017) find that resident macrophages can be programmed by local tissue signals not to respond to the nucleic acid of apoptotic cells.	[Allen, Judith E.; Ruckerl, Dominik] Univ Manchester, Div Infect Immun & Resp Med, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England	University of Manchester	Allen, JE (corresponding author), Univ Manchester, Div Infect Immun & Resp Med, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England.	judi.allen@manchester.ac.uk	Allen, Judith E/C-9198-2011	Allen, Judith E/0000-0002-3829-066X; Ruckerl, Dominik/0000-0002-0206-1451				A-Gonzalez N, 2017, J EXP MED, V214, P1281, DOI 10.1084/jem.20161375; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Perez OA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5520; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010	10	9	9	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					810	812		10.1016/j.immuni.2017.10.010	http://dx.doi.org/10.1016/j.immuni.2017.10.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166582	Bronze			2022-12-18	WOS:000416483700004
J	Andrabi, R; Su, CY; Liang, CH; Shivatare, SS; Briney, B; Voss, JE; Nawazi, SK; Wu, CY; Wong, CH; Burton, DR				Andrabi, Raiees; Su, Ching-Yao; Liang, Chi-Hui; Shivatare, Sachin S.; Briney, Bryan; Voss, James E.; Nawazi, Salar Khan; Wu, Chung-Yi; Wong, Chi-Huey; Burton, Dennis R.			Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development (vol 47, pg 524, 2017)	IMMUNITY			English	Correction												burton@scripps.edu	Wu, Chung-Yi/K-8334-2018		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI100663] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrabi R, 2017, IMMUNITY, V47, P524, DOI 10.1016/j.immuni.2017.08.006	1	9	9	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					1004	1004		10.1016/j.immuni.2017.10.012	http://dx.doi.org/10.1016/j.immuni.2017.10.012			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166578	Green Accepted, Bronze			2022-12-18	WOS:000416483700021
J	Karagiannis, F; Wilhelm, C				Karagiannis, Fotios; Wilhelm, Christoph			More Is Less: IL-9 in the Resolution of Inflammation	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; LUNG INFLAMMATION; SURVIVAL	In a recent study in Nature Medicine, Rauber et al. (2017) identify interleukin-9 (IL-9) derived from group 2 innate lymphoid cells as crucial regulators inducing resolution of chronic inflammation in rheumatoid arthritis. Their findings provide insight into the varied functions of IL-9 and open the door to novel therapeutic interventions.	[Karagiannis, Fotios; Wilhelm, Christoph] Univ Bonn, Univ Hosp Bonn, Dept Clin Chem & Clin Pharmacol, Unit Immunopathol, D-53127 Bonn, Germany	University of Bonn	Wilhelm, C (corresponding author), Univ Bonn, Univ Hosp Bonn, Dept Clin Chem & Clin Pharmacol, Unit Immunopathol, D-53127 Bonn, Germany.	christoph.wilhelm@uni-bonn.de	Wilhelm, Christoph/ABE-7176-2020	Wilhelm, Christoph/0000-0002-9839-0291				Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Rauber S, 2017, NAT MED, V23, P938, DOI 10.1038/nm.4373; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Wilhelm C, 2012, NAT IMMUNOL, V13, P637, DOI 10.1038/ni.2303; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133	10	9	9	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					403	405		10.1016/j.immuni.2017.09.004	http://dx.doi.org/10.1016/j.immuni.2017.09.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930656	Bronze			2022-12-18	WOS:000411128200007
J	Polletti, S; Natoli, G				Polletti, Sara; Natoli, Gioacchino			Understanding Spontaneous Conversion: The Case of the Ly6C(-) Monocyte	IMMUNITY			English	Editorial Material							MACROPHAGES; BLOOD; HOMEOSTASIS	Mouse blood monocytes include two main subsets usually discriminated by the expression of the Ly6C surface marker. The study by Mildner et al. (2017) in this issue of Immunity clarifies the transcriptional circuits controlling the generation of Ly6C(-) cells from their obligate precursors, the Ly6C(+) monocytes.	[Polletti, Sara] Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Milan, Italy; [Polletti, Sara; Natoli, Gioacchino] Humanitas Univ, Sch Med, Dept Biomed Sci, Via Manzoni 113, I-20089 Milan, Italy; [Natoli, Gioacchino] European Inst Oncol 1E0, Dept Expt Med, Via Adamello 16, I-20139 Milan, Italy	Humanitas University	Natoli, G (corresponding author), Humanitas Univ, Sch Med, Dept Biomed Sci, Via Manzoni 113, I-20089 Milan, Italy.; Natoli, G (corresponding author), European Inst Oncol 1E0, Dept Expt Med, Via Adamello 16, I-20139 Milan, Italy.	gioacchino.natoli@hunimed.eu	Polletti, Sara/K-3948-2018; Polletti, Sara/AAA-9543-2021; Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020	Polletti, Sara/0000-0002-5433-0502; Polletti, Sara/0000-0002-5433-0502; Natoli, Gioacchino/0000-0003-0711-2411				Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	10	9	9	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					764	766		10.1016/j.immuni.2017.04.010	http://dx.doi.org/10.1016/j.immuni.2017.04.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514680	Bronze			2022-12-18	WOS:000401316300009
J	Segura, E; Soumelis, V				Segura, Elodie; Soumelis, Vassili			Of Human DC Migrants and Residents	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; MIGRATION; CCR7		[Segura, Elodie; Soumelis, Vassili] PSL Res Univ, Inst Curie, INSERM, U932, 26 Rue Ulm, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Segura, E (corresponding author), PSL Res Univ, Inst Curie, INSERM, U932, 26 Rue Ulm, F-75005 Paris, France.	elodie.segura@curie.fr; vassili.soumelis@curie.fr	Segura, Elodie/K-7614-2017	Segura, Elodie/0000-0003-1795-1921				Granot T, 2017, IMMUNITY, V46, P504, DOI 10.1016/j.immuni.2017.02.019; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Segura E, 2014, IMMUNOL LETT, V158, P73, DOI 10.1016/j.imlet.2013.12.001; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Worbs T, 2017, NAT REV IMMUNOL, V17, P30, DOI 10.1038/nri.2016.116	10	9	10	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					342	344		10.1016/j.immuni.2017.03.006	http://dx.doi.org/10.1016/j.immuni.2017.03.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329699	Bronze			2022-12-18	WOS:000396818100006
J	Araya, RE; Goldszmid, RS				Araya, Romina E.; Goldszmid, Romina S.			Two Bugs a NOD Away from Improving Cancer Therapy Efficacy	IMMUNITY			English	Editorial Material							GUT MICROBIOTA; IMMUNOTHERAPY		[Araya, Romina E.; Goldszmid, Romina S.] NCI, Inflammatory Cell Dynam Sect, Canc & Inflammat Program, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Goldszmid, RS (corresponding author), NCI, Inflammatory Cell Dynam Sect, Canc & Inflammat Program, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	rgoldszmid@mail.nih.gov		Araya, Romina Elizabeth/0000-0001-9787-2670	NATIONAL CANCER INSTITUTE [ZIABC011670] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009; Gorjifard S., 2016, J LEUKOCYTE BIOL, V100, P1; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Paulos CM, 2007, CLIN CANCER RES, V13, P5280, DOI 10.1158/1078-0432.CCR-07-1378; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537	10	9	9	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					714	716		10.1016/j.immuni.2016.10.007	http://dx.doi.org/10.1016/j.immuni.2016.10.007			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760335	Bronze			2022-12-18	WOS:000389473200005
J	Chahroudi, A; Silvestri, G				Chahroudi, Ann; Silvestri, Guido			HIV and Tfh Cells: Circulating New Ideas to Identify and Protect	IMMUNITY			English	Editorial Material							ANTIBODY-RESPONSES; INFECTION	T follicular helper (Tfh) cells provide crucial support to antigen-specific B cells. In this issue of Immunity, Schultz et al. (2016) report that circulating IL-21-producing CD4(+) T cells are phenotypically, transcriptionally, and functionally similar to lymphoid Tfh cells and that such HIV-specific Tfh cells were increased in RV144 trial vaccine recipients.	[Chahroudi, Ann] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Silvestri, Guido] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Chahroudi, Ann; Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Silvestri, Guido] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA	Emory University; Emory University; Emory University; Emory University	Silvestri, G (corresponding author), Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.	gsilves@emory.edu						Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Schultz BT, 2016, IMMUNITY, V44, P167, DOI 10.1016/j.immuni.2015.12.011; Yamamoto T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3964	9	9	9	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					16	18		10.1016/j.immuni.2015.12.016	http://dx.doi.org/10.1016/j.immuni.2015.12.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789919	Bronze			2022-12-18	WOS:000368347000008
J	Schultze, JL; Beyer, M				Schultze, Joachim L.; Beyer, Marc			Myelopoiesis Reloaded: Single-Cell Transcriptomics Leads the Way	IMMUNITY			English	Editorial Material							RNA-SEQ; HETEROGENEITY	Lineage commitment during myelopoiesis has been linked to late-stage progenitors with multi-lineage potential. In a recent issue of Cell, Paul et al. (2015) now suggest a much earlier commitment toward distinct lineages even prior to the common myeloid progenitor state.	[Schultze, Joachim L.; Beyer, Marc] Univ Bonn, Life & Med Sci LIMES Inst, D-53115 Bonn, Germany; [Schultze, Joachim L.; Beyer, Marc] German Ctr Neurodegenerat Dis, Single Cell Ctr Genom & Epigen, D-53175 Bonn, Germany; [Schultze, Joachim L.; Beyer, Marc] Univ Bonn, D-53175 Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Schultze, JL (corresponding author), Univ Bonn, Life & Med Sci LIMES Inst, D-53115 Bonn, Germany.	j.schultze@uni-bonn.de; marc.beyer@uni-bonn.de	Schultze, Joachim L./ABA-8176-2020; Beyer, Marc/ABE-1408-2021; Schultze, Joachim L/D-7794-2011	Schultze, Joachim L./0000-0003-2812-9853; Beyer, Marc/0000-0001-9704-148X; Schultze, Joachim L/0000-0003-2812-9853				Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Jagannathan-Bogdan M, 2013, DEVELOPMENT, V140, P2463, DOI 10.1242/dev.083147; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Rieger MA, 2012, COLD SPRING HARB PER, V4; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	9	9	9	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					18	20		10.1016/j.immuni.2015.12.019	http://dx.doi.org/10.1016/j.immuni.2015.12.019			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789920	Bronze			2022-12-18	WOS:000368347000009
J	Russ, BE; Olshanksy, M; Smallwood, HS; Li, J; Denton, AE; Prier, JE; Stock, AT; Croom, HA; Cullen, JG; Nguyen, MLT; Rowe, S; Olson, MR; Finkelstein, DB; Kelso, A; Thomas, PG; Speed, TP; Rao, S; Turner, SJ				Russ, Brendan E.; Olshanksy, Moshe; Smallwood, Heather S.; Li, Jasmine; Denton, Alice E.; Prier, Julia E.; Stock, Angus T.; Croom, Hayley A.; Cullen, Jolie G.; Nguyen, Michelle L. T.; Rowe, Stephanie; Olson, Matthew R.; Finkelstein, David B.; Kelso, Anne; Thomas, Paul G.; Speed, Terry P.; Rao, Sudha; Turner, Stephen J.			Distinct Epigenetic Signatures Delineate Transcriptional Programs during Virus-Specific CD8(+) T Cell Differentiation (vol 41, pg 853, 2014)	IMMUNITY			English	Correction												sjturn@unimelb.edu.au	Thomas, Paul G./H-1063-2018; Turner, Stephen/GXM-4654-2022; Rao, Sudha/AAW-5192-2020	Thomas, Paul G./0000-0001-7955-0256; Rao, Sudha/0000-0001-9547-947X; Prier, Julia/0000-0002-2653-6300; Turner, Stephen/0000-0002-1002-0000; Kelso, Anne/0000-0002-3166-3267; Olson, Matthew/0000-0003-2351-6002; Denton, Alice/0000-0002-4580-3443				Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001	1	9	9	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					1064	1064		10.1016/j.immuni.2014.12.013	http://dx.doi.org/10.1016/j.immuni.2014.12.013			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM		Bronze			2022-12-18	WOS:000346654100023
J	Kyewski, B; Feuerer, M				Kyewski, Bruno; Feuerer, Markus			Love Is in the Aire: mTECs Share Their Assets	IMMUNITY			English	Editorial Material							THYMIC EPITHELIAL-CELLS; NEGATIVE SELECTION; EXPRESSION; MEDULLA	Self-tolerance imposition requires the presentation of self-antigens by a variety of thymic antigen-presenting cells. In this issue of Immunity, Perry et al. (2014) reveal unidirectional self-antigen transfer from medullary thymic epithelial cells to dendritic cells as an essential aspect.	[Kyewski, Bruno] German Canc Res Ctr, Div Dev Immunol, D-69120 Heidelberg, Germany; [Feuerer, Markus] German Canc Res Ctr, Tumor Immunol Program, Helmholtz Young Investigator Grp Immune Tolerance, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Kyewski, B (corresponding author), German Canc Res Ctr, Div Dev Immunol, D-69120 Heidelberg, Germany.	b.kyewski@dkfz.de						Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; HUMBLET C, 1994, INT IMMUNOL, V6, P1949, DOI 10.1093/intimm/6.12.1949; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Tykocinski LO, 2008, ANN NY ACAD SCI, V1143, P105, DOI 10.1196/annals.1443.018	9	9	9	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					343	345		10.1016/j.immuni.2014.08.013	http://dx.doi.org/10.1016/j.immuni.2014.08.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238088	Bronze			2022-12-18	WOS:000342626500002
J	Kwong, B; Lazarevic, V				Kwong, Brandon; Lazarevic, Vanja			T-bet Orchestrates CD8 alpha alpha IEL Differentiation	IMMUNITY			English	Editorial Material							INTRAEPITHELIAL LYMPHOCYTES; THYMOCYTES; CELL; FATE	Very little is known about the transcription factor network that regulates the development of intestinal intraepithelial lymphocytes (IELs). In this issue of Immunity, Klose et al. (2014b) and Reis et al. (2014) demonstrate an essential role for T-bet in regulating the CD8 alpha alpha IEL differentiation program.	[Kwong, Brandon; Lazarevic, Vanja] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lazarevic, V (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	lazarevicv@mail.nih.gov		Lazarevic, Vanja/0000-0002-5783-7130	Intramural NIH HHS [ZIA BC011431-02] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andrew DP, 1996, EUR J IMMUNOL, V26, P897, DOI 10.1002/eji.1830260427; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Klose CSN, 2014, IMMUNITY, V41, P230, DOI 10.1016/j.immuni.2014.06.018; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626	9	9	11	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					169	171		10.1016/j.immuni.2014.08.003	http://dx.doi.org/10.1016/j.immuni.2014.08.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148017	Bronze, Green Accepted			2022-12-18	WOS:000341455300002
J	Maizels, RM; Withers, DR				Maizels, Rick M.; Withers, David R.			MHC-II: A Mutual Support System for ILCs and T Cells?	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; INDUCTION; IMMUNITY	Innate and adaptive immune cells form an ongoing partnership during an immune response. In this issue of Immunity, Oliphant et al. (2014) show that MHC class II-peptide presentation by group 2 innate lymphoid cells is needed for reciprocal regulation of both cell types, resulting in effective antihelminth immunity.	[Maizels, Rick M.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Maizels, Rick M.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Withers, David R.] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, MRC Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Edinburgh; University of Edinburgh; University of Birmingham	Maizels, RM (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland.	rick.maizels@ed.ac.uk	Withers, David/C-7055-2015	Withers, David/0000-0003-3757-7594				Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003	8	9	10	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					174	176		10.1016/j.immuni.2014.07.006	http://dx.doi.org/10.1016/j.immuni.2014.07.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148019	Bronze			2022-12-18	WOS:000341455300004
J	Shakhar, G; Kolesnikov, M				Shakhar, Guy; Kolesnikov, Masha			Intestinal Macrophages and DCs Close the Gap on Tolerance	IMMUNITY			English	Editorial Material							CD103(+) DENDRITIC CELLS; JUNCTIONS; ANTIGEN	CD103(+) dendritic cells (DCs) must acquire soluble food antigens from the gut lumen to induce oral tolerance. In this issue of Immunity, Mazzini et al. (2014), report that CX(3)CR1(+) macrophages capture such antigen and transfer it to the DCs by a route involving gap junctions.	[Shakhar, Guy; Kolesnikov, Masha] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shakhar, G (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	shakhar@weizmann.ac.il						Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025	10	9	9	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					171	173		10.1016/j.immuni.2014.01.008	http://dx.doi.org/10.1016/j.immuni.2014.01.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24560193	Bronze			2022-12-18	WOS:000331637600003
J	Moussion, C; Sixt, M				Moussion, Christine; Sixt, Michael			A Conduit to Amplify Innate Immunity	IMMUNITY			English	Editorial Material							LYMPH-NODE CORTEX; ANTIGEN PRESENTATION; CELLS; CHEMOKINES; MOLECULES	In this issue of Immunity, Py et al. (2013) report that upon bacterial infection, a fragment of the matrix protein cochlin is released from the conduits of B cell follicles to trigger protective cytokines in the periphery.	[Moussion, Christine; Sixt, Michael] IST Austria, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Sixt, M (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	sixt@ist.ac.at		Sixt, Michael/0000-0002-6620-9179				Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Py BF, 2013, IMMUNITY, V38, P1063, DOI 10.1016/j.immuni.2013.01.015; Robertson NG, 2008, HUM MOL GENET, V17, P3426, DOI 10.1093/hmg/ddn236; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013	10	9	9	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					853	854		10.1016/j.immuni.2013.05.005	http://dx.doi.org/10.1016/j.immuni.2013.05.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23706666	Bronze			2022-12-18	WOS:000330942500005
J	Wilkins, C; Gale, M				Wilkins, Courtney; Gale, Michael, Jr.			Sterol-izing Innate Immunity	IMMUNITY			English	Editorial Material							MACROPHAGES; PATHWAY; CELLS		[Wilkins, Courtney; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gale, M (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	mgale@u.washington.edu		Wilkins, Courtney/0000-0003-4001-7686; Gale, Michael/0000-0002-6332-7436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI088778] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI088778] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Ma YJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1369, DOI 10.1152/ajpendo.90555.2008; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100	9	9	9	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 24	2013	38	1					3	5		10.1016/j.immuni.2013.01.002	http://dx.doi.org/10.1016/j.immuni.2013.01.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23352217	Bronze			2022-12-18	WOS:000314195500002
J	Le Borgne, M; Shaw, AS				Le Borgne, Marie; Shaw, Andrey S.			SAP Signaling: A Dual Mechanism of Action	IMMUNITY			English	Editorial Material							GENE-PRODUCT; RECEPTORS; ADAPTERS; CELLS	In this issue of Immunity, Kageyama et al. (2012), Zhao et al. (2012), and Dong et al. (2012) show that the adaptor protein SAP regulates both positive and negative signals through SLAM receptors to stabilize intercellular contacts.	[Le Borgne, Marie; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Le Borgne, Marie; Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	ashaw@wustl.edu	Le Borgne, Marie/P-2313-2015	Le Borgne, Marie/0000-0002-3439-4867; Shaw, Andrey/0000-0001-5685-0272				Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	10	9	9	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 29	2012	36	6					899	901		10.1016/j.immuni.2012.06.002	http://dx.doi.org/10.1016/j.immuni.2012.06.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22749348	Bronze			2022-12-18	WOS:000306097100007
J	Kagan, JC				Kagan, Jonathan C.			Recycling Endosomes and TLR Signaling-The Rab11 GTPase Leads the Way	IMMUNITY			English	Editorial Material							TOLL-LIKE-RECEPTOR-4	The ability of Toll-like receptors (TLRs) to activate innate immunity depends on their transport to pathogen-containing organelles In this issue of Immunity, Husebye et al (2010) report that delivery of TLR4 to phagosomes occurs via a recycling endosome intermediate, which is controlled by the GTPase Rab11a	[Kagan, Jonathan C.] Harvard Univ, Sch Med, Dept Pediat, Div Gastroenterol, Boston, MA 02115 USA; [Kagan, Jonathan C.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Div Gastroenterol, 300 Longwood Ave,Enders 730 2, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI072955] Funding Source: NIH RePORTER; NIAID NIH HHS [R00 AI072955] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605	10	9	9	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 29	2010	33	4					578	580		10.1016/j.immuni.2010.10.003	http://dx.doi.org/10.1016/j.immuni.2010.10.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029967	Bronze			2022-12-18	WOS:000284300200013
J	Smale, ST				Smale, Stephen T.			Seq-ing LPS-Induced Enhancers	IMMUNITY			English	Editorial Material							TRANSCRIPTIONAL CONTROL; HUMAN GENOME; CHROMATIN		Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu			NIAID NIH HHS [R01 AI073868] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073868] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037	9	9	9	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 26	2010	32	3					296	298		10.1016/j.immuni.2010.03.011	http://dx.doi.org/10.1016/j.immuni.2010.03.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20346768	Bronze			2022-12-18	WOS:000276125400001
J	Reardon, C; Mak, TW				Reardon, Colin; Mak, Tak W.			cIAP Proteins: Keystones in NOD Receptor Signal Transduction	IMMUNITY			English	Editorial Material							ACTIVATION; POLYUBIQUITINATION; DISEASE	NOD1 and 2 are intracellular sentinels critical to innate immunity. In this issue of Immunity, Bertrand et al. (2009) fill in a gap in the NOD signaling cascade by demonstrating that cIAP1 and 2 function as E3 ubiquitin ligases for the RIP2 signaling molecule.	[Reardon, Colin; Mak, Tak W.] Princess Margaret Hosp, Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Reardon, C (corresponding author), Princess Margaret Hosp, Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada.	creardon@uhnres.utoronto.ca		Reardon, Colin/0000-0003-2204-8091				Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200	8	9	9	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 19	2009	30	6					755	756		10.1016/j.immuni.2009.06.005	http://dx.doi.org/10.1016/j.immuni.2009.06.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19538923	Bronze			2022-12-18	WOS:000267270700001
J	Mills, KHG				Mills, Kingston H. G.			TLR9 Turns the Tide on Treg Cells	IMMUNITY			English	Editorial Material							SUPPRESSION		Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Mills, KHG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	kingston.mills@tcd.ie	Mills, Kingston H/F-5684-2013	Mills, Kingston H/0000-0003-3646-8222				Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Jarnicki AG, 2008, J IMMUNOL, V180, P3797, DOI 10.4049/jimmunol.180.6.3797; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kubo T, 2004, J IMMUNOL, V173, P7249, DOI 10.4049/jimmunol.173.12.7249; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720	10	9	12	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					518	520		10.1016/j.immuni.2008.09.005	http://dx.doi.org/10.1016/j.immuni.2008.09.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18957263	Green Submitted, Bronze			2022-12-18	WOS:000260316700005
J	Locksley, RM				Locksley, Richard M.			The roaring twenties	IMMUNITY			English	Editorial Material							CELLS; HYPERSENSITIVITY; DIFFERENTIATION; AUTOIMMUNITY; ELEMENTS; VITRO; MICE	New cell types and cytokines have emerged as key participants in the elaboration of and recovery from inflammation. A collection of reviews covers recent advances in our understanding of this crucial component of host defense.	[Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Scheinecker C, 2008, IMMUNITY, V28, P440, DOI 10.1016/j.immuni.2008.03.005; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	17	9	9	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2008	28	4					437	439		10.1016/j.immuni.2008.03.009	http://dx.doi.org/10.1016/j.immuni.2008.03.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400185	Bronze			2022-12-18	WOS:000254939400001
J	Kappes, DJ				Kappes, Dietmar J.			CD4 and CD8: Hogging all the Lck	IMMUNITY			English	Editorial Material							T-CELL REPERTOIRE	Specificity of T cell receptors (TCRs) to major histocompatibility complex (MHC) might be intrinsic or imposed by thymic selection. Van Laethem et al. (2007) propose that the sequestration of the kinase Lck by coreceptors prevents the selection of non-MHC-reactive TCRs.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Kappes, DJ (corresponding author), Fox Chase Canc Ctr, Philadelphia, PA 19111 USA.	dietmar.kappes@fccc.edu						BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	9	9	10	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					691	693		10.1016/j.immuni.2007.11.002	http://dx.doi.org/10.1016/j.immuni.2007.11.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18031691	Bronze			2022-12-18	WOS:000251269000002
J	Anderson, AC; Xiao, S; Kuchroo, VK				Anderson, Ana C.; Xiao, Sheng; Kuchroo, Vijay K.			Tim protein structures reveal a unique face for ligand binding	IMMUNITY			English	Editorial Material							T-CELL-ACTIVATION; GENE FAMILY; AUTOIMMUNITY; IMMUNITY	Tim molecules regulate T cell responses; however, the molecular basis of their ligand recognition remains largely unknown. In this issue of Immunity, Santiago et al. (2007) and Cao, et al. (2007) report the crystal structures of several Tims and provide insights into the structure-function relationship of these molecules.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Anderson, Ana C/ABD-6829-2021	Anderson, Ana C/0000-0002-0877-2932				Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Chakravarti S, 2005, J EXP MED, V202, P437, DOI 10.1084/jem.20050308; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102; Knickelbein JE, 2006, J IMMUNOL, V177, P4966, DOI 10.4049/jimmunol.177.8.4966; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Meyers JH, 2005, TRENDS MOL MED, V11, P362, DOI 10.1016/j.molmed.2005.06.008; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	10	9	11	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2007	26	3					273	275		10.1016/j.immuni.2007.03.004	http://dx.doi.org/10.1016/j.immuni.2007.03.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17376389	Bronze			2022-12-18	WOS:000245228100002
J	Beaven, MA				Beaven, Michael A.			Division of labor: Specialization of sphingosine kinases in mast cells	IMMUNITY			English	Editorial Material							1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE; RECEPTORS	Generation of sphingosine-1-phosphate by sphingosine kinases (SphKs) promotes allergic inflammatory diseases, but the roles of the individual SphK isoforms are unclear. Olivera et al. (2007) show that SphK2 regulates mast cell activation whereas SphK1 enhances susceptibility to antigen challenge in vivo.	Natl Heart Lung & Blood Inst, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Beaven, MA (corresponding author), Natl Heart Lung & Blood Inst, NIH, Room 8N109Bldg 10, Bethesda, MD 20892 USA.	beavenm@nhlbi.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000993, Z01HL000993] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baumruker T, 2007, EXPERT OPIN INV DRUG, V16, P283, DOI 10.1517/13543784.16.3.283; Choi OH, 1996, NATURE, V380, P634; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Melendez AJ, 2002, J BIOL CHEM, V277, P17255, DOI 10.1074/jbc.M110944200; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Olivera A, 2006, J BIOL CHEM, V281, P2515, DOI 10.1074/jbc.M508931200; Olivera A, 2005, J IMMUNOL, V174, P1153, DOI 10.4049/jimmunol.174.3.1153; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650	9	9	9	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2007	26	3					271	273		10.1016/j.immuni.2007.03.002	http://dx.doi.org/10.1016/j.immuni.2007.03.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17376388	Bronze			2022-12-18	WOS:000245228100001
J	Kioussis, D				Kioussis, Dimitris			Aiolos: An ungrateful member of the Ikaros family	IMMUNITY			English	Editorial Material							CENTROMERIC HETEROCHROMATIN; TRANSCRIPTION FACTOR; GENES; LOCUS	Ikaros family members play an important role in hematopoietic development. Thompson et al. (2007) show that pre-BCR signaling induces Aiolos expression, which in turn suppresses the expression of the pre-BCR component lambda 5 and eliminates the very structure that signaled its appearance.	Natl Inst Med Res, Med Res Council, Div Mol Immunol, London NW7 1AA, England	MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Kioussis, D (corresponding author), Natl Inst Med Res, Med Res Council, Div Mol Immunol, London NW7 1AA, England.	dkiouss@nimr.mrc.ac.uk						Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; NG SY, 2007, IN PRESS CURR OPIN I; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812	9	9	9	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2007	26	3					275	277		10.1016/j.immuni.2007.03.003	http://dx.doi.org/10.1016/j.immuni.2007.03.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17376390	Bronze			2022-12-18	WOS:000245228100003
J	Schwartzberg, PL				Schwartzberg, Pamela L.			Formin the way	IMMUNITY			English	Editorial Material							IMMUNOLOGICAL SYNAPSE; COMPLEX; POLARIZATION; CENTROSOME	Reorganization of the actin cytoskeleton requires nucleating factors, which initiate actin fiber formation. In this issue of Immunity, the functions of two classes of actin nucleators are examined in T lymphocytes, giving insight into the regulation of T cell polarity (Gomez et al., 2007).	NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schwartzberg, PL (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	pams@mail.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000123, ZIAHG000123] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Rey M, 2007, FRONT BIOSCI-LANDMRK, V12, P437, DOI 10.2741/2073; Sims TN, 2002, IMMUNOL REV, V186, P100, DOI 10.1034/j.1600-065X.2002.18610.x; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071	8	9	10	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2007	26	2					139	141		10.1016/j.immuni.2007.02.007	http://dx.doi.org/10.1016/j.immuni.2007.02.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17307700	Bronze			2022-12-18	WOS:000244628600003
J	Girardin, SE; Philpott, DJ				Girardin, SE; Philpott, DJ			PGRP-LB minds the fort	IMMUNITY			English	Editorial Material							REQUIREMENTS ALLOWING DETECTION; PEPTIDOGLYCAN; TOLL	Peptidoglycan recognition proteins (PGRPs) are a class of molecules that play a critical role in Drosophila immunity. In this issue of Immunity, Zaidman-Remy et al. (2006) show that PGRP-LB controls systemic immune responses as well as homeostasis at the barrier surfaces.	Univ Toronto, Dept Lab Med & Pathobiol, Med Sci Bldg, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Girardin, SE (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.							Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Xu M, 2004, MOL CELL BIOL, V24, P7949, DOI 10.1128/MCB.24.18.7949-7957.2004	9	9	9	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					363	366		10.1016/j.immuni.2006.04.001	http://dx.doi.org/10.1016/j.immuni.2006.04.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618594	Bronze			2022-12-18	WOS:000237153000005
J	Benedict, CA; Ware, CF				Benedict, CA; Ware, CF			Poxviruses aren't stuPYD	IMMUNITY			English	Editorial Material							IMMUNE-SYSTEM; INFLAMMASOME; PROTEIN; ASC	Pathogens utilize many strategies to dampen the host inflammatory response. In this issue of Immunity, a report by Johnston and colleagues reveals a poxvirus strategy that inhibits the inflammasome, arresting secretion of interleukin-1-related cytokines, thus silencing key alarms that mobilize host defenses.	La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Benedict, CA (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA.							Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Zuniga MC, 2002, VIRUS RES, V88, P17, DOI 10.1016/S0168-1702(02)00118-1	9	9	9	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2005	23	6					553	555		10.1016/j.immuni.2005.11.008	http://dx.doi.org/10.1016/j.immuni.2005.11.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356854	Bronze			2022-12-18	WOS:000234316900002
J	Good, MF				Good, MF			Identification of early cellular immune factors regulating growth of malaria parasites in humans	IMMUNITY			English	Editorial Material							T-CELLS; INFECTION; INDUCTION; ANTIBODY	In many host-parasite systems, regulatory T cells (CD4(+), CD25(+), FOXP3(+)) have been shown to modulate cellular immunity and pathology. In this issue of Immunity, Walther at al. have now shown that following experimental malaria infection of human volunteers, enhanced TGF-beta and T reg responses are associated with a faster parasite growth rate. The study demonstrates that regulation of cellular immunity must be addressed if we are to develop successful interventions.	PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Good, MF (corresponding author), PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.							Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Chaiyaroj SC, 2004, ACTA TROP, V89, P319, DOI 10.1016/j.actatropica.2003.10.010; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Good MF, 2005, ANNU REV IMMUNOL, V23, P69, DOI 10.1146/annurev.immunol.23.021704.115638; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRUN JL, 1983, INFECT IMMUN, V41, P1197, DOI 10.1128/IAI.41.3.1197-1204.1983; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Omer FM, 1998, J EXP MED, V188, P39, DOI 10.1084/jem.188.1.39; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006	11	9	10	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2005	23	3					241	242		10.1016/j.immuni.2005.08.011	http://dx.doi.org/10.1016/j.immuni.2005.08.011			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169495	Bronze			2022-12-18	WOS:000232382500001
J	Yewdell, JW; Princiotta, MF				Yewdell, JW; Princiotta, MF			Proteasomes get by with lots of help from their friends	IMMUNITY			English	Editorial Material							MHC CLASS-I; ANTIGEN PRESENTATION; GENERATION; MOLECULES; PEPTIDES; DEGRADATION	Proteasomes can't do it all. It was previously known that aminopeptidases frequently degrade proteasome-generated peptides. Now it appears that another protease, tripeptidyl peptidase 11 (TPP 11), plays a critical role in cleaving proteasomal produced peptides into shorter peptides that can then be degraded by aminopeptidases.	NIAID, Viral Dis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.		yewdell, jyewdell@nih.gov jonathan/A-1702-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000653, ZIAAI000653] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Princiotta MF, 2001, P NATL ACAD SCI USA, V98, P513, DOI 10.1073/pnas.021132398; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	11	9	11	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2004	20	4					362	363		10.1016/S1074-7613(04)00086-X	http://dx.doi.org/10.1016/S1074-7613(04)00086-X			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084265	Bronze			2022-12-18	WOS:000221442800002
J	Ema, H; Nakauchi, H				Ema, H; Nakauchi, H			"Homing to niche," a new criterion for hematopoietic stem cells?	IMMUNITY			English	Editorial Material							COLONY-FORMING CELLS; TERM	By combining cell surface staining with fluorochrome-conjugated monoclonal antibodies and Hoechst 33342 dye supravital staining, Matsuzaki et al. have succeeded in enriching hematopoietic stem cells (HSCs) essentially to homogeneity. When single-cell transplantation analysis was performed using the isolated cells, over 95% of the recipient mice showed long-term multilineage engraftment. The work demonstrates unexpectedly high marrow seeding efficiency of HSCs and proposes high marrow homing capacity as a new criterion for HSCs.	Univ Tokyo, Inst Med Sci, Lab Stem Cell Therapy, Ctr Med Expt,Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Ema, H (corresponding author), Univ Tokyo, Inst Med Sci, Lab Stem Cell Therapy, Ctr Med Expt,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.							Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; MATSUZAKI Y, IMMUNITY, V20, P87; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; VOGEL H, 1968, J CELL PHYSIOL, V72, P221, DOI 10.1002/jcp.1040720309; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	12	9	9	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2004	20	1					1	2		10.1016/S1074-7613(04)00002-0	http://dx.doi.org/10.1016/S1074-7613(04)00002-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738758	Bronze			2022-12-18	WOS:000221442200001
J	Abbas, AK; Sen, R				Abbas, AK; Sen, R			The activation of lymphocytes is in their CARMA	IMMUNITY			English	Editorial Material							NF-KAPPA-B; REGULATOR; BCL10		Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA; Brandeis Univ, Rosenstiel Res Ctr, Waltham, MA 02254 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	University of California System; University of California San Francisco; Brandeis University; Brandeis University	Abbas, AK (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA.							Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824	12	9	10	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2003	18	6					721	722		10.1016/S1074-7613(03)00143-2	http://dx.doi.org/10.1016/S1074-7613(03)00143-2			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818152	Bronze			2022-12-18	WOS:000183767700001
J	Yang, C; Jin, JS; Yang, YQ; Sun, HX; Wu, LL; Shen, MY; Hong, XC; Li, WW; Lu, L; Cao, DQ; Wang, XR; Sun, J; Ye, YQ; Su, B; Deng, LF				Yang, Chao; Jin, Jingsi; Yang, Yuanqin; Sun, Hongxiang; Wu, Lingling; Shen, Mingyi; Hong, Xiaochuan; Li, Wenwen; Lu, Lu; Cao, Dongqing; Wang, Xinran; Sun, Jing; Ye, Youqiong; Su, Bing; Deng, Liufu			Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity	IMMUNITY			English	Article							DENDRITIC CELLS; DNA-REPAIR; CANCER; SUBSETS; IMMUNOTHERAPY; DIMORPHISM; RESISTANCE; PHENOTYPE	The incidence and mortality rates of many non-reproductive human cancers are generally higher in males than in females. However, the immunological mechanism underlying sexual differences in cancers remains elusive. Here, we demonstrated that sex-related differences in tumor burden depended on adaptive immunity. Male CD8(+) T cells exhibited impaired effector and stem cell-like properties compared with female CD8(+ )T cells. Mechanistically, androgen receptor inhibited the activity and sternness of male tumor-infiltrating CD8(+) T cells by regulating epigenetic and transcriptional differentiation programs, Castration combined with anti-PD-L1 treatment synergistically restricted tumor growth in male mice. In humans, fewer male CD8(+) T cells maintained a stem cell-like memory state compared with female counterparts. Moreover, AR expression correlated with tumor-infiltrating CD8(+) T cell exhaustion in cancer patients. Our findings reveal sex-biased CD8(+) T cell stemness programs in cancer progression and in the responses to cancer immunotherapy, providing insights into the development of sex-based immunotherapeutic strategies for cancer treatment.	[Yang, Chao; Jin, Jingsi; Yang, Yuanqin; Sun, Hongxiang; Wu, Lingling; Shen, Mingyi; Hong, Xiaochuan; Li, Wenwen; Lu, Lu; Cao, Dongqing; Ye, Youqiong; Su, Bing] Shanghai Jiao Tong Univ, Shanghai Inst Immunol,Sch Med, Dept Immunol & Microbiol,Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis Chinese, Shanghai 200025, Peoples R China; [Yang, Chao; Yang, Yuanqin; Wu, Lingling; Hong, Xiaochuan; Lu, Lu; Deng, Liufu] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Wang, Xinran] Shanghai Jiao Tong Univ, Ren Ji Hosp, Dept Obstet & Gynecol, Shanghai Key Lab Gynecol Oncol,Sch Med, Shanghai 200127, Peoples R China; [Sun, Jing] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gen Surg, Sch Med, Shanghai 200025, Peoples R China; [Deng, Liufu] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Deng, LF (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China.; Deng, LF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai 200025, Peoples R China.	dengliufu@sjtu.edu.cn	Wu, Ling/GZN-2235-2022	, Liufu/0000-0002-1164-6777	National Natural Science Foundation of China [81771682, 82071741, 81702804]; National Thousand Youth Talents Program; Science and Technology Commission of Shanghai Municipality [16JC1406000, 20JC1410100]; Innovative research team of high-level local universities in Shanghai; Shanghai Municipal Commission of Health and Family Planning [20194Y0625]; Interdisciplinary Program of Shanghai Jiao Tong University [YG2021ZD03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Thousand Youth Talents Program; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Innovative research team of high-level local universities in Shanghai; Shanghai Municipal Commission of Health and Family Planning; Interdisciplinary Program of Shanghai Jiao Tong University	We gratefully acknowledge Yang-Xin Fu, Jinke Cheng, Meng Xu, and Sheng-dian Wang for helpful scientific discussion, and Shuchun Li and Yao Zhang for the collection of tissue specimens from cancer patients. This work was sup- ported from the National Natural Science Foundation of China (81771682 and 82071741 to L.D., 81702804 to W.L.) , National Thousand Youth Talents Program (to L.D.) , Science and Technology Commission of Shanghai Munici-pality (16JC1406000 to L.D., 20JC1410100) , Innovative research team of high-level local universities in Shanghai (to L.D. and W.L.) , Shanghai Municipal Commission of Health and Family Planning (20194Y0625 to W.L.) , and the Interdisciplinary Program of Shanghai Jiao Tong University (YG2021ZD03 to L.D.)	Acharya N, 2020, IMMUNITY, V53, P658, DOI 10.1016/j.immuni.2020.08.005; Andreatta M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23324-4; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Arlauckas SP, 2018, THERANOSTICS, V8, P5842, DOI 10.7150/thno.26888; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Bayik D, 2020, CANCER DISCOV, V10, P1210, DOI 10.1158/2159-8290.CD-19-1355; Boulch M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd4344; Bruni D, 2020, NAT REV CANCER, V20, P662, DOI 10.1038/s41568-020-0285-7; Bunders MJ, 2020, IMMUNITY, V53, P487, DOI 10.1016/j.immuni.2020.08.003; Chan JD, 2021, NAT REV IMMUNOL, V21, P769, DOI 10.1038/s41577-021-00539-6; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Clocchiatti A, 2018, J CLIN INVEST, V128, P5531, DOI 10.1172/JCI99159; Clocchiatti A, 2016, NAT REV CANCER, V16, P330, DOI 10.1038/nrc.2016.30; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Guan XN, 2022, NATURE, V606, P791, DOI 10.1038/s41586-022-04522-6; Haupt S, 2021, NAT REV CANCER, V21, P393, DOI 10.1038/s41568-021-00348-y; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hosokawa H, 2021, NAT REV IMMUNOL, V21, P162, DOI 10.1038/s41577-020-00426-6; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Johnnidis JB, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe3702; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Krishna S, 2020, SCIENCE, V370, P1328, DOI 10.1126/science.abb9847; Lee HO, 2020, NAT GENET, V52, P594, DOI 10.1038/s41588-020-0636-z; Li WW, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay9013; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Scotland RS, 2011, BLOOD, V118, P5918, DOI 10.1182/blood-2011-03-340281; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Takahashi T, 2020, NATURE, V588, DOI 10.1038/s41586-020-2700-3; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vasanthakumar A, 2020, NATURE, V579, P581, DOI 10.1038/s41586-020-2040-3; Verma V, 2021, NAT IMMUNOL, V22, P53, DOI 10.1038/s41590-020-00818-9; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Wculek SK, 2020, NAT REV IMMUNOL, V20, P7, DOI 10.1038/s41577-019-0210-z; Wei Z, 2018, BIOINFORMATICS, V34, P2664, DOI 10.1093/bioinformatics/bty141; Yang W, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aao5253; Yao C, 2021, NAT IMMUNOL, V22, P370, DOI 10.1038/s41590-021-00868-7; Zhao RZ, 2020, NATURE, V577, P416, DOI 10.1038/s41586-019-1873-0	50	8	8	13	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1268	+		10.1016/j.immuni.2022.05.012	http://dx.doi.org/10.1016/j.immuni.2022.05.012			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3D3AD	35700739				2022-12-18	WOS:000829177900003
J	Gideon, HP; Hughes, TK; Tzouanas, CN; Wadsworth, MH; Tu, AA; Gierahn, TM; Peters, JM; Hopkins, FF; Wei, JR; Kummerlowe, C; Nargan, K; Phuah, JY; Borish, HJ; Maiello, P; White, AG; Winchell, CG; Nyquist, SK; Ganchua, SKC; Myers, A; Patel, KV; Ameel, CL; Cochran, CT; Ibrahim, S; Tomko, JA; Frye, LJ; Rosenberg, JM; Shih, A; Chao, M; Klein, E; Scanga, CA; Ordovas-Montanes, J; Berger, B; Mattila, JT; Madansein, R; Love, JC; Lin, PL; Leslie, A; Behar, SM; Bryson, B; Flynn, JL; Fortune, SM; Shalek, AK				Gideon, Hannah P.; Hughes, Travis K.; Tzouanas, Constantine N.; Wadsworth, Marc H., II; Tu, Ang Andy; Gierahn, Todd M.; Peters, Joshua M.; Hopkins, Forrest F.; Wei, Jun-Rong; Kummerlowe, Conner; Nargan, Kievershen; Phuah, Jia Yao; Borish, H. Jacob; Maiello, Pauline; White, Alexander G.; Winchell, Caylin G.; Nyquist, Sarah K.; Ganchua, Sharie Keanne C.; Myers, Amy; V. Patel, Kush; Ameel, Cassaundra L.; Cochran, Catherine T.; Ibrahim, Samira; Tomko, Jaime A.; Frye, Lonnie James; Rosenberg, Jacob M.; Shih, Angela; Chao, Michael; Klein, Edwin; Scanga, Charles A.; Ordovas-Montanes, Jose; Berger, Bonnie; Mattila, Joshua T.; Madansein, Rajhmun; Love, J. Christopher; Lin, Philana Ling; Leslie, Alasdair; Behar, Samuel M.; Bryson, Bryan; Flynn, JoAnne L.; Fortune, Sarah M.; Shalek, Alex K.			Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; CCR6-EXPRESSING TH17 CELLS; HOST-DIRECTED THERAPY; MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; IMMUNE-RESPONSE; IFN-GAMMA; INFECTION; EXPRESSION; DIFFERENTIATION	Mycobacterium tuberculosis lung infection results in a complex multicellular structure: the granuloma. In some granulomas, immune activity promotes bacterial clearance, but in others, bacteria persist and grow. We identified correlates of bacterial control in cynomolgus macaque lung granulomas by co-registering longitudinal positron emission tomography and computed tomography imaging, single-cell RNA sequencing, and measures of bacterial clearance. Bacterial persistence occurred in granulomas enriched for mast, endothelial, fibroblast, and plasma cells, signaling amongst themselves via type 2 immunity and wound-healing pathways. Granulomas that drove bacterial control were characterized by cellular ecosystems enriched for type 1-type 17, stem-like, and cytotoxic T cells engaged in pro-inflammatory signaling networks involving diverse cell populations. Granulomas that arose later in infection displayed functional characteristics of restrictive granulomas and were more capable of killing Mtb. Our results define the complex multicellular ecosystems underlying (lack of) granuloma resolution and highlight host immune targets that can be leveraged to develop new vaccine and therapeutic strategies for TB.	[Gideon, Hannah P.; Phuah, Jia Yao; Borish, H. Jacob; Maiello, Pauline; White, Alexander G.; Winchell, Caylin G.; Ganchua, Sharie Keanne C.; Myers, Amy; V. Patel, Kush; Ameel, Cassaundra L.; Cochran, Catherine T.; Tomko, Jaime A.; Frye, Lonnie James; Scanga, Charles A.; Flynn, JoAnne L.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15260 USA; [Gideon, Hannah P.; Winchell, Caylin G.; Scanga, Charles A.; Mattila, Joshua T.; Lin, Philana Ling; Flynn, JoAnne L.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Hughes, Travis K.; Tzouanas, Constantine N.; Wadsworth, Marc H., II; Nyquist, Sarah K.; Ibrahim, Samira; Shalek, Alex K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hughes, Travis K.; Tzouanas, Constantine N.; Wadsworth, Marc H., II; Peters, Joshua M.; Wei, Jun-Rong; Nyquist, Sarah K.; Rosenberg, Jacob M.; Chao, Michael; Ordovas-Montanes, Jose; Love, J. Christopher; Bryson, Bryan; Fortune, Sarah M.; Shalek, Alex K.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA; [Hughes, Travis K.; Tzouanas, Constantine N.; Wadsworth, Marc H., II; Nyquist, Sarah K.; Ibrahim, Samira; Fortune, Sarah M.; Shalek, Alex K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wadsworth, Marc H., II; Fortune, Sarah M.; Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Tu, Ang Andy; Gierahn, Todd M.; Peters, Joshua M.; Bryson, Bryan] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hopkins, Forrest F.; Wei, Jun-Rong; Rosenberg, Jacob M.; Fortune, Sarah M.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kummerlowe, Conner; Nyquist, Sarah K.] MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nargan, Kievershen; Leslie, Alasdair] Africa Hlth Res Inst, Durban, South Africa; [Winchell, Caylin G.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Sch Med, Pittsburgh, PA USA; [Nyquist, Sarah K.; Berger, Bonnie] MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rosenberg, Jacob M.; Shih, Angela] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Klein, Edwin] Univ Pittsburgh, Div Lab Anim Res, Pittsburgh, PA USA; [Mattila, Joshua T.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Madansein, Rajhmun] Univ KwaZulu Natal, Dept Cardiothorac Surg, Durban, South Africa; [Love, J. Christopher] MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Love, J. Christopher; Shalek, Alex K.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Lin, Philana Ling] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA USA; [Leslie, Alasdair] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Leslie, Alasdair] UCL, Dept Infect & Immun, London, England; [Behar, Samuel M.] Univ Massachusetts, Dept Microbiol & Physiol Syst, Med Sch, Worcester, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Africa Health Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kwazulu Natal; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kwazulu Natal; University of London; University College London; University of Massachusetts System; University of Massachusetts Worcester	Flynn, JL (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15260 USA.; Flynn, JL (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.; Fortune, SM; Shalek, AK (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA.; Fortune, SM; Shalek, AK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Shalek, AK (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Fortune, SM (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Shalek, AK (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	joanne@pitt.edu; sfortune@hsph.harvard.edu; shalek@mit.edu	Shih, Angela R/AAQ-7578-2020	Shih, Angela R/0000-0002-8945-5997; Hopkins, Forrest/0000-0002-3801-4673; Kummerlowe, Conner/0000-0002-8641-2916; Peters, Joshua/0000-0001-9163-6706; Tzouanas, Constantine/0000-0002-7536-1156; Chao, Michael/0000-0003-3158-7337; Behar, Samuel/0000-0002-3374-6699; Fortune, Sarah/0000-0001-7565-9975; , Joshua/0000-0002-6384-1291	Bill and MelindaGates Foundation [OP1139972, OPP1202327]; Searle Scholars Program; Beckman Young Investigator Program; Sloan Fellowship in Chemistry; NIH [5U24AI118672, BAA-NIAID-NIHAI201700104, T32A1065380, R01A1022553, T32 A1007387]; American Lung Association [RG571577]; NSF GRFP grant [1122374]; Fannie and John Hertz Foundation Fellowship; Wellcome Trust [210662/Z/16/Z]; Koch Institute Support (core) grant from the National Cancer Institute [P30-CA14051]; NIH CFAR [P30 AI060354]; NIH K12;  [F30-AI143160]	Bill and MelindaGates Foundation(Bill & Melinda Gates Foundation); Searle Scholars Program; Beckman Young Investigator Program; Sloan Fellowship in Chemistry; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NSF GRFP grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Fannie and John Hertz Foundation Fellowship; Wellcome Trust(Wellcome Trust); Koch Institute Support (core) grant from the National Cancer Institute; NIH CFAR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH K12(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	We are grateful to the research and veterinary technicians: Chelsea Chedrick, Carolyn Bigbee, Nicholas Schindler, Mark Rogers, Tara Rutledge, Chelsea Causgrove, and Brianne Stein in the Flynn lab who assisted with this work, as well as helpful discussions with members of the Flynn, Scanga, Mattila, Lin, and Shalek laboratories. We also thank the efforts of the University of Pitts-burgh Division of Laboratory Animal Research technicians for husbandry of the animals. We acknowledge the following funding sources: Bill and MelindaGates Foundation (OP1139972, A.L., S.M.B., S.M.F., J.L.F., A.K.S.; OPP1202327, A.K.S.) , Searle Scholars Program (A.K.S.) , The Beckman Young Investigator Program (A.K.S.) , Sloan Fellowship in Chemistry (A.K.S.) . NIH (5U24AI118672 and BAA-NIAID-NIHAI201700104, A.K.S.) , American Lung As-sociation (RG571577, H.P.G.) , F30-AI143160 (T.K.H.) , NIH T32A1065380 (N.L.G.) , NSF GRFP grant (C.N.T., S.K.N., 1122374) . Fannie and John Hertz Foundation Fellowship (C.N.T.) , Wellcome Trust Fellowship award 210662/Z/16/Z (A.L.) , Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute (C.L.) , NIH CFAR P30 AI060354 (B.B.) , NIH R01A1022553 (B.B.) , T32 A1007387 (J.R.) , and NIH K12 (C.W.) .	A. G.White, 2020, bioRxiv, DOI 10.1101/2020.02.21.959353; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ahmed R, 2016, CELL REP, V17, P2811, DOI 10.1016/j.celrep.2016.11.037; Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Barone R, 2007, CLIN LAB, V53, P321; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Caccamo N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02832; Cadena AM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007305; Cadena AM, 2016, MBIO, V7, DOI 10.1128/mBio.00342-16; Canetti G, 1955, TUBERCLE BACILLUS PU; Cartwright EK, 2016, J VIROL, V90, P6699, DOI 10.1128/JVI.00492-16; Coleman MT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009500; Coleman MT, 2014, INFECT IMMUN, V82, P2400, DOI 10.1128/IAI.01599-13; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; Cronan MR, 2021, CELL, V184, P1757, DOI 10.1016/j.cell.2021.02.046; Darrah PA, 2020, NATURE, V577, P95, DOI 10.1038/s41586-019-1817-8; Datta M, 2015, P NATL ACAD SCI USA, V112, P1827, DOI 10.1073/pnas.1424563112; Dijkman K, 2019, NAT MED, V25, P255, DOI 10.1038/s41591-018-0319-9; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Esaulova E, 2021, CELL HOST MICROBE, V29, P165, DOI 10.1016/j.chom.2020.11.013; Flynn J.L.K.E., 2011, COLOR ATLAS COMP PAT, P83; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Foreman TW, 2016, P NATL ACAD SCI USA, V113, pE5636, DOI 10.1073/pnas.1611987113; Fujii R, 2018, CANCER IMMUNOL IMMUN, V67, P675, DOI 10.1007/s00262-018-2121-4; Garcia-Rodriguez KM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01290; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gideon HP, 2019, MUCOSAL IMMUNOL, V12, P1370, DOI 10.1038/s41385-019-0195-8; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Grant N.L., 2022, CELL REP, DOI [10.1101/2022.01.25.477732, DOI 10.1101/2022.01.25.477732]; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Han XP, 2018, CELL, V173, P1307, DOI 10.1016/j.cell.2018.05.012; Heemskerk MT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-98980-z; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hojo-Souza NS, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008840; Hughes TK, 2020, IMMUNITY, V53, P878, DOI 10.1016/j.immuni.2020.09.015; Hunter RL, 2016, TUBERCULOSIS, V97, P8, DOI 10.1016/j.tube.2015.11.010; Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jacobs AJ, 2016, TUBERCULOSIS, V101, P102, DOI 10.1016/j.tube.2016.08.001; Joshi N, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00646-2019; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Kanagaratham C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.603050; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kienzle N, 2005, J IMMUNOL, V174, P2021, DOI 10.4049/jimmunol.174.4.2021; Knudson KM, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0551-y; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Lee W, 2021, J VIROL, V95, DOI 10.1128/JVI.00530-21; Lenaerts A, 2015, IMMUNOL REV, V264, P288, DOI 10.1111/imr.12252; Li Q, 2013, ACTA BIOCH BIOPH SIN, V45, P593, DOI 10.1093/abbs/gmt049; Liang Y, 2015, INT REV IMMUNOL, V34, P318, DOI 10.3109/08830185.2014.954698; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Lin CC, 2016, J EXP MED, V213, P251, DOI 10.1084/jem.20150568; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lin PL, 2007, J INVEST DERM SYMP P, V12, P22, DOI 10.1038/sj.jidsymp.5650027; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2012, AIDS RES HUM RETROV, V28, P1693, DOI [10.1089/aid.2012.0028, 10.1089/AID.2012.0028]; Lin PL, 2013, ANTIMICROB AGENTS CH, V57, P4237, DOI 10.1128/AAC.00277-13; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lopez D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4167-7; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Lyadova IV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/854507; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Maiello P, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00505-17; Malherbe ST, 2016, NAT MED, V22, P1094, DOI 10.1038/nm.4177; Marraco SAF, 2015, GENOM DATA, V5, P297, DOI 10.1016/j.gdata.2015.06.024; Martin CJ, 2017, MBIO, V8, DOI 10.1128/mBio.00312-17; Mateus J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003432; Mattila JT, 2015, CELL MICROBIOL, V17, P1085, DOI 10.1111/cmi.12428; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Mattila JT, 2011, J IMMUNOL, V186, P3527, DOI 10.4049/jimmunol.1003773; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McCaffrey EF, 2022, NAT IMMUNOL, V23, P318, DOI 10.1038/s41590-021-01121-x; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005; Mpande CAM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00324; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nakano H., 2019, J IMMUNOL, V202, P1722; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Nikitina IY, 2018, J IMMUNOL, V200, P2090, DOI 10.4049/jimmunol.1701424; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Padela S, 2008, PEDIATR RES, V63, P232, DOI 10.1203/PDR.0b013e31815f6e3a; Pagan AJ, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018499; Phuah JY, 2012, AM J PATHOL, V181, P508, DOI 10.1016/j.ajpath.2012.05.009; Phuah J, 2016, INFECT IMMUN, V84, P1301, DOI 10.1128/IAI.00083-16; Polena H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33162; Potters EL, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abb4582; Prakadan SM, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.15; Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011; Rath JA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz7809; Reece ST, 2012, CURR OPIN MICROBIOL, V15, P63, DOI 10.1016/j.mib.2011.10.006; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sakai S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005667; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scriba TJ, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0016-2016; Shanmugasundaram U, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137858; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Stanley SA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003946; Szabo PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12464-3; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Todryk SM, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6040084; Touzot M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4987; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van Hamburg JP, 2018, J AUTOIMMUN, V87, P69, DOI 10.1016/j.jaut.2017.12.006; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Vesely MCA, 2019, CELL, V178, P1176, DOI 10.1016/j.cell.2019.07.032; Wacleche VS, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0293-6; White AG, 2017, JOVE-J VIS EXP, DOI 10.3791/56375; Wijesundara DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055788; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wong EA, 2020, J IMMUNOL, V204, P644, DOI 10.4049/jimmunol.1901211; Wong EA, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00426-18; Wu C, 2013, P NATL ACAD SCI USA, V110, P7802, DOI 10.1073/pnas.1211776110; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yap J, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00714; Young MD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa151; Zhang GL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004426; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; zu Horste GM, 2016, CELL REP, V16, P392, DOI 10.1016/j.celrep.2016.05.088	137	8	8	8	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					827	+		10.1016/j.immuni.2022.04.004	http://dx.doi.org/10.1016/j.immuni.2022.04.004			31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35483355	hybrid, Green Published			2022-12-18	WOS:000802171100009
J	Feng, J; Pucella, JN; Jang, G; Alcantara-Hernandez, M; Upadhaya, S; Adams, NM; Khodadadi-Jamayran, A; Lau, CM; Stoeckius, M; Hao, S; Smibert, P; Tsirigos, A; Idoyaga, J; Reizis, B				Feng, Jue; Pucella, Joseph N.; Jang, Geunhyo; Alcantara-Hernandez, Marcela; Upadhaya, Samik; Adams, Nicholas M.; Khodadadi-Jamayran, Alireza; Lau, Colleen M.; Stoeckius, Marlon; Hao, Stephanie; Smibert, Peter; Tsirigos, Aristotelis; Idoyaga, Juliana; Reizis, Boris			Clonal lineage tracing reveals shared origin of conventional and plasmacytoid dendritic cells	IMMUNITY			English	Article							TRANSCRIPTION FACTOR E2-2; HEMATOPOIETIC STEM-CELLS; NEGATIVE REGULATOR; READ ALIGNMENT; IN-VITRO; EXPRESSION; PROGENITORS; DIFFERENTIATION; MACROPHAGES; MONOCYTES	Developmental origins of dendritic cells (DCs) including conventional DCs (cDCs, comprising cDC1 and cDC2 subsets) and plasmacytoid DCs (pDCs) remain unclear. We studied DC development in unmanipulated adult mice using inducible lineage tracing combined with clonal DNA "barcoding" and single-cell transcriptome and phenotype analysis (CITE-seq). Inducible tracing of Cx3cr1(+) hematopoietic progenitors in the bone marrow showed that they simultaneously produce all DC subsets including pDCs, cDC1 s, and cDC2s. Clonal tracing of hematopoietic stem cells (HSCs) and of Cx3cr1(+) progenitors revealed clone sharing between cDC1 s and pDCs, but not between the two cDC subsets or between pDCs and B cells. Accordingly, CITE-seq analyses of differentiating HSCs and Cx3cr1(+) progenitors identified progressive stages of pDC development including Cx3cr1(+) Ly-6D(+) pro-pDCs that were distinct from lymphoid progenitors. These results reveal the shared origin of pDCs and cDCs and suggest a revised scheme of DC development whereby pDCs share clonal relationship with cDC1s.	[Feng, Jue; Pucella, Joseph N.; Jang, Geunhyo; Upadhaya, Samik; Adams, Nicholas M.; Khodadadi-Jamayran, Alireza; Lau, Colleen M.; Tsirigos, Aristotelis; Reizis, Boris] NYU, Dept Pathol, Grossman Sch Med, New York, NY 10016 USA; [Alcantara-Hernandez, Marcela; Idoyaga, Juliana] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Alcantara-Hernandez, Marcela; Idoyaga, Juliana] Stanford Univ, Immunol Program, Sch Med, Stanford, CA 94305 USA; [Khodadadi-Jamayran, Alireza; Tsirigos, Aristotelis] NYU, Grossman Sch Med, Appl Bioinformat Labs, New York, NY 10016 USA; [Stoeckius, Marlon; Hao, Stephanie; Smibert, Peter] New York Genome Ctr, Technol Innovat Lab, New York, NY 10013 USA	New York University; Stanford University; Stanford University; New York University	Feng, J; Reizis, B (corresponding author), NYU, Dept Pathol, Grossman Sch Med, New York, NY 10016 USA.	jue.feng@nyulangone.org; boris.reizis@nyulangone.org		Khodadadi-Jamayran, Alireza/0000-0003-2495-7504; Feng, Jue/0000-0002-2506-1294; Stoeckius, Marlon/0000-0002-5658-029X; Pucella, Joseph/0000-0003-0875-8046	NIH [AI072571, AG049074, AI115382, AI128730, AI158808, HL145997, CA009161, AI100853]; Damon Runyon postdoctoral fellowship [DRG 2408-20]; NIH at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon postdoctoral fellowship; NIH at the Laura and Isaac Perlmutter Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the NIH grants AI072571, AG049074, AI115382, and AI128730 (B.R.) , AI158808 (J.I.) , HL145997 and CA009161 (J.N.P.) and AI100853 (C.M.L.) , and by Damon Runyon postdoctoral fellowship DRG 2408-20 (N.M.A.) . We acknowledge the use of resources provided by NYU Genome Technology Center (GTC) , NYU Applied Bioinformatics Facility Laboratories (ABL) , and the NYU High Performance Computing Facility (HPCF) . GTC and ABL are Shared Resources partially supported by NIH grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center.	Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; B.-K.Lee, 2018, bioRxiv, DOI 10.1101/310680; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Bagadia P, 2019, NAT IMMUNOL, V20, P1174, DOI 10.1038/s41590-019-0449-3; Balan S, 2018, CELL REP, V24, P1902, DOI 10.1016/j.celrep.2018.07.033; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Cabeza-Cabrerizo M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw1941; Carrelha J, 2018, NATURE, V554, P106, DOI 10.1038/nature25455; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Cytlak U, 2020, IMMUNITY, V53, P353, DOI 10.1016/j.immuni.2020.07.003; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Dursun E, 2016, SCI REP-UK, V6, DOI 10.1038/srep37462; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grajkowska LT, 2017, IMMUNITY, V46, P65, DOI 10.1016/j.immuni.2016.11.006; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Harman BC, 2006, BLOOD, V108, P878, DOI 10.1182/blood-2005-11-4545; Helft J, 2017, CELL REP, V20, P529, DOI 10.1016/j.celrep.2017.06.075; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jacobsen SEW, 2019, NAT CELL BIOL, V21, P2, DOI 10.1038/s41556-018-0227-8; Kaitani A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25646-8; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kester L, 2018, CELL STEM CELL, V23, P166, DOI 10.1016/j.stem.2018.04.014; Khodadadi-Jamayran A., 2020, BIORXIV, DOI [10.1101/2020.05.05.078550, DOI 10.1101/2020.05.05.078550]; Khodadadi-Jamayran A., 2020, BIORXIV, DOI [10.1101/2020.03.31.019109, DOI 10.1101/2020.03.31.019109]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Leylek R, 2019, CELL REP, V29, P3736, DOI 10.1016/j.celrep.2019.11.042; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liggett LA, 2020, CELL, V182, P1384, DOI 10.1016/j.cell.2020.08.030; Lin DS, 2021, NAT CELL BIOL, V23, P219, DOI 10.1038/s41556-021-00636-7; Lin DS, 2018, CELL REP, V22, P2557, DOI 10.1016/j.celrep.2018.02.046; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Loschko J, 2016, J IMMUNOL METHODS, V434, P32, DOI 10.1016/j.jim.2016.04.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mach N, 2000, CANCER RES, V60, P3239; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mandl M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134176; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pei WK, 2017, NATURE, V548, P456, DOI 10.1038/nature23653; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Pucella JN, 2020, ANNU REV CELL DEV BI, V36, P529, DOI 10.1146/annurev-cellbio-020520-114601; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Siegemund S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124661; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tang KH, 2022, CANCER DISCOV, V12, P47, DOI 10.1158/2159-8290.CD-21-0369; Tian LY, 2021, IMMUNITY, V54, P1338, DOI 10.1016/j.immuni.2021.03.012; Upadhaya S, 2018, J EXP MED, V215, P2815, DOI 10.1084/jem.20180136; van Buggenum JAGL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22675; Weigert A, 2012, BLOOD, V120, P3001, DOI 10.1182/blood-2012-03-417022; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	96	8	8	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					405	+		10.1016/j.immuni.2022.01.016	http://dx.doi.org/10.1016/j.immuni.2022.01.016			30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35180378				2022-12-18	WOS:000791044400008
J	Zander, R; Kasmani, MY; Chen, Y; Topchyan, P; Shen, J; Zheng, SK; Burns, R; Ingram, J; Cui, C; Joshi, N; Craft, J; Zajac, A; Cui, WG				Zander, Ryan; Kasmani, Moujtaba Y.; Chen, Yao; Topchyan, Paytsar; Shen, Jian; Zheng, Shikan; Burns, Robert; Ingram, Jennifer; Cui, Can; Joshi, Nikhil; Craft, Joseph; Zajac, Allan; Cui, Weiguo			Tfh-cell-derived interleukin 21 sustains effector CD8(+) T cell responses during chronic viral infection	IMMUNITY			English	Article							FOLLICULAR HELPER-CELL; TRANSCRIPTION FACTOR; PROLIFERATIVE BURST; RNA-SEQ; DIFFERENTIATION; CD4(+); ANTIGEN; PERSISTENCE; EXPRESSION; ABSENCE	CD4(+) T cell-derived interleukin 21 (IL-21) sustains CD8(+) T cell responses during chronic viral infection, but the helper subset that confers this protection remains unclear. Here, we applied scRNA and ATAC-seq approaches to determine the heterogeneity of IL-21(+) CD4(+) T cells during LCMV clone 13 infection. CD4(+) T cells were comprised of three transcriptionally and epigenetically distinct populations: Cxcr6(+) Th1 cells, Cxcr5(+) Tfh cells, and a previously unrecognized Slamf6(+) memory-like (Tml) subset. T cell differentiation was specifically redirected toward the Tml subset during chronic, but not acute, LCMV infection, Although this subset displayed an enhanced capacity to accumulate and some developmental plasticity, it remained largely quiescent, which may hinder its helper potential. Conversely, mixed bone marrow chimera experiments revealed that Tfh cell-derived IL-21 was critical to sustain CD8(+) T cell responses and viral control. Thus, strategies that bolster IL-21(+)Tfh cell responses may prove effective in enhancing CD8(+) T cell-mediated immunity.	[Zander, Ryan; Kasmani, Moujtaba Y.; Chen, Yao; Topchyan, Paytsar; Shen, Jian; Zheng, Shikan; Burns, Robert; Cui, Weiguo] Versiti Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Kasmani, Moujtaba Y.; Chen, Yao; Topchyan, Paytsar; Shen, Jian; Cui, Weiguo] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA; [Cui, Can; Joshi, Nikhil; Craft, Joseph] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Ingram, Jennifer; Zajac, Allan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35233 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Yale University; University of Alabama System; University of Alabama Birmingham	Cui, WG (corresponding author), Versiti Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA.; Cui, WG (corresponding author), Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA.	weiguo.cui@bcw.edu	Cui, Can/AAA-2665-2021	Cui, Can/0000-0003-4736-4330; Zander, Ryan/0000-0002-7431-8535; Topchyan, Paytsar/0000-0002-3902-7652; Kasmani, Moujtaba/0000-0002-5753-5335; Shen, Jian/0000-0001-8398-2318	NIH [AI125741, AI148403, AI153537, AI156290, CA246920, DK127526]; American Cancer Society (ACS); Advancing a Healthier Wisconsin Endowment (AHW); Cancer Research Institute Irvington Fellowship; NIGMS [T32-GM080202]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); Advancing a Healthier Wisconsin Endowment (AHW); Cancer Research Institute Irvington Fellowship; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grants AI125741 (W.C.) , AI148403 (W.C.) , AI153537 (R.Z.) , AI156290 (A.Z) , CA246920 (P.T.) , and DK127526 (M.Y.K) ; by an American Cancer Society (ACS) Research Scholar Grant (W.C.) ; and by an Advancing a Healthier Wisconsin Endowment (AHW) grant (W.C.) . R.Z. was also supported by the Cancer Research Institute Irvington Fellowship dur-ing this study. M.Y.K. and P.T. are members of the Medical Scientist Training Program at the Medical College of Wisconsin (MCW) , which is partially sup-ported by a training grant from NIGMS (T32-GM080202) . This research was completed in part with computational resources and technical support pro-vided by the Research Computing Center at MCW.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Arnold CN, 2007, EUR J IMMUNOL, V37, P100, DOI 10.1002/eji.200636486; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chevrier S, 2014, J EXP MED, V211, P827, DOI 10.1084/jem.20131831; Choi J, 2021, TRENDS IMMUNOL, V42, P336, DOI 10.1016/j.it.2021.02.002; Choi JY, 2020, NAT IMMUNOL, V21, P777, DOI 10.1038/s41590-020-0706-5; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Cook KD, 2015, IMMUNITY, V43, P703, DOI 10.1016/j.immuni.2015.09.002; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cui C., 2021, Cell, V184, DOI 10.1016/; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Greczmiel U, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8686; HAN SH, 1995, J IMMUNOL, V155, P556; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hart GT, 2012, J IMMUNOL, V188, P521, DOI 10.4049/jimmunol.1101530; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kanev K, 2019, P NATL ACAD SCI USA, V116, P20070, DOI 10.1073/pnas.1902701116; Kang BY, 2005, MOL CELL BIOL, V25, P554, DOI 10.1128/MCB.25.2.554-562.2005; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Khatun A, 2021, J EXP MED, V218, DOI 10.1084/jem.20200650; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kunzli M, 2021, ELIFE, V10, DOI 10.7554/eLife.61869; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller B.C., 2019, Nat. Immunol., V20, DOI 10.1038; Moore MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.33057; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Osokine I, 2014, P NATL ACAD SCI USA, V111, P7409, DOI 10.1073/pnas.1401662111; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Parish IA, 2014, J CLIN INVEST, V124, P3455, DOI [10.1172/JC166108, 10.1172/JCI66108]; Penaloza-MacMaster P., 2015, Science, V347; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Ruterbusch M, 2020, ANNU REV IMMUNOL, V38, P705, DOI 10.1146/annurev-immunol-103019-085803; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Shin HM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006544; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Snell LM, 2021, NAT IMMUNOL, V22, P1524, DOI 10.1038/s41590-021-01060-7; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Snell LM, 2016, CELL REP, V16, P3286, DOI 10.1016/j.celrep.2016.08.065; Snook JP, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aas9103; Soon MSF, 2020, NAT IMMUNOL, V21, P1597, DOI 10.1038/s41590-020-0800-8; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Utzschneider DT, 2016, J EXP MED, V213, P1819, DOI 10.1084/jem.20150598; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Xin G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07492-4; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Xu W, 2019, IMMUNITY, V51, P826, DOI 10.1016/j.immuni.2019.10.006; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	90	8	8	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					475	+		10.1016/j.immuni.2022.01.018	http://dx.doi.org/10.1016/j.immuni.2022.01.018			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35216666				2022-12-18	WOS:000791044400012
J	Chhibber, A; Huang, LK; Zhang, H; Xu, JL; Cristescu, R; Liu, XQ; Mehrotra, DV; Shen, JD; Shaw, PM; Hellmann, MD; Snyder, A				Chhibber, Aparna; Huang, Lingkang; Zhang, Hong; Xu, Jialin; Cristescu, Razvan; Liu, Xiaoqiao; Mehrotra, Devan, V; Shen, Judong; Shaw, Peter M.; Hellmann, Matthew D.; Snyder, Alexandra			Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor types	IMMUNITY			English	Article							ACQUIRED-RESISTANCE; CHECKPOINT BLOCKADE; SINGLE-ARM; OPEN-LABEL; CANCER; MULTICENTER; CHEMOTHERAPY; FREQUENCIES; IPILIMUMAB; MUTATIONS	We evaluated the impact of class I and class II human leukocyte antigen (HLA) genotypes, heterozygosity, and diversity on the efficacy of pembrolizumab. Seventeen pembrolizumab clinical trials across eight tumor types and one basket trial in patients with advanced solid tumors were included (n > 3,500 analyzed). Germline DNA was genotyped using a custom genotyping array. HLA diversity (measured by heterozygosity and evolutionary divergence) across class I loci was not associated with improved response to pembrolizumab, either within each tumor type evaluated or across all patients. Similarly, HLA heterozygosity at each class I and class II gene was not associated with response to pembrolizumab after accounting for the number of tests conducted. No conclusive association between HLA genotype and response to pembrolizumab was identified in this data set. Germline HLA genotype or diversity alone is not an important independent determinant of response to pembrolizumab and should not be used for clinical decision-making in patients treated with pembrolizumab.	[Chhibber, Aparna; Cristescu, Razvan; Liu, Xiaoqiao; Shaw, Peter M.] Merck & Co Inc, Dept Biomarker & Genome Sci, Kenilworth, NJ 07033 USA; [Huang, Lingkang; Zhang, Hong; Xu, Jialin; Mehrotra, Devan, V; Shen, Judong] Merck & Co Inc, Dept Biostat & Res Decis Sci, Kenilworth, NJ 07033 USA; [Hellmann, Matthew D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Hellmann, Matthew D.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Snyder, Alexandra] Merck & Co Inc, Dept Med Oncol, Kenilworth, NJ 07033 USA; [Chhibber, Aparna] Bristol Myers Squibb, Lawrenceville, NJ 08540 USA; [Xu, Jialin] Janssen Pharmaceut Co Johnson & Johnson, Spring House, PA 19477 USA; [Snyder, Alexandra] Two River, 689 Fifth Ave,12th Floor, New York, NY 10022 USA	Merck & Company; Merck & Company; Memorial Sloan Kettering Cancer Center; Cornell University; Merck & Company; Bristol-Myers Squibb; Johnson & Johnson; Janssen Pharmaceuticals	Shaw, PM (corresponding author), Merck & Co Inc, Dept Biomarker & Genome Sci, Kenilworth, NJ 07033 USA.; Hellmann, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.; Hellmann, MD (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.; Snyder, A (corresponding author), Merck & Co Inc, Dept Med Oncol, Kenilworth, NJ 07033 USA.; Snyder, A (corresponding author), Two River, 689 Fifth Ave,12th Floor, New York, NY 10022 USA.	peter_shaw3@merck.com; hellmanm@mskcc.org; snyderalex@gmail.com	xu, jia/GSD-6347-2022	Shen, Judong/0000-0001-6150-1034; Zhang, Hong/0000-0002-8869-8671; Chhibber, Aparna/0000-0003-0675-9096				Adams S, 2019, ANN ONCOL, V30, P405, DOI 10.1093/annonc/mdy518; Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Anagnostou V, 2020, NAT CANCER, V1, P99, DOI 10.1038/s43018-019-0008-8; Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Bang YJ, 2019, GASTRIC CANCER, V22, P828, DOI 10.1007/s10120-018-00909-5; Bauml J, 2017, J CLIN ONCOL, V35, P1542, DOI 10.1200/JCO.2016.70.1524; Begovich AB, 2000, MAJOR HISTOCOMPATIBILITY COMPLEX, P412; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Burtness B, 2019, LANCET, V394, P1915, DOI 10.1016/S0140-6736(19)32591-7; Centers for Disease Control and Prevention (CDC), 2019, MEL INC MORT US 2012; Chowell D, 2019, NAT MED, V25, P1715, DOI 10.1038/s41591-019-0639-4; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Cohen EEW, 2019, LANCET, V393, P156, DOI 10.1016/S0140-6736(18)31999-8; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Fuchs CS, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.0013; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gettinger S, 2017, CANCER DISCOV, V7, P1420, DOI 10.1158/2159-8290.CD-17-0593; Gonzalez-Galarza FF, 2020, NUCLEIC ACIDS RES, V48, pD783, DOI 10.1093/nar/gkz1029; Gourraud PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097282; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Kojima T, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.01888; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Litchfield K, 2021, CELL, V184, P596, DOI 10.1016/j.cell.2021.01.002; Manczinger M, 2021, NAT CANCER, V2, P950, DOI 10.1038/s43018-021-00226-4; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Marabelle A, 2020, LANCET ONCOL, V21, P1353, DOI 10.1016/S1470-2045(20)30445-9; Marty R, 2017, CELL, V171, P1272, DOI 10.1016/j.cell.2017.09.050; Matulonis UA, 2019, ANN ONCOL, V30, P1080, DOI 10.1093/annonc/mdz135; McGranahan N, 2017, CELL, V171, P1259, DOI 10.1016/j.cell.2017.10.001; Middha S, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00321; Montesion M, 2021, CANCER DISCOV, V11, P282, DOI 10.1158/2159-8290.CD-20-0672; Moore E, 2018, HUM IMMUNOL, V79, P821, DOI 10.1016/j.humimm.2018.09.008; Negrao MV, 2019, J THORAC ONCOL, V14, P1021, DOI 10.1016/j.jtho.2019.02.008; Ollila HM, 2015, AM J HUM GENET, V96, P136, DOI 10.1016/j.ajhg.2014.12.010; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Rodig SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3342; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Schachter J, 2017, LANCET, V390, P1853, DOI 10.1016/S0140-6736(17)31601-X; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Shim JH, 2020, ANN ONCOL, V31, P902, DOI 10.1016/j.annonc.2020.04.004; Shitara K, 2018, LANCET, V392, P123, DOI 10.1016/S0140-6736(18)31257-1; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	53	8	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					56	+		10.1016/j.immuni.2021.12.006	http://dx.doi.org/10.1016/j.immuni.2021.12.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	34986342				2022-12-18	WOS:000743523600008
J	Peng, CW; Huggins, MA; Wanhainen, KM; Knutson, TP; Lu, HB; Georgiev, H; Mittelsteadt, KL; Jarjour, NN; Wang, HG; Hogquist, KA; Campbell, DJ; da Silva, HB; Jameson, SC				Peng, Changwei; Huggins, Matthew A.; Wanhainen, Kelsey M.; Knutson, Todd P.; Lu, Hanbin; Georgiev, Hristo; Mittelsteadt, Kristen L.; Jarjour, Nicholas N.; Wang, Haiguang; Hogquist, Kristin A.; Campbell, Daniel J.; da Silva, Henrique Borges; Jameson, Stephen C.			Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8+tissue-resident T cells	IMMUNITY			English	Article							FOLLICULAR HELPER-CELL; RESIDENT MEMORY; TRANSCRIPTION FACTORS; DOWN-REGULATION; CUTTING EDGE; CD8; DIFFERENTIATION; CD4(+); POPULATIONS; INFECTION	Elevated gene expression of the costimulatory receptor Icos is a hallmark of CD8+ tissue-resident memory (Trm) T cells. Here, we examined the contribution of ICOS in Trm cell differentiation. Upon transfer into WT mice, Icos-/-CD8+ T cells exhibited defective Trm generation but produced recirculating memory popula-tions normally. ICOS deficiency or ICOS-L blockade compromised establishment of CD8+ Trm cells but not their maintenance. ICOS ligation during CD8+ T cell priming did not determine Trm induction; rather, effector CD8+ T cells showed reduced Trm differentiation after seeding into Icosl-/-mice. IcosYF/YF CD8+ T cells were compromised in Trm generation, indicating a critical role for PI3K signaling. Modest transcrip-tional changes in the few Icos-/-Trm cells suggest that ICOS-PI3K signaling primarily enhances the effi-ciency of CD8+T cell tissue residency. Thus, local ICOS signaling promotes production of Trm cells, providing insight into the contribution of costimulatory signals in the generation of tissue-resident populations.	[Peng, Changwei; Huggins, Matthew A.; Wanhainen, Kelsey M.; Georgiev, Hristo; Jarjour, Nicholas N.; Wang, Haiguang; Hogquist, Kristin A.; da Silva, Henrique Borges; Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Knutson, Todd P.] Univ Minnesota, Minnesota Supercomp Inst, St Paul, MN 55108 USA; [Lu, Hanbin] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Mittelsteadt, Kristen L.; Campbell, Daniel J.] Univ Washington, Sch Med, Benaroya Res Inst, Seattle, WA 98101 USA; [Mittelsteadt, Kristen L.; Campbell, Daniel J.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98101 USA; [Georgiev, Hristo] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [da Silva, Henrique Borges] Mayo Clin, Dept Immunol, Scottsdale, AZ 85259 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Hannover Medical School; Mayo Clinic; Mayo Clinic Phoenix	Jameson, SC (corresponding author), Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013; Georgiev, Hristo/A-3261-2016	Jameson, Stephen C/0000-0001-9137-1146; Georgiev, Hristo/0000-0003-1369-960X; Peng, Changwei/0000-0002-0710-9573; Borges da Silva, Henrique/0000-0001-9424-3326; Jarjour, Nicholas/0000-0001-9400-4448	NIH [R01 AI038903, AI145147]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Jamequist lab for intellectual input. The authors acknowledge the Minnesota Supercomputing Institute (MSI) at the University of Minnesota for providing resources that contributed to the research results reported. This work was funded by NIH awards to S.C.J. (R01 AI038903 and AI145147) . The graphical abstract was created with BioRender.com .	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Bertram EM, 2002, EUR J IMMUNOL, V32, P3376, DOI 10.1002/1521-4141(200212)32:12<3376::AID-IMMU3376>3.0.CO;2-Y; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chu KL, 2020, J LEUKOCYTE BIOL, V107, P953, DOI 10.1002/JLB.4AB1219-254R; Chu KL, 2019, MUCOSAL IMMUNOL, V12, P363, DOI 10.1038/s41385-018-0105-5; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; da Silva HB, 2020, IMMUNITY, V53, P158, DOI 10.1016/j.immuni.2020.06.010; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Durlanik S, 2016, EUR J IMMUNOL, V46, P2566, DOI 10.1002/eji.201646420; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Iborra S, 2016, IMMUNITY, V45, P847, DOI 10.1016/j.immuni.2016.08.019; Im SJ, 2020, P NATL ACAD SCI USA, V117, P4292, DOI 10.1073/pnas.1917298117; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Kunzli M, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay5552; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kurd NS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz6894; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Lefrancois L, 1999, J EXP MED, V190, P1275, DOI 10.1084/jem.190.9.1275; Liu DY, 2016, J IMMUNOL, V196, P1000, DOI 10.4049/jimmunol.1500218; Liu XL, 2001, J EXP MED, V194, P1339, DOI 10.1084/jem.194.9.1339; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Malik BT, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6346; Mani V, 2019, SCIENCE, V366, P202, DOI 10.1126/science.aav5728; Marriott CL, 2015, EUR J IMMUNOL, V45, P1706, DOI 10.1002/eji.201445421; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mittelsteadt KL, 2021, J EXP MED, V218, DOI 10.1084/jem.20201142; Mittrucker HW, 2002, J IMMUNOL, V169, P5813, DOI 10.4049/jimmunol.169.10.5813; Moore TV, 2011, AM J RESP CELL MOL, V45, P843, DOI 10.1165/rcmb.2010-0466OC; Moore TV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016529; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nurieva RI, 2003, P NATL ACAD SCI USA, V100, P14163, DOI 10.1073/pnas.2335041100; Park SL, 2019, NATURE, V565, P366, DOI 10.1038/s41586-018-0812-9; Pedros C, 2016, NAT IMMUNOL, V17, P825, DOI 10.1038/ni.3463; Peng CW, 2020, INT IMMUNOL, V32, P583, DOI 10.1093/intimm/dxaa045; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Roussel L, 2018, J EXP MED, V215, P3151, DOI 10.1084/jem.20180668; Salek-Ardakani S, 2011, J VIROL, V85, P9051, DOI 10.1128/JVI.00619-11; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Son YM, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abb6852; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Swarnalekha N, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abb6808; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; Takahashi N, 2009, J IMMUNOL, V182, P5515, DOI 10.4049/jimmunol.0803256; Taylor PA, 2005, BLOOD, V105, P3372, DOI 10.1182/blood-2004-10-3869; Teichmann LL, 2015, IMMUNITY, V42, P552, DOI 10.1016/j.immuni.2015.02.015; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Wallin JJ, 2001, J IMMUNOL, V167, P132, DOI 10.4049/jimmunol.167.1.132; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Xin HY, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02084-2; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Zamarin D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14340; Zhou AC, 2017, MUCOSAL IMMUNOL, V10, P1294, DOI 10.1038/mi.2016.124; Zhou AC, 2019, J IMMUNOL, V202, P2482, DOI 10.4049/jimmunol.1800795	84	8	8	4	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					98	+		10.1016/j.immuni.2021.11.017	http://dx.doi.org/10.1016/j.immuni.2021.11.017			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	34932944				2022-12-18	WOS:000743523600011
J	Rivera, CA; Randrian, V; Richer, W; Gerber-Ferder, Y; Delgado, MG; Chikina, AS; Frede, A; Sorini, C; Maurin, M; Kammoun-Chaari, H; Parigi, SM; Goudot, C; Cabeza-Cabrerizo, M; Baulande, S; Lameiras, S; Guermonprez, P; Sousa, CRE; Lecuit, M; Moreau, HD; Helft, J; Vignjevic, DM; Villablanca, EJ; Lennon-Dumenil, AM				Rivera, Claudia A.; Randrian, Violaine; Richer, Wilfrid; Gerber-Ferder, Yohan; Delgado, Maria-Graciela; Chikina, Aleksandra S.; Frede, Annika; Sorini, Chiara; Maurin, Mathieu; Kammoun-Chaari, Hana; Parigi, Sara M.; Goudot, Christel; Cabeza-Cabrerizo, Mar; Baulande, Sylvain; Lameiras, Sonia; Guermonprez, Pierre; Reis e Sousa, Caetano; Lecuit, Marc; Moreau, Helene D.; Helft, Julie; Vignjevic, Danijela Matic; Villablanca, Eduardo J.; Lennon-Dumenil, Ana-Maria			Epithelial colonization by gut dendritic cells promotes their functional diversification	IMMUNITY			English	Article							RETINOIC ACID; SIGNALING CONTROLS; ORAL TOLERANCE; T-CELLS; RECEPTOR; DIFFERENTIATION; HOMEOSTASIS; MIGRATION; MACROPHAGES; EXPRESSION	Dendritic cells (DCs) patrol tissues and transport antigens to lymph nodes to initiate adaptive immune responses. Within tissues, DCs constitute a complex cell population composed of distinct subsets that can exhibit different activation states and functions. How tissue-specific cues orchestrate DC diversification remains elusive. Here, we show that the small intestine included two pools of cDC2s originating from common pre-DC precursors: (1) lamina propria (LP) CD103(+)CD11b(+) cDC2s that were mature-like proinflammatory cells and (2) intraepithelial cDC2s that exhibited an immature-like phenotype as well as tolerogenic properties. These phenotypes resulted from the action of food-derived retinoic acid (ATRA), which enhanced actomyosin contractility and promoted LP cDC2 transmigration into the epithelium. There, cDC2s were imprinted by environmental cues, including ATRA itself and the mucus component Muc2. Hence, by reaching distinct subtissular niches, DCs can exist as immature and mature cells within the same tissue, revealing an additional mechanism of DC functional diversification.	[Rivera, Claudia A.; Randrian, Violaine; Richer, Wilfrid; Gerber-Ferder, Yohan; Delgado, Maria-Graciela; Chikina, Aleksandra S.; Maurin, Mathieu; Goudot, Christel; Moreau, Helene D.; Helft, Julie; Lennon-Dumenil, Ana-Maria] PSL Res Univ, Inst Curie, INSERM U932, F-75005 Paris, France; [Chikina, Aleksandra S.; Vignjevic, Danijela Matic] PSL Res Univ, Inst Curie, CNRS UMR 144, F-75005 Paris, France; [Frede, Annika; Sorini, Chiara; Parigi, Sara M.; Villablanca, Eduardo J.] Karolinska Inst, Dept Med, Immunol & Allergy Div, Solna, Sweden; [Frede, Annika; Sorini, Chiara; Parigi, Sara M.; Villablanca, Eduardo J.] Univ Hosp, S-17176 Stockholm, Sweden; [Frede, Annika; Sorini, Chiara; Parigi, Sara M.; Villablanca, Eduardo J.] Ctr Mol Med, S-17176 Stockholm, Sweden; [Kammoun-Chaari, Hana; Lecuit, Marc] Inst Pasteur, INSERM U1117, Biol Infect Unit, F-75015 Paris, France; [Cabeza-Cabrerizo, Mar; Reis e Sousa, Caetano] Francis Crick Inst, Immunobiol Lab, London NW1 1AT, England; [Baulande, Sylvain; Lameiras, Sonia] PSL Res Univ, Inst Curie, ICGex Next Generat Sequencing Platform, F-75005 Paris, France; [Guermonprez, Pierre] Univ Paris, Ctr Inflammat Res, INSERM1149, CNRS ERL8252, Paris, France; [Lecuit, Marc] Univ Paris, Necker Enfants Malad Univ Hosp, AP HP, Inst Imagine,Dept Infect Dis & Trop Med, F-75015 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Francis Crick Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lennon-Dumenil, AM (corresponding author), PSL Res Univ, Inst Curie, INSERM U932, F-75005 Paris, France.	amlennon@curie.fr	Sorini, Chiara/M-5837-2015; Lecuit, Marc/J-4073-2013; Lecuit, Marc/M-4126-2019; Villablanca, Eduardo/E-1380-2016	Sorini, Chiara/0000-0002-6803-8377; Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; Chikina, Aleksandra/0000-0002-6801-7031; Villablanca, Eduardo/0000-0001-9522-9729; Moreau, Helene/0000-0001-5715-6864; Cabeza-Cabrerizo, Mar/0000-0001-9061-058X; Rivera, Claudia A/0000-0002-9926-1475	ARC foundation; INSERM; Institut Curie; DCBIOL Labex [ANR-10-IDEX-0001-02-PSL, ANR-11-LABX-0043]; Agence Nationale de la Recherche ("Investissements d'Avenir" program) [ANR-10-INBS-09-08, ANR-10-EQPX-03]; ITMO-CancerAviesan (Plan Cancer III); SiRIC-Curie program (SiRIC grant) [INCa-DGOS-4654]; Francis Crick Institute from Cancer Research UK [FC001136]; Francis Crick Institute from UK Medical Research Council [FC001136]; Francis Crick Institute from Wellcome Trust [FC001136]; ERC Advanced Investigator grant [AdG 268670]; Wellcome Investigator Award [WT106973/Z/15/Z]; Louis-Jeantet Foundation; Wellcome Trust [FC001136, 106973/Z/15/Z]	ARC foundation(Australian Research Council); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie; DCBIOL Labex; Agence Nationale de la Recherche ("Investissements d'Avenir" program)(French National Research Agency (ANR)); ITMO-CancerAviesan (Plan Cancer III); SiRIC-Curie program (SiRIC grant); Francis Crick Institute from Cancer Research UK; Francis Crick Institute from UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute from Wellcome Trust; ERC Advanced Investigator grant; Wellcome Investigator Award; Louis-Jeantet Foundation; Wellcome Trust(Wellcome Trust)	We thank Institut Curie for access to the flow cytometry, animal, and the cell and tissue imaging facilities (PICT-IBiSA) . We thank Emmanuel Gautier for kindly providing Ccr2<SUP>-/-</SUP>mice. C.A.R. thanks Gehenna Guerrero-Serrano for teaching her how to prepare gut organoids and the ARC foundation for financial support. This project has received funding from INSERM, Institut Curie, and the DCBIOL Labex (ANR-10-IDEX-0001-02-PSL and ANR-11-LABX-0043) . High-throughput sequencing was performed by the ICGex NGS plat-form of the Institut Curie supported by the grants ANR-10-EQPX-03 (Equipex) and ANR-10-INBS-09-08 (France Genomique Consortium) from the Agence Nationale de la Recherche ("Investissements d'Avenir" program) , by the ITMO-CancerAviesan (Plan Cancer III) , and by the SiRIC-Curie program (SiRIC grant INCa-DGOS-4654) . Research in the C.R.S. laboratory is supported by The Francis Crick Institute, which receives core funding from Cancer Research UK (FC001136) , the UK Medical Research Council (FC001136) , and theWellcome Trust (FC001136) , by an ERC Advanced Investigator grant (AdG 268670) , by a Wellcome Investigator Award (WT106973/Z/15/Z) , and by a prize from the Louis-Jeantet Foundation. Our research is funded in whole, or in part, by the Wellcome Trust (grants FC001136 and 106973/Z/15/Z) . For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.	Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bretou M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aak9573; Cabeza-Cabrerizo M, 2021, ANNU REV IMMUNOL, V39, P131, DOI 10.1146/annurev-immunol-061020-053707; Cabeza-Cabrerizo M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw1941; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Castillo PA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49471-9; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chabaud M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8526; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chikina AS, 2020, CELL, V183, P411, DOI 10.1016/j.cell.2020.08.048; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Fenton T.M., 2021, SINGLE CELL CHARACTE; Goswami D, 2017, BLOOD, V129, P1811, DOI 10.1182/blood-2016-08-733394; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Heidkamp GF, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7677; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Klebanoff CA, 2013, J EXP MED, V210, P1961, DOI 10.1084/jem.20122508; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Luda KM, 2016, IMMUNITY, V44, P860, DOI 10.1016/j.immuni.2016.02.008; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakano H, 2013, MUCOSAL IMMUNOL, V6, P678, DOI 10.1038/mi.2012.106; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Sun YL, 2014, J IMMUNOL, V193, P860, DOI 10.4049/jimmunol.1400045; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vargas P, 2016, NAT CELL BIOL, V18, P43, DOI 10.1038/ncb3284; Villablanca EJ, 2011, GASTROENTEROLOGY, V141, P176, DOI 10.1053/j.gastro.2011.04.010; Yashiro T, 2018, J IMMUNOL, V201, P3677, DOI 10.4049/jimmunol.1800492; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853; Zheng DH, 2017, METHODS MOL BIOL, V1648, P65, DOI 10.1007/978-1-4939-7204-3_6	56	8	8	3	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					129	+		10.1016/j.immuni.2021.11.008	http://dx.doi.org/10.1016/j.immuni.2021.11.008			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI5DT	34910930	hybrid, Green Published			2022-12-18	WOS:000743868800002
J	Sugiura, A; Andrejeva, G; Voss, K; Heintzman, DR; Xu, XC; Madden, MZ; Ye, X; Beier, KL; Chowdhury, NU; Wolf, MM; Young, AC; Greenwood, DL; Sewell, AE; Shahi, SK; Freedman, SN; Cameron, AM; Foerch, P; Bourne, T; Garcia-Canaveras, JC; Karijolich, J; Newcomb, DC; Mangalam, AK; Rabinowitz, JD; Rathmell, JC				Sugiura, Ayaka; Andrejeva, Gabriela; Voss, Kelsey; Heintzman, Darren R.; Xu, Xincheng; Madden, Matthew Z.; Ye, Xiang; Beier, Katherine L.; Chowdhury, Nowrin U.; Wolf, Melissa M.; Young, Arissa C.; Greenwood, Dalton L.; Sewell, Allison E.; Shahi, Shailesh K.; Freedman, Samantha N.; Cameron, Alanna M.; Foerch, Patrik; Bourne, Tim; Garcia-Canaveras, Juan C.; Karijolich, John; Newcomb, Dawn C.; Mangalam, Ashutosh K.; Rabinowitz, Joshua D.; Rathmell, Jeffrey C.			MTHFD2 is a metabolic checkpoint controlling effector and T cell fate and function	IMMUNITY			English	Article							ONE-CARBON METABOLISM; PURINE; DIFFERENTIATION; SERINE; ACID	Antigenic stimulation promotes T cell metabolic reprogramming to meet increased biosynthetic, bioenergetic, and signaling demands. We show that the one-carbon (1C) metabolism enzyme methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) regulates de novo purine synthesis and signaling in activated T cells to promote proliferation and inflammatory cytokine production. In pathogenic T helper-17 (Th17) cells, MTHFD2 prevented aberrant upregulation of the transcription factor FoxP3 along with inappropriate gain of suppressive capacity. MTHFD2 deficiency also promoted regulatory T (Treg) cell differentiation. Mechanistically, MTHFD2 inhibition led to depletion of purine pools, accumulation of purine biosynthetic intermediates, and decreased nutrient sensor mTORC1 signaling. MTHFD2 was also critical to regulate DNA and histone methylation in Th17 cells. Importantly, MTHFD2 deficiency reduced disease severity in multiple in vivo inflammatory disease models. MTHFD2 is thus a metabolic checkpoint to integrate purine metabolism with pathogenic effector cell signaling and is a potential therapeutic target within 1C metabolism pathways.	[Sugiura, Ayaka; Andrejeva, Gabriela; Voss, Kelsey; Heintzman, Darren R.; Madden, Matthew Z.; Ye, Xiang; Beier, Katherine L.; Young, Arissa C.; Greenwood, Dalton L.; Sewell, Allison E.; Karijolich, John; Rathmell, Jeffrey C.] Vanderbilt Univ, Vanderbilt Ctr Immunobiol, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37232 USA; [Chowdhury, Nowrin U.; Wolf, Melissa M.; Newcomb, Dawn C.] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol & Oncol, Nashville, TN 37232 USA; [Shahi, Shailesh K.; Freedman, Samantha N.; Mangalam, Ashutosh K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Cameron, Alanna M.; Foerch, Patrik; Bourne, Tim] Sitryx Therapeut Ltd, Magdalen Ctr, Oxford Sci Pk, Oxford, England; [Xu, Xincheng; Garcia-Canaveras, Juan C.; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Ludwig Canc Res Inst, Dept Chem,Princeton Branch, Princeton, NJ 08544 USA	Vanderbilt University; Vanderbilt University; University of Iowa; Princeton University	Rathmell, JC (corresponding author), Vanderbilt Univ, Vanderbilt Ctr Immunobiol, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37232 USA.	jeff.rathmell@vumc.org	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Andrejeva, Gabriela/0000-0002-3508-7682; Shahi, Shailesh/0000-0002-8506-7655; Chowdhury, Nowrin/0000-0002-4621-1423; Sugiura, Ayaka/0000-0001-5326-5019; Bourne, Tim/0000-0002-2780-0070; Madden, Matthew/0000-0003-4062-4427; M Wolf, Melissa/0000-0003-2038-6978				Anderson GR, 2017, CELL REP, V20, P999, DOI 10.1016/j.celrep.2017.07.006; Aune TM, 2017, J AUTOIMMUN, V81, P99, DOI 10.1016/j.jaut.2017.03.014; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Brown PM, 2016, NAT REV RHEUMATOL, V12, P731, DOI 10.1038/nrrheum.2016.175; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; Cronstein BN, 2020, NAT REV RHEUMATOL, V16, P145, DOI 10.1038/s41584-020-0373-9; Dembitz V, 2019, J BIOL CHEM, V294, P15257, DOI 10.1074/jbc.RA119.009396; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Emmanuel N, 2017, CELL REP, V19, P2665, DOI 10.1016/j.celrep.2017.05.043; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; Field MS, 2015, RARE DIS, V3, DOI 10.1080/21675511.2015.1112479; Fuseini H, 2018, J IMMUNOL, V201, P1843, DOI 10.4049/jimmunol.1800293; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Green NH, 2019, ONCOGENE, V38, P6211, DOI 10.1038/s41388-019-0869-4; Gustafsson R, 2017, CANCER RES, V77, P937, DOI 10.1158/0008-5472.CAN-16-1476; Hoxhaj G, 2017, CELL REP, V21, P1331, DOI 10.1016/j.celrep.2017.10.029; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Ju HQ, 2019, JNCI-J NATL CANCER I, V111, P584, DOI 10.1093/jnci/djy160; Kawai J, 2019, J MED CHEM, V62, P10204, DOI 10.1021/acs.jmedchem.9b01113; Kim JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.115; Koufaris C, 2016, J PROTEOME RES, V15, P2618, DOI 10.1021/acs.jproteome.6b00188; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Palmer LD, 2019, AM J RESP CELL MOL, V61, P459, DOI 10.1165/rcmb.2018-0217OC; Pikman Y, 2016, J EXP MED, V213, P1285, DOI 10.1084/jem.20151574; Quemeneur L, 2004, J IMMUNOL, V173, P4945, DOI 10.4049/jimmunol.173.8.4945; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Rae Colin, 2019, Oncotarget, V10, P749, DOI 10.18632/oncotarget.26598; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Shahi SK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00462; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharma U, 2017, CELL METAB, V25, P544, DOI 10.1016/j.cmet.2017.02.003; Sheppard NG, 2015, SCI REP-UK, V5, DOI 10.1038/srep15029; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shin M, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0173-0; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Su CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071647; Su XY, 2016, CURR OPIN CHEM BIOL, V30, P52, DOI 10.1016/j.cbpa.2015.10.030; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Toffalini F, 2009, HAEMATOL-HEMATOL J, V94, P1085, DOI 10.3324/haematol.2008.001149; Wan XY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02825-y; Wang L, 2019, ANAL CHEM, V91, P1838, DOI 10.1021/acs.analchem.8b03132; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yue L, 2020, STEM CELL REP, V15, P529, DOI 10.1016/j.stemcr.2020.06.018; Zhu ZY, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00658	53	8	8	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					65	+		10.1016/j.immuni.2021.10.011	http://dx.doi.org/10.1016/j.immuni.2021.10.011			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	34767747	Green Submitted			2022-12-18	WOS:000743523600009
J	Venkataraman, T; Valencia, C; Mangino, M; Morgenlander, W; Clipman, SJ; Liechti, T; Valencia, A; Christofidou, P; Spector, T; Roederer, M; Duggal, P; Larman, HB				Venkataraman, Thiagarajan; Valencia, Cristian; Mangino, Massimo; Morgenlander, William; Clipman, Steven J.; Liechti, Thomas; Valencia, Ana; Christofidou, Paraskevi; Spector, Tim; Roederer, Mario; Duggal, Priya; Larman, H. Benjamin			Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; BARR-VIRUS INFECTION; HUMAN IMMUNE-SYSTEM; SEROLOGICAL MEASURES; STRATIFICATION; SUSCEPTIBILITY; DIAGNOSIS; MEMORY	Human immune responses to viral infections are highly variable, but the genetic factors that contribute to this variability are not well characterized. We used VirScan, a high-throughput epitope scanning technology, to analyze pan-viral antibody reactivity profiles of twins and SNP-genotyped individuals. Using these data, we determined the heritability and genomic loci associated with antibody epitope selection, response breadth, and control of Epstein-Barr virus (EBV) viral load. 107 EBV peptide reactivities were heritable and at least two Epstein-Barr nuclear antigen 2 (EBNA-2) reactivities were associated with variants in the MHC class II locus. We identified an EBV serosignature that predicted viral load in peripheral blood mononuclear cells and was associated with variants in the MHC class I locus. Our study illustrates the utility of epitope profiling to investigate the genetics of pathogen immunity, reports heritable features of the antibody response to viruses, and identifies specific HLA loci important for EBV epitope selection.	[Venkataraman, Thiagarajan; Morgenlander, William; Larman, H. Benjamin] Johns Hopkins Univ, Inst Cell Engn, Dept Pathol, Div Immunol, Baltimore, MD 21218 USA; [Valencia, Cristian; Duggal, Priya] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Clipman, Steven J.; Duggal, Priya] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Mangino, Massimo; Christofidou, Paraskevi; Spector, Tim] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Mangino, Massimo] Guys & St Thomas Fdn Trust, NIHR Biomed Res Ctr, London SE1 9RT, England; [Liechti, Thomas; Roederer, Mario] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Valencia, Ana] Univ Pontificia Bolivariana, Sch Med, Medellin, Colombia	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidad Pontificia Bolivariana	Larman, HB (corresponding author), Johns Hopkins Univ, Inst Cell Engn, Dept Pathol, Div Immunol, Baltimore, MD 21218 USA.	hlarman1@jhu.edu	Mangino, Massimo/F-5134-2011	Mangino, Massimo/0000-0002-2167-7470; Liechti, Thomas/0000-0001-8738-6679; Morgenlander, William/0000-0001-7205-3732	National Institute of General Medical Sciences (NIGMS) [R01GM136724]; National Institute of Allergy and Infectious Diseases (NIAID) [U24AI118633]; NIH, Intramural Research Program of the Vaccine Research Center, (NIAID); Wellcome Trust [212904/Z/18/Z]; European Union H2020 contract [733100]	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH, Intramural Research Program of the Vaccine Research Center, (NIAID); Wellcome Trust(Wellcome Trust); European Union H2020 contract	National Institute of General Medical Sciences (NIGMS), grant R01GM136724 (H.B.L.); National Institute of Allergy and Infectious Diseases (NIAID), grant U24AI118633 (H.B.L.); NIH, Intramural Research Program of the Vaccine Research Center, (NIAID) (M.R. and T.L.); Wellcome Trust 212904/Z/18/Z (M.M., T.S., and P.C.), and European Union H2020 contract #733100 (M.M., T.S., and P.C.).	ALLANSMITH M, 1969, J IMMUNOL, V102, P1504; Antia A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006601; Babcock GJ, 1999, J EXP MED, V190, P567, DOI 10.1084/jem.190.4.567; Baer A.N., 2018, IMPROVED ANAL PHAGE, DOI [10.1101/285916, DOI 10.1101/285916]; Bertalot G, 2001, DIGEST LIVER DIS, V33, P551, DOI 10.1016/S1590-8658(01)80106-7; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Csuka D, 2013, CLIN EXP IMMUNOL, V171, P255, DOI 10.1111/cei.12022; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Draborg AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/370516; DUQUETTE P, 1992, CAN J NEUROL SCI, V19, P466, DOI 10.1017/S0317167100041664; Eshleman SH, 2019, CELL REP, V27, P1422, DOI 10.1016/j.celrep.2019.03.097; Finton KAK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004403; GRUNDBACHER FJ, 1974, AM J HUM GENET, V26, P1; Harley JB, 2006, BULL HOSP JT DIS, V64, P45; Harley JB, 2018, NAT GENET, V50, P699, DOI 10.1038/s41588-018-0102-3; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; IARC Monographs on the Evaluation of Carcinogenic Risks to Humans and IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGRAPHS EVAL, P49; Isnard P, 2019, P NATL ACAD SCI USA, V116, P10899, DOI 10.1073/pnas.1821166116; James JA, 2012, CURR OPIN RHEUMATOL, V24, P383, DOI 10.1097/BOR.0b013e3283535801; Jonsson S, 2017, NAT GENET, V49, P1182, DOI 10.1038/ng.3897; Kachuri L, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00790-x; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; KALFF MW, 1969, CLIN EXP IMMUNOL, V5, P469; Kempkes B, 2015, CURR OPIN VIROL, V14, P138, DOI 10.1016/j.coviro.2015.09.007; Khanna R, 2000, ANNU REV MICROBIOL, V54, P19, DOI 10.1146/annurev.micro.54.1.19; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Limou S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00118; Liu JP, 2020, CELL, V182, P317, DOI 10.1016/j.cell.2020.05.038; Mangino M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13850; Maurmann S, 2003, J CLIN MICROBIOL, V41, P5419, DOI 10.1128/JCM.41.12.5419-5428.2003; McAulay KA, 2015, TISSUE ANTIGENS, V86, P98, DOI 10.1111/tan.12604; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485; Mohan D, 2018, NAT PROTOC, V13, P1958, DOI 10.1038/s41596-018-0025-6; Monaco DR, 2022, EBIOMEDICINE, V75, DOI 10.1016/j.ebiom.2021.103747; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Morgenlander William, 2020, medRxiv, DOI 10.1101/2020.12.16.20248294; Morgenlander WR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146927; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Neale MC, 2016, PSYCHOMETRIKA, V81, P535, DOI 10.1007/s11336-014-9435-8; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pedergnana V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102501; Pou C, 2019, NAT MED, V25, P591, DOI 10.1038/s41591-019-0392-8; Price AM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004656; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S., 2021, CC PLINK 1 9; Rickinson AB, 2001, FIELDS VIROLOGY, P2511; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; ROWE D. S., 1968, CLIN EXP IMMUNOL, V3, P233; Rubicz R, 2015, EUR J HUM GENET, V23, P1544, DOI 10.1038/ejhg.2015.24; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Rubicz R, 2011, HUM HERED, V72, P133, DOI 10.1159/000331220; Scepanovic P, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0568-8; Scheike TH, 2014, LIFETIME DATA ANAL, V20, P210, DOI 10.1007/s10985-013-9244-x; Schubert RD, 2019, NAT MED, V25, P1748, DOI 10.1038/s41591-019-0613-1; Shrock E, 2020, SCIENCE, V370, P1058, DOI 10.1126/science.abd4250; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Su WH, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00299; Tsai DE, 2008, AM J TRANSPLANT, V8, P1016, DOI 10.1111/j.1600-6143.2008.02183.x; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Tzellos S, 2012, PATHOGENS, V1, P156, DOI 10.3390/pathogens1020156; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Verhulst B, 2017, BEHAV GENET, V47, P255, DOI 10.1007/s10519-016-9828-9; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watson CT, 2012, GENES IMMUN, V13, P363, DOI 10.1038/gene.2012.12; Watson CT, 2017, TRENDS IMMUNOL, V38, P459, DOI 10.1016/j.it.2017.04.003; Xu GJ, 2016, P NATL ACAD SCI USA, V113, pE7526, DOI 10.1073/pnas.1615990113; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698; Young LS, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P461; Zhou Y, 2016, MULT SCLER J, V22, P1655, DOI 10.1177/1352458515626598	74	8	8	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					174	+		10.1016/j.immuni.2021.12.004	http://dx.doi.org/10.1016/j.immuni.2021.12.004			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI5DT	35021055				2022-12-18	WOS:000743868800005
J	Vega-Perez, A; Villarrubia, LH; Godio, C; Gutierrez-Gonzalez, A; Feo-Lucas, L; Ferriz, M; Martinez-Puente, N; Alcain, J; Mora, A; Sabio, G; Lopez-Bravo, M; Ardavin, C				Vega-Perez, Adrian; Villarrubia, Laura H.; Godio, Cristina; Gutierrez-Gonzalez, Alejandra; Feo-Lucas, Lidia; Ferriz, Margarita; Martinez-Puente, Natalia; Alcain, Julieta; Mora, Alfonso; Sabio, Guadalupe; Lopez-Bravo, Maria; Ardavin, Carlos			Resident macrophage-dependent immune cell scaffolds drive anti-bacterial defense in the peritoneal cavity	IMMUNITY			English	Article							TISSUE FACTOR; SEVERE SEPSIS; GASDERMIN D; INFECTION; FIBRIN; ACTIVATION; DEFICIENT; RESPONSES; RECEPTOR; TRIGGER	Peritoneal immune cells reside unanchored within the peritoneal fluid in homeostasis. Here, we examined the mechanisms that control bacterial infection in the peritoneum using a mouse model of abdominal sepsis following intraperitoneal Escherichia coli infection. Whole-mount immunofluorescence and confocal microscopy of the peritoneal wall and omentum revealed that large peritoneal macrophages (LPMs) rapidly cleared bacteria and adhered to the mesothelium, forming multilayered cellular aggregates composed by sequentially recruited LPMs, B1 cells, neutrophils, and monocyte-derived cells (moCs). The formation of resident macrophage aggregates (resM4)-aggregates) required LPMs and thrombin-dependent fibrin polymerization. E. coli infection triggered LPM pyroptosis and release of inflammatory mediators. Resolution of these potentially inflammatory aggregates required LPM-mediated recruitment of moCs, which were essential for fibrinolysis-mediated resM4)-aggregate disaggregation and the prevention of peritoneal overt inflammation. Thus, resM4)-aggregates provide a physical scaffold that enables the efficient control of peritoneal infection, with implications for antimicrobial immunity in other body cavities, such as the pleural cavity or brain ventricles.	[Vega-Perez, Adrian; Villarrubia, Laura H.; Godio, Cristina; Gutierrez-Gonzalez, Alejandra; Feo-Lucas, Lidia; Ferriz, Margarita; Martinez-Puente, Natalia; Alcain, Julieta; Lopez-Bravo, Maria; Ardavin, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Darwin 3, Madrid 28049, Spain; [Mora, Alfonso; Sabio, Guadalupe] Ctr Nacl Invest Cardiovasc, Melchor Fernandez Almagro 3, Madrid 28029, Spain; [Alcain, Julieta] Consejo Nacl Invest Cient & Tecn, Inst Med Expt, Buenos Aires, DF, Argentina	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lopez-Bravo, M; Ardavin, C (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Darwin 3, Madrid 28049, Spain.	mlbravo@cnb.csic.es; ardavin@cnb.csic.es		Ferriz Salcedo, Margarita/0000-0002-0201-1972; Mora, Alfonso/0000-0002-6397-4836; Martinez-Puente, Natalia/0000-0002-1521-4111; Vega-Perez, Adrian/0000-0003-2698-0046; Lopez-Bravo, Maria/0000-0002-1898-9465	Pro CNIC Foundation; Insti-tuto de Salud Carlos III, Ministerio de Ciencia e Innovacion;  [SAF2015-69905];  [PGC2018-101899-B-100];  [S2017/BMD3731];  [PID2019-104399RB-100]	Pro CNIC Foundation; Insti-tuto de Salud Carlos III, Ministerio de Ciencia e Innovacion(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); ; ; ; 	We thank E. Veiga and P. Pelegrn for experimental advice and the Advanced Light Microscopy and the Electron Microscopy facilities of the CNB for technical advice and sample processing. This work was supported by grants SAF2015-69905, PGC2018-101899-B-100, and S2017/BMD3731 to C.A. and grant PID2019-104399RB-100 to G.S. The CNIC is supported by the Insti-tuto de Salud Carlos III, Ministerio de Ciencia e Innovacion, and the Pro CNIC Foundation.	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Ahamed J, 2007, BLOOD, V109, P5251, DOI 10.1182/blood-2006-10-051334; Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Bain CC, 2018, CELL IMMUNOL, V330, P126, DOI 10.1016/j.cellimm.2018.01.003; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Buscher K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10828; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Chapin JC, 2015, BLOOD REV, V29, P17, DOI 10.1016/j.blre.2014.09.003; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Gando S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.37; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Jackson-Jones LH, 2020, IMMUNITY, V52, P700, DOI 10.1016/j.immuni.2020.03.011; Johnson LL, 2003, J EXP MED, V197, P801, DOI 10.1084/jem.20021493; Jorch SK, 2019, J CLIN INVEST, V129, P4643, DOI 10.1172/JCI127286; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LEAK LV, 1985, AM J ANAT, V173, P171, DOI 10.1002/aja.1001730303; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Lewis AJ, 2016, SURG INFECT, V17, P385, DOI 10.1089/sur.2016.021; Louwe PA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21778-0; Luo DY, 2011, J IMMUNOL, V187, P1866, DOI 10.4049/jimmunol.1101094; Luyendyk JP, 2019, BLOOD, V133, P511, DOI 10.1182/blood-2018-07-818211; Meza-Perez S, 2017, TRENDS IMMUNOL, V38, P526, DOI 10.1016/j.it.2017.03.002; Motley MP, 2016, BLOOD, V127, P1085, DOI 10.1182/blood-2015-05-644260; Mutsaers SE, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00113; Mutsaers SE, 2016, FERTIL STERIL, V106, P1018, DOI 10.1016/j.fertnstert.2016.09.005; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Opal SM, 2003, CLIN INFECT DIS, V37, P50, DOI 10.1086/375593; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Rathkey JK, 2017, J BIOL CHEM, V292, P14649, DOI 10.1074/jbc.M117.797217; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Rothmeier AS, 2015, J CLIN INVEST, V125, P1471, DOI 10.1172/JCI79329; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wu CQ, 2019, IMMUNITY, V50, P1401, DOI 10.1016/j.immuni.2019.04.003; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024; Zindel J, 2021, SCIENCE, V371, P1013, DOI 10.1126/science.abe0595	45	8	8	6	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2578	+		10.1016/j.immuni.2021.10.007	http://dx.doi.org/10.1016/j.immuni.2021.10.007		NOV 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LN	34717795	Bronze			2022-12-18	WOS:000718365500002
J	Duan, LH; Liu, D; Chen, H; Mintz, MA; Chou, MY; Kotov, DI; Xu, Y; An, JP; Laidlaw, BJ; Cyster, JG				Duan, Lihui; Liu, Dan; Chen, Hsin; Mintz, Michelle A.; Chou, Marissa Y.; Kotov, Dmitri, I; Xu, Ying; An, Jinping; Laidlaw, Brian J.; Cyster, Jason G.			Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation	IMMUNITY			English	Article							AFFINITY MATURATION; IMMUNE-RESPONSES; PLASMA-CELLS; DIFFERENTIATION; SELECTION; IL-4; ANTIGEN; MAINTENANCE; ACTIVATION; RECEPTORS	B cells within germinal centers (GCs) enter cycles of antibody affinity maturation or exit the GC as memory cells or plasma cells. Here, we examined the contribution of interleukin (IL)-4 on B cell fate decisions in the GC. Single-cell RNA-sequencing identified a subset of light zone GC B cells expressing high IL-4 receptora (IL4Ra) and CD23 and lacking a Myc-associated signature. These cells could differentiate into pre-memory cells. B cell- specific deletion of IL4Ra or STAT6 favored the pre-memory cell trajectory, and provision of exogenous IL-4 in a wild-type context reduced pre-memory cell frequencies. IL-4 acted during antigen-specific interactions but also influenced bystander cells. Deletion of IL4Ra from follicular dendritic cells (FDCs) increased the availability of IL-4 in the GC, impaired the selection of affinity-matured B cells, and reduced memory cell generation. We propose that GC FDCs establish a niche that limits bystander IL-4 activity, focusing IL-4 action on B cells undergoing selection and enhancing memory cell differentiation.	[Duan, Lihui; Liu, Dan; Chen, Hsin; Mintz, Michelle A.; Chou, Marissa Y.; Xu, Ying; An, Jinping; Laidlaw, Brian J.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Duan, Lihui; Liu, Dan; Chen, Hsin; Mintz, Michelle A.; Chou, Marissa Y.; Xu, Ying; An, Jinping; Laidlaw, Brian J.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Kotov, Dmitri, I] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Kotov, Dmitri, I] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Laidlaw, Brian J.] Washington Univ, Sch Med, Dept Med, Div Allergy & Immunol, St Louis, MO 63110 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Washington University (WUSTL)	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Mintz, Michelle/0000-0002-0300-8126	NIH [R01AI045073]; Irvington Cancer Research Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Cancer Research Institute	We thank Chris Allen, Mark Ansel, Marlys Fassett, Rich Locksley, Burkhard Ludewig, and Takaharu Okada for the mice. This work was supported by grants from the NIH (R01AI045073). D.L. and H.C. were supported by the Irvington Cancer Research Institute. J.G.C. is an investigator of the Howard Hughes Medical Institute.	Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Andoh A, 2000, IMMUNOL LETT, V73, P35, DOI 10.1016/S0165-2478(00)00202-9; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Bemark M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12698; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chen EY, 2012, BIOINFORMATICS, V28, P105, DOI 10.1093/bioinformatics/btr625; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Chevrier S, 2017, IMMUNOL CELL BIOL, V95, P925, DOI 10.1038/icb.2017.71; CHILTON PM, 1993, J IMMUNOL, V151, P5907; Cortes-Selva D, 2019, EUR J IMMUNOL, V49, P428, DOI 10.1002/eji.201847789; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cunningham AF, 2004, EUR J IMMUNOL, V34, P686, DOI 10.1002/eji.200324510; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; De Tomaso D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12235-0; DEFRANCE T, 1987, J EXP MED, V165, P1459, DOI 10.1084/jem.165.6.1459; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Dubey LK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00504-9; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Finkin S, 2019, IMMUNITY, V51, P324, DOI 10.1016/j.immuni.2019.06.013; Friedrich K, 1999, EUR J BIOCHEM, V265, P457, DOI 10.1046/j.1432-1327.1999.00773.x; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Gaya M, 2018, CELL, V172, P517, DOI 10.1016/j.cell.2017.11.036; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; Gonzalez DG, 2018, J IMMUNOL, V201, P3569, DOI 10.4049/jimmunol.1500497; Granato A, 2014, J IMMUNOL, V192, P5761, DOI 10.4049/jimmunol.1300749; Haberman AM, 2019, IMMUNOL REV, V288, P10, DOI 10.1111/imr.12731; Haniuda K, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108333; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Holmes AB, 2020, J EXP MED, V217, DOI 10.1084/jem.20200483; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; JACK RS, 1977, EUR J IMMUNOL, V7, P559, DOI 10.1002/eji.1830070813; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JELINEK DF, 1988, J IMMUNOL, V141, P164; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Khodoun M, 2007, J IMMUNOL, V179, P6429, DOI 10.4049/jimmunol.179.10.6429; Kotov DI, 2019, J IMMUNOL, V202, P2535, DOI 10.4049/jimmunol.1801609; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Laidlaw BJ, 2020, NAT IMMUNOL, V21, P1082, DOI 10.1038/s41590-020-0713-6; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Li X, 2018, IMMUNITY, V48, P530, DOI 10.1016/j.immuni.2018.03.006; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; McCormick SM, 2015, CYTOKINE, V75, P38, DOI 10.1016/j.cyto.2015.05.023; Milpied P, 2018, NAT IMMUNOL, V19, P1013, DOI 10.1038/s41590-018-0181-4; Mokada-Gopal L, 2017, J IMMUNOL, V198, P3737, DOI 10.4049/jimmunol.1601838; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Paterson RLK, 1996, EUR J IMMUNOL, V26, P1979, DOI 10.1002/eji.1830260902; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Pignarre A, 2021, BLOOD, V137, P1166, DOI 10.1182/blood.2020005083; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Radtke D, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03106; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Reiter R, 2002, IMMUNOLOGY, V106, P222, DOI 10.1046/j.1365-2567.2002.01405.x; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Robinson MJ, 2019, IMMUNOL CELL BIOL, V97, P826, DOI 10.1111/imcb.12283; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Siepmann K, 1996, EUR J IMMUNOL, V26, P1544, DOI 10.1002/eji.1830260721; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Sundling C, 2021, IMMUNITY, V54, P988, DOI 10.1016/j.immuni.2021.03.013; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Turqueti-Neves A, 2014, EUR J IMMUNOL, V44, P2130, DOI 10.1002/eji.201344203; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Viant C, 2020, CELL, V183, P1298, DOI 10.1016/j.cell.2020.09.063; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang XM, 2014, J IMMUNOL, V192, P4601, DOI 10.4049/jimmunol.1400090; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Zhang Y, 2018, J EXP MED, V215, P1227, DOI 10.1084/jem.20160832	92	8	8	8	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2256	+		10.1016/j.immuni.2021.08.028	http://dx.doi.org/10.1016/j.immuni.2021.08.028		OCT 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34555336	Bronze, Green Accepted			2022-12-18	WOS:000706854100014
J	Luecke, S; Sheu, KM; Hoffmann, A				Luecke, Stefanie; Sheu, Katherine M.; Hoffmann, Alexander			Stimulus-specific responses in innate immunity: Multilayered regulatory circuits	IMMUNITY			English	Review							NF-KAPPA-B; TOLL-LIKE RECEPTOR; PATTERN-RECOGNITION RECEPTORS; IKK-BETA; GENE-EXPRESSION; UBIQUITIN CHAINS; TEMPORAL CONTROL; KINASE-ACTIVITY; I INTERFERON; RIG-I	Immune sentinel cells initiate immune responses to pathogens and tissue injury and are capable of producing highly stimulus-specific responses. Insight into the mechanisms underlying such specificity has come from the identification of regulatory factors and biochemical pathways, as well as the definition of signaling circuits that enable combinatorial and temporal coding of information. Here, we review the multi-layered molecular mechanisms that underlie stimulus-specific gene expression in macrophages. We categorize components of inflammatory and anti-pathogenic signaling pathways into five layers of regulatory control and discuss unifying mechanisms determining signaling characteristics at each layer. In this context, we review mechanisms that enable combinatorial and temporal encoding of information, identify recurring regulatory motifs and principles, and present strategies for integrating experimental and computational approaches toward the understanding of signaling specificity in innate immunity.	[Luecke, Stefanie; Sheu, Katherine M.; Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet MIMG, Los Angeles, CA 90095 USA; [Luecke, Stefanie; Sheu, Katherine M.; Hoffmann, Alexander] Univ Calif Los Angeles, Inst Quantitat & Computat Biosci QCB, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hoffmann, A (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet MIMG, Los Angeles, CA 90095 USA.; Hoffmann, A (corresponding author), Univ Calif Los Angeles, Inst Quantitat & Computat Biosci QCB, Los Angeles, CA 90095 USA.	ahoffmann@ucla.edu		Luecke, Stefanie/0000-0001-5320-8110	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [419234150]; UCLA Medical Scientist Training Program [NIH NIGMS T32 GM008042]; NIH [R01AI127867, R01AI132835, R01AI127864, R01GM117134]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); UCLA Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S.L. is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - 419234150. K.M.S. is supported by the UCLA Medical Scientist Training Program (NIH NIGMS T32 GM008042). Research in the Hoffmann lab on described topics is funded by NIH R01AI127867, R01AI132835, R01AI127864, and R01GM117134.	Abe H, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00509-19; Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ablasser A, 2020, NAT IMMUNOL, V21, P17, DOI 10.1038/s41590-019-0556-1; Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Adelaja A, 2021, IMMUNITY, V54, P916, DOI 10.1016/j.immuni.2021.04.011; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bagnall J, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaf3998; Balka KR, 2019, J LEUKOCYTE BIOL, V105, P339, DOI 10.1002/JLB.MR0318-096R; Bardwell L, 2008, CURR BIOL, V18, pR910, DOI 10.1016/j.cub.2008.07.082; Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Barrat FJ, 2019, NAT IMMUNOL, V20, P1574, DOI 10.1038/s41590-019-0466-2; Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; Behar M, 2013, BIOPHYS J, V105, P231, DOI 10.1016/j.bpj.2013.05.013; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Bhaumik SR, 2011, BBA-GENE REGUL MECH, V1809, P97, DOI 10.1016/j.bbagrm.2010.08.009; Boraschi D, 2018, IMMUNOL REV, V281, P197, DOI 10.1111/imr.12606; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Brignall R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00609; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Cadena C, 2019, CELL, V177, P1187, DOI 10.1016/j.cell.2019.03.017; Caldwell AB, 2014, GENE DEV, V28, P2120, DOI 10.1101/gad.244749.114; Care BR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-48; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chen HH, 2013, PROTEIN CELL, V4, P27, DOI 10.1007/s13238-012-2063-0; Chen JW, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005805; Chen QJ, 2021, SCIENCE, V372, P1349, DOI 10.1126/science.abc0269; Cheng CS, 2017, CELL SYST, V4, P330, DOI 10.1016/j.cels.2017.01.012; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Cheng Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40503-y; Cheng Z, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5208; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Chhabra S, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000498; Chopra SS, 2020, CELL SYST, V10, P66, DOI 10.1016/j.cels.2019.11.001; Cohen P, 2017, CELL DEATH DIFFER, V24, P1153, DOI 10.1038/cdd.2017.17; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Deguine Jacques, 2014, F1000Prime Rep, V6, P97, DOI 10.12703/P6-97; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dostert C, 2019, PHYSIOL REV, V99, P115, DOI 10.1152/physrev.00045.2017; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Dunphy G, 2018, MOL CELL, V71, P745, DOI 10.1016/j.molcel.2018.07.034; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Eng CHL, 2019, NATURE, V568, P235, DOI 10.1038/s41586-019-1049-y; Fang R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006720; Fang R, 2017, J IMMUNOL, V199, P3222, DOI 10.4049/jimmunol.1700699; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Feinerman O, 2008, MOL IMMUNOL, V45, P619, DOI 10.1016/j.molimm.2007.03.028; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P612, DOI 10.1016/j.tibs.2014.10.002; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Foreman R, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20199146; Freaney JE, 2013, CELL REP, V4, P959, DOI 10.1016/j.celrep.2013.07.043; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Funes SC, 2018, IMMUNOLOGY, V154, P186, DOI 10.1111/imm.12910; Ganti RS, 2020, P NATL ACAD SCI USA, V117, P26020, DOI 10.1073/pnas.2008303117; Gantke T, 2012, IMMUNOL REV, V246, P168, DOI 10.1111/j.1600-065X.2012.01104.x; Gaudet S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002482; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gottschalk RA, 2019, ELIFE, V8, DOI 10.7554/eLife.46836; Gottschalk RA, 2016, CELL SYST, V2, P378, DOI 10.1016/j.cels.2016.04.016; Gu MD, 2014, CELL SIGNAL, V26, P2930, DOI 10.1016/j.cellsig.2014.09.007; Gustine JN, 2021, AM J PATHOL, V191, P4, DOI 10.1016/j.ajpath.2020.08.009; Gutschow MV, 2019, MOL BIOL CELL, V30, P282, DOI 10.1091/mbc.E18-07-0423; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heemskerk I, 2019, ELIFE, V8, DOI 10.7554/eLife.40526; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoffmann A, 2016, TRENDS IMMUNOL, V37, P570, DOI 10.1016/j.it.2016.07.003; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hughey JJ, 2015, MOL BIOL CELL, V26, P583, DOI 10.1091/mbc.E14-08-1267; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Junkin M, 2016, CELL REP, V15, P411, DOI 10.1016/j.celrep.2016.03.033; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kellogg RA, 2015, CELL, V160, P381, DOI 10.1016/j.cell.2015.01.013; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Kholodenko BN, 2009, WIRES SYST BIOL MED, V1, P28, DOI 10.1002/wsbm.16; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kundert K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09985-2; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lamers MM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01763; Lane K, 2019, CELL SYST, V8, P183, DOI 10.1016/j.cels.2019.02.008; Lane K, 2017, CELL SYST, V4, P458, DOI 10.1016/j.cels.2017.03.010; Lee REC, 2014, MOL CELL, V53, P867, DOI 10.1016/j.molcel.2014.01.026; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Li PL, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.170977; Lin B, 2017, CELL SYST, V5, P25, DOI 10.1016/j.cels.2017.06.014; Lin J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11531-z; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu D, 2015, MOL CELL BIOL, V35, P2400, DOI 10.1128/MCB.00090-15; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Longo DM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003112; Luo L, 2020, J CELL SCI, V133, DOI 10.1242/jcs.239194; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Manes NP, 2015, MOL CELL PROTEOMICS, V14, P2661, DOI 10.1074/mcp.M115.048918; Mann CCD, 2019, CELL REP, V27, P1165, DOI 10.1016/j.celrep.2019.03.098; Mann M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00972-z; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Martins AJ, 2017, CELL SYST, V4, P379, DOI 10.1016/j.cels.2017.03.002; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Meier-Schellersheim M, 2006, PLOS COMPUT BIOL, V2, P710, DOI 10.1371/journal.pcbi.0020082; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mikuda N, 2018, EMBO J, V37, DOI 10.15252/embj.201798658; Mitchell S, 2016, WIRES SYST BIOL MED, V8, P227, DOI 10.1002/wsbm.1331; Monie TP, 2009, IMMUNOL REV, V227, P161, DOI 10.1111/j.1600-065X.2008.00735.x; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Ni GX, 2020, MBIO, V11, DOI 10.1128/mBio.01728-20; Ni GX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah7119; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ohto Umeharu, 2016, Biophys Rev, V8, P33, DOI 10.1007/s12551-015-0187-1; Ourthiague DR, 2015, J LEUKOCYTE BIOL, V98, P119, DOI 10.1189/jlb.4A1014-483RR; Pandey S, 2020, CELL SYST, V11, P495, DOI 10.1016/j.cels.2020.10.001; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Parvatiyar K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05168-7; Pattison MJ, 2016, BIOCHEM J, V473, P2845, DOI 10.1042/BCJ20160502; Pauls E, 2012, J BIOL CHEM, V287, P19216, DOI 10.1074/jbc.M112.345405; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Regot S., 2019, 826917 BIORXIV; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Roget K, 2012, MOL CELL BIOL, V32, P4684, DOI 10.1128/MCB.01065-12; Rothchild AC, 2016, P NATL ACAD SCI USA, V113, pE6172, DOI 10.1073/pnas.1608255113; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Satija R, 2014, TRENDS IMMUNOL, V35, P219, DOI 10.1016/j.it.2014.03.004; Scholes C, 2017, CELL SYST, V4, P97, DOI 10.1016/j.cels.2016.11.012; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Schrofelbauer B, 2011, IMMUNOL REV, V244, P29, DOI 10.1111/j.1600-065X.2011.01060.x; Sen S, 2020, CELL SYST, V10, P169, DOI 10.1016/j.cels.2019.12.004; Sheu Katherine, 2019, Curr Opin Syst Biol, V18, P53, DOI 10.1016/j.coisb.2019.10.011; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shinohara H, 2014, SCIENCE, V344, P760, DOI 10.1126/science.1250020; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Sparrer KMJ, 2015, CURR OPIN MICROBIOL, V26, P1, DOI 10.1016/j.mib.2015.03.001; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Stempel M, 2019, EMBO J, V38, DOI 10.15252/embj.2018100983; Sung MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004764; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan RST, 2014, INT REV IMMUNOL, V33, P443, DOI 10.3109/08830185.2014.921164; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Testa Ugo, 2017, Non-Coding RNA, V3, P22, DOI 10.3390/ncrna3030022; Tokunaga F, 2013, J BIOCHEM, V154, P313, DOI 10.1093/jb/mvt079; Tomida T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9350; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Vanaja KG, 2018, MOL CELL, V72, P60, DOI 10.1016/j.molcel.2018.08.025; Voisinne G, 2015, CELL REP, V11, P1208, DOI 10.1016/j.celrep.2015.04.051; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Witzel F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00475; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia CL, 2019, P NATL ACAD SCI USA, V116, P19490, DOI 10.1073/pnas.1912459116; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xiang WW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501889; Xu XH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000980; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; Zanoni I, 2012, EUR J IMMUNOL, V42, P1924, DOI 10.1002/eji.201242580; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang C, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7959; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444; Zhang LL, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007435; Zhao YL, 2012, CELL SIGNAL, V24, P2197, DOI 10.1016/j.cellsig.2012.06.017	219	8	8	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1915	1932		10.1016/j.immuni.2021.08.018	http://dx.doi.org/10.1016/j.immuni.2021.08.018		SEP 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34525335	Bronze, Green Accepted			2022-12-18	WOS:000695789800005
J	Keerthivasan, S; Senbabaoglu, Y; Martinez-Martin, N; Husain, B; Verschueren, E; Wong, A; Yang, YA; Sun, YL; Pham, V; Hinkle, T; Oei, Y; Madireddi, S; Corpuz, R; Tam, L; Carlisle, S; Roose-Girma, M; Modrusan, Z; Ye, ZM; Koerber, JT; Turley, SJ				Keerthivasan, Shilpa; Senbabaoglu, Yasin; Martinez-Martin, Nadia; Husain, Bushra; Verschueren, Erik; Wong, Anne; Yang, Yeqing Angela; Sun, Yonglian; Pham, Victoria; Hinkle, Trent; Oei, Yoko; Madireddi, Shravan; Corpuz, Racquel; Tam, Lucinda; Carlisle, Samantha; Roose-Girma, Merone; Modrusan, Zora; Ye, Zhengmao; Koerber, James T.; Turley, Shannon J.			Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; IG-LIKE RECEPTOR-1; INHIBITORY RECEPTOR; FACTOR CSF-1; PROTEIN; SUBSETS; CELLS; DIFFERENTIATION; IDENTIFICATION; SEQUENCES	Myeloid cells encounter stromal cells and their matrix determinants on a continual basis during their residence in any given organ. Here, we examined the impact of the collagen receptor LAIR1 on myeloid cell homeostasis and function. LAIR1 was highly expressed in the myeloid lineage and enriched in non-classical monocytes. Proteomic definition of the LAIR1 interactome identified stromal factor Colec12 as a high-affinity LAIR1 ligand. Proteomic profiling of LAIR1 signaling triggered by Collagen1 and Colec12 highlighted pathways associated with survival, proliferation, and differentiation. Lair1(-/-) mice had reduced frequencies of Ly6C(-) monocytes, which were associated with altered proliferation and apoptosis of non-classical monocytes from bone marrow and altered heterogeneity of interstitial macrophages in lung. Myeloid-specific LAIR1 deficiency promoted metastatic growth in a melanoma model and LAIR1 expression associated with improved clinical outcomes in human metastatic melanoma. Thus, monocytes and macrophages rely on LAIR1 sensing of stromal determinants for fitness and function, with relevance in homeostasis and disease.	[Keerthivasan, Shilpa; Senbabaoglu, Yasin; Martinez-Martin, Nadia; Husain, Bushra; Verschueren, Erik; Wong, Anne; Yang, Yeqing Angela; Sun, Yonglian; Pham, Victoria; Hinkle, Trent; Oei, Yoko; Madireddi, Shravan; Corpuz, Racquel; Tam, Lucinda; Carlisle, Samantha; Roose-Girma, Merone; Modrusan, Zora; Ye, Zhengmao; Koerber, James T.; Turley, Shannon J.] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Turley, SJ (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	turley.shannon@gene.com	Hinkle, Trent/AAW-5373-2021	MADIREDDI, SHRAVAN/0000-0002-7069-1252; Yang, Angela/0000-0002-9868-7431; Carlisle, Samantha/0000-0002-8968-4300				Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Brondijk THC, 2010, BLOOD, V115, P1364, DOI 10.1182/blood-2009-10-246322; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Carvalheiro T, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01793; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hughes E.D., 2001, ADV PROTOCOLS ANIMAL, P291; Husain B, 2019, MOL CELL PROTEOMICS, V18, P2310, DOI 10.1074/mcp.TIR119.001433; Kang XL, 2015, NAT CELL BIOL, V17, P665, DOI 10.1038/ncb3158; Khalaji S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46532; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Lebbink RJ, 2004, J IMMUNOL, V172, P5535, DOI 10.4049/jimmunol.172.9.5535; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Martinez-Martin N, 2018, CELL, V174, P1158, DOI 10.1016/j.cell.2018.06.028; Martinez-Martin N, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2197615; Meyaard L, 1999, CURR TOP MICROBIOL, V244, P151; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 1999, J IMMUNOL, V162, P5800; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Newman RJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv600; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; PRALORAN V, 1991, NOUV REV FR HEMATOL, V33, P323; RETTENMIER CW, 1989, HEMATOL ONCOL CLIN N, V3, P479, DOI 10.1016/S0889-8588(18)30543-4; Roth P., 1992, MACROPHAGE BIOL ACTI, P141; Ryder E, 2014, TRANSGENIC RES, V23, P177, DOI 10.1007/s11248-013-9764-x; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Schultz HS, 2015, J IMMUNOL, V194, P3169, DOI 10.4049/jimmunol.1402800; Schyns J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11843-0; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Son M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00290-w; Son M, 2012, P NATL ACAD SCI USA, V109, pE3160, DOI 10.1073/pnas.1212753109; STANLEY ER, 1976, J EXP MED, V143, P631, DOI 10.1084/jem.143.3.631; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tang XB, 2012, J IMMUNOL, V188, P548, DOI 10.4049/jimmunol.1102044; Thomas GD, 2017, ARTERIOSCL THROM VAS, V37, P1548, DOI 10.1161/ATVBAHA.117.309145; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Verschueren E, 2020, CELL, V182, P329, DOI 10.1016/j.cell.2020.06.007; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Vogel WF, 2001, EUR J DERMATOL, V11, P506; Walker DG, 1998, MOL CHEM NEUROPATHOL, V34, P197, DOI 10.1007/BF02815080; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu TD, 2016, METHODS MOL BIOL, V1418, P283, DOI 10.1007/978-1-4939-3578-9_15; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu MJ, 2000, J BIOL CHEM, V275, P17440, DOI 10.1074/jbc.M001313200; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yu YRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150606; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	72	8	8	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1511	+		10.1016/j.immuni.2021.06.012	http://dx.doi.org/10.1016/j.immuni.2021.06.012		JUL 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34260887	Bronze			2022-12-18	WOS:000672812100015
J	Tian, LY; Tomei, S; Schreuder, J; Weber, TS; Amann-Zalcenstein, D; Lin, DS; Tran, J; Audiger, C; Chu, M; Jarratt, A; Willson, T; Hilton, A; Pang, ES; Patton, T; Kelly, M; Su, SA; Gouil, Q; Diakumis, P; Bahlo, M; Sargeant, T; Kats, LM; Hodgkin, PD; O'Keeffe, M; Ng, AP; Ritchie, ME; Naik, SH				Tian, Luyi; Tomei, Sara; Schreuder, Jaring; Weber, Tom S.; Amann-Zalcenstein, Daniela; Lin, Dawn S.; Tran, Jessica; Audiger, Cindy; Chu, Mathew; Jarratt, Andrew; Willson, Tracy; Hilton, Adrienne; Pang, Ee Shan; Patton, Timothy; Kelly, Madison; Su, Shian; Gouil, Quentin; Diakumis, Peter; Bahlo, Melanie; Sargeant, Toby; Kats, Lev M.; Hodgkin, Philip D.; O'Keeffe, Meredith; Ng, Ashley P.; Ritchie, Matthew E.; Naik, Shalin H.			Clonal multi-omics reveals Bcor as a negative regulator of emergency dendritic cell development	IMMUNITY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; STEADY-STATE; FLT3 LIGAND; LONG-TERM; IN-VITRO; RNA-SEQ; LINEAGE; GENERATION; DISTINCT; PROGRAM	Despite advances in single-cell multi-omics, a single stem or progenitor cell can only be tested once. We developed clonal multi-omics, in which daughters of a clone act as surrogates of the founder, thereby allowing multiple independent assays per clone. With SIS-seq, clonal siblings in parallel "sister'' assays are examined either for gene expression by RNA sequencing (RNA-seq) or for fate in culture. We identified, and then validated using CRISPR, genes that controlled fate bias for different dendritic cell (DC) subtypes. This included Bcor as a suppressor of plasmacytoid DC (pDC) and conventional DC type 2 (cDC2) numbers during Flt3 ligand-mediated emergency DC development. We then developed SIS-skew to examine development of wild-type and Bcor-deficient siblings of the same clone in parallel. We found Bcor restricted clonal expansion, especially for cDC2s, and suppressed clonal fate potential, especially for pDCs. Therefore, SIS-seq and SIS-skew can reveal the molecular and cellular mechanisms governing clonal fate.	[Tian, Luyi; Tomei, Sara; Schreuder, Jaring; Weber, Tom S.; Lin, Dawn S.; Tran, Jessica; Audiger, Cindy; Chu, Mathew; Hodgkin, Philip D.; Naik, Shalin H.] Walter & Eliza Hall Inst Med Res, Immunol Div, Parkville, Vic 3052, Australia; [Tian, Luyi; Su, Shian; Gouil, Quentin; Ritchie, Matthew E.] Walter & Eliza Hall Inst Med Res, Epigenet & Dev Div, Parkville, Vic 3052, Australia; [Tian, Luyi; Tomei, Sara; Weber, Tom S.; Amann-Zalcenstein, Daniela; Lin, Dawn S.; Audiger, Cindy; Jarratt, Andrew; Willson, Tracy; Hilton, Adrienne; Su, Shian; Gouil, Quentin; Diakumis, Peter; Bahlo, Melanie; Sargeant, Toby; Hodgkin, Philip D.; Ng, Ashley P.; Ritchie, Matthew E.; Naik, Shalin H.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Amann-Zalcenstein, Daniela; Naik, Shalin H.] Walter & Eliza Hall Inst Med Res, Single Cell Open Res Endeavour SCORE, Parkville, Vic 3052, Australia; [Jarratt, Andrew; Willson, Tracy; Hilton, Adrienne; Sargeant, Toby; Ng, Ashley P.] Walter & Eliza Hall Inst Med Res, Blood Cells & Blood Canc Div, Parkville, Vic 3052, Australia; [Pang, Ee Shan; Patton, Timothy; O'Keeffe, Meredith] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Diakumis, Peter; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic 3052, Australia; [Kelly, Madison; Kats, Lev M.] Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia; [Kelly, Madison; Kats, Lev M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Monash University; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Naik, SH (corresponding author), Walter & Eliza Hall Inst Med Res, Immunol Div, Parkville, Vic 3052, Australia.; Naik, SH (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.; Naik, SH (corresponding author), Walter & Eliza Hall Inst Med Res, Single Cell Open Res Endeavour SCORE, Parkville, Vic 3052, Australia.	naik.s@wehi.edu.au	Kats, Lev/AAW-3252-2021; Luyi, Tian/H-1192-2018; Naik, Shalin/AFD-5605-2022; Patton, Timothy/AEQ-3899-2022; Ng, Ashley/D-3842-2011	Kats, Lev/0000-0001-8742-8138; Luyi, Tian/0000-0003-3420-3685; Patton, Timothy/0000-0002-9642-7003; Ng, Ashley/0000-0001-9690-0879; Kelly, Madison/0000-0002-2752-9014; Weber, Tom S/0000-0003-3836-3299; Gouil, Quentin/0000-0002-5142-7886; Tomei, Sara/0000-0001-7832-5807; Amann-Zalcenstein, Daniela/0000-0003-4928-1846; Diakumis, Peter/0000-0002-7502-7545; Chu, Mathew/0000-0001-8611-8496	National Health and Medical Research Council, Australia [GNT1062820, GNT1100033, GNT1101378, GNT1124812, GNT1145184]; Australia Research Council's special initiative Stem Cells Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council's special initiative Stem Cells Australia(Australian Research Council)	We thank WEHI core facilities, including Bioservices, Centre for Dynamic Imaging, Flow cytometry, and Genomics; D. Hilton, M. Blewitt, S. Nutt, S. Taoudi, and J. Powell for critical reading of the manuscript; and J.-G. Zhang for Flt3L. This work was supported by grants from the National Health and Medical Research Council, Australia (GNT1062820, GNT1100033, GNT1101378, GNT1124812, and GNT1145184), and the Australia Research Council's special initiative Stem Cells Australia.	Amezquita RA, 2020, NAT METHODS, V17, P137, DOI 10.1038/s41592-019-0654-x; Anderson DA, 2021, NAT REV IMMUNOL, V21, P101, DOI 10.1038/s41577-020-00413-x; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biddy BA, 2018, NATURE, V564, P219, DOI 10.1038/s41586-018-0744-4; Bottcher JP, 2018, TRENDS CANCER, V4, P784, DOI 10.1016/j.trecan.2018.09.001; BRADLEY TR, 1966, AUST J EXP BIOL MED, V44, P287, DOI 10.1038/icb.1966.28; Chopin M, 2019, IMMUNITY, V50, P77, DOI 10.1016/j.immuni.2018.11.010; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P5; Dai Zhiyin, 2014, F1000Res, V3, P95, DOI 10.12688/f1000research.3928.2; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Eidenschenk C, 2010, P NATL ACAD SCI USA, V107, P9759, DOI 10.1073/pnas.1005186107; Emert BL, 2021, NAT BIOTECHNOL, V39, P865, DOI 10.1038/s41587-021-00837-3; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Haas S, 2018, CELL STEM CELL, V22, P627, DOI 10.1016/j.stem.2018.04.003; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hofer T, 2016, ANNU REV IMMUNOL, V34, P449, DOI 10.1146/annurev-immunol-032414-112019; Horton MB, 2018, J IMMUNOL, V201, P1097, DOI 10.4049/jimmunol.1800481; Huang M, 2018, NAT METHODS, V15, P539, DOI 10.1038/s41592-018-0033-z; Huynh KD, 2000, GENE DEV, V14, P1810; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kelly MJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09250-6; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin DS, 2021, NAT CELL BIOL, V23, P219, DOI 10.1038/s41556-021-00636-7; Lin DS, 2018, CELL REP, V22, P2557, DOI 10.1016/j.celrep.2018.02.046; Macaulay IC, 2017, TRENDS GENET, V33, P155, DOI 10.1016/j.tig.2016.12.003; Maraskovsky E, 1997, ADV EXP MED BIOL, V417, P33; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Merino D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08595-2; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2020, MOL IMMUNOL, V124, P190, DOI 10.1016/j.molimm.2020.06.012; Naik SH, 2014, EXP HEMATOL, V42, P598, DOI 10.1016/j.exphem.2014.05.003; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Naik SH, 2010, METHODS MOL BIOL, V595, P167, DOI 10.1007/978-1-60761-421-0_10; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Ng AP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16828-y; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Ohtsuka H, 2011, J IMMUNOL, V186, P255, DOI 10.4049/jimmunol.0903714; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Paul F, 2016, CELL, V164, P325, DOI 10.1016/j.cell.2015.12.046; Perez CR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13368-y; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Skylaki S, 2016, NAT BIOTECHNOL, V34, P1137, DOI 10.1038/nbt.3713; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tanaka T, 2017, J EXP MED, V214, P2901, DOI 10.1084/jem.20170167; Tara S, 2018, BLOOD, V132, P2470, DOI 10.1182/blood-2018-01-827964; Tian L., 2018, 403113 BIORXIV; Tian LY, 2019, NAT METHODS, V16, P479, DOI 10.1038/s41592-019-0425-8; Tian LY, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006361; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Vollstedt S, 2006, EUR J IMMUNOL, V36, P1231, DOI 10.1002/eji.200535759; Wculek S.K., 2020, NAT REV IMMUNOL, V20, P7, DOI DOI 10.1038/S41577-019-0210-Z; Weinreb C, 2020, SCIENCE, V367, DOI 10.1126/science.aaw3381; Wumesh KC, 2014, NATURE, V507, P243, DOI 10.1038/nature12967; Yoon J, 2014, J BIOL CHEM, V289, P34250, DOI 10.1074/jbc.M114.571182	82	8	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1338	+		10.1016/j.immuni.2021.03.012	http://dx.doi.org/10.1016/j.immuni.2021.03.012		JUN 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	33862015	Bronze			2022-12-18	WOS:000659882900021
J	Misasi, J; Sullivan, NJ				Misasi, John; Sullivan, Nancy J.			Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein	IMMUNITY			English	Review							VIRUS VP35 PROTEIN; FC-GAMMA RECEPTORS; ANTIBODY-MEDIATED NEUTRALIZATION; HUMAN MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER; EFFECTOR FUNCTIONS; NONHUMAN-PRIMATES; ZAIRE-EBOLAVIRUS; STRUCTURAL BASIS; HUMAN IGG1	The 2014 Ebola virus disease (EVD) outbreak in West Africa and the subsequent outbreaks of 2018-2020 in Equator and North Kivu provinces of the Democratic Republic of the Congo illustrate the public health challenges of emerging and reemerging viruses. EVD has a high case fatality rate with a rapidly progressing syndrome of fever, rash, vomiting, diarrhea, and bleeding diathesis. Recently, two monoclonal-antibody-based therapies received United States Food and Drug Administration (FDA) approval, and there are several other passive immunotherapies that hold promise as therapeutics against other species of Ebolavirus. Here, we review concepts needed to understand mechanisms of action, present an expanded schema to define additional sites of vulnerability on the viral glycoprotein, and review current antibody-based therapeutics. The concepts described are used to gain insights into the key characteristics that represent functional targets for immunotherapies against Zaire Ebolavirus and other emerging viruses within the Ebolavirus genus.	[Misasi, John; Sullivan, Nancy J.] NIAID, NIH, Vaccine Res Ctr, 40 Convent Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sullivan, NJ (corresponding author), NIAID, NIH, Vaccine Res Ctr, 40 Convent Dr, Bethesda, MD 20892 USA.	njsull@mail.nih.gov		Misasi, John/0000-0001-7169-2639				Ahuka-Mundeke S, 2018, LANCET, V392, P213, DOI 10.1016/S0140-6736(18)31387-4; Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Alfson K.J., 2018, VIRUSES, V10, P1; Alfson KJ, 2015, J INFECT DIS, V212, pS295, DOI 10.1093/infdis/jiv216; Alfson KJ, 2015, J VIROL, V89, P6773, DOI 10.1128/JVI.00649-15; Altman MO, 2018, VIRAL IMMUNOL, V31, P142, DOI 10.1089/vim.2017.0129; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Banadyga L, 2016, J MOL BIOL, V428, P3449, DOI 10.1016/j.jmb.2016.05.008; Barnes N, 2002, IMMUNITY, V16, P379, DOI 10.1016/S1074-7613(02)00287-X; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003; Basler CF, 2017, SEMIN IMMUNOPATHOL, V39, P551, DOI 10.1007/s00281-017-0637-x; Battles MB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01708-9; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Berry JD, 2011, NEW BIOTECHNOL, V28, P489, DOI 10.1016/j.nbt.2011.03.018; Bevaart L, 2006, BRIT J HAEMATOL, V132, P317, DOI 10.1111/j.1365-2141.2005.05884.x; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Bornholdt ZA, 2019, CELL HOST MICROBE, V25, P49, DOI 10.1016/j.chom.2018.12.005; Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788; Bournazos S, 2019, P NATL ACAD SCI USA, V116, P20054, DOI 10.1073/pnas.1911842116; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Bournazos S, 2014, J CLIN INVEST, V124, P725, DOI 10.1172/JCI72676; Brannan JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08040-w; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Bray M, 2001, J GEN VIROL, V82, P1365, DOI 10.1099/0022-1317-82-6-1365; BRES P, 1978, B WORLD HEALTH ORGAN, V56, P245; Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Cagigi A, 2018, J INFECT DIS, V218, pS537, DOI 10.1093/infdis/jiy450; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; CDC, 2020, OUTBR EB EB VIR DIS; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chen Q, 2016, P NATL ACAD SCI USA, V113, P9404, DOI 10.1073/pnas.1610803113; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Chiang JJ, 2014, CYTOKINE GROWTH F R, V25, P491, DOI 10.1016/j.cytogfr.2014.06.005; Childs J.E., 1993, ARENAVIRIDAE, P331, DOI DOI 10.1007/978-1-4615-3028-2_19; Cilloniz C, 2011, J VIROL, V85, P9060, DOI 10.1128/JVI.00659-11; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Cox E, 2018, NOTES RECORD CONSULT; Crowe SJ, 2016, EMERG INFECT DIS, V22, P217, DOI 10.3201/eid2202.151250; Dahlmann F, 2015, J INFECT DIS, V212, pS247, DOI 10.1093/infdis/jiv140; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247; Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Donaldson E., 2019, FIL VIR AN NONCL GRO; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; ELLIS DS, 1978, J CLIN PATHOL, V31, P201, DOI 10.1136/jcp.31.3.201; ELLIS DS, 1978, BRIT J EXP PATHOL, V59, P584; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; FDA, 2020, FDA APPR TREATM EB V; FDA, 2020, FDA APPR 1 TREATM EB; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Fiebiger BM, 2015, P NATL ACAD SCI USA, V112, pE2385, DOI 10.1073/pnas.1505292112; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Flyak AI, 2018, NAT MICROBIOL, V3, P670, DOI 10.1038/s41564-018-0157-z; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Gaudinski MR, 2019, LANCET, V393, P889, DOI 10.1016/S0140-6736(19)30036-4; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Gibb TR, 2001, J COMP PATHOL, V125, P233, DOI 10.1053/jcpa.2001.0502; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; Gramberg T, 2008, VIROLOGY, V373, P189, DOI 10.1016/j.virol.2007.11.001; Groseth A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002847; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hamaguchi Y, 2006, J EXP MED, V203, P743, DOI 10.1084/jem.20052283; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Hartlieb B, 2003, J BIOL CHEM, V278, P41830, DOI 10.1074/jbc.M307036200; Hartlieb B, 2007, P NATL ACAD SCI USA, V104, P624, DOI 10.1073/pnas.0606730104; Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Haynes BF, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaz2686; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hoenen T, 2015, J INFECT DIS, V212, pS242, DOI 10.1093/infdis/jiv111; Hofmann-Winkler H, 2012, VIRUSES-BASEL, V4, P3336, DOI 10.3390/v4123336; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Howell KA, 2016, CELL REP, V15, P1514, DOI 10.1016/j.celrep.2016.04.026; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Hunt L, 2015, LANCET INFECT DIS, V15, P1292, DOI 10.1016/S1473-3099(15)00144-9; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Iseda S, 2016, J VIROL, V90, P6276, DOI 10.1128/JVI.00557-16; Jahrling PB, 1996, ARCH VIROL, P135; Janus BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06113-4; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232; JOHNSON VA, 1991, J INFECT DIS, V164, P646, DOI 10.1093/infdis/164.4.646; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Keck ZY, 2016, J VIROL, V90, P279, DOI 10.1128/JVI.02172-15; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Kindzelskii AL, 2000, J IMMUNOL, V164, P953, DOI 10.4049/jimmunol.164.2.953; King LB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09732-7; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Kudoyarova-Zubavichene NM, 1999, J INFECT DIS, V179, pS218, DOI 10.1086/514294; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Lanini S, 2015, J CLIN INVEST, V125, P4692, DOI 10.1172/JCI83111; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee J, 2017, P NATL ACAD SCI USA, V114, pE7987, DOI 10.1073/pnas.1708052114; Leonard AS, 2016, J VIROL, V90, P11247, DOI 10.1128/JVI.01657-16; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2001, CLIN EXP IMMUNOL, V124, P453, DOI 10.1046/j.1365-2249.2001.01517.x; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Mahanty S, 2003, VIROLOGY, V312, P415, DOI 10.1016/S0042-6822(03)00233-2; Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797; Malvy D, 2019, LANCET, V393, P936, DOI 10.1016/S0140-6736(18)33132-5; Martinez O, 2011, J INFECT DIS, V204, pS825, DOI 10.1093/infdis/jir295; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; Mas V, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005859; Mason CP, 2015, MOLECULES, V20, P2229, DOI 10.3390/molecules20022229; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Mateo M, 2011, J INFECT DIS, V204, pS1011, DOI 10.1093/infdis/jir338; McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112; McLellan JS, 2015, CURR OPIN VIROL, V11, P70, DOI 10.1016/j.coviro.2015.03.002; Messaoudi I, 2015, NAT REV MICROBIOL, V13, P663, DOI 10.1038/nrmicro3524; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Mire CE, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8711; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Misasi J, 2014, CELL, V159, P477, DOI 10.1016/j.cell.2014.10.006; Misasi J, 2012, J VIROL, V86, P3284, DOI 10.1128/JVI.06346-11; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Moldt B, 2012, J VIROL, V86, P6189, DOI 10.1128/JVI.00491-12; Moldt B, 2011, J VIROL, V85, P10572, DOI 10.1128/JVI.05541-11; Moller-Tank S, 2014, J VIROL, V88, P6702, DOI 10.1128/JVI.00300-14; Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13; Mousa JJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.271; Muhlberger E, 1999, J VIROL, V73, P2333; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Mulherkar N, 2011, VIROLOGY, V419, P72, DOI 10.1016/j.virol.2011.08.009; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298; Nag Anish, 2020, VirusDisease, V31, DOI 10.1007/s13337-020-00619-6; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nishimura Y, 2017, CELL HOST MICROBE, V22, P207, DOI 10.1016/j.chom.2017.07.010; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Pallesen J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.128, 10.1038/nmicrobiol.2016.128]; PALMIERI JR, 1982, NATURE, V298, P220, DOI 10.1038/298220d0; Pascal KE, 2018, J INFECT DIS, V218, pS612, DOI 10.1093/infdis/jiy285; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Ploquin A, 2018, J IMMUNOL, V201, P833, DOI 10.4049/jimmunol.1700827; Prins KC, 2010, J VIROL, V84, P10581, DOI 10.1128/JVI.00925-10; Qiu XG, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9875; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2011, CLIN IMMUNOL, V141, P218, DOI 10.1016/j.clim.2011.08.008; Quan YD, 2014, J ANTIMICROB CHEMOTH, V69, P21, DOI 10.1093/jac/dkt326; Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Reid SP, 2007, J VIROL, V81, P13469, DOI 10.1128/JVI.01097-07; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Ruibal P, 2016, NATURE, V533, P100, DOI 10.1038/nature17949; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; SANCHEZ A, 1987, VIROLOGY, V157, P414, DOI 10.1016/0042-6822(87)90283-2; Saphire EO, 2018, NAT IMMUNOL, V19, P1169, DOI 10.1038/s41590-018-0233-9; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schornberg KL, 2009, P NATL ACAD SCI USA, V106, P8003, DOI 10.1073/pnas.0807578106; Schuster M, 2005, CANCER RES, V65, P7934, DOI 10.1158/0008-5472.CAN-04-4212; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; SHAFER RW, 1994, J INFECT DIS, V169, P722, DOI 10.1093/infdis/169.4.722; Shedlock DJ, 2010, VIROLOGY, V401, P228, DOI 10.1016/j.virol.2010.02.029; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Sivapalasingam S, 2018, LANCET INFECT DIS, V18, P884, DOI 10.1016/S1473-3099(18)30397-9; Sondermann P, 2016, CURR OPIN IMMUNOL, V40, P78, DOI 10.1016/j.coi.2016.03.005; Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300; STCLAIR MH, 1991, SCIENCE, V253, P1557, DOI 10.1126/science.1716788; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Trefry JC, 2015, VIRUSES-BASEL, V7, P6739, DOI 10.3390/v7122969; Tseng A, 2015, BRIT J CLIN PHARMACO, V79, P182, DOI 10.1111/bcp.12403; Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013; van Griensven J, 2016, NEW ENGL J MED, V375, P2307, DOI 10.1056/NEJMc1609116; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 2001, SCIENCE, V291, P1965, DOI 10.1126/science.1057269; Volchkova VA, 1998, VIROLOGY, V250, P408, DOI 10.1006/viro.1998.9389; Volchkova VA, 2015, J INFECT DIS, V212, pS226, DOI 10.1093/infdis/jiv309; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; Watanabe Y, 2018, J VIROL, V92, DOI [10.1128/JVI.02004-17, 10.1128/jvi.02004-17]; Wauquier N, 2009, EMERG INFECT DIS, V15, P1136, DOI 10.3201/eid1507.090402; Wec AZ, 2019, CELL HOST MICROBE, V25, P39, DOI 10.1016/j.chom.2018.12.004; Wec AZ, 2017, CELL, V169, P878, DOI 10.1016/j.cell.2017.04.037; Wec AZ, 2016, SCIENCE, V354, P350, DOI 10.1126/science.aag3267; Wen ZY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-331; West BR, 2019, NAT STRUCT MOL BIOL, V26, P204, DOI 10.1038/s41594-019-0191-4; West BR, 2018, MBIO, V9, DOI [10.1128/mBio.01674-18, 10.1128/mbio.01674-18]; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Wong G, 2016, J INFECT DIS, V214, pS281, DOI 10.1093/infdis/jiw267; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; World Health Organization, 2020, 98 WHO, V98, P1; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yamamoto T, 2009, J VIROL, V83, P5514, DOI 10.1128/JVI.00145-09; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zhang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009294; Zhao XL, 2017, CELL, V169, P891, DOI 10.1016/j.cell.2017.04.038; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhou Y, 2015, CURR OPIN IMMUNOL, V35, P131, DOI 10.1016/j.coi.2015.06.006; Zhu YL, 2012, J VIROL, V86, P3038, DOI 10.1128/JVI.05741-11	236	8	8	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					412	436		10.1016/j.immuni.2021.01.015	http://dx.doi.org/10.1016/j.immuni.2021.01.015		MAR 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691133	Bronze			2022-12-18	WOS:000627409300011
J	Starkl, P; Watzenboeck, ML; Popov, LM; Zahalka, S; Hladik, A; Lakovits, K; Radhouani, M; Haschemi, A; Marichal, T; Reber, LL; Gaudenzio, N; Sibilano, R; Stulik, L; Fontaine, F; Mueller, AC; Amieva, MR; Galli, SJ; Knapp, S				Starkl, Philipp; Watzenboeck, Martin L.; Popov, Lauren M.; Zahalka, Sophie; Hladik, Anastasiya; Lakovits, Karin; Radhouani, Mariem; Haschemi, Arvand; Marichal, Thomas; Reber, Laurent L.; Gaudenzio, Nicolas; Sibilano, Riccardo; Stulik, Lukas; Fontaine, Frederic; Mueller, Andre C.; Amieva, Manuel R.; Galli, Stephen J.; Knapp, Sylvia			IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against Staphylococcus aureus (vol 53, pg 793, 2020)	IMMUNITY			English	Correction												philipp.starkl@meduniwien.ac.at; sgalli@stanford.edu; sylvia.knapp@meduniwien.ac.at	Reber, Laurent L/K-4148-2014	Reber, Laurent L/0000-0003-3384-6769; Watzenboeck, Martin/0000-0001-9445-3331	Austrian Science Fund FWF [P 31113] Funding Source: Medline; NIAID NIH HHS [R01 AI023990, R01 AI070813, R01 AI132494] Funding Source: Medline; NIAMS NIH HHS [R01 AR067145] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Starkl P, 2020, IMMUNITY, V53, P793, DOI 10.1016/j.immuni.2020.08.002	1	8	8	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1333	1333		10.1016/j.immuni.2020.11.012	http://dx.doi.org/10.1016/j.immuni.2020.11.012			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33326769	Bronze, Green Accepted			2022-12-18	WOS:000599363300020
J	Yewdell, WT; Kim, Y; Chowdhury, P; Lau, CM; Smolkin, RM; Belcheva, KT; Fernandez, KC; Cols, M; Yen, WF; Vaidyanathan, B; Angeletti, D; McDermott, AB; Yewdell, JW; Sun, JC; Chaudhuri, J				Yewdell, William T.; Kim, Youngjun; Chowdhury, Priyanka; Lau, Colleen M.; Smolkin, Ryan M.; Belcheva, Kalina T.; Fernandez, Keith C.; Cols, Montserrat; Yen, Wei-Feng; Vaidyanathan, Bharat; Angeletti, Davide; McDermott, Adrian B.; Yewdell, Jonathan W.; Sun, Joseph C.; Chaudhuri, Jayanta			A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization	IMMUNITY			English	Article							B-CELL LYMPHOMA; CLASS-SWITCH RECOMBINATION; TARGETED DNA DEAMINATION; SOMATIC HYPERMUTATION; SEQUENCING REVEALS; HLA-DR; AID; EXPRESSION; TRANSCRIPTION; GENE	Precise targeting of activation-induced cytidine deaminase (AID) to immunoglobulin (Ig) loci promotes antibody class switch recombination (CSR) and somatic hypermutation (SHM), whereas AID targeting of non-Ig loci can generate oncogenic DNA lesions. Here, we examined the contribution of G-quadruplex (G4) nucleic acid structures to AID targeting in vivo. Mice bearing a mutation in Aicda (AID(G133V)) that disrupts AID-G4 binding modeled the pathology of hyper-IgM syndrome patients with an orthologous mutation, lacked CSR and SHM, and had broad defects in genome-wide AID(G133V) chromatin localization. Genome-wide analyses also revealed that wild-type AID localized to MHCII genes, and AID expression correlated with decreased MHCII expression in germinal center B cells and diffuse large B cell lymphoma. Our findings indicate a crucial role for G4 binding in AID targeting and suggest that AID activity may extend beyond Ig loci to regulate the expression of genes relevant to the physiology and pathology of activated B cells.	[Yewdell, William T.; Lau, Colleen M.; Cols, Montserrat; Yen, Wei-Feng; Sun, Joseph C.; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Kim, Youngjun; Chowdhury, Priyanka; Fernandez, Keith C.; Vaidyanathan, Bharat; Sun, Joseph C.; Chaudhuri, Jayanta] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Smolkin, Ryan M.; Sun, Joseph C.; Chaudhuri, Jayanta] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [Belcheva, Kalina T.] Weill Cornell Grad Sch Med Sci, Biochem Cellular & Mol Biol Allied Program, New York, NY 10065 USA; [Angeletti, Davide; Yewdell, Jonathan W.] NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [McDermott, Adrian B.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Angeletti, Davide] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, S-41390 Gothenburg, Sweden	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Gothenburg	Chaudhuri, J (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.; Chaudhuri, J (corresponding author), Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA.; Chaudhuri, J (corresponding author), Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA.	chaudhuj@mskcc.org	Kim, Youngjun/HCH-4290-2022; Angeletti, Davide/H-7350-2019	Kim, Youngjun/0000-0003-3346-9457; Angeletti, Davide/0000-0002-5256-1972; McDermott, Adrian/0000-0003-0616-9117; Fernandez, Keith Conrad/0000-0003-3757-8271	Leukemia & Lymphoma Society; National Institutes of Health (NIH) [CA009149]; T32 award from the NIH [CA009149]; Division of Intramural Research (DIR); National Institute of Allergy and Infectious Diseases (NIAID); NIH [R01AI072194, R01AI124186, R56AI072194, U54CA137788, P30CA008748]; Ludwig Center for Cancer Immunotherapy; Burroughs Wellcome Fund; American Cancer Society; Starr Cancer Research Foundation; Ludwig Center for Cancer Immunotherapy, MSKCC Functional Genomics; Geoffrey Beene Cancer Center - National Cancer Institute (NCI) Cancer Center Support Grant [P30 CA08748]; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; NCI CCSG [P30 CA08748]; Memorial Sloan Kettering Cancer Center; Molecular Cytology Core Facility at Memorial Sloan Kettering Cancer Center [P30 CA008748]	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 award from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research (DIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center for Cancer Immunotherapy; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); Starr Cancer Research Foundation; Ludwig Center for Cancer Immunotherapy, MSKCC Functional Genomics; Geoffrey Beene Cancer Center - National Cancer Institute (NCI) Cancer Center Support Grant; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; NCI CCSG; Memorial Sloan Kettering Cancer Center; Molecular Cytology Core Facility at Memorial Sloan Kettering Cancer Center	W.T.Y. was supported by a Special Fellow award from the Leukemia & Lymphoma Society and a National Institutes of Health (NIH) T32 training grant (CA009149). C.M.L. is a Cancer Research Institute-Carson Family Fellow and was supported by a T32 award from the NIH (CA009149). J.W.Y. and D.A. were supported by the Division of Intramural Research (DIR), National Institute of Allergy and Infectious Diseases (NIAID). J.C.S. was supported by grants from the NIH (AI100874, AI130043, and P30CA008748), the Ludwig Center for Cancer Immunotherapy, the Burroughs Wellcome Fund, and the American Cancer Society. J.C. was supported by grants from the NIH (R01AI072194, R01AI124186, R56AI072194, U54CA137788, and P30CA008748), the Starr Cancer Research Foundation, the Ludwig Center for Cancer Immunotherapy, MSKCC Functional Genomics, and the Geoffrey Beene Cancer Center. We acknowledge the use of the Integrated Genomics Operation Core, funded by the National Cancer Institute (NCI) Cancer Center Support Grant (CCSG; P30 CA08748), Cycle for Survival, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology. This work was supported by NCI CCSG P30 CA08748 to the Microchemistry and Proteomics Core Laboratory, Memorial Sloan Kettering Cancer Center. We are grateful to the Molecular Cytology Core Facility at Memorial Sloan Kettering Cancer Center, funded by a Core Grant (P30 CA008748) for immunofluorescence technical assistance. We thank A. Bravo for help with maintenance of the mouse colony. We thank Dr. Ashutosh Chaudhry for assistance with sorting experiments, Dr. Rahul Kohli for plasmids and advice regarding the MBP-AID purification strategy, and Dr. Louis Staudt for advice regarding the DLBCL analysis.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altman MO, 2018, VIRAL IMMUNOL, V31, P142, DOI 10.1089/vim.2017.0129; Alvarez-Prado AF, 2018, J EXP MED, V215, P761, DOI 10.1084/jem.20171738; Arima H, 2018, LEUKEMIA LYMPHOMA, V59, P2085, DOI 10.1080/10428194.2017.1410884; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Bardin C, 2008, NUCLEIC ACIDS RES, V36, P477, DOI 10.1093/nar/gkm1050; Bhattacharyya D, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00038; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boulianne B, 2013, J IMMUNOL, V191, P5840, DOI 10.4049/jimmunol.1301776; Carrasco-Salas Y, 2019, NUCLEIC ACIDS RES, V47, P6783, DOI 10.1093/nar/gkz341; Casellas R, 2016, NAT REV IMMUNOL, V16, P164, DOI 10.1038/nri.2016.2; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cortizas EM, 2016, J EXP MED, V213, P2459, DOI 10.1084/jem.20160635; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Duquette ML, 2007, CANCER RES, V67, P2586, DOI 10.1158/0008-5472.CAN-06-2419; Duquette ML, 2005, ONCOGENE, V24, P5791, DOI 10.1038/sj.onc.1208746; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Durandy A, 2006, HUM MUTAT, V27, P1185, DOI 10.1002/humu.20414; EISEN HN, 1985, ANNU REV IMMUNOL, V3, P337, DOI 10.1146/annurev.iy.03.040185.002005; Frank GM, 2015, MBIO, V6, DOI 10.1128/mBio.01156-15; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; GILLIAM AC, 1984, P NATL ACAD SCI-BIOL, V81, P4164, DOI 10.1073/pnas.81.13.4164; Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424; Greiner A, 2005, J PATHOL, V205, P541, DOI 10.1002/path.1746; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hogenbirk MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069815; Hogenbirk MA, 2012, NAT IMMUNOL, V13, P797, DOI 10.1038/ni.2367; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; Jiao JN, 2020, NEOPLASIA, V22, P142, DOI 10.1016/j.neo.2020.01.002; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kawamura K, 2016, J CANCER RES CLIN, V142, P27, DOI 10.1007/s00432-015-2001-7; Khodabakhshi AH, 2012, ONCOTARGET, V3, P1308; Kim J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1482; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee SH, 2019, NATURE, V570, P344, DOI 10.1038/s41586-019-1305-1; LEJEUNE JM, 1982, J IMMUNOL, V129, P673; Lieber MR, 2016, NAT REV CANCER, V16, P387, DOI 10.1038/nrc.2016.40; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Lossos IS, 2004, LEUKEMIA, V18, P1775, DOI 10.1038/sj.leu.2403488; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu ZF, 2013, BLOOD, V121, P4551, DOI 10.1182/blood-2012-10-464958; Mahdaviani SA, 2012, EXPERT REV CLIN IMMU, V8, P539, DOI 10.1586/ECI.12.46; Matthews AJ, 2014, ADV IMMUNOL, V122, P1, DOI 10.1016/B978-0-12-800267-4.00001-8; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Methot SP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03387-6; Methot SP, 2015, J EXP MED, V212, P581, DOI 10.1084/jem.20141157; MILLER TP, 1988, J CLIN INVEST, V82, P370, DOI 10.1172/JCI113598; Moldenhauer G, 2006, BLOOD, V107, P2470, DOI 10.1182/blood-2005-06-2502; MOMBURG F, 1987, INT J CANCER, V40, P598, DOI 10.1002/ijc.2910400504; Mondal S, 2016, P NATL ACAD SCI USA, V113, pE1545, DOI 10.1073/pnas.1601678113; Mottok A, 2015, CELL REP, V13, P1418, DOI 10.1016/j.celrep.2015.10.008; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P6269, DOI 10.1093/nar/gkp679; PALESE P, 1977, CELL, V10, P1, DOI 10.1016/0092-8674(77)90133-7; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pasqualucci L, 2018, BLOOD, V131, P2307, DOI 10.1182/blood-2017-11-764332; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Qiao Q, 2017, MOL CELL, V67, P361, DOI 10.1016/j.molcel.2017.06.034; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Vuong BQ, 2013, NAT IMMUNOL, V14, P1183, DOI 10.1038/ni.2732; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOLOSCHAK GE, 1987, MOL IMMUNOL, V24, P751, DOI 10.1016/0161-5890(87)90058-7; Wright GW, 2020, CANCER CELL, V37, P551, DOI 10.1016/j.ccell.2020.03.015; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yewdell WT, 2017, INT IMMUNOL, V29, P183, DOI 10.1093/intimm/dxx027; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng SM, 2015, CELL, V161, P762, DOI 10.1016/j.cell.2015.03.020; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	103	8	8	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					952	+		10.1016/j.immuni.2020.10.003	http://dx.doi.org/10.1016/j.immuni.2020.10.003			30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33098766	Bronze, Green Accepted			2022-12-18	WOS:000599348200009
J	Karagiannis, F; Masouleh, SK; Wunderling, K; Surendar, J; Schmitt, V; Kazakov, A; Michla, M; Holzel, M; Thiele, C; Wilhelm, C				Karagiannis, Fotios; Masouleh, Schekufe Kharabi; Wunderling, Klaus; Surendar, Jayagopi; Schmitt, Vanessa; Kazakov, Alexander; Michla, Marcel; Holzel, Michael; Thiele, Christoph; Wilhelm, Christoph			Lipid-Droplet Formation Drives Pathogenic Group 2 Innate Lymphoid Cells in Airway Inflammation (vol 52, pg 620, 2020)	IMMUNITY			English	Correction												christoph.wilhelm@uni-bonn.de						Karagiannis F, 2020, IMMUNITY, V52, P620, DOI 10.1016/j.immuni.2020.03.003	1	8	8	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					885	885		10.1016/j.immuni.2020.04.021	http://dx.doi.org/10.1016/j.immuni.2020.04.021			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433951	Bronze			2022-12-18	WOS:000535371100019
J	Reglero-Real, N; Rolas, L; Nourshargh, S				Reglero-Real, Natalia; Rolas, Loic; Nourshargh, Sussan			Leukocyte Trafficking: Time to Take Time Seriously	IMMUNITY			English	Editorial Material								Leukocyte trafficking is a key component of steady-state tissue homing and in mounting an inflammatory response. Two recent publications in Immunity by He et al. (2018) and Adrover et al. (2019) report on the diurnal regulation of these responses and the associated pathophysiological implications.	[Reglero-Real, Natalia; Rolas, Loic; Nourshargh, Sussan] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England	University of London; Queen Mary University London	Reglero-Real, N; Rolas, L; Nourshargh, S (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England.	n.reglero@qmul.ac.uk; l.rolas@qmul.ac.uk; s.nourshargh@qmul.ac.uk	Reglero, Natalia/AAU-2845-2021; Rolas, Loic/AAA-6717-2022	Rolas, Loic/0000-0001-7617-0768; Nourshargh, Sussan/0000-0001-5677-1806; Reglero Real, Natalia/0000-0002-3916-119X	Wellcome Trust [098291/Z/12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors are funded by the Wellcome Trust (098291/Z/12/Z to S.N.).	Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Girbl T, 2018, IMMUNITY, V49, P1062, DOI 10.1016/j.immuni.2018.09.018; Granton E, 2018, TRENDS IMMUNOL, V39, P890, DOI 10.1016/j.it.2018.09.002; He WY, 2018, IMMUNITY, V49, P1175, DOI 10.1016/j.immuni.2018.10.007; Hellebrekers P, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12943; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Uhl B, 2016, BLOOD, V128, P2327, DOI 10.1182/blood-2016-05-718999; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	11	8	8	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					273	275		10.1016/j.immuni.2019.01.013	http://dx.doi.org/10.1016/j.immuni.2019.01.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30784571	Bronze			2022-12-18	WOS:000459006700001
J	Hosokawa, H; Ungerback, J; Wang, X; Matsumoto, M; Nakayama, KI; Cohen, SM; Tanaka, T; Rothenberg, EV				Hosokawa, Hiroyuki; Ungerback, Jonas; Wang, Xun; Matsumoto, Masaki; Nakayama, Keiichi I.; Cohen, Sarah M.; Tanaka, Tomoaki; Rothenberg, Ellen V.			Transcription Factor PU.1 Represses and Activates Gene Expression in Early T Cells by Redirecting Partner Transcription Factor Binding (vol 48, pg 1119, 2018)	IMMUNITY			English	Correction												evroth@its.caltech.edu		Hosokawa, Hiroyuki/0000-0002-9592-2889	NIAID NIH HHS [R01 AI095943] Funding Source: Medline; NICHD NIH HHS [R01 HD076915] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095943] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Hosokawa H, 2018, IMMUNITY, V48, P1119, DOI 10.1016/j.immuni.2018.04.024	1	8	8	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					782	782		10.1016/j.immuni.2018.09.019	http://dx.doi.org/10.1016/j.immuni.2018.09.019			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332634	Green Accepted, Bronze			2022-12-18	WOS:000447386700022
J	Horton, B; Spranger, S				Horton, Brendan; Spranger, Stefani			A Tumor Cell-Intrinsic Yin-Yang Determining Immune Evasion	IMMUNITY			English	Editorial Material								Pancreatic adenocarcinoma (PDAC) is mostly refractory to immunotherapies. In this issue of Immunity, Li et al. (2018) generate a library of clonal PDAC tumors to examine the tumor-intrinsic features shaping the anti-tumor immune response and find that tumor cell-derived CXCL1 directly blunts T cell infiltration and reduces responsiveness to immunotherapy.	[Horton, Brendan; Spranger, Stefani] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Spranger, Stefani] MIT, Dept Biol, Cambridge, MA 02139 USA; [Spranger, Stefani] 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Spranger, S (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Spranger, S (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Spranger, S (corresponding author), 77 Massachusetts Ave, Cambridge, MA 02139 USA.	spranger@mit.edu			NATIONAL CANCER INSTITUTE [R00CA204595] Funding Source: NIH RePORTER; NCI NIH HHS [R00 CA204595] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Koyama S, 2016, CANCER RES, V76, P999, DOI 10.1158/0008-5472.CAN-15-1439; Li JY, 2018, IMMUNITY, V49, P178, DOI 10.1016/j.immuni.2018.06.006; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035	9	8	8	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					11	13		10.1016/j.immuni.2018.07.001	http://dx.doi.org/10.1016/j.immuni.2018.07.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30021140	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000438949100005
J	Di Cara, F; Sheshachalam, A; Braverman, NE; Rachubinski, RA; Simmonds, AJ				Di Cara, Francesca; Sheshachalam, Avinash; Braverman, Nancy E.; Rachubinski, Richard A.; Simmonds, Andrew J.			Peroxisome-Mediated Metabolism Is Required for Immune Response to Microbial Infection (vol 47, pg 93, 2017)	IMMUNITY			English	Correction												dicara@ualberta.ca; andrew.simmonds@ualberta.ca		Braverman, Nancy/0000-0003-1621-5164				Di Cara F, 2017, IMMUNITY, V47, P93, DOI 10.1016/j.immuni.2017.06.016	1	8	8	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					832	833		10.1016/j.immuni.2018.03.035	http://dx.doi.org/10.1016/j.immuni.2018.03.035			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669255	Bronze			2022-12-18	WOS:000430198900027
J	Choi, YJ; Bowman, JW; Jung, JU				Choi, Youn Jung; Bowman, James W.; Jung, Jae U.			A Talented Duo: IFIT1 and IFIT3 Patrol Viral RNA Caps	IMMUNITY			English	Editorial Material							PROTEIN; RECOGNITION	Hosts respond to viral infection by expressing interferon-stimulated genes, of which IFITs are potent inhibitors of viral RNA translation. Johnson et al. (2018) solved the structure of the IFIT1-IFIT3 complex bound cap 0 RNA and explored their concerted antiviral activity.	[Choi, Youn Jung; Bowman, James W.; Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	University of Southern California	Jung, JU (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	jaeujung@med.usc.edu		Choi, Youn Jung (Chloe)/0000-0001-6879-0115	NATIONAL CANCER INSTITUTE [R35CA200422] Funding Source: NIH RePORTER; NCI NIH HHS [R35 CA200422] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbas YM, 2017, P NATL ACAD SCI USA, V114, pE2106, DOI 10.1073/pnas.1612444114; Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Daugherty MD, 2016, ELIFE, V5, DOI 10.7554/eLife.14228; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465; Johnson B, 2018, IMMUNITY, V48, P487, DOI 10.1016/j.immuni.2018.01.014; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048	10	8	8	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					474	476		10.1016/j.immuni.2018.03.001	http://dx.doi.org/10.1016/j.immuni.2018.03.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562196	Bronze, Green Accepted			2022-12-18	WOS:000427916900005
J	Glodde, N; Holzel, M				Glodde, Nicole; Hoelzel, Michael			RAS and PD-L1: A Masters' Liaison in Cancer Immune Evasion	IMMUNITY			English	Editorial Material							CELL	Mutant RAS is a major oncoprotein in human cancer and PD-L1 is a key driver of cancer immune evasion. In this issue of Immunity, Coelho et al. (2017) demonstrate that oncogenic RAS signaling promotes tumor immune escape by stabilizing PD-L1 mRNA.	[Glodde, Nicole; Hoelzel, Michael] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit RNA Biol, D-53105 Bonn, Germany	University of Bonn	Holzel, M (corresponding author), Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit RNA Biol, D-53105 Bonn, Germany.	michael.hoelzel@ukb.uni-bonn.de			Else-Kroner Fresenius Stiftung [2013_A297]; DFG [HO4281/2-1]; DFG cluster of excellence [EXC1023]	Else-Kroner Fresenius Stiftung; DFG(German Research Foundation (DFG)); DFG cluster of excellence(German Research Foundation (DFG))	This work was supported by grants to M.H. from the Else-Kroner Fresenius Stiftung (2013_A297), the DFG (HO4281/2-1), and the DFG cluster of excellence (EXC1023). M.H. is a member of DFG cluster of excellence ImmunoSensation (EXC1023).	Coelho MA, 2017, IMMUNITY, V47, P1083, DOI 10.1016/j.immuni.2017.11.016; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; Ebner F, 2017, J CLIN INVEST, V127, P2051, DOI 10.1172/JCI80631; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Kratochvill F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.93; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669; Wang QH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00892-y; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	10	8	8	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1007	1009		10.1016/j.immuni.2017.12.001	http://dx.doi.org/10.1016/j.immuni.2017.12.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262340	Bronze			2022-12-18	WOS:000418486500002
J	Alon, R				Alon, Ronen			A Sweet Solution: Glycolysis-Dependent Treg Cell Migration	IMMUNITY			English	Editorial Material							ACTIVATION	mTORC2 is a metabolic regulatory complex activated by PI3K. In this issue of Immunity, Kishore et al. (2017) demonstrate a specialized role for this complex in the migration of regulatory T (Treg) cells to sites of inflammation rather than their differentiation and survival.	[Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022	Alon, Ronen/0000-0001-9161-6369				Barzilai S, 2017, CELL REP, V18, P685, DOI 10.1016/j.celrep.2016.12.076; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Jung JH, 2002, J BIOL CHEM, V277, P48931, DOI 10.1074/jbc.M208806200; Kishore M, 2017, IMMUNITY, V47, P875, DOI 10.1016/j.immuni.2017.10.017; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	11	8	9	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					805	807		10.1016/j.immuni.2017.11.006	http://dx.doi.org/10.1016/j.immuni.2017.11.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166580	Bronze			2022-12-18	WOS:000416483700002
J	Maryanovich, M; Frenette, PS				Maryanovich, Maria; Frenette, Paul S.			T-Regulating Hair Follicle Stem Cells	IMMUNITY			English	Editorial Material							REG CELLS; DIFFERENTIATION; ACCUMULATION; TOLERANCE; PHENOTYPE	Regulatory T (Treg) cells are well known to modulate inflammatory responses. In a recent issue of Cell, Ali et al. (2017) reveal a function for Treg cells in stem cell maintenance by showing that skin-resident Foxp3(+) Treg cells preferentially localize to the hair follicle stem cell (HFSC) niche to control HFSC-mediated hair regeneration.	[Maryanovich, Maria; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, New York, NY 10461 USA; [Maryanovich, Maria; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, New York, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL069438] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Ambler CA, 2010, DEVELOPMENT, V137, P3569, DOI 10.1242/dev.050310; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Lu JL, 2015, CELL IMMUNOL, V297, P53, DOI 10.1016/j.cellimm.2015.06.005; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010	11	8	11	5	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					979	981		10.1016/j.immuni.2017.06.011	http://dx.doi.org/10.1016/j.immuni.2017.06.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636968	Bronze			2022-12-18	WOS:000403665900011
J	Sim, MJW; Sun, PD				Sim, Malcolm J. W.; Sun, Peter D.			HLA-F: A New Kid Licensed for Peptide Presentation	IMMUNITY			English	Editorial Material							OPEN CONFORMERS; CELL; LIGANDS; RECEPTORS; COMPLEX	HLA-F, a non-classical MHC molecule, is not known to present peptides. Dulberger et al. (2017) show that HLA-F contains a distinct peptide-binding groove and can present a diverse array of peptides. LIR1, however, recognized HLA-F away from bound peptide, leaving open whether peptide-HLA-F-specific T and NK receptors exist.	[Sim, Malcolm J. W.; Sun, Peter D.] NIAID, Lab Immunogenet, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sun, PD (corresponding author), NIAID, Lab Immunogenet, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@nih.gov		Sim, Malcolm/0000-0003-3407-9661	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000697, ZIAAI000853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Dulberger CL, 2017, IMMUNITY, V46, P1018, DOI 10.1016/j.immuni.2017.06.002; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; Hackmon R, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12643; Lee N, 2003, J IMMUNOL, V171, P5264, DOI 10.4049/jimmunol.171.10.5264; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Sim MJW, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00193	10	8	8	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					972	974		10.1016/j.immuni.2017.06.004	http://dx.doi.org/10.1016/j.immuni.2017.06.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636965	Bronze			2022-12-18	WOS:000403665900008
J	Sok, D; Burton, DR				Sok, Devin; Burton, Dennis R.			HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98%	IMMUNITY			English	Editorial Material							HUMAN MONOCLONAL-ANTIBODY	In this issue of Immunity, Huang et al. (2016) describe an exceptionally broad and potent neutralizing antibody to HIV. This antibody, N6, is capable of neutralizing up to 98% of global isolates with a potent median IC50 of 0.04 mu g/mL, making it the current "best-in-class'' for bNAbs targeting the CD4 binding site.	[Sok, Devin] Int AIDS Vaccine Initiat, New York, NY 10004 USA; [Sok, Devin; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sok, Devin; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Sok, Devin; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA	International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Sok, D (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10004 USA.; Sok, D; Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Sok, D; Burton, DR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Sok, D; Burton, DR (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA.	devinsok@scripps.edu; burton@scripps.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI100663] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boesch AW, 2015, CURR OPIN HIV AIDS, V10, P160, DOI 10.1097/COH.0000000000000149; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Ledgerwood JE, 2015, CLIN EXP IMMUNOL, V182, P289, DOI 10.1111/cei.12692; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007	9	8	8	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					958	960		10.1016/j.immuni.2016.10.033	http://dx.doi.org/10.1016/j.immuni.2016.10.033			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851923	Green Accepted, Bronze			2022-12-18	WOS:000389473500007
J	Blidner, AG; Marino, KV; Rabinovich, GA				Blidner, Ada G.; Marino, Karina V.; Rabinovich, Gabriel A.			Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer	IMMUNITY			English	Editorial Material							MUC1; RECEPTOR; THERAPY	Engineering T cells with chimeric antigen receptors (CARs) has demonstrated remarkable success in eradicating hematological malignancies. In this issue of Immunity, June and colleagues demonstrate the broad antitumor efficacy of a newly-designed CAR targeting the O-linked hypoglycosylated epitopes Tn and sialyl-Tn on cancer-associated MUC-1.	[Blidner, Ada G.; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, Lab Inmunopatol, C1428ADN Buenos Aires, RA-2490 Vuelta De Obligado, Argentina; [Marino, Karina V.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, Lab Glicom Func & Mol, C1428ADN Buenos Aires, RA-2490 Vuelta De Obligado, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, C1428EGA Buenos Aires, RA-2160 Intendente Guiraldes, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Rabinovich, GA (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, Lab Inmunopatol, C1428ADN Buenos Aires, RA-2490 Vuelta De Obligado, Argentina.; Rabinovich, GA (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, C1428EGA Buenos Aires, RA-2160 Intendente Guiraldes, Argentina.	gabyrabi@gmail.com		Marino, Karina Valeria/0000-0002-0581-8640				Gill S, 2015, IMMUNOL REV, V263, P68, DOI 10.1111/imr.12243; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Kimura T, 2013, EXPERT OPIN BIOL TH, V13, P35, DOI 10.1517/14712598.2012.725719; Newick K, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.6; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; Wilkie S, 2008, J IMMUNOL, V180, P4901, DOI 10.4049/jimmunol.180.7.4901	10	8	8	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1248	1250		10.1016/j.immuni.2016.06.010	http://dx.doi.org/10.1016/j.immuni.2016.06.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332727	Green Published, Bronze			2022-12-18	WOS:000378341200004
J	Kanellopoulou, C; Muljo, SA				Kanellopoulou, Chrysi; Muljo, Stefan A.			Fine-Tuning Th17 Cells: To Be or Not To Be Pathogenic?	IMMUNITY			English	Editorial Material							PROGRESSIVE HEARING-LOSS; T(H)17 CELLS; DIFFERENTIATION; INDUCTION; MIR-96; SGK1	Like the story of Jekyll and Hyde, Th17 cells have two guises. One helps with host immunity, but the other can cause immunopathology. In this issue of Immunity, Dong and colleagues report that three microRNAs, miR183, miR-96, and miR-182, can enhance the pathogenicity of Th17 cells (Ichiyama et al., 2016).	[Kanellopoulou, Chrysi; Muljo, Stefan A.] NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Muljo, SA (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	stefan.muljo@nih.gov	Muljo, Stefan A/F-5671-2015	Muljo, Stefan A/0000-0003-1013-446X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001131] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Ichiyama K, 2016, IMMUNITY, V44, P1284, DOI 10.1016/j.immuni.2016.05.015; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984	10	8	12	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1241	1243		10.1016/j.immuni.2016.06.003	http://dx.doi.org/10.1016/j.immuni.2016.06.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332724	Bronze			2022-12-18	WOS:000378341200001
J	Coffelt, SB; de Visser, KE				Coffelt, Seth B.; de Visser, Karin E.			Revving Up Dendritic Cells while Braking PD-L1 to Jump-Start the Cancer-Immunity Cycle Motor	IMMUNITY			English	Editorial Material							RESPONSES; BLOCKADE	Although it is successful for some, most melanoma patients are refractory to T cell checkpoint inhibition. In this issue of Immunity, Merad and colleagues (2016) describe a dendritic-cell-based strategy to heighten the efficacy of therapeutic anti-PD-L1 and BRAF inhibitors in mouse melanoma models.	[Coffelt, Seth B.; de Visser, Karin E.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	de Visser, KE (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	k.d.visser@nki.nl	Coffelt, Seth/O-9929-2019	Coffelt, Seth/0000-0003-2257-2862; de Visser, Karin/0000-0002-0293-868X				Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954	10	8	8	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					722	724		10.1016/j.immuni.2016.03.014	http://dx.doi.org/10.1016/j.immuni.2016.03.014			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096314	Bronze			2022-12-18	WOS:000374444300005
J	Herz, J; Kipnis, J				Herz, Jasmin; Kipnis, Jonathan			Bugs and Brain: How Infection Makes You Feel Blue	IMMUNITY			English	Editorial Material							T-CELLS; INFLAMMATION; DEPRESSION; IL-4	In this issue of Immunity, Prinz and colleagues (2016) describe an unexpected mechanism underlying the role of type I interferon in the initiation of cognitive impairment and sickness behavior during viral infection through induction of chemokine CXCL10 in central nervous system epithelial and endothelial cells.	[Herz, Jasmin; Kipnis, Jonathan] Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22908 USA	University of Virginia	Herz, J; Kipnis, J (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22908 USA.	jh2vc@virginia.edu; kipnis@virginia.edu	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X				Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Valentin A. P., 2015, IMMUNOL RES, V63, P38; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]	10	8	8	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					718	720		10.1016/j.immuni.2016.03.010	http://dx.doi.org/10.1016/j.immuni.2016.03.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096312	Bronze			2022-12-18	WOS:000374444300003
J	Anderson, MS; Casanova, JL				Anderson, Mark S.; Casanova, Jean-Laurent			More than Meets the Eye: Monogenic Autoimmunity Strikes Again	IMMUNITY			English	Editorial Material							AIRE; MUTATIONS; GENE	Autoimmunity is often familial, suggesting that inborn genetic variations might underlie its development. Curiously, autoimmunity has long been thought to be typically polygenic. Contrary to this prediction and consistent with growing discoveries of monogenic autoimmunity, Oftedal et al. discovered heterozygous dominant-negative AIRE mutations in patients with certain forms of autoimmunity.	[Anderson, Mark S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, INSERM, Lab Human Genet Infect Dis, Necker Branch,U980, F-75015 Paris, France; [Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, F-75015 Paris, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol & Immunol Unit, F-75015 Paris, France	University of California System; University of California San Francisco; Rockefeller University; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Anderson, MS (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	mark.anderson@ucsf.edu; jean-laurent.casanova@rockefeller.edu	Casanova, Jean-Laurent/I-3418-2017	Casanova, Jean-Laurent/0000-0002-7782-4169				Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Magerus-Chatinet A, 2011, J CLIN INVEST, V121, P106, DOI 10.1172/JCI43752; Oftedal BE, 2015, IMMUNITY, V42, P1185, DOI 10.1016/j.immuni.2015.04.021; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523	9	8	8	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					986	988		10.1016/j.immuni.2015.06.004	http://dx.doi.org/10.1016/j.immuni.2015.06.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084018	Bronze			2022-12-18	WOS:000356362800005
J	Dzutsev, A; Trinchieri, G				Dzutsev, Amiran; Trinchieri, Giorgio			Proteus mirabilis: The Enemy Within	IMMUNITY			English	Editorial Material							INFLAMMASOME		[Dzutsev, Amiran; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dzutsev, Amiran] Leidos Biomed Res Inc, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Trinchieri, G (corresponding author), NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	trinchig@mail.nih.gov	Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464	NATIONAL CANCER INSTITUTE [ZIABC011153, ZIABC010793] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Cheng YL, 2015, IMMUNOLOGY, V145, P258, DOI 10.1111/imm.12442; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Engler DB, 2015, INFLAMM BOWEL DIS, V21, P854, DOI 10.1097/MIB.0000000000000318; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026	9	8	9	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					602	604		10.1016/j.immuni.2015.04.004	http://dx.doi.org/10.1016/j.immuni.2015.04.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902478	Bronze			2022-12-18	WOS:000353347500006
J	Wu, C; Chen, ZJ; Kuchroo, VK				Wu, Chuan; Chen, Zuojia; Kuchroo, Vijay K.			Ezh2 Lines Up the Chromatin in T Regulatory Cells	IMMUNITY			English	Editorial Material							TRANSCRIPTION FACTOR FOXP3	Epigenetic modulation is critical for regulating the development and function of T cells. In this issue of Immunity, DuPage et al. (2015) show that the chromatin-modifying enzyme Ezh2 induced by CD28 costimulation is essential for regulatory T (Treg) cell maintenance during activation and differentiation.	[Wu, Chuan; Chen, Zuojia; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kuchroo, VK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.	vkuchroo@evergrande.hms.harvard.edu	Chen, Zuojia/AAM-9465-2020; Wu, Chuan/H-6379-2013	Wu, Chuan/0000-0003-2288-353X	NIAID NIH HHS [K99 AI110649] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI110649] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348	10	8	9	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					201	203		10.1016/j.immuni.2015.01.019	http://dx.doi.org/10.1016/j.immuni.2015.01.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692693	Green Accepted, Bronze			2022-12-18	WOS:000349916400001
J	Condamine, T; Gabrilovich, DI				Condamine, Thomas; Gabrilovich, Dmitry I.			Can the Suppressive Activity of Myeloid-Derived Suppressor Cells Be "Chop"ped?	IMMUNITY			English	Editorial Material							STRESS	Myeloid-derived suppressor cells (MDSCs) are one of the major negative regulators of immune responses. In this issue of Immunity, Thevenot et al. (2014) showed that in tumors, the suppressive activity of MDSCs is regulated by transcription factor Chop.	[Condamine, Thomas; Gabrilovich, Dmitry I.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Gabrilovich, DI (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	dgabrilovich@wistar.org	Gabrilovich, Dmitry/ABE-7122-2020		NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Mahadevan NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051845; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Thevenot PT, 2014, IMMUNITY, V41, P389, DOI 10.1016/j.immuni.2014.08.015; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	7	8	8	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					341	342		10.1016/j.immuni.2014.08.016	http://dx.doi.org/10.1016/j.immuni.2014.08.016			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238087	Bronze			2022-12-18	WOS:000342626500001
J	Okoye, IS; Coomes, SM; Pelly, VS; Czieso, S; Papayannopoulos, V; Tolmachova, T; Seabra, MC; Wilson, MS				Okoye, Isobel S.; Coomes, Stephanie M.; Pelly, Victoria S.; Czieso, Stephanie; Papayannopoulos, Venizelos; Tolmachova, Tanya; Seabra, Miguel C.; Wilson, Mark S.			MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells (vol 41, pg 89, 2014)	IMMUNITY			English	Correction												mwilson@nimr.mrc.ac.uk	Seabra, Miguel/AAC-3099-2019; Seabra, Miguel C/M-3280-2013	Seabra, Miguel C/0000-0002-6404-4892				Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]	1	8	8	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					503	503		10.1016/j.immuni.2014.08.008	http://dx.doi.org/10.1016/j.immuni.2014.08.008			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON		Green Published, hybrid			2022-12-18	WOS:000342626500019
J	Full, F; Gack, MU				Full, Florian; Gack, Michaela U.			Prostaglandin E-2: the Villain in the Host Response to Influenza Virus	IMMUNITY			English	Editorial Material							MACROPHAGES	Prostaglandins are lipid mediators that are involved in a plethora of biological processes. In this issue of Immunity, Coulombe et al. (2014) report that prostaglandin E-2 suppresses innate and adaptive immune responses to influenza virus.	[Full, Florian; Gack, Michaela U.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Gack, MU (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	michaela_gack@hms.harvard.edu		Full, Florian/0000-0003-1900-5891				Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Hogner K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003188; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001	6	8	8	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					453	454		10.1016/j.immuni.2014.03.008	http://dx.doi.org/10.1016/j.immuni.2014.03.008			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745327	Bronze			2022-12-18	WOS:000334849400002
J	Wilson, EB; Brooks, DG				Wilson, Elizabeth B.; Brooks, David G.			Inflammation Makes T Cells Sensitive	IMMUNITY			English	Editorial Material							MEMORY		[Wilson, Elizabeth B.; Brooks, David G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Wilson, Elizabeth B.; Brooks, David G.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wilson, EB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	lizbwilson@ucla.edu; dbrooks@microbio.ucla.edu		Brooks, David/0000-0001-7763-8764	NIAID NIH HHS [R01 AI085043, U01 AI082975] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082975, R01AI085043] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Raue HP, 2013, IMMUNITY, V38, P131, DOI 10.1016/j.immuni.2012.09.019; Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650	6	8	10	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 24	2013	38	1					5	7		10.1016/j.immuni.2013.01.001	http://dx.doi.org/10.1016/j.immuni.2013.01.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23352218	Green Accepted, Bronze			2022-12-18	WOS:000314195500003
J	Staal, FJT; Clevers, H				Staal, Frank J. T.; Clevers, Hans			Tales of the Unexpected: Tcf1 Functions as a Tumor Suppressor for Leukemias	IMMUNITY			English	Editorial Material							WNT; HEMATOPOIESIS	The Wnt-responsive transcription factors Tcf1 and Lef1 are well-known for their roles in lymphocyte development. In this issue of Immunity, Yu et al. (2012) report that Tcf1-deficient mice develop aggressive T cell lymphomas that are characterized by high Lef1 expression.	[Staal, Frank J. T.] Leiden Univ Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 AD Utrecht, Netherlands; [Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 AD Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Staal, FJT (corresponding author), Leiden Univ Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands.	f.j.t.staal@lumc.nl			Worldwide Cancer Research [07-0049] Funding Source: Medline	Worldwide Cancer Research		Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Luis TC, 2012, LEUKEMIA, V26, P414, DOI 10.1038/leu.2011.387; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Tiemessen MM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001430; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009	10	8	8	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					761	763		10.1016/j.immuni.2012.10.008	http://dx.doi.org/10.1016/j.immuni.2012.10.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23159221	Bronze			2022-12-18	WOS:000311460000002
J	Malmberg, KJ; Michaelsson, J; Parham, P; Ljunggren, HG				Malmberg, Karl-Johan; Michaelsson, Jakob; Parham, Peter; Ljunggren, Hans-Gustaf			Killer Cell Immunoglobulin-like Receptor Workshop: Insights into Evolution, Genetics, Function, and Translation	IMMUNITY			English	News Item							ACUTE MYELOGENOUS LEUKEMIA; MHC CLASS-I; TRANSPLANTATION; EDUCATION; GENES; HLA; PLACENTATION; SELECTION	The seventh killer cell immunoglobulin-like receptor (KIR) workshop was held at Tammsvik, Stockholm, Sweden, in the summer of 2011. This intimate and isolated setting brought together approximately 100 investigators, from a range of scientific disciplines, who are all actively working on KIRs in humans or closely related primate species.	[Malmberg, Karl-Johan; Michaelsson, Jakob; Ljunggren, Hans-Gustaf] Karolinska Univ Hosp, Ctr Infect Med, Dept Med, Karolinska Inst, S-14186 Stockholm, Sweden; [Parham, Peter] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Karolinska Institutet; Karolinska University Hospital; Stanford University	Malmberg, KJ (corresponding author), Karolinska Univ Hosp, Ctr Infect Med, Dept Med, Karolinska Inst, S-14186 Stockholm, Sweden.	kalle.malmberg@ki.se		Malmberg, Karl-Johan/0000-0002-8718-9373				Andersson S, 2010, EXP CELL RES, V316, P1309, DOI 10.1016/j.yexcr.2010.02.030; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Colucci F, 2011, PLACENTA, V32, P539, DOI 10.1016/j.placenta.2011.05.001; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Haas P, 2011, BLOOD, V117, P1021, DOI 10.1182/blood-2010-02-269381; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Parham P, 2008, SEMIN IMMUNOL, V20, P311, DOI 10.1016/j.smim.2008.10.002	15	8	8	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					653	657		10.1016/j.immuni.2011.11.007	http://dx.doi.org/10.1016/j.immuni.2011.11.007			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118518	Bronze			2022-12-18	WOS:000297390800002
J	Turner, SJ; Rossjohn, J				Turner, Stephen J.; Rossjohn, Jamie			alpha beta T Cell Receptors Come Out Swinging	IMMUNITY			English	Editorial Material							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I	It is unclear how an effective T cell repertoire is built from a limited array of T cell receptor (TCR) genes. In this issue of Immunity, Stadinski et al. (2011) demonstrate that TCR variable (V) alpha chains can indirectly affect V beta-mediated recognition of the major histocompatibility complex (MHC) molecule.	[Turner, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Monash Univ, Prot Crystallog Unit, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	University of Melbourne; Monash University	Turner, SJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	sjturn@unimelb.edu.au; jamie.rossjohn@monash.edu	Turner, Stephen/GXM-4654-2022; Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Turner, Stephen/0000-0002-1002-0000				Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Gras S, 2011, IMMUNOL CELL BIOL, V89, P388, DOI 10.1038/icb.2010.150; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; La Gruta NL, 2010, J CLIN INVEST, V120, P1885, DOI 10.1172/JCI41538; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Rist M, 2009, BLOOD, V114, P2244, DOI 10.1182/blood-2009-05-222596; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017	10	8	9	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					660	662		10.1016/j.immuni.2011.11.002	http://dx.doi.org/10.1016/j.immuni.2011.11.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118520	Bronze			2022-12-18	WOS:000297390800004
J	Morita, R; Schmitt, N; Bentebibel, SE; Ranganathan, R; Bourdery, L; Zurawski, G; Foucat, E; Dullaers, M; Oh, SK; Sabzghabaei, N; Lavecchio, EM; Punaro, M; Pascual, V; Banchereau, J; Ueno, H				Morita, Rimpei; Schmitt, Nathalie; Bentebibel, Salah-Eddine; Ranganathan, Rajaram; Bourdery, Laure; Zurawski, Gerard; Foucat, Emile; Dullaers, Melissa; Oh, SangKon; Sabzghabaei, Natalie; Lavecchio, Elizabeth M.; Punaro, Marilynn; Pascual, Virginia; Banchereau, Jacques; Ueno, Hideki			Human Blood CXCR5(+)CD4(+) T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion (vol 34, pg 108, 2011)	IMMUNITY			English	Correction												jacquesb@baylorhealth.edu; hidekiu@baylorhealth.edu	Pascual, Virginia/ABD-3099-2020; Bentebibel, Salah-Eddine/AAS-9766-2021; sabzghabaei, natalie/GQQ-9897-2022; Ueno, Hideki/L-1237-2016	Schmitt, Nathalie/0000-0001-9993-2788; Ueno, Hideki/0000-0001-7747-0738				Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012	1	8	8	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 28	2011	34	1					135	135		10.1016/j.immuni.2011.01.009	http://dx.doi.org/10.1016/j.immuni.2011.01.009			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO		Bronze			2022-12-18	WOS:000287336600017
J	Veldhoen, M				Veldhoen, Marc			Interferon Regulatory Factor 4: Combinational Control of Lymphocyte Differentiation	IMMUNITY			English	Editorial Material							T-CELLS; EXPRESSION; PU.1; SUBSET; BETA	Transcriptional mechanisms involved in the differentiation of the recently identified interleukin-9 (IL-9) secreting T helper cell subset are still poorly defined. In this issue of immunity, Staudt et al. (2010) now report an essential role for the interferon regulatory factor-4 in IL-9 production.	Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Veldhoen, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	marc.veldhoen@bbsrc.ac.uk	Veldhoen, Marc/AAM-5357-2021	Veldhoen, Marc/0000-0002-1478-9562				Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chang HC, 2009, J IMMUNOL, V183, P4887, DOI 10.4049/jimmunol.0900363; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	10	8	8	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 27	2010	33	2					141	143		10.1016/j.immuni.2010.08.007	http://dx.doi.org/10.1016/j.immuni.2010.08.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20732634	Bronze			2022-12-18	WOS:000281654900001
J	Munz, C				Muenz, Christian			Selective Macroautophagy for Immunity	IMMUNITY			English	Editorial Material							AUTOPHAGY; PROTEIN		Univ Zurich Hosp, Inst Expt Immunol, CH-8057 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Munz, C (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, CH-8057 Zurich, Switzerland.	christian.muenz@usz.ch	Münz, Christian/W-4881-2017	Munz, Christian/0000-0001-6419-1940				Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800	8	8	8	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 26	2010	32	3					298	299		10.1016/j.immuni.2010.03.002	http://dx.doi.org/10.1016/j.immuni.2010.03.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20346769	Green Accepted, Bronze			2022-12-18	WOS:000276125400002
J	Hsieh, CS				Hsieh, Chyi-Song			Kickstarting Foxp3 with c-Rel	IMMUNITY			English	Editorial Material							CELL	In this issue of Immunity by Long et al. (2009) and Ruan et al. (2009) and Ruan et al. (2009) suggest that the transcription factor NF-kappa B-c-Rel is an important molecular mechanism by which T cell receptor-specificity for self-antigens instructs the selection of Foxp3(+) regulatory T cells.	Washington Univ, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA	Washington University (WUSTL)	Hsieh, CS (corresponding author), Washington Univ, Dept Internal Med, Div Rheumatol, Box 8045,660 S Euclid Ave, St Louis, MO 63110 USA.	chsieh@wustl.edu						Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Wirnsberger G, 2009, P NATL ACAD SCI USA, V106, P10278, DOI 10.1073/pnas.0901877106	11	8	10	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					852	853		10.1016/j.immuni.2009.11.006	http://dx.doi.org/10.1016/j.immuni.2009.11.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064443	Bronze			2022-12-18	WOS:000273616400004
J	Penaranda, C; Bluestone, JA				Penaranda, Cristina; Bluestone, Jeffrey A.			Is Antigen Specificity of Autoreactive T Cells the Key to Islet Entry?	IMMUNITY			English	Editorial Material							NOD MICE; RECEPTOR; CHEMOKINES; EXPRESSION; PANCREAS	It has been widely hypothesized that pancreatic islet infiltrates include both islet-antigen-specific and nonspecific T cells. In this issue of Immunity, Lennon et al. (2009) demonstrate that islet-antigen specificity is required for accumulation in the islets.	[Penaranda, Cristina; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Penaranda, Cristina; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu		Penaranda, Cristina/0000-0002-2595-2863				Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Cameron MJ, 2000, J IMMUNOL, V165, P1102, DOI 10.4049/jimmunol.165.2.1102; DREXLER K, 1993, IMMUNOL LETT, V37, P187, DOI 10.1016/0165-2478(93)90030-6; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Peterson JD, 1998, CELL IMMUNOL, V189, P92, DOI 10.1006/cimm.1998.1377	10	8	10	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					534	536		10.1016/j.immuni.2009.09.006	http://dx.doi.org/10.1016/j.immuni.2009.09.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833083	Bronze			2022-12-18	WOS:000271403900004
J	Lazarski, CA; Hughson, A; Sojka, DK; Fowell, DJ				Lazarski, Christopher A.; Hughson, Angela; Sojka, Dorothy K.; Fowell, Deborah J.			Regulating Treg Cells at Sites of Inflammation	IMMUNITY			English	Letter									[Lazarski, Christopher A.; Hughson, Angela; Sojka, Dorothy K.; Fowell, Deborah J.] Univ Rochester, Aab Inst Biomed Sci, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA	University of Rochester	Fowell, DJ (corresponding author), Univ Rochester, Aab Inst Biomed Sci, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	deborah_fowell@urmc.rochester.edu			MRC [G120/854] Funding Source: UKRI; Medical Research Council [G120/854] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Katzman SD, 2008, J CLIN INVEST, V118, P801, DOI 10.1172/JCI33174; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	4	8	9	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					511	511		10.1016/j.immuni.2008.09.012	http://dx.doi.org/10.1016/j.immuni.2008.09.012			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18957259	Bronze			2022-12-18	WOS:000260316700001
J	Valitutti, S				Valitutti, Salvatore			Immunological synapse: Center of attention again	IMMUNITY			English	Editorial Material							ACTIVATION; CELLS	The functional role of molecular clustering in the center of the immunological synapse is controversial. In this issue of Immunity, Oemerski et al. (2008) report that the synapse center can serve as a major site of sustained signal transduction.	[Valitutti, Salvatore] INSERM, U563, Ctr Physiopathol Toulouse Purpan, Sect Dynam Mol Interact Iymphocytaires, F-31300 Toulouse, France; [Valitutti, Salvatore] Univ Toulouse 3, F-31400 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Valitutti, S (corresponding author), INSERM, U563, Ctr Physiopathol Toulouse Purpan, Sect Dynam Mol Interact Iymphocytaires, F-31300 Toulouse, France.	salvatore.valitutti@inserm.fr	Valitutti, Salvatore/M-2999-2014	Valitutti, Salvatore/0000-0002-6432-4421				Barcia C, 2008, J IMMUNOL, V180, P1344, DOI 10.4049/jimmunol.180.3.1344; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010	10	8	8	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 19	2008	29	3					384	386		10.1016/j.immuni.2008.08.002	http://dx.doi.org/10.1016/j.immuni.2008.08.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799146	Bronze			2022-12-18	WOS:000259708900007
J	Lamb, TJ; Graham, AL; Petrie, A				Lamb, Tracey J.; Graham, Andrea L.; Petrie, Aviva			t Testing the immune System	IMMUNITY			English	Editorial Material							STATISTICS NOTES		[Petrie, Aviva] UCL, Eastman Dent Inst, Biostat Unit, London WC1X 8LD, England; [Lamb, Tracey J.] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Graham, Andrea L.] Univ Edinburgh, Sch Biol Sci, Inst Evolut Immunol, Inst Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland	University of London; University College London; MRC National Institute for Medical Research; University of Edinburgh	Petrie, A (corresponding author), UCL, Eastman Dent Inst, Biostat Unit, 256 Grays Inn Rd, London WC1X 8LD, England.	a.petrie@eastman.ucl.ac.uk	Graham, Andrea/GON-8450-2022; Graham, Andrea L./A-8808-2010; Graham, Andrea L./P-7296-2019	Graham, Andrea L./0000-0002-6580-2755; Graham, Andrea L./0000-0002-6580-2755; Lamb, Tracey/0000-0003-0620-3944	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman DG, 1998, STAT MED, V17, P2661, DOI 10.1002/(SICI)1097-0258(19981215)17:23<2661::AID-SIM33>3.0.CO;2-B; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Altman DG, 1997, BRIT MED J, V314, P1874, DOI 10.1136/bmj.314.7098.1874; ALTMAN DG, 1982, STAT PRACTICE ARTICL; [Anonymous], 2006, STAT VET ANIMAL SCI; Armitage P., 2002, STAT METHODS MED RES; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bland JM, 1996, BRIT MED J, V312, P770; Bland M., 2000, INTRO MED STAT, V3rd; COX DR, 2000, THEORY DESIGN EXPT; Edwards L., 1993, APPL ANAL VARIANCE B; Festing Michael F W, 2002, ILAR J, V43, P244; Grafen A., 2002, MODERN STAT LIFE SCI; HOWELL DC, 1999, FUNDAMENTAL STAT BEH; Kirkwood B.R., 2010, ESSENTIAL MED STAT; Lang TA, 2006, ANNOTATED GUIDELINES; LEHR R, 1992, STAT MED, V11, P1099, DOI 10.1002/sim.4780110811; LEVENE H, 1960, CONTRIBUTIONS PROBAB, V1, P278; LINDMAN HR, 1992, ANAL VARIANCE EXPERI; Machin D, 1997, SAMPLE SIZE TABLES C; Mead R., 1988, DESIGN EXPT STAT PRI; Olsen CH, 2003, INFECT IMMUN, V71, P6689, DOI 10.1128/IAI.71.12.6689-6692.2003; Weber D.C., 2000, 1 COURSE DESIGN EXPT	23	8	8	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2008	28	3					288	292		10.1016/j.immuni.2008.02.003	http://dx.doi.org/10.1016/j.immuni.2008.02.003			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18341999	Bronze			2022-12-18	WOS:000254142500002
J	Chatila, T				Chatila, Talal			The regulatory T cell transcriptosome: E Pluribus Unum	IMMUNITY			English	Editorial Material							FOXP3	The regulatory T (Treg) cell transcriptional program is formed of distinct genetic networks that respond to different activators. In this issue of Immunity, Hill et al. (2007) provide insights into the interactions among the different networks and the overall role of Foxp3 in shaping the Treg cell transcriptosome.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Rheumatol Allergy & Immunol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chatila, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Rheumatol Allergy & Immunol, Los Angeles, CA 90095 USA.	tchatila@mednet.ucla.edu		Chatila, Talal/0000-0001-7439-2762				Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hu H, 2007, TRENDS IMMUNOL, V28, P329, DOI 10.1016/j.it.2007.06.006; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	10	8	16	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					693	695		10.1016/j.immuni.2007.11.004	http://dx.doi.org/10.1016/j.immuni.2007.11.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18031692	Bronze			2022-12-18	WOS:000251269000003
J	Macpherson, AJ; McCoy, K				Macpherson, Andrew J.; McCoy, Kathy			APRIL in the intestine: A good destination for immunoglobulin a2	IMMUNITY			English	Editorial Material							LAMINA PROPRIA; GUT; RESPONSES; BACTERIA; CELLS; TACI	Immunoglobulin A (IgA) confers mucosal protection against bacteria in the intestine. In this issue, He et al. (2007) find that bacterial molecules promote IgA(2) generation via the cytokine APRIL, produced by intestinal epithelial and dendritic cells.	McMaster Univ, Med Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada	McMaster University	Macpherson, AJ (corresponding author), McMaster Univ, Med Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada.	macpher@mcmaster.ca	McCoy, Kathy/ABD-5814-2021					Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3	10	8	11	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2007	26	6					755	757		10.1016/j.immuni.2007.06.003	http://dx.doi.org/10.1016/j.immuni.2007.06.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582349	Bronze			2022-12-18	WOS:000247646900011
J	Ramaswamy, M; Siegel, RM				Ramaswamy, Madhu; Siegel, Richard M.			A FAScinating receptor in self-tolerance	IMMUNITY			English	Editorial Material							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; APOPTOSIS; MICE; MUTATIONS	In this issue of Immunity, Stranges et al. (2007) ablate expression of the death receptor Fas in T cells, B cells, and DC. Fas deficiency in any of these lineages is sufficient to break self-tolerance.	NIAMS, Immunoregulat Unit, Autoimmun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Siegel, RM (corresponding author), NIAMS, Immunoregulat Unit, Autoimmun Branch, NIH, Bethesda, MD 20892 USA.	rsiegel@nih.gov	Siegel, Richard/C-7592-2009	Siegel, Richard/0000-0001-5953-9893; Ramaswamy, Madhu/0000-0001-8870-5328	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041133, ZIAAR041133] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chan O, 1998, J IMMUNOL, V160, P51; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Holzelova E, 2004, NEW ENGL J MED, V351, P1409, DOI 10.1056/NEJMoa040036; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; SOBEL ES, 1994, J IMMUNOL, V152, P6011; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0	10	8	10	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2007	26	5					545	547		10.1016/j.immuni.2007.05.004	http://dx.doi.org/10.1016/j.immuni.2007.05.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17521581	Bronze			2022-12-18	WOS:000246895900005
J	Chaplin, DD; Zindl, CL				Chaplin, DD; Zindl, CL			Taking control of follicular dendritic cells	IMMUNITY			English	Editorial Material							TUMOR-NECROSIS-FACTOR; ALPHA-DEFICIENT MICE; B-CELLS; MATURATION; MIGRATION; RECEPTOR		Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Chaplin, DD (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.			Chaplin, David/0000-0002-1354-3069; Zindl, Carlene/0000-0003-4841-3552				Aydar Y, 2005, J IMMUNOL, V174, P5358, DOI 10.4049/jimmunol.174.9.5358; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; LeHir M, 1996, J EXP MED, V183, P2367, DOI 10.1084/jem.183.5.2367; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Mandik-Nayak L, 2001, J IMMUNOL, V167, P1920, DOI 10.4049/jimmunol.167.4.1920; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Tew JG, 2001, TRENDS IMMUNOL, V22, P361, DOI 10.1016/S1471-4906(01)01942-1; TIMENS W, 1991, HISTOCHEMISTRY, V95, P605, DOI 10.1007/BF00266748; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013	11	8	8	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2006	24	1					13	15		10.1016/j.immuni.2005.12.008	http://dx.doi.org/10.1016/j.immuni.2005.12.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413918	Bronze			2022-12-18	WOS:000234850200005
J	Bolland, S				Bolland, S			A newly discovered Fc receptor that explains IgG-isotype disparities in effector responses	IMMUNITY			English	Editorial Material							PROTECTION; ARTHRITIS	The known IgG FcRs primarily mediate inflammation by interacting with IgG1, even though IgG2 isotypes tend to be more pathogenic. Nimmerjahn et al. (2005) have just identified a novel Fc gamma R that binds IgG2 but not IgG1, potentially explaining differences in biological activity that are seen with various IgG isotypes (Nimmerjahn et al., 2005).	NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bolland, S (corresponding author), NIAID, Immunogenet Lab, NIH, 12441 Parklawn Dr 217, Rockville, MD 20852 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000912, ZIAAI000912, ZIAAI000911, Z01AI000911] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Meyer D, 1998, BLOOD, V92, P3997, DOI 10.1182/blood.V92.11.3997.423k52_3997_4002; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275	7	8	48	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					2	4		10.1016/j.immuni.2005.07.002	http://dx.doi.org/10.1016/j.immuni.2005.07.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039573	Bronze			2022-12-18	WOS:000231024800002
J	Ley, K; Deem, TL				Ley, K; Deem, TL			Oxidative modification of leukocyte adhesion	IMMUNITY			English	Editorial Material							E-SELECTIN; LYMPHOCYTE MIGRATION; IN-VIVO; BINDING; OXIDASE	In this issue of Immunity, Marko Salmi and colleagues describe mice lacking AOC3, an endothelial cell mono-aminooxidase that is involved in modulating leukocyte rolling, adhesion, and migration (Stolen et al., 2005). Their data demonstrate the importance of oxidative modification of (unknown) adhesion molecules in regulating inflammation and lymphocyte homing.	Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; Univ Virginia, Dept Mol Physiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biol Phys, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ley, K (corresponding author), Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.							Jalkanen S, 2001, EMBO J, V20, P3893, DOI 10.1093/emboj/20.15.3893; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550; Puri KD, 1996, J BIOL CHEM, V271, P5404, DOI 10.1074/jbc.271.10.5404; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Simon SI, 2000, J IMMUNOL, V164, P4348, DOI 10.4049/jimmunol.164.8.4348; Smith ML, 2004, J EXP MED, V200, P935, DOI 10.1084/jem.20040424; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407	10	8	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2005	22	1					5	7		10.1016/j.immuni.2005.01.002	http://dx.doi.org/10.1016/j.immuni.2005.01.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664154	Bronze			2022-12-18	WOS:000226682900002
J	Versnel, MA				Versnel, MA			Id3 knockout mice as a new model for Sjogren's Syndrome: Only a T cell defect or more?	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; PROLIFERATION; RESPONSES	Id3(-/-) mice were found to have autoantibodies, lymphocytic infiltrates in, and decreased secretion by exocrine glands. Similar symptoms are found in primary Sjogren's Syndrome. In this issue of Immunity, Li and colleagues (Li et al., 2004) suggest an important role for Id3 function in T cell development and Sjogren's Syndrome.	Erasmus MC, Dept Immunol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Versnel, MA (corresponding author), Erasmus MC, Dept Immunol, Rotterdam, Netherlands.							Cha S, 2001, EXP CLIN IMMUNOGENET, V18, P143, DOI 10.1159/000049194; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; HANEJI N, 1994, J IMMUNOL, V153, P2769; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; van Blokland SCA, 2000, LAB INVEST, V80, P575, DOI 10.1038/labinvest.3780062	9	8	8	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2004	21	4					457	458		10.1016/j.immuni.2004.10.003	http://dx.doi.org/10.1016/j.immuni.2004.10.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485622	Bronze			2022-12-18	WOS:000224744400001
J	Collora, JA; Liu, RX; Pinto-Santini, D; Ravindra, N; Ganoza, C; Lama, JR; Alfaro, R; Chiarella, J; Spudich, S; Mounzer, K; Tebas, P; Montaner, LJ; van Dijk, D; Duerr, A; Ho, YC				Collora, Jack A.; Liu, Runxia; Pinto-Santini, Delia; Ravindra, Neal; Ganoza, Carmela; Lama, Javier R.; Alfaro, Ricardo; Chiarella, Jennifer; Spudich, Serena; Mounzer, Karam; Tebas, Pablo; Montaner, Luis J.; van Dijk, David; Duerr, Ann; Ho, Ya-Chi			Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones	IMMUNITY			English	Article							LATENT RESERVOIR; ANTIRETROVIRAL THERAPY; INTACT HIV-1; PROVIRUSES; IDENTIFICATION; RECOVERY; PROLIFERATION; LYMPHOCYTES; ACTIVATION; EXPANSION	Understanding the drivers and markers of clonally expanding HIV-1-infected CD4(+) T cells is essential for HIV-1 eradication. We used single-cell ECCITE-seq, which captures surface protein expression, cellular transcriptome, HIV-1 RNA, and TCR sequences within the same single cell to track clonal expansion dynamics in longitudinally archived samples from six HIV-1-infected individuals (during viremia and after suppressive antiretroviral therapy) and two uninfected individuals, in unstimulated conditions and after CMV and HIV-1 antigen stimulation. Despite antiretroviral therapy, persistent antigen and TNF responses shaped T cell clonal expansion. HIV-1 resided in Th1-polarized, antigen-responding T cells expressing BCL2 and SERPINB9 that may resist cell death. HIV-1 RNA(+) T cell clones were larger in clone size, established during viremia, persistent after viral suppression, and enriched in GZMB(+) cytotoxic effector memory Th1 cells. Targeting HIV-1-infected cytotoxic CD4(+) T cells and drivers of clonal expansion provides another direction for HIV-1 eradication.	[Collora, Jack A.; Liu, Runxia; Ho, Ya-Chi] Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06519 USA; [Pinto-Santini, Delia; Duerr, Ann] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis, Seattle, WA 98109 USA; [Ravindra, Neal; van Dijk, David] Yale Sch Med, Dept Internal Med Cardiol, New Haven, CT 06520 USA; [Ravindra, Neal; van Dijk, David] Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA; [Ganoza, Carmela; Lama, Javier R.] Asociac Civil Impacta Salud & Educ, Lima 15063, Peru; [Alfaro, Ricardo] Ctr Invest Tecnol Biomed & Medioambientales CITBM, Lima 07006, Peru; [Chiarella, Jennifer; Spudich, Serena] Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06519 USA; [Mounzer, Karam] Philadelphia FIGHT Community Hlth Ctr, Philadelphia, PA 19107 USA; [Tebas, Pablo] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Montaner, Luis J.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	Yale University; Fred Hutchinson Cancer Center; Yale University; Yale University; Yale University; University of Pennsylvania; The Wistar Institute	Ho, YC (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06519 USA.	ya-chi.ho@yale.edu		Ravindra, Neal/0000-0001-5558-3758; Collora, Jack/0000-0002-6423-2316	Yale Top Scholar, Rudolf J. Anderson Fellowship; NIH REACH Martin Delaney Collaboratory [UM1 AI164565]; NIH BEAT-HIV Martin Delaney Collaboratory [UM1 AI126620]; American Foundation for AIDS Research (amfAR) [110029-67-RGRL]; Robert I. Jacobs Fund of The Philadelphia Foundation; Yale Gruber Fellowship; Yale Center for Genome Analysis-10X Genomics Pilot Award; NIH [R01 AI141009, R61/R33 DA047037, R37 AI147868, R01 DA051906, R01AI145164, UM1 DA051410, U01 DA053628, CHEETAH P50 AI150464, T32 AI055403, R01 DA032106, R01 DA040532]	Yale Top Scholar, Rudolf J. Anderson Fellowship; NIH REACH Martin Delaney Collaboratory; NIH BEAT-HIV Martin Delaney Collaboratory; American Foundation for AIDS Research (amfAR); Robert I. Jacobs Fund of The Philadelphia Foundation; Yale Gruber Fellowship; Yale Center for Genome Analysis-10X Genomics Pilot Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all study participants. We thank Alex Shalek, Sam Kazer, Carly Ziegler, Joseph Craft, Steven Kleinstein, Roy Jiang, Nicolas Chomont, Pierre Gantner, Michael Betts, Vincent Wu, Dan Kaufmann, Elsa Brunet-Ratnasingham, and R. Brad Jones for their insightful suggestions. We thank Siavash Pasalar, Beth Peterson, and Kenneth Lynn for coordinating study participant recruitment. This work is supported by Yale Top Scholar, Rudolf J. Anderson Fellowship, NIH R01 AI141009, NIH R61/R33 DA047037, NIH R37 AI147868, NIH R01 DA051906, NIH R01AI145164, NIH UM1 DA051410, NIH U01 DA053628, NIH CHEETAH P50 AI150464, NIH REACH Martin Delaney Collaboratory UM1 AI164565, NIH BEAT-HIV Martin Delaney Collaboratory UM1 AI126620, Gilead HIV Research Scholar, and American Foundation for AIDS Research (amfAR 110029-67-RGRL) (Y.-C.H and D.D.); NIH R35 GM143072 (D.D.); the Robert I. Jacobs Fund of The Philadelphia Foundation (L.J.M.); Yale Gruber Fellowship (J.A.C.); NIH T32 AI055403 (J.A.C.); and a Yale Center for Genome Analysis-10X Genomics Pilot Award (R.L). The Sabes and MERLIN studies were supported by NIH R01 DA032106 and NIH R01 DA040532 (A.D.). We thank NIH HIV Reagent Program providing antigen peptides and enfuvirtide. We gratefully acknowledge ART drug donation from Merck & Co. and Gilead Sciences Inc for the Sabes and Merlin cohorts.	A. O.Pisco, 2020, bioRxiv, DOI 10.1101/2020.08.03.233650; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; Bruner KM, 2019, NATURE, V566, P120, DOI 10.1038/s41586-019-0898-8; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bui JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006283; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Coffin JM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128432; Cohn LB, 2018, NAT MED, V24, P604, DOI 10.1038/s41591-018-0017-7; Cole B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24080-1; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Duette G, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI154422; Einkauf KB, 2022, CELL, V185, P266, DOI 10.1016/j.cell.2021.12.011; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Gantner P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17898-8; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Halvas EK, 2020, J CLIN INVEST, V130, P5847, DOI 10.1172/JCI138099; Hiener B, 2017, CELL REP, V21, P813, DOI 10.1016/j.celrep.2017.09.081; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hoang TN, 2021, CELL, V184, P460, DOI 10.1016/j.cell.2020.11.007; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Hu YL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3317-7; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Kazer SW, 2020, NAT MED, V26, P511, DOI 10.1038/s41591-020-0799-2; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lama JR, 2021, CLIN INFECT DIS, V72, P1042, DOI 10.1093/cid/ciaa167; Lama JR, 2018, AM J EPIDEMIOL, V187, P1577, DOI 10.1093/aje/kwy030; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02214; Lee GQ, 2017, J CLIN INVEST, V127, P2689, DOI 10.1172/JCI93289; Lemaitre G, 2017, J MACH LEARN RES, V18; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu RX, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz0802; Lorenzi JCC, 2016, P NATL ACAD SCI USA, V113, pE7908, DOI 10.1073/pnas.1617789113; Macallan Derek C, 2019, Curr Opin Syst Biol, V18, P77, DOI 10.1016/j.coisb.2019.10.002; Malandro N, 2016, IMMUNITY, V44, P179, DOI 10.1016/j.immuni.2015.12.018; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; McGary CS, 2017, IMMUNITY, V47, P776, DOI 10.1016/j.immuni.2017.09.018; McInnes L., 2020, ARXIV, DOI [10.48550/arXiv.1802.03426, DOI 10.48550/ARXIV.1802.03426, 10.48550/arxiv.1802.03426]; Meckiff BJ, 2020, CELL, V183, P1340, DOI 10.1016/j.cell.2020.10.001; Mellors JW, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi8795; Mendoza P, 2020, J EXP MED, V217, DOI 10.1084/jem.20200051; Morou A, 2019, NAT IMMUNOL, V20, P1059, DOI 10.1038/s41590-019-0418-x; Ndhlovu ZM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau0528; Neidleman J, 2020, ELIFE, V9, DOI 10.7554/eLife.60933; Nguyen S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax4077; Oh DY, 2020, CELL, V181, P1612, DOI 10.1016/j.cell.2020.05.017; Pape KA, 1997, J IMMUNOL, V159, P591; Pappalardo JL, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb8786; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Pollack RA, 2017, CELL HOST MICROBE, V21, P494, DOI 10.1016/j.chom.2017.03.008; R Core Team, 2021, COMPUTER SOFTWARE; Ren YQ, 2020, J CLIN INVEST, V130, P2542, DOI 10.1172/JCI132374; Rullo EV, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133157; Sergushichev AA., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Simonetti FR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145254; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Stout-Delgado HW, 2007, HEPATOLOGY, V46, P1530, DOI 10.1002/hep.21820; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Thomas JK, 2019, CANCERS, V11, DOI 10.3390/cancers11121857; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Torang A, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2994-z; van Leeuwen EMM, 2004, J IMMUNOL, V173, P1834, DOI 10.4049/jimmunol.173.3.1834; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Wang Z, 2018, P NATL ACAD SCI USA, V115, pE2575, DOI 10.1073/pnas.1720665115; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yeh YHJ, 2020, J CLIN INVEST, V130, P4969, DOI 10.1172/JCI137371; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zaunders JJ, 2004, BLOOD, V103, P2238, DOI 10.1182/blood-2003-08-2765; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	95	7	7	4	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1013	+		10.1016/j.immuni.2022.03.004	http://dx.doi.org/10.1016/j.immuni.2022.03.004			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35320704	Bronze			2022-12-18	WOS:000823293900011
J	Maruhashi, T; Sugiura, D; Okazaki, IM; Shimizu, K; Maeda, TK; Ikubo, J; Yoshikawa, H; Maenaka, K; Ishimaru, N; Kosako, H; Takemoto, T; Okazaki, T				Maruhashi, Takumi; Sugiura, Daisuke; Okazaki, Il-Mi; Shimizu, Kenji; Maeda, Takeo K.; Ikubo, Jun; Yoshikawa, Harunori; Maenaka, Katsumi; Ishimaru, Naozumi; Kosako, Hidetaka; Takemoto, Tatsuya; Okazaki, Taku			Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity	IMMUNITY			English	Article							RECEPTORS; RESPONSES; BLOCKADE; PD-L1; MOUSE; CD223	Lymphocyte activation gene-3 (LAG-3) is a potent inhibitory co-receptor; yet, its functional ligand remains elusive, with distinct potential ligands identified. Here, we investigated the relative contribution of potential ligands, stable peptide-MHC class II complexes (pMHCII) and fibrinogen-like protein 1 (FGL1), to LAG-3 activity in vitro and in vivo. Binding of LAG-3 to stable pMHCII but not to FGL1 induced T cell suppression in vitro. Consistently, LAG-3 mutants lacking FGL1-binding capacity but not those lacking stable pMHCII-binding capacity retained suppressive activity in vitro. Accordingly, targeted disruption of stable pMHCII- but not FGL1-binding capacity of LAG-3 in NOD mice recapitulated diabetes exacerbation by LAG-3 deficiency. Additionally, the loss of stable pMHCII-binding capacity of LAG-3 augmented anti-cancer immunity comparably with LAG-3 deficiency in C57BL/6 mice. These results identify stable pMHCII as a functional ligand of LAG-3 both in autoimmunity and anti-cancer immunity. Thus, stable pMHCII-LAG-3 interaction is a potential therapeutic target in human diseases.	[Maruhashi, Takumi; Sugiura, Daisuke; Okazaki, Il-Mi; Shimizu, Kenji; Okazaki, Taku] Univ Tokyo, Inst Quantitat Biosci, Lab Mol Immunol, Tokyo 1130032, Japan; [Okazaki, Il-Mi; Maeda, Takeo K.; Ikubo, Jun; Okazaki, Taku] Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, Tokushima 7708503, Japan; [Yoshikawa, Harunori; Kosako, Hidetaka] Tokushima Univ, Fujii Mem Inst Med Sci, Inst Adv Med Sci, Div Cell Signaling, Tokushima 7708503, Japan; [Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido 0600812, Japan; [Ishimaru, Naozumi] Tokushima Univ, Dept Oral Mol Pathol, Grad Sch Biomed Sci, Tokushima 7708504, Japan; [Takemoto, Tatsuya] Tokushima Univ, Inst Adv Med Sci, Lab Embryol, Tokushima 7708503, Japan	University of Tokyo; Tokushima University; Tokushima University; Hokkaido University; Tokushima University; Tokushima University	Okazaki, T (corresponding author), Univ Tokyo, Inst Quantitat Biosci, Lab Mol Immunol, Tokyo 1130032, Japan.; Okazaki, T (corresponding author), Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, Tokushima 7708503, Japan.	tokazaki@iqb.u-tokyo.ac.jp	; Yoshikawa, Harunori/H-6623-2017	Okazaki, Taku/0000-0003-4790-1925; Maruhashi, Takumi/0000-0003-2944-1611; Okazaki, Il-mi/0000-0001-8644-0100; maenaka, katsumi/0000-0002-5459-521X; Sugiura, Daisuke/0000-0002-3865-3889; Shimizu, Kenji/0000-0003-4204-555X; Yoshikawa, Harunori/0000-0003-3793-6219	Japan Society for the Promotion of Science [JP18H05417, JP19H01029, 19K16694, 21K07076, 19H03423]; Takeda Science Foundation; FSI Research Grant Program by the UTEC; University of Tokyo; Institute of Advanced Medical Sciences of Tokushima University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); FSI Research Grant Program by the UTEC; University of Tokyo; Institute of Advanced Medical Sciences of Tokushima University	We thank T. Kitamura (Plat-E cells), T. Kurosaki (IIA1.6 cells), L. Ignatowicz (BW-1100.129.237 cells), and T. Honjo (DO11.10 T hybridoma, P815, and Sp2/O cells) for kindly providing materials; K. Nishio (LC-MS/MS), S. Kawagoe (SEC-MALS), and T. Saio (SEC-MALS) for their technical insights; J. Tsueda, Y. Okamoto, M. Aoki, H. Tsuduki, A. Mikuniya, S.C. Chiu, R. Sakamoto, R. Matsumura, and M. Saito for technical and secretarial assistance; and the other members of our laboratory for helpful discussions. This work was supported by grant-in-aid by the Japan Society for the Promotion of Science (JP18H05417, T.O.; JP19H01029, T.O.; 19K16694, T.M.; 21K07076, T.M.; 19H03423, I.O.), Takeda Science Foundation (T.O. and T.M.), FSI Research Grant Program by the UTEC and the University of Tokyo (T.O.), and Joint Research Program by the Institute of Advanced Medical Sciences of Tokushima University (T.O., T.M., D.S., H.K., and T.T.).	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Andrews LP, 2019, NAT IMMUNOL, V20, P1425, DOI 10.1038/s41590-019-0512-0; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Hara H, 2001, BBA-GENE STRUCT EXPR, V1520, P45, DOI 10.1016/S0167-4781(01)00249-4; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Huard B, 1997, P NATL ACAD SCI USA, V94, P5744, DOI 10.1073/pnas.94.11.5744; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; Lecocq Q, 2021, J NUCL MED, V62, P1638, DOI 10.2967/jnumed.120.258871; Lecocq Q, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010075; Lino AC, 2018, IMMUNITY, V49, P120, DOI 10.1016/j.immuni.2018.06.007; Maeda TK, 2019, J BIOL CHEM, V294, P6017, DOI 10.1074/jbc.RA119.007455; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Maruhashi T, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001014; Maruhashi T, 2018, NAT IMMUNOL, V19, P1415, DOI 10.1038/s41590-018-0217-9; MCKEAN D, 1973, BIOCHEMISTRY-US, V12, P760, DOI 10.1021/bi00728a028; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Saio T, 2018, ELIFE, V7, DOI 10.7554/eLife.35731; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Tawbi HA, 2022, NEW ENGL J MED, V386, P24, DOI 10.1056/NEJMoa2109970; Terskikh AV, 1997, P NATL ACAD SCI USA, V94, P1663, DOI 10.1073/pnas.94.5.1663; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Triebel F, 2003, TRENDS IMMUNOL, V24, P619, DOI 10.1016/j.it.2003.10.001; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010; WHITE J, 1983, J IMMUNOL, V130, P1033; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Yu XJ, 2019, MABS-AUSTIN, V11, P1139, DOI 10.1080/19420862.2019.1629239	38	7	7	14	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					912	+		10.1016/j.immuni.2022.03.013	http://dx.doi.org/10.1016/j.immuni.2022.03.013			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F7RT	35413245				2022-12-18	WOS:000830862400001
J	MacLean, AJ; Richmond, N; Koneva, L; Attar, M; Medina, CAP; Thornton, EE; Gomes, AC; El-Turabi, A; Bachmann, MF; Rijal, P; Tan, TK; Townsend, A; Sansom, SN; Bannard, O; Arnon, TI				MacLean, Andrew J.; Richmond, Niamh; Koneva, Lada; Attar, Moustafa; Medina, Cesar A. P.; Thornton, Emily E.; Gomes, Ariane Cruz; El-Turabi, Aadil; Bachmann, Martin F.; Rijal, Pramila; Tan, Tiong Kit; Townsend, Alain; Sansom, Stephen N.; Bannard, Oliver; Arnon, Tal, I			Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites	IMMUNITY			English	Article							GERMINAL CENTER SELECTION; RIPLEYS K-FUNCTION; LYMPHOCYTE EGRESS; VIRUS; RESPONSES; GENE; VISUALIZATION; REVEALS; VACCINE	Resident memory B (BRM) cells develop and persist in the lungs of influenza-infected mice and humans; however, their contribution to recall responses has not been defined. Here, we used two-photon microscopy to visualize BRM cells within the lungs of influenza -virus immune and reinfected mice. Prior to re-exposure, BRM cells were sparsely scattered throughout the tissue, displaying limited motility. Within 24 h of rechallenge, these cells increased their migratory capacity, localized to infected sites, and subsequently differentiated into plasma cells. Alveolar macrophages mediated this process, in part by inducing expression of chemokines CXCL9 and CXCL10 from infiltrating inflammatory cells. This led to the recruitment of chemokine receptor CXCR3-expressing BRM cells to infected regions and increased local antibody concentrations. Our study uncovers spatiotemporal mechanisms that regulate lung BRM cell reactivation and demonstrates their capacity to rapidly deliver antibodies in a highly localized manner to sites of viral replication.	[MacLean, Andrew J.; Richmond, Niamh; Koneva, Lada; Attar, Moustafa; Medina, Cesar A. P.; Sansom, Stephen N.; Arnon, Tal, I] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Thornton, Emily E.; Rijal, Pramila; Tan, Tiong Kit; Townsend, Alain; Bannard, Oliver] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Gomes, Ariane Cruz; El-Turabi, Aadil; Bachmann, Martin F.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Bachmann, Martin F.] Univ Bern, Rheumatol Immunol & Allergol, Dept BioMed Res, Bern, Switzerland	University of Oxford; University of Oxford; University of Oxford; Jenner Institute; University of Bern	Arnon, TI (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.; Bannard, O (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.	oliver.bannard@ndm.ox.ac.uk; tal.arnon@kennedy.ox.ac.uk		Tan, Tiong Kit/0000-0001-8746-8308; Richmond, Niamh/0000-0002-9372-247X; Thornton, Emily/0000-0002-0068-2502; Attar, Moustafa/0000-0003-4116-1276	Wellcome Trust Investigator Award [106245/Z/14/Z]; Kennedy Trust; Clarendon Fund Scholarship; Wellcome Henry Dale/Senior Fellowships [105654/Z/14/Z, 220219/Z/20/Z]; Medical Research Council (MRC)	Wellcome Trust Investigator Award(Wellcome Trust); Kennedy Trust; Clarendon Fund Scholarship; Wellcome Henry Dale/Senior Fellowships; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Saitou and E. Robertson for the Blimp1mVenus mice, N. Ashley and E. Repapi (WIMM single cell and CBRG facilities) for RNA-seq library generation and analysis assistance, and C. Lagerholm (Wolfson Imaging Centre Oxford) for imaging assistance. We also thank Anne Chauveau for critical reading of the manuscript. This work was supported by a Wellcome Trust Investigator Award (106245/Z/14/Z) and a Kennedy Trust Senior Fellowship (T.I.A.), Kennedy Trust Studentship Prizes (A.M.), the Clarendon Fund Scholarship (N.R.), and Wellcome Henry Dale/Senior Fellowships (105654/Z/14/Z, 220219/Z/20/Z) (O.B.), and by the Medical Research Council (MRC) through core funding to the MRC Human Immunology Unit and MRC WIMM.	Adachi Y, 2015, J EXP MED, V212, P1709, DOI 10.1084/jem.20142284; Aegerter H, 2020, NAT IMMUNOL, V21, P145, DOI 10.1038/s41590-019-0568-x; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEY MR, 1980, VET PATHOL, V17, P372, DOI 10.1177/030098588001700311; Allie SR, 2020, VIRAL IMMUNOL, V33, P282, DOI 10.1089/vim.2019.0141; Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Alon R, 2021, NAT REV IMMUNOL, V21, P49, DOI 10.1038/s41577-020-00470-2; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Barker KA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI141810; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; BURNETT D, 1986, THORAX, V41, P337, DOI 10.1136/thx.41.5.337; Carter RH, 2008, SEMIN IMMUNOL, V20, P43, DOI 10.1016/j.smim.2007.12.007; Chiu C, 2015, CURR TOP MICROBIOL, V386, P381, DOI 10.1007/82_2014_425; Cornelis R, 2021, CURR OPIN IMMUNOL, V71, P97, DOI 10.1016/j.coi.2021.06.012; Corti D, 2017, CURR OPIN VIROL, V24, P60, DOI 10.1016/j.coviro.2017.03.002; Coughlan L, 2018, CELL HOST MICROBE, V24, P18, DOI 10.1016/j.chom.2018.06.016; COVID-19 Multi-omics Blood ATlas (COMBAT) Con-sortium, BIORXIV 2021, DOI [10.1101/2021.05.11.21256877v1, DOI 10.1101/2021.05.11.21256877, 10.1101/2021.05.11.21256877]; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Frank GM, 2015, MBIO, V6, DOI 10.1128/mBio.01156-15; Gomes AC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00226; Good-Jacobson KL, 2012, INT IMMUNOL, V24, P403, DOI 10.1093/intimm/dxs050; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Iwasaki A, 2016, ANNU REV IMMUNOL, V34, P575, DOI 10.1146/annurev-immunol-032414-112315; Jafari-Mamaghani M, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fninf.2010.00009; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; Khodadadi L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00721; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; KOZLOVSKA TM, 1993, GENE, V137, P133, DOI 10.1016/0378-1119(93)90261-Z; Krammer F, 2019, NAT REV IMMUNOL, V19, P383, DOI 10.1038/s41577-019-0143-6; Kulikauskaite J, 2020, TRENDS IMMUNOL, V41, P864, DOI 10.1016/j.it.2020.08.008; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Lelkes E, 2014, TRENDS IMMUNOL, V35, P379, DOI 10.1016/j.it.2014.05.005; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Neu KE, 2016, CURR OPIN IMMUNOL, V42, P48, DOI 10.1016/j.coi.2016.05.012; Oh JE, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj5129; Oh JE, 2019, NATURE, V571, P122, DOI 10.1038/s41586-019-1285-1; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Powell T.J., 2019, J GEN; Powell TJ, 2012, J VIROL, V86, P13397, DOI 10.1128/JVI.01820-12; Radtke D, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03106; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Rommel PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069208; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Suan D, 2017, CURR OPIN IMMUNOL, V45, P97, DOI 10.1016/j.coi.2017.03.006; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Phan TG, 2017, CURR OPIN IMMUNOL, V45, P132, DOI 10.1016/j.coi.2017.03.005; Ulbricht C, 2021, METHODS MOL BIOL, V2308, P163, DOI 10.1007/978-1-0716-1425-9_14; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; Weltzin R, 1999, CLIN MICROBIOL REV, V12, P383, DOI 10.1128/CMR.12.3.383; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu NC, 2018, NAT STRUCT MOL BIOL, V25, P115, DOI 10.1038/s41594-018-0025-9; Xin HY, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02084-2; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313	79	7	7	8	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					718	+		10.1016/j.immuni.2022.03.003	http://dx.doi.org/10.1016/j.immuni.2022.03.003			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z9WH	35349789	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000791419000005
J	Xiong, Z; Zhu, XX; Geng, JJ; Xu, YW; Wu, RY; Li, CZ; Fan, DD; Qin, XW; Du, Y; Tian, Y; Fan, ZS				Xiong, Zhen; Zhu, Xiaoxiao; Geng, Jingjing; Xu, Yuwei; Wu, Runyuan; Li, Cunzhen; Fan, Dongdong; Qin, Xiwen; Du, Ying; Tian, Yong; Fan, Zusen			Intestinal Tuft-2 cells exert antimicrobial immunity via sensing bacterial metabolite N-undecanoylglycine	IMMUNITY			English	Article							TYPE-2 IMMUNITY; ACTIVATION; EXPRESSION; MUCUS	Tuft cells are a type of intestinal epithelial cells that exist in epithelial barriers and play a critical role in immunity against parasite infection. It remains insufficiently clear whether Tuft cells participate in bacterial eradication. Here, we identified Sh2d6 as a signature marker for CD45(+) Tuft-2 cells. Depletion of Tuft-2 cells resulted in susceptibility to bacterial infection. Tuft-2 cells quickly expanded in response to bacterial infection and sensed the bacterial metabolite N-undecanoylglycine through vomeronasal receptor Vmn2r26. Mechanistically, Vmn2r26 engaged with N-undecanoylglycine activated G-protein-coupled receptor-phospholipase C gamma2 (GPCR-PLC gamma 2)-Ca2+ signaling axis, which initiated prostaglandin D2 (PGD2) production. PGD2 enhanced the mucus secretion of goblet cells and induced antibacterial immunity. Moreover, Vmn2r26 signaling also promoted SpiB transcription factor expression, which is responsible for Tuft-2 cell development and expansion in response to bacterial challenge. Our findings reveal an additional function of Tuft-2 cells in immunity against bacterial infection through Vmn2r26-mediated recognition of bacterial metabolites.	[Xiong, Zhen; Geng, Jingjing; Xu, Yuwei; Wu, Runyuan; Li, Cunzhen; Qin, Xiwen; Du, Ying; Fan, Zusen] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Key Lab Infect & Immun CAS, Beijing 100101, Peoples R China; [Xiong, Zhen; Zhu, Xiaoxiao; Xu, Yuwei; Fan, Dongdong; Tian, Yong] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol CAS, Beijing, Peoples R China; [Xu, Yuwei; Wu, Runyuan; Li, Cunzhen; Qin, Xiwen; Tian, Yong; Fan, Zusen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Geng, Jingjing] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Key Lab Infect & Immun CAS, Beijing 100101, Peoples R China.; Tian, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol CAS, Beijing, Peoples R China.; Tian, Y; Fan, ZS (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	ytian@ibp.ac.cn; fanz@moon.ibp.ac.cn		Geng, Jingjing/0000-0001-8733-7746; TIAN, YONG/0000-0002-8790-1148	National Key R&D Program of China [2020YFA0803501, 2019YFA0508501, 2021YFF0702802]; National Natural Science Foundation of China [31930036, 81921003, 92042302, 32070533, 91940305, 81772646, 82130088]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDB19030203]; Young Elite Scientist Sponsorship Program by CAST [2018QNRC001]; Biological Resources Program of Chinese Academy of Sciences [KFJ-BRP-017]; Beijing Natural Science Foundation [5222023];  [2020M680712]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Programs of the Chinese Academy of Sciences; Young Elite Scientist Sponsorship Program by CAST; Biological Resources Program of Chinese Academy of Sciences; Beijing Natural Science Foundation(Beijing Natural Science Foundation); 	We thank Yihui Xu for technical support. We thank Xiang Shi, Xing Gao, Zixin Zhao, MingHao, JiajiaHou and XinWen for animal procedures. We thank Zhimin Wang for data analysis. We thank Yan Teng and Yun Feng for imaging technical support. We thank YaWang for technical support. We also thank Jing Li (Cnkingbio Company Ltd, Beijing, China) for technical support. This work was supported by the National Key R&D Program of China (2020YFA0803501, 2019YFA0508501, 2021YFF0702802), National Natural Science Foundation of China (31930036, 81921003, 92042302, 32070533, 91940305, 81772646, 82130088), Strategic Priority Research Programs of the Chinese Academy of Sciences (XDB19030203), Biological Resources Program of Chinese Academy of Sciences (KFJ-BRP-017), the Young Elite Scientist Sponsorship Program by CAST (2018QNRC001), the Beijing Natural Science Foundation (5222023), and the Postdoctoral grant (2020M680712).	Bellono NW, 2017, CELL, V170, DOI 10.1016/j.cell.2017.05.034; Bergstrom K, 2020, SCIENCE, V370, P467, DOI 10.1126/science.aay7367; Beumer J, 2021, NAT REV MOL CELL BIO, V22, P39, DOI 10.1038/s41580-020-0278-0; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; Brightling CE, 2020, ALLERGY, V75, P761, DOI 10.1111/all.14001; Bufe B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12842-x; Caers J, 2014, JOVE-J VIS EXP, DOI 10.3791/51516; Care MA, 2014, NUCLEIC ACIDS RES, V42, P7588, DOI 10.1093/nar/gku451; Dalton RP, 2015, ANNU REV NEUROSCI, V38, P331, DOI 10.1146/annurev-neuro-071714-034145; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Desai P, 2021, CELL, V184, P1214, DOI 10.1016/j.cell.2021.01.051; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Gerbe F., 2011, DISTINCT ATOH1 NEURO; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Hasegawa Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188257; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kishikawa S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14509; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Luo X.-C., 2019, P NATL ACAD SCI; Macal M, 2018, IMMUNITY, V48, P730, DOI 10.1016/j.immuni.2018.03.020; Manco R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23245-2; McGinty JW, 2020, IMMUNITY, V52, P528, DOI 10.1016/j.immuni.2020.02.005; Meixiong J, 2019, P NATL ACAD SCI USA, V116, P10525, DOI 10.1073/pnas.1903316116; Miller CN, 2018, NATURE, V559, P627, DOI 10.1038/s41586-018-0345-2; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Moor AE, 2018, CELL, V175, P1156, DOI 10.1016/j.cell.2018.08.063; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Nystrom EEL, 2021, SCIENCE, V372, P257, DOI 10.1126/science.abb1590; O'Leary CE, 2019, ANNU REV IMMUNOL, V37, P47, DOI 10.1146/annurev-immunol-042718-041505; Okumura R, 2016, NATURE, V532, P117, DOI 10.1038/nature17406; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Roulis M, 2020, NATURE, V580, P524, DOI 10.1038/s41586-020-2166-3; Schneider C, 2019, NAT REV IMMUNOL, V19, P584, DOI 10.1038/s41577-019-0176-x; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wei J, 2019, TRENDS BIOCHEM SCI, V44, P214, DOI 10.1016/j.tibs.2018.10.007; Weiss E, 2018, TRENDS IMMUNOL, V39, P815, DOI 10.1016/j.it.2018.08.005; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Willis SN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01605-1; Wootten D, 2018, NAT REV MOL CELL BIO, V19, P638, DOI 10.1038/s41580-018-0049-3; Xiong Z, 2020, J EXP MED, V217, DOI 10.1084/jem.20190974; Zhu PP, 2019, NAT IMMUNOL, V20, P183, DOI 10.1038/s41590-018-0297-6; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	50	7	7	19	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					686	+		10.1016/j.immuni.2022.03.001	http://dx.doi.org/10.1016/j.immuni.2022.03.001			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z9WH	35320705				2022-12-18	WOS:000791419000003
J	Collins, N; Belkaid, Y				Collins, Nicholas; Belkaid, Yasmine			Control of immunity via nutritional interventions	IMMUNITY			English	Review							FASTING-MIMICKING DIET; REGULATORY T-CELLS; CALORIC RESTRICTION MIMETICS; INNATE LYMPHOID-CELLS; FATTY-ACID-METABOLISM; BONE-MARROW; GUT-MICROBIOTA; RETINOIC-ACID; BETA-HYDROXYBUTYRATE; KETOGENIC DIET	Nutrition affects all physiological processes including those linked to the development and function of our immune system. Here, we discuss recent evidence and emerging concepts supporting the idea that our newfound relationship with nutrition in industrialized countries has fundamentally altered the way in which our immune system is wired. This will be examined through the lens of studies showing that mild or transient reductions in dietary intake can enhance protective immunity while also limiting aberrant inflammatory responses. We will further discuss how trade-offs and priorities begin to emerge in the context of severe nutritional stress. In those settings, specific immunological functions are heightened to re-enforce processes and tissue sites most critical to survival. Altogether, these examples will emphasize the profound influence nutrition has over the immune system and highlight how a mechanistic exploration of this cross talk could ultimately lead to the design of novel therapeutic approaches that prevent and treat disease.	[Collins, Nicholas; Belkaid, Yasmine] NIAID, Metaorganism Immun Sect, Lab Host Immun & Microbiome, NIH, Bethesda, MD 20892 USA; [Belkaid, Yasmine] NIAID, NIAID Microbiome Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Collins, N; Belkaid, Y (corresponding author), NIAID, Metaorganism Immun Sect, Lab Host Immun & Microbiome, NIH, Bethesda, MD 20892 USA.; Belkaid, Y (corresponding author), NIAID, NIAID Microbiome Program, NIH, Bethesda, MD 20892 USA.	nicholas.collins@nih.gov; ybelkaid@niaid.nih.gov			Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID) [ZIA-AI001115, ZIA-AI001132]; K99/R00 award (NCI) [1K99CA252443-01]; Paul Allen Foundation	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); K99/R00 award (NCI); Paul Allen Foundation	We would like to thank members of the Belkaid Laboratory for their very useful suggestions and discussion. This work was supported by the Division of Intra-mural Research of the National Institute of Allergy and Infectious Diseases (NIAID; ZIA-AI001115 and ZIA-AI001132) . N.C. is funded by a K99/R00 award (NCI; 1K99CA252443-01) and the Paul Allen Foundation. Figures were created with BioRender.com .	Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Ahmed AMS, 2016, EPIDEMIOL INFECT, V144, P3494, DOI 10.1017/S0950268816001771; Ahmed T, 2009, J GERONTOL A-BIOL, V64, P1107, DOI 10.1093/gerona/glp101; Ang QY, 2020, CELL, V181, P1263, DOI 10.1016/j.cell.2020.04.027; Ansaldo E, 2021, ANNU REV IMMUNOL, V39, P449, DOI 10.1146/annurev-immunol-093019-112348; Aoki K, 2021, BRIT J HAEMATOL, V193, P659, DOI 10.1111/bjh.17396; Apelo SIA, 2016, J GERONTOL A-BIOL, V71, P841, DOI 10.1093/gerona/glw090; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Attane C, 2020, CELL REP, V30, P949, DOI 10.1016/j.celrep.2019.12.089; Bachem A, 2019, IMMUNITY, V51, P285, DOI 10.1016/j.immuni.2019.06.002; BEATTY DW, 1983, J CLIN LAB IMMUNOL, V12, P31; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; BELL RG, 1976, AM J CLIN NUTR, V29, P392, DOI 10.1093/ajcn/29.4.392; Besedovsky L, 2014, AM J PHYSIOL-ENDOC M, V306, pE1322, DOI 10.1152/ajpendo.00678.2013; Besedovsky L, 2014, FASEB J, V28, P67, DOI 10.1096/fj.13-237958; Bhattacharjee A, 2021, IMMUNITY, V54, P1745, DOI 10.1016/j.immuni.2021.07.005; Blanton LV, 2016, SCIENCE, V352, DOI 10.1126/science.aad9359; Bourke CD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01728; Bourke CD, 2016, TRENDS IMMUNOL, V37, P386, DOI 10.1016/j.it.2016.04.003; Brandhorst S, 2016, RECENT RESULTS CANC, V207, P241, DOI 10.1007/978-3-319-42118-6_12; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Burr AHP, 2020, J IMMUNOL, V205, P1479, DOI 10.4049/jimmunol.2000419; Caffa I, 2020, NATURE, V583, P620, DOI 10.1038/s41586-020-2502-7; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Campbell C, 2020, P NATL ACAD SCI USA, V117, P33446, DOI 10.1073/pnas.2020619117; Cawthorn WP, 2014, CELL METAB, V20, P368, DOI 10.1016/j.cmet.2014.06.003; Cha HR, 2010, J IMMUNOL, V184, P6799, DOI 10.4049/jimmunol.0902944; Chan JD, 2021, NAT REV IMMUNOL, V21, P769, DOI 10.1038/s41577-021-00539-6; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Christ A, 2019, IMMUNITY, V51, P794, DOI 10.1016/j.immuni.2019.09.020; Church JA, 2019, LANCET INFECT DIS, V19, P203, DOI 10.1016/S1473-3099(18)30602-9; Cignarella F, 2018, CELL METAB, V27, P1222, DOI 10.1016/j.cmet.2018.05.006; Collins N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124363; Collins N, 2019, CELL, V178, P1088, DOI 10.1016/j.cell.2019.07.049; Constantinides MG, 2019, SCIENCE, V366, P445, DOI 10.1126/science.aax6624; Contreras NA, 2018, GEROSCIENCE, V40, P279, DOI 10.1007/s11357-018-0022-2; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crupi AN, 2020, CURR DIABETES REP, V20, DOI 10.1007/s11892-020-01362-4; Dai XM, 2021, MOL CELL, V81, P2317, DOI 10.1016/j.molcel.2021.03.037; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Delannoy-Bruno O, 2021, NATURE, V595, P91, DOI 10.1038/s41586-021-03671-4; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; EFFROS RB, 1991, J GERONTOL, V46, pB142, DOI 10.1093/geronj/46.4.B142; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Eriau E, 2021, CANCERS, V13, DOI 10.3390/cancers13061260; Ferrere G, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.145207; Fontana L, 2012, CIRC RES, V110, P1139, DOI 10.1161/CIRCRESAHA.111.246470; Frizzell H, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay9283; Fujita Y, 2002, CLIN EXP IMMUNOL, V128, P21, DOI 10.1046/j.1365-2249.2002.01797.x; Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050; Gardner EM, 2005, J GERONTOL A-BIOL, V60, P688, DOI 10.1093/gerona/60.6.688; Gehrig JL, 2019, SCIENCE, V365, P139, DOI 10.1126/science.aau4732; Geltink RIK, 2020, NAT METAB, V2, P703, DOI 10.1038/s42255-020-0256-z; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Ghosh MC, 2009, BLOOD, V113, P575, DOI 10.1182/blood-2008-04-151803; Goldberg EL, 2020, NAT METAB, V2, P50, DOI 10.1038/s42255-019-0160-6; Goldberg EL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav2026; Goldberg EL, 2019, CELL METAB, V30, P621, DOI 10.1016/j.cmet.2019.08.022; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Goldberg EL, 2015, AGING CELL, V14, P130, DOI 10.1111/acel.12280; Gonzalez-Martinez H, 2008, J CLIN IMMUNOL, V28, P593, DOI 10.1007/s10875-008-9204-5; Gonzalez-Torres C, 2013, NUTRIENTS, V5, P579, DOI 10.3390/nu5020579; Gurven M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055679; Hales Craig M, 2020, NCHS Data Brief, P1; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hall KD, 2021, NAT MED, V27, P344, DOI 10.1038/s41591-020-01209-1; Hall KD, 2018, CURR OPIN CLIN NUTR, V21, P308, DOI 10.1097/MCO.0000000000000470; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Hofer SJ, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.717343; Huus KE, 2021, NAT REV IMMUNOL, V21, P514, DOI 10.1038/s41577-021-00506-1; Huus KE, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00890-1; Huus KE, 2020, CELL HOST MICROBE, V27, P909, DOI 10.1016/j.chom.2020.03.012; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karagiannis F, 2020, IMMUNITY, V52, P620, DOI 10.1016/j.immuni.2020.03.003; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kaymak I, 2021, CANCER CELL, V39, P28, DOI 10.1016/j.ccell.2020.09.004; Kirchengast S, 1998, ANN HUM BIOL, V25, P541, DOI 10.1080/03014469800006782; KUBO C, 1992, P NATL ACAD SCI USA, V89, P3145, DOI 10.1073/pnas.89.7.3145; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Lee AH, 2020, IMMUNITY, V53, P510, DOI 10.1016/j.immuni.2020.08.013; Lee C., 2016, F1000 RES, V5, P117, DOI [DOI 10.12688/F1000RESEARCH.7136.1, 10.12688/f1000research.7136.1]; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Leone RD, 2019, SCIENCE, V366, P1013, DOI 10.1126/science.aav2588; Lien EC, 2021, NATURE, V599, P302, DOI 10.1038/s41586-021-04049-2; Lim AI, 2021, SCIENCE, V373, DOI 10.1126/science.abf3002; Linehan JL, 2018, CELL, V172, P784, DOI 10.1016/j.cell.2017.12.033; Lussier DM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2337-7; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391; Malik VS, 2020, NAT REV ENDOCRINOL, V16, P615, DOI 10.1038/s41574-020-00411-y; Mannick JB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1564; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Messaoudi I, 2008, AGING CELL, V7, P908, DOI 10.1111/j.1474-9726.2008.00440.x; Meydani SN, 2016, AGING-US, V8, P1416, DOI 10.18632/aging.100994; Michael H, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00196; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Moreno B, 2014, ENDOCRINE, V47, P793, DOI 10.1007/s12020-014-0192-3; Morseth MS, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12552; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nagai M, 2019, CELL, V178, P1072, DOI 10.1016/j.cell.2019.07.047; Naylor C, 2015, EBIOMEDICINE, V2, P1759, DOI 10.1016/j.ebiom.2015.09.036; Newman JC, 2017, CELL METAB, V26, P547, DOI 10.1016/j.cmet.2017.08.004; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Nikolich-Zugich J, 2005, EXP GERONTOL, V40, P884, DOI 10.1016/j.exger.2005.06.007; Palma C, 2021, CELL METAB, V33, P300, DOI 10.1016/j.cmet.2020.12.016; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Piccio L, 2008, J LEUKOCYTE BIOL, V84, P940, DOI 10.1189/jlb.0208133; Pietrocola F, 2016, CELL CYCLE, V15, P3327, DOI 10.1080/15384101.2016.1224797; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Pontzer H, 2018, OBES REV, V19, P24, DOI 10.1111/obr.12785; Prendergast AJ, 2016, CURR OPIN INFECT DIS, V29, P229, DOI 10.1097/QCO.0000000000000261; Prendergast AJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0141; Puleston DJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03706; Raman AS, 2019, SCIENCE, V365, P140, DOI 10.1126/science.aau4735; Rangan P, 2019, CELL REP, V26, P2704, DOI 10.1016/j.celrep.2019.02.019; Redman LM, 2018, CELL METAB, V27, P805, DOI 10.1016/j.cmet.2018.02.019; Remis MJ, 2014, AM J PHYS ANTHROPOL, V154, P365, DOI 10.1002/ajpa.22521; Rho S, 2017, IMMUNOL LETT, V190, P247, DOI 10.1016/j.imlet.2017.08.025; Roberts MN, 2017, CELL METAB, V26, P539, DOI 10.1016/j.cmet.2017.08.005; Robertson LT, 2013, EXP GERONTOL, V48, P1043, DOI 10.1016/j.exger.2013.01.009; Roy DG, 2020, CELL METAB, V31, P250, DOI 10.1016/j.cmet.2020.01.006; Rubio-Patino C, 2018, CELL METAB, V27, P828, DOI 10.1016/j.cmet.2018.02.009; Rytter MJH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105017; Ryu S, 2021, ELIFE, V10, DOI 10.7554/eLife.66522; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Salvadori G, 2021, CANCERS, V13, DOI 10.3390/cancers13184587; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Scheller EL, 2019, BONE, V118, P32, DOI 10.1016/j.bone.2018.01.016; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Snir A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131422; Sonnenburg ED, 2019, NAT REV MICROBIOL, V17, P383, DOI 10.1038/s41579-019-0191-8; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Sonnenburg JL, 2019, SCIENCE, V366, P444, DOI 10.1126/science.aaw9255; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spencer SP, 2019, IMMUNITY, V51, P225, DOI 10.1016/j.immuni.2019.08.002; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vangay P, 2018, CELL, V175, P962, DOI 10.1016/j.cell.2018.10.029; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; von Schwartzenberg RJ, 2021, NATURE, V595, P272, DOI 10.1038/s41586-021-03663-4; Walker R, 2006, AM J HUM BIOL, V18, P295, DOI 10.1002/ajhb.20510; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wastyk HC, 2021, CELL, V184, P4137, DOI 10.1016/j.cell.2021.06.019; Wilhelm C, 2021, TRENDS IMMUNOL, V42, P389, DOI 10.1016/j.it.2021.03.007; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Wilson KA, 2021, CELL METAB, V33, P2142, DOI 10.1016/j.cmet.2021.08.018; WING EJ, 1988, IMMUNOLOGY, V63, P677; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Yang HW, 2009, J IMMUNOL, V183, P3040, DOI 10.4049/jimmunol.0900562; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804	177	7	7	11	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					210	223		10.1016/j.immuni.2022.01.004	http://dx.doi.org/10.1016/j.immuni.2022.01.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	YX7WH	35139351				2022-12-18	WOS:000754308000008
J	Elliot, TAE; Jennings, EK; Lecky, DAJ; Thawait, N; Flores-Langarica, A; Copland, A; Maslowski, KM; Wraith, DC; Bending, D				Elliot, Thomas A. E.; Jennings, Emma K.; Lecky, David A. J.; Thawait, Natasha; Flores-Langarica, Adriana; Copland, Alastair; Maslowski, Kendle M.; Wraith, David C.; Bending, David			Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength	IMMUNITY			English	Article							R/BIOCONDUCTOR PACKAGE; CLINICAL-RESPONSE; ACTIVATION; BLOCKADE; TUMOR; DIFFERENTIATION; TRANSCRIPTION; MECHANISMS; EXPRESSION; CD4	How T cell receptor (TCR) signal strength modulates T cell function and to what extent this is modified by immune checkpoint blockade (ICB) are key questions in immunology. Using Nr4a3-Tocky mice, we characterized early quantitative and qualitative changes that occur in CD4(+) T cells in relation to TCR signaling strength. We captured how dose- and time-dependent programming of distinct co-inhibitory receptors rapidly recalibrates T cell activation thresholds and visualized the immediate effects of ICB on T cell re-activation. Our findings reveal that anti-PD1 immunotherapy leads to an increased TCR signal strength. We defined a strong TCR signal metric of five genes upregulated by anti-PD1 in T cells (TCR.strong), which was superior to a canonical T cell activation gene signature in stratifying melanoma patient outcomes to anti-PD1 therapy. Our study therefore reveals how analysis of TCR signal strength-and its manipulation-can provide powerful metrics for monitoring outcomes to immunotherapy.	[Elliot, Thomas A. E.; Jennings, Emma K.; Lecky, David A. J.; Thawait, Natasha; Copland, Alastair; Maslowski, Kendle M.; Wraith, David C.; Bending, David] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England; [Flores-Langarica, Adriana] Univ Birmingham, Coll Med & Dent Sci, Infrastruct & Facil, Birmingham B15 2TT, W Midlands, England; [Maslowski, Kendle M.] Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England; [Jennings, Emma K.] Univ Leeds, Fac Med & Hlth, Leeds Inst Med Res, St JamesUniv Hosp, Leeds LS9 7TF, W Yorkshire, England; [Thawait, Natasha] Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Birmingham; University of Birmingham; University of Birmingham; University of Leeds; University of Edinburgh	Bending, D (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England.	d.a.bending@bham.ac.uk	; Maslowski, Kendle/R-9331-2018	Thawait, Natasha/0000-0002-8321-3292; Wraith, David/0000-0003-2147-5614; Maslowski, Kendle/0000-0003-1995-5424; Bending, David/0000-0003-0071-1163; Lecky, David/0000-0002-9333-5605; Flores-Langarica, Adriana/0000-0003-2183-4437; Jennings, Emma/0000-0002-0892-4756	University of Birmingham; Wellcome Trust [214018/Z/18/Z]; MRC [MR/V009052/1]; Wellcome Trust 4-year Basic Science PhD program; MRC Discovery Medicine North (DiMeN) Doctoral Training Partnership [MR/N103840/1]; CRUK Career Establishment Award [C61638/A27112]; University of Birmingham (UoB)	University of Birmingham; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust 4-year Basic Science PhD program(Wellcome Trust); MRC Discovery Medicine North (DiMeN) Doctoral Training Partnership; CRUK Career Establishment Award; University of Birmingham (UoB)	Work funded by the University of Birmingham (D.B.) , the Wellcome Trust (214018/Z/18/Z to D.B.) , and the MRC (MR/V009052/1 to D.B.) . D.A.L. is funded by a Wellcome Trust 4-year Basic Science PhD program. E.K.J. is sup-ported by a studentship from the MRC Discovery Medicine North (DiMeN) Doctoral Training Partnership (MR/N103840/1) . A.C. and K.M.M. are funded by a CRUK Career Establishment Award (C61638/A27112 to K.M.M.) . D.C.W and A.F-L. are funded by the University of Birmingham (UoB) . Diagrams in Figures 1, 4, and 5 were adapted from the Servier Medical Art templates, which are licensed under a CC BY 3.0 unported license, https://smart.servier.com . We thank Dr. Leila Khoja, Dr. Neil Steven, and Dr. Lalit Pallan (Medical Oncology, UoB) for helpful discussion around the potential clinical utility of the TCR.strong metric. We also thank Dr. Sarah Dimeloe, Dr. Rebecca Drum-mond, and Dr. Wei-Yu Lu for their continued support and feedback on data in the manuscript. The graphical abstract was created using BioRender.com .	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bending D, 2018, J CELL BIOL, V217, P2931, DOI 10.1083/jcb.201711048; Bending D, 2018, EMBO J, V37, DOI 10.15252/embj.201899013; Bevington SL, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107748; Bonavita E, 2020, IMMUNITY, V53, P1215, DOI 10.1016/j.immuni.2020.10.020; Borcoman E, 2019, ANN ONCOL, V30, P385, DOI 10.1093/annonc/mdz003; Borst J, 2018, NAT REV IMMUNOL, V18, P635, DOI 10.1038/s41577-018-0044-0; Burton BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5741; Cachot A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe3348; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Conley JM, 2020, J IMMUNOL, V205, P335, DOI 10.4049/jimmunol.1900853; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Efremova M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02424-0; Gallagher M.P., 2020, TEC KINASE ITK DIFFE, DOI [10.1101/2020.11.12.380725, DOI 10.1101/2020.11.12.380725]; Gallagher Michael P, 2018, Immunohorizons, V2, P208, DOI 10.4049/immunohorizons.1800032; Gide TN, 2019, CANCER CELL, V35, P238, DOI 10.1016/j.ccell.2019.01.003; Grasso CS, 2020, CANCER CELL, V38, P500, DOI 10.1016/j.ccell.2020.08.005; Grossman Z, 2015, ANNU REV IMMUNOL, V33, P677, DOI 10.1146/annurev-immunol-032712-100027; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; House IG, 2020, CLIN CANCER RES, V26, P487, DOI 10.1158/1078-0432.CCR-19-1868; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Jennings E, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108328; Jennings Emma K, 2021, STAR Protoc, V2, P100284, DOI 10.1016/j.xpro.2020.100284; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Keck S, 2014, P NATL ACAD SCI USA, V111, P14852, DOI 10.1073/pnas.1403271111; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Litchfield K, 2021, CELL, V184, P596, DOI 10.1016/j.cell.2021.01.002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Maruhashi T, 2018, NAT IMMUNOL, V19, P1415, DOI 10.1038/s41590-018-0217-9; Mizuno R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00630; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Moreno BH, 2016, CANCER IMMUNOL RES, V4, P845, DOI 10.1158/2326-6066.CIR-16-0060; Pachter L., 2011, ARXIV Q BIO GN; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Price AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039750; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Richard AC, 2018, NAT IMMUNOL, V19, P849, DOI 10.1038/s41590-018-0160-9; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shimizu K, 2020, MOL CELL, V77, P937, DOI 10.1016/j.molcel.2019.12.012; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Subach FV, 2009, NAT CHEM BIOL, V5, P118, DOI 10.1038/nchembio.138; Trefzer A, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108748; Tubo NJ, 2014, TRENDS IMMUNOL, V35, P591, DOI 10.1016/j.it.2014.09.008; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Xiao ZY, 2020, CANCER RES, V80, P3023, DOI 10.1158/0008-5472.CAN-19-3265; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zinzow-Kramer WM, 2019, P NATL ACAD SCI USA, V116, P15160, DOI 10.1073/pnas.1904096116	61	7	7	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2481	+		10.1016/j.immuni.2021.08.020	http://dx.doi.org/10.1016/j.immuni.2021.08.020		NOV 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34534438	Green Published, hybrid			2022-12-18	WOS:000718366000008
J	Tsutsumi, N; Qu, QH; Mavri, M; Baggesen, MS; Maeda, S; Waghray, D; Berg, C; Kobilka, BK; Rosenkilde, MM; Skiniotis, G; Garcia, KC				Tsutsumi, Naotaka; Qu, Qianhui; Mavri, Masa; Baggesen, Maibritt S.; Maeda, Shoji; Waghray, Deepa; Berg, Christian; Kobilka, Brian K.; Rosenkilde, Mette M.; Skiniotis, Georgios; Garcia, K. Christopher			Structural basis for the constitutive activity and immunomodulatory properties of the Epstein-Barr virus-encoded G protein-coupled receptor BILF1	IMMUNITY			English	Article							CLASS-I MOLECULES; HIGH-LEVEL EXPRESSION; LIGAND RECOGNITION; BINDING-SITE; CHEMOKINE; IDENTIFICATION; COMPLEX; SYSTEM; VISUALIZATION; ACTIVATION	Epstein-Barr virus (EBV) encodes a G protein-coupled receptor (GPCR) termed BILF1 that is essential for EBV-mediated immunosuppression and oncogenesis. BILF1 couples with inhibitory G protein (Gi), the major intracellular signaling effector for human chemokine receptors, and exhibits constitutive signaling activity; the ligand(s) for BILF1 are unknown. We studied the origins of BILF1's constitutive activity through structure determination of BILF1 bound to the inhibitory G protein (Gi) heterotrimer. The 3.2-angstrom resolution cryo-electron microscopy structure revealed an extracellular loop within BILF1 that blocked the typical chemokine binding site, suggesting ligand-autonomous receptor activation. Rather, amino acid substitutions within BILF1 transmembrane regions at hallmark ligand-activated class A GPCR "microswitches'' stabilized a constitutively active BILF1 conformation for Gi coupling in a ligand-independent fashion. Thus, the constitutive activity of BILF1 promotes immunosuppression and virulence independent of ligand availability, with implications for the function of GPCRs encoded by related viruses and for therapeutic targeting of EBV.	[Tsutsumi, Naotaka; Qu, Qianhui; Maeda, Shoji; Waghray, Deepa; Kobilka, Brian K.; Skiniotis, Georgios; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Tsutsumi, Naotaka; Qu, Qianhui; Skiniotis, Georgios; Garcia, K. Christopher] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Tsutsumi, Naotaka; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Mavri, Masa; Baggesen, Maibritt S.; Berg, Christian; Rosenkilde, Mette M.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Mavri, Masa] Univ Ljubljana, Vet Fac, Inst Preclin Sci, Ljubljana, Slovenia; [Qu, Qianhui] Fudan Univ, Shanghai Stomatol Hosp, Inst Biomed Sci, Dept Syst Biol Med, Shanghai, Peoples R China	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Copenhagen; University of Ljubljana; Fudan University	Garcia, KC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Maeda, Shoji/0000-0002-7762-9793; Kobilka, Brian/0000-0001-5958-3990; Tsutsumi, Naotaka/0000-0002-3617-7145; Berg, Christian/0000-0002-0539-7081; Rosenkilde, Mette Marie/0000-0001-9600-3254; Skiniotis, Georgios/0000-0003-0238-7846	NIH [R01AI125320]; Kirsten and Freddy Johansens Foundation [2017-112697]; Lundbeck Foundation [R242-2017-409]; Novo Nordisk Foundation [NNF17OC0029222]; Human Science Frontier Program Organization [LT000011/2016-L]; Slovenian Research Agency [P40053]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirsten and Freddy Johansens Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Human Science Frontier Program Organization; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	Cryo-EM data were collected at the Stanford-SLAC Cryo-EM facility. Wethank Dr. Elizabeth Montabana for user support. We thank Andrew Velasco for technical assistance and Drs. Kevin Jude and Michelle Yen for scientific discussions. This work was supported by the NIH (R01AI125320) to K.C.G. and the Kirsten and Freddy Johansens Foundation (2017-112697), Lundbeck Foundation (R242-2017-409), and Novo Nordisk Foundation (NNF17OC0029222) to M.M.R. K.C.G. is an investigator of the Howard Hughes Medical Institute and the Younger Family Chair and is a member of the Ludwig Institute. N.T. was supported by long-term fellowships from the Human Science Frontier Program Organization (LT000011/2016-L). M.M. was supported by the Slovenian Research Agency (Young Researcher PhD program and P40053). Part of the graphical abstract was created with BioRender.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Audet M, 2019, NAT CHEM BIOL, V15, P11, DOI 10.1038/s41589-018-0160-y; Beisser PS, 2005, J VIROL, V79, P441, DOI 10.1128/JVI.79.1.441-449.2005; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Burger M, 1999, J IMMUNOL, V163, P2017; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Chakravorty S, 2019, CANCER RES, V79, P6010, DOI 10.1158/0008-5472.CAN-19-0615; Chen SH, 2002, BIOCHEMISTRY-US, V41, P6045, DOI 10.1021/bi012189c; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; De Groof TWM, 2021, PHARMACOL REV, V73, P828, DOI 10.1124/pharmrev.120.000186; de Munnik SM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00040; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan HX, 2019, NAT CHEM BIOL, V15, P27, DOI 10.1038/s41589-018-0170-9; Fares S, 2019, MBIO, V10, DOI 10.1128/mBio.01707-18; Farrell PJ, 2019, ANNU REV PATHOL-MECH, V14, P29, DOI 10.1146/annurev-pathmechdis-012418-013023; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gewurz BE, 2001, P NATL ACAD SCI USA, V98, P6794, DOI 10.1073/pnas.121172898; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Tamayo JCG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199843; Griffin BD, 2013, J IMMUNOL, V190, P1672, DOI 10.4049/jimmunol.1102462; Heydorn A, 2004, MOL PHARMACOL, V66, P250, DOI 10.1124/mol.66.2.250; Heymann JB, 2018, PROTEIN SCI, V27, P159, DOI 10.1002/pro.3293; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jaeger K, 2019, CELL, V178, P1222, DOI 10.1016/j.cell.2019.07.028; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Kato HE, 2019, NATURE, V572, P80, DOI 10.1038/s41586-019-1337-6; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Kostenis E, 2005, J PHARMACOL EXP THER, V313, P78, DOI 10.1124/jpet.104.080424; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lin X, 2020, NATURE, V579, P152, DOI 10.1038/s41586-020-2019-0; Liu KW, 2020, NATURE, V585, P135, DOI 10.1038/s41586-020-2492-5; Lyngaa R, 2010, ONCOGENE, V29, P4388, DOI 10.1038/onc.2010.173; Maeda S, 2019, SCIENCE, V364, P552, DOI 10.1126/science.aaw5188; Maeda S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06002-w; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Meyrath M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16664-0; Miles TF, 2018, ELIFE, V7, DOI 10.7554/eLife.35850; Montaner S, 2013, ANNU REV PHARMACOL, V53, P331, DOI 10.1146/annurev-pharmtox-010510-100608; Morimoto K, 2019, NAT CHEM BIOL, V15, P8, DOI 10.1038/s41589-018-0171-8; Mundo L, 2020, MODERN PATHOL, V33, P2407, DOI 10.1038/s41379-020-0575-3; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Nijmeijer S, 2010, J BIOL CHEM, V285, P29632, DOI 10.1074/jbc.M110.115618; Olivella M, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-3; Oswald C, 2016, NATURE, V540, P462, DOI 10.1038/nature20606; Paulsen SJ, 2005, J VIROL, V79, P536, DOI 10.1128/JVI.79.1.536-546.2005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Quinn LL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004322; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Salchow K, 2010, BRIT J PHARMACOL, V159, P1429, DOI 10.1111/j.1476-5381.2009.00623.x; Schuren ABC, 2016, CURR OPIN IMMUNOL, V40, P43, DOI 10.1016/j.coi.2016.02.007; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Spiess K, 2015, J VIROL, V89, P2253, DOI 10.1128/JVI.02716-14; Tierney RJ, 2015, VIROLOGY, V474, P117, DOI 10.1016/j.virol.2014.10.030; Toyoda Y, 2019, NAT CHEM BIOL, V15, P18, DOI 10.1038/s41589-018-0131-3; Wang JJ, 2020, CURR OPIN STRUC BIOL, V63, P82, DOI 10.1016/j.sbi.2020.04.008; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Yang ZL, 2018, NATURE, V556, P520, DOI 10.1038/s41586-018-0046-x; Young LS, 2016, NAT REV CANCER, V16, P789, DOI 10.1038/nrc.2016.92; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Y, 2020, BIORXIV, DOI [10.1101/2020.05.24.111823, DOI 10.1101/2020.05.24.111823]; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zheng Y, 2016, NATURE, V540, P458, DOI 10.1038/nature20605; Zhou QT, 2019, ELIFE, V8, DOI 10.7554/eLife.50279; Ziffert I, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00537-6; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; Zuo JM, 2011, J VIROL, V85, P1604, DOI 10.1128/JVI.01608-10; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	76	7	7	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1405	+		10.1016/j.immuni.2021.06.001	http://dx.doi.org/10.1016/j.immuni.2021.06.001		JUL 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34216564	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000672812100008
J	Harker, JA; Lloyd, CM				Harker, James A.; Lloyd, Clare M.			Overlapping and distinct features of viral and allergen immunity in the human lung	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; BARRIER EPITHELIAL-CELLS; REGULATORY T-CELLS; TISSUE-RESIDENT; IFN-GAMMA; TYPE-2 INFLAMMATION; DENDRITIC CELLS; VIRUS-INFECTION; ASTHMA; MEMORY	Immunity in the human respiratory tract is provided by a diverse range of tissue-resident cells, including specialized epithelial and macrophage populations and a network of innate and innate-like lymphocytes, such as natural killer cells, innate lymphoid cells, and invariant T cells. Lung-resident memory T and B cells contribute to this network following initial exposure to antigenic stimuli. This review explores how advances in the study of human immunology have shaped our understanding of this resident immune network and its response to two of the most commonly encountered inflammatory stimuli in the airways: viruses and allergens. It discusses the many ways in which pathogenic infection and allergic inflammation mirror each other, highlighting the key checkpoints at which they diverge and how this can result in a lifetime of allergic exacerbation versus protective anti-viral immunity.	[Harker, James A.; Lloyd, Clare M.] Imperial Coll London, Natl Heart & Lung Inst, London SW7 2AZ, England	Imperial College London	Lloyd, CM (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London SW7 2AZ, England.	c.lloyd@imperial.ac.uk		Lloyd, Clare/0000-0001-8977-6726	 [107059/z/15/z]		C.M.L. is a Wellcome Senior Fellow in Basic Biomedical Sciences (107059/z/15/z). The figures were created with Biorender.com.	Abolins S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14811; Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Arellano-Orden E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152737; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bosnjak B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00840; Bosteels C, 2020, IMMUNITY, V52, P1039, DOI 10.1016/j.immuni.2020.04.005; Boyd DF, 2020, NATURE, V587, P466, DOI 10.1038/s41586-020-2877-5; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Byrne AJ, 2015, THORAX, V70, P1189, DOI 10.1136/thoraxjnl-2015-207020; Byrneee AJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20191236; Califano D, 2018, MUCOSAL IMMUNOL, V11, P209, DOI 10.1038/mi.2017.41; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Canete PF, 2019, J EXP MED, V216, P1843, DOI 10.1084/jem.20190493; Castanhinha S, 2015, J ALLERGY CLIN IMMUN, V136, P312, DOI 10.1016/j.jaci.2015.01.016; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chandra S, 2018, J IMMUNOL, V200, P1995, DOI 10.4049/jimmunol.1701525; Chen SS, 2019, AM J PHYSIOL-LUNG C, V316, pL280, DOI 10.1152/ajplung.00552.2017; Christianson CA, 2015, J ALLERGY CLIN IMMUN, V136, P59, DOI 10.1016/j.jaci.2014.11.037; Clement RL, 2019, NAT IMMUNOL, V20, P1360, DOI 10.1038/s41590-019-0472-4; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Custovic A, 2018, AM J RESP CRIT CARE, V197, P1265, DOI 10.1164/rccm.201708-1762OC; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; Deckers J, 2017, IMMUNOL REV, V278, P131, DOI 10.1111/imr.12542; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Deprez M, 2020, AM J RESP CRIT CARE, V202, P1636, DOI 10.1164/rccm.201911-2199OC; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Elliot JG, 2004, AM J RESP CRIT CARE, V169, P712, DOI 10.1164/rccm.200308-1167OC; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Filbin Michael R, 2020, bioRxiv, DOI 10.1101/2020.11.02.365536; Forbester JL, 2021, MUCOSAL IMMUNOL, V14, P14, DOI 10.1038/s41385-020-00355-6; Forero A, 2019, IMMUNITY, V51, P451, DOI 10.1016/j.immuni.2019.07.007; Foster WS, 2020, ALLERGY, V75, P1240, DOI 10.1111/all.14150; Froidure A, 2016, EUR RESPIR J, V47, P304, DOI 10.1183/13993003.01824-2014; Gandhi VD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00147; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gauvreau GM, 2015, EUR RESPIR J, V46, DOI [10.1183/13993003.congress-2015.PA5091, 10.1183/13993003.00536-2015]; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Gisby J, 2021, ELIFE, V10, DOI 10.7554/eLife.64827; Gould VMW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00900; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Guia S, 2020, TRENDS IMMUNOL, V41, P436, DOI 10.1016/j.it.2020.03.002; Guo XZJ, 2018, IMMUNITY, V49, P531, DOI 10.1016/j.immuni.2018.07.011; Guvenel A, 2020, J CLIN INVEST, V130, P523, DOI 10.1172/JCI131696; Habibi MS, 2020, SCIENCE, V370, P188, DOI 10.1126/science.aba9301; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Han MY, 2017, AM J RESP CELL MOL, V56, P242, DOI 10.1165/rcmb.2016-0056OC; Hanf G, 2004, EUR RESPIR J, V23, P414, DOI 10.1183/09031936.04.00024504; Hansel TT, 2017, EBIOMEDICINE, V19, P128, DOI 10.1016/j.ebiom.2017.03.033; Harker JA, 2014, J VIROL, V88, P604, DOI 10.1128/JVI.02620-13; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hinks TSC, 2019, CELL REP, V28, P3249, DOI 10.1016/j.celrep.2019.07.039; Hinks TSC, 2015, J ALLERGY CLIN IMMUN, V136, P323, DOI 10.1016/j.jaci.2015.01.014; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Ichikawa T, 2019, NAT IMMUNOL, V20, P1469, DOI 10.1038/s41590-019-0494-y; Invernizzi R, 2020, IMMUNOLOGY, V160, P171, DOI 10.1111/imm.13195; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Iwamura C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01942; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Josset L, 2014, MBIO, V5, DOI 10.1128/mBio.01102-13; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224; Kariyawasam HH, 2007, AM J RESP CRIT CARE, V175, P896, DOI 10.1164/rccm.200609-1260OC; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Kerrin A, 2017, THORAX, V72, P620, DOI 10.1136/thoraxjnl-2015-207358; Kinoshita T, 2014, J ALLERGY CLIN IMMUN, V133, P696, DOI 10.1016/j.jaci.2013.08.025; Klinkhammer J, 2018, ELIFE, V7, DOI 10.7554/eLife.33354; Kobayashi T, 2017, J ALLERGY CLIN IMMUN, V139, P300, DOI 10.1016/j.jaci.2016.04.021; Koutsakos M, 2019, NAT IMMUNOL, V20, P613, DOI 10.1038/s41590-019-0320-6; Krammer F, 2019, NAT REV IMMUNOL, V19, P383, DOI 10.1038/s41577-019-0143-6; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lee AH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08794-x; Legoux F, 2020, IMMUNITY, V53, P710, DOI 10.1016/j.immuni.2020.09.009; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Lim HK, 2019, J EXP MED, V216, P2038, DOI 10.1084/jem.20181621; Lin YP, 2018, MOL CELL, V70, P228, DOI 10.1016/j.molcel.2018.03.025; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Loh ZX, 2020, PLOS PATHOG, V16, DOI [10.1371/journal.ppat.1008651, 10.1371/journal.ppat.1008651.r001, 10.1371/journal.ppat.1008651.r002, 10.1371/journal.ppat.1008651.r003, 10.1371/journal.ppat.1008651.r004]; Lourenco O, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00638; Garcia-Garcia ML, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006787; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197; Marquardt N, 2017, J ALLERGY CLIN IMMUN, V139, P1321, DOI 10.1016/j.jaci.2016.07.043; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Matusali G, 2012, J ALLERGY CLIN IMMUN, V130, P1003, DOI 10.1016/j.jaci.2012.07.004; Maucourant C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6832; Menachery VD, 2014, MBIO, V5, DOI 10.1128/mBio.01174-14; Minutti CM, 2017, IMMUNITY, V47, P710, DOI 10.1016/j.immuni.2017.09.013; Monk PD, 2021, LANCET RESP MED, V9, P196, DOI 10.1016/S2213-2600(20)30511-7; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Morimoto Y, 2018, IMMUNITY, V49, P134, DOI 10.1016/j.immuni.2018.04.023; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Muehling LM, 2020, J ALLERGY CLIN IMMUN, V146, P555, DOI 10.1016/j.jaci.2020.03.037; Nagakumar P, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01809-2018; Nagakumar P, 2016, J ALLERGY CLIN IMMUN, V137, P624, DOI 10.1016/j.jaci.2015.06.038; Oja AE, 2018, MUCOSAL IMMUNOL, V11, P654, DOI 10.1038/mi.2017.94; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Perez GF, 2014, EUR RESPIR J, V44, P1075, DOI 10.1183/09031936.00049214; Perkins TN, 2021, ALLERGY, V76, P1350, DOI 10.1111/all.14600; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Provine NM, 2020, ANNU REV IMMUNOL, V38, P203, DOI 10.1146/annurev-immunol-080719-015428; Puttur F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7638; Rahimi R, 2020, J EXP MED, V217, DOI 10.1084/jem.20190865; Ramos I, 2019, J VIROL, V93, DOI 10.1128/JVI.00559-19; Ravanetti L, 2019, J ALLERGY CLIN IMMUN, V143, P1355, DOI 10.1016/j.jaci.2018.08.051; Rendeiro A.F., 2020, SPATIO TEMPORAL LAND, DOI [10.1101/202010.26.20219584, DOI 10.1101/202010.26.20219584]; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; Saravia J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005217; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Scharenberg M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01116; Schiller HB, 2019, AM J RESP CELL MOL, V61, P31, DOI 10.1165/rcmb.2018-0416TR; Schoettler N, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0657-2; Schroder PC, 2016, PEDIAT ALLERG IMM-UK, V27, P687, DOI 10.1111/pai.12597; Seumois G, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba6087; Smole U, 2020, NAT IMMUNOL, V21, P756, DOI 10.1038/s41590-020-0698-1; Szabo Peter A, 2020, medRxiv, DOI 10.1101/2020.10.15.20208041; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Thwaites RS, 2018, AM J RESP CRIT CARE, V198, P1074, DOI 10.1164/rccm.201712-2567OC; Tibbitt CA, 2019, IMMUNITY, V51, P169, DOI 10.1016/j.immuni.2019.05.014; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Turner DL, 2018, J IMMUNOL, V200, P1561, DOI 10.4049/jimmunol.1700257; Ural BB, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax8756; Uwadiae FI, 2019, ALLERGY, V74, P650, DOI 10.1111/all.13602; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; van de Ven K, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01278-5; van Wilgenburg B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07207-9; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Vanderheiden A, 2020, J VIROL, V94, DOI 10.1128/JVI.00985-20; Varricchi G, 2016, ALLERGY, V71, P1086, DOI 10.1111/all.12878; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Vu LD, 2019, AM J RESP CRIT CARE, V200, P1414, DOI 10.1164/rccm.201812-2366OC; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wong MT, 2016, IMMUNITY, V45, P442, DOI 10.1016/j.immuni.2016.07.007; Ye LY, 2020, J ALLERGY CLIN IMMUN, V145, P1469, DOI 10.1016/j.jaci.2019.12.891; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	163	7	7	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					617	631		10.1016/j.immuni.2021.03.010	http://dx.doi.org/10.1016/j.immuni.2021.03.010		APR 2021	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33852829	Bronze			2022-12-18	WOS:000640102800006
J	Burzynski, LC; Clarke, MCH				Burzynski, Laura C.; Clarke, Murray C. H.			Death Is Coming and the Clot Thickens, as Pyroptosis Feeds the Fire	IMMUNITY			English	Editorial Material							MECHANISM	Pyroptotic cell death during endotoxemia causes death via unknown mechanisms. In this issue of Immunity, Wu et al. (2019) show that T3SS rod proteins or LPS induces inflammasome activation, macrophage pyroptosis, and accompanying tissue factor release, directly connecting inflammation to coagulation.	[Burzynski, Laura C.; Clarke, Murray C. H.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Cardiovasc Med, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Clarke, MCH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Cardiovasc Med, Cambridge CB2 0QQ, England.	mchc2@cam.ac.uk			British Heart Foundation [FS/13/3/30038, FS/18/19/33371, RG/16/8/32388, RE/13/6/30180]; Cambridge NIHR Biomedical Research Centre	British Heart Foundation(British Heart Foundation); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was funded by British Heart Foundation grants FS/13/3/30038, FS/18/19/33371, and RG/16/8/32388 to M.C.H.C., the BHF Cambridge Centre for Research Excellence RE/13/6/30180, and the Cambridge NIHR Biomedical Research Centre.	Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Burzynski LC, 2019, IMMUNITY, V50, P1033, DOI 10.1016/j.immuni.2019.03.003; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; DUNN DL, 1982, SURGERY, V92, P513; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Wu CQ, 2019, IMMUNITY, V50, P1401, DOI 10.1016/j.immuni.2019.04.003	8	7	8	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1339	1341		10.1016/j.immuni.2019.05.015	http://dx.doi.org/10.1016/j.immuni.2019.05.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216455	Bronze, Green Submitted			2022-12-18	WOS:000471876100003
J	Papayannopoulos, V				Papayannopoulos, Venizelos			Neutrophils Stepping Through (to the Other Side)	IMMUNITY			English	Editorial Material							RECRUITMENT; MICE	The neutrophil's journey through the vascular wall constitutes a critical step during inflammation. In this issue of Immunity, Girbl et al. (2018) demonstrate that neutrophil extravasation is mediated by sequential and compartmentalized chemokine action, endowing unexpected specificity to promiscuous chemokine receptors.	[Papayannopoulos, Venizelos] Francis Crick Inst, London, England	Francis Crick Institute	Papayannopoulos, V (corresponding author), Francis Crick Inst, London, England.	veni.p@crick.ac.uk		Papayannopoulos, Venizelos/0000-0002-3741-8190				Bogoslowski A, 2018, P NATL ACAD SCI USA, V115, P2449, DOI 10.1073/pnas.1715756115; Del Prete A, 2017, BLOOD, V130, P1223, DOI 10.1182/blood-2017-04-777680; Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413; Girbl T, 2018, IMMUNITY, V49, P1062, DOI 10.1016/j.immuni.2018.09.018; Li JL, 2016, J INVEST DERMATOL, V136, P416, DOI 10.1038/JID.2015.410; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Ramos CDL, 2006, EUR J IMMUNOL, V36, P2025, DOI 10.1002/eji.200636057; Thiriot A, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0381-7; Wan WZ, 2015, CARDIOVASC RES, V106, P478, DOI 10.1093/cvr/cvv124; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690	10	7	7	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					992	994		10.1016/j.immuni.2018.12.006	http://dx.doi.org/10.1016/j.immuni.2018.12.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566887	Bronze			2022-12-18	WOS:000453556500003
J	Feltham, R; Vince, JE				Feltham, Rebecca; Vince, James E.			Ion Man: GSDMD Punches Pores to Knock Out cGAS	IMMUNITY			English	Editorial Material							DNA	The pore-forming protein GSDMD promotes cytokine release and induces pyroptotic cell death. In this issue of Immunity, Banerjee et al. (2018) document how GSDMD triggers potassium efflux to inhibit cGAS-STING and prevent damaging interferon production after bacterial infection.	[Feltham, Rebecca; Vince, James E.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Feltham, Rebecca; Vince, James E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Feltham, R; Vince, JE (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Feltham, R; Vince, JE (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	feltham.r@wehi.edu.au; vince@wehi.edu.au		Feltham, Rebecca/0000-0001-8376-6869				Banerjee I, 2018, IMMUNITY, V49, P413, DOI 10.1016/j.immuni.2018.07.006; Corrales L, 2016, J IMMUNOL, V196, P3191, DOI 10.4049/jimmunol.1502538; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Kambara H, 2018, CELL REP, V22, P2924, DOI 10.1016/j.celrep.2018.02.067; Monteleone M, 2018, CELL REP, V24, P1425, DOI 10.1016/j.celrep.2018.07.027; Seo GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02936-3; Swanson KV, 2017, J EXP MED, V214, P3611, DOI 10.1084/jem.20171749; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017; Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011; Zhu QF, 2018, CELL REP, V22, P3168, DOI 10.1016/j.celrep.2018.02.096	10	7	8	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					379	381		10.1016/j.immuni.2018.08.026	http://dx.doi.org/10.1016/j.immuni.2018.08.026			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30231975	Bronze			2022-12-18	WOS:000444909600002
J	Gefen, T; Geva-Zatorsky, N				Gefen, Tal; Geva-Zatorsky, Naama			What Came First: The Microbiota or the Tr(egg) Cells?	IMMUNITY			English	Editorial Material							HOMEOSTASIS; METABOLITES	Studies have shown that gut commensals facilitate the differentiation of peripheral regulatory T cells (pTregs) via their metabolic products. In this issue of Immunity, Campbell et al. (2018) demonstrate a reciprocal effect of pTregs on the metabolic functions of specific gut commensals that affects their overall energy harvest capacity.	[Gefen, Tal; Geva-Zatorsky, Naama] Technion Israel Inst Technol, Technion Integrated Canc Ctr, Fac Med, 1 Efron St Bat Galim, IL-3525433 Haifa, Israel	Technion Israel Institute of Technology	Geva-Zatorsky, N (corresponding author), Technion Israel Inst Technol, Technion Integrated Canc Ctr, Fac Med, 1 Efron St Bat Galim, IL-3525433 Haifa, Israel.	naama_gz@technion.ac.il	Geva-Zatorsky, Naama/AAP-9176-2021	Geva-Zatorsky, Naama/0000-0002-7303-854X				Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Oeser K, 2015, MUCOSAL IMMUNOL, V8, P672, DOI 10.1038/mi.2014.101; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Welch JLM, 2016, P NATL ACAD SCI USA, V113, pE791, DOI 10.1073/pnas.1522149113	9	7	8	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1072	1074		10.1016/j.immuni.2018.06.005	http://dx.doi.org/10.1016/j.immuni.2018.06.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924971	Bronze			2022-12-18	WOS:000436456900006
J	Novakovic, B; Stunnenberg, HG				Novakovic, Boris; Stunnenberg, Hendrik G.			I Remember You: Epigenetic Priming in Epithelial Stem Cells	IMMUNITY			English	Editorial Material								Exposure to inflammatory stimuli can remodel immune cells in a way that alters their response to future insults. In a landmark paper in Nature, Elaine Fuchs and colleagues show that memory of inflammation is not restricted to the hematopoietic lineage (Naik et al., 2017).	[Novakovic, Boris; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Novakovic, Boris; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Fac Sci, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Stunnenberg, HG (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands.; Stunnenberg, HG (corresponding author), Radboud Univ Nijmegen, Fac Sci, NL-6525 GA Nijmegen, Netherlands.	h.stunnenberg@science.ru.nl	Stunnenberg, Hendrik G./D-6875-2012; Novakovic, Boris/D-8018-2013	Stunnenberg, Hendrik G./0000-0002-0066-1576; Novakovic, Boris/0000-0002-5623-9008	ZonMW TOP grant [91216061]; NWO ALW grant [ALWOP.2015.101]; NHMRC (Australia) CJ Martin Fellowship	ZonMW TOP grant; NWO ALW grant; NHMRC (Australia) CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a ZonMW TOP grant (nr. 91216061) and NWO ALW grant (ALWOP.2015.101). B.N. is supported by a NHMRC (Australia) CJ Martin Fellowship.	Atlasi Y, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.57; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Novakovic B, 2016, CELL, V167, P1354, DOI 10.1016/j.cell.2016.09.034; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086	10	7	7	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1019	1021		10.1016/j.immuni.2017.12.005	http://dx.doi.org/10.1016/j.immuni.2017.12.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262345	Bronze			2022-12-18	WOS:000418486500007
J	Wang, S; Xia, PY; Fan, ZS				Wang, Shuo; Xia, Pengyan; Fan, Zusen			Natural-Killer-like B Cells Function as a Separate Subset of Innate B Cells	IMMUNITY			English	Letter							LYMPHOCYTES		[Wang, Shuo; Xia, Pengyan; Fan, Zusen] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China; [Fan, Zusen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, S; Fan, ZS (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China.; Fan, ZS (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wangshuo@moon.ibp.ac.cn; fanz@moon.ibp.ac.cn						Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Wang S, 2016, IMMUNITY, V45, P131, DOI 10.1016/j.immuni.2016.06.019	3	7	8	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					201	202		10.1016/j.immuni.2017.07.023	http://dx.doi.org/10.1016/j.immuni.2017.07.023			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813648	Bronze			2022-12-18	WOS:000407788300002
J	Zhao, JJE; Sun, LL; Li, XX				Zhao, Junjie; Sun, Lillian; Li, Xiaoxia			Commanding CNS Invasion: GM-CSF	IMMUNITY			English	Editorial Material							T-CELLS; PATHOGENESIS; DRIVES	Granulocyte-macrophage colony-stimulating factor (GM-CSF or Csf-2) is a pro-inflammatory mediator implicated in the pathogenesis of various autoimmune diseases. In this issue of Immunity, Spath et al. (2017) show that the dysregulated production of GM-CSF rather than IL-17 induces spontaneous immunopathology in a mouse model of CNS inflammation.	[Zhao, Junjie; Li, Xiaoxia] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA; [Sun, Lillian] Case Western Reserve Univ, Cleveland Clin, Sch Med, Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA.	lix@ccf.org	Zhao, Junjie/AAH-1152-2021	Sun, Lillian/0000-0001-7890-4489	NHLBI NIH HHS [P01 HL029582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Ransohoff RM, 2009, NATURE, V462, P41, DOI 10.1038/462041a; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007	10	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					165	167		10.1016/j.immuni.2017.02.003	http://dx.doi.org/10.1016/j.immuni.2017.02.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228272	Green Accepted, Bronze			2022-12-18	WOS:000396410900002
J	Kim, KW; Zhang, N; Choi, K; Randolph, GJ				Kim, Ki-Wook; Zhang, Nan; Choi, Kyunghee; Randolph, Gwendalyn J.			Homegrown Macrophages	IMMUNITY			English	Editorial Material							TISSUE-RESIDENT MACROPHAGES; HEMATOPOIETIC STEM-CELLS; MONOCYTES	Macrophages residing in different organs have diverse gene-expression programs. Mass et al. (2016) propose that this diversity develops ''at home''-within those organs-after the recruitment of a common precursor that had not made prior commitments to diversity.	[Kim, Ki-Wook; Zhang, Nan; Choi, Kyunghee; Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63105 USA	Washington University (WUSTL)	Randolph, GJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63105 USA.	grandolph@path.wustl.edu		/0000-0002-7207-4389; Zhang, Nan/0000-0002-6736-2781	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063736] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063736] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	9	7	7	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					468	470		10.1016/j.immuni.2016.09.006	http://dx.doi.org/10.1016/j.immuni.2016.09.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27653599	Bronze			2022-12-18	WOS:000388454300006
J	Balmer, ML; Hess, C				Balmer, Maria L.; Hess, Christoph			Feeling Worn Out? PGC1 alpha to the Rescue for Dysfunctional Mitochondria in T Cell Exhaustion	IMMUNITY			English	Editorial Material								In chronic viral infections and cancer, T cells acquire a functional state characterized by reduced effector functionality, termed exhaustion. In two related studies by Scharping et al. (2016) and Bengsch et al. (2016) in this issue of Immunity, dysfunctional mitochondria are identified as a key correlate of CD8(+) T cell exhaustion.	[Balmer, Maria L.; Hess, Christoph] Univ Basel, Dept Biomed, Immunobiol, CH-4031 Basel, Switzerland; [Balmer, Maria L.; Hess, Christoph] Univ Basel Hosp, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Hess, C (corresponding author), Univ Basel, Dept Biomed, Immunobiol, CH-4031 Basel, Switzerland.; Hess, C (corresponding author), Univ Basel Hosp, CH-4031 Basel, Switzerland.	chess@uhbs.ch	Balmer, Maria L/A-8546-2013; Balmer, Maria Luisa/AAB-8993-2021	Balmer, Maria Luisa/0000-0003-0356-6352				Assmann N, 2016, J CLIN INVEST, V126, P2031, DOI 10.1172/JCI83005; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862	8	7	7	2	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					233	235		10.1016/j.immuni.2016.07.024	http://dx.doi.org/10.1016/j.immuni.2016.07.024			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533009	Bronze			2022-12-18	WOS:000382267300005
J	Corcoran, LM; Nutt, SL				Corcoran, Lynn M.; Nutt, Stephen L.			Long-Lived Plasma Cells Have a Sweet Tooth	IMMUNITY			English	Editorial Material							BONE-MARROW; SURVIVAL	Long-lived plasma cells (LLPCs) are durable antibody-producing cells that are key to immunity. Bhattacharya and colleagues find that LLPCs derive their enhanced survival capacity from a higher rate of glucose import. Some of this glucose sustains the cells through glycolysis, while the bulk is required for antibody glycosylation.	[Corcoran, Lynn M.; Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Parkville, Vic 3052, Australia; [Corcoran, Lynn M.; Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne	Corcoran, LM (corresponding author), Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Parkville, Vic 3052, Australia.; Corcoran, LM (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.	corcoran@wehi.edu.au	Nutt, Stephen/C-9256-2013	Nutt, Stephen/0000-0002-0020-6637				Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440	10	7	7	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					3	5		10.1016/j.immuni.2016.07.003	http://dx.doi.org/10.1016/j.immuni.2016.07.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438759	Bronze			2022-12-18	WOS:000380749000002
J	Kolb, JP; Martinez, J				Kolb, Joseph P.; Martinez, Jennifer			Bon EPOtit! S1P-Mediated EPO Signaling Whets a Macrophage's Appetite for Apoptotic Cells	IMMUNITY			English	Editorial Material							ERYTHROPOIETIN; CLEARANCE	Phagocytes clear dying cells within an organism to prevent damaging inflammation and autoimmunity. In this issue of Immunity, Luo et al. (2016) describe how "find-me'' signals from apoptotic cells induce erythropoietin signaling within macrophages to prime them for efferocytosis.	[Kolb, Joseph P.; Martinez, Jennifer] NIEHS, Immun Inflammat & Dis Lab, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Martinez, J (corresponding author), NIEHS, Immun Inflammat & Dis Lab, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	jennifer.martinez3@nih.gov	Martinez, Jennifer/C-3740-2019	Martinez, Jennifer/0000-0002-3060-2518; Kolb, Joseph/0000-0001-5945-9404	Intramural NIH HHS [ZIA ES103286-01, ZIA ES103286-02] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103286] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Luo BW, 2016, IMMUNITY, V44, P287, DOI 10.1016/j.immuni.2016.01.002; Luo BW, 2013, BBA-MOL BASIS DIS, V1832, P1260, DOI 10.1016/j.bbadis.2013.04.015; Martinez J., 2015, CURRENT TOPICS MICRO, P1; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607	9	7	7	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					209	211		10.1016/j.immuni.2016.01.023	http://dx.doi.org/10.1016/j.immuni.2016.01.023			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885850	Green Accepted, Bronze			2022-12-18	WOS:000370294000002
J	Guilliams, M; Malissen, B				Guilliams, Martin; Malissen, Bernard			A Matter of Perspective: Moving from a Pre-omic to a Systems-Biology Vantage of Monocyte-Derived Cell Function and Nomenclature	IMMUNITY			English	Letter							MACROPHAGES; REVEALS		[Guilliams, Martin] VIB Inflammat Res Ctr, Lab Immunoregulat, B-9052 Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Malissen, Bernard] Aix Marseille Univ, UM2, INSERM, Ctr Immunol Marseille Luminy,U1104,CNRS,UMR7280, F-13288 Marseille, France	Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier	Guilliams, M (corresponding author), VIB Inflammat Res Ctr, Lab Immunoregulat, B-9052 Ghent, Belgium.	martin.guilliams@irc.ugent.be; bernardm@ciml.univ-mrs.fr	Guilliams, Martin/N-7803-2013; Malissen, Bernard/AAK-4659-2020	Guilliams, Martin/0000-0003-3525-7570; Malissen, Bernard/0000-0003-1340-9342				Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Guilliams M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00406; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	10	7	7	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					5	6		10.1016/j.immuni.2015.12.020	http://dx.doi.org/10.1016/j.immuni.2015.12.020			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789914	Bronze			2022-12-18	WOS:000368347000003
J	Bedoui, S; Heath, WR				Bedoui, Sammy; Heath, William R.			Kruppel-ling of IRF4-Dependent DCs into Two Functionally Distinct DC Subsets	IMMUNITY			English	Editorial Material							DERMAL DENDRITIC CELLS; RESPONSES; DIFFERENTIATION; IMMUNITY	IRF4-dependent DCs have been associated with induction of both Th1 and Th17 cells. In this issue of Immunity, Tussiwand et al. (2015) demonstrate that a dependence on KLF4 identifies a subset of IRF4-dependent DC that preferentially promotes Th2 cell differentiation.	[Bedoui, Sammy; Heath, William R.] Univ Melbourne, Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia	University of Melbourne	Bedoui, S (corresponding author), Univ Melbourne, Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	sbedoui@unimelb.edu.au		Heath, William/0000-0001-9670-259X; BEDOUI, SAMMY/0000-0002-7443-0543				Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017	9	7	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					785	787		10.1016/j.immuni.2015.04.020	http://dx.doi.org/10.1016/j.immuni.2015.04.020			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992853	Bronze			2022-12-18	WOS:000354827400004
J	Tracey, KJ				Tracey, Kevin J.			Hypertension: An Immune Disorder?	IMMUNITY			English	Editorial Material							CELLS; NERVE; TNF	T cell depletion can prevent hypertension in experimental animals. What is the nature of T cell activation in hypertension? In this issue of Immunity, Carnevale et al. (2014) implicate PlGF signaling in a reservoir of splenic T cells.	Feinstein Inst, Manhasset, NY 11030 USA	Northwell Health	Tracey, KJ (corresponding author), Feinstein Inst, Manhasset, NY 11030 USA.	kjtracey@nshs.edu		Tracey, Kevin J/0000-0003-1884-6314	NIGMS NIH HHS [R01 GM057226] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Carnevale D, 2014, IMMUNITY, V41, P737, DOI 10.1016/j.immuni.2014.11.002; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; OKUDA T, 1967, TEX REP BIOL MED, V25, P257; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0	7	7	7	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					673	674		10.1016/j.immuni.2014.11.007	http://dx.doi.org/10.1016/j.immuni.2014.11.007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517606	Bronze			2022-12-18	WOS:000345504900002
J	Weinberg, SE; Chandel, NS				Weinberg, Samuel E.; Chandel, Navdeep S.			Futility Sustains Memory T Cells	IMMUNITY			English	Editorial Material							ACTIVATION; REGULATOR	Memory T cells display a distinct metabolic profile compared to effector T cells. In this issue of Immunity, O'Sullivan et al. (2014) report that memory T cells activate a "futile cycle'' of de novo fatty-acid synthesis and concurrent fatty-acid oxidation to generate ATP for cell survival.	[Weinberg, Samuel E.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	nav@northwestern.edu	Weinberg, Sam/ABD-5721-2021	Weinberg, Sam/0000-0002-9532-7051	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, T32HL076139] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL076139, P01 HL071643] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021	10	7	7	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					1	3		10.1016/j.immuni.2014.06.009	http://dx.doi.org/10.1016/j.immuni.2014.06.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035944	Bronze, Green Accepted			2022-12-18	WOS:000341444200001
J	Merkenschlager, M				Merkenschlager, Matthias			Jarid2 Links MicroRNA and Chromatin in Th17 Cells	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; PROTEIN	In this issue of Immunity, Escobar et al. (2014) bring microRNAs and chromatin together by showing how activation-induced miR-155 targets the chromatin protein Jarid2 to regulate proinflammatory cytokine production in T helper 17 cells.	Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England	Imperial College London	Merkenschlager, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	matthias.merkenschlager@csc.mrc.ac.uk		Merkenschlager, Matthias/0000-0003-2889-3288	MRC [MC_U120027516] Funding Source: UKRI; Medical Research Council [MC_U120027516] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bolisetty MT, 2009, J VIROL, V83, P12009, DOI 10.1128/JVI.01182-09; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012	10	7	8	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					855	856		10.1016/j.immuni.2014.06.004	http://dx.doi.org/10.1016/j.immuni.2014.06.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24950205	Bronze			2022-12-18	WOS:000341440200005
J	Sutherland, DB; Fagarasan, S				Sutherland, Duncan B.; Fagarasan, Sidonia			Gut Reactions: Eosinophils Add another String to Their Bow	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; HOMEOSTASIS	Eosinophils are found in abundance in the gut. In this issue of Immunity, Chu et al. (2014) report that eosinophil-deficient mice have impaired intestinal immunoglobulin A production, accompanied by a disrupted mucosal layer and alterations in microbiota density and composition.	[Sutherland, Duncan B.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lab Intestinal Immunol, CH-1015 Lausanne, Switzerland; [Fagarasan, Sidonia] RIKEN Yokohama Inst, Ctr Integrat Med Sci IMS RCAI, Lab Mucosal Immun, Yokohama, Kanagawa 2300045, Japan	Ecole Polytechnique Federale de Lausanne; RIKEN	Fagarasan, S (corresponding author), RIKEN Yokohama Inst, Ctr Integrat Med Sci IMS RCAI, Lab Mucosal Immun, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	sidonia-f@rcai.riken.jp	Fagarasan, Sidonia/A-5258-2016	Fagarasan, Sidonia/0000-0003-2086-6402				Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Kato LM, 2014, IMMUNOL CELL BIOL, V92, P49, DOI 10.1038/icb.2013.54; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	10	7	8	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					455	457		10.1016/j.immuni.2014.04.003	http://dx.doi.org/10.1016/j.immuni.2014.04.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745328	Bronze			2022-12-18	WOS:000334849400003
J	Borregaard, N				Borregaard, Niels			What Doesn't Kill You Makes You Stronger: The Anti-inflammatory Effect of Neutrophil Respiratory Burst	IMMUNITY			English	Editorial Material									Univ Copenhagen, Dept Hematol, Natl Univ Hosp, DK-2100 Copenhagen, Denmark	University of Copenhagen	Borregaard, N (corresponding author), Univ Copenhagen, Dept Hematol, Natl Univ Hosp, DK-2100 Copenhagen, Denmark.	borregaard@rh.dk						Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Harris ES, 2013, CURR OPIN HEMATOL, V20, P16, DOI 10.1097/MOH.0b013e32835a0091; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; Ramasundara M, 2009, J GASTROEN HEPATOL, V24, P202, DOI 10.1111/j.1440-1746.2008.05772.x; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Rosen H, 2002, J BIOL CHEM, V277, P30463, DOI 10.1074/jbc.M202331200; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; VOETMAN AA, 1981, J CLIN INVEST, V67, P1541, DOI 10.1172/JCI110185; Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273	10	7	7	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					1	2		10.1016/j.immuni.2013.12.003	http://dx.doi.org/10.1016/j.immuni.2013.12.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24439260	Bronze			2022-12-18	WOS:000331476900001
J	Wang, XH; Dong, C				Wang, Xiaohu; Dong, Chen			The CD70-CD27 Axis, a New Brake in the T Helper 17 Cell Response	IMMUNITY			English	Editorial Material							CD27-CD70 INTERACTIONS; BALANCE		[Wang, Xiaohu; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130	NIAMS NIH HHS [R01 AR050772] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Coquet JM, 2013, IMMUNITY, V38, P53, DOI 10.1016/j.immuni.2012.09.009; Francosalinas G., 2012, J NEUROIMMUNOL; Libregts S, 2011, IMMUNOL LETT, V136, P177, DOI 10.1016/j.imlet.2011.01.008; Nakajima A, 2000, J NEUROIMMUNOL, V109, P188, DOI 10.1016/S0165-5728(00)00324-6; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Nurieva RI, 2011, IMMUNOL REV, V241, P133, DOI 10.1111/j.1600-065X.2011.01012.x; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869	10	7	7	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 24	2013	38	1					1	3		10.1016/j.immuni.2013.01.005	http://dx.doi.org/10.1016/j.immuni.2013.01.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23352216	Green Accepted, Bronze			2022-12-18	WOS:000314195500001
J	Tang, C; Iwakura, Y				Tang, Ce; Iwakura, Yoichiro			IL-23 in Colitis: Targeting the Progenitors	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; INTESTINAL INFLAMMATION; INTERLEUKIN-23	Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract. In this issue of Immunity, Griseri et al. (2012) show that IL-23-induced dysregulation of hematopoietic stem and progenitor cells contributes to the pathogenesis of two IBD models.	[Tang, Ce; Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 2780022, Japan; [Tang, Ce; Iwakura, Yoichiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan	Tokyo University of Science; Japan Science & Technology Agency (JST)	Iwakura, Y (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Yamazaki 2669, Noda, Chiba 2780022, Japan.	iwakura@ims.u-tokyo.ac.jp	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775				Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kim MH, 2011, BLOOD, V117, P3343, DOI 10.1182/blood-2010-07-296970; Morrison PJ, 2011, IMMUNOLOGY, V133, P397, DOI 10.1111/j.1365-2567.2011.03454.x; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	9	7	7	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					957	959		10.1016/j.immuni.2012.11.010	http://dx.doi.org/10.1016/j.immuni.2012.11.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23244717	Bronze			2022-12-18	WOS:000312575000005
J	Geijtenbeek, TBH				Geijtenbeek, Teunis B. H.			Actin' as a Death Signal	IMMUNITY			English	Editorial Material							C-TYPE LECTIN; IMMUNE-RESPONSES; DENDRITIC CELLS; RECEPTOR; INNATE; CLEC9A	Cell death needs to be detected by immune cells. In this issue of Immunity, Ahrens et al. (2012) and Zhang et al. (2012) show that actin filaments become exposed on necrotic cells and act as ligands for the C-type lectin receptor Clec9a.	Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.b.geijtenbeek@amc.nl						Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Michelot A, 2011, CURR BIOL, V21, pR560, DOI 10.1016/j.cub.2011.06.019; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schreibelt G, 2012, BLOOD, V119, P2284, DOI 10.1182/blood-2011-08-373944; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	11	7	8	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 20	2012	36	4					557	559		10.1016/j.immuni.2012.04.004	http://dx.doi.org/10.1016/j.immuni.2012.04.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22520851	Bronze			2022-12-18	WOS:000303223900008
J	Obermann, HL; Bauer, S				Obermann, Hannah-Lena; Bauer, Stefan			Toll-like Receptor 9, What O'Clock Is It?	IMMUNITY			English	Editorial Material							IMMUNE-RESPONSES; CIRCADIAN CLOCK; LIGHT; TLR9	In this issue of Immunity, Silver et al. (2012) provide evidence that murine Toll-like receptor 9 (TLR9) expression and function in innate and adaptive immunity is controlled by the circadian cycle.	[Obermann, Hannah-Lena; Bauer, Stefan] Univ Marburg, Inst Immunol, BMFZ, D-235043 Marburg, Germany	Philipps University Marburg	Bauer, S (corresponding author), Univ Marburg, Inst Immunol, BMFZ, Hans Meerweinstr 2, D-235043 Marburg, Germany.	stefan.bauer@staff.uni-marburg.de		Bauer, Stefan/0000-0002-8462-1845				Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jurk M, 2007, BIODRUGS, V21, P387, DOI 10.2165/00063030-200721060-00006; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Roberts JE, 2000, ANN NY ACAD SCI, V917, P435; Roden LC, 2009, PLANT CELL, V21, P2546, DOI 10.1105/tpc.109.069922; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017	10	7	7	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					159	161		10.1016/j.immuni.2012.02.003	http://dx.doi.org/10.1016/j.immuni.2012.02.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22365660	Bronze			2022-12-18	WOS:000300812400003
J	Zhang, SL; Bhandoola, A				Zhang, Shirley L.; Bhandoola, Avinash			Losing TREC with Age	IMMUNITY			English	Editorial Material							NAIVE T-CELLS; PHENOTYPE; TURNOVER; MICE	In this issue of Immunity, den Braber et al. (2012) highlight differences in naive T cell lifespan between mice and humans. Their data suggest that mechanisms of naive T cell maintenance may differ between mice and men.	[Zhang, Shirley L.; Bhandoola, Avinash] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Bhandoola, A (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu	Zhang, Shirley/AAL-7187-2021	Zhang, Shirley/0000-0002-6672-2044	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059621] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL110741] Funding Source: Medline; NIAID NIH HHS [R01 AI059621] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dutilh BE, 2003, J THEOR BIOL, V224, P351, DOI 10.1016/S0022-5193(03)00172-3; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Legrand N, 2006, BLOOD, V108, P238, DOI 10.1182/blood-2006-01-0190; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105	10	7	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					163	165		10.1016/j.immuni.2012.02.005	http://dx.doi.org/10.1016/j.immuni.2012.02.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22365662	Green Accepted, Bronze			2022-12-18	WOS:000300812400005
J	Narni-Mancinelli, E; Vivier, E				Narni-Mancinelli, Emilie; Vivier, Eric			NK Cell Genesis: A Trick of the Trail	IMMUNITY			English	Editorial Material							NATURAL-KILLER-CELLS; MATURATION; RECEPTOR; LIVER	In this issue of Immunity, Gordon et al. (2012) analyzed the role of the transcription factors T-bet and Eomesodermin in natural killer (NK) cell development, revealing a distinct spatiotemporal requirement of these factors for NK cell maturation.	[Narni-Mancinelli, Emilie; Vivier, Eric] Aix Marseille Univ UM 631, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Narni-Mancinelli, Emilie; Vivier, Eric] INSERM, U1104, F-13288 Marseille, France; [Narni-Mancinelli, Emilie; Vivier, Eric] CNRS, UMR7280, F-13288 Marseille, France; [Vivier, Eric] Hop Conception, Assistance Publ Hop Marseille, F-13385 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vivier, E (corresponding author), Aix Marseille Univ UM 631, Ctr Immunol Marseille Luminy, Campus Luminy Case 906, F-13288 Marseille, France.	vivier@ciml.univ-mrs.fr	Narni-Mancinelli, Emilie/X-1888-2018; Vivier, Eric/F-8939-2010	Narni-Mancinelli, Emilie/0000-0002-7001-1026; Vivier, Eric/0000-0001-7022-8287				Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Martin-Fontecha A, 2011, CELL MOL LIFE SCI, V68, P3495, DOI 10.1007/s00018-011-0800-9; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523	10	7	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 27	2012	36	1					1	3		10.1016/j.immuni.2012.01.001	http://dx.doi.org/10.1016/j.immuni.2012.01.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22284412	Bronze			2022-12-18	WOS:000299766000001
J	Olson, JA; Jameson, SC				Olson, Janelle A.; Jameson, Stephen C.			Keeping STATs on Memory CD8(+) T Cells	IMMUNITY			English	Editorial Material							GENERATION; INFECTION	The CD8(+) T cell response is characterized by generation of a population of effector cells and establishment of a persistent memory pool. In this issue, Cui et al. (2011) and Siegel et al. (2011) show that cytokine receptor signaling through the transcription factor STAT3 establishes stable memory CD8(+) T cells.	[Olson, Janelle A.; Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146	NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009138] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Foulds KE, 2006, J IMMUNOL, V177, P2565, DOI 10.4049/jimmunol.177.4.2565; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Yi JS, 2010, J IMMUNOL, V185, P4835, DOI 10.4049/jimmunol.1001032; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	11	7	8	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					663	665		10.1016/j.immuni.2011.11.006	http://dx.doi.org/10.1016/j.immuni.2011.11.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118521	Bronze			2022-12-18	WOS:000297390800005
J	Sadler, AJ; Williams, BRG				Sadler, Anthony J.; Williams, Bryan R. G.			Dynamiting Viruses with MxA	IMMUNITY			English	Editorial Material							CRYSTAL-STRUCTURE; INFLUENZA; RESISTANCE; PROTEIN	The crystal structure of the interferon-induced member of the dynamin family MxA presented by Gao et al. (2011) in this issue of Immunity reveals the molecule's higher-order structure, thereby providing insight into the protein's antiviral action as a molecular machine.	[Sadler, Anthony J.; Williams, Bryan R. G.] Monash Univ, Ctr Canc Res, Monash Inst Med Res, Clayton, Vic 3168, Australia	Monash University	Williams, BRG (corresponding author), Monash Univ, Ctr Canc Res, Monash Inst Med Res, Clayton, Vic 3168, Australia.	bryan.williams@monash.edu	sadler, anthony/ABA-5572-2020; Williams, Bryan R. G./A-5021-2009	sadler, anthony/0000-0002-7970-8030; Williams, Bryan R. G./0000-0002-4969-1151				Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Hertzog P, 2011, J INTERF CYTOK RES, V31, P5, DOI 10.1089/jir.2010.0126; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; LINDENMANN J, 1962, VIROLOGY, V16, P203, DOI 10.1016/0042-6822(62)90297-0; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	10	7	8	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					491	493		10.1016/j.immuni.2011.10.005	http://dx.doi.org/10.1016/j.immuni.2011.10.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035841	Bronze			2022-12-18	WOS:000296657700006
J	Babich, A; Burkhardt, JK				Babich, Alexander; Burkhardt, Janis K.			Lymphocyte Signaling Converges on Microtubules	IMMUNITY			English	Editorial Material							T-CELL-ACTIVATION; IMMUNOLOGICAL SYNAPSE; CYTOSKELETON; ACTIN	Movement of immunoreceptor microclusters tunes lymphocyte activation, but the underlying mechanisms are incompletely understood. In this issue of Immunity, Schnyder et al. (2011) and Hashimoto-Tane et al. (2011) show that cytoplasmic dynein drives microcluster centralization along microtubules.	[Babich, Alexander; Burkhardt, Janis K.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Babich, Alexander; Burkhardt, Janis K.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Burkhardt, JK (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	jburkhar@mail.med.upenn.edu		Burkhardt, Janis/0000-0002-8176-1375				Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Lasserre R, 2010, FEBS LETT, V584, P4845, DOI 10.1016/j.febslet.2010.09.001; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Schnyder T, 2011, IMMUNITY, V34, P905, DOI 10.1016/j.immuni.2011.06.001; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0	11	7	7	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					825	827		10.1016/j.immuni.2011.06.004	http://dx.doi.org/10.1016/j.immuni.2011.06.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703536	Bronze			2022-12-18	WOS:000292349700003
J	Rudensky, AY; Chervonsky, AV				Rudensky, Alexander Y.; Chervonsky, Alexander V.			A Narrow Circle of Mutual Friends	IMMUNITY			English	Editorial Material							SYMBIOSIS	Commensal microbiota confers a goldilocks state of alertness to pathogens, yet restrains deleterious inflammation. In this issue of Immunity, Geuking et al. (2011) demonstrate that a minimal bacterial community of the Schaedler flora establishes a balance between pro- and anti-inflammatory T cells in the gut.	[Rudensky, Alexander Y.] Howard Hughes Med Inst, New York, NY 10021 USA; [Rudensky, Alexander Y.] Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA; [Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Chicago	Rudensky, AY (corresponding author), Howard Hughes Med Inst, New York, NY 10021 USA.	rudenska@mskcc.org; achervon@bsd.uchicago.edu		Chervonsky, Alexander/0000-0001-7547-871X				Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; ROUND JL, 2011, SCIENCE; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	10	7	7	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 27	2011	34	5					697	699		10.1016/j.immuni.2011.05.008	http://dx.doi.org/10.1016/j.immuni.2011.05.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21616440	Bronze			2022-12-18	WOS:000291456500008
J	Strober, W				Strober, Warren			The LTi Cell, an Immunologic Chameleon	IMMUNITY			English	Editorial Material							NATURAL-KILLER-CELLS; ROR-GAMMA-T; RECEPTOR	Lymphoid tissue inducer (LTi) cells are key components of the machinery required for the construction of the lymphoid structures underlying immune responses. In this issue of Immunity,, Vonarbourg et. al. (2010) describe how these cells assume several different guises, each associated with different LTi functions.	NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strober, W (corresponding author), NIAID, NIH, Bethesda, MD 20892 USA.	wstrober@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000354, ZIAAI000872] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000872-08] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017	9	7	7	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					650	652		10.1016/j.immuni.2010.11.016	http://dx.doi.org/10.1016/j.immuni.2010.11.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21094460	Bronze, Green Accepted			2022-12-18	WOS:000286082600003
J	Wu, L				Wu, Li			A Flt3L Encounter: mTOR Signaling in Dendritic Cells	IMMUNITY			English	Editorial Material							DIFFERENTIATION	The signaling pathway of the cytokine Flt3L in dendntic cells (DCs) is poorly defined In this issue of Immunity, Sathaliyawala et al (2010) report that the kinase mTOR functions as a mediator of Flt3L signaling in the development and homeostasis of DCs, particularly of the CD8(+) and CD103(+) DCs	[Wu, Li] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia; [Wu, Li] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Walter & Eliza Hall Institute; Tsinghua University	Wu, L (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia.							Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002	10	7	7	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 29	2010	33	4					580	582		10.1016/j.immuni.2010.10.001	http://dx.doi.org/10.1016/j.immuni.2010.10.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029968	Bronze			2022-12-18	WOS:000284300200014
J	Paley, MA; Wherry, EJ				Paley, Michael A.; Wherry, E. John			TCF-1 Flips the Switch on Eomes	IMMUNITY			English	Editorial Material							CELL FATES; T-BET; MEMORY; EFFECTOR	The interaction between different transcriptional pathways in CD8(+) T cell memory remains incompletely understood. In this issue, Zhou et al. (2010) demonstrate an important role for T cell factor 1 in regulating CD8(+) T cell memory via control of a second transcription factor, Eomesodermin.	[Paley, Michael A.; Wherry, E. John] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Paley, Michael A.; Wherry, E. John] Univ Penn, Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wherry, EJ (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020	Paley, Michael/0000-0001-8724-3176				Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	10	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					145	147		10.1016/j.immuni.2010.08.008	http://dx.doi.org/10.1016/j.immuni.2010.08.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20732636	Bronze			2022-12-18	WOS:000281654900003
J	Hayward, AP; Dinesh-Kumar, SP				Hayward, Andrew P.; Dinesh-Kumar, S. P.			Special Delivery for MHC II via Autophagy	IMMUNITY			English	Editorial Material							ADAPTIVE IMMUNITY; MACROPHAGES; MOLECULES; PATHWAY; INNATE	In this issue of Immunity, Blanchet et al. (2010) report that human immunodeficiency virus-1 inhibits macro-autophagy in dendritic cells, attenuating MHC II presentation. Lee et al. (2010) previously revealed the requirement of autophagic machinery for MHC II presentation of herpes viral antigens.	[Dinesh-Kumar, S. P.] Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA; [Hayward, Andrew P.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Dinesh-Kumar, S. P.] Univ Calif Davis, Coll Biol Sci, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; Yale University; University of California System; University of California Davis	Dinesh-Kumar, SP (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA.	spdineshkumar@ucdavis.edu	Dinesh-Kumar, Savithramma/E-1153-2011					Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018	10	7	7	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 28	2010	32	5					587	590		10.1016/j.immuni.2010.04.015	http://dx.doi.org/10.1016/j.immuni.2010.04.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20510868	Bronze			2022-12-18	WOS:000278280500004
J	Brownlie, R; Zamoyska, R				Brownlie, Rebecca; Zamoyska, Rose			LAT Polices T Cell Activation	IMMUNITY			English	Editorial Material							INHIBITORY FUNCTION; TOLERANCE; ZAP-70	Mutations in the adaptor molecule LAT can lead to autoimmunity. In this issue of Immunity, Mingueneau et al. (2009) describe how this may not be a failure of central tolerance.	[Brownlie, Rebecca; Zamoyska, Rose] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Zamoyska, R (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	rose.zamoyska@ed.ac.uk		Mingueneau, Michael/0000-0002-3873-7329; Zamoyska, Rose/0000-0001-9816-2638; Brownlie, Rebecca/0000-0003-4897-1044				Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Malissen B, 2005, ADV IMMUNOL, V87, P1, DOI 10.1016/S0065-2776(05)87001-4; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Yamasaki S, 2003, MOL CELL BIOL, V23, P2515, DOI 10.1128/MCB.23.7.2515-2529.2003; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	10	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					174	176		10.1016/j.immuni.2009.08.002	http://dx.doi.org/10.1016/j.immuni.2009.08.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19699166	Bronze			2022-12-18	WOS:000269338600002
J	Altman, A; Becart, S				Altman, Amnon; Becart, Stephane			Does Def6 Deficiency Cause Autoimmunity?	IMMUNITY			English	Letter							TRANSCRIPTION FACTOR; PROTEIN; CELLS		[Altman, Amnon; Becart, Stephane] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	amnon@liai.org						Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007	10	7	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 17	2009	31	1					1	2		10.1016/j.immuni.2009.06.013	http://dx.doi.org/10.1016/j.immuni.2009.06.013			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604483	Bronze			2022-12-18	WOS:000268219900001
J	Deretic, V				Deretic, Vojo			Strange Bedfellows Expose Ancient Secrets of Autophagy in Immunity	IMMUNITY			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; RECOGNITION	Autophagy has many roles in immunity, including the control of intracellular microbes by a cell-autonomous mechanism. In this issue of Immunity, Shelly et al. (2009) use VSV infection in Drosophila to show the role of autophagy genes in controlling viruses.	Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Deretic, V (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, 915 Camino Salud,NE, Albuquerque, NM 87131 USA.	vderetic@salud.unm.edu		Deretic, Vojo/0000-0002-3624-5208	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069345, R01AI042999, R01AI045148] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045148-11, R37 AI042999, R01 AI042999, R01 AI045148, R01 AI042999-12, R01 AI069345-03, R01 AI069345] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	10	7	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 17	2009	30	4					479	481		10.1016/j.immuni.2009.03.005	http://dx.doi.org/10.1016/j.immuni.2009.03.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19371713	Bronze, Green Accepted			2022-12-18	WOS:000265319000005
J	Finberg, RW; Wang, JP				Finberg, Robert W.; Wang, Jennifer P.			Antiviral Responses: Different Roles for Different Tolls	IMMUNITY			English	Editorial Material							LETHAL ENCEPHALITIS; VIRUS-INFECTION; MYD88; ACTIVATION		[Finberg, Robert W.; Wang, Jennifer P.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Finberg, RW (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.	robert.finberg@umassmed.edu		wang, jennifer/0000-0002-2556-9100				Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Zhou SH, 2005, EUR J IMMUNOL, V35, P822, DOI 10.1002/eji.200425730; Zhou S, 2008, J NEUROIMMUNOL, V194, P70, DOI 10.1016/j.jneuroim.2007.11.018; Zhou SH, 2007, J IMMUNOL, V178, P5173, DOI 10.4049/jimmunol.178.8.5173; Zhou SH, 2009, J VIROL, V83, P1625, DOI 10.1128/JVI.01770-08	10	7	7	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 20	2009	30	2					173	175		10.1016/j.immuni.2009.02.001	http://dx.doi.org/10.1016/j.immuni.2009.02.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19239899	Bronze			2022-12-18	WOS:000263710500003
J	Nurieva, RI; Dong, C				Nurieva, Roza I.; Dong, Chen			Keeping Autoimmunity in Check: How to Control a Th17 Cell Controller	IMMUNITY			English	Editorial Material							FOLLICULAR-HELPER-CELLS; T-CELLS; GENERATION; INTERLEUKIN-21; LEADS	The transcription factor IRF-4 is necessary for Th17 cell differentiation. In this issue of Immunity, Chen et al. (2008) show that IRF-4-binding protein is a critical negative regulator of IRF-4 function, regulating production of the cytokines IL-21 and IL-17.	[Nurieva, Roza I.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130				Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Dong C, 2003, J AUTOIMMUN, V21, P255, DOI 10.1016/S0896-8411(03)00119-7; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001	10	7	7	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					841	843		10.1016/j.immuni.2008.12.001	http://dx.doi.org/10.1016/j.immuni.2008.12.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100696	Bronze			2022-12-18	WOS:000262012400003
J	Monroe, JG; Keir, ME				Monroe, John G.; Keir, Mary E.			Bridging Toll-like- and B cell-receptor signaling: Meet me at the autophagosome	IMMUNITY			English	Editorial Material								In this issue of Immunity, Chaturvedi et al. (2008) describe a mechanism for the bridging of innate and adaptive immune receptor functions. In their model, B cell-receptor signaling induces the fusion of Toll-like receptor 9 (TLR9)-containing endosomes with internalized signaling-competent BCR into autophagosomes.	[Monroe, John G.; Keir, Mary E.] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Monroe, JG (corresponding author), Genentech Inc, 1 DNA Way,MS 93b, San Francisco, CA 94080 USA.	monroe.john@gene.com; keir.mary@gene.com						Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251	9	7	7	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2008	28	6					729	731		10.1016/j.immuni.2008.05.006	http://dx.doi.org/10.1016/j.immuni.2008.05.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549794	Bronze			2022-12-18	WOS:000256760200003
J	Murre, C				Murre, Cornelis			Ribosomal proteins and the control of alpha beta T lineage development	IMMUNITY			English	Editorial Material								How do committed alpha beta T lineage cells undergo rapid proliferation and developmental progression during beta selection? A new study shows that a ribosomal protein, RPL22, promotes the survival of expanding alpha beta T cells (Anderson et al. [2007]; this issue of Immunity).	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	cmurre@ucsd.edu						Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; von Boehmer H, 1998, IMMUNOL REV, V165, P111; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200	6	7	7	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					751	752		10.1016/j.immuni.2007.06.001	http://dx.doi.org/10.1016/j.immuni.2007.06.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582347	Bronze			2022-12-18	WOS:000247646900009
J	Horwitz, DA				Horwitz, David A.			Transforming growth factor-beta: Taking control of T cells' life and death	IMMUNITY			English	Editorial Material							MICE; SUPPRESSION	To determine how transforming growth factor-beta (TGF-beta) controls T cell function, Marie et al. (2006) and Li et al. (2006a) created mice with T cells lacking TGF-beta signaling receptors. Both report that TGF-beta signaling by T cells is absolutely essential for tolerance and homeostasis.	Univ So Calif, Keck Sch Med, Div Rheumatol & Immunol, Los Angeles, CA 90033 USA	University of Southern California	Horwitz, DA (corresponding author), Univ So Calif, Keck Sch Med, Div Rheumatol & Immunol, 2011 Zonal Ave HMR 711, Los Angeles, CA 90033 USA.							Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669	9	7	8	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2006	25	3					399	401		10.1016/j.immuni.2006.08.013	http://dx.doi.org/10.1016/j.immuni.2006.08.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16979574	Bronze			2022-12-18	WOS:000240862200009
J	Litman, GW				Litman, Gary W.			How Botryllus chooses to fuse	IMMUNITY			English	Editorial Material							ALLORECOGNITION	In Botryllus schlosseri, a highly polymorphic allorecognition system limits the potential for vascular fusion by genetically dissimilar, adjacent colonies. In this issue, Nyholm et al. (2006) uncover the nature of the receptor that recognizes the products of the histocompatibility genes.	Univ S Florida, Coll Med, Dept Pediat, St Petersburg, FL 33701 USA	State University System of Florida; University of South Florida	Litman, GW (corresponding author), Univ S Florida, Coll Med, Dept Pediat, St Petersburg, FL 33701 USA.				NIAID NIH HHS [R01 AI023338, R01 AI023338-21, R01 AI023338-20] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023338] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Laird DJ, 2006, CELL, V124, P647, DOI 10.1016/j.cell.2006.01.030; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Nyholm SV, 2006, IMMUNITY, V25, P163, DOI 10.1016/j.immuni.2006.04.011; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148	6	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					13	15		10.1016/j.immuni.2006.07.004	http://dx.doi.org/10.1016/j.immuni.2006.07.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860752	Bronze, Green Accepted			2022-12-18	WOS:000239713000005
J	Altieri, DC				Altieri, DC			T cell expansion: The Survivin interface between cell proliferation and cell death	IMMUNITY			English	Editorial Material								T cell proliferation is tightly controlled by intersecting signaling networks. In this issue of Immunity, Song et al. (2005) uncover Survivin as a new mediator of this process. Abundantly studied as a cancer gene, Survivin now emerges as an essential arbiter of T cell expansion, coupling cell cycle progression to apoptosis resistance.	Univ Massachusetts, Sch Med, Ctr Canc, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Altieri, DC (corresponding author), Univ Massachusetts, Sch Med, Ctr Canc, Dept Canc Biol, Worcester, MA 01605 USA.							Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012	7	7	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					534	535		10.1016/j.immuni.2005.05.001	http://dx.doi.org/10.1016/j.immuni.2005.05.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894270	Bronze			2022-12-18	WOS:000229447200002
J	Su, H; Bidere, N; Lenardo, M				Su, H; Bidere, N; Lenardo, M			Another fork in the road: Foxo3a regulates NF-kappa B activation	IMMUNITY			English	Editorial Material							TRANSCRIPTION FACTORS; CELL-PROLIFERATION; DIFFERENTIATION		NIAID, Mol Dev Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Su, H (corresponding author), NIAID, Mol Dev Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Su, Helen C/H-9541-2015; Bidère, Nicolas/K-8887-2015	Su, Helen C/0000-0002-5582-9110; Bidère, Nicolas/0000-0001-9177-0008	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000769, Z01AI000769] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; TRAN H, 2003, SCI STKE 2003; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	11	7	7	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2004	21	2					133	134		10.1016/j.immuni.2004.07.015	http://dx.doi.org/10.1016/j.immuni.2004.07.015			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308093	Bronze			2022-12-18	WOS:000223441900001
J	Cancro, MP				Cancro, MP			Tipping the scales of selection with BAFF	IMMUNITY			English	Editorial Material							B-CELLS; COMPETITION; BLYS; BCMA		Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Cancro, MP (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 284 John Morgan, Philadelphia, PA 19104 USA.			Cancro, Michael/0000-0002-8659-3227	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054488] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI054488] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Harless SM, 2001, CURR BIOL, V11, P1986, DOI 10.1016/S0960-9822(01)00598-X; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010	10	7	7	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2004	20	6					655	656		10.1016/j.immuni.2004.06.001	http://dx.doi.org/10.1016/j.immuni.2004.06.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189730	Bronze			2022-12-18	WOS:000222205300001
J	Jamieson, AM; Diefenbach, A; McMahon, CW; Xiong, N; Carlyle, JR; Raulet, DH				Jamieson, AM; Diefenbach, A; McMahon, CW; Xiong, N; Carlyle, JR; Raulet, DH			The role of the NKG2D immunoreceptor in immune cell activation and natural killing (vol 17, pg 19, 2002)	IMMUNITY			English	Correction									Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 489 Life Sci Addit, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu	Carlyle, James R/A-1224-2008; Jamieson, Amanda/U-7169-2019	Jamieson, Amanda/0000-0002-5781-9231; Carlyle, James/0000-0002-3579-0300; Raulet, David/0000-0002-1257-8649				Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3	1	7	7	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					799	799		10.1016/j.immuni.2004.05.003	http://dx.doi.org/10.1016/j.immuni.2004.05.003			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY		Bronze			2022-12-18	WOS:000222205300014
J	Lin, X; Gaudino, SJ; Jang, KK; Bahadur, T; Singh, A; Banerjee, A; Beaupre, M; Chu, T; Wong, HT; Kim, CK; Kempen, C; Axelrad, J; Huang, H; Khalid, S; Shah, V; Eskiocak, O; Parks, OB; Berisha, A; McAleer, JP; Good, M; Hoshino, M; Blumberg, R; Bialkowska, AB; Gaffen, SL; Kolls, JK; Yang, VW; Beyaz, S; Cadwell, K; Kumar, P				Lin, Xun; Gaudino, Stephen J.; Jang, Kyung Ku; Bahadur, Tej; Singh, Ankita; Banerjee, Anirban; Beaupre, Michael; Chu, Timothy; Wong, Hoi Tong; Kim, Chang-Kyung; Kempen, Cody; Axelrad, Jordan; Huang, Huakang; Khalid, Saba; Shah, Vyom; Eskiocak, Onur; Parks, Olivia B.; Berisha, Artan; McAleer, Jeremy P.; Good, Misty; Hoshino, Miko; Blumberg, Richard; Bialkowska, Agnieszka B.; Gaffen, Sarah L.; Kolls, Jay K.; Yang, Vincent W.; Beyaz, Semir; Cadwell, Ken; Kumar, Pawan			IL-17RA-signaling in Lgr(5+) intestinal stem cells induces expression of transcription factor ATOH1 to promote secretory cell lineage commitment	IMMUNITY			English	Article							AUTOPHAGY GENE ATG16L1; PANETH CELLS; INTERLEUKIN-17 RECEPTOR; GUT MICROBIOTA; IN-VITRO; WNT; MAINTAIN; COLITIS; TUMORIGENESIS; HOMEOSTASIS	The Th17 cell-lineage-defining cytokine IL-17A contributes to host defense and inflammatory disease by coordinating multicellular immune responses. The IL-17 receptor (IL-17RA) is expressed by diverse intestinal cell types, and therapies targeting IL-17A induce adverse intestinal events, suggesting additional tissue -specific functions. Here, we used multiple conditional deletion models to identify a role for IL-17A in secretory epithelial cell differentiation in the gut. Paneth, tuft, goblet, and enteroendocrine cell numbers were dependent on IL-17A-mediated induction of the transcription factor ATOH1 in Lgr5+ intestinal epithelial stem cells. Although dispensable at steady state, IL-17RA signaling in ATOH1+ cells was required to regenerate secretory cells following injury. Finally, IL-17A stimulation of human-derived intestinal organoids that were locked into a cystic immature state induced ATOH1 expression and rescued secretory cell differentiation. Our data suggest that the cross talk between immune cells and stem cells regulates secretory cell lineage commitment and the integrity of the mucosa.	[Lin, Xun; Gaudino, Stephen J.; Bahadur, Tej; Singh, Ankita; Banerjee, Anirban; Beaupre, Michael; Chu, Timothy; Wong, Hoi Tong; Kempen, Cody; Huang, Huakang; Khalid, Saba; Berisha, Artan; Kumar, Pawan] SUNY Stony Brook, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA; [Jang, Kyung Ku; Cadwell, Ken] NYU, Kimmel Ctr Biol & Med Skirball Inst, Grossman Sch Med, New York, NY 10012 USA; [Kim, Chang-Kyung; Bialkowska, Agnieszka B.; Yang, Vincent W.] SUNY Stony Brook, Renaissance Sch Med, Dept Med, Stony Brook, NY 11794 USA; [Axelrad, Jordan; Cadwell, Ken] NYU, Dept Med, Div Gastroenterol & Hepatol, Grossman Sch Med, New York, NY 10016 USA; [Shah, Vyom; Eskiocak, Onur; Beyaz, Semir] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Parks, Olivia B.] Univ Pittsburgh, Med Scientist Training Program, Sch Med, Pittsburgh, PA 15213 USA; [McAleer, Jeremy P.] Marshall Univ, Dept Pharmaceut Sci, Sch Pharm, Huntington, WV 25701 USA; [Good, Misty] Washington Univ, Dept Pediat, Div Newborn Med, Sch Med,St Louis Childrens Hosp, St Louis, MO 63110 USA; [Hoshino, Miko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Kodaira, Tokyo 1878502, Japan; [Blumberg, Richard] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Gaffen, Sarah L.] Univ Pittsburgh, Sch Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA; [Kolls, Jay K.] Tulane Sch Med, Ctr Translat Res Infect & Inflammat, New Orleans, LA 70112 USA; [Cadwell, Ken] NYU, Grossman Sch Med, Dept Microbiol, New York, NY 10016 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; New York University; Cold Spring Harbor Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Marshall University; St. Louis Children's Hospital; Washington University (WUSTL); National Center for Neurology & Psychiatry - Japan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tulane University; New York University	Kumar, P (corresponding author), SUNY Stony Brook, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA.; Cadwell, K (corresponding author), NYU, Kimmel Ctr Biol & Med Skirball Inst, Grossman Sch Med, New York, NY 10012 USA.; Cadwell, K (corresponding author), NYU, Dept Med, Div Gastroenterol & Hepatol, Grossman Sch Med, New York, NY 10016 USA.; Cadwell, K (corresponding author), NYU, Grossman Sch Med, Dept Microbiol, New York, NY 10016 USA.	ken.cadwell@med.nyu.edu; pawan.kumar@stonybrook.edu	Kumar, Pawan/GXF-7072-2022; Jang, Kyungku/GLT-4101-2022	Jang, Kyungku/0000-0002-0403-1256; Banerjee, Anirban/0000-0001-7678-1868; Lin, Xun/0000-0003-1860-3996	National Cancer Institute [P30 CA016087]; Crohn's and Colitis Foundation [476637, DK121798, AI149257]; SUNY Research Foundation [DE022550, DK103788, AI121244, HL123340, DK093668, AI130945, HL125816, DK124336, AI140754]; NYU CTSA [UL1TR001445]; NYU Cancer Center [P30CA016087]; NYU Colton Center for Autoimmunity; Howard Hughes Medical Institute; Crohn's & Colitis Foundation; Burroughs Wellcome Fund PATH award; Kenneth Rainin Foundation; Abbvie; Pfizer; National Science Foundation Graduate Research Fellowship; NRSA [T32AI007539, DK088199, R35 HL139930, R01 AI120033, DK052230]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Crohn's and Colitis Foundation; SUNY Research Foundation; NYU CTSA; NYU Cancer Center; NYU Colton Center for Autoimmunity; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Crohn's & Colitis Foundation; Burroughs Wellcome Fund PATH award(Burroughs Wellcome Fund); Kenneth Rainin Foundation; Abbvie(AbbVie); Pfizer(Pfizer); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to acknowledge the Flow Cytometry Core at Stony Brook University. We would like to acknowledge the Research Histology Core Laboratory at Stony Brook University. We would like to acknowledge the RNA sequencing core at Cold Spring Harbor Laboratory. We would like to acknowledge the New York University Langone Health (NYULH) Microscopy Lab supported by the National Cancer Institute grant P30 CA016087. We thank Makheni Jean-Pierre and Suzanne Tawch for their help. This work was supported by the Crohn's and Colitis Foundation (476637), DK121798, AI149257, and the SUNY Research Foundation to P.K.; DE022550 to S.L.G.; DK103788, AI121244, HL123340, DK093668, AI130945, HL125816, DK124336, AI140754, pilot awards from the NYU CTSA grant UL1TR001445, NYU Cancer Center grant P30CA016087, NYU Colton Center for Autoimmunity, Faculty Scholar grant from the Howard Hughes Medical Institute, Crohn's & Colitis Foundation, Burroughs Wellcome Fund PATH award, Kenneth Rainin Foundation, and industry contracts from Abbvie and Pfizer to K.C.; the National Science Foundation Graduate Research Fellowship and the NRSA T32 training grant (T32AI007539) to S.J.G.; DK088199 to R.B.; R35 HL139930 and R01 AI120033 to J.K.K.; and DK052230 to V.W.Y.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Ali AK, 2021, DERMATOL THER, V34, DOI 10.1111/dth.15151; Amatya N, 2017, TRENDS IMMUNOL, V38, P310, DOI 10.1016/j.it.2017.01.006; Ayyaz A, 2019, NATURE, V569, P121, DOI 10.1038/s41586-019-1154-y; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Borten MA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18815-8; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Castillo-Azofeifa D, 2019, EMBO J, V38, DOI 10.15252/embj.201899984; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fauny M, 2020, ANN RHEUM DIS, V79, P1132, DOI 10.1136/annrheumdis-2020-217927; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Fujii M, 2021, NAT MATER, V20, P156, DOI 10.1038/s41563-020-0754-0; Fujii M, 2018, CELL STEM CELL, V23, P787, DOI 10.1016/j.stem.2018.11.016; Gaudino SJ, 2021, MUCOSAL IMMUNOL, V14, P389, DOI 10.1038/s41385-020-00348-5; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Gordon KB, 2016, NEW ENGL J MED, V375, P345, DOI 10.1056/NEJMoa1512711; Gracz AD, 2018, GASTROENTEROLOGY, V155, P1508, DOI 10.1053/j.gastro.2018.07.023; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hyun YS, 2012, CARCINOGENESIS, V33, P931, DOI 10.1093/carcin/bgs106; Ishibashi F, 2018, STEM CELL REP, V10, P27, DOI 10.1016/j.stemcr.2017.11.006; Kumar P, 2016, IMMUNITY, V44, P659, DOI 10.1016/j.immuni.2016.02.007; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Li YH, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0051-0; Liu TC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86907; Lo YH, 2017, CELL MOL GASTROENTER, V3, P51, DOI 10.1016/j.jcmgh.2016.10.001; Mah AT, 2016, J PHYSIOL-LONDON, V594, P4837, DOI 10.1113/JP271754; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Martin PK, 2018, NAT MICROBIOL, V3, P1131, DOI 10.1038/s41564-018-0229-0; Matsuzawa-Ishimoto Y, 2020, BLOOD, V135, P2388, DOI 10.1182/blood.2019004116; Matsuzawa-Ishimoto Y, 2017, J EXP MED, V214, P3687, DOI 10.1084/jem.20170558; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; McGeachy MJ, 2019, IMMUNITY, V50, P892, DOI 10.1016/j.immuni.2019.03.021; Middendorp S, 2014, STEM CELLS, V32, P1083, DOI 10.1002/stem.1655; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Mu X, 2021, BMC GASTROENTEROL, V21, DOI 10.1186/s12876-021-01936-w; Nanki K, 2020, NATURE, V577, P254, DOI 10.1038/s41586-019-1844-5; Neil JA, 2019, NAT MICROBIOL, V4, P1737, DOI 10.1038/s41564-019-0470-1; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Oshiro K, 2012, IMMUNOBIOLOGY, V217, P54, DOI 10.1016/j.imbio.2011.08.002; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Ramanan D, 2016, CELL HOST MICROBE, V19, P434, DOI 10.1016/j.chom.2016.03.003; Salzman NH, 2010, GUT MICROBES, V1, P401, DOI 10.4161/gmic.1.6.14076; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmitt M, 2018, CELL REP, V24, P2312, DOI 10.1016/j.celrep.2018.07.085; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Targan SR, 2016, AM J GASTROENTEROL, V111, P1599, DOI 10.1038/ajg.2016.298; Thorne CA, 2018, DEV CELL, V44, P624, DOI 10.1016/j.devcel.2018.01.024; Tomic G, 2018, CELL STEM CELL, V23, P436, DOI 10.1016/j.stem.2018.07.002; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; VanDussen KL, 2014, GASTROENTEROLOGY, V146, P200, DOI 10.1053/j.gastro.2013.09.048; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wright MC, 2015, J CELL BIOL, V208, P367, DOI 10.1083/jcb.201407101; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Zha JM, 2019, CELL MOL GASTROENTER, V7, P255, DOI 10.1016/j.jcmgh.2018.09.006	69	6	6	7	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					237	+		10.1016/j.immuni.2021.12.016	http://dx.doi.org/10.1016/j.immuni.2021.12.016			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35081371				2022-12-18	WOS:000754308000010
J	Yeh, CH; Finney, J; Okada, T; Kurosaki, T; Kelsoe, G				Yeh, Chen-Hao; Finney, Joel; Okada, Takaharu; Kurosaki, Tomohiro; Kelsoe, Garnett			Primary germinal center-resident T follicular helper cells are a physiologically distinct subset of CXCR5(hi)PD-1(hi) T follicular helper cells	IMMUNITY			English	Article							CENTER B-CELL; PRIMARY IMMUNE-RESPONSE; CXC CHEMOKINE RECEPTOR-5; TRANSCRIPTION FACTOR; ANTIBODY-RESPONSES; BCL6 EXPRESSION; ANTIGEN; AFFINITY; DIFFERENTIATION; SELECTION	T follicular helper (Tfh) cells are defined by a Bcl6(+)CXCR5(hi)PD-1(hi) phenotype, but only a minor fraction of these reside in germinal centers (GCs). Here, we examined whether GC-resident and-nonresident Tfh cells share a common physiology and function. Fluorescently labeled, GC-resident Tfh cells in different mouse models were distinguished by low expression of CD90. CD90(neg/lo) GCTfh cells required antigen-specific, MHCII+ B cells to develop and stopped proliferating soon after differentiation. In contrast, nonresident, CD90(hi) Tfh (GCTfh-like) cells developed normally in the absence of MHCII+ B cells and proliferated continuously during primary responses. The TCR repertoires of both Tfh subsets overlapped initially but later diverged in association with dendritic cell-dependent proliferation of CD90(hi) GCTfh-like cells, suggestive of TCR-dependency seen also in TCR-transgenic adoptive transfer experiments. Furthermore, the transcriptomes of CD90(neg/lo) and CD90(hi) GCTfh-like cells were enriched in different functional pathways. Thus, GC resident and nonresident Tfh cells have distinct developmental requirements and activities, implying distinct functions.	[Yeh, Chen-Hao; Finney, Joel; Kelsoe, Garnett] Duke Univ, Dept Immunol, Sch Med, Durham, NC 27710 USA; [Okada, Takaharu] RIKEN, Lab Tissue Dynam, Ctr Integrat Med Sci IMS, Yokohama, Kanagawa 2300045, Japan; [Okada, Takaharu] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2300045, Japan; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka 5650871, Japan; [Kurosaki, Tomohiro] RIKEN, Lab Lymphocyte Differentiat, Ctr Integrat Med Sci IMS, Yokohama, Kanagawa 2300045, Japan; [Kelsoe, Garnett] Duke Univ, Sch Med, Dept Surg, Durham, NC 27710 USA; [Kelsoe, Garnett] Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA	Duke University; RIKEN; Yokohama City University; Osaka University; RIKEN; Duke University; Duke University	Kelsoe, G (corresponding author), Duke Univ, Dept Immunol, Sch Med, Durham, NC 27710 USA.; Kelsoe, G (corresponding author), Duke Univ, Sch Med, Dept Surg, Durham, NC 27710 USA.; Kelsoe, G (corresponding author), Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA.	ghkelsoe@duke.edu		Finney, Joel/0000-0002-3755-8425; Yeh, Chen-Hao/0000-0001-5801-2918	Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID) [AI100645]; Duke Consortium for HIV/AIDS Vaccine Development (CHAVD), Division of AIDS, NIAID, NIH [AI44371]; NIH [AI089618, AI117892]	Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID); Duke Consortium for HIV/AIDS Vaccine Development (CHAVD), Division of AIDS, NIAID, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Garnett, D. Liao, X. Nie, A. Watanabe, X. Liang, W. Zhang, and R. Qi for technical assistance. We thank Drs. M. Kuraoka, S. Song, and R. Kotaki for helpful discussion and feedback on the manuscript. We thank Drs. R. Ji and C. Jiang for advice and vibratome use. We thank Dr. E.A. Moseman for advice on multi-photon microscopy. We thank Drs. B. Carlson, Y. Gao, and L. Cameron of the Duke University Light Microscopy Core Facility for imaging equipment and consultation. We thank the Duke University School of Medicine for the use of the Sequencing and Genomic Technologies/Genomic Analysis and Bioinformatics Shared Resource. This work was supported by AI100645, the Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID); AI44371, the Duke Consortium for HIV/AIDS Vaccine Development (CHAVD), Division of AIDS, NIAID, NIH; and by NIH grants AI089618 and AI117892.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; ASHWELL JD, 1988, J IMMUNOL, V141, P2536; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Beissert S, 1998, J IMMUNOL, V161, P5296; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Cho S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05196-3; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Dan JM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau3776; Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dustin ML, 2017, EUR J IMMUNOL, V47, P31, DOI 10.1002/eji.201646786; Fernandez-Messina L, 2020, EMBO REP, V21, DOI 10.15252/embr.201948925; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; Furlong S, 2017, MOL MED REP, V16, P5683, DOI 10.3892/mmr.2017.7242; Gardell JL, 2017, EUR J IMMUNOL, V47, P41, DOI 10.1002/eji.201646504; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; GulbransonJudge A, 1997, ANN NY ACAD SCI, V815, P199, DOI 10.1111/j.1749-6632.1997.tb52061.x; HAN SH, 1995, J IMMUNOL, V155, P556; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; HARRIMAN GR, 1990, J IMMUNOL, V145, P2406; Havenar-Daughton C, 2019, CELL REP, V29, P1756, DOI 10.1016/j.celrep.2019.10.008; Havenar-Daughton C, 2016, CELL REP, V17, P2195, DOI 10.1016/j.celrep.2016.10.085; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kuraoka M, 2009, J IMMUNOL, V183, P3237, DOI 10.4049/jimmunol.0901548; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03128-9; Meli AP, 2015, METHODS MOL BIOL, V1291, P3, DOI 10.1007/978-1-4939-2498-1_1; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Merkenschlager J, 2021, NATURE, V591, P458, DOI 10.1038/s41586-021-03187-x; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nance JP, 2015, J IMMUNOL, V194, P5599, DOI 10.4049/jimmunol.1500200; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Papa I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01858; Papa I, 2017, NATURE, V547, P318, DOI 10.1038/nature23013; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Randall TD, 1998, IMMUNITY, V8, P733, DOI 10.1016/S1074-7613(00)80578-6; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Wan ZR, 2019, IMMUNOL REV, V288, P28, DOI 10.1111/imr.12747; Wang P, 2016, J IMMUNOL, V197, P1169, DOI 10.4049/jimmunol.1600411; WHITE J, 1983, J IMMUNOL, V130, P1033; Wing JB, 2017, P NATL ACAD SCI USA, V114, pE6400, DOI 10.1073/pnas.1705551114; Wittenbrink N, 2011, J IMMUNOL, V187, P6185, DOI 10.4049/jimmunol.1101440; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu H, 2015, J IMMUNOL, V195, P2080, DOI 10.4049/jimmunol.1500335; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yeh CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03382-x; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zheng B, 1996, J EXP MED, V184, P1083, DOI 10.1084/jem.184.3.1083	98	6	6	4	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					272	+		10.1016/j.immuni.2021.12.015	http://dx.doi.org/10.1016/j.immuni.2021.12.015			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35081372				2022-12-18	WOS:000754308000012
J	Czepielewski, RS; Erlich, EC; Onufer, EJ; Young, S; Saunders, BT; Han, YH; Wohltmann, M; Wang, PL; Kim, KW; Kumar, S; Hsieh, CS; Scallan, JP; Yang, Y; Zinselmeyer, BH; Davis, MJ; Randolph, GJ				Czepielewski, Rafael S.; Erlich, Emma C.; Onufer, Emily J.; Young, Shannon; Saunders, Brian T.; Han, Yong-Hyun; Wohltmann, Mary; Wang, Peter L.; Kim, Ki-Wook; Kumar, Shashi; Hsieh, Chyi-Song; Scallan, Joshua P.; Yang, Ying; Zinselmeyer, Bernd H.; Davis, Michael J.; Randolph, Gwendalyn J.			Ileitis-associated tertiary lymphoid organs arise at lymphatic valves and impede mesenteric lymph flow in response to tumor necrosis factor	IMMUNITY			English	Article							REGULATORY T-CELLS; CROHNS-DISEASE; COLLECTING VESSELS; REGIONAL ILEITIS; ORAL TOLERANCE; CREEPING FAT; MECHANISMS; TISSUE; FOXC2; PROX1	Lymphangitis and the formation of tertiary lymphoid organs (TLOs) in the mesentery are features of Crohn's disease. Here, we examined the genesis of these TLOs and their impact on disease progression. Whole-mount and intravital imaging of the ileum and ileum-draining collecting lymphatic vessels (CLVs) draining to mesenteric lymph nodes from TNF Delta ARE mice, a model of ileitis, revealed TLO formation at valves of CLVs. TLOs obstructed cellular and molecular outflow from the gut and were sites of lymph leakage and backflow. Tumor necrosis factor (TNF) neutralization begun at early stages of TLO formation restored lymph transport. However, robustly developed, chronic TLOs resisted regression and restoration of flow after TNF neutralization. TNF stimulation of cultured lymphatic endothelial cells reprogrammed responses to oscillatory shear stress, preventing the induction of valve-associated genes. Disrupted transport of immune cells, driven by loss of valve integrity and TLO formation, may contribute to the pathology of Crohn's disease.	[Czepielewski, Rafael S.; Erlich, Emma C.; Saunders, Brian T.; Han, Yong-Hyun; Wohltmann, Mary; Wang, Peter L.; Kim, Ki-Wook; Kumar, Shashi; Zinselmeyer, Bernd H.; Randolph, Gwendalyn J.] Washington Univ, Dept Pathol, Sch Med, St Louis, MO 63110 USA; [Onufer, Emily J.] Washington Univ, Dept Surg, Sch Med, St Louis, MO 63110 USA; [Young, Shannon; Hsieh, Chyi-Song] Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA; [Scallan, Joshua P.; Yang, Ying] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Davis, Michael J.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of South Florida; University of Missouri System; University of Missouri Columbia	Randolph, GJ (corresponding author), Washington Univ, Dept Pathol, Sch Med, St Louis, MO 63110 USA.	gjrandolph@wustl.edu	Yang, Ying/ADL-4165-2022; Scallan, Joshua/ADC-3295-2022; Zinselmeyer, Bernd/X-4802-2018	Yang, Ying/0000-0002-3469-7681; Scallan, Joshua/0000-0002-1190-7308; /0000-0002-7207-4389; Zinselmeyer, Bernd/0000-0003-4172-6767; Young, Shannon/0000-0002-1179-4315; Erlich, Emma/0000-0003-2584-1407	NIH [DP1 DK1109668, R01 HL145397, R01 HL142905, R37 AI0499653, P30 DK097948]; Rainin Foundation; Digestive Diseases Research Core Center of Washington University - NIH [P30 DK052574];  [T32 DK077653];  [FA-2020-01-IBD-1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rainin Foundation; Digestive Diseases Research Core Center of Washington University - NIH; ; 	This work was funded by NIH grant DP1 DK1109668 and a Synergy Grant from the Rainin Foundation to G.J.R. and M.J.D. Additional support included NIH grants R01 HL145397 to Y.Y., R01 HL142905 to J.P.S., and R37 AI0499653 to G.J.R., with the latter including a Primary Caregiver Supplement to support career development of E.J.O. E.J.O. also received support from T32 DK077653. R.S.C. was supported by a fellowship award "FA-2020-01-IBD-1 from the Lawrence C. Pakula, MD IBD Education & Innovation Fund". Histol-ogy was carried out using core facilities supported by the Digestive Diseases Research Core Center of Washington University, funded by NIH P30 DK052574. We thank Natalia Jaeger for experimental support. TNFDARE mice were obtained from the Cleveland DDRCC, supported by NIH P30 DK097948, and we thank Dr. T. Pizarro and F. Cominelli for facilitating access to the strain through the Cleveland DDRCC. Requests for this strain should be directed to the Cleveland DDRCC via MTA. Graphical abstract created with BioRender.com .	Antonioli L, 2020, TRENDS MOL MED, V26, P1021, DOI 10.1016/j.molmed.2020.06.004; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Becker F, 2019, AM J PATHOL, V189, P1953, DOI 10.1016/j.ajpath.2019.05.013; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Blumenstein I, 2011, J CROHNS COLITIS, V5, P203, DOI 10.1016/j.crohns.2010.12.012; Bovay E, 2018, J EXP MED, V215, P2760, DOI 10.1084/jem.20180217; Cao E, 2021, NAT METAB, V3, P1175, DOI 10.1038/s42255-021-00457-w; Castorena-Gonzalez JA, 2018, CIRC RES, V123, P964, DOI 10.1161/CIRCRESAHA.117.312576; Cha B, 2016, GENE DEV, V30, P1454, DOI 10.1101/gad.282400.116; Choi D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125068; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Coffey CJ, 2018, J CROHNS COLITIS, V12, P1139, DOI 10.1093/ecco-jcc/jjx187; Collins CB, 2011, GASTROENTEROLOGY, V141, P1821, DOI 10.1053/j.gastro.2011.05.049; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; CROHN BB, 1954, JAMA-J AM MED ASSOC, V156, P1221, DOI 10.1001/jama.1954.02950130001001; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Danese S, 2017, GUT, V66, P2179, DOI 10.1136/gutjnl-2017-314519; Davis MJ, 2012, AM J PHYSIOL-HEART C, V303, pH795, DOI 10.1152/ajpheart.01097.2011; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Friedrich M, 2019, IMMUNITY, V50, P992, DOI 10.1016/j.immuni.2019.03.017; Furtado GC, 2014, MUCOSAL IMMUNOL, V7, P602, DOI 10.1038/mi.2013.79; Goodman WA, 2020, NAT REV GASTRO HEPAT, V17, P740, DOI 10.1038/s41575-020-0354-0; Goodman WA, 2020, P NATL ACAD SCI USA, V117, P17166, DOI 10.1073/pnas.2002266117; Gossa S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06664; Graham DB, 2020, NATURE, V578, P527, DOI 10.1038/s41586-020-2025-2; Ha CWY, 2020, CELL, V183, P666, DOI 10.1016/j.cell.2020.09.009; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Houston SA, 2016, MUCOSAL IMMUNOL, V9, P468, DOI 10.1038/mi.2015.77; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Huang LH, 2020, GASTROENTEROLOGY, V159, P1955, DOI 10.1053/j.gastro.2020.07.012; Iliopoulou L, 2022, MUCOSAL IMMUNOL, V15, P10, DOI 10.1038/s41385-021-00433-3; Jafarnejad M, 2015, LYMPHAT RES BIOL, V13, P234, DOI 10.1089/lrb.2015.0028; KALIMA TV, 1976, SCAND J GASTROENTERO, V11, P353; Kawai Y, 2014, LYMPHAT RES BIOL, V12, P124, DOI 10.1089/lrb.2014.0002; Kazenwadel J, 2015, J CLIN INVEST, V125, P2979, DOI 10.1172/JCI78888; Kazenwadel J, 2012, BLOOD, V119, P1283, DOI 10.1182/blood-2011-08-374363; Khanna R, 2015, LANCET, V386, P1825, DOI 10.1016/S0140-6736(15)00068-9; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Liebl J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8274; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Mao R, 2019, INFLAMM BOWEL DIS, V25, P421, DOI 10.1093/ibd/izy331; McNamee EN, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00308; McNamee EN, 2013, GUT, V62, P53, DOI 10.1136/gutjnl-2011-301272; Mikulski Z, 2015, GASTROENTEROLOGY, V148, P783, DOI 10.1053/j.gastro.2015.01.027; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Nutsch K, 2016, CELL REP, V17, P206, DOI 10.1016/j.celrep.2016.08.092; Oliver G, 2020, CELL, V182, P270, DOI 10.1016/j.cell.2020.06.039; Petrova TV, 2020, SCIENCE, V369, P157, DOI 10.1126/science.aax4063; Rahier JF, 2011, ALIMENT PHARM THER, V34, P533, DOI 10.1111/j.1365-2036.2011.04759.x; Randolph GJ, 2016, AM J PATHOL, V186, P3066, DOI 10.1016/j.ajpath.2016.07.026; Reed HO, 2019, J CLIN INVEST, V129, P2514, DOI 10.1172/JCI125044; Rehal S, 2017, AM J PATHOL, V187, P798, DOI 10.1016/j.ajpath.2016.12.007; Roulis M, 2016, MUCOSAL IMMUNOL, V9, P787, DOI 10.1038/mi.2015.102; Sabine A, 2016, ANTIOXID REDOX SIGN, V25, P451, DOI 10.1089/ars.2016.6685; Sabine A, 2015, J CLIN INVEST, V125, P3861, DOI 10.1172/JCI80454; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Scallan JP, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142341; Scallan JP, 2016, J PHYSIOL-LONDON, V594, P5749, DOI 10.1113/JP272088; Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333; SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987, DOI 10.1152/physrev.1990.70.4.987; Severs M, 2018, INFLAMM BOWEL DIS, V24, P1298, DOI 10.1093/ibd/izy004; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Sura R, 2011, ALIMENT PHARM THER, V33, P930, DOI 10.1111/j.1365-2036.2011.04605.x; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Van Kruiningen HJ, 2008, GUT, V57, P1; Van Kruiningen HJ, 2014, APMIS, V122, P1125, DOI 10.1111/apm.12268; WARREN S, 1954, JAMA-J AM MED ASSOC, V154, P189, DOI 10.1001/jama.1954.02940370001001; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yang Y, 2019, CELL REP, V28, P2397, DOI 10.1016/j.celrep.2019.07.072; Zawieja David C., 2009, Lymphatic Research and Biology, V7, P87, DOI 10.1089/lrb.2009.0007	81	6	6	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2795	+		10.1016/j.immuni.2021.10.003	http://dx.doi.org/10.1016/j.immuni.2021.10.003		DEC 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6LX	34788601	Green Accepted			2022-12-18	WOS:000731658800001
J	Grzes, KM; Sanin, DE; Kabat, AM; Stanczak, MA; Edwards-Hicks, J; Matsushita, M; Hackl, A; Hassler, F; Knoke, K; Zahalka, S; Villa, M; Kofler, DM; Voll, RE; Zigrino, P; Fabri, M; Pearce, EL; Pearce, EJ				Grzes, Katarzyna M.; Sanin, David E.; Kabat, Agnieszka M.; Stanczak, Michal A.; Edwards-Hicks, Joy; Matsushita, Mai; Hackl, Alexandra; Haessler, Fabian; Knoke, Kristin; Zahalka, Sophie; Villa, Matteo; Kofler, David M.; Voll, Reinhard E.; Zigrino, Paola; Fabri, Mario; Pearce, Erika L.; Pearce, Edward J.			Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON-PRODUCING CELLS; COLONY-STIMULATING FACTOR; GM-CSF; INHIBITOR; GROWTH; METABOLISM; REVEALS; ALPHA; INTERLEUKIN-3	Human plasmacytoid dendritic cells (pDCs) are interleukin-3 (IL-3)-dependent cells implicated in autoimmunity, but the role of IL-3 in pDC biology is poorly understood. We found that IL-3-induced Janus kinase 2 dependent expression of SLC7A5 and SLC3A2, which comprise the large neutral amino acid transporter, was required for mammalian target of rapamycin complex 1 (mTORC1) nutrient sensor activation in response to toll-like receptor agonists. mTORC1 facilitated increased anabolic activity resulting in type I interferon, tumor necrosis factor, and chemokine production and the expression of the cystine transporter SLC7A11. Loss of function of these amino acid transporters synergistically blocked cytokine production by pDCs. Comparison of in vitro-activated pDCs with those from lupus nephritis lesions identified not only SLC7A5, SLC3A2, and SLC7A11 but also ectonucleotide pyrophosphatase-phosphodiesterase 2 (ENPP2) as components of a shared transcriptional signature, and ENPP2 inhibition also blocked cytokine production. Our data identify additional therapeutic targets for autoimmune diseases in which pDCs are implicated.	[Grzes, Katarzyna M.; Sanin, David E.; Kabat, Agnieszka M.; Stanczak, Michal A.; Edwards-Hicks, Joy; Matsushita, Mai; Hackl, Alexandra; Haessler, Fabian; Villa, Matteo; Pearce, Erika L.; Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Knoke, Kristin; Zigrino, Paola; Fabri, Mario] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Zahalka, Sophie] Med Univ Vienna, Dept Med 1, Res Lab Infect Biol, A-1090 Vienna, Austria; [Zahalka, Sophie] Austrian Acad Sci, CeMM, Res Ctr Mol Med, A-1090 Vienna, Austria; [Kofler, David M.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Voll, Reinhard E.] Univ Freiburg, Med Ctr Univ Freiburg, Fac Med, Dept Rheumatol & Clin Immunol, D-79106 Freiburg, Germany; [Grzes, Katarzyna M.; Sanin, David E.; Stanczak, Michal A.; Pearce, Erika L.; Pearce, Edward J.] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Dept Oncol, Sch Med, Baltimore, MD 21287 USA; [Pearce, Erika L.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; [Pearce, Edward J.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Pearce, Edward J.] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA	Max Planck Society; University of Cologne; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Cologne; University of Freiburg; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Freiburg; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pearce, EJ (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.; Pearce, EJ (corresponding author), Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Dept Oncol, Sch Med, Baltimore, MD 21287 USA.; Pearce, EJ (corresponding author), Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.; Pearce, EJ (corresponding author), Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA.	epearce7@jhmi.edu	Sanin, David E/CAA-0373-2022; Sanin, David E/CAA-0391-2022	Sanin, David E/0000-0003-0188-7267; Sanin, David E/0000-0003-0188-7267; Zigrino, Paola/0000-0002-7470-0064; Stanczak, Michal/0000-0003-2563-7254; Edwards-Hicks, Joy/0000-0002-9313-5718; Matsushita, Mai/0000-0001-5693-461X	NIH [AI 110481]; German Research Foundation (DFG) [SFB1160]; DFG under Germany's Excellence Strategy (CIBSS EXC-2189) [390939984]; Alexander von Humboldt Fellowship Foundation; Swiss National Science Foundation; Japan Society for the Promotion of Science; DK Cell Communication in Health and Disease [W 1205-B09]; DFG [TRR130, 12]; Max Planck Society	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG under Germany's Excellence Strategy (CIBSS EXC-2189)(German Research Foundation (DFG)); Alexander von Humboldt Fellowship Foundation(Alexander von Humboldt Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); DK Cell Communication in Health and Disease; DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	The authors thank Gustavo Carrizo, Mauro Corrado, Johan Friden, Beth Kelly, and Nisha Rana for helpful discussions, Jan Zamek at Cologne University for technical assistance with immunohistochemistry, and Theresa Schleyer at the ImmRheum Biobank for PBMCs from SLE patients. We also thank the core facilities (Deep Sequencing, Metabolomics, and Flow Cytometry) at the Max Planck of Immunobiology and Epigenetics for technical support. This work was supported by NIH AI 110481 (E.J.P.) ; German Research Foundation (DFG) SFB1160; DFG under Germany's Excellence Strategy (CIBSS EXC-2189 project ID 390939984) ; the Alexander von Humboldt Fellowship Foundation (A.M.K. and M.V.) ; Swiss National Science Foundation (M.M.) ; Japan Society for the Promotion of Science (M.M.) ; DK Cell Communication in Health and Disease W 1205-B09 (S.Z.) ; DFG, TRR130, project 12 to R.E.V.; and the Max Planck Society.	Albertini G, 2018, GLIA, V66, P1845, DOI 10.1002/glia.23343; Alculumbre SG, 2018, NAT IMMUNOL, V19, P63, DOI 10.1038/s41590-017-0012-z; Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x; Baccala R, 2013, P NATL ACAD SCI USA, V110, P2940, DOI 10.1073/pnas.1222798110; Bajwa G, 2016, J IMMUNOL, V196, P2004, DOI 10.4049/jimmunol.1501557; Basit F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02489; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Bhardwaj V, 2019, BIOINFORMATICS, V35, P4757, DOI 10.1093/bioinformatics/btz436; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Boor PPC, 2017, TRANSL RES, V188, P67, DOI 10.1016/j.trsl.2016.11.006; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Castelino FV, 2016, ARTHRITIS RHEUMATOL, V68, P2964, DOI 10.1002/art.39797; Cederblad B, 1998, J AUTOIMMUN, V11, P465, DOI 10.1006/jaut.1998.0215; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/nchembio.557, 10.1038/NCHEMBIO.557]; Choi J., 2020, SULFASALAZINE; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Conaghan PG, 2016, ANN RHEUM DIS, V75, P1024, DOI 10.1136/annrheumdis-2015-208267; Condon KJ, 2019, J CELL SCI, V132, DOI 10.1242/jcs.222570; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Daher B, 2019, CANCER RES, V79, P3877, DOI 10.1158/0008-5472.CAN-18-3855; Desroy N, 2017, J MED CHEM, V60, P3580, DOI 10.1021/acs.jmedchem.7b00032; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dougan M, 2019, IMMUNITY, V50, P796, DOI 10.1016/j.immuni.2019.03.022; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; ENDO A, 1985, J ANTIBIOT, V38, P920, DOI 10.7164/antibiotics.38.920; Eriksson P, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00082; FISHMAN P, 1993, INT ARCH ALLERGY IMM, V100, P215, DOI 10.1159/000236414; Ghirelli C, 2010, BLOOD, V115, P5037, DOI 10.1182/blood-2010-01-266932; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gottschalk TA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00550; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Jegalian AG, 2009, ADV ANAT PATHOL, V16, P392, DOI 10.1097/PAP.0b013e3181bb6bc2; Karrich JJ, 2014, J IMMUNOL, V193, P5772, DOI 10.4049/jimmunol.1401541; Kunnath-Velayudhan Shajo, 2019, Immunohorizons, V3, P161, DOI 10.4049/immunohorizons.1900028; Lai ZW, 2018, LANCET, V391, P1186, DOI 10.1016/S0140-6736(18)30485-9; Lam GKW, 2005, CLIN EXP RHEUMATOL, V23, pS120; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; LARDY HA, 1958, ARCH BIOCHEM BIOPHYS, V78, P587, DOI 10.1016/0003-9861(58)90383-7; Leonard D, 2016, ANN RHEUM DIS, V75, P1728, DOI 10.1136/annrheumdis-2015-208055; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Liao XF, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6012715; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Maidhof William, 2012, P T, V37, P240; Markham A, 2017, DRUGS, V77, P697, DOI 10.1007/s40265-017-0723-3; Mascia F, 2010, J INVEST DERMATOL, V130, P682, DOI 10.1038/jid.2009.336; McInnes L., 2018, J OPEN SOURCE SOFTW, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]; Merckx E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0787-0; Morand EF, 2020, NEW ENGL J MED, V382, P211, DOI 10.1056/NEJMoa1912196; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Murphy G, 2019, NAT REV RHEUMATOL, V15, P403, DOI 10.1038/s41584-019-0235-5; Navines-Ferrer A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072555; Ninou J, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00180; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Oh BM, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122210; Olweus J, 1997, P NATL ACAD SCI USA, V94, P12551, DOI 10.1073/pnas.94.23.12551; Oon S, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1097; Oon S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86131; Park Y, 2017, CELL REP, V19, P1083, DOI 10.1016/j.celrep.2017.04.042; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027; Sabatini DM, 2017, P NATL ACAD SCI USA, V114, P11818, DOI 10.1073/pnas.1716173114; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944; Schwartz DM, 2016, NAT REV RHEUMATOL, V12, P25, DOI 10.1038/nrrheum.2015.167; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sinclair LV, 2019, ELIFE, V8, DOI 10.7554/eLife.44210; Sinclair LV, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-04366-7, 10.1038/S41467-018-04366-7]; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Siska PJ, 2016, J IMMUNOL METHODS, V438, P51, DOI 10.1016/j.jim.2016.08.013; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Valvezan AJ, 2019, NAT METAB, V1, P321, DOI 10.1038/s42255-019-0038-7; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wallace DJ, 2018, LANCET, V392, P222, DOI 10.1016/S0140-6736(18)31363-1; Willeke P, 2004, LUPUS, V13, P257, DOI 10.1191/0961203304lu1009oa; Wills J, 2017, ANAL CHEM, V89, P9616, DOI 10.1021/acs.analchem.7b02401; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	92	6	6	11	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2514	+		10.1016/j.immuni.2021.10.009	http://dx.doi.org/10.1016/j.immuni.2021.10.009		NOV 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34717796	Bronze			2022-12-18	WOS:000718366000010
J	Collins, DR; Urbach, JM; Racenet, ZJ; Arshad, U; Power, KA; Newman, RM; Mylvaganam, GH; Ly, NL; Lian, XD; Rull, A; Rassadkina, Y; Yanez, AG; Peluso, MJ; Deeks, SG; Vidal, F; Lichterfeld, M; Yu, XG; Gaiha, GD; Allen, TM; Walker, BD				Collins, David R.; Urbach, Jonathan M.; Racenet, Zachary J.; Arshad, Umar; Power, Karen A.; Newman, Ruchi M.; Mylvaganam, Geetha H.; Ly, Ngoc L.; Lian, Xiaodong; Rull, Anna; Rassadkina, Yelizaveta; Yanez, Adrienne G.; Peluso, Michael J.; Deeks, Steven G.; Vidal, Francesc; Lichterfeld, Mathias; Yu, Xu G.; Gaiha, Gaurav D.; Allen, Todd M.; Walker, Bruce D.			Functional impairment of HIV-specific CD8+T cells precedes aborted spontaneous control of viremia	IMMUNITY			English	Article							CD8(+) T-CELLS; SEQUENCE ALIGNMENT; EX-VIVO; REPLICATION; EXHAUSTION; RESPONSES; PD-1; ACTIVATION; EXPRESSION; INFECTION	Spontaneous control of HIV infection has been repeatedly linked to antiviral CD8(+) T cells but is not always permanent. To address mechanisms of durable and aborted control of viremia, we evaluated immunologic and virologic parameters longitudinally among 34 HIV-infected subjects with differential outcomes. Despite sustained recognition of autologous virus, HIV-specific proliferative and cytolytic T cell effector functions became selectively and intrinsically impaired prior to aborted control. Longitudinal transcriptomic profiling of functionally impaired HIV-specific CD8(+) T cells revealed altered expression of genes related to activation, cytokine-mediated signaling, and cell cycle regulation, including increased expression of the antiproliferative transcription factor KLF2 but not of genes associated with canonical exhaustion. Lymphoid HIV-specific CD8(+) T cells also exhibited poor functionality during aborted control relative to durable control. Our results identify selective functional impairment of HIV-specific CD8(+) T cells as prognostic of impending aborted HIV control, with implications for clinical monitoring and immunotherapeutic strategies.	[Collins, David R.; Urbach, Jonathan M.; Racenet, Zachary J.; Arshad, Umar; Power, Karen A.; Newman, Ruchi M.; Mylvaganam, Geetha H.; Ly, Ngoc L.; Lian, Xiaodong; Rassadkina, Yelizaveta; Yanez, Adrienne G.; Lichterfeld, Mathias; Yu, Xu G.; Gaiha, Gaurav D.; Allen, Todd M.; Walker, Bruce D.] MIT & Harvard, MGH, Ragon Inst, Cambridge, MA 02139 USA; [Collins, David R.; Mylvaganam, Geetha H.; Yanez, Adrienne G.; Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Lian, Xiaodong; Rassadkina, Yelizaveta; Lichterfeld, Mathias; Yu, Xu G.] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Rull, Anna; Vidal, Francesc] Rovira & Virgili Univ, Joan XXIII Univ Hosp, Pere Virgili Inst IISPV, Tarragona, Spain; [Peluso, Michael J.; Deeks, Steven G.] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA; [Gaiha, Gaurav D.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Walker, Bruce D.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Walker, Bruce D.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Walker, BD (corresponding author), MIT & Harvard, MGH, Ragon Inst, Cambridge, MA 02139 USA.; Walker, BD (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Walker, BD (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Walker, BD (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bwalker@mgh.harvard.edu	Rull, Anna/A-9438-2017	Rull, Anna/0000-0002-8907-7754; Racenet, Zachary/0000-0002-5299-3716; Collins, David/0000-0001-7903-346X; Arshad, Umar/0000-0002-9671-8193; Rassadkina, Yelizaveta/0000-0002-2450-476X; Urbach, Jonathan/0000-0003-0597-2848; Lian, Xiaodong/0000-0002-6163-9452	Howard Hughes Medical Institute; Lisa Schwartz Foundation; Susan Ragon Foundation; United States National Institutes of Health (NIH) [R01 AI149704]; NIH Extramural LRP-CR; Fondo de Investigacion Sanitaria [PI16/00503, PI19/01337, PI20/00326-ISCIII-FEDER]; AGUAR [2017SGR948]; Spanish AIDS Research Network [RD16/0025/0006-ISCIIIFEDER, INT20/00031-ISCIII]; Grupo de Estudio del SIDA-SEIMC; CFAR Network of Integrated Clinical Systems [R24 AI067039]; AIDS Research Enterprise [AI096109, UM1AI126611]; amfAR Institute for HIV Cure Research [109301]; NIH [HL134539, AI155171, AI155233, AI152979]; Bill and Melinda Gates Foundation [INV-002703]; UCSF/Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR); Harvard University CFAR [P30 AI027763]; Harvard University [P30 AI060354]; NIH: NIAID; NCI; NICHD; NHLBI; NIMH; NIA; FIC; OAR;  [CP19/00146-ISCIII]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Lisa Schwartz Foundation; Susan Ragon Foundation; United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Extramural LRP-CR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); AGUAR; Spanish AIDS Research Network; Grupo de Estudio del SIDA-SEIMC; CFAR Network of Integrated Clinical Systems; AIDS Research Enterprise; amfAR Institute for HIV Cure Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UCSF/Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR); Harvard University CFAR; Harvard University; NIH: NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC; OAR; 	This work was supported by funding from Howard Hughes Medical Institute, Mark and Lisa Schwartz Foundation, Phillip and Susan Ragon Foundation, and the United States National Institutes of Health (NIH) R01 AI149704 to B.D.W.; NIH Extramural LRP-CR to D.R.C.; Fondo de Investigacion Sanitaria (PI16/00503, PI19/01337, and PI20/00326-ISCIII-FEDER), Recera AGUAR (2017SGR948), Spanish AIDS Research Network (RD16/0025/0006-ISCIIIFEDER) and INT20/00031-ISCIII to F.V.; CP19/00146-ISCIII and Grupo de Estudio del SIDA-SEIMC (GeSIDA) to A.R.; the CFAR Network of Integrated Clinical Systems (R24 AI067039), Delaney AIDS Research Enterprise (DARE; AI096109 and UM1AI126611), and amfAR Institute for HIV Cure Research (amfAR 109301) to S.G.D.; NIH HL134539 and AI155171 and Bill and Melinda Gates Foundation (INV-002703) to X.G.Y.; NIH AI155233 and AI152979 to M.L.; and by the UCSF/Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR) and Harvard University CFAR (P30 AI027763 to S.G.D. and P30 AI060354 to B.D.W., respectively), which are supported by the following institutes and centers co-funded by and participating with the NIH: NIAID, NCI, NICHD, NHLBI, NIMH, NIA, FIC, and OAR. Funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahn E, 2018, P NATL ACAD SCI USA, V115, P4749, DOI 10.1073/pnas.1718217115; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Boritz EA, 2016, CELL, V166, P1004, DOI 10.1016/j.cell.2016.06.039; Borrell M, 2021, J INT AIDS SOC, V24, DOI 10.1002/jia2.25675; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Buggert M, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar4526; Chan HY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00591; Chereau F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173893; Chowdhury A, 2015, J VIROL, V89, P8677, DOI 10.1128/JVI.00869-15; Clayton KL, 2018, NAT IMMUNOL, V19, P475, DOI 10.1038/s41590-018-0085-3; Collins DR, 2020, NAT REV IMMUNOL, V20, P471, DOI 10.1038/s41577-020-0274-9; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; Connick E, 2014, J IMMUNOL, V193, P5613, DOI 10.4049/jimmunol.1401161; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estes JD, 2017, NAT MED, V23, P1271, DOI 10.1038/nm.4411; Fenwick C, 2019, IMMUNOL REV, V292, P149, DOI 10.1111/imr.12823; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Gaiha GD, 2019, SCIENCE, V364, P480, DOI 10.1126/science.aav5095; Gaiha GD, 2014, IMMUNITY, V41, P1001, DOI 10.1016/j.immuni.2014.12.011; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabar S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184441; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Jiang CY, 2020, NATURE, V585, P261, DOI 10.1038/s41586-020-2651-8; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Koofhethile CK, 2016, J VIROL, V90, P6818, DOI 10.1128/JVI.00276-16; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee GQ, 2017, J CLIN INVEST, V127, P2689, DOI 10.1172/JCI93289; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Leon A, 2016, AIDS, V30, P1209, DOI 10.1097/QAD.0000000000001050; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Llano A, 2019, HIV MOL IMMUNOLOGY; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2020, J VIROL, V94, DOI 10.1128/JVI.01595-20; Migueles SA, 2015, NAT IMMUNOL, V16, P563, DOI 10.1038/ni.3161; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Ndhlovu ZM, 2013, BLOOD, V121, P801, DOI 10.1182/blood-2012-06-436295; Nguyen S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax4077; Noel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131922; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pernas M, 2018, J VIROL, V92, DOI 10.1128/JVI.01805-17; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pohlmeyer CW, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-152; Preston GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077537; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Reuter MA, 2017, CELL REP, V21, P3458, DOI 10.1016/j.celrep.2017.11.075; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Gallego E, 2019, J INFECT DIS, V219, P867, DOI 10.1093/infdis/jiy599; Rogan DC, 2021, CURR HIV-AIDS REP, V18, P211, DOI 10.1007/s11904-021-00545-2; Rosas-Umbert M, 2019, J VIROL, V93, DOI 10.1128/JVI.01436-18; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rutishauser RL, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.136648; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Schober SL, 1999, J IMMUNOL, V163, P3662; Sekine T, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba7918; Tarancon-Diez L, 2019, EBIOMEDICINE, V42, P86, DOI 10.1016/j.ebiom.2019.03.004; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tully DC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005619; Villani AC, 2017, METHODS MOL BIOL, V1514, P203, DOI 10.1007/978-1-4939-6548-9_16; Wang K, 2012, ANN HUM GENET, V76, P402, DOI 10.1111/j.1469-1809.2012.00718.x; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Yang OO, 2017, AIDS, V31, P1090, DOI 10.1097/QAD.0000000000001443; Yang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-674; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475; Zyla J, 2019, BIOINFORMATICS, V35, P5146, DOI 10.1093/bioinformatics/btz447	87	6	6	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2372	+		10.1016/j.immuni.2021.08.007	http://dx.doi.org/10.1016/j.immuni.2021.08.007		OCT 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34496223	Green Accepted, Bronze			2022-12-18	WOS:000706854100021
J	Haykin, H; Rolls, A				Haykin, Hedva; Rolls, Asya			The neuroimmune response during stress: A physiological perspective	IMMUNITY			English	Review							REGULATORY T-CELLS; DEPRESSIVE-LIKE BEHAVIOR; PITUITARY-ADRENAL AXIS; INNATE LYMPHOID-CELLS; IMMUNE-SYSTEM; PSYCHOLOGICAL-STRESS; BETA(2)-ADRENERGIC RECEPTOR; DIFFERENTIAL CONTROL; SEX-DIFFERENCES; HEALTHY-MEN	Stress is an essential adaptive response that enables the organism to cope with challenges and restore homeostasis. Different stressors require distinctive corrective responses in which immune cells play a critical role. Hence, effects of stress on immunity may vary accordingly. Indeed, epidemiologically, stress can induce either inflammation or immune suppression in an organism. However, in the absence of a conceptual framework, these effects appear chaotic, leading to confusion. Here, we examine how stressor diversity is imbedded in the neuroimmune axis. Stressors differ in the brain patterns they induce, diversifying the neuronal and endocrine mediators dispatched to the periphery and generating a wide range of potential immune effects. Uncovering this complexity and diversity of the immune response to different stressors will allow us to understand the involvement of stress in pathological conditions, identify ways to modulate it, and even harness the therapeutic potential embedded in an adaptive response to stress.	[Haykin, Hedva; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, IL-3525422 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, IL-3525422 Haifa, Israel.	rolls@technion.ac.il		Rolls, Asya/0000-0001-5862-4287	Israel Science Foundation (ISF); Adelis Foundation; European Research Council (ERC; NEIMO STG); Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain; Colleck Research Fund; international Howard Hughes Medical Institute HHMI-Wellcome Trust scholar	Israel Science Foundation (ISF)(Israel Science Foundation); Adelis Foundation; European Research Council (ERC; NEIMO STG)(European Research Council (ERC)); Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain; Colleck Research Fund; international Howard Hughes Medical Institute HHMI-Wellcome Trust scholar	We would like to thank H. Azulay-Debby, M. Reshef, M. Amer, E. Avishai, T. Haran, and R. Yifa for helpful discussions. We thank S. Schwarzbaum for thoughtful input and editing the manuscript. A.R is an international Howard Hughes Medical Institute HHMI-Wellcome Trust scholar, and we are grateful for their funding as well as to the Israel Science Foundation (ISF), Adelis Foundation, European Research Council (ERC; NEIMO STG), Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain, and Colleck Research Fund for their financial support. The figures created with Bio-Render.com.	Abe C, 2017, NAT NEUROSCI, V20, P700, DOI 10.1038/nn.4526; Agac D, 2018, BRAIN BEHAV IMMUN, V74, P176, DOI 10.1016/j.bbi.2018.09.004; AKIL H, 1985, SCIENCE, V227, P424, DOI 10.1126/science.3155575; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Babb JA, 2013, NEUROSCIENCE, V234, P40, DOI 10.1016/j.neuroscience.2012.12.051; Ben-Shaanan TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05283-5; Ben-Shaanan TL, 2016, NAT MED, V22, P940, DOI 10.1038/nm.4133; Berger JM, 2019, CELL METAB, V30, P890, DOI 10.1016/j.cmet.2019.08.012; Besedovsky HO, 2007, BRAIN BEHAV IMMUN, V21, P34, DOI 10.1016/j.bbi.2006.09.008; BODNAR RJ, 1978, PHARMACOL BIOCHEM BE, V8, P667, DOI 10.1016/0091-3057(78)90264-2; Bollinger JL, 2020, NEUROPSYCHOPHARMACOL, V45, P1766, DOI 10.1038/s41386-020-0720-1; Brede M, 2003, MOL ENDOCRINOL, V17, P1640, DOI 10.1210/me.2003-0035; Broug-Holub E, 1998, AM J RESP CELL MOL, V19, P842, DOI 10.1165/ajrcmb.19.5.3103; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Carnevale D, 2014, IMMUNITY, V41, P737, DOI 10.1016/j.immuni.2014.11.002; Carter CS, 2020, PHARMACOL REV, V72, P829, DOI 10.1124/pr.120.019398; Casnici C, 2018, INFLAMMATION, V41, P1648, DOI 10.1007/s10753-018-0808-5; Chen CS, 2021, CURR OPIN PHYSIOL, V19, P73, DOI 10.1016/j.cophys.2020.09.009; Chikazoe J, 2014, NAT NEUROSCI, V17, P1114, DOI 10.1038/nn.3749; Clodi M, 2008, AM J PHYSIOL-ENDOC M, V295, pE686, DOI 10.1152/ajpendo.90263.2008; Cohen H, 2006, J NEUROBIOL, V66, P552, DOI 10.1002/neu.20249; Cortal A, 2021, NAT BIOTECHNOL, V39, P1095, DOI 10.1038/s41587-021-00896-6; Crum AJ, 2020, EMOTION, V20, P120, DOI 10.1037/emo0000670; Danese A, 2017, NEUROPSYCHOPHARMACOL, V42, P99, DOI 10.1038/npp.2016.198; Daviu N, 2020, NAT NEUROSCI, V23, P398, DOI 10.1038/s41593-020-0591-0; Deschamps S, 2003, J NEUROENDOCRINOL, V15, P486, DOI 10.1046/j.1365-2826.2003.01022.x; Devi S, 2021, IMMUNITY, V54, P1219, DOI 10.1016/j.immuni.2021.03.025; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Diaz-Salazar C, 2020, J EXP MED, V217, DOI 10.1084/jem.20190549; Dieckmann L, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0730-0; Ding XF, 2019, CELL REP, V27, P3799, DOI 10.1016/j.celrep.2019.05.082; Du Preez A, 2021, BRAIN BEHAV IMMUN, V91, P24, DOI 10.1016/j.bbi.2020.07.015; Du Preez A, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01000-3; Duque ED, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00078; Ebner K, 2017, CURR OPIN BEHAV SCI, V14, P54, DOI 10.1016/j.cobeha.2016.11.016; Edwards SL, 1996, NEUROSCIENCE, V70, P825, DOI 10.1016/S0306-4522(96)83019-3; Estrada LD, 2016, EUR J IMMUNOL, V46, P1948, DOI 10.1002/eji.201646395; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Fink G., 2017, REFERENCE MODULE NEU, P1, DOI [10.1016/b978-0-12-809324-5.02208-2, DOI 10.1016/B978-0-12-809324-5.02208-2]; Forkosh O, 2019, NAT NEUROSCI, V22, P2023, DOI 10.1038/s41593-019-0516-y; Gao XH, 2018, P NATL ACAD SCI USA, V115, pE2960, DOI 10.1073/pnas.1720696115; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Godoy LD, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00127; Goldfarb EV, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16492-2; Grailer JJ, 2014, J INNATE IMMUN, V6, P607, DOI 10.1159/000358524; Gray M, 2012, NEUROPSYCHOPHARMACOL, V37, P2712, DOI 10.1038/npp.2012.136; Guereschi MG, 2013, EUR J IMMUNOL, V43, P1001, DOI 10.1002/eji.201243005; Hale MW, 2011, EXP NEUROL, V227, P264, DOI 10.1016/j.expneurol.2010.11.012; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Herrmann M, 2000, RHEUM DIS CLIN N AM, V26, P737, DOI 10.1016/S0889-857X(05)70167-8; Ho TC, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.642976; Hodes GE, 2015, J NEUROSCI, V35, P16362, DOI 10.1523/JNEUROSCI.1392-15.2015; Hong JY, 2020, CELL, V180, P847, DOI 10.1016/j.cell.2020.02.018; Horchar MJ, 2019, BRAIN BEHAV IMMUN, V81, P329, DOI 10.1016/j.bbi.2019.06.030; Huang JL, 2012, INFLAMMATION, V35, P527, DOI 10.1007/s10753-011-9342-4; Imami AS, 2020, PHYSIOL GENOMICS, V52, P401, DOI 10.1152/physiolgenomics.00095.2020; Iriki M, 2012, J PHYSIOL SCI, V62, P275, DOI 10.1007/s12576-012-0208-9; Jaeger M, 2021, IMMUNOLOGY, V163, P155, DOI 10.1111/imm.13306; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Jezova D, 2007, STRESS, V10, P205, DOI 10.1080/10253890701292168; Karagiannis TT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16159-y; Karl JP, 2017, AM J PHYSIOL-GASTR L, V312, pG559, DOI 10.1152/ajpgi.00066.2017; Kertser A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4111; Kim D, 2020, IMMUNITY, V53, P581, DOI 10.1016/j.immuni.2020.07.002; Kim WB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15121-2; Kleiner S, 2021, J ALLERGY CLIN IMMUN, V147, P1521, DOI 10.1016/j.jaci.2020.12.645; Koenen J, 2019, MOL PHARMACOL, V96, P809, DOI 10.1124/mol.118.115329; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Kressel AM, 2020, P NATL ACAD SCI USA, V117, P29803, DOI 10.1073/pnas.2008213117; Labuz D, 2009, J CLIN INVEST, V119, P278, DOI [10.1172/JCI36246, 10.1172/JCI36246C1]; Lafrance M, 2010, NEUROSCIENCE, V166, P639, DOI 10.1016/j.neuroscience.2009.12.042; Lennartsson AK, 2011, PSYCHONEUROENDOCRINO, V36, P1530, DOI 10.1016/j.psyneuen.2011.04.007; Lewitus GM, 2008, BRAIN BEHAV IMMUN, V22, P1108, DOI 10.1016/j.bbi.2008.05.002; Li SB, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc2590; Li YF, 2019, BRAIN IMAGING BEHAV, V13, P1780, DOI 10.1007/s11682-018-9956-3; Limbachia C, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01537-5; Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316; LOOKINGLAND KJ, 1991, NEUROENDOCRINOLOGY, V53, P91, DOI 10.1159/000125703; Lucas M, 2014, STRESS, V17, P423, DOI 10.3109/10253890.2014.930430; Macfarlane E, 2020, BONE RES, V8, DOI 10.1038/s41413-020-00112-2; MADDEN J, 1977, NATURE, V265, P358, DOI 10.1038/265358a0; Marsland AL, 2017, BRAIN BEHAV IMMUN, V62, P162, DOI 10.1016/j.bbi.2017.01.013; Maryanovich M, 2018, NAT MED, V24, P782, DOI 10.1038/s41591-018-0030-x; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.1993.00410180039004; Mckim DB, 2018, CELL REP, V25, P2552, DOI 10.1016/j.celrep.2018.10.102; Meyrath M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16664-0; Miller ES, 2019, AM J SURG, V218, P677, DOI 10.1016/j.amjsurg.2019.07.006; Miller WL, 2018, HORM RES PAEDIAT, V89, P212, DOI 10.1159/000487755; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Moyano J, 2019, REV ASSOC MED BRAS, V65, P262, DOI 10.1590/1806-9282.65.2.262; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Muller PA, 2020, NATURE, V583, P441, DOI 10.1038/s41586-020-2474-7; Neumann ID, 2000, REGUL PEPTIDES, V96, P31, DOI 10.1016/S0167-0115(00)00197-X; Nishitani N, 2019, NEUROPSYCHOPHARMACOL, V44, P721, DOI 10.1038/s41386-018-0254-y; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Pavlovic S, 2011, J IMMUNOL, V186, P848, DOI 10.4049/jimmunol.0903878; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Qing H, 2020, CELL, V182, P372, DOI 10.1016/j.cell.2020.05.054; Ramot A, 2017, NAT NEUROSCI, V20, P385, DOI 10.1038/nn.4491; Rengarajan S, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100124; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Richter-Levin G, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01514-4; Sarjan HN, 2018, IMMUNOL LETT, V197, P31, DOI 10.1016/j.imlet.2018.02.008; Schiller M, 2021, IMMUNITY, V54, P1022, DOI 10.1016/j.immuni.2021.04.007; Schiller M, 2021, NAT REV IMMUNOL, V21, P20, DOI 10.1038/s41577-020-0387-1; Schneider A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56017-6; Schwartz M, 2012, HUM VACC IMMUNOTHER, V8, P1465, DOI 10.4161/hv.21649; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Seillet C, 2020, NAT IMMUNOL, V21, P168, DOI 10.1038/s41590-019-0567-y; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Shakiryanova D, 2005, NAT NEUROSCI, V8, P173, DOI 10.1038/nn1377; SHAVIT Y, 1984, SCIENCE, V223, P188, DOI 10.1126/science.6691146; Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004; Sloan EK, 2007, J NEUROSCI, V27, P8857, DOI 10.1523/JNEUROSCI.1247-07.2007; Sousa N, 2016, MOL PSYCHIATR, V21, P302, DOI 10.1038/mp.2015.196; Stevens FL, 2011, J NEUROPSYCH CLIN N, V23, P120, DOI 10.1176/appi.neuropsych.23.2.121; Su Q, 2017, J STEROID BIOCHEM, V171, P201, DOI 10.1016/j.jsbmb.2017.03.023; Sugita J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22178-0; Talbot J, 2020, NATURE, V579, P575, DOI 10.1038/s41586-020-2039-9; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Thorsell A, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvw012; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Bodegom M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00087; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wahle M, 2001, CYTOKINE, V16, P205, DOI 10.1006/cyto.2001.0965; Wiedermann FJ, 2018, OPEN MED-WARSAW, V13, P122, DOI 10.1515/med-2018-0020; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Wu W, 2014, GUT, V63, P1883, DOI 10.1136/gutjnl-2013-306083; Xiu FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069167; Xu CL, 2020, IMMUNITY, V53, P417, DOI 10.1016/j.immuni.2020.06.025; Xu XR, 2021, CNS NEUROSCI THER, V27, P206, DOI [10.1111/cns.13465, 10.13196/j.cims.2021.01.19]; Zelena D, 2009, J ENDOCRINOL, V202, P263, DOI 10.1677/JOE-09-0096; Zhang CX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64305-9; Zhang X, 2020, NATURE, V581, P204, DOI 10.1038/s41586-020-2235-7; Zhao B, 2011, CELL RES, V21, P741, DOI 10.1038/cr.2011.29; Zheng Jun-Qi, 1995, Okajimas Folia Anatomica Japonica, V72, P119; Zheng PY, 2009, GUT, V58, P1473, DOI 10.1136/gut.2009.181701	147	6	6	7	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1933	1947		10.1016/j.immuni.2021.08.023	http://dx.doi.org/10.1016/j.immuni.2021.08.023		SEP 2021	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	UQ0VB	34525336	Bronze			2022-12-18	WOS:000695789800006
J	Bhattacharjee, A; Burr, AHP; Overacre-Delgoffe, AE; Tometich, JT; Yang, DY; Huckestein, BR; Linehan, JL; Spencer, SP; Hall, JA; Harrison, OJ; da Fonseca, DM; Norton, EB; Belkaid, Y; Hand, TW				Bhattacharjee, Amrita; Burr, Ansen H. P.; Overacre-Delgoffe, Abigail E.; Tometich, Justin T.; Yang, Deyi; Huckestein, Brydie R.; Linehan, Jonathan L.; Spencer, Sean P.; Hall, Jason A.; Harrison, Oliver J.; da Fonseca, Denise Morais; Norton, Elizabeth B.; Belkaid, Yasmine; Hand, Timothy W.			Environmental enteric dysfunction induces regulatory T cells that inhibit local CD4+T cell responses and impair oral vaccine efficacy	IMMUNITY			English	Article							INVASIVE ESCHERICHIA-COLI; IMMUNE-RESPONSES; MUCOSAL IMMUNITY; RETINOIC ACID; TH17 CELLS; GUT; MICROBIOTA; IGA; COLONIZATION; ENTEROPATHY	Environmental enteric dysfunction (EED) is a gastrointestinal inflammatory disease caused by malnutrition and chronic infection. EED is associated with stunting in children and reduced efficacy of oral vaccines. To study the mechanisms of oral vaccine failure during EED, we developed a microbiota- and diet-dependent mouse EED model. Analysis of E. coli-labile toxin vaccine-specific CD4(+) T cells in these mice revealed impaired CD4(+) T cell responses in the small intestine and but not the lymph nodes. EED mice exhibited increased frequencies of small intestine-resident ROR gamma T(+)FOXP3(+) regulatory T (Treg) cells. Targeted deletion of ROR gamma T from Treg cells restored small intestinal vaccine-specific CD4 T cell responses and vaccine-mediated protection upon challenge. However, ablation of ROR gamma T(+)FOXP3(+) Treg cells made mice more susceptible to EED-induced stunting. Our findings provide insight into the poor efficacy of oral vaccines in EED and highlight how ROR gamma T(+)FOXP3(+) Treg cells can regulate intestinal immunity while leaving systemic responses intact.	[Bhattacharjee, Amrita; Burr, Ansen H. P.; Overacre-Delgoffe, Abigail E.; Tometich, Justin T.; Yang, Deyi; Hand, Timothy W.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, RK Mellon Inst Pediat Res, Pediat Dept, Pittsburgh, PA 15224 USA; [Burr, Ansen H. P.; Huckestein, Brydie R.; Hand, Timothy W.] Univ Pittsburgh, Sch Med, Dept Immunol, Program Microbiol & Immunol, Pittsburgh, PA 15261 USA; [Yang, Deyi] Cent South Univ, Xiangya Sch Med, Changsha, Peoples R China; [Linehan, Jonathan L.; Spencer, Sean P.; Hall, Jason A.; Harrison, Oliver J.; da Fonseca, Denise Morais; Belkaid, Yasmine] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Norton, Elizabeth B.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Linehan, Jonathan L.] Genentech Inc, San Francisco, CA 94080 USA; [Spencer, Sean P.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA; [Hall, Jason A.] ArsenalBio Inc, San Francisco, CA USA; [Harrison, Oliver J.] Benaroya Res Inst, Seattle, WA USA; [da Fonseca, Denise Morais] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tulane University; Roche Holding; Genentech; Stanford University; Benaroya Research Institute; Universidade de Sao Paulo	Hand, TW (corresponding author), Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, RK Mellon Inst Pediat Res, Pediat Dept, Pittsburgh, PA 15224 USA.; Hand, TW (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Program Microbiol & Immunol, Pittsburgh, PA 15261 USA.	timothy.hand@chp.edu	Hand, Timothy W/AAH-1216-2021	Hand, Timothy W/0000-0002-2684-9462; Spencer, Sean/0000-0002-7328-5399	National Institutes of Health [R21AI142051]; NIAID division of Intramural Research; FAPESP-JP [2015/25364-0]; R.K. Mellon Institute for Pediatric Research; UPMC Children's Hospital of Pittsburgh RAC award; Damon Runyon Cancer Research Foundation Postdoctoral Fellowship [2360-19]; NIH [T32AI089443]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FAPESP-JP; R.K. Mellon Institute for Pediatric Research; UPMC Children's Hospital of Pittsburgh RAC award; Damon Runyon Cancer Research Foundation Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (R21AI142051; T.W.H., NIAID division of Intramural Research; Y.B., FAPESP-JP 2015/25364-0; D.M.F.), the R.K. Mellon Institute for Pediatric Research (T.W.H.), and the UPMC Children's Hospital of Pittsburgh RAC award (A.B.). A.E.O. is supported by a Damon Runyon Cancer Research Foundation Postdoctoral Fellowship (2360-19), and A.H.P.B. is supported by a NIH T32 (T32AI089443). The authors would like to thank J. Michel and A. Styche for assistance with cell sorting, the UPMCChildren's Hospital of Pittsburgh Histology core for the preparation of tissue slides, and the University of Pittsburgh Division of Laboratory Animal Research. We would also like to thank D. Vignali (Foxp3eGFP-Cre-ERT2), K. Simpson (CUMT8 E. coli), R. Longman (2A E. coli), J. Fleckenstein (ETEC), and J. Williams (Foxp3DTR-GFP) for sharing critical reagents, and M. Pepper and M. Jenkins for assistance with making and using MHC class II tetramer reagents. We would like to thank the University of Pittsburgh Center for Research Computing for resources and assistance with microbiome sequence analysis. We would like to thank the members of the Hand, Belkaid, Poholek, and Canna labs for discussion and critical reading of the manuscript. The graphical abstract was produced using BioRender.	Abdel-Gadir A, 2019, NAT MED, V25, P1164, DOI 10.1038/s41591-019-0461-z; Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Bemark M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12698; Bhattacharjee A, 2018, CLIN SCI, V132, P1169, DOI [10.1042/CS20171106, 10.1042/cs20171106]; Blanton LV, 2016, SCIENCE, V352, DOI 10.1126/science.aad9359; Boehm F, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-97; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Burr AHP, 2020, J IMMUNOL, V205, P1479, DOI 10.4049/jimmunol.2000419; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Campbell DI, 2003, J NUTR, V133, P1332; Cao AT, 2012, J IMMUNOL, V189, P4666, DOI 10.4049/jimmunol.1200955; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Chen RY, 2020, NEW ENGL J MED, V383, P321, DOI 10.1056/NEJMoa1916004; Chiaranunt P, 2018, J IMMUNOL, V201, P243, DOI 10.4049/jimmunol.1800236; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Clements JD, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00215-18; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Di Luccia B, 2020, CELL HOST MICROBE, V27, P899, DOI 10.1016/j.chom.2020.04.008; Dickson BC, 2006, J CLIN PATHOL, V59, P1008, DOI 10.1136/jcp.2005.035345; Dogan B, 2014, INFLAMM BOWEL DIS, V20, P1919, DOI 10.1097/MIB.0000000000000183; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; GERSON CD, 1971, ANN INTERN MED, V75, P41, DOI 10.7326/0003-4819-75-1-41; Grassly NC, 2009, J INFECT DIS, V200, P794, DOI 10.1086/605330; Gribonika I, 2019, MUCOSAL IMMUNOL, V12, P1268, DOI 10.1038/s41385-019-0202-0; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hand TW, 2016, TRENDS ENDOCRIN MET, V27, P831, DOI 10.1016/j.tem.2016.08.003; Hand TW, 2016, TRENDS IMMUNOL, V37, P647, DOI 10.1016/j.it.2016.08.007; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Harro C, 2019, VACCINE, V37, P1978, DOI 10.1016/j.vaccine.2019.02.025; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kim M, 2018, IMMUNITY, V49, P151, DOI 10.1016/j.immuni.2018.05.009; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Leung JM, 2014, MUCOSAL IMMUNOL, V7, P124, DOI 10.1038/mi.2013.31; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lycke NY, 2017, MUCOSAL IMMUNOL, V10, P1361, DOI 10.1038/mi.2017.62; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurchy AN, 2012, EUR J IMMUNOL, V42, P27, DOI 10.1002/eji.201141651; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Naylor C, 2015, EBIOMEDICINE, V2, P1759, DOI 10.1016/j.ebiom.2015.09.036; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Omenetti S, 2019, IMMUNITY, V51, P77, DOI 10.1016/j.immuni.2019.05.004; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramirez JEV, 2017, ADV DRUG DELIVER REV, V114, P116, DOI 10.1016/j.addr.2017.04.008; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Roy K, 2011, CLIN VACCINE IMMUNOL, V18, P1803, DOI 10.1128/CVI.05217-11; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Schreiber F, 2015, J MOL BIOL, V427, P3676, DOI 10.1016/j.jmb.2015.10.013; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shaikh H, 2020, VACCINE, V38, pA118, DOI 10.1016/j.vaccine.2019.12.011; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Tumis ME, 2016, IMMUNITY, V44, P316, DOI 10.1016/j.immuni.2016.01.013; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Viladomiu M, 2021, CELL HOST MICROBE, V29, P607, DOI 10.1016/j.chom.2021.01.002; Vonaesch P, 2018, P NATL ACAD SCI USA, V115, pE8489, DOI 10.1073/pnas.1806573115; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988; Watanabe K, 2016, EBIOMEDICINE, V10, P25, DOI 10.1016/j.ebiom.2016.07.030; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yan YQ, 2021, IMMUNITY, V54, P499, DOI 10.1016/j.immuni.2021.02.002; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Zhao Q, 2017, J IMMUNOL, V199, P312, DOI 10.4049/jimmunol.1700171; Zhou L, 2019, NATURE, V568, P405, DOI 10.1038/s41586-019-1082-x	93	6	8	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1745	+		10.1016/j.immuni.2021.07.005	http://dx.doi.org/10.1016/j.immuni.2021.07.005		AUG 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34348118	Bronze, Green Accepted			2022-12-18	WOS:000684589700013
J	Krueger, PD; Goldberg, MF; Hong, SW; Osum, KC; Langlois, RA; Kotov, DI; Dileepan, T; Jenkins, MK				Krueger, Peter D.; Goldberg, Michael F.; Hong, Sung-Wook; Osum, Kevin C.; Langlois, Ryan A.; Kotov, Dmitri, I; Dileepan, Thamotharampillai; Jenkins, Marc K.			Two sequential activation modules control the differentiation of protective T helper-1 (Th1) cells	IMMUNITY			English	Article							CD4(+) T-CELLS; FOLLICULAR HELPER-CELL; MESENTERIC LYMPH-NODES; INFLUENZA-A VIRUS; TRANSCRIPTION FACTOR; TERMINAL DIFFERENTIATION; SALMONELLA-TYPHIMURIUM; LISTERIA-MONOCYTOGENES; INTERFERON-GAMMA; DENDRITIC CELLS	Interferon-gamma (IFN-gamma)-producing CD4(+) T helper-1 (Th1) cells are critical for protection from microbes that infect the phagosomes of myeloid cells. Current understanding of Th1 cell differentiation is based largely on reductionist cell culture experiments. We assessed Th1 cell generation in vivo by studying antigen-specific CD4(+) T cells during infection with the phagosomal pathogen Salmonella enterica (Se), or influenza A virus (IAV), for which CD4(+) T cells are less important. Both microbes induced T follicular helper (Tfh) and interleukin-12 (IL-12)-independent Th1 cells. During Se infection, however, the Th1 cells subsequently outgrew the Tfh cells via an IL-12-dependent process and formed subsets with increased IFN-gamma production, ZEB2-transcription factor-dependent cytotoxicity, and capacity to control Se infection. Our results indicate that many infections induce a module that generates Tfh and poorly differentiated Th1 cells, which is followed in phagosomal infections by an IL-12-dependent Th1 cell amplification module that is critical for pathogen control.	[Krueger, Peter D.; Goldberg, Michael F.; Hong, Sung-Wook; Osum, Kevin C.; Langlois, Ryan A.; Kotov, Dmitri, I; Dileepan, Thamotharampillai; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA; [Goldberg, Michael F.] BostonGene, Univ Off Pk 3,95 Sawyer Rd, Waltham, MA 02453 USA; [Kotov, Dmitri, I] Univ Calif Berkeley, 415 Life Sci Addit, Berkeley, CA 94720 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	; Jenkins, Marc/G-1063-2012	Hong, Sung-Wook/0000-0001-9718-726X; DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996; Jenkins, Marc/0000-0001-8009-7655	US National Institutes of Health [R01 AI039614, R01 AI103760, T32 AI83196, T32 HL007062]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the US National Institutes of Health R01 AI039614 and R01 AI103760 to M.K.J., T32 AI83196 to D.I.K., and T32 HL007062 to P. D. K. and M.F.G. The authors acknowledge Jennifer Walter and Charles Elwood for their help with maintaining mice and Juan Abrahante Llorens for his help with analysis of RNA sequence data.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; ALLAN W, 1990, J IMMUNOL, V144, P3980; BALDRIDGE JR, 1990, INFECT IMMUN, V58, P654, DOI 10.1128/IAI.58.3.654-658.1990; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Batista Nathalia V, 2020, Immunohorizons, V4, P701, DOI 10.4049/immunohorizons.2000059; Benoun JM, 2018, P NATL ACAD SCI USA, V115, P10416, DOI 10.1073/pnas.1808339115; Califano D, 2018, MUCOSAL IMMUNOL, V11, P209, DOI 10.1038/mi.2017.41; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chu HH, 2016, IMMUNITY, V45, P159, DOI 10.1016/j.immuni.2016.06.013; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; De Giovanni M, 2020, NAT IMMUNOL, V21, P321, DOI 10.1038/s41590-020-0596-6; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Elsner RA, 2019, CELL REP, V29, P2796, DOI 10.1016/j.celrep.2019.10.069; Goldberg MF, 2018, IMMUNITY, V49, P1090, DOI 10.1016/j.immuni.2018.10.009; Golstein P, 2018, NAT REV IMMUNOL, V18, P526, DOI 10.1038/s41577-018-0009-3; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hemann EA, 2019, NAT IMMUNOL, V20, P1035, DOI 10.1038/s41590-019-0408-z; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; HSIEH CS, 1993, INT IMMUNOL, V5, P371; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Ishikawa H, 2016, J MED VIROL, V88, P1487, DOI 10.1002/jmv.24494; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Johanns TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001043; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaplanski G, 2018, IMMUNOL REV, V281, P138, DOI 10.1111/imr.12616; Karunakaran KP, 2017, J PROTEOME RES, V16, P298, DOI 10.1021/acs.jproteome.6b00926; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Kostense S, 1998, ANTIVIR RES, V38, P117, DOI 10.1016/S0166-3542(98)00019-9; Kotov DI, 2019, J IMMUNOL, V202, P2535, DOI 10.4049/jimmunol.1801609; Kotov DI, 2018, J IMMUNOL, V200, P2004, DOI 10.4049/jimmunol.1700420; Krishnamoorthy V, 2017, IMMUNITY, V47, P481, DOI 10.1016/j.immuni.2017.09.001; Kunzli M, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay5552; LADEL CH, 1994, J IMMUNOL, V153, P3116; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Linehan JL, 2015, P NATL ACAD SCI USA, V112, P12782, DOI 10.1073/pnas.1513532112; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Monteiro JM, 1998, J VIROL, V72, P4825, DOI 10.1128/JVI.72.6.4825-4831.1998; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nelson RW, 2013, J IMMUNOL, V190, P2828, DOI 10.4049/jimmunol.1202183; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Oxenius A, 1999, J IMMUNOL, V162, P965; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Quah BJC, 2013, J IMMUNOL METHODS, V387, P181, DOI 10.1016/j.jim.2012.10.013; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sallin MA, 2017, CELL REP, V18, P3091, DOI 10.1016/j.celrep.2017.03.007; Schijns VECJ, 1998, J IMMUNOL, V160, P3958; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; SCOTT P, 1991, J IMMUNOL, V147, P3149; Sun B, 2014, ADV EXP MED BIOL, V841, P1, DOI 10.1007/978-94-017-9487-9_1; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Tubo NJ, 2016, SCIENCE, V351, P511, DOI 10.1126/science.aad0483; Tubo NJ, 2014, CLIN MICROBIOL REV, V27, P200, DOI 10.1128/CMR.00097-13; Turner DL, 2013, J VIROL, V87, P4496, DOI 10.1128/JVI.03413-12; van der Sluijs KF, 2006, ANTIVIR RES, V70, P75, DOI 10.1016/j.antiviral.2006.01.007; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Xing Z, 2001, CELL MOL BIOL, V47, P689; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	83	6	7	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					687	+		10.1016/j.immuni.2021.03.006	http://dx.doi.org/10.1016/j.immuni.2021.03.006		APR 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33773107	Green Accepted, Bronze			2022-12-18	WOS:000640102800011
J	Villar, J; Segura, E				Villar, Javiera; Segura, Elodie			The More, the Merrier: DC3s Join the Human Dendritic Cell Family	IMMUNITY			English	Editorial Material								Recent studies have reported additional subpopulations of human dendritic cells (DCs), but whether they are distinct subsets has been unclear. In this issue of Immunity, Cytlak et al. and Bourdely et al. show that DC3s possess a specific precursor and represent a separate DC lineage.	[Villar, Javiera; Segura, Elodie] PSL Res Univ, Inst Curie, INSERM, U932, 26 Rue Ulm, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Segura, E (corresponding author), PSL Res Univ, Inst Curie, INSERM, U932, 26 Rue Ulm, Paris, France.	elodie.segura@curie.fr		Villar, Javiera/0000-0002-8581-4155; Segura, Elodie/0000-0003-1795-1921	INSERM; Agence Nationale de la Recherche [ANR-17-CE15-0011-01]; ERC [666003]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission)	E.S. is supported by INSERM and Agence Nationale de la Recherche (ANR-17-CE15-0011-01). J.V. is a fellow of the IC-3i PhD program supported by the ERC Horizon 2020-Marie Sklodowska-Curie Actions (grant no. 666003). The authors wish to thank Me ' lanie Durand for graphic designing.	Bosteels C, 2020, IMMUNITY, V52, P1039, DOI 10.1016/j.immuni.2020.04.005; Bourdely P, 2020, IMMUNITY, V53, P335, DOI 10.1016/j.immuni.2020.06.002; Breton G, 2016, J EXP MED, V213, P2861, DOI 10.1084/jem.20161135; Cytlak U, 2020, IMMUNITY, V53, P353, DOI 10.1016/j.immuni.2020.07.003; Duluc D, 2013, MUCOSAL IMMUNOL, V6, P626, DOI 10.1038/mi.2012.104; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Michea Paula, 2018, Nat Immunol, V19, P885, DOI 10.1038/s41590-018-0145-8; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573	11	6	6	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					233	235		10.1016/j.immuni.2020.07.014	http://dx.doi.org/10.1016/j.immuni.2020.07.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814019	Bronze			2022-12-18	WOS:000561190600001
J	Bandyopadhyay, M; Larregina, AT				Bandyopadhyay, Mohna; Larregina, Adriana T.			Keratinocyte-Polyamines and Dendritic Cells: A Bad Duet for Psoriasis	IMMUNITY			English	Editorial Material								The role of keratinocyte metabolism in psoriasis is not fully elucidated. In this issue of Immunity, Lou et al. describe that interleukin-17 (IL-17) re-programs the urea cycle in keratinocytes increasing polyamines that stabilize RNA-Ag-complexes that upon cellular turnover activate dendritic cells, which amplify psoriasis inflammation.	[Bandyopadhyay, Mohna; Larregina, Adriana T.] Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15213 USA; [Larregina, Adriana T.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Larregina, Adriana T.] Univ Pittsburgh, Sch Med, McGowan Ctr Regenerat Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Larregina, AT (corresponding author), Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15213 USA.; Larregina, AT (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA.; Larregina, AT (corresponding author), Univ Pittsburgh, Sch Med, McGowan Ctr Regenerat Med, Pittsburgh, PA 15213 USA.	adrianal@pitt.edu						[Anonymous], TITLE ERROR, DOI 10.1016/j.bbi.2019.12.019; Bruch-Gerharz D, 2003, AM J PATHOL, V162, P203, DOI 10.1016/S0002-9440(10)63811-4; Cibrian D, 2020, TRENDS MOL MED, V26, P975, DOI 10.1016/j.molmed.2020.04.004; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Jones DA, 2004, J INVEST DERMATOL, V123, P93, DOI 10.1111/j.0022-202X.2004.22709.x; Rendon A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061475; Schoenen H, 2014, J IMMUNOL, V193, P3664, DOI 10.4049/jimmunol.1301593; Swindell WR, 2016, J INVEST DERMATOL, V136, P1820, DOI 10.1016/j.jid.2016.04.035; Yan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8652; Zhang ZZ, 2018, NAT MED, V24, P617, DOI 10.1038/s41591-018-0003-0	10	6	7	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					16	18		10.1016/j.immuni.2020.06.015	http://dx.doi.org/10.1016/j.immuni.2020.06.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668224	Bronze			2022-12-18	WOS:000551116800006
J	Neurath, MF; Chiriac, MT				Neurath, Markus F.; Chiriac, Mircea T.			Targeting Immune Cell Wiring in Ulcerative Colitis	IMMUNITY			English	Editorial Material								The cytokine TNF is thought to play a major role in the immunopathogenesis of ulcerative colitis, and anti-TNF antibodies are considered as cornerstones of clinical therapy. Two clinical trials published in The New England Journal of Medicine now challenge this paradigm and suggest new avenues for research.	[Neurath, Markus F.; Chiriac, Mircea T.] Univ Erlangen Nurnberg, Dept Med 1, Kussmaul Campus Med Res, Erlangen, Germany; [Neurath, Markus F.] DZI, Erlangen, Germany	University of Erlangen Nuremberg	Neurath, MF (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, Kussmaul Campus Med Res, Erlangen, Germany.; Neurath, MF (corresponding author), DZI, Erlangen, Germany.	markus.neurath@uk-eriangen.de	Chiriac, Mircea T./AHB-7164-2022	Chiriac, Mircea T./0000-0002-9990-7862	Clinical Research Group 257 CEDER; Deutsche Forschungsgemeinschaft [SFB1181, TRR241, CH1428/2-1, FOR2438]; Interdisciplinary Center for Clinical Research (IZKF); Emerging Fields Initiative (EFI) of the Friedrich Alexander Universitat Erlangen-Nurnberg	Clinical Research Group 257 CEDER; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF); Emerging Fields Initiative (EFI) of the Friedrich Alexander Universitat Erlangen-Nurnberg	This work was supported by the following funders: Clinical Research Group 257 CEDER, the SFB1181, the TRR241, the grant CH1428/2-1, and the FOR2438 of the Deutsche Forschungsgemeinschaft, the Interdisciplinary Center for Clinical Research (IZKF), and the Emerging Fields Initiative (EFI) of the Friedrich Alexander Universitat Erlangen-Nurnberg.	Eftychi C, 2019, IMMUNITY, V51, P367, DOI 10.1016/j.immuni.2019.06.008; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kvedaraite E, 2016, GUT, V65, P1632, DOI 10.1136/gutjnl-2014-309014; Langer V., 2019, J CLIN INVEST; Neurath MF, 2019, CYTOKINE GROWTH F R, V45, P1, DOI 10.1016/j.cytogfr.2018.12.002; Sands BE, 2019, NEW ENGL J MED, V381, P1201, DOI 10.1056/NEJMoa1900750; Sands BE, 2019, NEW ENGL J MED, V381, P1215, DOI 10.1056/NEJMoa1905725; Schmitt H, 2019, GUT, V68, P814, DOI 10.1136/gutjnl-2017-315671; Zundler S, 2019, NAT IMMUNOL, V20, P288, DOI 10.1038/s41590-018-0298-5	10	6	8	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					791	793		10.1016/j.immuni.2019.10.011	http://dx.doi.org/10.1016/j.immuni.2019.10.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31747580	Bronze			2022-12-18	WOS:000497811300005
J	Becher, B; Waisman, A; Lu, LF				Becher, B.; Waisman, A.; Lu, L. F.			Cre-lox: Target Sensitivity Matters	IMMUNITY			English	Letter									[Becher, B.] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Waisman, A.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Obere Zahlbacher Str 67, D-55131 Mainz, Germany; [Lu, L. F.] Univ Calif San Diego, Ctr Microbiome Innovat, Div Biol Sci, La Jolla, CA 92093 USA; [Lu, L. F.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Zurich; Johannes Gutenberg University of Mainz; University of California System; University of California San Diego; University of California System; University of California San Diego	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Lu, Li-Fan/0000-0002-9727-0036				Mundt S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8380	1	6	6	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					595	595		10.1016/j.immuni.2019.09.012	http://dx.doi.org/10.1016/j.immuni.2019.09.012			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31618648	Bronze			2022-12-18	WOS:000490141700003
J	Aranda, CJ; de Lafaille, MAC				Aranda, Carlos J.; de lafaille, Maria A. Curotto			The Secret Life of IgE-Producing Cells	IMMUNITY			English	Editorial Material							ANTIBODIES	IgE antibodies are essential mediators of allergies. In a recent study in Science, Croote et al. (2018) characterize IgE cells isolated from individuals allergic to peanuts. Their findings provide insight into the differentiation of IgE cells in humans and have implications for our understanding of allergic disease.	[Aranda, Carlos J.; de lafaille, Maria A. Curotto] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10016 USA; [de lafaille, Maria A. Curotto] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	de Lafaille, MAC (corresponding author), NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10016 USA.; de Lafaille, MAC (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	maria.lafaille@med.nyu.edu	Aranda, Carlos J/K-3842-2014	Aranda, Carlos J/0000-0001-6224-9352; Curotto de Lafaille, Maria Alicia/0000-0002-3510-3777				Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Berkowska MA, 2014, J ALLERGY CLIN IMMUN, V134, P688, DOI 10.1016/j.jaci.2014.03.036; Croote D, 2018, SCIENCE, V362, P1306, DOI 10.1126/science.aau2599; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; He JS, 2015, CURR TOP MICROBIOL, V388, P1, DOI 10.1007/978-3-319-13725-4_1; Hofmaier S, 2015, J ALLERGY CLIN IMMUN, V135, P1367, DOI 10.1016/j.jaci.2014.09.048; Kiyotani K, 2018, J HUM GENET, V63, P239, DOI 10.1038/s10038-017-0364-0; Looney TJ, 2016, J ALLERGY CLIN IMMUN, V137, P579, DOI 10.1016/j.jaci.2015.07.014; Oettgen HC, 2016, J ALLERGY CLIN IMMUN, V137, P1631, DOI 10.1016/j.jaci.2016.04.009	10	6	6	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					285	287		10.1016/j.immuni.2019.01.018	http://dx.doi.org/10.1016/j.immuni.2019.01.018			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30784576	Bronze			2022-12-18	WOS:000459006700006
J	Lobel, L; Garrett, WS				Lobel, Lior; Garrett, Wendy S.			Butyrate Makes Macrophages "Go Nuclear'' against Bacterial Pathogens	IMMUNITY			English	Editorial Material							CHAIN FATTY-ACIDS; METABOLITES	Butyrate is a microbial metabolite with pleiotropic effects. Schulthess et al. (2019) report that butyrate pre-conditioning of macrophages enhances their anti-bacterial preparedness by inducing anti-microbial proteins that restrict bacterial growth. This study augments understanding of how microbial metabolites shape host defense.	[Lobel, Lior; Garrett, Wendy S.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Garrett, WS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wgarrett@hsph.harvard.edu	Lobel, Lior/AAW-4055-2021	Lobel, Lior/0000-0001-9146-5839; Garrett, Wendy/0000-0002-5092-0150				Akimova T, 2012, BLOOD, V119, P2443, DOI 10.1182/blood-2011-10-292003; Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Jacobson A, 2018, CELL HOST MICROBE, V24, P296, DOI 10.1016/j.chom.2018.07.002; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165	10	6	6	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					275	278		10.1016/j.immuni.2019.01.015	http://dx.doi.org/10.1016/j.immuni.2019.01.015			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30784572	Bronze			2022-12-18	WOS:000459006700002
J	Evans, AS; Coyne, CB				Evans, Azia S.; Coyne, Carolyn B.			RIPK3: Beyond Necroptosis	IMMUNITY			English	Editorial Material							PATHOGENESIS	In this issue of Immunity, Daniels et al. (2019) demonstrate that RIPK3 signaling limits Zika virus (ZIKV) infection in the central nervous system independently of its function in necroptosis by promoting itaconate production in infected neurons, thereby revealing a neuron-specific mechanism of metabolite-mediated ZIKV control.	[Evans, Azia S.; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Evans, Azia S.; Coyne, Carolyn B.] UPMC Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA USA; [Coyne, Carolyn B.] UPMC Childrens Hosp Pittsburgh, RK Mellon Inst Pediat Res, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Coyne, CB (corresponding author), UPMC Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA USA.; Coyne, CB (corresponding author), UPMC Childrens Hosp Pittsburgh, RK Mellon Inst Pediat Res, Pittsburgh, PA 15219 USA.	coynec2@pitt.edu		Evans, Azia/0000-0002-8309-5222	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081759] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Daniels BP, 2019, IMMUNITY, V50, P64, DOI 10.1016/j.immuni.2018.11.017; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Maximova OA, 2018, ANNU REV VIROL, V5, P255, DOI 10.1146/annurev-virology-092917-043439; Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004; Nair S, 2015, CURR OPIN IMMUNOL, V36, P47, DOI 10.1016/j.coi.2015.06.011; Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1	8	6	6	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					1	3		10.1016/j.immuni.2018.12.031	http://dx.doi.org/10.1016/j.immuni.2018.12.031			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650369	Bronze			2022-12-18	WOS:000455661600001
J	Kim, CJ; Lee, CG; Jung, JY; Ghosh, A; Hasan, SN; Hwang, SM; Kang, H; Lee, C; Kim, GC; Rudra, D; Suh, CH; Im, SH				Kim, Chan Johng; Lee, Choong-Gu; Jung, Ju-Yang; Ghosh, Ambarnil; Hasan, Syed Nurul; Hwang, Sung-Min; Kang, Hyeji; Lee, Changhon; Kim, Gi-Cheon; Rudra, Dipayan; Suh, Chang-Hee; Im, Sin-Hyeog			The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus (vol 49, pg 1034, 2018)	IMMUNITY			English	Correction												iimsh@postech.ac.kr	Im, Sin-Hyeog/AAM-9586-2021; HASAN, SYED NURUL/E-2647-2019; Im, Sin-Hyeog/E-6811-2013; Rudra, Dipayan/AAZ-5426-2020	Im, Sin-Hyeog/0000-0002-3173-1856; HASAN, SYED NURUL/0000-0002-4564-872X; Im, Sin-Hyeog/0000-0002-3173-1856; Rudra, Dipayan/0000-0002-9667-5891; Hwang, Sung-Min/0000-0002-4868-147X				Kim CJ, 2018, IMMUNITY, V49, P1034, DOI 10.1016/j.immuni.2018.10.012	1	6	6	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					272	272		10.1016/j.immuni.2018.12.023	http://dx.doi.org/10.1016/j.immuni.2018.12.023			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650378	Bronze			2022-12-18	WOS:000455661600025
J	Thommen, DS				Thommen, Daniela S.			The First Shall (Be) Last: Understanding Durable T Cell Responses in Immunotherapy	IMMUNITY			English	Editorial Material								Efforts to understand how cancer immunotherapy restores anti-tumor T cell responses have largely concentrated on assessing the reactivation of dysfunctional T cells. In this issue of Immunity, Kurtulus et al. (2019) and Siddiqui et al. (2019) provide evidence that durable anti-tumor responses require less differentiated T cells that express the transcription factor Tcf1 and sustain the tumor-reactive T cell pool.	[Thommen, Daniela S.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Thommen, DS (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.thommen@nki.nl	Thommen, Daniela/AAS-1669-2020	Thommen, Daniela/0000-0002-7431-2854				Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021	10	6	6	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					6	8		10.1016/j.immuni.2018.12.029	http://dx.doi.org/10.1016/j.immuni.2018.12.029			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650381	Bronze			2022-12-18	WOS:000455661600003
J	Wu, B; Zhang, S; Guo, ZL; Wang, G; Zhang, G; Xie, L; Lou, JT; Chen, X; Wu, D; Bergmeier, W; Zheng, JN; Wan, YSY				Wu, Bing; Zhang, Song; Guo, Zengli; Wang, Gang; Zhang, Ge; Xie, Ling; Lou, Jitong; Chen, Xian; Wu, Di; Bergmeier, Wolfgang; Zheng, Junnian; Wan, Yisong Y.			RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs	IMMUNITY			English	Article							INTERFERON-REGULATORY FACTOR-4; TH17 CELLS; TRANSCRIPTION FACTOR; T(H)17 CELLS; IN-VIVO; LINEAGE COMMITMENT; GENE-EXPRESSION; TGF-BETA; DIFFERENTIATION; INFLAMMATION	Pathogenic Th17 (pTh17) cells drive inflammation and immune-pathology, but whether pTh17 cells are a Th17 cell subset whose generation is under specific molecular control remains unaddressed. We found that Ras p21 protein activator 3 (RASA3) was highly expressed by pTh17 cells relative to non-pTh17 cells and was required specifically for pTh17 generation in vitro and in vivo. Mice conditionally deficient for Rasa3 in T cells showed less pathology during experimental autoimmune encephalomyelitis. Rasa3-deficient T cells acquired a Th2 cell-biased program that dominantly trans-suppressed pTh17 cell generation via interleukin 4 production. The Th2 cell bias of Rasa3-deficient T cells was due to aberrantly elevated transcription factor IRF4 expression. RASA3 promoted proteasome-mediated IRF4 protein degradation by facilitating interaction of IRF4 with E3-ubiquitin ligase Cbl-b. Therefore, a RASA3-IRF4-Cbl-b pathway specifically directs pTh17 cell generation by balancing reciprocal Th17-Th2 cell programs. These findings indicate that a distinct molecular program directs pTh17 cell generation and reveals targets for treating pTh17 cell-related pathology and diseases.	[Wu, Bing; Zhang, Song; Guo, Zengli; Wang, Gang; Zhang, Ge; Xie, Ling; Chen, Xian; Wan, Yisong Y.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wu, Bing; Zhang, Song; Guo, Zengli; Wang, Gang; Zhang, Ge; Wan, Yisong Y.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Wang, Gang; Zheng, Junnian] Xuzhou Med Univ, Inst Canc, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou 221002, Jiangsu, Peoples R China; [Zhang, Ge] Dalian Med Univ, Dept Immunol, Dalian 116044, Peoples R China; [Xie, Ling; Chen, Xian; Bergmeier, Wolfgang] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Lou, Jitong; Wu, Di] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27515 USA; [Wu, Di] Univ N Carolina, Sch Dent, Dept Periodontol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Xuzhou Medical University; Dalian Medical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wan, YSY (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Wan, YSY (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Zheng, JN (corresponding author), Xuzhou Med Univ, Inst Canc, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou 221002, Jiangsu, Peoples R China.	jnzheng@xzmc.edu.cn; wany@email.unc.edu	Guo, Zengli/AAE-4706-2021; , UNC Flow Cytometry Core/AGU-9839-2022; Wu, Di/AAB-7566-2021; Wan, Yisong/ABE-1200-2021; Guo, Zengli/F-5743-2019	Guo, Zengli/0000-0003-2950-4790; Wu, Di/0000-0001-8331-2357; Wan, Yisong/0000-0003-4346-9717; Guo, Zengli/0000-0003-2950-4790; Zhang, Song/0000-0003-1492-8988; Wu, Bing/0000-0003-1656-3783; LOU, Jitong/0000-0002-1049-0416	Cancer Center Core Support Grant [P30 CA016086]; National Natural Science Foundation of China [81402549, LJQ2015033]; NIH/NHLBI [HL130404]; NIH/NIAID [AI097392, AI123193]; National Multiple Sclerosis Society [RG-1802-30483]; Yang Family Biomedical Scholars Award; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097392, R01AI123193] Funding Source: NIH RePORTER	Cancer Center Core Support Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Yang Family Biomedical Scholars Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Fisher (University of North Carolina Flow-cytometry facility support in part by P30 CA016086 Cancer Center Core Support Grant), supports from the National Natural Science Foundation of China (81402549, LJQ2015033) for G.Z., from NIH/NHLBI (HL130404) for W.B., and from NIH/NIAID (AI097392; AI123193), National Multiple Sclerosis Society (RG-1802-30483), and Yang Family Biomedical Scholars Award for Y.Y.W.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huber M, 2014, EUR J IMMUNOL, V44, P1886, DOI 10.1002/eji.201344279; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kathania M, 2016, NAT IMMUNOL, V17, P997, DOI 10.1038/ni.3488; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krishnamoorthy V, 2017, IMMUNITY, V47, P481, DOI 10.1016/j.immuni.2017.09.001; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Panzer M, 2012, J IMMUNOL, V188, P615, DOI 10.4049/jimmunol.1101164; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Qiao GL, 2014, CELL REP, V6, P709, DOI 10.1016/j.celrep.2014.01.012; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schurmans Stephane, 2015, Adv Biol Regul, V57, P153, DOI 10.1016/j.jbior.2014.09.006; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Stefanini L, 2015, J CLIN INVEST, V125, P1419, DOI 10.1172/JCI77993; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Zhang S, 2017, NATURE, V551, P105, DOI 10.1038/nature24283; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	57	6	7	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					886	+		10.1016/j.immuni.2018.09.004	http://dx.doi.org/10.1016/j.immuni.2018.09.004			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30446383	Green Accepted, Bronze			2022-12-18	WOS:000450752200014
J	Hill, AA; Diehl, GE				Hill, Andrea A.; Diehl, Gretchen E.			Identifying the Patterns of Pattern Recognition Receptors	IMMUNITY			English	Editorial Material							GUT MICROBIOTA; ANTICANCER IMMUNOSURVEILLANCE; HEALTH	Intestinal homeostasis requires microbial recognition that results in appropriate responses to commensals and pathogens. In this issue of Immunity, Price et al. (2018) map the in vivo expression of five toll-like receptors (TLR) in intestinal epithelia, revealing distinct spatio-temporal expression patterns that shape responses to TLR ligands.	[Hill, Andrea A.; Diehl, Gretchen E.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Hill, Andrea A.; Diehl, Gretchen E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Diehl, Gretchen E.] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Diehl, GE (corresponding author), Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA.; Diehl, GE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Diehl, GE (corresponding author), Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA.	gdiehl@bcm.edu		Diehl, Gretchen/0000-0002-1841-2842; McAlester, Andrea/0000-0002-7405-5915				Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Price AE, 2018, IMMUNITY, V49, P560, DOI 10.1016/j.immuni.2018.07.016; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Routy B, 2018, NAT REV CLIN ONCOL, V15, P382, DOI 10.1038/s41571-018-0006-2; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Yan H, 2018, BLOOD, V132, P559, DOI 10.1182/blood-2018-02-832519; Zitvogel L, 2016, CELL, V165, P276, DOI 10.1016/j.cell.2016.03.001	9	6	9	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					389	391		10.1016/j.immuni.2018.08.027	http://dx.doi.org/10.1016/j.immuni.2018.08.027			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30231979	Bronze			2022-12-18	WOS:000444909600006
J	Watts, ER; Walmsley, SR				Watts, Emily R.; Walmsley, Sarah R.			Getting DAMP(s) Wets the Whistle for Neutrophil Recruitment	IMMUNITY			English	Editorial Material								Neutrophil recruitment in response to pathogen invasion is mediated through "self'' tissue damage signals (DAMPs) and pathogen associated signals (PAMPs). In this issue of Immunity, Huang and Niethammer, (2018) demonstrate that DAMP signaling is a prerequisite for neutrophil recruitment.	[Watts, Emily R.; Walmsley, Sarah R.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Walmsley, SR (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	sarah.walmsley@ed.ac.uk		Walmsley, Sarah/0000-0001-9584-174X; Watts, Emily/0000-0001-6496-7366	Wellcome Trust [209220/Z/17/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Enyedi B, 2016, CELL, V165, P1160, DOI 10.1016/j.cell.2016.04.016; Enyedi B, 2013, NAT CELL BIOL, V15, P1123, DOI 10.1038/ncb2818; Henry KM, 2013, J LEUKOCYTE BIOL, V94, P633, DOI 10.1189/jlb.1112594; Hoenderdos K, 2013, AM J RESP CELL MOL, V48, P531, DOI 10.1165/rcmb.2012-0492TR; Huang C, 2018, IMMUNITY, V48, P1006, DOI 10.1016/j.immuni.2018.04.020; Nemeth T, 2012, IMMUNOL LETT, V143, P9, DOI 10.1016/j.imlet.2012.01.013; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395	7	6	8	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					846	848		10.1016/j.immuni.2018.04.027	http://dx.doi.org/10.1016/j.immuni.2018.04.027			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768171	Bronze, Green Submitted			2022-12-18	WOS:000432488600006
J	Montinaro, A; Walczak, H				Montinaro, Antonella; Walczak, Henning			Sterile Inflammation Fuels Gastric Cancer	IMMUNITY			English	Editorial Material							NF-KAPPA-B; RISK	Constitutively activated NF-kappa B signaling has long been known to be oncogenic. In this issue of Immunity, O'Reilly et al. (2018) unveil a link between loss of NF-kappa B1, aberrant STAT1 signaling, sterile inflammation, and the increased expression of immune checkpoint molecules as cancer drivers.	[Montinaro, Antonella; Walczak, Henning] UCL, UCL Canc Inst, Ctr Cell Death Canc & Inflammat CCCI, 72 Huntley St, London WC1E 6DD, England	University of London; University College London	Walczak, H (corresponding author), UCL, UCL Canc Inst, Ctr Cell Death Canc & Inflammat CCCI, 72 Huntley St, London WC1E 6DD, England.	h.walczak@ucl.ac.uk	Walczak, Henning/AAV-2214-2020	Walczak, Henning/0000-0002-6312-4591	Cancer Research UK (CRUK) programme grant [A17341]; Wellcome Trust Senior Investigator Award [096831/Z/11/Z]; European Research Council (ERC) advanced grant [294880]; CRUK Centre grant [515818]; CRUK Centre Network Accelerator Award on Cancer Immunotherapy (CITA) [525877]; Manchester-UCL CRUK Lung Cancer Centre of Excellence [522434]; National Institute for Health Research University College London Hospitals Biomedical Research Centre	Cancer Research UK (CRUK) programme grant; Wellcome Trust Senior Investigator Award(Wellcome Trust); European Research Council (ERC) advanced grant(European Research Council (ERC)); CRUK Centre grant; CRUK Centre Network Accelerator Award on Cancer Immunotherapy (CITA); Manchester-UCL CRUK Lung Cancer Centre of Excellence; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric)	The authors were supported by a Cancer Research UK (CRUK) programme grant (A17341), a Wellcome Trust Senior Investigator Award (096831/Z/11/Z), a European Research Council (ERC) advanced grant (294880) held by H.W., a CRUK Centre grant (515818), a CRUK Centre Network Accelerator Award on Cancer Immunotherapy (CITA) (525877), the Manchester-UCL CRUK Lung Cancer Centre of Excellence (522434), and the National Institute for Health Research University College London Hospitals Biomedical Research Centre.	Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Long JY, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0511-2; O'Reilly LA, 2018, IMMUNITY, V48, P570, DOI 10.1016/j.immuni.2018.03.003; Ott PA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0218-5; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Sun SC, 2013, TRENDS IMMUNOL, V34, P282, DOI 10.1016/j.it.2013.01.004; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011	10	6	7	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					481	483		10.1016/j.immuni.2018.03.011	http://dx.doi.org/10.1016/j.immuni.2018.03.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562199	Bronze, Green Submitted			2022-12-18	WOS:000427916900008
J	Boyd, AS; Rodrigues, NP				Boyd, Ashleigh S.; Rodrigues, Neil P.			Stem Cells Cycle toward Immune Surveillance	IMMUNITY			English	Editorial Material								Immune surveillance is an established regulatory mechanism that spares tissues from malignant transformation. Agudo et al. (2018) find that the chief cell type to generate tissues in the body-somatic stem cells-is subject to immune surveillance only during proliferation.	[Boyd, Ashleigh S.] UCL, Royal Free Hosp, UCL Div Surg & Intervent Sci, Dept Nanotechnol, London NW3 2PF, England; [Boyd, Ashleigh S.] UCL, Royal Free Hosp, UCL Inst Immun & Transplantat, London NW3 2QG, England; [Rodrigues, Neil P.] Cardiff Univ, Sch Biosci, European Canc Stem Cell Res Inst, Cardiff CF24 4HQ, Wales	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Cardiff University	Boyd, AS (corresponding author), UCL, Royal Free Hosp, UCL Div Surg & Intervent Sci, Dept Nanotechnol, London NW3 2PF, England.; Boyd, AS (corresponding author), UCL, Royal Free Hosp, UCL Inst Immun & Transplantat, London NW3 2QG, England.; Rodrigues, NP (corresponding author), Cardiff Univ, Sch Biosci, European Canc Stem Cell Res Inst, Cardiff CF24 4HQ, Wales.	a.boyd@ucl.ac.uk; rodriguesn@cardiff.ac.uk		Rodrigues, Neil/0000-0002-1925-7733				Agudo J, 2018, IMMUNITY, V48, P271, DOI 10.1016/j.immuni.2018.02.001; Artandi SE, 2015, CELL STEM CELL, V16, P578; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lloyd-Lewis B, 2017, TRENDS CELL BIOL, V27, P556, DOI 10.1016/j.tcb.2017.04.001; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038	9	6	6	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					187	190		10.1016/j.immuni.2018.02.006	http://dx.doi.org/10.1016/j.immuni.2018.02.006			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466747	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000425507800002
J	Dyck, L; Lynch, L				Dyck, Lydia; Lynch, Lydia			New Job for NK Cells: Architects of the Tumor Microenvironment	IMMUNITY			English	Editorial Material							RECEPTOR NKP46/NCR1; FIBRONECTIN; METASTASIS; MELANOMA		[Dyck, Lydia; Lynch, Lydia] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Lynch, Lydia] Harvard Med Sch, Boston, MA 02115 USA; [Lynch, Lydia] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Trinity College Dublin; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Lynch, L (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.; Lynch, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Lynch, L (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	llynch@bwh.harvard.edu	Lynch, Lydia/ABD-5598-2021	Lynch, Lydia/0000-0002-4273-4681				Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Glasner A, 2018, IMMUNITY, V48, P107, DOI 10.1016/j.immuni.2017.12.007; Glasner A, 2012, J IMMUNOL, V188, P2509, DOI 10.4049/jimmunol.1102461; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; Pellacani G, 2007, J INVEST DERMATOL, V127, P2759, DOI 10.1038/sj.jid.5700993; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Wang JP, 2017, J CANCER, V8, P674, DOI 10.7150/jca.16901	11	6	10	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					9	11		10.1016/j.immuni.2018.01.001	http://dx.doi.org/10.1016/j.immuni.2018.01.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343443	Bronze			2022-12-18	WOS:000422751600004
J	Lambrecht, BN				Lambrecht, Bart N.			TGF-beta Gives an Air of Exclusivity to Alveolar Macrophages	IMMUNITY			English	Editorial Material							TISSUE-RESIDENT MACROPHAGES; FETAL MONOCYTES; GM-CSF; ONTOGENY; DEVELOP; NICHE; CELLS	Tissue-resident macrophages shape the development and homeostasis of the organs that they colonize. Yu et al. (2017) demonstrate that, unique to the lung, the instructive cytokine TGF-beta collaborates with GM-CSF to induce the master transcription factor PPAR gamma to drive alveolar macrophage differentiation and maintenance early in life.	[Lambrecht, Bart N.] Univ Ghent, VIB Ctr Inflammat Res, Ghent, Belgium; [Lambrecht, Bart N.] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium; [Lambrecht, Bart N.] ErasmusMC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), Univ Ghent, VIB Ctr Inflammat Res, Ghent, Belgium.; Lambrecht, BN (corresponding author), Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium.; Lambrecht, BN (corresponding author), ErasmusMC, Dept Pulm Med, Rotterdam, Netherlands.	bart.lambrecht@ugent.be	Lambrecht, Bart N/K-2484-2014	Lambrecht, Bart N/0000-0003-4376-6834				Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; Garbi N, 2017, PFLUG ARCH EUR J PHY, V469, P561, DOI 10.1007/s00424-017-1965-3; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Meliopoulos VA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005804; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007	10	6	6	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					807	809		10.1016/j.immuni.2017.11.005	http://dx.doi.org/10.1016/j.immuni.2017.11.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166581	Bronze			2022-12-18	WOS:000416483700003
J	Mattapallil, MJ; Caspi, RR				Mattapallil, Mary J.; Caspi, Rachel R.			Compliments of Factor H: What's in it for AMD?	IMMUNITY			English	Editorial Material							MACULAR DEGENERATION	Genetic variations in complement factor H (CFH) confer greater risk for age-related macular degeneration (AMD). In this issue of Immunity, Calippe et al. (2017) uncover a non-canonical role for CFH in the inhibition of mononuclear phagocyte elimination from sub-retinal lesions, providing insight into the pathophysiology of AMD associated with CFH variants.	[Mattapallil, Mary J.; Caspi, Rachel R.] NEI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Caspi, RR (corresponding author), NEI, Bethesda, MD 20892 USA.	caspir@nei.nih.gov		Caspi, Rachel/0000-0002-7140-7671; Mattapallil, Mary/0000-0003-0615-7343	NIH/NEI Intramural grant [ZIA EY000184-34]; NATIONAL EYE INSTITUTE [ZIAEY000184] Funding Source: NIH RePORTER	NIH/NEI Intramural grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH/NEI Intramural grant ZIA EY000184-34 (R.R.C.) provided funding for this research.	Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Calippe B, 2017, IMMUNITY, V46, P261, DOI 10.1016/j.immuni.2017.01.006; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; He Shikun, 2006, Yan Ke Xue Bao, V22, P265; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Zhang M., 2016, OPHTHALMIC GENET	9	6	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					167	169		10.1016/j.immuni.2017.02.008	http://dx.doi.org/10.1016/j.immuni.2017.02.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228273	Bronze, Green Accepted			2022-12-18	WOS:000396410900003
J	Widenmaier, SB; Hotamisligil, GS				Widenmaier, Scott B.; Hotamisligil, Gokhan S.			Immune Cell Intolerance for Excess Cholesterol	IMMUNITY			English	Editorial Material							INFLAMMATION	Chronic metabolic challenges have severe consequences on physiological systems. In this issue of Immunity, Ito et al. (2016) show that defects in cholesterol metabolism in CD11c(+) immune cells result in impaired antigen presentation and ultimately in autoimmune disease.	[Widenmaier, Scott B.; Hotamisligil, Gokhan S.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Widenmaier, Scott B.; Hotamisligil, Gokhan S.] Harvard TH Chan Sch Publ Hlth, Sabri Ulker Ctr, Boston, MA 02115 USA; [Hotamisligil, Gokhan S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.; Hotamisligil, GS (corresponding author), Harvard TH Chan Sch Publ Hlth, Sabri Ulker Ctr, Boston, MA 02115 USA.; Hotamisligil, GS (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	ghotamis@hsph.harvard.edu		Widenmaier, Scott/0000-0001-5684-2707	NIH [AI116901, DK052539, HL125753]; Juvenile Diabetes Research Foundation [2-SRA-2016-147-Q-R]; Servier; UCB Pharmaceuticals; Canadian Institutes of Health Research fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Servier(Servier); UCB Pharmaceuticals(UCB Pharma SA); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR))	Studies in the G.S.H. laboratory are currently supported by grants from the NIH (AI116901, DK052539, HL125753) and the Juvenile Diabetes Research Foundation (2-SRA-2016-147-Q-R) as well as by sponsored research agreements from Servier and UCB Pharmaceuticals. S.B.W. was supported by a Canadian Institutes of Health Research fellowship. We are grateful to Kathryn Claiborn for her editorial input.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Henriksbo BD, 2015, ADIPOCYTE, V4, P232, DOI 10.1080/21623945.2015.1024394; Henriksbo BD, 2014, DIABETES, V63, P3742, DOI 10.2337/db13-1398; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ito A, 2016, IMMUNITY, V45, P1311, DOI 10.1016/j.immuni.2016.11.008; Khattri S, 2013, IMMUNOL RES, V56, P348, DOI 10.1007/s12026-013-8409-8; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793	9	6	6	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1186	1188		10.1016/j.immuni.2016.12.006	http://dx.doi.org/10.1016/j.immuni.2016.12.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002726	Bronze			2022-12-18	WOS:000392918100005
J	Rothenberg, EV				Rothenberg, Ellen V.			Multiple Curricula for B Cell Developmental Programming	IMMUNITY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; PROGENITORS; LEVEL	B-1 B cells differ from conventional B-2 B cells functionally, but how these differences relate to the ontogeny of these lineages has been unclear. Two recent Immunity articles, Kristiansen et al. (2016) and Montecino-Rodriguez et al. (2016), now provide insight into the origins of B-1 and B-2 B cells, revealing a multi-layered developmental program and successive waves of B cell precursors.	[Rothenberg, Ellen V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Rothenberg, Ellen/0000-0002-3901-347X				Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kobayashi M, 2014, P NATL ACAD SCI USA, V111, P12151, DOI 10.1073/pnas.1407370111; Kristiansen TA, 2016, IMMUNITY, V45, P346, DOI 10.1016/j.immuni.2016.07.014; Montecino-Rodriguez E, 2016, IMMUNITY, V45, P527, DOI 10.1016/j.immuni.2016.07.012; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Ramond C, 2014, NAT IMMUNOL, V15, P27, DOI 10.1038/ni.2782; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557	13	6	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					457	458		10.1016/j.immuni.2016.09.005	http://dx.doi.org/10.1016/j.immuni.2016.09.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27653594	Bronze			2022-12-18	WOS:000388454300001
J	Masuda, K; Kishimoto, T				Masuda, Kazuya; Kishimoto, Tadamitsu			CD5: A New Partner for IL-6	IMMUNITY			English	Editorial Material							B-CELLS; CANCER	IL-6-STAT3 axis is known as a key factor of tumor progression. In this issue of Immunity, Yu and colleagues (2016) show that IL-6-binding CD5, rather than IL-6 receptor-alpha in B cells, amplifies STAT3 activation via JAK-STAT signaling to promote cancer.	[Masuda, Kazuya; Kishimoto, Tadamitsu] Osaka Univ, Lab Immune Regulat, World Premier Int WPI Immunol Frontier Res Ctr IF, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Kishimoto, T (corresponding author), Osaka Univ, Lab Immune Regulat, World Premier Int WPI Immunol Frontier Res Ctr IF, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kishimoto@ifrec.osaka-u.ac.jp	Kishimoto, Tadamitsu/C-8470-2009					Mantovani A, 2011, NAT MED, V17, P285, DOI 10.1038/nm0311-285; Masuda K, 2016, J EXP MED, V213, P605, DOI 10.1084/jem.20151289; Szczepek AJ, 2001, EXP HEMATOL, V29, P1076, DOI 10.1016/S0301-472X(01)00682-8; Tabbekh M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22841; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Yang CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064159; Yang CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054029; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang CY, 2016, IMMUNITY, V44, P913, DOI 10.1016/j.immuni.2016.04.003	9	6	6	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					720	722		10.1016/j.immuni.2016.03.011	http://dx.doi.org/10.1016/j.immuni.2016.03.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096313	Bronze			2022-12-18	WOS:000374444300004
J	Johnson, MO; Rathmell, JC				Johnson, Marc O.; Rathmell, Jeffrey C.			AIF Is "Always In Fashion'' for T Cells	IMMUNITY			English	Editorial Material							METABOLISM; IMMUNITY	AIF has been known to have both apoptotic and metabolic roles. Green and colleagues show that T cells, but not B cells, rely on AIF to maintain mitochondrial electron transport and that metabolic, rather than apoptotic, pathways mediate this dependence.	[Johnson, Marc O.; Rathmell, Jeffrey C.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Vanderbilt Ctr Immunobiol, Nashville, TN 37232 USA	Vanderbilt University	Rathmell, JC (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Vanderbilt Ctr Immunobiol, Nashville, TN 37232 USA.	jeff.rathmell@vanderbilt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK105550] Funding Source: Medline; NIGMS NIH HHS [T32 GM007105] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blair D, 2012, BIOCHEM J, V448, P165, DOI 10.1042/BJ20121225; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; Milasta S, 2016, IMMUNITY, V44, P88, DOI 10.1016/j.immuni.2015.12.002; Prabhu SB, 2013, INDIAN J MED RES, V138, P577; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5	10	6	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					11	13		10.1016/j.immuni.2015.12.015	http://dx.doi.org/10.1016/j.immuni.2015.12.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789917	Green Accepted, Bronze			2022-12-18	WOS:000368347000006
J	Cyster, JG				Cyster, Jason G.			Germinal Centers: Gaining Strength from the Dark Side	IMMUNITY			English	Editorial Material							CELL-CYCLE; DIFFERENTIATION; SELECTION; FOXO1; MYC	Germinal center B cells exist in two conditions, a dark zone state and a light zone state. Two studies in this issue (Dominguez-Sola et al., 2015; Sander et al., 2015) report that Foxo1 deficiency causes an almost complete loss of dark zone cells and an inability to undergo robust antibody affinity maturation.	[Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu						Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Trinh DL, 2013, BLOOD, V121, P3666, DOI 10.1182/blood-2013-01-479865; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032	11	6	6	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1026	1028		10.1016/j.immuni.2015.11.019	http://dx.doi.org/10.1016/j.immuni.2015.11.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682975	Bronze			2022-12-18	WOS:000366846600003
J	van Den Berg, TK; van Bruggen, R				van den Berg, Timo K.; van Bruggen, Robin			Loss of CD47 Makes Dendritic Cells See Red	IMMUNITY			English	Editorial Material							HUMAN SPLEEN; EXPRESSION	Whereas dendritic cells (DCs) can be activated in many ways to trigger immunity, hardly anything is known about the mechanisms that counterbalance DC activation. Cyster and colleagues now demonstrate that the "self'' molecule CD47 on erythrocytes critically restricts splenic DC activation.	[van den Berg, Timo K.; van Bruggen, Robin] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van Den Berg, TK (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	k.vandenberg@sanquin.nl; r.vanbruggen@sanquin.nl	van den Berg, Timo K/AAC-2479-2022					Banerjee R, 2015, P NATL ACAD SCI USA, V112, P3062, DOI 10.1073/pnas.1418144112; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Ehrlich P., 1891, DEUT MED WOCHENSCHR, V17, P979, DOI [10.1055/s-0029-1206682, DOI 10.1055/S-0029-1206682]; Hempel C, 2014, MOL BIOCHEM PARASIT, V198, P29, DOI 10.1016/j.molbiopara.2014.11.003; KRAAL G, 1982, NATURE, V298, P377, DOI 10.1038/298377a0; Landsteiner K., 1900, CENTRALBL BAKTERIOL, V27, P357; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Pack M, 2008, IMMUNOLOGY, V123, P438, DOI 10.1111/j.1365-2567.2007.02710.x; Steiniger BS, 2015, IMMUNOLOGY, V145, P334, DOI 10.1111/imm.12469; Yi TS, 2015, IMMUNITY, V43, P764, DOI 10.1016/j.immuni.2015.08.021	10	6	7	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					622	624		10.1016/j.immuni.2015.09.008	http://dx.doi.org/10.1016/j.immuni.2015.09.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26488810	Bronze			2022-12-18	WOS:000363478700003
J	Bluestone, JA; Crellin, N; Trotta, E				Bluestone, Jeffrey A.; Crellin, Natasha; Trotta, Eleonora			IL-2: Change Structure . . . Change Function	IMMUNITY			English	Editorial Material							INTERLEUKIN-2	In this issue of Immunity, Spangler et al. and Mitra et al. demonstrate how structural changes in the IL-2 molecule alter interactions with the IL-2 receptor, leading to differential cellular targeting and biochemical responses and selective immune consequences.	[Bluestone, Jeffrey A.; Trotta, Eleonora] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Crellin, Natasha] Pfizer Ctr Therapeut Innovat, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Pfizer	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jeff.bluestone@ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046643] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI046643] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bayer AL, 2013, IMMUNOL RES, V57, P197, DOI 10.1007/s12026-013-8452-5; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Mitra S, 2015, IMMUNITY, V42, P826, DOI 10.1016/j.immuni.2015.04.018; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Van Gool F, 2014, BLOOD, V124, P3572, DOI 10.1182/blood-2014-07-587493	9	6	7	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					779	781		10.1016/j.immuni.2015.05.002	http://dx.doi.org/10.1016/j.immuni.2015.05.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992850	Bronze, Green Published			2022-12-18	WOS:000354827400001
J	Liew, FY				Liew, Foo Yew			Cigarette Smoke Resets the Alarmin IL-33 in COPD	IMMUNITY			English	Editorial Material							CELLS; DISEASE; CYTOKINE		[Liew, Foo Yew] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Liew, Foo Yew] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215006, Peoples R China	University of Glasgow; Soochow University - China	Liew, FY (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland.	foo.liew@glasgow.ac.uk						Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Qiu CA, 2013, IMMUNOLOGY, V138, P76, DOI 10.1111/imm.12020; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787	10	6	7	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					401	403		10.1016/j.immuni.2015.02.014	http://dx.doi.org/10.1016/j.immuni.2015.02.014			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786171	Bronze			2022-12-18	WOS:000351301900005
J	Molawi, K; Sieweke, MH				Molawi, Kaaweh; Sieweke, Michael H.			Monocytes Compensate Kupffer Cell Loss during Bacterial Infection	IMMUNITY			English	Editorial Material							CIRCULATING MONOCYTES; CARDIAC MACROPHAGES; CONTRIBUTE; POOL		[Molawi, Kaaweh; Sieweke, Michael H.] Aix Marseille Univ, UM2, CIML, F-13288 Marseille, France; [Molawi, Kaaweh; Sieweke, Michael H.] INSERM, U1104, F-13288 Marseille, France; [Molawi, Kaaweh; Sieweke, Michael H.] CNRS, UMR7280, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Sieweke, MH (corresponding author), Aix Marseille Univ, UM2, CIML, F-13288 Marseille, France.	sieweke@ciml.univ-mrs.fr	Sieweke, Michael/AAR-7515-2020	Sieweke, Michael/0000-0002-3228-9537				Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Perdiguero E.G., 2014, NATURE	9	6	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					10	12		10.1016/j.immuni.2014.12.032	http://dx.doi.org/10.1016/j.immuni.2014.12.032			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607453	Bronze			2022-12-18	WOS:000348197500005
J	Thauland, TJ; Butte, MJ				Thauland, Timothy J.; Butte, Manish J.			Taking T Cell Priming Down a Notch: Signaling through Notch Receptors Enhances T Cell Sensitivity to Antigen	IMMUNITY			English	Editorial Material							PATHWAY	Notch receptors are widely expressed and have recognized functions in thymocytes and mature T cells. In this issue, Laky et al. (2015) show that Notch interactions with Delta-like ligand 4 (DLL4) amplify priming of naive T cells.	[Thauland, Timothy J.; Butte, Manish J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University	Butte, MJ (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	manish.butte@stanford.edu	Butte, Manish/AAM-8604-2020; Butte, Manish/T-8860-2019	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595				Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Dongre A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00054; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Helbig C, 2012, P NATL ACAD SCI USA, V109, P9041, DOI 10.1073/pnas.1206044109; Laky K, 2015, IMMUNITY, V42, P80, DOI 10.1016/j.immuni.2014.12.027; Maekawa Y., 2014, NAT MED; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524	10	6	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					6	8		10.1016/j.immuni.2014.12.026	http://dx.doi.org/10.1016/j.immuni.2014.12.026			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607451	Bronze			2022-12-18	WOS:000348197500003
J	Kim, J; Kim, JH; Winau, F				Kim, Jessica; Kim, Ji Hyung; Winau, Florian			Thinking Inside the Box: Endogenous alpha-Anomeric Lipid Antigens	IMMUNITY			English	Editorial Material							NKT CELLS	The most powerful iNKT cell antigen is alpha-galactosylceramide (a-GalCer), derived from the marine sponge. However, alpha-anomeric glycolipids are thought to be absent in mammals. In this issue of Immunity, Kain et al., (2014) demonstrate the presence of mammalian alpha-linked glycosylceramides, such as alpha-GalCer.	[Kim, Jessica; Kim, Ji Hyung; Winau, Florian] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Kim, Jessica; Kim, Ji Hyung; Winau, Florian] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Winau, F (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	florian.winau@childrens.harvard.edu						Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Darmoise A, 2010, IMMUNITY, V33, P216, DOI 10.1016/j.immuni.2010.08.003; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinio Y., 2006, NAT IMMUNOL, V7, P978; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	9	6	6	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					505	506		10.1016/j.immuni.2014.09.020	http://dx.doi.org/10.1016/j.immuni.2014.09.020			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367563	Bronze			2022-12-18	WOS:000345504300001
J	Yu, D				Yu, Di			MicroRNAs in Tfh Cells: Micromanaging Inflammaging	IMMUNITY			English	Editorial Material							RESPONSES; DIFFERENTIATION	MicroRNA (miR)-146a-deficient mice develop low-grade, chronic, and systemic inflammation, similar to inflammaging. Hu et al. (2014) demonstrate that the lack of miR-155 prevents the accumulation of Tfh cells and inflammaging in miR-146a-deficient mice. They identify Fosl2 as a functionally important target of miR-155 in Tfh cells.	Monash Univ, Lab Mol Immunomodulat, Dept Biochem & Mol Biol, Sch Biomed Sci,Dept Med,Southern Clin Sch, Clayton, Vic, Australia	Monash University	Yu, D (corresponding author), Monash Univ, Lab Mol Immunomodulat, Dept Biochem & Mol Biol, Sch Biomed Sci,Dept Med,Southern Clin Sch, Clayton, Vic, Australia.	di.yu@monash.edu	Yu, Di/C-2163-2009	Yu, Di/0000-0003-1721-8922				Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hu RZ, 2014, IMMUNITY, V41, P605, DOI 10.1016/j.immuni.2014.09.015; Huffaker TB, 2012, CELL REP, V2, P1697, DOI 10.1016/j.celrep.2012.10.025; Lind EF, 2014, EUR J IMMUNOL, V44, P11, DOI 10.1002/eji.201343962; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Shen N, 2012, NAT REV RHEUMATOL, V8, P701, DOI 10.1038/nrrheum.2012.142; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yu D, 2014, NAT IMMUNOL, V15, P597, DOI 10.1038/ni.2922	10	6	6	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					509	+		10.1016/j.immuni.2014.10.003	http://dx.doi.org/10.1016/j.immuni.2014.10.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367565	Bronze			2022-12-18	WOS:000345504300003
J	Cummings, RD				Cummings, Richard D.			T Cells Are Smad'ly in Love with Galectin-9	IMMUNITY			English	Editorial Material							TGF-BETA; PROMOTES; TIM-3	In this issue of Immunity, Wu et al. (2014) report that galectin-9 is required for the formation and stability of iTreg cells. Galectin-9 interacts with CD44 in association with TGF-beta receptors to drive both Foxp3 and galectin-9 expression in a positive-feedforward loop involving Smad3 activation.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rdcummi@emory.edu						Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Nagae M, 2009, GLYCOBIOLOGY, V19, P112, DOI 10.1093/glycob/cwn121; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Vega-Carrascal I, 2014, J IMMUNOL, V192, P2418, DOI 10.4049/jimmunol.1300711; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	9	6	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					171	173		10.1016/j.immuni.2014.08.001	http://dx.doi.org/10.1016/j.immuni.2014.08.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148018	Bronze			2022-12-18	WOS:000341455300003
J	Rescigno, M				Rescigno, Maria			Tfr Cells and IgA Join Forces to Diversify the Microbiota	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; IMMUNE-SYSTEM; HOMEOSTASIS	How diversity of the microbiota is generated and maintained is an open question. In this issue of Immunity, Kawamoto et al. show that T follicular regulatory cells foster microbiota diversity via the regulation of IgA selection.	European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy.	maria.rescigno@ieo.eu	Rescigno, Maria/J-9704-2012	Rescigno, Maria/0000-0002-6464-509X				Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kaetzel C.S., 2014, IMMUNOL LETT; Kato LM, 2014, IMMUNOL CELL BIOL, V92, P49, DOI 10.1038/icb.2013.54; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Macpherson AJ, 2012, TRENDS IMMUNOL, V33, P160, DOI 10.1016/j.it.2012.02.002; Rescigno M, 2014, CELL MICROBIOL, V16, P1004, DOI 10.1111/cmi.12301; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991	10	6	6	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					9	11		10.1016/j.immuni.2014.06.012	http://dx.doi.org/10.1016/j.immuni.2014.06.012			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035948	Bronze			2022-12-18	WOS:000341444200005
J	Flutter, B; Nestle, FO				Flutter, Barry; Nestle, Frank O.			What on "Irf" Is This Gene 4? Irf4 Transcription-Factor-Dependent Dendritic Cells Are Required for T Helper 2 Cell Responses in Murine Skin	IMMUNITY			English	Editorial Material								Interferon regulatory factors play an important role in the transcriptional regulation of immunity. In this issue of Immunity, Kumamoto et al. (2013) and Gao et al. (2013) identify an Irf4-dependent migratory dendritic cell subset required for T helper 2 cell polarization following cutaneous challenge.	[Flutter, Barry; Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England; [Nestle, Frank O.] Guys & St Thomas NHS Fdn Trust, Comprehens Biomed Res Ctr, NIHR GSTT KCL, London SE1 9RT, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Nestle, FO (corresponding author), Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England.	frank.nestle@kcl.ac.uk		Flutter, Barry/0000-0002-8084-6369	Medical Research Council [MR/J006742/1] Funding Source: Medline; National Institute for Health Research [NF-SI-0512-10140] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Kool Mirjam, 2012, F1000 Biol Rep, V4, P6, DOI 10.3410/B4-6; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Murphy KM, 2013, ADV IMMUNOL, V120, P239, DOI 10.1016/B978-0-12-417028-5.00009-0; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250	11	6	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					625	627		10.1016/j.immuni.2013.09.008	http://dx.doi.org/10.1016/j.immuni.2013.09.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138876	Bronze			2022-12-18	WOS:000330950000002
J	An, DD; Kasper, DL				An, Dingding; Kasper, Dennis L.			Testosterone: More Than Having the Guts to Win the Tour de France	IMMUNITY			English	Editorial Material							SEX-DIFFERENCES; MICROBIOME; DISEASE	Sex bias in susceptibility to autoimmune diseases is evident but poorly characterized. Yurkovetskiy et al. (2013) report that host testosterone mediates changes in the microbiome to confer protection to adult male NOD mice from type 1 diabetes.	[An, Dingding; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kasper, DL (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu						An DD, 2011, P NATL ACAD SCI USA, V108, P4666, DOI 10.1073/pnas.1001501107; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/S0065-2776(10)07001-X, 10.1016/B978-0-12-381300-8.00008-3]; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mathis D, 2012, IMMUNOL REV, V245, P239, DOI 10.1111/j.1600-065X.2011.01084.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	10	6	6	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					208	210		10.1016/j.immuni.2013.08.015	http://dx.doi.org/10.1016/j.immuni.2013.08.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973219	Bronze			2022-12-18	WOS:000330948800005
J	Lukens, JR; Kanneganti, TD				Lukens, John R.; Kanneganti, Thirumala-Devi			Fat Chance: Not Much against NKT Cells	IMMUNITY			English	Editorial Material							KILLER T-CELLS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; OBESITY; ACTIVATION; MICE	Obesity-induced inflammation contributes to multiple metabolic diseases. In this issue of Immunity, Lynch et al. (2012) show that invariant natural killer T (iNKT) cells are enriched in adipose tissue and induce anti-inflammatory pathways to confer protection against obesity.	[Lukens, John R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Lukens, John/0000-0002-6795-0866				Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Thompson BR, 2010, MOL CELL ENDOCRINOL, V318, P24, DOI 10.1016/j.mce.2009.08.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109	10	6	6	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					447	449		10.1016/j.immuni.2012.09.006	http://dx.doi.org/10.1016/j.immuni.2012.09.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22999952	Bronze			2022-12-18	WOS:000309199000009
J	Dalod, M				Dalod, Marc			Professional Cross-Presenting CD8 alpha-Type CD141(hi) Dendritic Cells: We Have Got You in Our Skin!	IMMUNITY			English	Editorial Material							C-TYPE LECTIN; SUBSETS		[Dalod, Marc] Aix Marseille Univ UM2, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Dalod, Marc] INSERM, UMR1104, F-13288 Marseille, France; [Dalod, Marc] CNRS, UMR7280, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Dalod, M (corresponding author), Aix Marseille Univ UM2, Ctr Immunol Marseille Luminy, Campus Luminy Case 906, F-13288 Marseille, France.	dalod@ciml.univ-mrs.fr	Dalod, Marc/AAK-6163-2020	Dalod, Marc/0000-0002-6436-7966				Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Guilliams M, 2010, EUR J IMMUNOL, V40, P2089, DOI 10.1002/eji.201040498; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	9	6	6	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					3	5		10.1016/j.immuni.2012.07.008	http://dx.doi.org/10.1016/j.immuni.2012.07.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22840836	Bronze			2022-12-18	WOS:000307133200002
J	Goto, A; Imler, JL				Goto, Akira; Imler, Jean-Luc			Toll Signaling in Flies and Mammals: Two Sorts of MyD88	IMMUNITY			English	Editorial Material							DROSOPHILA EMBRYO; PATHWAY	The mammalian MyD88 signaling molecule participates in Toll receptor signaling within the cytoplasm. In this issue of Immunity, Marek and Kagan (2012) report that Drosophila (d)MyD88 acts instead at the plasma membrane to sort the signaling adaptor Tube.	[Goto, Akira; Imler, Jean-Luc] CNRS, UPR9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Imler, Jean-Luc] Univ Strasbourg, Fac Sci Vie, F-67083 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Goto, A (corresponding author), CNRS, UPR9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France.	a.goto@ibmc-cnrs.unistra.fr; jl.imler@unistra.fr	Imler, Jean-Luc/GXH-4323-2022; GOTO, Akira/V-7847-2017	GOTO, Akira/0000-0003-3395-484X				Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Chen LY, 2006, CURR BIOL, V16, P1183, DOI 10.1016/j.cub.2006.05.050; da Fonseca RN, 2008, DEV CELL, V14, P605, DOI 10.1016/j.devcel.2008.02.011; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang HR, 2010, P NATL ACAD SCI USA, V107, P8322, DOI 10.1073/pnas.1004031107; Kambris Z, 2003, EMBO REP, V4, P64, DOI 10.1038/sj.embor.embor714; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lund VK, 2010, P NATL ACAD SCI USA, V107, P18028, DOI 10.1073/pnas.1009157107; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773	10	6	6	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 20	2012	36	4					555	557		10.1016/j.immuni.2012.04.001	http://dx.doi.org/10.1016/j.immuni.2012.04.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22520850	Bronze			2022-12-18	WOS:000303223900007
J	Migueles, SA; Connors, M				Migueles, Stephen A.; Connors, Mark			Small Molecules and Big Killers: The Challenge of Eliminating the Latent HIV Reservoir	IMMUNITY			English	Editorial Material							INFECTION	In this issue of Immunity, Shan et al. (2012) explore the elimination of cells latently infected with HIV and the potential implications for strategies to eradicate the virus from infected patients.	[Migueles, Stephen A.; Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Connors, M (corresponding author), NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mconnors@nih.gov	qiao, zhixin/I-3408-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000855] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; WHO/UNAIDS/UNICEF, 2011, PROGR REP 2011 GLOB; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	10	6	6	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					320	321		10.1016/j.immuni.2012.03.006	http://dx.doi.org/10.1016/j.immuni.2012.03.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22444629	Bronze			2022-12-18	WOS:000302048400005
J	Powell, JD; Pollizzi, K				Powell, Jonathan D.; Pollizzi, Kristen			Fueling Memories	IMMUNITY			English	Editorial Material							T-CELL MEMORY; RESPIRATORY CAPACITY; REGULATOR	A hallmark of the adaptive immune response is rapid and robust activation upon rechallenge. In the current issue of Immunity, van der Windt et al., (2012) provide an important link between mitochondrial respiratory capacity and the development of CD8(+) T cell memory.	[Powell, Jonathan D.; Pollizzi, Kristen] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Powell, JD (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA.	poweljo@jhmi.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077610, T32AI007247, R01AI091481] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI077610, R01 AI091481-01, R01 AI077610-02, T32 AI007247, R01 AI091481] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510	10	6	6	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 27	2012	36	1					3	5		10.1016/j.immuni.2012.01.003	http://dx.doi.org/10.1016/j.immuni.2012.01.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22284413	Green Accepted, Bronze			2022-12-18	WOS:000299766000002
J	Niemeyer, BA; Hoth, M				Niemeyer, Barbara A.; Hoth, Markus			Excitable T Cells: Ca(v)1.4 Channel Contributions and Controversies	IMMUNITY			English	Editorial Material							GATED CALCIUM-CHANNELS; MICE LACKING; STIM1; LYMPHOCYTES; SUBUNIT; ORAI1	Store-operated CRAC channels encoded by the Oral genes mediate calcium entry in T cells. In this issue of Immunity, Omilusik et al. (2011) record Ca(v)1.4-mediated voltage-gated calcium currents in T cells and address their role for T cell development and function.	[Niemeyer, Barbara A.; Hoth, Markus] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany	Saarland University	Hoth, M (corresponding author), Univ Saarland, Dept Biophys, D-66421 Homburg, Germany.	markus.hoth@uks.eu	Niemeyer, Barbara A./AAL-8972-2021	Niemeyer, Barbara A./0000-0002-6963-0575; Hoth, Markus/0000-0001-7080-4643				Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Jha MK, 2009, NAT IMMUNOL, V10, P1275, DOI 10.1038/ni.1793; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086	10	6	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 23	2011	35	3					315	317		10.1016/j.immuni.2011.09.001	http://dx.doi.org/10.1016/j.immuni.2011.09.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21943485	Bronze			2022-12-18	WOS:000295748100002
J	Platt, AM; Randolph, GJ				Platt, Andrew M.; Randolph, Gwendalyn J.			Does Deleting Dendritic Cells Delete Autoimmunity?	IMMUNITY			English	Editorial Material							B-CELLS; SELF-TOLERANCE; T-CELLS; IN-VIVO; HOMEOSTASIS; ACTIVATION; ABLATION	A role for dendritic cells (DCs) in autoimmunity remains to be fully delineated. In this issue of Immunity, Teichmann et al. (2010) reveal critical functions for DCs in augmenting, but surprisingly not in initiating, spontaneous autoimmune disease.	[Platt, Andrew M.; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Platt, Andrew M.; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Platt, AM (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, 1425 Madison Ave, New York, NY 10029 USA.	andrew.platt@mssm.edu; gwendalyn.randolph@mssm.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049653] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI049653] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bar-On L, 2010, IMMUNOL REV, V234, P76, DOI 10.1111/j.0105-2896.2009.00875.x; Benson RA, 2010, J IMMUNOL, V184, P6378, DOI 10.4049/jimmunol.0903951; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025	10	6	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 22	2010	33	6					840	842		10.1016/j.immuni.2010.12.003	http://dx.doi.org/10.1016/j.immuni.2010.12.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21168776	Green Accepted, Bronze			2022-12-18	WOS:000286293900005
J	Weichhart, T; Saemann, MD				Weichhart, Thomas; Saeemann, Marcus D.			T Helper Cell Differentiation: Understanding the Needs of Hierarchy	IMMUNITY			English	Editorial Material							MTOR; EFFECTOR; PKC; AKT	In this issue of immunity, Lee et al. (2010) demonstrate that the mammalian Target of Rapamycin Complex 2 promotes the differentiation of T helper 1 (Th1) cells via the kinase Akt, whereas it independently fosters Th2 cell generation via another kinase, PKC-theta.	[Weichhart, Thomas; Saeemann, Marcus D.] Med Univ Vienna, Dept Internal Med 3, Clin Div Nephrol & Dialysis, A-1090 Vienna, Austria	Medical University of Vienna	Weichhart, T (corresponding author), Med Univ Vienna, Dept Internal Med 3, Clin Div Nephrol & Dialysis, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	thomas.weichhart@meduniwien.ac.at; marcus.saemann@meduniwien.ac.at	Weichhart, Thomas/J-3531-2014	Weichhart, Thomas/0000-0002-4349-0797				Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arimura Y, 2004, J BIOL CHEM, V279, P11408, DOI 10.1074/jbc.M309063200; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Marsland BJ, 2008, TRENDS IMMUNOL, V29, P179, DOI 10.1016/j.it.2008.01.005; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	10	6	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 25	2010	32	6					727	729		10.1016/j.immuni.2010.06.008	http://dx.doi.org/10.1016/j.immuni.2010.06.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620936	Bronze			2022-12-18	WOS:000279365800001
J	Zaccone, P; Cooke, A				Zaccone, Paola; Cooke, Anne			Harnessing CD8(+) Regulatory T Cells: Therapy for Type 1 Diabetes?	IMMUNITY			English	Editorial Material							DENDRITIC CELLS	In this issue of Immunity, Tsai et al. (2010) demonstrate that low-avidity autoantigen-specific regulatory CD8(+) T cells can reverse ongoing autoimmune disease and provide insight into the mechanism by which this is achieved.	[Zaccone, Paola; Cooke, Anne] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Cooke, A (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.		Cooke, Anne/E-8709-2012; Cooke, Anne/S-4763-2019	Cooke, Anne/0000-0003-3327-6081				Chatenoud L, 2010, NAT REV ENDOCRINOL, V6, P149, DOI 10.1038/nrendo.2009.275; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Phillips Jenny M, 2009, Rev Diabet Stud, V6, P97, DOI 10.1900/RDS.2009.6.97; Sarkar SA, 2007, DIABETES, V56, P72, DOI 10.2337/db06-0617; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966	10	6	6	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 23	2010	32	4					504	506		10.1016/j.immuni.2010.04.009	http://dx.doi.org/10.1016/j.immuni.2010.04.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20412762	Bronze			2022-12-18	WOS:000277171900009
J	Graf, T; Busslinger, M				Graf, Thomas; Busslinger, Meinrad			B young again	IMMUNITY			English	Editorial Material							MATURE B; NUCLEAR TRANSFER; STEM-CELLS; PLURIPOTENCY		[Graf, Thomas] Ctr Gene Regulat, E-08003 Barcelona, Spain; [Busslinger, Meinrad] Res Inst Mol Pathol, A-1030 Vienna, Austria	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Graf, T (corresponding author), Ctr Gene Regulat, Carrer Dr Aigudar 88, E-08003 Barcelona, Spain.	thomas.graf@crg.es; busslinger@imp.ac.at	Busslinger, Meinrad J./J-1249-2016; Graf, Thomas/B-4252-2015; Wilson, Matthew H/K-3193-2013	Busslinger, Meinrad J./0000-0002-9111-9351; Graf, Thomas/0000-0003-2774-4117; 				AOI T, 2008, IN PRESS SCIENC 0214, DOI DOI 10.1126/SCIENCE.1154884; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	10	6	8	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY	2008	28	5					606	608		10.1016/j.immuni.2008.04.004	http://dx.doi.org/10.1016/j.immuni.2008.04.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18482566	Bronze			2022-12-18	WOS:000256003900007
J	Wang, JH; Mallis, RJ; Reinherzl, EL				Wang, Jia-Huai; Mallis, Robert J.; Reinherzl, Ellis L.			Lmmunodominant-peptide recognition: Beta testing TCR alpha beta	IMMUNITY			English	Editorial Material							INFLUENZA-A VIRUS; COMPLEX; REPERTOIRE; SELECTION	In this issue, Ishizuka et al. (2008) define human T cell-receptor recognition of an immunodominant influenza A matrix peptide bound to human leukocyte antigen HLA-A*0201 in atomic detail, raising provocative questions about beta chain function.	[Wang, Jia-Huai; Mallis, Robert J.; Reinherzl, Ellis L.] Dana Farber Canc Inst, Dept Med Oncol, Immunobiol Lab, Medford, MA 02155 USA; [Wang, Jia-Huai] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Wang, Jia-Huai; Mallis, Robert J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Reinherzl, Ellis L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Reinherzl, EL (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Immunobiol Lab, 44 Binney St, Medford, MA 02155 USA.	ellis_reinherz@dfci.harvard.edu	Mallis, Robert/A-2270-2015					Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; Zhong WM, 2007, J MOL BIOL, V372, P535, DOI 10.1016/j.jmb.2007.06.057	10	6	6	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2008	28	2					139	141		10.1016/j.immuni.2008.01.007	http://dx.doi.org/10.1016/j.immuni.2008.01.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275824	Bronze			2022-12-18	WOS:000253275000002
J	Dustin, ML; Chakraborty, AK				Dustin, Michael L.; Chakraborty, Arup K.			Tug of war at the exit door	IMMUNITY			English	Editorial Material							LYMPH-NODE; MIGRATION	The lipid sphingosine-1-phosphate has been identified as a key exit signal for lymph nodes. In this issue of Immunity, Pham et al. (2008) show that its action can only be understood in the context of retention signals transduced by CCR7.	[Dustin, Michael L.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	New York University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dustin, ML (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu; arupc@mit.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389	NIAID NIH HHS [R01 AI055037-05, R01 AI055037, P01 AI071195-03, P01 AI071195] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI071195, R01AI055037] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Chakraborty AK, 2003, NAT IMMUNOL, V4, P933, DOI 10.1038/ni1003-933; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; van Kampen N. G., 1992, STOCHASTIC PROCESSES; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269	9	6	6	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2008	28	1					15	17		10.1016/j.immuni.2008.01.001	http://dx.doi.org/10.1016/j.immuni.2008.01.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199414	Green Accepted, Bronze			2022-12-18	WOS:000252627300006
J	Radermacher, AN; Crabtree, GR				Radermacher, Amy N.; Crabtree, Gerald R.			Monster protein controls calcium entry and fights infection	IMMUNITY			English	Editorial Material							CA2+; CHANNELS; AHNAK	Sustained calcium signaling in T cells is critical for development and activation. In this issue of Immunity, Matza et al. (2007) demonstrate that the huge scaffold protein, AHNAK1, interacts with L-type calcium channels, regulates Ca2+ influx, and defends against Leishmania major infection.	[Radermacher, Amy N.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Radermacher, Amy N.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Radermacher, Amy N.; Crabtree, Gerald R.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Dept Pathol, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu						Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Haase H, 2007, CARDIOVASC RES, V73, P19, DOI 10.1016/j.cardiores.2006.09.001; Hohaus A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0855com; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; LOCKSLEY RM, 1987, ANN INST PASTEUR IMM, V138, P744, DOI 10.1016/S0769-2625(87)80030-2; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006	10	6	6	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					13	14		10.1016/j.immuni.2007.12.009	http://dx.doi.org/10.1016/j.immuni.2007.12.009			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199413	Bronze			2022-12-18	WOS:000252627300005
J	Hagman, J; Lukin, K				Hagman, James; Lukin, Kara			"Hands-on" regulation of B cell development by the transcription factor Pax5	IMMUNITY			English	Editorial Material							GENE; DIFFERENTIATION; PAX5/BSAP	The transcription factor Pax5 is a critical regulator of B lymphocyte commitment and identity. In this issue of Immunity, Schebesta et al. (2007) demonstrate how Pax5 activates 170 different genes involved in B cell signaling, adhesion, migration, and maturation.	Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA	National Jewish Health	Hagman, J (corresponding author), Natl Jewish Med & Res Ctr, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	hagmanj@njc.org	Hagman, James/R-7013-2019	Hagman, James/0000-0002-5436-8455				Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5	10	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2007	27	1					8	10		10.1016/j.immuni.2007.07.001	http://dx.doi.org/10.1016/j.immuni.2007.07.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17663980	Bronze			2022-12-18	WOS:000248398100004
J	Brink, R				Brink, Robert			Germinal-center B cells in the zone	IMMUNITY			English	Editorial Material								Visualization of lymphocyte dynamics in vivo has only recently become feasible. In this issue of Immunity, Hauser et al. (2007) gaze into the germinal-center reaction and find B cells making some unexpected moves.	Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Garvan Institute of Medical Research	Brink, R (corresponding author), Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	r.brink@garvan.org.au	Brink, Robert/B-7910-2010	Brink, Robert/0000-0002-9586-3655				Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573	7	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2007	26	5					552	554		10.1016/j.immuni.2007.05.002	http://dx.doi.org/10.1016/j.immuni.2007.05.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17521584	Bronze			2022-12-18	WOS:000246895900008
J	Dubois, B; Caux, C				Dubois, B; Caux, C			Critical role of ITIM-bearing Fc gamma R on DCs in the capture and presentation of native antigen to B cells	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; DIFFERENTIATION; LYMPHOCYTES; RESPONSES; INTERACT; GROWTH	The contribution of dendritic cells (DCs) to antibody responses through antigen-unspecific B cell costimulation is well documented. Bergtold et al. (2005) now demonstrate that the ITIM-bearing Fc gamma RIIB allows DCs to recycle internalized native antigen (Ag) for presentation to B cells, a process that might be critical for the initiation of humoral responses.	INSERM, U404, IFR 128 Biosci, F-69365 Lyon, France; INSERM, U590, Equipe Cytokines & Canc, F-69373 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Dubois, B (corresponding author), INSERM, U404, IFR 128 Biosci, 21 Ave Tony Garnier, F-69365 Lyon, France.		Caux, Christophe/G-2851-2013; Dubois, Bertrand/D-4446-2013	Caux, Christophe/0000-0003-2438-833X; Dubois, Bertrand/0000-0002-7859-4975				Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; DIAZDEDURANA Y, 2005, IN PRESS BLOOD; Dubois B, 1999, J LEUKOCYTE BIOL, V66, P224, DOI 10.1002/jlb.66.2.224; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Wykes M, 1998, J IMMUNOL, V161, P1313	13	6	7	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2005	23	5					463	464		10.1016/j.immuni.2005.10.005	http://dx.doi.org/10.1016/j.immuni.2005.10.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK	16286014	Bronze			2022-12-18	WOS:000233660700003
J	Henson, PM				Henson, PM			Fingering IL-12 with apoptotic cells	IMMUNITY			English	Editorial Material							MACROPHAGES	Exposure of phosphatidylserine on the surface of apoptotic cells contributes to their removal in situ by quiet, noninflammatory, and nonimmunogenic mechanisms. In this issue of Immunity, Kim et al. (2004) describe a completely new mechanism for this effect that involves a novel zinc finger nuclear factor that inhibits IL-12 production.	Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	National Jewish Health	Henson, PM (corresponding author), Natl Jewish Med & Res Ctr, 1400 Jackson St, Denver, CO 80206 USA.							Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6	6	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2004	21	5					604	606		10.1016/j.immuni.2004.11.002	http://dx.doi.org/10.1016/j.immuni.2004.11.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539147	Bronze			2022-12-18	WOS:000225365000002
J	Hopken, UE; Lipp, M				Hopken, UE; Lipp, M			All roads lead to Rome: Triggering dendritic cell migration	IMMUNITY			English	Editorial Material							NICOTINAMIDE ADENINE-DINUCLEOTIDE; CD38; RESPONSES	Migration of dendritic cells to secondary lymphatic organs is a key event in acquired immunity. The role of the multifunctional ectoenzyme CD38 in humoral immune responses has now been revisited, suggesting that CD38 links innate and adaptive immunity by triggering chemokine-mediated dendritic cell chemotaxis.	Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, MDC, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hopken, UE (corresponding author), Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, MDC, Robert Rossle Str 10, D-13092 Berlin, Germany.		Lipp, Martin/G-2235-2010	Lipp, Martin/0000-0002-0087-2672				Cesano A, 1998, J IMMUNOL, V160, P1106; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Hopken UE, 2004, EUR J IMMUNOL, V34, P461, DOI 10.1002/eji.200324690; Lund FE, 1998, IMMUNOL REV, V161, P79, DOI 10.1111/j.1600-065X.1998.tb01573.x; Okamoto S, 1998, J IMMUNOL, V160, P4190; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611	9	6	6	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2004	20	3					244	246		10.1016/S1074-7613(04)00056-1	http://dx.doi.org/10.1016/S1074-7613(04)00056-1			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030768	Bronze			2022-12-18	WOS:000221442600002
J	Margulies, DH				Margulies, DH			Molecular interactions: Stiff or floppy (or somewhere in between?)	IMMUNITY			English	Editorial Material							ACTIVATING IMMUNORECEPTOR NKG2D; PEPTIDE-MHC; RECOGNITION; RECEPTOR; LIGANDS; BINDING; MECHANISM; COMPLEX; MICA		NIAID, Mol Biol Sect, Immunol Lab, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Margulies, DH (corresponding author), NIAID, Mol Biol Sect, Immunol Lab, NIH,Dept Hlth & Human Serv, Bldg 10,Room 11N311,10 Ctr Dr, Bethesda, MD 20892 USA.			Margulies, David/0000-0001-8530-7375	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000394, Z01AI000622, ZIAAI000622, ZIAAI000394] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li PW, 2002, IMMUNITY, V16, P77, DOI 10.1016/S1074-7613(02)00258-3; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; McFarland BJ, 2003, STRUCTURE, V11, P411, DOI 10.1016/S0969-2126(03)00047-9; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Radaev S, 2002, J IMMUNOL, V169, P6279, DOI 10.4049/jimmunol.169.11.6279; Radaev S, 2001, IMMUNITY, V15, P1039, DOI 10.1016/S1074-7613(01)00241-2; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	16	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2003	19	6					772	774		10.1016/S1074-7613(03)00331-5	http://dx.doi.org/10.1016/S1074-7613(03)00331-5			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670294	Bronze			2022-12-18	WOS:000187230700002
J	Shuai, K				Shuai, K			Serine phosphorylation: Arming Stat1 against infection	IMMUNITY			English	Editorial Material							TRANSCRIPTIONAL ACTIVATION; STAT1-ALPHA		Univ Calif Los Angeles, Div Hematol Oncol, Dept Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Shuai, K (corresponding author), Univ Calif Los Angeles, Div Hematol Oncol, Dept Med, Dept Biol Chem, Los Angeles, CA 90095 USA.							Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Zakharova N, 2003, J BIOL CHEM, V278, P43067, DOI 10.1074/jbc.M308166200; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963	9	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2003	19	6					771	772		10.1016/S1074-7613(03)00329-7	http://dx.doi.org/10.1016/S1074-7613(03)00329-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670293	Bronze			2022-12-18	WOS:000187230700001
J	Starr, R; Hilton, DJ				Starr, R; Hilton, DJ			Defining control: Regulation of dendritic cell activation and immune homeostasis by SOCS1	IMMUNITY			English	Article							CYTOKINE SIGNALING-1; SUPPRESSOR		Cooperat Res Ctr Cellular Growth Factors, Melbourne, Vic, Australia		Starr, R (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.		Hilton, Douglas J/C-7250-2013	Hilton, Douglas J/0000-0002-7698-2392				Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Cornish AL, 2003, J IMMUNOL, V170, P878, DOI 10.4049/jimmunol.170.2.878; Fujimoto M, 2000, J IMMUNOL, V165, P1799, DOI 10.4049/jimmunol.165.4.1799; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Metcalf D, 2002, P NATL ACAD SCI USA, V99, P943, DOI 10.1073/pnas.022628499	7	6	7	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2003	19	3					308	309		10.1016/S1074-7613(03)00243-7	http://dx.doi.org/10.1016/S1074-7613(03)00243-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499106	Bronze			2022-12-18	WOS:000185499800002
J	Rowntree, LC; Nguyen, THO; Kedzierski, L; Neeland, MR; Petersen, J; Crawford, JC; Allen, LF; Clemens, EB; Chua, B; McQuilten, HA; Minervina, AA; Pogorelyy, MV; Chaurasia, P; Tan, HX; Wheatley, AK; Jia, XX; Amanat, F; Krammer, F; Allen, EK; Sonda, S; Flanagan, KL; Jumarang, J; Pannaraj, PS; Licciardi, PV; Kent, SJ; Bond, KA; Williamson, DA; Rossjohn, J; Thomas, PG; Tosif, S; Crawford, NW; van de Sandt, CE; Kedzierska, K				Rowntree, Louise C.; Nguyen, Thi H. O.; Kedzierski, Lukasz; Neeland, Melanie R.; Petersen, Jan; Crawford, Jeremy Chase; Allen, Lilith F.; Clemens, E. Bridie; Chua, Brendon; McQuilten, Hayley A.; Minervina, Anastasia A.; Pogorelyy, Mikhail, V; Chaurasia, Priyanka; Tan, Hyon-Xhi; Wheatley, Adam K.; Jia, Xiaoxiao; Amanat, Fatima; Krammer, Florian; Allen, E. Kaitlynn; Sonda, Sabrina; Flanagan, Katie L.; Jumarang, Jaycee; Pannaraj, Pia S.; Licciardi, Paul, V; Kent, Stephen J.; Bond, Katherine A.; Williamson, Deborah A.; Rossjohn, Jamie; Thomas, Paul G.; Tosif, Shidan; Crawford, Nigel W.; van de Sandt, Carolien E.; Kedzierska, Katherine			SARS-CoV-2-specific T cell memory with common TCR alpha beta motifs is established in unvaccinated children who seroconvert after infection	IMMUNITY			English	Article								As the establishment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell memory in children remains largely unexplored, we recruited convalescent COVID-19 children and adults to define their circulating memory SARS-CoV-2-specific CD4(+) and CD8(+)T cells prior to vaccination. We analyzed epitopespecific T cells directly ex vivo using seven HLA class I and class II tetramers presenting SARS-CoV-2 epitopes, together with Spike-specific B cells. Unvaccinated children who seroconverted had comparable Spike-specific but lower ORF1a- and N-specific memory T cell responses compared with adults. This agreed with our TCR Pc.quencing data showing reduced clonal expansion in children. A strong stem cell memory phenotype and common T cell receptor motifs were detected within tetramer-specific T cells in seroconverted children. Conversely, children who did not seroconvert had tetramer-specific T cells of predominantly naive phenotypes and diverse TCR alpha beta repertoires. Our study demonstrates the generation of SARS-CoV-2-specific T cell memory with common TCR alpha beta motifs in unvaccinated seroconverted children after their first virus encounter.	[Rowntree, Louise C.; Nguyen, Thi H. O.; Kedzierski, Lukasz; Allen, Lilith F.; Clemens, E. Bridie; Chua, Brendon; McQuilten, Hayley A.; Tan, Hyon-Xhi; Wheatley, Adam K.; Jia, Xiaoxiao; Kent, Stephen J.; Bond, Katherine A.; van de Sandt, Carolien E.; Kedzierska, Katherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Kedzierski, Lukasz] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic 3000, Australia; [Neeland, Melanie R.; Licciardi, Paul, V; Tosif, Shidan; Crawford, Nigel W.] Murdoch Childrens Res Inst, Infect & Immun, Melbourne, Vic 3000, Australia; [Neeland, Melanie R.; Licciardi, Paul, V; Tosif, Shidan; Crawford, Nigel W.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3000, Australia; [Petersen, Jan; Chaurasia, Priyanka; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Infect & Immun Program, Clayton, Vic 3800, Australia; [Crawford, Jeremy Chase; Minervina, Anastasia A.; Pogorelyy, Mikhail, V; Allen, E. Kaitlynn; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wheatley, Adam K.; Kent, Stephen J.] Univ Melbourne, ARC Ctr Excellence Convergent Bionano Sci & Techn, Melbourne, Vic 3000, Australia; [Amanat, Fatima; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Amanat, Fatima] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA; [Krammer, Florian] Icahn Sch Med Mt Sinai, Ctr Vaccine Res & Pandem Preparedness C VARPP, New York, NY 10029 USA; [Sonda, Sabrina; Flanagan, Katie L.] Univ Tasmania, Sch Hlth Sci & Sch Med, Launceston, Tas 7248, Australia; [Flanagan, Katie L.] Monash Univ, Dept Immunol & Pathol, Commercial Rd, Melbourne, Vic 3004, Australia; [Flanagan, Katie L.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic 3000, Australia; [Flanagan, Katie L.] Clifford Craig Fdn, Launceston Gen Hosp, Tasmanian Vaccine Trial Ctr, Launceston, Tas 7250, Australia; [Jumarang, Jaycee; Pannaraj, Pia S.] Childrens Hosp Los Angeles, Div Infect Dis, Los Angeles, CA 90027 USA; [Pannaraj, Pia S.] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90089 USA; [Pannaraj, Pia S.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol, Los Angeles, CA 90089 USA; [Pannaraj, Pia S.] Univ Southern Calif, Keck Sch Med, Dept Immunol, Los Angeles, CA 90089 USA; [Kent, Stephen J.] Monash Univ, Cent Clin Sch, Alfred Hlth, Melbourne Sexual Hlth Ctr,Infect Dis Dept, Melbourne, Vic 3004, Australia; [Bond, Katherine A.] Royal Melbourne Hosp, Dept Microbiol, Melbourne, Vic 3000, Australia; [Williamson, Deborah A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Melbourne, Vic 3000, Australia; [Williamson, Deborah A.] Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, Melbourne, Vic 3000, Australia; [Williamson, Deborah A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3000, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, Wales; [Tosif, Shidan; Crawford, Nigel W.] Royal Childrens Hosp Melbourne, Dept Gen Med, Melbourne, Vic 3000, Australia; [Crawford, Nigel W.] Royal Childrens Hosp Melbourne, Immunisat Serv, Melbourne, Vic 3000, Australia	University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; Monash University; St Jude Children's Research Hospital; University of Melbourne; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Tasmania; Monash University; Royal Melbourne Institute of Technology (RMIT); Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California; Monash University; Royal Melbourne Hospital; University of Melbourne; Victorian Infectious Diseases Reference Laboratory; Walter & Eliza Hall Institute; Cardiff University; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne	Kedzierska, K (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	kkedz@unimelb.edu.au	Krammer, Florian/H-3237-2019; Crawford, Jeremy Chase/G-5711-2013	Krammer, Florian/0000-0003-4121-776X; Crawford, Jeremy Chase/0000-0003-4096-6048; Jumarang, Jaycee/0000-0002-0123-7718; Bond, Katherine/0000-0002-4473-9232	NHMRC Leadership Investigator Grant [1173871]; NHMRC Emerging Leadership Level 1 Investigator Grant [1194036, 1173433]; Research Grants Council of the Hong Kong Special Administrative Region, China [T11-712/19-N]; Doherty Collaborative Seed grant; Victorian Government; Clifford Craig Foundation [186]; MRFF [2002073, 1202445, 2005544]; NHMRC [1149990, 1162760, 1136322]; NIH contract CIVC-HRP [HHS-NIH-NIAID-BAA2018]; NIAID UO1 grant [1U01AI144616-01]; European Union [792532]; ARC-DECRA Fellowship [DE200100185]; University of Melbourne Establishment grant; ARC; NIH NIAID [R01 AI136514-03]; ALSAC at St. Jude; NHMRC; Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400008C]; Centers of Excellence for Influenza Research and Response (CEIRR) [75N93021C00014]; Collaborative Influenza Vaccine Innovation Centers (CIVICs) [75N93019C00051]; RCH Foundation; COVID-19 Grant, Department of Jobs, Precincts and Regions, Victoria State Government; DHB Foundation, Australia	NHMRC Leadership Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Emerging Leadership Level 1 Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Doherty Collaborative Seed grant; Victorian Government; Clifford Craig Foundation; MRFF(Medical Research Future Fund (MRFF)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH contract CIVC-HRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID UO1 grant; European Union(European Commission); ARC-DECRA Fellowship(Australian Research Council); University of Melbourne Establishment grant; ARC(Australian Research Council); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ALSAC at St. Jude; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Centers of Excellence for Influenza Research and Surveillance (CEIRS); Centers of Excellence for Influenza Research and Response (CEIRR); Collaborative Influenza Vaccine Innovation Centers (CIVICs); RCH Foundation; COVID-19 Grant, Department of Jobs, Precincts and Regions, Victoria State Government; DHB Foundation, Australia	We thank the participating families involved in the study and Kate Dohle, Jill Nguyen, Isabella Overmars, Philip Sutton, and Daniel Pellicci for their support with the cohorts. We thank the Melbourne Cytometry Platform for the technical assistance. This work was supported by the NHMRC Leadership Investigator Grant to K.K. (1173871) ; the NHMRC Emerging Leadership Level 1 Investigator Grant to T.H.O.N. (#1194036) and A.K.W. (#1173433) ; the Research Grants Council of the Hong Kong Special Administrative Region, China (#T11-712/19-N) to K.K.; the Doherty Collaborative Seed grant to M.R.N., A.K.W., S.J.K., S.T., C.E.v.d.S., and K.K.; the Victorian Government (S.J.K. and A.K.W.) ; the Clifford Craig Foundation Project Grant to K.L.F. and K.K. (#186) ; the MRFF award (#2002073) to S.J.K. and A.K.W.; the MRFF Award (#1202445) to K.K.; the MRFF Award (#2005544) to K.K., S.J.K., and A.K.W.; the NHMRC program grant 1149990 (S.J.K.) ; the NHMRC project grant 1162760 (A.K.W.) ; the NIH contract CIVC-HRP (HHS-NIH-NIAID-BAA2018) to P.G.T. and K.K.; and the NIAID UO1 grant 1U01AI144616-01 ?Dissection of Influenza Vaccination and Infection for Childhood Immunity? (DIVINCI) to F.K., P.G.T., K.K., and P.S.P. S.J.K. is supported by the NHMRC Senior Prin-cipal Research Fellowship (#1136322) . C.E.v.d.S. received funding from the European Union?s Horizon 2020 research program under the Marie Sk1odow-ska-Curie grant agreement (#792532) and is supported by the ARC-DECRA Fellowship (#DE200100185) and University of Melbourne Establishment grant. J.R. is supported by an ARC Laureate Fellowship. J.C.C. and P.G.T. are sup-ported by the NIH NIAID R01 AI136514-03 and the ALSAC at St. Jude. P.V.L. is supported by an NHMRC Career Development Fellowship. Work in the F.K. laboratory was partially funded by the Centers of Excellence for Influenza Research and Surveillance (CEIRS, #HHSN272201400008C) , the Centers of Excellence for Influenza Research and Response (CEIRR, #75N93021C00014) , by the Collaborative Influenza Vaccine Innovation Cen-ters (CIVICs, #75N93019C00051) , and by institutional funds. We acknowledge the RCH Foundation for their support of the study and recruitment of the fam-ilies involved. Recruitment of the household contacts was enable by COVID-19 Grant, Department of Jobs, Precincts and Regions, Victoria State Government and Research Grant, DHB Foundation, Australia. The graphical abstract was created with BioRender.com .	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brodin P, 2022, IMMUNITY, V55, P201, DOI 10.1016/j.immuni.2022.01.014; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI 10.15585/mmwr.mm6915e4; Chaurasia P, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101065; Chou J, 2022, NAT IMMUNOL, V23, P177, DOI 10.1038/s41590-021-01123-9; Cohen CA, 2021, NAT COMMUN, V12, DOI [10.1101/2021.02.02.21250988, 10.1038/s41467-021-24938-4]; Collier DA, 2021, NATURE, V596, P417, DOI 10.1038/s41586-021-03739-1; Cotugno N, 2021, PEDIAT ALLERG IMM-UK, V32, P1833, DOI 10.1111/pai.13585; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Delahoy MJ, 2021, MMWR-MORBID MORTAL W, V70, P1255, DOI 10.15585/mmwr.mm7036e2; Dowell AC, 2022, NAT IMMUNOL, V23, P40, DOI 10.1038/s41590-021-01089-8; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Francis JM, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abk3070; Gangaev A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22811-y; Goenka A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100327; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Habel JR, 2020, P NATL ACAD SCI USA, V117, P24384, DOI 10.1073/pnas.2015486117; Hsieh LE, 2022, EUR J IMMUNOL, V52, P123, DOI 10.1002/eji.202149556; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Koutsakos M, 2019, NAT IMMUNOL, V20, P613, DOI 10.1038/s41590-019-0320-6; Liao BL, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.724763; Loske J, 2022, NAT BIOTECHNOL, V40, P319, DOI 10.1038/s41587-021-01037-9; Mallapaty S, 2021, NATURE, V597, P166, DOI 10.1038/d41586-021-02423-8; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Minervina AA, 2022, NAT IMMUNOL, V23, P781, DOI 10.1038/s41590-022-01184-4; Moratto D, 2020, EUR J IMMUNOL, V50, P1412, DOI 10.1002/eji.202048724; Moreews M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh1516; Mudd PA, 2022, CELL, V185, P603, DOI 10.1016/j.cell.2021.12.026; Mullen J.L., 2020, OUTBREAKINFO; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Neeland MR, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.741639; Neeland MR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21414-x; Nguyen THO, 2021, IMMUNITY, V54, P1066, DOI 10.1016/j.immuni.2021.04.009; Nguyen THO, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23018-x; Nguyen THO, 2018, J LEUKOCYTE BIOL, V103, P321, DOI 10.1189/jlb.5MA0517-207R; Niessl J, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abk0894; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Oberhardt V, 2021, NATURE, V597, P268, DOI 10.1038/s41586-021-03841-4; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Porritt RA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146614; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Procop GW, 2021, AM J CLIN PATHOL, V155, P69, DOI [10.1093/AJCP/AQAA181, 10.1093/ajcp/aqaa181]; Ramaswamy A, 2021, IMMUNITY, V54, P1083, DOI 10.1016/j.immuni.2021.04.003; Rowntree LC, 2021, IMMUNOL CELL BIOL, V99, P990, DOI 10.1111/imcb.12482; Rowntree LC, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1258; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; Saini SK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf7550; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Selva KJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22236-7; Shomuradova AS, 2020, IMMUNITY, V53, P1245, DOI 10.1016/j.immuni.2020.11.004; Short KR, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00343; Toh ZQ, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.1313; Tosif S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19545-8; Valkenburg SA, 2016, P NATL ACAD SCI USA, V113, P4440, DOI 10.1073/pnas.1603106113; van de Sandt CE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13346-4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhu YS, 2021, CLIN INFECT DIS, V72, pE1146, DOI 10.1093/cid/ciaa1825	60	5	5	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1299	+		10.1016/j.immuni.2022.06.003	http://dx.doi.org/10.1016/j.immuni.2022.06.003			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3D3AD	35750048	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000829177900005
J	Angkeow, JW; Monaco, DR; Chen, A; Venkataraman, T; Jayaraman, S; Valencia, C; Sie, BM; Liechti, T; Farhadi, PN; Funez-dePagnier, G; Sherman-Baust, CA; Wong, MQ; Ruczinski, I; Caturegli, P; Sears, CL; Simner, PJ; Round, JL; Duggal, P; Laserson, U; Steiner, TS; Sen, R; Lloyd, TE; Roederer, M; Mammen, AL; Longman, RS; Rider, LG; Larman, HB				Angkeow, Julia W.; Monaco, Daniel R.; Chen, Athena; Venkataraman, Thiagarajan; Jayaraman, Sahana; Valencia, Cristian; Sie, Brandon M.; Liechti, Thomas; Farhadi, Payam N.; Funez-dePagnier, Gabriela; Sherman-Baust, Cheryl A.; Wong, May Q.; Ruczinski, Ingo; Caturegli, Patrizio; Sears, Cynthia L.; Simner, Patricia J.; Round, June L.; Duggal, Priya; Laserson, Uri; Steiner, Theodore S.; Sen, Ranjan; Lloyd, Thomas E.; Roederer, Mario; Mammen, Andrew L.; Longman, Randy S.; Rider, Lisa G.; Larman, H. Benjamin			Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses	IMMUNITY			English	Article							HELICOBACTER-PYLORI INFECTION; HAEMOPHILUS-INFLUENZAE; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; GUT MICROBIOTA; PHT PROTEINS; DISEASE; PATHOGENESIS; FLAGELLIN; SEROPREVALENCE	Microbial exposures are crucial environmental factors that impact healthspan by sculpting the immune system and microbiota. Antibody profiling via Phage ImmunoPrecipitation Sequencing (PhIP-Seq) provides a high-throughput, cost-effective approach for detecting exposure and response to microbial protein products. We designed and constructed a library of 95,601 56-amino acid peptide tiles spanning 14,430 proteins with ???toxin???or ???virulence factor???keyword annotations. We used PhIP-Seq to profile the antibodies of 1,000 individuals against this ???ToxScan???library. In addition to enumerating immunodominant antibody epitopes, we studied the age-dependent stability of the ToxScan profile and used a genome-wide association study to find that the MHC-II locus modulates bacterial epitope selection. We detected previously described anti-flagellin antibody responses in a Crohn???s disease cohort and identified an association between antiflagellin antibodies and juvenile dermatomyositis. PhIP-Seq with the ToxScan library is thus an effective tool for studying the environmental determinants of health and disease at cohort scale.	[Angkeow, Julia W.; Monaco, Daniel R.; Venkataraman, Thiagarajan; Jayaraman, Sahana; Sie, Brandon M.; Larman, H. Benjamin] Johns Hopkins Univ, Sch Med, Dept Pathol, Inst Cell Engn,Div Immunol, Baltimore, MD 21205 USA; [Chen, Athena; Ruczinski, Ingo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Valencia, Cristian; Duggal, Priya] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Liechti, Thomas; Roederer, Mario] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, Bethesda, MD USA; [Farhadi, Payam N.; Rider, Lisa G.] NIEHS, Environm Autoimmun Grp, Clin Res Branch, NIH, Bethesda, MD USA; [Funez-dePagnier, Gabriela; Longman, Randy S.] Weill Cornell Med, Dept Med, Div Gastroenterol & Hepatol, Jill Roberts Inst Res IBD, New York, NY USA; [Sherman-Baust, Cheryl A.; Sen, Ranjan] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD USA; [Wong, May Q.; Steiner, Theodore S.] BC Childrens Hosp Res Inst, Vancouver, BC, Canada; [Caturegli, Patrizio] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Immunol, Baltimore, MD 21205 USA; [Sears, Cynthia L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Sears, Cynthia L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Sears, Cynthia L.] Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Simner, Patricia J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Round, June L.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT USA; [Laserson, Uri] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Lloyd, Thomas E.] Johns Hopkins Sch Med, Dept Neurol, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Mammen, Andrew L.] NIAMSD, Muscle Dis Unit, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Utah System of Higher Education; University of Utah; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Larman, HB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Inst Cell Engn,Div Immunol, Baltimore, MD 21205 USA.	hlarman1@jhmi.edu		Liechti, Thomas/0000-0001-8738-6679	National Institute of General Medical Sciences (NIGMS) [R01GM136724]; Leona M. and Harry B. Helmsley Charitable Trust; Cure JM Foundation; Peter and Carmen Lucia Buck Foundation Myositis Discovery Fund; Crohn's & Colitis Foundation Student Research Fellowship Award; Harold F. Linder Summer Internship Fund (Columbia University Center for Career Education Summer Funding Program award); Burroughs-Wellcome Fund, Maryland: Genetics, Epidemiology and Medicine training programat Johns Hopkins University; Intramural Research Programof the National Institute of Environmental Health Sciences; National Institute of Environmental Health Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Vaccine Research Center, NIAID, NIH; National Institute on Aging; Innovation to Commercialization grant from the Michael Smith Foundation for Health Research; Canadian Institutes for Health Research; NCI [R01CA264217]	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Leona M. and Harry B. Helmsley Charitable Trust; Cure JM Foundation; Peter and Carmen Lucia Buck Foundation Myositis Discovery Fund; Crohn's & Colitis Foundation Student Research Fellowship Award; Harold F. Linder Summer Internship Fund (Columbia University Center for Career Education Summer Funding Program award); Burroughs-Wellcome Fund, Maryland: Genetics, Epidemiology and Medicine training programat Johns Hopkins University; Intramural Research Programof the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Innovation to Commercialization grant from the Michael Smith Foundation for Health Research; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Terrance O'Hanlon and Frederick Miller (National Institute of Environmental Health Sciences) for their support related to the juvenile dermatomyositis samples. We thank Dr. Luigi Ferrucci (National Institute on Aging) and participantsof theBaltimoreLongitudinal StudyonAgingfor samples.WethankDrs. Peter Burbelo (National Institute of Dental and Craniofacial Research) and Sandra Wolin (National Cancer Institute) for their critical reading of the manuscript. We are grateful to Stephen J. Elledge (Harvard Medical School) for generously providing the VirScan library used in this study. Funding: This work was made possible by National Institute of General Medical Sciences (NIGMS) grant R01GM136724 (I.R., U.L., and H.B.L.), a grant from The Leona M. and Harry B. Helmsley Charitable Trust (R.S.L., J.L.R., and H.B.L.), a grant from the Cure JM Foundation (A.L.M., H.B.L., and P.N.F.), and a grant from the Peter and Carmen Lucia Buck Foundation Myositis Discovery Fund (T.E.L., S.J., and H.B.L.). J.W.A. was supported by a Crohn's & Colitis Foundation Student Research Fellowship Award and the Harold F. Linder Summer Internship Fund (Columbia University Center for Career Education Summer Funding Program award). C.V. was supported by theBurroughs-Wellcome Fund, Maryland: Genetics, Epidemiology andMedicine training programat JohnsHopkinsUniversity. Thisworkwas supported in part by the Intramural Research Programof the National Institute of Environmental Health Sciences (L.G.R. and P.N.F.), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (A.L.M.), Vaccine Research Center, NIAID, NIH (M.R. and T.L.), and National Institute on Aging (C.A.S.-B. and R.S.). M.Q.W. was supported by an Innovation to Commercialization grant from the Michael Smith Foundation for Health Research and the Canadian Institutes for Health Research. C.L.S. was supported by NCI R01CA264217.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Babiuk S, 2008, MICROB PATHOGENESIS, V45, P7, DOI 10.1016/j.micpath.2008.01.005; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balasubramanian D, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx005; Bouter KE, 2017, GASTROENTEROLOGY, V152, P1671, DOI 10.1053/j.gastro.2016.12.048; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Chin CL, 2005, AM J RESP CRIT CARE, V172, P85, DOI 10.1164/rccm.200412-1687OC; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P5; Cunningham MW, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0045-2018; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Donnelly MA, 2002, J BIOL CHEM, V277, P40456, DOI 10.1074/jbc.M206851200; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237; Eshleman SH, 2019, CELL REP, V27, P1422, DOI 10.1016/j.celrep.2019.03.097; Gan L, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-67; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Ghaisas S, 2016, PHARMACOL THERAPEUT, V158, P52, DOI 10.1016/j.pharmthera.2015.11.012; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Hajam IA, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.172; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kallio A, 2014, INFECT IMMUN, V82, P1683, DOI 10.1128/IAI.00699-13; Kurtti P, 1997, SCAND J INFECT DIS, V29, P485, DOI 10.3109/00365549709011859; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468; Lynskey NN, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006493; MacGillivray DM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00434; Massa M, 2002, ARTHRITIS RHEUM, V46, P3015, DOI 10.1002/art.10566; McHugh NJ, 2018, NAT REV RHEUMATOL, V14, P290, DOI 10.1038/nrrheum.2018.56; McNeilly TN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128391; Melin M, 2010, INFECT IMMUN, V78, P2089, DOI 10.1128/IAI.00811-09; Rodriguez JM, 2015, MICROB ECOL HEALTH D, V26, DOI 10.3402/mehd.v26.26050; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Miller FW, 2018, NAT REV RHEUMATOL, V14, P255, DOI 10.1038/nrrheum.2018.48; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485; Mohan D, 2018, NAT PROTOC, V13, P1958, DOI 10.1038/s41596-018-0025-6; Monaco DR, 2022, EBIOMEDICINE, V75, DOI 10.1016/j.ebiom.2021.103747; Monaco DR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20622-1; Morgenlander WR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146927; Murphy TF, 2015, J INFECT DIS, V212, P1798, DOI 10.1093/infdis/jiv299; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Pachman LM, 2018, J PEDIATR-US, V195, P16, DOI 10.1016/j.jpeds.2017.12.053; Paller AS, 2019, J ALLERGY CLIN IMMUN, V143, P26, DOI 10.1016/j.jaci.2018.11.015; Parente F, 1997, SCAND J GASTROENTERO, V32, P1140, DOI 10.3109/00365529709002994; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Pou C, 2019, NAT MED, V25, P591, DOI 10.1038/s41591-019-0392-8; Prieto S, 2010, AUTOIMMUN REV, V9, pA330, DOI 10.1016/j.autrev.2009.11.006; Riebisch AK, 2020, FUTURE MICROBIOL, V15, P945, DOI 10.2217/fmb-2019-0274; Scepanovic P, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0568-8; Schubert RD, 2019, NAT MED, V25, P1748, DOI 10.1038/s41591-019-0613-1; Seiberling M, 2012, VACCINE, V30, P7455, DOI 10.1016/j.vaccine.2012.10.080; Shrock E, 2020, SCIENCE, V370, P1058, DOI 10.1126/science.abd4250; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sie B., 2020, R PACKAGE PHIPMAKE; Sie B., 2020, R PACKAGE PHIPCC; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Tack DM, 2020, MMWR-MORBID MORTAL W, V69, P509, DOI 10.15585/mmwr.mm6917a1; Tanaka M, 2017, ALLERGOL INT, V66, P515, DOI 10.1016/j.alit.2017.07.010; van Aar F, 2014, SEX TRANSM INFECT, V90, P434, DOI 10.1136/sextrans-2013-051074; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vare PO, 2001, SCAND J GASTROENTERO, V36, P1295, DOI 10.1080/003655201317097155; Venkataraman T, 2022, IMMUNITY, V55, P174, DOI 10.1016/j.immuni.2021.12.004; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Vogl T, 2021, NAT MED, V27, P1442, DOI 10.1038/s41591-021-01409-3; Wang M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93359-6; Wei T., 2021, R PACKAGE CORRPLOT V; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698	76	5	5	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1051	+		10.1016/j.immuni.2022.05.002	http://dx.doi.org/10.1016/j.immuni.2022.05.002			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F2TY	35649416				2022-12-18	WOS:000830524400001
J	Eisenstein, A; Hilliard, BK; Pope, SD; Zhang, CL; Taskar, P; Waizman, DA; Israni-Winger, K; Tian, H; Luan, HH; Wang, A				Eisenstein, Anna; Hilliard, Brandon K.; Pope, Scott D.; Zhang, Cuiling; Taskar, Pranali; Waizman, Daniel A.; Israni-Winger, Kavita; Tian, Hui; Luan, Harding H.; Wang, Andrew			Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs	IMMUNITY			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; NUCLEAR FACTOR; DRUGS; EXPRESSION; INDUCTION; CELLS; MICE; CYCLOOXYGENASE; OSTEOARTHRITIS	Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) enzymes and are ubiquitously used for their anti-inflammatory properties. However, COX inhibition alone fails to explain numerous clinical outcomes of NSAID usage. Screening commonly used NSAIDs in primary human and murine myeloid cells demonstrated that NSAIDs could be differentiated by their ability to induce growth/differentiation factor 15 (GDF15), independent of COX specificity. Using genetic and pharmacologic approaches, NSAID-mediated GDF15 induction was dependent on the activation of nuclear factor erythroid 2-related factor 2 (NRF2) in myeloid cells. Sensing by Cysteine 151 of the NRF2 chaperone, Kelch-like ECH-associated protein 1 (KEAP1) was required for NSAID activation of NRF2 and subsequent anti-inflammatory effects both in vitro and in vivo. Myeloid-specific deletion of NRF2 abolished NSAID-mediated tissue protection in murine models of gout and endotoxemia. This highlights a noncanonical NRF2-dependent mechanism of action for the anti-inflammatory activity of a subset of commonly used NSAIDs.	[Eisenstein, Anna] Yale Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Hilliard, Brandon K.; Zhang, Cuiling; Wang, Andrew] Yale Sch Med, Dept Internal Med & Immunobiol, New Haven, CT 06520 USA; [Pope, Scott D.; Waizman, Daniel A.; Israni-Winger, Kavita] Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Pope, Scott D.] Howard Hughes Med Inst, New Haven, CT 06510 USA; [Taskar, Pranali; Tian, Hui; Luan, Harding H.] NGM Biopharmaceut, San Francisco, CA 94080 USA; [Hilliard, Brandon K.] Univ Colorado, Med Scientist Training Program, Anschutz Med Campus, Aurora, CO 80045 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus	Wang, A (corresponding author), Yale Sch Med, Dept Internal Med & Immunobiol, New Haven, CT 06520 USA.; Luan, HH (corresponding author), NGM Biopharmaceut, San Francisco, CA 94080 USA.	hluan@ngmbio.com; andrew.wang@yale.edu		Taskar, Pranali/0000-0001-9677-6273; Hilliard, Brandon/0000-0001-5030-4828; Wang, Andrew/0000-0002-6951-8081	NIH [K08 AI128745, R01 AI162645]; Charles H. Hood Foundation; Food Allergy Science Initiative; Pew Charitable Trusts; NIH/NIAMS [T32 AR007016-43]; Dermatologist Investigator Research Fellowship from the Dermatology Foundation; Yale Center for Clinical Investigation/Yale Physician Scientist Development Award; Robert E. Leet and Clara Guthrie Patterson Trust	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Hood Foundation; Food Allergy Science Initiative; Pew Charitable Trusts; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatologist Investigator Research Fellowship from the Dermatology Foundation; Yale Center for Clinical Investigation/Yale Physician Scientist Development Award; Robert E. Leet and Clara Guthrie Patterson Trust	We thank the Wang lab for valuable discussions. We thank Dr. Anton Komar (Cleveland State University) for providing bone marrow from Eif2a-deficient mice. We thank Dr. Masayuki Yamamoto (RIKEN Institute) for the KEAP1 C151S transgenic animals. We thank Dr. Andy MacMahon for the GDF15-deficient animals (University of Southern California). We thank Drs. Ruslan Medzhitov, Michael Brown, DeepDixit, Ruth Franklin, and KristaWang for critical review of themanuscript. TheWang lab is supported in part by grants fromthe NIH (K08 AI128745 and R01 AI162645), the Charles H. Hood Foundation, the Food Allergy Science Initiative, and by the Pew Charitable Trusts. A.E. received support from the following sources: T32 AR007016-43 fromNIH/NIAMS, Dermatologist Investigator Research Fellowship from the Dermatology Foundation, Yale Center for Clinical Investigation/Yale Physician Scientist Development Award, and the Robert E. Leet and Clara Guthrie Patterson Trust.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Al-Harbi NO, 2019, EUR J PHARMACOL, V855, P276, DOI 10.1016/j.ejphar.2019.05.026; ANGEL J, 1994, EUR J BIOCHEM, V226, P125, DOI 10.1111/j.1432-1033.1994.tb20033.x; ARIASNEGRETE S, 1995, BIOCHEM BIOPH RES CO, V208, P582, DOI 10.1006/bbrc.1995.1378; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Behnammanesh G, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101527; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Blanca-Lopez N, 2019, J ASTHMA ALLERGY, V12, P217, DOI 10.2147/JAA.S164806; Borner T, 2020, CELL METAB, V31, P351, DOI 10.1016/j.cmet.2019.12.004; Brater DC, 2001, AM J NEPHROL, V21, P1, DOI 10.1159/000046212; Castiglione GM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16129-4; Chen QM, 2018, PHYSIOL GENOMICS, V50, P77, DOI 10.1152/physiolgenomics.00041.2017; Ching TT, 2011, AGING CELL, V10, P506, DOI 10.1111/j.1474-9726.2011.00688.x; Chubak J, 2016, ANN INTERN MED, V164, P814, DOI 10.7326/M15-2117; Cilenti F, 2021, IMMUNITY, V54, P1665, DOI 10.1016/j.immuni.2021.05.016; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Coll AP, 2020, NATURE, V578, P444, DOI 10.1038/s41586-019-1911-y; CRESTANI F, 1991, BRAIN RES, V542, P330, DOI 10.1016/0006-8993(91)91587-Q; Cuadrado A, 2019, NAT REV DRUG DISCOV, V18, P295, DOI 10.1038/s41573-018-0008-x; da Costa BR, 2017, LANCET, V390, pE21, DOI 10.1016/S0140-6736(17)31744-0; Day EA, 2019, NAT METAB, V1, P1202, DOI 10.1038/s42255-019-0146-4; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Desborough MJR, 2017, BRIT J HAEMATOL, V177, P674, DOI 10.1111/bjh.14520; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dona I, 2012, J INVEST ALLERG CLIN, V22, P363; Foresti R, 2013, PHARMACOL RES, V76, P132, DOI 10.1016/j.phrs.2013.07.010; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; FU JY, 1990, J BIOL CHEM, V265, P16737; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao JX, 2018, J AM CHEM SOC, V140, P4259, DOI 10.1021/jacs.7b11639; Gil CI, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56922-w; Gurpinar E, 2014, CLIN CANCER RES, V20, P1104, DOI 10.1158/1078-0432.CCR-13-1573; Gurpinar E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00181; Hanif R, 1996, BIOCHEM PHARMACOL, V52, P237, DOI 10.1016/0006-2952(96)00181-5; Hasan R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71449-1; He C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004860; Herndon CM, 2008, PHARMACOTHERAPY, V28, P788, DOI 10.1592/phco.28.6.788; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kavian N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01896; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kim KH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25098-0; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112; Li MT, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036748; Liang X, 2015, ELIFE, V4, DOI 10.7554/eLife.08973; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu J, 2020, J AM SOC NEPHROL, V31, P701, DOI 10.1681/ASN.2019090876; Lo PC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005109; Lombard DB, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz7628; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; MacLagan T., 1876, LANCET, VI, P585; Mallinson PI, 2014, SKELETAL RADIOL, V43, P277, DOI 10.1007/s00256-013-1771-8; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mulderrig L, 2021, NATURE, V600, P158, DOI 10.1038/s41586-021-04133-7; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Nagashima R, 2019, J IMMUNOL, V202, P1331, DOI 10.4049/jimmunol.1801180; Naidu SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26269-9; Ogawa T, 2020, J IMMUNOL, V205, P907, DOI 10.4049/jimmunol.2000274; Ong CKS, 2007, CLIN MED RES, V5, P17, DOI 10.3121/cmr.2007.698; Patel S, 2019, CELL METAB, V29, P707, DOI 10.1016/j.cmet.2018.12.016; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Ratnam NM, 2017, J CLIN INVEST, V127, P3796, DOI 10.1172/JCI91561; Robledinos-Anton N, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9372182; Rollason V, 2014, CURR DRUG METAB, V15, P326, DOI 10.2174/1389200215666140202214454; Saito R, 2016, MOL CELL BIOL, V36, P271, DOI 10.1128/MCB.00868-15; Santos I, 2020, P NATL ACAD SCI USA, V117, P12281, DOI [10.1073/pnas.1918508117/-/DCSupplemental, 10.1073/pnas.1918508117]; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schjerning AM, 2020, NAT REV CARDIOL, V17, P574, DOI 10.1038/s41569-020-0366-z; Schmidt A., 1934, IND CHEMIE IHRER BED; Schumacher HR, 2004, JCR-J CLIN RHEUMATOL, V10, pS18, DOI 10.1097/01.rhu.0000131745.37852.bb; SHEN TY, 1963, J AM CHEM SOC, V85, P488, DOI 10.1021/ja00887a038; Shi JY, 2018, METHODS MOL BIOL, V1784, P263, DOI 10.1007/978-1-4939-7837-3_24; Smith CE, 2017, CELL CHEM BIOL, V24, P281, DOI 10.1016/j.chembiol.2017.02.003; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Stone E., 1763, PHILOS T, V53, P195; Suzuki T, 2017, CELL REP, V18, P2045, DOI 10.1016/j.celrep.2017.01.076; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; Toth RK, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020027; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Weng JH, 2021, NAT METAB, V3, P513, DOI 10.1038/s42255-021-00366-y; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; WINTER CA, 1963, J PHARMACOL EXP THER, V141, P369; Wu WQ, 2019, MOL MED REP, V20, P1761, DOI 10.3892/mmr.2019.10405; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhou SF, 2005, DRUG METAB REV, V37, P41, DOI 10.1081/DMR-200028812	98	5	5	8	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1082	+		10.1016/j.immuni.2022.04.015	http://dx.doi.org/10.1016/j.immuni.2022.04.015			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F2TY	35588739				2022-12-18	WOS:000830524400003
J	MacNabb, BW; Tumuluru, S; Chen, XF; Godfrey, J; Kasal, DN; Yu, J; Jongsma, MLM; Spaapen, RM; Kline, DE; Kline, J				MacNabb, Brendan W.; Tumuluru, Sravya; Chen, Xiufen; Godfrey, James; Kasal, Darshan N.; Yu, Jovian; Jongsma, Marlieke L. M.; Spaapen, Robbert M.; Kline, Douglas E.; Kline, Justin			Dendritic cells can prime anti-tumor CD8(+) T cell responses through major histocompatibility complex cross-dressing	IMMUNITY			English	Article							CLASS-I MOLECULES; B16 MELANOMA; PEPTIDE; REJECTION; ANTIGENS; IMMUNITY; RECEPTOR; EXOSOMES; SUBSETS; CROSSPRESENTATION	Antigen cross-presentation, wherein dendritic cells (DCs) present exogenous antigen on major histocompatibility class I (MHC-I) molecules, is considered the primary mechanism by which DCs initiate tumor-specific CD8(+) T cell responses. Here, we demonstrate that MHC-I cross-dressing, an antigen presentation pathway in which DCs acquire and display intact tumor-derived peptide:MHC-I molecules, is also important in orchestrating anti-tumor immunity. Cancer cell MHC-I expression was required for optimal CD8(+) T cell activation in two subcutaneous tumor models. In vivo acquisition of tumor-derived peptide:MHC-I molecules by DCs was sufficient to induce antigen-specific CD8(+) T cell priming. Transfer of tumor-derived human leukocyte antigen (HLA) molecules to myeloid cells was detected in vitro and in human tumor xenografts. In conclusion, MHC-I cross-dressing is crucial for anti-tumor CD8(+) T cell priming by DCs. In addition to quantitatively enhancing tumor antigen presentation, MHC cross-dressing might also enable DCs to more faithfully and efficiently mirror the cancer cell peptidome.	[MacNabb, Brendan W.; Kasal, Darshan N.; Kline, Douglas E.; Kline, Justin] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Tumuluru, Sravya; Kline, Justin] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Chen, Xiufen; Godfrey, James; Yu, Jovian; Kline, Justin] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Jongsma, Marlieke L. M.; Spaapen, Robbert M.] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands; [Jongsma, Marlieke L. M.; Spaapen, Robbert M.] Univ Amsterdam, Landsteiner Lab, Amsterdam UMC, Amsterdam, Netherlands; [Jongsma, Marlieke L. M.; Spaapen, Robbert M.] Canc Ctr Amsterdam, Amsterdam, Netherlands	University of Chicago; University of Chicago; University of Chicago; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Kline, J (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.; Kline, J (corresponding author), Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA.; Kline, J (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jkline@medicine.bsd.uchicago.edu			Immunology Training Grant at the University of Chicago [T32 AI007090]; American Association of Immunologists;  [R01 CA16670];  [P30 CA014599]	Immunology Training Grant at the University of Chicago(University of Chicago); American Association of Immunologists; ; 	We would like to thank Drs. T. Gajewski, A. Bendelac, T. Schumacher, and S. Springer for sharing mice, cell lines, and constructs central to this research. Special thanks to L. Degenstein of the University of Chicago Transgenics/ES Cell Technology Mouse Core Facility for help with microinjections. Thanks also to Dr. P. Savage for careful review of the manuscript and insightful conversations during the project. The authors have no financial interests to disclose. This work was funded by R01 CA16670 to J.K. and used common resources managed by the University of Chicago Cytometry and Antibody Technology core facility, supported by P30 CA014599 to the University of Chicago Comprehensive Cancer Center. B.W.M., D.N.K., and D.E.K. were supported by the Immunology Training Grant at the University of Chicago (T32 AI007090). B.W.M. was supported by a Careers in Immunology Fellowship from the American Association of Immunologists.	Anderson DA, 2021, NAT REV IMMUNOL, V21, P101, DOI 10.1038/s41577-020-00413-x; Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bohm W, 1998, J IMMUNOL, V161, P897; Bracamonte-Baran W, 2017, P NATL ACAD SCI USA, V114, P1099, DOI 10.1073/pnas.1618364114; Canton J, 2021, NAT IMMUNOL, V22, P140, DOI 10.1038/s41590-020-00824-x; Chefalo PJ, 2001, J IMMUNOL, V167, P1274, DOI 10.4049/jimmunol.167.3.1274; de Witte MA, 2006, BLOOD, V108, P870, DOI 10.1182/blood-2005-08-009357; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Dougan M, 2019, ANNU REV CANC BIOL, V3, P55, DOI 10.1146/annurev-cancerbio-030518-055552; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Duong E, 2022, IMMUNITY, V55, P308, DOI 10.1016/j.immuni.2021.10.020; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Hanc P, 2015, IMMUNITY, V42, P839, DOI 10.1016/j.immuni.2015.04.009; Hein Z, 2014, J CELL SCI, V127, P2885, DOI 10.1242/jcs.145334; Herrera OB, 2004, J IMMUNOL, V173, P4828, DOI 10.4049/jimmunol.173.8.4828; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kline DE, 2018, J IMMUNOL, V201, P3759, DOI 10.4049/jimmunol.1801184; Kline J, 2008, CLIN CANCER RES, V14, P3156, DOI 10.1158/1078-0432.CCR-07-4696; Kline J, 2012, J IMMUNOL, V188, P2630, DOI 10.4049/jimmunol.1100845; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Kroger CJ, 2017, J IMMUNOL, V198, P249, DOI 10.4049/jimmunol.1601516; LaBelle JL, 2002, BLOOD, V99, P2146, DOI 10.1182/blood.V99.6.2146; Lee MY, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001111; Li LJ, 2012, P NATL ACAD SCI USA, V109, P12716, DOI 10.1073/pnas.1203468109; Liu Q, 2016, J CLIN INVEST, V126, P2805, DOI 10.1172/JCI84577; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Montealegre S, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03098; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Perry JSA, 2018, IMMUNITY, V48, P923, DOI 10.1016/j.immuni.2018.04.007; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Reich Z, 1997, P NATL ACAD SCI USA, V94, P2495, DOI 10.1073/pnas.94.6.2495; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Ruhland MK, 2020, CANCER CELL, V37, P786, DOI 10.1016/j.ccell.2020.05.002; Russo V, 2000, BLOOD, V95, P3473, DOI 10.1182/blood.V95.11.3473.011k06_3473_3477; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sanchez-Paulete AR, 2017, ANN ONCOL, V28, P44, DOI 10.1093/annonc/mdx237; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Schober K, 2020, NAT IMMUNOL, V21, P434, DOI 10.1038/s41590-020-0628-2; Seliger B, 2001, CANCER RES, V61, P1095; Spiotto MT, 2002, IMMUNITY, V17, P737, DOI 10.1016/S1074-7613(02)00480-6; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; van Endert P, 2016, IMMUNOL REV, V272, P80, DOI 10.1111/imr.12424; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Waldman AD, 2020, NAT REV IMMUNOL, V20, P651, DOI 10.1038/s41577-020-0306-5; Wculek SK, 2020, NAT REV IMMUNOL, V20, P7, DOI 10.1038/s41577-019-0210-z; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Worbs T, 2017, NAT REV IMMUNOL, V17, P30, DOI 10.1038/nri.2016.116; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhang L, 2013, J CLIN INVEST, V123, P1999, DOI 10.1172/JCI63980	61	5	5	20	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					982	+		10.1016/j.immuni.2022.04.016	http://dx.doi.org/10.1016/j.immuni.2022.04.016			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35617964				2022-12-18	WOS:000823293900009
J	Wang, ZQ; Lu, Z; Lin, SL; Xia, J; Zhong, ZW; Xie, ZJ; Xing, Y; Qie, JB; Jiao, MX; Li, YF; Wen, HY; Zhao, PY; Zhang, D; Zhou, PH; Qian, JW; Luo, FF; Wang, LM; Yu, HX; Liu, J; Gu, J; Liu, RH; Chu, YW				Wang, Zhiqiang; Lu, Zhou; Lin, Shengli; Xia, Jie; Zhong, Ziwen; Xie, Zhangjuan; Xing, Yun; Qie, Jingbo; Jiao, Mengxia; Li, Yifan; Wen, Haoyu; Zhao, Pengyuan; Zhang, Dan; Zhou, Pinghong; Qian, Jiawen; Luo, Feifei; Wang, Luman; Yu, Hongxiu; Liu, Jie; Gu, Jie; Liu, Ronghua; Chu, Yiwei			Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion	IMMUNITY			English	Article							IMMUNOTHERAPY; INFLAMMATION; HOMEOSTASIS; METABOLISM; SURVIVAL	Immunoregulatory B cells impede antitumor immunity through unknown features and mechanisms. We report the existence of leucine-tRNA-synthase-2 (LARS2)-expressing B cell (LARS B) subset with a transforming growth factor-beta 1 (TGF-beta 1)-dominant regulatory feature in both mouse and human progressive colorectal cancer (CRC). Of note, LARS B cells exhibited a leucine nutrient preference and displayed active mitochondrial aminoacyl-tRNA biosynthesis. They were located outside the tertiary lymphoid structure and correlated with colorectal hyperplasia and shortened survival in CRC patients. A leucine diet induced LARS B cell generation, whereas LARS B cell deletion by Lars2 gene ablation or leucine blockage repressed CRC immunoevasion. Mechanistically, LARS2 programmed mitochondrial nicotinamide adenine dinucleotide (NAD(+)) regeneration and oxidative metabolism, thus determining the regulatory feature of LARS B cells in which the NAD-dependent protein deacetylase sirtuin-1 (SIRT1) was involved. We propose a leucine-dieting scheme to inhibit LARS B cells, which is safe and useful for CRC therapy.	[Wang, Zhiqiang; Xing, Yun; Qie, Jingbo; Li, Yifan; Zhang, Dan; Qian, Jiawen; Wang, Luman; Chu, Yiwei] Fudan Univ, Dept Immunol, Sch Basic Med Sci,Inst Biomed Sci, Shanghai Key Lab Med Epigenet & Metab, Shanghai 200032, Peoples R China; [Xia, Jie; Xie, Zhangjuan; Jiao, Mengxia; Zhao, Pengyuan; Liu, Ronghua] Fudan Univ, Inst Biomed Sci, Shanghai Key Lab Med Epigenet, Shanghai Peoples Hosp 9, Shanghai 200032, Peoples R China; [Lin, Shengli; Wen, Haoyu; Zhou, Pinghong; Gu, Jie] Fudan Univ, Zhongshan Hosp, Endoscopy Ctr, Endoscopy Res Inst,Dept Thorac Surg, Shanghai 200032, Peoples R China; [Lu, Zhou; Zhong, Ziwen] Zhongshan Hosp, Liver Canc Inst, Dept Anesthesiol, Shanghai 200032, Peoples R China; [Luo, Feifei; Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200032, Peoples R China; [Yu, Hongxiu] Fudan Univ, Shanghai Stomatol Hosp, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Chu, YW (corresponding author), Fudan Univ, Dept Immunol, Sch Basic Med Sci,Inst Biomed Sci, Shanghai Key Lab Med Epigenet & Metab, Shanghai 200032, Peoples R China.; Liu, RH (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai Key Lab Med Epigenet, Shanghai Peoples Hosp 9, Shanghai 200032, Peoples R China.	ronghualiu@fudan.edu.cn; yiweichu@fudan.edu.cn	Li, Yifan/HGA-6843-2022	Li, Yifan/0000-0002-3249-1778; Zhong, Ziwen/0000-0002-4578-174X; Wang, Zhiqiang/0000-0001-5928-0500	National Science Foundation of China [81730045, 82121002, 82130050, 81972666]; Shanghai Rising-Star Program [19QA1406900]; National Science and Technology Major Project of China [2020YFC2008402]; Innovative Research Team of High-Level Local Universities in Shanghai	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; National Science and Technology Major Project of China; Innovative Research Team of High-Level Local Universities in Shanghai	This work was supported by the National Science Foundation of China (81730045, 82121002, 82130050, and 81972666), the Shanghai Rising-Star Program (19QA1406900), the National Science and Technology Major Project of China (2020YFC2008402), and Innovative Research Team of High-Level Local Universities in Shanghai. We thank Dr. Zhongjun Dong (Professor, the School of Medicine, Tsinghua University, Beijing, China) for providing the Cd79a-Cre mice. We thank Dr. Guangwei Liu (Professor, College of Life Sciences, Beijing Normal University, Beijing, China) for providing the Sirt1<SUP>fl/fl</SUP> mice.	Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Asosingh K, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.127801; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bleve A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165845; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Choera T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01996; Correale J, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.600428; Damsky W, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0613-1; Field CS, 2020, CELL METAB, V31, P422, DOI 10.1016/j.cmet.2019.11.021; He T, 2011, J BIOL CHEM, V286, P14137, DOI 10.1074/jbc.M110.176289; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hinshaw DC, 2021, CANCER RES, V81, P5425, DOI 10.1158/0008-5472.CAN-20-1723; Horii M, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.10.019; Huang LJ, 2021, IMMUNITY, V54, P1728, DOI 10.1016/j.immuni.2021.07.004; Kalaitzidis D, 2017, J CLIN INVEST, V127, P1405, DOI 10.1172/JCI89452; Kelly B, 2020, CELL METAB, V32, P154, DOI 10.1016/j.cmet.2020.06.010; Kieler M, 2021, FEBS J, V288, P3694, DOI 10.1111/febs.15715; Koelwyn GJ, 2020, NAT METAB, V2, P849, DOI 10.1038/s42255-020-00277-4; Lemos H, 2019, NAT REV CANCER, V19, P162, DOI 10.1038/s41568-019-0106-z; Leone RD, 2020, NAT REV CANCER, V20, P516, DOI 10.1038/s41568-020-0273-y; Leone RD, 2019, SCIENCE, V366, P1013, DOI 10.1126/science.aav2588; Liu JJ, 2019, IMMUNOLOGY, V156, P56, DOI 10.1111/imm.12998; Magaway C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121584; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Prendergast GC, 2014, CANCER IMMUNOL IMMUN, V63, P721, DOI 10.1007/s00262-014-1549-4; Reinfeld BI, 2022, CELL MOL IMMUNOL, V19, P46, DOI 10.1038/s41423-021-00727-3; Ren XW, 2021, CELL, V184, P1895, DOI 10.1016/j.cell.2021.01.053; Rouers A, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102482; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Shi H, 2019, IMMUNITY, V51, P1012, DOI 10.1016/j.immuni.2019.10.001; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Storck LJ, 2020, CLIN NUTR, V39, P3637, DOI 10.1016/j.clnu.2020.04.008; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Veglia F, 2019, NATURE, V569, P73, DOI 10.1038/s41586-019-1118-2; Wang L, 2015, MUCOSAL IMMUNOL, V8, P1297, DOI 10.1038/mi.2015.20; Wang LM, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.08.019; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015901; Watson MJ, 2021, NATURE, V591, P645, DOI 10.1038/s41586-020-03045-2; Zheng MZ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106754118	43	5	5	13	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1067	+		10.1016/j.immuni.2022.04.017	http://dx.doi.org/10.1016/j.immuni.2022.04.017			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F2TY	35659337				2022-12-18	WOS:000830524400002
J	Mettelman, RC; Allen, EK; Thomas, PG				Mettelman, Robert C.; Allen, Kaitlynn E.; Thomas, Paul G.			Mucosal immune responses to infection and vaccination in the respiratory tract	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; NEUTROPHIL EXTRACELLULAR TRAPS; MEMORY T-CELLS; ANGIOTENSIN-CONVERTING ENZYME-2; INFLUENZA-VIRUS INFECTION; ACUTE LUNG INJURY; DENDRITIC CELLS; DISTRESS-SYNDROME; TYPE-2 IMMUNITY; INTERSTITIAL MACROPHAGES	The lungs are constantly exposed to inhaled debris, allergens, pollutants, commensal or pathogenic microorganisms, and respiratory viruses. As a result, innate and adaptive immune responses in the respiratory tract are tightly regulated and are in continual flux between states of enhanced pathogen clearance, immune-modulation, and tissue repair. New single-cell-sequencing techniques are expanding our knowledge of airway cellular complexity and the nuanced connections between structural and immune cell compartments. Understanding these varied interactions is critical in treatment of human pulmonary disease and infections and in next-generation vaccine design. Here, we review the innate and adaptive immune responses in the lung and airways following infection and vaccination, with particular focus on influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The ongoing SARS-CoV-2 pandemic has put pulmonary research firmly into the global spotlight, challenging previously held notions of respiratory immunity and helping identify new populations at high risk for respiratory distress.	[Mettelman, Robert C.; Allen, Kaitlynn E.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Thomas, PG (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	paul.thomas@stjude.org	Thomas, Paul G./H-1063-2018	Thomas, Paul G./0000-0001-7955-0256	ALSAC at St. Jude Children's Research Hospital (SJCRH); Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) [75N93019C00052]; National Institute of Allergy and Infectious Diseases (NIAID) [3U01AI144616-02S1, HHSN272201400006C]; Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (NRSA-NIAID) [F32AI157296]; SJCRH Center of Excellence for Influenza Research and Surveillance	ALSAC at St. Jude Children's Research Hospital (SJCRH); Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (NRSA-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SJCRH Center of Excellence for Influenza Research and Surveillance	This publication was supported by ALSAC at St. Jude Children's Research Hospital (SJCRH) , the Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) contract number 75N93019C00052 (P.G.T.) , the SJCRH Center of Excellence for Influenza Research and Surveillance (P.G.T.) , HHSN272201400006C, National Institute of Allergy and Infectious Diseases (NIAID) award 3U01AI144616-02S1 (P.G.T.) , and Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (NRSA-NIAID) award number F32AI157296 (R.C.M.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abboud G, 2016, J VIROL, V90, P129, DOI 10.1128/JVI.01894-15; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Adachi Y, 2015, J EXP MED, V212, P1709, DOI 10.1084/jem.20142284; Aguirre A, 2017, J MOL MED, V95, P487, DOI 10.1007/s00109-017-1510-z; Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370; Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Alon R, 2021, NAT REV IMMUNOL, V21, P49, DOI 10.1038/s41577-020-00470-2; Amersfoort J, 2022, NAT REV IMMUNOL, V22, P576, DOI 10.1038/s41577-022-00694-4; Amirlak L, 2021, HUM VACC IMMUNOTHER, V17, P3913, DOI 10.1080/21645515.2021.1956228; Angelidis I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08831-9; Ardain A, 2020, IMMUNOLOGY, V159, P245, DOI 10.1111/imm.13143; Ardain A, 2019, NATURE, V570, P528, DOI 10.1038/s41586-019-1276-2; Ardain A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00092; Artiaga BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37999; Bajaj V, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.571416; Barker KA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI141810; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bayes HK, 2016, INFECT IMMUN, V84, P3507, DOI 10.1128/IAI.00717-16; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bergenfelz C, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00109; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bertoletti A, 2021, CELL MOL IMMUNOL, V18, P2307, DOI 10.1038/s41423-021-00743-3; Beura LK, 2019, J EXP MED, V216, P1214, DOI 10.1084/jem.20181365; Blazquez-Prieto J, 2018, AM J RESP CELL MOL, V59, P289, DOI 10.1165/rcmb.2018-0101PS; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Boyd DF, 2020, NATURE, V587, P466, DOI 10.1038/s41586-020-2877-5; Branchfield K, 2016, SCIENCE, V351, P707, DOI 10.1126/science.aad7969; Brand JD, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123467; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821; Brown RL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01803-x; Brune K, 2015, AM J PHYSIOL-LUNG C, V308, pL731, DOI 10.1152/ajplung.00309.2014; Capucetti A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01259; Casanova JL, 2021, ANNU REV PATHOL-MECH, V16, P23, DOI 10.1146/annurev-pathol-031920-101429; Cervia C, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-021-27797-1; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chason KD, 2018, J GERONTOL A-BIOL, V73, P1643, DOI 10.1093/gerona/gly126; Chatzikleanthous D, 2021, MOL PHARMACEUT, V18, P2867, DOI 10.1021/acs.molpharmaceut.1c00447; Chen J, 2020, J IMMUNOL, V205, P313, DOI 10.4049/jimmunol.2000380; Chen K, 2013, ANNU REV IMMUNOL, V31, P605, DOI 10.1146/annurev-immunol-032712-100019; Chumakov K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101718118; Clark BL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21238903; Clem AS, 2011, J GLOB INFECT DIS, V3, P73, DOI 10.4103/0974-777X.77299; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Cohen CA, 2021, NAT COMMUN, V12, DOI [10.1101/2021.02.02.21250988, 10.1038/s41467-021-24938-4]; Collaborators G.B.D.L.R.I., 2018, LANCET INFECT DIS, V18, P1191, DOI [10.1016/S1473-3099(18)30310-4, DOI 10.1016/S1473-3099(18)30310-4]; Cooper GE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01671; Crainiciuc G, 2022, NATURE, V601, P415, DOI 10.1038/s41586-021-04263-y; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cuesta-Llavona Elias, 2021, Curr Res Virol Sci, V2, P100016, DOI 10.1016/j.crviro.2021.100016; Cukalac T, 2014, P NATL ACAD SCI USA, V111, P1485, DOI 10.1073/pnas.1323736111; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; DAVENPORT FM, 1955, LANCET, V2, P469; DeGrace MM, 2022, NATURE, V605, P640, DOI 10.1038/s41586-022-04690-5; Delaveris CS, 2020, P NATL ACAD SCI USA, V117, P12643, DOI 10.1073/pnas.1921962117; Deng XF, 2019, J VIROL, V93, DOI [10.1128/JVI.02000-18, 10.1128/jvi.02000-18]; Deng XF, 2017, P NATL ACAD SCI USA, V114, pE4251, DOI 10.1073/pnas.1618310114; Deprez M, 2020, AM J RESP CRIT CARE, V202, P1636, DOI 10.1164/rccm.201911-2199OC; Devarajan P, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2111064119; Di Domizio J, 2022, NATURE, V603, P145, DOI 10.1038/s41586-022-04421-w; Diamond MS, 2022, NAT IMMUNOL, V23, P165, DOI 10.1038/s41590-021-01091-0; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dinnon KH., 2022, BIORXIV, DOI [10.1101/2022.02.15.480515, DOI 10.1101/2022.02.15.480515]; Dong CH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024998118; Downes DJ, 2021, NAT GENET, V53, P1606, DOI 10.1038/s41588-021-00955-3; El Agha E, 2017, CELL STEM CELL, V20, P261, DOI 10.1016/j.stem.2016.10.004; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Evren E, 2022, J EXP MED, V219, DOI 10.1084/jem.20210987; Falck-Jones S, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI144734; Fathi M, 2001, EXP MOL PATHOL, V70, P77, DOI 10.1006/exmp.2000.2344; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Feld JJ, 2021, LANCET RESP MED, V9, P498, DOI 10.1016/S2213-2600(20)30566-X; Feldstein LR, 2021, JAMA-J AM MED ASSOC, V325, P1074, DOI 10.1001/jama.2021.2091; de Araujo JLF, 2022, REV MED VIROL, V32, DOI 10.1002/rmv.2283; Flament H, 2021, EUR J IMMUNOL, V51, P298, DOI 10.1038/s41590-021-00870-z; Flerlage T, 2021, NAT REV MICROBIOL, V19, P425, DOI 10.1038/s41579-021-00542-7; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Forero A, 2019, IMMUNITY, V51, P451, DOI 10.1016/j.immuni.2019.07.007; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Fulop T, 2021, CLIN REV ALLERG IMMU, DOI 10.1007/s12016-021-08899-6; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Geitani R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01198; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; Gonzalez-Lopez A, 2011, AM J PHYSIOL-LUNG C, V301, pL500, DOI 10.1152/ajplung.00010.2011; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Gould VMW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00900; Grant RA, 2021, NATURE, V590, P635, DOI 10.1038/s41586-020-03148-w; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guo K., 2022, BIORXIV, DOI [10.1101/2022.02.14.480379, DOI 10.1101/2022.02.14.480379]; Guo XZJ, 2018, IMMUNITY, V49, P531, DOI 10.1016/j.immuni.2018.07.011; Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Harker JA, 2021, IMMUNITY, V54, P617, DOI 10.1016/j.immuni.2021.03.010; Harrison AG, 2020, TRENDS IMMUNOL, V41, P1100, DOI 10.1016/j.it.2020.10.004; Hassan AO, 2020, CELL, V183, P169, DOI 10.1016/j.cell.2020.08.026; Hemann EA, 2019, NAT IMMUNOL, V20, P1035, DOI 10.1038/s41590-019-0408-z; Hemann EA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01707; Hemann EA, 2016, J VIROL, V90, P2830, DOI 10.1128/JVI.02546-15; Henry C, 2018, TRENDS IMMUNOL, V39, P70, DOI 10.1016/j.it.2017.08.003; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hewitt RJ, 2021, NAT REV IMMUNOL, V21, P347, DOI 10.1038/s41577-020-00477-9; Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Honce R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01071; Hoppstadter J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-124; Hou XC, 2021, NAT REV MATER, V6, P1078, DOI 10.1038/s41578-021-00358-0; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Humphries DC, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.738955; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Janssen WJ, 2016, EUR RESPIR J, V48, P1201, DOI 10.1183/13993003.00120-2015; Jenkins MM, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg6895; Jouan Y, 2020, J EXP MED, V217, DOI 10.1084/jem.20200872; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022; Kandasamy M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005754; Kang SM, 2009, MOL CELLS, V27, P5, DOI 10.1007/s10059-009-0015-1; Karki R, 2021, TRENDS IMMUNOL, V42, P681, DOI 10.1016/j.it.2021.06.001; Karki Rajendra, 2021, Cell, V184, P149, DOI [10.1101/2020.10.29.361048, 10.1016/j.cell.2020.11.025]; Kastenhuber Edward R, 2021, bioRxiv, DOI 10.1101/2021.03.31.437960; Kawano H, 2016, INT IMMUNOL, V28, P489, DOI 10.1093/intimm/dxw012; Kedzierska K, 2022, CELL REP MED, V3, DOI 10.1016/j.xcrm.2022.100562; Kedzierska K, 2006, J IMMUNOL, V177, P6705, DOI 10.4049/jimmunol.177.10.6705; Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004; Kim YM, 2021, EXP MOL MED, V53, P750, DOI 10.1038/s12276-021-00592-0; Klinkhammer J, 2018, ELIFE, V7, DOI 10.7554/eLife.33354; Knudsen L, 2018, HISTOCHEM CELL BIOL, V150, P661, DOI 10.1007/s00418-018-1747-9; Ko EJ, 2018, HUM VACC IMMUNOTHER, V14, P3041, DOI 10.1080/21645515.2018.1495301; Kohli J, 2021, EMBO REP, V22, DOI 10.15252/embr.202052243; Kohli K, 2016, EUR J IMMUNOL, V46, P2659, DOI 10.1002/eji.201646359; Konrad FM, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/1208086; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Kousathanas A., 2022, NATURE, V7, DOI [10.1038/s41586-022-04576, DOI 10.1038/S41586-022-04576]; Koushki K, 2021, BIOMED PHARMACOTHER, V144, DOI 10.1016/j.biopha.2021.112346; Koutsakos M, 2019, NAT IMMUNOL, V20, P613, DOI 10.1038/s41590-019-0320-6; Kratzel A, 2020, J INFECTION, V81, P474, DOI 10.1016/j.jinf.2020.05.074; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kulkarni RR, 2014, J VIROL, V88, P13990, DOI 10.1128/JVI.02273-14; Kumar BV, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123568; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lamers MM, 2021, EMBO J, V40, DOI 10.15252/embj.2020105912; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Lang FM, 2020, NAT REV IMMUNOL, V20, P507, DOI 10.1038/s41577-020-0357-7; Lanzer KG, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-9; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Lehmann R, 2018, MUCOSAL IMMUNOL, V11, P627, DOI 10.1038/mi.2017.100; Leroy C, 2006, AM J PHYSIOL-LUNG C, V291, pL1207, DOI 10.1152/ajplung.00376.2005; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li ZY, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0048-6; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Liong S, 2020, P NATL ACAD SCI USA, V117, P24964, DOI 10.1073/pnas.2006905117; Liu Y, 2021, J HOSP INFECT, V107, P105, DOI 10.1016/j.jhin.2020.10.021; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Londrigan SL, 2020, VIROLOGY, V540, P17, DOI 10.1016/j.virol.2019.11.003; Lu XY, 2021, J EXP MED, V218, DOI 10.1084/jem.20211327; Lund SJ, 2017, J IMMUNOL, V199, P1096, DOI 10.4049/jimmunol.1601569; Maamary J, 2017, P NATL ACAD SCI USA, V114, P10172, DOI 10.1073/pnas.1707950114; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mades A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-03931-3; Madissoon E, 2019, GENOME BIOL, V21, DOI 10.1186/s13059-019-1906-x; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; Mao T., 2022, BIORXIV, DOI [10.1101/2022.01.24.477597v1., DOI 10.1101/2022.01.24.477597, 10.1101/2022.01.24.477597]; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Mettelman RC, 2021, CSH PERSPECT MED, V11, DOI 10.1101/cshperspect.a038711; Meyer NJ, 2013, SEMIN RESP CRIT CARE, V34, P459, DOI 10.1055/s-0033-1351121; Meyer-Arndt L, 2022, J IMMUNOL, V208, P1001, DOI 10.4049/jimmunol.2100990; Meyerowitz EA, 2021, ANN INTERN MED, V174, P69, DOI 10.7326/M20-5008; Mindt BC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00840; Minervina AA, 2022, NAT IMMUNOL, V23, P781, DOI 10.1038/s41590-022-01184-4; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Miyauchi K, 2016, NAT IMMUNOL, V17, P1447, DOI 10.1038/ni.3563; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mohammed FS, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.692254; Moldoveanu B, 2009, J INFLAMM RES, V2, P1; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Moorlag SJCFM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108387; Mould KJ, 2021, AM J RESP CRIT CARE, V203, P946, DOI 10.1164/rccm.202005-1989OC; Mould KJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126556; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Mudd PA, 2022, CELL, V185, P603, DOI 10.1016/j.cell.2021.12.026; Mudd PA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abe3024; Murphy JM, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.836999; NAKAMURA H, 1992, J CLIN INVEST, V89, P1478, DOI 10.1172/JCI115738; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nathan N, 2016, INT J BIOCHEM CELL B, V81, P151, DOI 10.1016/j.biocel.2016.11.003; National Center for Immunization and Respiratory Diseases (NCIRD) DvoVD, 2020, CDC COVID 19 SCI BRI; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Neudecker V, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5360; Nguyen THO, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1242; Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x; Niessl J, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abk0894; Nobs S.P., 2020, EUR MED J, P80, DOI [10.33590/emj/20-00089, DOI 10.33590/EMJ/20-00089]; Nobs SP, 2019, J ALLERGY CLIN IMMUN, V143, P1513, DOI 10.1016/j.jaci.2018.08.044; O'Leary CE, 2019, ANNU REV IMMUNOL, V37, P47, DOI 10.1146/annurev-immunol-042718-041505; Oja AE, 2018, MUCOSAL IMMUNOL, V11, P654, DOI 10.1038/mi.2017.94; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Organization WH, 2020, TOP 10 CAUS DEATH; Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Pan YD, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-020-00265-5; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Patarcic I, 2015, SCI REP-UK, V5, DOI 10.1038/srep16119; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Pietrobon AJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.579220; Pijls BG, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044640; Piters WAAD, 2020, CELL HOST MICROBE, V28, P223, DOI 10.1016/j.chom.2020.07.004; Piters WAAD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0294; Pizzolla A, 2018, J CLIN INVEST, V128, P721, DOI 10.1172/JCI96957; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Poon MML, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl9105; Menezes NP, 2021, SYST REV-LONDON, V10, DOI 10.1186/s13643-021-01749-8; Preston LE, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.5298; Provine NM, 2020, ANNU REV IMMUNOL, V38, P203, DOI 10.1146/annurev-immunol-080719-015428; Pulendran B, 2021, NAT REV DRUG DISCOV, V20, P454, DOI 10.1038/s41573-021-00163-y; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Puttur F, 2019, IMMUNOL CELL BIOL, V97, P246, DOI 10.1111/imcb.12235; Pyle CJ, 2021, J EXP MED, V218, DOI 10.1084/jem.20201555; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Rahmatpanah F, 2019, MUCOSAL IMMUNOL, V12, P77, DOI 10.1038/s41385-018-0097-1; Rangel-Moreno J, 2008, J IMMUNOL, V180, P454, DOI 10.4049/jimmunol.180.1.454; Ranjeva S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09652-6; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Ripperger TJ, 2021, ANNU REV IMMUNOL, V39, P345, DOI 10.1146/annurev-immunol-093019-125603; Rivas MN, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145157; Robinson KM, 2013, J IMMUNOL, V191, P5153, DOI 10.4049/jimmunol.1301237; Rodda LB, 2022, CELL, V185, P1588, DOI 10.1016/j.cell.2022.03.018; Rowlands M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.697405; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Sant S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01453; Sappenfield Elisabeth, 2013, Infect Dis Obstet Gynecol, V2013, P752852, DOI 10.1155/2013/752852; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Schattgen SA, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf2886; Schneider C, 2017, J LEUKOCYTE BIOL, V101, P367, DOI 10.1189/jlb.4HI0316-157R; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Schupp JC, 2020, AM J RESP CRIT CARE, V202, P1419, DOI 10.1164/rccm.202004-0991OC; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Schyns J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11843-0; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Severa M, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009878; Sharma A, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00316-8; Shelton JF, 2021, NAT GENET, V53, P801, DOI 10.1038/s41588-021-00854-7; Shenoy AT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26045-w; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Son YM, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abb6852; Sorensen GL, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00018; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sprent J, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj9256; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Standiford LR, 2012, AM J PHYSIOL-LUNG C, V302, pL447, DOI 10.1152/ajplung.00415.2010; Steer CA, 2017, J ALLERGY CLIN IMMUN, V140, P593, DOI 10.1016/j.jaci.2016.12.984; Strutt TM, 2013, IMMUNOL REV, V255, P149, DOI 10.1111/imr.12088; Su YP, 2022, CELL, V185, P881, DOI 10.1016/j.cell.2022.01.014; Sugamata R, 2012, MICROBIOL IMMUNOL, V56, P171, DOI 10.1111/j.1348-0421.2011.00424.x; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Swarnalekha N, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abb6808; Szabo PA, 2021, IMMUNITY, V54, P797, DOI 10.1016/j.immuni.2021.03.005; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; TAKAHASHI GW, 1993, BLOOD, V81, P357; Takamura S, 2019, J EXP MED, V216, P2736, DOI 10.1084/jem.20190557; Tan AT, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108728; Tan HX, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00611; Tan SYS, 2016, DEVELOPMENT, V143, P1318, DOI 10.1242/dev.129122; Tarke A, 2022, CELL, V185, P847, DOI 10.1016/j.cell.2022.01.015; Tay MZ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00332; Teijaro JR, 2021, NAT REV IMMUNOL, V21, P195, DOI 10.1038/s41577-021-00526-x; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thacker VV, 2021, EMBO REP, V22, DOI 10.15252/embr.202152744; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; Todd EM, 2016, BLOOD, V128, P2785, DOI 10.1182/blood-2016-03-705962; Treerat P, 2017, MUCOSAL IMMUNOL, V10, P1069, DOI 10.1038/mi.2017.15; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Tsang TK, 2020, CLIN INFECT DIS, V71, P1195, DOI 10.1093/cid/ciz968; Tsuji S., 2022, NAT AGING, DOI [10.1038/s43587-022-00170-7, DOI 10.1038/S43587-022-00170-7]; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Turner JS, 2020, NATURE, V586, P127, DOI 10.1038/s41586-020-2711-0; Ursin RL, 2021, ANNU REV VIROL, V8, P393, DOI 10.1146/annurev-virology-091919-092720; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; van Gisbergen KPJM, 2011, IMMUNITY, V35, P97, DOI 10.1016/j.immuni.2011.04.020; Van Maele L, 2014, J INFECT DIS, V210, P493, DOI 10.1093/infdis/jiu106; van Wilgenburg B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07207-9; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Varma DM, 2022, ACS BIOMATER SCI ENG, V8, P1573, DOI 10.1021/acsbiomaterials.2c00015; Vashist N, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.00505, 10.3389/fiimmu.2018.00505]; Velavan TP, 2021, EBIOMEDICINE, V72, DOI 10.1016/j.ebiom.2021.103629; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vijayakumar B, 2022, IMMUNITY, V55, P542, DOI 10.1016/j.immuni.2022.01.017; von Massow G, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.741218; Vroman H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00941; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690; Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Wang Y, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102775118; Wang ZF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03243-7; Wardzala C.L., 2022, MUCINS INHIBIT CORON, P1369, DOI [10.1021/ACSCENTSCI.1C01369, DOI 10.1021/ACSCENTSCI.1C01369]; Watford WT, 2000, AM J PHYSIOL-LUNG C, V279, pL790, DOI 10.1152/ajplung.2000.279.5.L790; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wheatley AK, 2021, TRENDS IMMUNOL, V42, P956, DOI 10.1016/j.it.2021.09.001; Wight TN, 2017, MATRIX BIOL, V60-61, P38, DOI 10.1016/j.matbio.2016.12.001; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; WIZEMANN TM, 1994, AM J RESP CELL MOL, V11, P358, DOI 10.1165/ajrcmb.11.3.8086172; Wong SS, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100237; Wong SS, 2018, J INFECT DIS, V217, P245, DOI 10.1093/infdis/jix571; Wu HL, 2011, J IMMUNOL, V187, P4474, DOI 10.4049/jimmunol.1101443; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Wu Y, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00624-2; Li X, 2022, bioRxiv, DOI 10.1101/2022.01.30.478325; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017; Yang H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00302; Youk J, 2020, CELL STEM CELL, V27, P905, DOI 10.1016/j.stem.2020.10.004; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007; Zani A., 2021, BIORXIV, DOI [10.1101/2021.12.22.473914, DOI 10.1101/2021.12.22.473914]; Zaragosi LE, 2020, BIOCHEM SOC T, V48, P327, DOI 10.1042/BST20191010; Zeberg H, 2020, NATURE, V587, P610, DOI 10.1038/s41586-020-2818-3; Zens KD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85832; Zhang HR, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12111042; Zhang HJ, 2008, ACTA PHARMACOL SIN, V29, P1202, DOI 10.1111/j.1745-7254.2008.00860.x; Zhang HH, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6646071; Zhou G, 2013, EUR J IMMUNOL, V43, P929, DOI 10.1002/eji.201242620; Zhou J.Q., 2022, BIORXIV, DOI [10.1101/2021.10.31.466651, DOI 10.1101/2021.10.31.466651]; Zhu LL, 2018, J INFECT DIS, V217, P428, DOI 10.1093/infdis/jix475; Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999	368	5	5	19	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					749	780		10.1016/j.immuni.2022.04.013	http://dx.doi.org/10.1016/j.immuni.2022.04.013			32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35545027	Bronze, Green Published			2022-12-18	WOS:000802171100003
J	Dahling, S; Mansilla, AM; Knopper, K; Grafen, A; Utzschneider, DT; Ugur, M; Whitney, PG; Bachem, A; Arampatzi, P; Imdahl, F; Kaisho, T; Zehn, D; Klauschen, F; Garbi, N; Kallies, A; Saliba, AE; Gasteiger, G; Bedoui, S; Kastenmuller, W				Daehling, Sabrina; Mansilla, Ana Maria; Knoepper, Konrad; Grafen, Anika; Utzschneider, Daniel T.; Ugur, Milas; Whitney, Paul G.; Bachem, Annabell; Arampatzi, Panagiota; Imdahl, Fabian; Kaisho, Tsuneyasu; Zehn, Dietmar; Klauschen, Frederick; Garbi, Natalio; Kallies, Axel; Saliba, Antoine-Emmanuel; Gasteiger, Georg; Bedoui, Sammy; Kastenmueller, Wolfgang			Type 1 conventional dendritic cells maintain and guide the differentiation of precursors of exhausted T cells in distinct cellular niches	IMMUNITY			English	Article							RECEPTOR; EXPRESSION; INFECTION; SUBSETS; HELP	Reinvigoration of exhausted CD8(+) T (Tex) cells by checkpoint immunotherapy depends on the activation of precursors of exhausted T (Tpex) cells, but the local anatomical context of their maintenance, differentiation, and interplay with other cells is not well understood. Here, we identified transcriptionally distinct Tpex subpopulations, mapped their differentiation trajectories via transitory cellular states toward Tex cells, and localized these cell states to specific splenic niches. Conventional dendritic cells (cDCs) were critical for successful alpha PD-L1 therapy and were required to mediate viral control. cDC1s were dispensable for Tpex cell expansion but provided an essential niche to promote Tpex cell maintenance, preventing their overactivation and T-cell-mediated immunopathology. Mechanistically, cDC1s insulated Tpex cells via MHC-I-dependent interactions to prevent their activation within other inflammatory environments that further aggravated their exhaustion, Our findings reveal that cDC1s maintain and safeguard Tpex cells within distinct anatomical niches to balance viral control, exhaustion, and immunopathology.	[Daehling, Sabrina; Mansilla, Ana Maria; Knoepper, Konrad; Grafen, Anika; Ugur, Milas; Gasteiger, Georg; Kastenmueller, Wolfgang] Julius Maximilians Univ Wurzburg, Wurzburg Inst Syst Immunol, Max Planck Res Grp, D-97078 Wurzburg, Germany; [Daehling, Sabrina; Utzschneider, Daniel T.; Whitney, Paul G.; Bachem, Annabell; Kallies, Axel; Bedoui, Sammy] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Mansilla, Ana Maria] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Mansilla, Ana Maria] Albert Ludwig Univ, Fac Biol, D-79104 Freiburg, Germany; [Arampatzi, Panagiota] Univ Wurzburg, Core Unit Syst Med, D-97078 Wurzburg, Germany; [Imdahl, Fabian; Saliba, Antoine-Emmanuel] Helmholtz Ctr Infect Res HZI, Helmholtz Inst RNA Based Infect Res HIRI, D-97078 Wurzburg, Germany; [Kaisho, Tsuneyasu] Wakayama Med Univ, Inst Adv Med, Dept Immunol, Wakayama 6418509, Japan; [Zehn, Dietmar] Tech Univ Munich, Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, D-85354 Freising Weihenstephan, Germany; [Klauschen, Frederick] Ludwig Maximilian Univ Munich, Inst Pathol, D-81675 Munich, Germany; [Garbi, Natalio] Univ Bonn, Med Fac, Inst Expt Immunol, D-53127 Bonn, Germany	Max Planck Society; University of Wurzburg; University of Melbourne; Max Planck Society; University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Wakayama Medical University; Technical University of Munich; University of Munich; University of Bonn	Kastenmuller, W (corresponding author), Julius Maximilians Univ Wurzburg, Wurzburg Inst Syst Immunol, Max Planck Res Grp, D-97078 Wurzburg, Germany.	wolfgang.kastenmueller@uni-wuerzburg.de	Klauschen, Frederick/C-5637-2015; Utzschneider, Daniel/D-5855-2016	Klauschen, Frederick/0000-0002-9131-2389; Mansilla Merlano, Ana Maria/0000-0003-2307-6887; Saliba, Antoine-Emmanuel/0000-0001-8539-2784; Ugur, Milas/0000-0003-2115-5389; Gasteiger, Georg/0000-0001-6986-127X; Utzschneider, Daniel/0000-0003-2205-9057	Core Unit for FACS; Core Unit SysMed of the IZKF Wurzburg; IMPRS Max Planck research school Freiburg; German Research Foundation (DFG) Emmy Noether program [GA2129/1-1]; NHMRC [IRTG2168]; European Research Council (ERC) under the European Union [819329, 759176]; NHMRC; Max Planck Society (Max Planck Research Groups)	Core Unit for FACS; Core Unit SysMed of the IZKF Wurzburg; IMPRS Max Planck research school Freiburg(Max Planck Society); German Research Foundation (DFG) Emmy Noether program(German Research Foundation (DFG)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); European Research Council (ERC) under the European Union(European Research Council (ERC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Max Planck Society (Max Planck Research Groups)(Max Planck Society)	We would like to thank the Core Unit for FACS, the Core Unit SysMed of the IZKF W_urzburg, and the IMPRS Max Planck research school Freiburg for supporting this study. The gp33 tetramer was obtained through the NIH Tetramer Core Facility. This work was supported by grants through the German Research Foundation (DFG) Emmy Noether program (GA2129/1-1 [G.G.]) and the NHMRC (IRTG2168 [S.B.]). This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement numbers 819329 and 759176). A.K. is supported by a fellowship and grants from the NHMRC. W.K. and G.G. are supported by the Max Planck Society (Max Planck Research Groups).	Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Basak O., 2018, PROC NATL ACAD; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Borst J, 2018, NAT REV IMMUNOL, V18, P635, DOI 10.1038/s41577-018-0044-0; Brewitz A, 2017, IMMUNITY, V46, P205, DOI 10.1016/j.immuni.2017.01.003; Cabeza-Cabrerizo M, 2021, ANNU REV IMMUNOL, V39, P131, DOI 10.1146/annurev-immunol-061020-053707; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Ferris ST, 2020, NATURE, V584, P624, DOI 10.1038/s41586-020-2611-3; Garris CS, 2018, IMMUNITY, V49, P1148, DOI 10.1016/j.immuni.2018.09.024; Gueguen P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd5778; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hochweller K, 2008, EUR J IMMUNOL, V38, P2776, DOI 10.1002/eji.200838659; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Janowska-Wieczorek A, 2001, BLOOD, V98, P3143, DOI 10.1182/blood.V98.10.3143; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lai JY, 2020, NAT IMMUNOL, V21, P914, DOI 10.1038/s41590-020-0676-7; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Liu J, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1546068; Liu SR, 2020, J IMMUNOL, V204, P1982, DOI 10.4049/jimmunol.1901338; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mayoux M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aav7431; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Ng CT, 2012, P NATL ACAD SCI USA, V109, P14116, DOI 10.1073/pnas.1211910109; Oh SA, 2020, NAT CANCER, V1, P681, DOI 10.1038/s43018-020-0075-x; Ozga AJ, 2022, IMMUNITY, V55, P82, DOI 10.1016/j.immuni.2021.11.002; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peng Q, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18570-x; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts E.W., 2016, CRITICAL ROLE CD103; Rock KL, 2014, TRENDS IMMUNOL, V35, P144, DOI 10.1016/j.it.2014.01.002; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schenkel JM, 2021, IMMUNITY, V54, P2338, DOI 10.1016/j.immuni.2021.08.026; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Xie Zhuorui, 2021, Curr Protoc, V1, pe90, DOI 10.1002/cpz1.90; Xu HC, 2015, J VIROL, V89, P4748, DOI 10.1128/JVI.02976-14; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	62	5	5	8	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					656	+		10.1016/j.immuni.2022.03.006	http://dx.doi.org/10.1016/j.immuni.2022.03.006			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z9WH	35366396				2022-12-18	WOS:000791419000001
J	Kuchroo, VK; Weiner, HL				Kuchroo, Vijay K.; Weiner, Howard L.			How does Epstein-Barr virus trigger MS?	IMMUNITY			English	Editorial Material								Epstein-Barr virus (EBV) is a putative trigger for multiple sclerosis (MS), but clear causality is lacking. In a recent issue of Science, Bjornevik and Cortese et al. utilize longitudinal evaluation of over 10 million adults to demonstrate increased MS risk after EBV infection.	[Kuchroo, Vijay K.; Weiner, Howard L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Weiner, HL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu						Baecher-Allan C, 2018, NEURON, V97, P742, DOI 10.1016/j.neuron.2018.01.021; Balfour HH, 2020, PEDIATR RES, V87, P345, DOI 10.1038/s41390-019-0591-5; Bar-Or A, 2020, TRENDS MOL MED, V26, P296, DOI 10.1016/j.molmed.2019.11.003; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bjornevik K, 2022, SCIENCE, V375, P296, DOI 10.1126/science.abj8222; Jilek S, 2008, BRAIN, V131, P1712, DOI 10.1093/brain/awn108; Lanz TV, 2022, NATURE, DOI 10.1038/s41586-022-04432-7; Li R, 2018, NAT IMMUNOL, V19, P696, DOI 10.1038/s41590-018-0135-x; Pender MP, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124714; Rojas M, 2018, J AUTOIMMUN, V95, P100, DOI 10.1016/j.jaut.2018.10.012	10	5	5	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					390	392		10.1016/j.immuni.2022.02.008	http://dx.doi.org/10.1016/j.immuni.2022.02.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35263566				2022-12-18	WOS:000791044400006
J	Kratochvil, S; Shen, CH; Lin, YC; Xu, K; Nair, U; Pereira, LD; Tripathi, P; Arnold, J; Chuang, GY; Melzi, E; Schon, A; Zhang, BS; Dillon, M; Bonilla, B; Flynn, BJ; Kirsch, KH; Kisalu, NK; Kiyuka, PK; Liu, T; Ou, L; Pancera, M; Rawi, R; Reveiz, M; Seignon, K; Wang, LT; Waring, MT; Warner, J; Yang, YP; Francica, JR; Idris, AH; Seder, RA; Kwong, PD; Batista, FD				Kratochvil, Sven; Shen, Chen-Hsiang; Lin, Ying-Cing; Xu, Kai; Nair, Usha; Pereira, Lais Da Silva; Tripathi, Prabhanshu; Arnold, Johan; Chuang, Gwo-Yu; Melzi, Eleonora; Schon, Arne; Zhang, Baoshan; Dillon, Marlon; Bonilla, Brian; Flynn, Barbara J.; Kirsch, Kathrin H.; Kisalu, Neville K.; Kiyuka, Patience K.; Liu, Tracy; Ou, Li; Pancera, Marie; Rawi, Reda; Reveiz, Mateo; Seignon, Kareen; Wang, Lawrence T.; Waring, Michael T.; Warner, John; Yang, Yongping; Francica, Joseph R.; Idris, Azza H.; Seder, Robert A.; Kwong, Peter D.; Batista, Facundo D.			Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies	IMMUNITY			English	Article							FALCIPARUM CIRCUMSPOROZOITE PROTEIN; RTS,S/AS01 MALARIA VACCINE; PLASMODIUM-FALCIPARUM; INFECTION; PHASE-3; REGION; CELLS	Repeat antigens, such as the Plasmodium falciparum circumsporozoite protein (PfCSP), use both sequence degeneracy and structural diversity to evade the immune response. A few PfCSP-directed antibodies have been identified that are effective at preventing malaria infection, including CIS43, but how these repeat -targeting antibodies might be improved has been unclear. Here, we engineered a humanized mouse model in which B cells expressed inferred human germline CIS43 (iGL-CIS43) B cell receptors and used both vaccination and bioinformatic analysis to obtain variant CIS43 antibodies with improved protective capacity. One such antibody, iGL-CIS43.D3, was significantly more potent than the current best-in-class PfCSP-directed antibody. We found that vaccination with a junctional epitope peptide was more effective than full-length PfCSP at recruiting iGL-CIS43 B cells to germinal centers. Structure-function analysis revealed multiple somatic hypermutations that combinatorically improved protection. This mouse model can thus be used to understand vaccine immunogens and to develop highly potent anti-malarial antibodies.	[Kratochvil, Sven; Lin, Ying-Cing; Nair, Usha; Arnold, Johan; Melzi, Eleonora; Kirsch, Kathrin H.; Seignon, Kareen; Waring, Michael T.; Warner, John; Idris, Azza H.; Batista, Facundo D.] MIT, Ragon Inst, Massachusetts Gen Hosp, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kratochvil, Sven; Lin, Ying-Cing; Nair, Usha; Arnold, Johan; Melzi, Eleonora; Kirsch, Kathrin H.; Seignon, Kareen; Waring, Michael T.; Warner, John; Idris, Azza H.; Batista, Facundo D.] Harvard Univ, Cambridge, MA 02138 USA; [Shen, Chen-Hsiang; Xu, Kai; Pereira, Lais Da Silva; Tripathi, Prabhanshu; Chuang, Gwo-Yu; Zhang, Baoshan; Dillon, Marlon; Bonilla, Brian; Flynn, Barbara J.; Kisalu, Neville K.; Kiyuka, Patience K.; Liu, Tracy; Ou, Li; Pancera, Marie; Rawi, Reda; Reveiz, Mateo; Wang, Lawrence T.; Yang, Yongping; Francica, Joseph R.; Idris, Azza H.; Seder, Robert A.; Kwong, Peter D.] NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA; [Schon, Arne] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Pancera, Marie] Fred Hutchinson Canc Res Ctr, Vaccine Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Waring, Michael T.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Batista, Facundo D.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Batista, Facundo D.] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; National Institutes of Health (NIH) - USA; Johns Hopkins University; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Batista, FD (corresponding author), MIT, Ragon Inst, Massachusetts Gen Hosp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Batista, FD (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.; Seder, RA; Kwong, PD (corresponding author), NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA.; Batista, FD (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.; Batista, FD (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.	rseder@nih.gov; pdkwong@nih.gov; fbatista1@mgh.harvard.edu		Melzi, Eleonora/0000-0002-1520-735X; Tripathi, Prabhanshu/0000-0003-1282-2848; Bonilla, Brian/0000-0002-4067-7476	Ragon Institute of MGH; MIT; Harvard; Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID); U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]	Ragon Institute of MGH; MIT; Harvard; Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE))	We thank the Batista Lab members at the Ragon Institute, in particular Stepha-nie R. Weldon, for critically reading, editing, and discussing the manuscript. We thank the members of the Ragon Institute FACS facility for technical advice and expertise. Flexible funding provided by the Ragon Institute of MGH, MIT, and Harvard. We also thank V. Kholodenko for assistance with ITC, M. Sastry for assistance with peptide probes for AlphaLISA, J. Stuckey for assistance with figures, and members of the Virology Laboratory and Vector Core, Vac-cine Research Center for discussion and comments. This work was also sup-ported by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID) . Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science (contract W-31-109-Eng-38) .	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Atcheson E, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00302-x; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Budeus B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146409; Calvo-Calle JM, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-020-00272-6; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Cockburn IA, 2018, NAT IMMUNOL, V19, P1199, DOI 10.1038/s41590-018-0228-6; Dosenovic P, 2018, P NATL ACAD SCI USA, V115, P4743, DOI 10.1073/pnas.1803457115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006469; Flores-Garcia Y, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3055-9; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Francica JR, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030272; Gaudinski MR, 2021, NEW ENGL J MED, V385, P803, DOI 10.1056/NEJMoa2034031; Guo YC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02365; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Havenar-Daughton C, 2018, CURR OPIN IMMUNOL, V53, P209, DOI 10.1016/j.coi.2018.08.002; HOLLINGDALE MR, 1984, J IMMUNOL, V132, P909; Huang DL, 2020, P NATL ACAD SCI USA, V117, P22920, DOI 10.1073/pnas.2004489117; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Imkeller K, 2018, SCIENCE, V360, P1358, DOI 10.1126/science.aar5304; Jelinkova L, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-020-00274-4; Julien JP, 2019, NAT REV IMMUNOL, V19, P761, DOI 10.1038/s41577-019-0209-5; Kisalu NK, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.143958; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lin YC, 2018, EMBO J, V37, DOI 10.15252/embj.201899243; McNamara HA, 2020, CELL HOST MICROBE, V28, P572, DOI 10.1016/j.chom.2020.07.001; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Murugan R, 2020, NAT MED, V26, P1135, DOI 10.1038/s41591-020-0881-9; Ota T, 2013, J IMMUNOL, V191, P3179, DOI 10.4049/jimmunol.1301283; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyen D, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008373; Oyen D, 2017, P NATL ACAD SCI USA, V114, pE10438, DOI 10.1073/pnas.1715812114; Phillips MA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.50; Raghunandan R, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03181-0; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sheng ZZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00537; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Tan J, 2019, ANNU REV IMMUNOL, V37, P225, DOI 10.1146/annurev-immunol-042617-053301; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Triller G, 2017, IMMUNITY, V47, P1197, DOI 10.1016/j.immuni.2017.11.007; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Wang LT, 2020, IMMUNITY, V53, P733, DOI 10.1016/j.immuni.2020.08.014; Wang XS, 2021, EMBO J, V40, DOI 10.15252/embj.2020105926; Wardemann H, 2018, CURR OPIN IMMUNOL, V53, P119, DOI 10.1016/j.coi.2018.04.023; White MT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0117-2; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Xu K, 2018, NAT MED, V24, P857, DOI 10.1038/s41591-018-0042-6; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947	54	5	5	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2859	+		10.1016/j.immuni.2021.10.017	http://dx.doi.org/10.1016/j.immuni.2021.10.017		DEC 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6LX	34788599	Green Accepted, hybrid			2022-12-18	WOS:000731658800005
J	Bortoluzzi, S; Dashtsoodol, N; Engleitner, T; Drees, C; Helmrath, S; Mir, J; Toska, A; Flossdorf, M; Ollinger, R; Solovey, M; Colome-Tatche, M; Kalfaoglu, B; Ono, M; Buch, T; Ammon, T; Rad, R; Schmidt-Supprian, M				Bortoluzzi, Sabrina; Dashtsoodol, Nyambayar; Engleitner, Thomas; Drees, Christoph; Helmrath, Sabine; Mir, Jonas; Toska, Albulena; Flossdorf, Michael; Oellinger, Rupert; Solovey, Maria; Colome-Tatche, Maria; Kalfaoglu, Bahire; Ono, Masahiro; Buch, Thorsten; Ammon, Tim; Rad, Roland; Schmidt-Supprian, Marc			Brief homogeneous TCR signals instruct common iNKT progenitors whose effector diversification is characterized by subsequent cytokine signaling	IMMUNITY			English	Article							SET ENRICHMENT ANALYSIS; NKT CELL-DEVELOPMENT; GAMMA-DELTA T; ZINC-FINGER; INNATE; EXPRESSION; PLZF; HOMEOSTASIS; IL-15; TRANSCRIPTION	Innate-like T cell populations expressing conserved TCRs play critical roles in immunity through diverse developmentally acquired effector functions. Focusing on the prototypical lineage of invariant natural killer T (iNKT) cells, we sought to dissect the mechanisms and timing of fate decisions and functional effector differentiation. Utilizing induced expression of the semi-invariant NKT cell TCR on double positive thymocytes, an initially highly synchronous wave of iNKT cell development was triggered by brief homogeneous TCR signaling. After reaching a uniform progenitor state characterized by IL-4 production potential and proliferation, effector subsets emerged simultaneously, but then diverged toward different fates. While NKT17 specification was quickly completed, NKT1 cells slowly differentiated and expanded. NKT2 cells resembled maturing progenitors, which gradually diminished in numbers. Thus, iNKT subset diversification occurs in dividing progenitor cells without acute TCR input but utilizes multiple active cytokine signaling pathways. These data imply a two-step model of iNKT effector differentiation.	[Bortoluzzi, Sabrina; Dashtsoodol, Nyambayar; Drees, Christoph; Helmrath, Sabine; Ammon, Tim; Schmidt-Supprian, Marc] Tech Univ Munich, Sch Med, Inst Expt Hematol, D-81675 Munich, Germany; [Bortoluzzi, Sabrina; Dashtsoodol, Nyambayar; Engleitner, Thomas; Helmrath, Sabine; Oellinger, Rupert; Ammon, Tim; Rad, Roland; Schmidt-Supprian, Marc] Tech Univ Munich2, Ctr Translat Canc Res TranslaTUM, Sch Med, D-81675 Munich, Germany; [Dashtsoodol, Nyambayar] Mongolian Natl Univ Med Sci, Sch Biomed, Dept Immunol, Ulan Bator 14210, Mongolia; [Engleitner, Thomas; Oellinger, Rupert; Rad, Roland] Tech Univ Munich, Sch Med, Inst Mol Oncol & Funct Genom, D-81675 Munich, Germany; [Engleitner, Thomas; Oellinger, Rupert; Rad, Roland; Schmidt-Supprian, Marc] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Engleitner, Thomas; Oellinger, Rupert; Rad, Roland; Schmidt-Supprian, Marc] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Mir, Jonas; Toska, Albulena; Flossdorf, Michael] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Solovey, Maria; Colome-Tatche, Maria] Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Colome-Tatche, Maria] Ludwig Maximilians Univ Munchen, Biomed Ctr BMC, Fac Med, Physiol Chem, D-82152 Planegg Martinsried, Germany; [Kalfaoglu, Bahire; Ono, Masahiro] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Buch, Thorsten] Univ Zurich, Inst Lab Anim Sci, CH-8952 Schlieren, Switzerland; [Dashtsoodol, Nyambayar] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Dept Immunol & Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan; [Drees, Christoph] Univ Hosp Tubingen, Inst Clin Chem & Pathobiochem, Dept Diagnost Lab Med, D-72076 Tubingen, Germany	Technical University of Munich; Mongolian National University of Medical Sciences; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Imperial College London; Kanazawa University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schmidt-Supprian, M (corresponding author), Tech Univ Munich, Sch Med, Inst Expt Hematol, D-81675 Munich, Germany.; Schmidt-Supprian, M (corresponding author), Tech Univ Munich2, Ctr Translat Canc Res TranslaTUM, Sch Med, D-81675 Munich, Germany.; Schmidt-Supprian, M (corresponding author), German Canc Consortium DKTK, D-69120 Heidelberg, Germany.	marc.supprian@tum.de	Schmidt-Supprian, Marc/F-5893-2011	Schmidt-Supprian, Marc/0000-0002-8543-6166; Mir, Jonas/0000-0003-2067-6289; Toska, Albulena/0000-0002-4519-9493; Dashtsoodol, Nyambayar/0000-0003-4890-9267	DFG through CRC1054	DFG through CRC1054	This work was supported by the DFG through CRC1054, project A02 to M.S.S. We thank J. Knogler, M. Mittermeier, L. Zaygerman, and M. Utzt for technical help as well as T. Korn and L. Klein for advice. We thank Derek Sant'Angelo for PLZFeGFP mice and the NIH Tetramer Core facility for mCD1d-PBS57 Tetramers.	Allende ML, 2008, FASEB J, V22, P307, DOI 10.1096/fj.07-9087com; Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bending D, 2018, J CELL BIOL, V217, P2931, DOI 10.1083/jcb.201711048; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bennstein SB, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01950; Blume J, 2016, IMMUNOL CELL BIOL, V94, P741, DOI 10.1038/icb.2016.40; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen SS, 2017, J EXP MED, V214, P475, DOI 10.1084/jem.20161312; Cui GW, 2014, P NATL ACAD SCI USA, V111, P1915, DOI 10.1073/pnas.1318281111; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dashtsoodol N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00841; Dashtsoodol N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153347; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Drees C, 2017, J IMMUNOL, V198, P2747, DOI 10.4049/jimmunol.1601732; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; Fohse L, 2013, J IMMUNOL, V191, P2384, DOI 10.4049/jimmunol.1301359; Gleimer M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00374; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gordy LE, 2011, J IMMUNOL, V187, P6335, DOI 10.4049/jimmunol.1003965; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Havenar-Daughton C, 2012, BLOOD, V119, P3486, DOI 10.1182/blood-2012-01-401604; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hogquist Kristin, 2020, F1000Res, V9, DOI 10.12688/f1000research.21378.1; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kretschmer L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13788-w; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee YJ, 2016, J IMMUNOL, V197, P1460, DOI 10.4049/jimmunol.1600643; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Y, 2019, NAT IMMUNOL, V20, P447, DOI 10.1038/s41590-019-0334-0; Ma CY, 2020, ELIFE, V9, DOI 10.7554/eLife.53948; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malhotra N, 2018, J EXP MED, V215, P2887, DOI 10.1084/jem.20172021; Mao AP, 2016, P NATL ACAD SCI USA, V113, P7602, DOI 10.1073/pnas.1601504113; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Miller CN, 2018, NATURE, V559, P627, DOI 10.1038/s41586-018-0345-2; Pandiyan P, 2012, J IMMUNOL, V189, P4237, DOI 10.4049/jimmunol.1201476; Parekh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25533; Park JY, 2019, CELL REP, V27, P2548, DOI 10.1016/j.celrep.2019.05.012; Pereira RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5540; Prevot N, 2015, J IMMUNOL, V194, P223, DOI 10.4049/jimmunol.1401985; Pyaram K, 2019, CELL REP, V27, P699, DOI 10.1016/j.celrep.2019.03.052; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Salio M, 2014, P NATL ACAD SCI USA, V111, pE5678, DOI 10.1073/pnas.1413935112; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; St Leger AJ, 2018, J EXP MED, V215, P1079, DOI 10.1084/jem.20170369; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Tuttle KD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05026-6; Vahl JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001589; Wang HG, 2018, ELIFE, V7, DOI 10.7554/eLife.34793; Webster KE, 2014, MUCOSAL IMMUNOL, V7, P1058, DOI 10.1038/mi.2013.122; White AJ, 2014, J IMMUNOL, V192, P2659, DOI 10.4049/jimmunol.1303057; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson RP, 2015, J EXP MED, V212, P855, DOI 10.1084/jem.20141992; Zhao M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05095-7; Zhu LQ, 2013, J IMMUNOL, V191, P737, DOI 10.4049/jimmunol.1300862; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	68	5	5	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2497	+		10.1016/j.immuni.2021.09.003	http://dx.doi.org/10.1016/j.immuni.2021.09.003		NOV 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34562377	Bronze			2022-12-18	WOS:000718366000009
J	Russler-Germain, EV; Jung, JS; Miller, AT; Young, SN; Yi, J; Wehmeier, A; Fox, LE; Monte, KJ; Chai, JN; Kulkarni, DH; Funkhouser-Jones, LJ; Wilke, G; Durai, V; Zinselmeyer, BH; Czepielewski, RS; Greco, S; Murphy, KM; Newberry, RD; Sibley, LD; Hsieh, CS				Russler-Germain, Emilie, V; Jung, Jisun; Miller, Aidan T.; Young, Shannon; Yi, Jaeu; Wehmeier, Alec; Fox, Lindsey E.; Monte, Kristen J.; Chai, Jiani N.; Kulkarni, Devesha H.; Funkhouser-Jones, Lisa J.; Wilke, Georgia; Durai, Vivek; Zinselmeyer, Bernd H.; Czepielewski, Rafael S.; Greco, Suellen; Murphy, Kenneth M.; Newberry, Rodney D.; Sibley, L. David; Hsieh, Chyi-Song			Commensal Cryptosporidium colonization elicits a cDC1-dependent Th1 response that promotes intestinal homeostasis and limits other infections	IMMUNITY			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; REGULATORY T-CELLS; N. SP APICOMPLEXA; INTERFERON-GAMMA; PARVUM INFECTION; DEFICIENT MICE; GLOBAL BURDEN; UNITED-STATES; NEONATAL MICE; DIFFERENTIATION	Cryptosporidium can cause severe diarrhea and morbidity, but many infections are asymptomatic. Here, we studied the immune response to a commensal strain of Cryptosporidium tyzzeri (Ct-STL) serendipitously discovered when conventional type 1 dendritic cell (cDC1)-deficient mice developed cryptosporidiosis. Ct- STL was vertically transmitted without negative health effects in wild-type mice. Yet, Ct-STL provoked profound changes in the intestinal immune system, including induction of an IFN-g-producing Th1 response. TCR sequencing coupled with in vitro and in vivo analysis of common Th1 TCRs revealed that Ct-STL elicited a dominant antigen-specific Th1 response. In contrast, deficiency in cDC1s skewed the Ct-STL CD4 T cell response toward Th17 and regulatory T cells. Although Ct-STL predominantly colonized the small intestine, colon Th1 responses were enhanced and associated with protection against Citrobacter rodentium infection and exacerbation of dextran sodium sulfate and anti-IL10R-triggered colitis. Thus, Ct-STL represents a commensal pathobiont that elicits Th1-mediated intestinal homeostasis that may reflect asymptomatic human Cryptosporidium infection.	[Russler-Germain, Emilie, V; Jung, Jisun; Miller, Aidan T.; Young, Shannon; Yi, Jaeu; Wehmeier, Alec; Fox, Lindsey E.; Monte, Kristen J.; Chai, Jiani N.; Hsieh, Chyi-Song] Washington Univ, Dept Internal Med, Div Rheumatol, Sch Med, St Louis, MO 63110 USA; [Kulkarni, Devesha H.; Newberry, Rodney D.] Washington Univ, Dept Internal Med, Div Gastroenterol, Sch Med, St Louis, MO 63110 USA; [Funkhouser-Jones, Lisa J.; Wilke, Georgia; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Durai, Vivek; Zinselmeyer, Bernd H.; Czepielewski, Rafael S.; Murphy, Kenneth M.] Washington Univ, Dept Pathol, Div Immunobiol, Sch Med, St Louis, MO 63110 USA; [Greco, Suellen] Washington Univ, Div Comparat Med, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hsieh, CS (corresponding author), Washington Univ, Dept Internal Med, Div Rheumatol, Sch Med, St Louis, MO 63110 USA.; Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	sibley@wustl.edu; chsieh@wustl.edu	; Zinselmeyer, Bernd/X-4802-2018	Fox, Lindsey/0000-0001-7558-618X; Jung, Jisun/0000-0001-8885-1579; Zinselmeyer, Bernd/0000-0003-4172-6767	BWF; Wolff Professorship; National Institute of Allergy and Infectious Diseases (NIAID) [AI145496]; NIH [F30 DK111071, T32 GM007200-42];  [U01 AI131349];  [R01 AI136515];  [R01 AI079187]	BWF; Wolff Professorship; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; 	We would like to thank Nicole Santacruz and Patricia Hsieh for technical assistance (Washington University in St. Louis). C.-S.H. is supported by grants U01 AI131349, R01 AI136515, and R01 AI079187; BWF; and the Wolff Professorship. L.D.S. is supported by grant AI145496 from the National Institute of Allergy and Infectious Diseases (NIAID). E.V.R.-G. is supported by NIH grants F30 DK111071 and T32 GM007200-42. Additional acknowledgments are provided in the Supplemental information.	AGUIRRE SA, 1994, INFECT IMMUN, V62, P697, DOI 10.1128/IAI.62.2.697-699.1994; Ajuebor MN, 2001, J IMMUNOL, V166, P552, DOI 10.4049/jimmunol.166.1.552; Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Barbosa JMM, 2008, CYTOM PART A, V73A, P44, DOI 10.1002/cyto.a.20502; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Berube J, 2009, CELL SIGNAL, V21, P448, DOI 10.1016/j.cellsig.2008.12.001; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Bry L, 2006, INFECT IMMUN, V74, P673, DOI 10.1128/IAI.74.1.673-681.2006; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Cama VA, 2008, EMERG INFECT DIS, V14, P1567, DOI 10.3201/eid1410.071273; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Charania R, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8060879; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; CHEN WX, 1993, INFECT IMMUN, V61, P3548, DOI 10.1128/IAI.61.8.3548-3551.1993; CHEN WX, 1993, INFECT IMMUN, V61, P3928, DOI 10.1128/IAI.61.9.3928-3932.1993; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; Condlova S, 2019, EUR J PROTISTOL, V69, P1, DOI 10.1016/j.ejop.2019.02.005; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Cortez VS, 2016, IMMUNOL LETT, V179, P19, DOI 10.1016/j.imlet.2016.07.005; CURRENT WL, 1983, NEW ENGL J MED, V308, P1252, DOI 10.1056/NEJM198305263082102; CURRENT WL, 1986, J PROTOZOOL, V33, P98, DOI 10.1111/j.1550-7408.1986.tb05567.x; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Escalante NK, 2016, J EXP MED, V213, P2841, DOI 10.1084/jem.20161776; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753; Fayer R, 2010, VET PARASITOL, V172, P23, DOI 10.1016/j.vetpar.2010.04.028; Flanigan T P, 1993, Prog Clin Parasitol, V3, P1; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gharpure R, 2019, MMWR-MORBID MORTAL W, V68, P568, DOI 10.15585/mmwr.mm6825a3; Groom JR, 2019, IMMUNOL REV, V289, P101, DOI 10.1111/imr.12742; Gupta J., 2014, BIOPROTOC, V4, pe1289, DOI [10.21769/BioProtoc.1289, DOI 10.21769/BIOPROTOC.1289]; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; HEINE J, 1984, INFECT IMMUN, V43, P856, DOI 10.1128/IAI.43.3.856-859.1984; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r88; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwano S, 2018, SCIENCE, V359, P935, DOI 10.1126/science.aaq1067; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kominsky DJ, 2014, J IMMUNOL, V192, P1267, DOI 10.4049/jimmunol.1301757; Kotloff KL, 2019, LANCET GLOB HEALTH, V7, pE568, DOI 10.1016/S2214-109X(19)30076-2; KUHLS TL, 1992, J COMP PATHOL, V106, P399, DOI 10.1016/0021-9975(92)90024-O; Kulkarni DH, 2020, MUCOSAL IMMUNOL, V13, P271, DOI 10.1038/s41385-019-0240-7; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Leitch GJ, 2011, J BIOMED RES, V25, P1, DOI 10.1016/S1674-8301(11)60001-8; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu JG, 2005, J BIOL CHEM, V280, P24347, DOI 10.1074/jbc.M500973200; Lv CC, 2009, APPL ENVIRON MICROB, V75, P7692, DOI 10.1128/AEM.01386-09; Mach N, 2000, CANCER RES, V60, P3239; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; MCDONALD V, 1994, INFECT IMMUN, V62, P2289, DOI 10.1128/IAI.62.6.2289-2294.1994; MEAD JR, 1991, J INFECT DIS, V163, P1297, DOI 10.1093/infdis/163.6.1297; Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807; Morgan UM, 1999, J CLIN MICROBIOL, V37, P1302, DOI 10.1128/JCM.37.5.1302-1305.1999; Morgan-Ryan UM, 2002, J EUKARYOT MICROBIOL, V49, P433, DOI 10.1111/j.1550-7408.2002.tb00224.x; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Nutsch K, 2016, CELL REP, V17, P206, DOI 10.1016/j.celrep.2016.08.092; Osman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189422; Osman M, 2017, PARASITOL RES, V116, P3419, DOI 10.1007/s00436-017-5645-1; PETERSEN C, 1992, CLIN INFECT DIS, V15, P903, DOI 10.1093/clind/15.6.903; Pollok RCG, 2001, GASTROENTEROLOGY, V120, P99, DOI 10.1053/gast.2001.20907; Potiron L, 2019, J INFECT DIS, V219, P925, DOI 10.1093/infdis/jiy528; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Ren XP, 2012, EXP PARASITOL, V130, P274, DOI 10.1016/j.exppara.2011.07.012; Roncarolo MG, 2018, IMMUNITY, V49, P1004, DOI 10.1016/j.immuni.2018.12.001; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; Sateriale A, 2019, CELL HOST MICROBE, V26, P135, DOI 10.1016/j.chom.2019.05.006; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; Shiomi H, 2010, INFECT IMMUN, V78, P2653, DOI 10.1128/IAI.01343-09; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Solomon BD, 2016, J IMMUNOL, V197, P3512, DOI 10.4049/jimmunol.1601217; Spahn TW, 2008, SCAND J IMMUNOL, V67, P238, DOI 10.1111/j.1365-3083.2007.02063.x; Stensvold CR, 2014, J CLIN MICROBIOL, V52, P2311, DOI 10.1128/JCM.00598-14; Sulzyc-Bielicka V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195834; Tandel J, 2019, NAT MICROBIOL, V4, P2226, DOI 10.1038/s41564-019-0539-x; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tessema TS, 2009, IMMUNOBIOLOGY, V214, P454, DOI 10.1016/j.imbio.2008.11.015; Theodos CM, 1997, INFECT IMMUN, V65, P4761, DOI 10.1128/IAI.65.11.4761-4769.1997; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; UPTON SJ, 1985, J PARASITOL, V71, P625, DOI 10.2307/3281435; Urban JF, 1996, J IMMUNOL, V156, P263; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; VAUGHAN JA, 1991, J MED ENTOMOL, V28, P780, DOI 10.1093/jmedent/28.6.780; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Wilke G, 2019, CELL HOST MICROBE, V26, P123, DOI 10.1016/j.chom.2019.05.007; Wilke G, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00124-18, 10.1128/msphere.00124-18]; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500	99	5	5	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2547	+		10.1016/j.immuni.2021.10.002	http://dx.doi.org/10.1016/j.immuni.2021.10.002		NOV 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34715017	Bronze, Green Accepted			2022-12-18	WOS:000718366000012
J	Liu, D; Yan, JC; Sun, JH; Liu, B; Ma, WW; Li, Y; Shao, XX; Qi, H				Liu, Dan; Yan, Jiacong; Sun, Jiahui; Liu, Bo; Ma, Weiwei; Li, Ye; Shao, Xingxing; Qi, Hai			BCL6 controls contact-dependent help delivery during follicular T-B cell interactions	IMMUNITY			English	Article							OPERATED CA2+ ENTRY; ANTIGEN; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; CHEMOKINE; RESPONSES; MEMORY; ACTIVATION; GENERATION	BCL6 is required for development of follicular T helper (Tfh) cells to support germinal center (GC) formation. However, it is not clear what unique functions programmed by BCL6 can explain its absolute essentiality in T cells for GC formation. We found that ablation of one Bcl6 allele did not appreciably alter early T cell activation and follicular localization but inhibited GC formation and Tfh cell maintenance. BCL6 impinged on Tfh calciumsignaling and also controlled Tfh entanglement with and CD40L delivery to B cells. Amounts of BCL6 protein and nominal frequencies of Tfh cells markedly changed within hours after strengths of T-B cell interactions were altered in vivo, while CD40L overexpression rectified both defective GC formation and Tfh cell maintenance because of the BCL6 haploinsufficiency. Our results reveal BCL6 functions in Tfh cells that are essential for GC formation and suggest that BCL6 helps maintain Tfh cell phenotypes in a T cell non-autonomous manner.	[Liu, Dan; Yan, Jiacong; Sun, Jiahui; Liu, Bo; Shao, Xingxing; Qi, Hai] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Liu, Dan; Yan, Jiacong; Sun, Jiahui; Liu, Bo; Ma, Weiwei; Li, Ye; Shao, Xingxing; Qi, Hai] Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing 100084, Peoples R China; [Liu, Dan; Yan, Jiacong; Sun, Jiahui; Liu, Bo; Ma, Weiwei; Li, Ye; Shao, Xingxing; Qi, Hai] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Yan, Jiacong; Shao, Xingxing; Qi, Hai] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Qi, Hai] Tsinghua Univ, Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China; [Qi, Hai] Tsinghua Univ, Beijing Frontier Res Ctr Biol Struct, Beijing 100084, Peoples R China; [Liu, Dan] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Yan, Jiacong] First Peoples Hosp Yunnan Prov, Reprod Med Ctr, Kunming, Yunnan, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; University of California System; University of California San Francisco	Qi, H (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing 100084, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Beijing Frontier Res Ctr Biol Struct, Beijing 100084, Peoples R China.	qihai@tsinghua.edu.cn		Qi, Hai/0000-0001-5475-3989; Yan, Jiacong/0000-0002-2429-036X	National Key R&D Program of China (Ministry of Science and Technology) [2018YFE0200300]; Natural Science Foundation of China [8162002, 81761128019]; Beijing Municipal Science and Technology Commission; Bill & Melinda Gates Foundation; Howard Hughes Medical Institute	National Key R&D Program of China (Ministry of Science and Technology); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors thank Drs. L. Staudt and P. Schwartzberg for providing the germline Bcl6/and Sap/mice, respectively; Dr. T. Takemori for providing Bcl6fl/fl mice; and Dr. M. Nussenzweig for providing the aDEC-OVA reagent. This work was supported in part by the National Key R&D Program of China (Ministry of Science and Technology, 2018YFE0200300), the Natural Science Foundation of China (8162002 and 81761128019), and the Beijing Municipal Science and Technology Commission. H.Q. is an HHMI International Research Scholar, and this work was also funded in part by the Bill & Melinda Gates Foundation and the Howard Hughes Medical Institute. The findings and conclusions within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation or the Howard Hughes Medical Institute.	Arnold CN, 2007, EUR J IMMUNOL, V37, P100, DOI 10.1002/eji.200636486; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cheli VT, 2016, GLIA, V64, P1396, DOI 10.1002/glia.23013; Chen X, 2015, PROTEIN CELL, V6, P825, DOI 10.1007/s13238-015-0210-0; Chu C, 2014, J IMMUNOL, V193, P3860, DOI 10.4049/jimmunol.1401660; COICO RF, 1983, J IMMUNOL, V131, P2254; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Koguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031296; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Li FY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07853-z; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Liu XD, 2016, CELL REP, V14, P1735, DOI 10.1016/j.celrep.2016.01.038; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Martinez GJ, 2016, J IMMUNOL, V196, P2015, DOI 10.4049/jimmunol.1501841; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pedros C, 2016, NAT IMMUNOL, V17, P825, DOI 10.1038/ni.3463; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Qi H, 2014, CURR OPIN IMMUNOL, V28, P34, DOI 10.1016/j.coi.2014.01.016; Qi H, 2012, IMMUNOL REV, V247, P24, DOI 10.1111/j.1600-065X.2012.01119.x; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Vaeth M, 2016, IMMUNITY, V44, P1350, DOI 10.1016/j.immuni.2016.04.013; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wan ZR, 2019, IMMUNOL REV, V288, P28, DOI 10.1111/imr.12747; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	59	5	6	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2245	+		10.1016/j.immuni.2021.08.003	http://dx.doi.org/10.1016/j.immuni.2021.08.003		OCT 2021	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34464595	Green Published, hybrid			2022-12-18	WOS:000706854100013
J	Amaral, MP; Bortoluci, KR				Amaral, Marcelo Pires; Bortoluci, Karina Ramalho			Caspase-8 and FADD: Where Cell Death and Inflammation Collide	IMMUNITY			English	Editorial Material								Caspase-8 is a master regulator of cell death pathways, although its regulation during inflammation remains elusive. Using elegant mouse genetic approaches, Schwarzer et al. and Tummers et al. revealed the importance of FADD in regulating caspase-8-mediated inflammatory responses and gut homeostasis.	[Amaral, Marcelo Pires; Bortoluci, Karina Ramalho] Fed Univ Sao Paulo UNIFESP, Ctr Cellular & Mol Therapy CTCMol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Bortoluci, KR (corresponding author), Fed Univ Sao Paulo UNIFESP, Ctr Cellular & Mol Therapy CTCMol, Sao Paulo, Brazil.	kbortoluci@gmail.com	Bortoluci, Karina R/C-6018-2012; Amaral, Marcelo Pires/AAB-5077-2020; Bortoluci, Karina/P-9296-2019	Bortoluci, Karina R/0000-0001-6780-5397; Amaral, Marcelo Pires/0000-0002-5335-6196; Bortoluci, Karina/0000-0001-6780-5397				Amaral MP, 2020, CELL DEATH DIFFER, V27, P1740, DOI 10.1038/s41418-020-0526-z; Fritsch M, 2019, NATURE, V575, P683, DOI 10.1038/s41586-019-1770-6; Hartwig T, 2017, MOL CELL, V65, P730, DOI 10.1016/j.molcel.2017.01.021; Henry CM, 2017, MOL CELL, V65, P715, DOI 10.1016/j.molcel.2017.01.022; Newton K, 2019, NATURE, V575, P679, DOI 10.1038/s41586-019-1752-8; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Schwarzer R, 2020, IMMUNITY, V52, P978, DOI 10.1016/j.immuni.2020.04.002; Tang DL, 2019, CELL RES, V29, P347, DOI 10.1038/s41422-019-0164-5; Tummers B, 2020, IMMUNITY, V52, P994, DOI 10.1016/j.immuni.2020.04.010	10	5	6	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					890	892		10.1016/j.immuni.2020.05.008	http://dx.doi.org/10.1016/j.immuni.2020.05.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32553174	Bronze			2022-12-18	WOS:000541890000002
J	Notarangelo, G; Haigis, MC				Notarangelo, Giulia; Haigis, Marcia C.			Sweet Temptation: From Sugar Metabolism to Gene Regulation	IMMUNITY			English	Editorial Material							LACTATE; INFLAMMATION	In a recent issue of Nature, Zhang et al. (2019) describe an additional histone post-translational modification, named histone lactylation. Following increased lactate production as a consequence of M1 polarization, histone lactylation regulates the induction of an M2-like phenotype in late stages of M1 macrophage activation to promote wound healing.	[Notarangelo, Giulia; Haigis, Marcia C.] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Haigis, MC (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu						Andrejeva G, 2017, CELL METAB, V26, P49, DOI 10.1016/j.cmet.2017.06.004; Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Pucino V, 2017, EUR J IMMUNOL, V47, P14, DOI 10.1002/eji.201646477; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1	9	5	6	10	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					980	981		10.1016/j.immuni.2019.11.008	http://dx.doi.org/10.1016/j.immuni.2019.11.008			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31851904	Bronze			2022-12-18	WOS:000503162900006
J	Reizis, B				Reizis, Boris			The Specificity of Conditional Gene Targeting: A Case for Cre Reporters	IMMUNITY			English	Letter							CELLS		[Reizis, Boris] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University	Reizis, B (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	boris.reizis@nyumc.org		Reizis, Boris/0000-0003-1140-7853				Becher B, 2018, IMMUNITY, V48, P835, DOI 10.1016/j.immuni.2018.05.002; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Loschko J, 2016, J EXP MED, V213, P517, DOI 10.1084/jem.20160062; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Puttur F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003648; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Zhu XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052141	10	5	6	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					593	594		10.1016/j.immuni.2019.09.009	http://dx.doi.org/10.1016/j.immuni.2019.09.009			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31618647	Bronze			2022-12-18	WOS:000490141700002
J	Park, SL; Mackay, LK				Park, Simone L.; Mackay, Laura K.			Bhlhe40 Keeps Resident T Cells Too Fit to Quit	IMMUNITY			English	Editorial Material								Factors regulating the differentiation of tissue-resident memory T (TRM) cells and tumor-infiltrating lymphocytes (TILs) are incompletely understood. In this issue of Immunity, Li et al. identify Bhlhe40 as a transcriptional regulator of CD8(+) T-RM cell and TIL persistence and activity by orchestrating metabolic and epigenetic programming.	[Park, Simone L.; Mackay, Laura K.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia	University of Melbourne	Mackay, LK (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	lkmackay@unimelb.edu.au	Mackay, Laura K/HGC-6580-2022	Mackay, Laura K/0000-0002-8496-6632; Park, Simone/0000-0003-1507-0864				Behr FM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01770; Doedens AL, 2016, CANCER IMMUNOL RES, V4, P799, DOI 10.1158/2326-6066.CIR-15-0178; Li CF, 2019, IMMUNITY, V51, P491, DOI 10.1016/j.immuni.2019.08.013; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Milner JJ, 2018, NATURE, V554, P393, DOI 10.1038/nature25445; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Park SL, 2019, TRENDS IMMUNOL, V40, P735, DOI 10.1016/j.it.2019.06.002; Philip M, 2019, CURR OPIN IMMUNOL, V58, P98, DOI 10.1016/j.coi.2019.04.014; Rodriguez D, 2019, IEEE TOPIC CONF WIRE, P400; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155	11	5	5	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					418	420		10.1016/j.immuni.2019.08.016	http://dx.doi.org/10.1016/j.immuni.2019.08.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31533052	Bronze			2022-12-18	WOS:000486184600003
J	Stoilova, B; Vyas, P				Stoilova, Bilyana; Vyas, Paresh			The Inflammasome: More Than a Protective Innate Immune Mechanism	IMMUNITY			English	Editorial Material							DRIVER	Little is known about the inflammasome beyond its function in innate immune response. In this issue of Immunity, Tyrkalska et al. report that the inflammasome regulates the balance between erythroid and myeloid differentiation in model systems, providing insights into hematopoietic lineage bias associated with inflammatory conditions.	[Stoilova, Bilyana; Vyas, Paresh] Univ Oxford, Radcliffe Dept Med, Oxford Biomed Res Ctr,WIMM, MRC MHU,BRC Haematol Theme,Oxford Ctr Haematol,, Oxford, England; [Vyas, Paresh] Oxford Univ Hosp NHS Trust, Dept Haematol, Oxford, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust	Vyas, P (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford Biomed Res Ctr,WIMM, MRC MHU,BRC Haematol Theme,Oxford Ctr Haematol,, Oxford, England.; Vyas, P (corresponding author), Oxford Univ Hosp NHS Trust, Dept Haematol, Oxford, England.	paresh.vyas@imm.ox.ac.uk	Vyas, Paresh/B-5708-2009	Vyas, Paresh/0000-0003-3931-0914; Stoilova, Bilyana/0000-0001-6192-9145	Bloodwise [13001]; Medical Research Council [MC_UU_12009/11, G1000729/94931, MR/L008963/1]; NIHR Oxford Biomedical Research Centre [oxfbrc-2012-1]; MRC [MC_U137961146, MC_UU_00016/11, G1000729, MR/L008963/1, MC_UU_12009/11] Funding Source: UKRI	Bloodwise; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Bloodwise (grant number 13001), Medical Research Council (MC_UU_12009/11, G1000729/94931, MR/L008963/1), NIHR Oxford Biomedical Research Centre (oxfbrc-2012-1).	Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Basiorka AA, 2016, BLOOD, V128, P2960, DOI 10.1182/blood-2016-07-730556; Drissen R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7148; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; Tyrkalska SD, 2019, IMMUNITY, V51, P50, DOI 10.1016/j.immuni.2019.05.005; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020	10	5	6	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					3	5		10.1016/j.immuni.2019.06.022	http://dx.doi.org/10.1016/j.immuni.2019.06.022			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31315035	Green Submitted, Bronze			2022-12-18	WOS:000475561000002
J	Dustin, ML; Scotet, E; Olive, D				Dustin, Michael L.; Scotet, Emmanuel; Olive, Daniel			An X-ray Vision for Phosphoantigen Recognition	IMMUNITY			English	Editorial Material							ACTIVATION; BTN3A1; DOMAIN	Invariant V gamma 9V delta 2 T cells respond to "phosphoantigen" metabolites through binding to the B30.2 domain of butyrophilin BTN3A. Yang et al. (2019) use molecular dynamic simulations based on X-ray structures of distinct B30.2 domain dimers to identify the asymmetric dimer as most active, which has implications for the inside-out signaling mechanism.	[Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Scotet, Emmanuel] Univ Nantes, Univ Angers, CNRS, INSERM,CRCINA, Nantes, France; [Olive, Daniel] Aix Marseille Univ, CNRS, INSERM, CRCM,Immun & Canc Team,Inst Paoli Calmettes, Marseille, France	University of Oxford; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Dustin, ML (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.	michael.dustin@kennedy.ox.ac.uk	SCOTET, Emmanuel/AAC-9971-2019; Dustin, Michael/AAM-4611-2020; SCOTET, Emmanuel/L-2576-2015	SCOTET, Emmanuel/0000-0001-8010-9556; SCOTET, Emmanuel/0000-0001-8010-9556; Dustin, Michael/0000-0003-4983-6389				Afrache H, 2012, IMMUNOGENETICS, V64, P781, DOI 10.1007/s00251-012-0619-z; Biswas KH, 2015, P NATL ACAD SCI USA, V112, P10932, DOI 10.1073/pnas.1513775112; Boutin L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00828; Gertner-Dardenne J, 2009, BLOOD, V113, P4875, DOI 10.1182/blood-2008-08-172296; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Peigne CM, 2017, J IMMUNOL, V198, P4228, DOI 10.4049/jimmunol.1601910; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Yang YY, 2019, IMMUNITY, V50, P1043, DOI 10.1016/j.immuni.2019.02.016	10	5	6	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1026	1028		10.1016/j.immuni.2019.03.015	http://dx.doi.org/10.1016/j.immuni.2019.03.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995494	Bronze, Green Submitted			2022-12-18	WOS:000464660800018
J	Liberatore, RA; Ho, DD				Liberatore, Rachel A.; Ho, David D.			The Miami Monkey: A Sunny Alternative to the Berlin Patient	IMMUNITY			English	Editorial Material							GENE-TRANSFER; HIV; ANTIBODIES; INFECTION; SIV	Curing HIV infection has been impossible, with the exception of the "Berlin Patient.'' Martinez-Navio et al. (2019) in Miami herein present a rare monkey whose virus was controlled for >3 years after a single genetic intervention that led to persistent production of HIV-neutralizing antibodies in vivo.	[Liberatore, Rachel A.] RenBio Inc, New York, NY USA; [Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Ho, DD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA.	dho@adarc.org		Liberatore, Rachel/0000-0002-3861-5858				Andrews CD, 2017, MOL THER-METH CLIN D, V7, P74, DOI 10.1016/j.omtm.2017.09.003; Bar-On Y, 2018, NAT MED, V24, P1701, DOI 10.1038/s41591-018-0186-4; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Martinez-Navio JM, 2019, IMMUNITY, V50, P567, DOI 10.1016/j.immuni.2019.02.005; Martinez-Navio JM, 2016, MOL THER, V24, P76, DOI 10.1038/mt.2015.191; Siliciano JD, 2016, J CLIN INVEST, V126, P409, DOI 10.1172/JCI86047; Sok D, 2018, NAT IMMUNOL, V19, P1179, DOI 10.1038/s41590-018-0235-7; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047	9	5	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					537	539		10.1016/j.immuni.2019.02.010	http://dx.doi.org/10.1016/j.immuni.2019.02.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30893580	Bronze			2022-12-18	WOS:000461660500002
J	Pascual-Gil, S; Epelman, S				Pascual-Gil, Simon; Epelman, Slava			Monocyte-Derived Macrophages: The Missing Link in Organ Transplantation	IMMUNITY			English	Editorial Material								Successful organ transplantation requires an optimal innate immune response to avoid tissue injury. In this issue of Immunity, Braza et al. (2018) inhibit pro-inflammatory activation of infiltrating graft macrophages using nanotechnology tools to promote immune tolerance, leading to long-term transplant acceptance in mouse models.	[Pascual-Gil, Simon; Epelman, Slava] Toronto Gen Hosp, Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Pascual-Gil, Simon] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Epelman, Slava] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Epelman, Slava] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Epelman, Slava] Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Epelman, Slava] Ted Rogers Ctr Heart Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Peter Munk Cardiac Centre	Epelman, S (corresponding author), Toronto Gen Hosp, Res Inst, Univ Hlth Network, Toronto, ON, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Epelman, S (corresponding author), Peter Munk Cardiac Ctr, Toronto, ON, Canada.; Epelman, S (corresponding author), Ted Rogers Ctr Heart Res, Toronto, ON, Canada.	slava.epelman@uhn.ca	Epelman, Slava/AAO-1728-2020	Epelman, Slava/0000-0003-3400-4475; Pascual-Gil, Simon/0000-0003-0560-456X				Bajpai G, 2018, NAT MED, V24, P1234, DOI 10.1038/s41591-018-0059-x; Braza MS, 2018, IMMUNITY, V49, P819, DOI 10.1016/j.immuni.2018.09.008; Conde P, 2015, IMMUNITY, V42, P1143, DOI 10.1016/j.immuni.2015.05.009; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Ikeda N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat0207; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Sanchez-Gaytan BL, 2015, BIOCONJUGATE CHEM, V26, P443, DOI 10.1021/bc500517k; van den Bosch TPP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00153	10	5	6	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					783	785		10.1016/j.immuni.2018.11.005	http://dx.doi.org/10.1016/j.immuni.2018.11.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30462990	Bronze			2022-12-18	WOS:000450752200001
J	Kiernan, K; Maclver, NJ				Kiernan, Kaitlin; Maclver, Nancie J.			Viral Infection "Interferes'' with Glucose Tolerance	IMMUNITY			English	Editorial Material							INSULIN-RESISTANCE; MICE	In this issue of Immunity, Sestan et al. (2018) show that viral-induced inflammation leads to insulin resistance in skeletal muscle, followed by compensatory hyperinsulinemia, which promotes the anti-viral effector response of CD8(+) T cells. Interestingly, this leads to persistent glucose intolerance and the progression of type 2 diabetes in pre-diabetic animals.	[Kiernan, Kaitlin; Maclver, Nancie J.] Duke Univ, Dept Immunol, Durham, NC 27708 USA; [Maclver, Nancie J.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Maclver, Nancie J.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Maclver, NJ (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27708 USA.; Maclver, NJ (corresponding author), Duke Univ, Dept Pediat, Durham, NC 27706 USA.; Maclver, NJ (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	nancie.maciver@duke.edu		MacIver, Nancie/0000-0003-3676-9391	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106090] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI052077] Funding Source: Medline; NIDDK NIH HHS [R01 DK106090] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chen SJ, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-18; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Mason CC, 2007, DIABETES, V56, P2054, DOI 10.2337/db07-0053; Sestan M, 2018, IMMUNITY, V49, P164, DOI 10.1016/j.immuni.2018.05.005; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Yamaguchi K, 2015, LIVER INT, V35, P550, DOI 10.1111/liv.12645	9	5	5	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					6	8		10.1016/j.immuni.2018.06.013	http://dx.doi.org/10.1016/j.immuni.2018.06.013			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30021147	Bronze			2022-12-18	WOS:000438949100003
J	Wolterink, RGJK; Pirzgalska, RM; Veiga-Fernandes, H				Klein Wolterink, Roel G. J.; Pirzgalska, Roksana M.; Veiga-Fernandes, Henrique			Neuroendocrine Cells Take Your Breath Away	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; NEUROMEDIN U; INFLAMMATION; HOMEOSTASIS; IMMUNE; SYSTEM	Pulmonary neuroimmune networks have emerged as important regulators of lung homeostasis. In a recent issue of Science, Sui et al. show that strategically positioned pulmonary neuroendocrine cells amplify allergic airway responses via group 2 innate lymphoid cells.	[Klein Wolterink, Roel G. J.; Pirzgalska, Roksana M.; Veiga-Fernandes, Henrique] Champalimaud Ctr Unknown, Champalimaud Res, Ave Brasilia, P-1400038 Lisbon, Portugal	Fundacao Champalimaud	Wolterink, RGJK (corresponding author), Champalimaud Ctr Unknown, Champalimaud Res, Ave Brasilia, P-1400038 Lisbon, Portugal.	roel.kleinwolterink@research.fchampalimaud.org; roksana.pirzgalska@research.fchampalimaud.org; henrique.veigafernandes@research.fchampalimaud.org	Pirzgalska, Roksana/AAM-3922-2020	Pirzgalska, Roksana/0000-0003-2314-0439; Klein Wolterink, Roel/0000-0001-6506-3270				Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Cutz E, 2013, SEMIN CELL DEV BIOL, V24, P40, DOI 10.1016/j.semcdb.2012.09.003; de Jong PR, 2015, MUCOSAL IMMUNOL, V8, P491, DOI 10.1038/mi.2014.82; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546; Veiga-Fernandes H, 2018, SCIENCE, V359, P1465, DOI 10.1126/science.aap9598; Veiga-Fernandes H, 2017, NAT IMMUNOL, V18, P116, DOI 10.1038/ni.3634; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604	10	5	5	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					9	11		10.1016/j.immuni.2018.06.010	http://dx.doi.org/10.1016/j.immuni.2018.06.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30021148	Bronze			2022-12-18	WOS:000438949100004
J	Loke, P; Cadwell, K				Loke, P'ng; Cadwell, Ken			Getting a Taste for Parasites in the Gut	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; TYPE-2 IMMUNITY; NEUROMEDIN U; TUFT CELLS; ACTIVATION	How type 2 immune responses are initiated is obscure. Nadjsombati et al. (2018), along with two other studies (Lei et al., 2018; Schneider et al., 2018), show that tuft cells can initiate type 2 responses by recognizing the metabolite succinate produced by intestinal parasites.	[Loke, P'ng; Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Cadwell, Ken] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA	New York University; New York University	Loke, P; Cadwell, K (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.; Cadwell, K (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	png.loke@nyumc.org; ken.cadwell@med.nyu.edu	Loke, Png/X-2278-2019	Cadwell, Ken/0000-0002-5860-0661	National Institutes of Health [AI130945, AI133977, DK103788, HL084312, HL123340, DK093668, AI121244]; Department of Defense [W81XWH-16-1-0256]; Merieux Institute 2016-Cadwell; Rainin Foundation [2016-1258]; Faculty Scholar grant from the Howard Hughes Medical Institute [55108508]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Merieux Institute 2016-Cadwell; Rainin Foundation; Faculty Scholar grant from the Howard Hughes Medical Institute	P.L. and K.C. are funded by the National Institutes of Health (AI130945, AI133977, DK103788, HL084312, HL123340, DK093668, AI121244), the Department of Defense (W81XWH-16-1-0256), Merieux Institute 2016-Cadwell, and Rainin Foundation 2016-1258. K.C. is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases and recipient of the Faculty Scholar grant from the Howard Hughes Medical Institute 55108508. The funders had no role in the decision to publish, or preparation of the manuscript.	Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; Escalante NK, 2016, J EXP MED, V213, P2841, DOI 10.1084/jem.20161776; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161	11	5	5	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					16	18		10.1016/j.immuni.2018.07.002	http://dx.doi.org/10.1016/j.immuni.2018.07.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30021142	Bronze			2022-12-18	WOS:000438949100007
J	Babic, M; Romagnani, C				Babic, Marina; Romagnani, Chiara			Boosting Type 2 Immunity: When OX40L Comes from ILC2s	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS	Accumulating evidence supports a role for the innate lymphoid cells (ILCs) in the modulation of T cell responses. In this issue of Immunity, Halim et al. (2018) identify a role for the costimulatory OX40-OX40L axis in ILC2-mediated regulation of adaptive type 2 immunity during helminth infection and allergen exposure.	[Babic, Marina; Romagnani, Chiara] German Rheumatism Res Ctr DRFZ, Innate Immun, Berlin, Germany; [Babic, Marina; Romagnani, Chiara] Charite, Med Dept 1, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Romagnani, C (corresponding author), German Rheumatism Res Ctr DRFZ, Innate Immun, Berlin, Germany.; Romagnani, C (corresponding author), Charite, Med Dept 1, Berlin, Germany.	romagnani@drfz.de	Romagnani, Chiara/E-4708-2016; Cac, Marina Babic/ABH-3595-2020; Babic Cac, Marina/AFO-1124-2022	Romagnani, Chiara/0000-0002-5167-7463; 				Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Drake LY, 2014, ALLERGY, V69, P1300, DOI 10.1111/all.12446; Halim TYF, 2018, IMMUNITY, V48, P1195, DOI 10.1016/j.immuni.2018.05.003; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; von Burg N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00416; Withers DR, 2011, IMMUNOL REV, V244, P134, DOI 10.1111/j.1600-065X.2011.01057.x	10	5	6	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1067	1069		10.1016/j.immuni.2018.06.004	http://dx.doi.org/10.1016/j.immuni.2018.06.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924969	Bronze			2022-12-18	WOS:000436456900004
J	Lelios, I; Greter, M				Lelios, Iva; Greter, Melanie			Trained Microglia Trigger Memory Loss	IMMUNITY			English	Editorial Material							NEURODEGENERATION; HOMEOSTASIS; IMMUNITY	Innate immune training is a recently described mechanism that allows innate cells to recollect a previous inflammatory episode. In a recent issue of Nature, Wendeln et al. (2018) show that peripheral inflammation can alter long-term microglia function, influencing neuropathology later in life.	[Lelios, Iva; Greter, Melanie] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland	University of Zurich	Greter, M (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	greter@immunology.uzh.ch		Greter, Melanie/0000-0002-7220-5369				Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Datta M, 2018, IMMUNITY, V48, P514, DOI 10.1016/j.immuni.2018.02.016; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4	9	5	5	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					849	851		10.1016/j.immuni.2018.04.033	http://dx.doi.org/10.1016/j.immuni.2018.04.033			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768172	Bronze			2022-12-18	WOS:000432488600007
J	Scally, SW; Julien, JP				Scally, Stephen W.; Julien, Jean-Philippe			Peek-Peak-Pique: Repeating Motifs of Subtle Variance Are Targets for Potent Malaria Antibodies	IMMUNITY			English	Editorial Material							INFECTION; PARASITE	Biomedical interventions to curb malaria-causing Plasmodium falciparum (Pf) infections are critically needed. Two studies in Nature Medicine, Kisalu et al. (2018) and Tan et al. (2018), report the isolation of potent human antibodies that target a new epitope on Pf sporozoites and mediate effective parasite inhibition in pre-clinical models.	[Scally, Stephen W.; Julien, Jean-Philippe] Hosp Sick Children, Res Inst, Program Mol Med, 686 Bay St, Toronto, ON M5G 0A4, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Immunol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Julien, JP (corresponding author), Hosp Sick Children, Res Inst, Program Mol Med, 686 Bay St, Toronto, ON M5G 0A4, Canada.; Julien, JP (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.; Julien, JP (corresponding author), Univ Toronto, Dept Immunol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	jean-philippe.julien@sickkids.ca		Scally, Stephen/0000-0002-4264-7772	Hospital for Sick Children Lap-Chee Tsui Postdoctoral Fellowship; Bill and Melinda Gates Foundation [OPP1179906]; Canada Research Chairs program	Hospital for Sick Children Lap-Chee Tsui Postdoctoral Fellowship; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canada Research Chairs program(Canada Research Chairs)	S.W.S. is supported by a Hospital for Sick Children Lap-Chee Tsui Postdoctoral Fellowship. This work was undertaken, in part, thanks to funding from the Bill and Melinda Gates Foundation (OPP1179906; J.-P.J.) and the Canada Research Chairs program (J.-P.J.).	Fisher CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006469; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Murugan R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aap8029; Oyen D, 2017, P NATL ACAD SCI USA, V114, pE10438, DOI 10.1073/pnas.1715812114; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Scally SW, 2018, J EXP MED, V215, P63, DOI 10.1084/jem.20170869; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Triller G, 2017, IMMUNITY, V47, P1197, DOI 10.1016/j.immuni.2017.11.007; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947	11	5	5	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					851	854		10.1016/j.immuni.2018.04.037	http://dx.doi.org/10.1016/j.immuni.2018.04.037			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768173	Bronze			2022-12-18	WOS:000432488600008
J	Mathys, H; Penney, J; Tsai, LH				Mathys, Hansruedi; Penney, Jay; Tsai, Li-Huei			A Developmental Switch in Microglial HDAC Function	IMMUNITY			English	Editorial Material							DISEASE	The epigenetic mechanisms controlling microglia functions are largely unknown. In this issue of Immunity, Datta et al. (2018) uncover surprising and distinct effects of deleting the epigenetic regulators HDAC1 and HDAC2 during microglial development versus during the course of neurodegeneration.	[Mathys, Hansruedi; Penney, Jay; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Mathys, Hansruedi; Penney, Jay; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Tsai, Li-Huei] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	lhtsai@mit.edu						Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Datta M, 2018, IMMUNITY, V48, P514, DOI 10.1016/j.immuni.2018.02.016; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Li Q, 2017, NAT REV IMMUNOL; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Volmar C. H., 2014, NEUROEPIGENETICS, V1, P20	10	5	5	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					476	478		10.1016/j.immuni.2018.03.010	http://dx.doi.org/10.1016/j.immuni.2018.03.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562197	Green Submitted, Bronze			2022-12-18	WOS:000427916900006
J	Rosowski, EE; Huttenlocher, A				Rosowski, Emily E.; Huttenlocher, Anna			Motile Collectors: Platelets Promote Innate Immunity	IMMUNITY			English	Editorial Material							NEUTROPHIL EXTRACELLULAR TRAPS; BACTERIA; SEPSIS; THROMBOCYTOPENIA; BLOOD		[Rosowski, Emily E.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.; Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53792 USA.	huttenlocher@wisc.edu	Rosowski, Emily E./U-9654-2019	Rosowski, Emily E./0000-0002-6761-1098				Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Claushuis TAM, 2016, BLOOD, V127, P3062, DOI 10.1182/blood-2015-11-680744; de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915; Deppermann C, 2016, SEMIN IMMUNOL, V28, P536, DOI 10.1016/j.smim.2016.10.005; Feng D, 1998, INT ARCH ALLERGY IMM, V116, P188, DOI 10.1159/000023944; Gaertner F, 2017, CELL, V171, P1368, DOI 10.1016/j.cell.2017.11.001; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Pitchford SC, 2008, AM J RESP CRIT CARE, V177, P604, DOI 10.1164/rccm.200702-214OC	10	5	5	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					16	18		10.1016/j.immuni.2017.12.015	http://dx.doi.org/10.1016/j.immuni.2017.12.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343436	Bronze			2022-12-18	WOS:000422751600007
J	Pollard, JW				Pollard, Jeffrey W.			The Yolk Sac Feeds Pancreatic Tumors	IMMUNITY			English	Editorial Material							MACROPHAGES; PROGRESSION; METASTASIS; HOMEOSTASIS; MONOCYTES	In this issue of Immunity, Zhu et al. (2017) report that tumor-associated macrophages in a mouse model of pancreatic ductal adenocarcinoma (PDAC) originate from both the yolk sac (YS) and bone marrow. Differential ablation of these populations indicates that only the YS-derived macrophages promote PDAC progression and growth.	[Pollard, Jeffrey W.] Univ Edinburgh, Queens Med Res Inst, MRC, Edinburgh, Midlothian, Scotland; [Pollard, Jeffrey W.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA	University of Edinburgh; University of Edinburgh; Yeshiva University; Albert Einstein College of Medicine	Pollard, JW (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC, Edinburgh, Midlothian, Scotland.; Pollard, JW (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.; Pollard, JW (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	jeff.pollard@ed.ac.uk			MRC [MR/N022556/1] Funding Source: UKRI; Medical Research Council [MR/N022556/1, G1002033] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Jiang H, 2017, CANCER IMMUNOL IMMUN, V66, P1037, DOI 10.1007/s00262-017-2003-1; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	10	5	5	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					217	218		10.1016/j.immuni.2017.07.021	http://dx.doi.org/10.1016/j.immuni.2017.07.021			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813653	Bronze, Green Accepted			2022-12-18	WOS:000407788300007
J	Assen, FP; Sixt, M				Assen, Frank P.; Sixt, Michael			The Dynamic Cytokine Niche	IMMUNITY			English	Editorial Material							T-CELLS; SECRETION	Immune cells communicate using cytokine signals, but the quantitative rules of this communication aren't clear. In this issue of Immunity, Oyler-Yaniv et al. (2017) suggest that the distribution of a cytokine within a lymphatic organ is primarily governed by the local density of cells consuming it.	[Assen, Frank P.; Sixt, Michael] IST Austria, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Sixt, M (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.	sixt@ist.ac.at		Assen, Frank/0000-0003-3470-6119; Sixt, Michael/0000-0002-6620-9179				Hofer T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00268; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Monneau Y, 2016, J LEUKOCYTE BIOL, V99, P935, DOI 10.1189/jlb.3MR0915-440R; Oyler-Yaniv A, 2017, IMMUNITY, V46, P609, DOI 10.1016/j.immuni.2017.03.011; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	8	5	5	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					519	520		10.1016/j.immuni.2017.04.006	http://dx.doi.org/10.1016/j.immuni.2017.04.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423329	Bronze			2022-12-18	WOS:000399451100002
J	Brubaker, SW; Monack, DM				Brubaker, Sky W.; Monack, Denise M.			Cell-Intrinsic Defense at the Epithelial Border Wall: Salmonella Pays the Price	IMMUNITY			English	Editorial Material							INFLAMMASOME; ACTIVATION; DEATH	Within the gut, Salmonella-infected enterocytes are expelled into the lumen, limiting pathogen replication. In this issue of Immunity, Rauch et al. (2017) expand our understanding of this cell-intrinsic response by characterizing the genetic determinants that control the expulsion and death of epithelial cells.	[Brubaker, Sky W.; Monack, Denise M.] Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Monack, DM (corresponding author), Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	dmonack@stanford.edu		Monack, Denise/0000-0003-3804-2209	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351	10	5	5	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					522	524		10.1016/j.immuni.2017.03.021	http://dx.doi.org/10.1016/j.immuni.2017.03.021			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423331	Bronze			2022-12-18	WOS:000399451100004
J	Hickman, HD; Pierson, TC				Hickman, Heather D.; Pierson, Theodore C.			T Cells Take on Zika Virus	IMMUNITY			English	Editorial Material							DENGUE VIRUS; PEPTIDES	Although CD8(+) T cells provide protection against many viral infections, their role in Zika virus (ZIKV) immunity has not been extensively examined. In a recent issue of Cell Host & Microbe, Elong Ngono et al. (2017) define antigenic epitopes determining CD8(+) T cell immunity in murine models of ZIKV infection.	[Hickman, Heather D.; Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pierson, TC (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	piersontc@niaid.nih.gov		Hickman, Heather/0000-0003-4168-4894	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001209, ZIAAI001225] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617; Laumont CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10238; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Starck SR, 2016, IMMUNOL REV, V272, P8, DOI 10.1111/imr.12434; Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974	10	5	5	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					13	14		10.1016/j.immuni.2016.12.020	http://dx.doi.org/10.1016/j.immuni.2016.12.020			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28099861	Bronze			2022-12-18	WOS:000392918300006
J	Reading, JL; Quezada, SA				Reading, James L.; Quezada, Sergio A.			Too Much of a Good Thing? Chronic IFN Fuels Resistance to Cancer Immunotherapy	IMMUNITY			English	Editorial Material							IMMUNE CHECKPOINT BLOCKADE; PERSISTENT LCMV INFECTION; INTERFERON-ALPHA; MELANOMA; EXHAUSTION	Immune checkpoint blockade (ICB) is revolutionizing cancer medicine, yet the molecular basis of resistance remains unclear. In a recent issue of Cell, Benci et al. (2016) demonstrate that sustained interferon signaling is central to the development of PD-L1-dependent and -independent resistance to ICB.	[Reading, James L.; Quezada, Sergio A.] UCL, UCL Canc Inst, Canc Immunol Unit, London WC1E 6DD, England	University of London; University College London	Quezada, SA (corresponding author), UCL, UCL Canc Inst, Canc Immunol Unit, London WC1E 6DD, England.	s.quezada@ucl.ac.uk	Quezada, Sergio/ABF-6466-2020	Quezada, Sergio/0000-0002-9763-1700; READING, JAMES/0000-0001-5381-978X	Cancer Research UK; senior Cancer Research UK Fellowship; Versus Arthritis [20265] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); senior Cancer Research UK Fellowship; Versus Arthritis(Versus Arthritis)	The authors would like to thank Dr. Ehsan Ghorani for his critical appraisal of the article. S.A.Q. and J.L.R. are funded by Cancer Research UK. S.A.Q. is funded by a senior Cancer Research UK Fellowship.	Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Kaufmann R, 2005, J CLIN ONCOL, V23, P9001, DOI 10.1200/JCO.2005.01.1551; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Wheatley K, 2003, CANCER TREAT REV, V29, P241, DOI 10.1016/S0305-7372(03)00074-4; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	10	5	5	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1181	1183		10.1016/j.immuni.2016.12.004	http://dx.doi.org/10.1016/j.immuni.2016.12.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002724	Green Submitted, Bronze			2022-12-18	WOS:000392918100003
J	Gross, CJ; Gross, O				Gross, Christina J.; Gross, Olaf			PKA Has the Gall to Oppose NLRP3	IMMUNITY			English	Editorial Material							INFLAMMASOME; INHIBITION		[Gross, Christina J.; Gross, Olaf] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany	Technical University of Munich	Gross, O (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany.	olaf.gross@tum.de	Gross, Olaf/E-4570-2010	Gross, Olaf/0000-0001-8660-3619; Gross, Christina/0000-0002-5982-6881				Camell C, 2015, SEMIN IMMUNOL, V27, P334, DOI 10.1016/j.smim.2015.10.004; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Mortimer L, 2016, NAT IMMUNOL, V17, P1176, DOI 10.1038/ni.3538; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047	10	5	5	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					707	709		10.1016/j.immuni.2016.09.019	http://dx.doi.org/10.1016/j.immuni.2016.09.019			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760332	Bronze			2022-12-18	WOS:000389473200002
J	Ito, K; Frenette, PS				Ito, Keisuke; Frenette, Paul S.			HSC Contribution in Making Steady-State Blood	IMMUNITY			English	Editorial Material							STEM-CELLS; IN-VIVO; CLONAL DYNAMICS; HEMATOPOIESIS; DIFFERENTIATION; MARROW	In homeostasis, whether blood cells are derived from committed progenitor or mutipotent stem cell activity remains controversial. In this issue of Immunity, Sawai et al. (2016) describe murine HSCs as the major contributor to the maintenance of multilineage hematopoiesis, both in the steady state and during cytokine response.	[Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Ito, Keisuke] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Ito, K; Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.; Ito, K; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.; Ito, K; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.; Ito, K; Frenette, PS (corresponding author), Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA.; Ito, K (corresponding author), Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA.	keisuke.ito@einstein.yu.edu; paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922	NIDDK NIH HHS [R01 DK100689, R01 DK098263] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098263, R01DK100689] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Barber CL, 2011, P NATL ACAD SCI USA, V108, P13700, DOI 10.1073/pnas.1107172108; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	10	5	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					464	466		10.1016/j.immuni.2016.09.002	http://dx.doi.org/10.1016/j.immuni.2016.09.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27653597	Green Accepted, Bronze			2022-12-18	WOS:000388454300004
J	Agudo, J; Brown, BD				Agudo, Judith; Brown, Brian D.			Silence of the ROS	IMMUNITY			English	Editorial Material								Reactive oxygen species (ROS) are generated during T cell activation and serve a signaling function but can also be damaging. In this issue of Immunity, Zhang et al. (2016) show that miR-23a prevents ROS-elicited necrosis by suppressing cyclophilin D (PPIF), a regulator of ROS escape from mitochondria.	[Agudo, Judith; Brown, Brian D.] Icahn Sch Med Mt Sinai, Genet & Genom Sci Dept, New York, NY 10029 USA; [Brown, Brian D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Genet & Genom Sci Dept, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.	brian.brown@mssm.edu						Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Cho S, 2016, J EXP MED, V213, P235, DOI 10.1084/jem.20150990; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pua HH, 2016, IMMUNITY, V44, P821, DOI 10.1016/j.immuni.2016.01.003; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Simeoni L, 2015, BIOL CHEM, V396, P555, DOI 10.1515/hsz-2014-0312	7	5	5	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					520	522		10.1016/j.immuni.2016.02.027	http://dx.doi.org/10.1016/j.immuni.2016.02.027			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982360	Bronze			2022-12-18	WOS:000372784200009
J	Nagao, K; Segre, JA				Nagao, Keisuke; Segre, Julia A.			"Bringing Up Baby'' to Tolerate Germs	IMMUNITY			English	Editorial Material							ATOPIC-DERMATITIS; SKIN MICROBIOME; T-CELLS		[Nagao, Keisuke] NCI, Dermatol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Segre, Julia A.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Nagao, K (corresponding author), NCI, Dermatol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	keisuke.nagao@nih.gov; jsegre@nhgri.nih.gov	Nagao, Keisuke/P-3837-2018; Nagao, Keisuke/J-5116-2013	Nagao, Keisuke/0000-0002-7005-3138; Nagao, Keisuke/0000-0002-7005-3138	NATIONAL CANCER INSTITUTE [ZIABC011561] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	10	5	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					842	844		10.1016/j.immuni.2015.10.020	http://dx.doi.org/10.1016/j.immuni.2015.10.020			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588777	Bronze			2022-12-18	WOS:000366846000006
J	Shin, S; Argon, Y				Shin, Sunny; Argon, Yair			Stressed-Out Endoplasmic Reticulum Inflames the Mitochondria	IMMUNITY			English	Editorial Material							THIOREDOXIN-INTERACTING PROTEIN; ER STRESS; NLRP3 INFLAMMASOME; CELL-DEATH	Bacterial infection induces inflammasome activation and release of interleukin-1 (IL-1) cytokines. Bronner et al. (2015) show that during Brucella abortus infection, an endoplasmic reticulum stress sensor, IRE1 alpha, initiates NLRP3- and caspase-2-mediated mitochondrial damage that potentiates NLRP3 inflammasome assembly.	[Shin, Sunny] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Argon, Yair] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Argon, Yair] Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Argon, Y (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	yargon@med.upenn.edu						Arellano-Reynoso B, 2004, VET MICROBIOL, V98, P307, DOI 10.1016/j.vetmic.2003.10.024; Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Celli J, 2015, NAT REV MICROBIOL, V13, P71, DOI 10.1038/nrmicro3393; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	10	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					409	411		10.1016/j.immuni.2015.08.027	http://dx.doi.org/10.1016/j.immuni.2015.08.027			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26377891	Bronze			2022-12-18	WOS:000361575300001
J	Ryu, SH; Stappenbeck, TS				Ryu, Stacy H.; Stappenbeck, Thaddeus S.			Gut-Pancreatic Axis AMPlified in Islets of Langerhans	IMMUNITY			English	Editorial Material							INTESTINAL MICROBIOTA; INNATE IMMUNITY; AUTOIMMUNITY	Microbially derived metabolites in the intestine regulate host immunity and impact disease pathophysiology in various organs. Sun et al. (2015) suggest a direct effect of microbial metabolites on pancreatic endocrine cells in regulating type 1 diabetes pathophysiology.	[Ryu, Stacy H.; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	stappenb@pathology.wustl.edu		Ryu, Stacy Hyunji/0000-0002-5448-339X				Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Sun J, 2015, IMMUNITY, V43, P304, DOI 10.1016/j.immuni.2015.07.013; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	10	5	5	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					216	218		10.1016/j.immuni.2015.08.003	http://dx.doi.org/10.1016/j.immuni.2015.08.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287677	Bronze			2022-12-18	WOS:000360101200003
J	Gilroy, DW; Yona, S				Gilroy, Derek W.; Yona, Simon			HIF1 alpha Allows Monocytes to Take a Breather during Sepsis	IMMUNITY			English	Editorial Material							GENOMIC RESPONSES; HUMANS		[Gilroy, Derek W.; Yona, Simon] UCL, Div Med, Ctr Clin Pharmacol & Therapeut, London WC1E 6JJ, England	University of London; University College London	Gilroy, DW (corresponding author), UCL, Div Med, Ctr Clin Pharmacol & Therapeut, 5 Univ St, London WC1E 6JJ, England.	d.gilroy@ucl.ac.uk; s.yona@ucl.ac.uk	Gilroy, Derek W/C-2588-2009; Gilroy, Derek/AAP-7227-2020; Yona, Simon/ABE-6572-2020	Gilroy, Derek/0000-0003-3476-0844; Yona, Simon/0000-0002-3984-2008	Wellcome Trust [087520] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Fullerton JN, 2011, SEMIN RESP CRIT CARE, V32, P581, DOI 10.1055/s-0031-1287866; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Shay T, 2015, P NATL ACAD SCI USA, V112, pE346, DOI 10.1073/pnas.1416629111; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	10	5	6	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					397	399		10.1016/j.immuni.2015.02.016	http://dx.doi.org/10.1016/j.immuni.2015.02.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786169	Bronze			2022-12-18	WOS:000351301900003
J	Palin, AC; Love, PE				Palin, Amy C.; Love, Paul E.			CD5 Helps Aspiring Regulatory T Cells Ward Off Unwelcome Cytokine Advances	IMMUNITY			English	Editorial Material							SELECTION; DISEASE		[Palin, Amy C.; Love, Paul E.] NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Love, PE (corresponding author), NICHHD, NIH, Bethesda, MD 20892 USA.	lovep@mail.nih.gov		Palin, Amy/0000-0002-7724-9563	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Henderson JG, 2015, IMMUNITY, V42, P471, DOI 10.1016/j.immuni.2015.02.010; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Soldevila G, 2011, CURR OPIN IMMUNOL, V23, P310, DOI 10.1016/j.coi.2011.03.003; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	11	5	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					395	396		10.1016/j.immuni.2015.02.018	http://dx.doi.org/10.1016/j.immuni.2015.02.018			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786168	Bronze			2022-12-18	WOS:000351301900002
J	Schroder, JM				Schroeder, Jens-Michael			Revealing the Achilles Heel of Bacterial Toxins	IMMUNITY			English	Editorial Material							INNATE IMMUNITY; ALPHA-DEFENSINS	In addition to having antimicrobial properties, defensins inactivate various structurally unrelated bacterial toxins by a yet unknown manner. In this issue of Immunity, Kudryashova et al. (2014b) provide insights into mechanisms by which human alpha-defensins destabilize and inactivate bacterial toxins.	Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Schroder, JM (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Campus Kiel, D-24105 Kiel, Germany.	jschroeder@dermatology.uni-kiel.de						Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; Kim C, 2006, BIOCHEM J, V399, P225, DOI 10.1042/BJ20060425; Kudryashova E, 2014, IMMUNITY, V41, P709, DOI 10.1016/j.immuni.2014.10.018; Kudryashova E, 2014, MOL MICROBIOL, V92, P1056, DOI 10.1111/mmi.12615; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Niu S, 2013, CURR OPIN CHEM BIOL, V17, P809, DOI 10.1016/j.cbpa.2013.06.019; Zhao L, 2014, CURR OPIN HEMATOL, V21, P37, DOI 10.1097/MOH.0000000000000005	10	5	5	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					671	U20		10.1016/j.immuni.2014.11.006	http://dx.doi.org/10.1016/j.immuni.2014.11.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517605	Bronze			2022-12-18	WOS:000345504900001
J	Kurd, N; Robey, EA				Kurd, Nadia; Robey, Ellen A.			Unconventional Intraepithelial Gut T Cells: The TCR Says It All	IMMUNITY			English	Editorial Material							THYMUS; LYMPHOCYTES; PRECURSORS; SELECTION	The intestinal epithelium harbors a large number of T cells, including TCR alpha beta cells that lack expression of CD4 and CD8 alpha beta coreceptors. In this issue of Immunity, Mayans et al. (2014) and McDonald et al. (2014) shed light on the specificity and development of this enigmatic T cell population.	[Kurd, Nadia; Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Robey, EA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA.	erobey@berkeley.edu						Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Mayans S, 2014, IMMUNITY, V41, P207, DOI 10.1016/j.immuni.2014.07.010; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; REGNAULT A, 1994, J EXP MED, V180, P1345, DOI 10.1084/jem.180.4.1345; Rocha B, 2007, IMMUNOL REV, V215, P166, DOI 10.1111/j.1600-065X.2006.00467.x; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035	11	5	5	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					167	168		10.1016/j.immuni.2014.08.004	http://dx.doi.org/10.1016/j.immuni.2014.08.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148016	Bronze			2022-12-18	WOS:000341455300001
J	Green, DR				Green, Douglas R.			Pseudokiller, Qu'est-ce que C'est?	IMMUNITY			English	Editorial Material							MIXED LINEAGE KINASE; DOMAIN-LIKE; NECROSIS; NECROPTOSIS; DOWNSTREAM		St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38139 USA	St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38139 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417	NCI NIH HHS [R01 CA169291] Funding Source: Medline; NIAID NIH HHS [R01 AI044828] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Wu XR, 2012, MOL CELL PROTEOMICS, V11, P1640, DOI 10.1074/mcp.M112.019091; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	10	5	5	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					421	422		10.1016/j.immuni.2013.08.020	http://dx.doi.org/10.1016/j.immuni.2013.08.020			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054322	Green Accepted, Bronze			2022-12-18	WOS:000330949600003
J	Jones, JC; Freeman, GJ				Jones, Jennifer C.; Freeman, Gordon J.			Costimulatory Genes: Hotspots of Conflict between Host Defense and Autoimmunity	IMMUNITY			English	Editorial Material									[Jones, Jennifer C.] NCI, Vaccine Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Freeman, GJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	Gordon_Freeman@dfci.harvard.edu	Jones, Jennifer/C-8691-2015; Freeman, Gordon/AAC-5380-2019	Jones, Jennifer/0000-0002-9488-7719; Freeman, Gordon/0000-0002-7210-5616	NIAID NIH HHS [P01 AI080192, P01 AI056299, R01 AI089955, U19 AI082630] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC011503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI080192, R01AI089955, U19AI082630, P01AI056299] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Forni D, 2013, IMMUNITY, V38, P1129, DOI 10.1016/j.immuni.2013.04.008; Freeman GJ, 2008, P NATL ACAD SCI USA, V105, P10275, DOI 10.1073/pnas.0805459105; Frigola X, 2011, CLIN CANCER RES, V17, P1915, DOI 10.1158/1078-0432.CCR-10-0250; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Rennert P, 1997, INT IMMUNOL, V9, P805, DOI 10.1093/intimm/9.6.805; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947	10	5	5	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1083	1085		10.1016/j.immuni.2013.06.008	http://dx.doi.org/10.1016/j.immuni.2013.06.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809156	Bronze, Green Accepted			2022-12-18	WOS:000330947500002
J	Marty-Roix, R; Lien, E				Marty-Roix, Robyn; Lien, Egil			(De-) Oiling Inflammasomes	IMMUNITY			Unspecified	Editorial Material							INFLAMMATION		[Marty-Roix, Robyn; Lien, Egil] UMass Med Sch, Dept Med, Program Innate Immun, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Lien, Egil] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Biol, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway	University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU)	Lien, E (corresponding author), UMass Med Sch, Dept Med, Program Innate Immun, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	egil.lien@umassmed.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082676, R56AI075318, R01AI075318, R01AI057588] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI082676, R56 AI075318, R01 AI057588, R01 AI075318] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson M, 2002, J NUTR, V132, P3566, DOI 10.1093/jn/132.12.3566; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vladimer GI, 2013, CURR OPIN MICROBIOL, V16, P23, DOI 10.1016/j.mib.2012.11.008; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015	10	5	5	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1088	1090		10.1016/j.immuni.2013.06.006	http://dx.doi.org/10.1016/j.immuni.2013.06.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809158	Green Accepted, Bronze			2022-12-18	WOS:000330947500004
J	Williams, MA				Williams, Matthew A.			Instant Recall: A Key Role for Effector-Phenotype CD8(+) Memory T Cells in Immune Protection	IMMUNITY			English	Editorial Material							LINEAGE RELATIONSHIP; SUBSETS; EXPRESSION		Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84121 USA	Utah System of Higher Education; University of Utah	Williams, MA (corresponding author), Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84121 USA.	matthew.williams@path.utah.edu		Williams, Matthew/0000-0002-4721-4482				Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Benmira S, 2010, CURR HIV RES, V8, P441, DOI 10.2174/157016210793499286; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889	9	5	5	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1090	1091		10.1016/j.immuni.2013.06.007	http://dx.doi.org/10.1016/j.immuni.2013.06.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809159	Bronze			2022-12-18	WOS:000330947500005
J	Boyle, JP; Bryant, CE; Monie, TP				Boyle, Joseph P.; Bryant, Clare E.; Monie, Tom P.			Cell Swelling and the NLRP3 Inflammasome	IMMUNITY			English	Letter									[Boyle, Joseph P.; Monie, Tom P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of Cambridge; University of Cambridge	Monie, TP (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	tpm22@cam.ac.uk	Monie, Tom/H-4662-2019	Monie, Tom/0000-0003-4097-1680	Wellcome Trust [085090] Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42	4	5	5	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					399	399		10.1016/j.immuni.2013.02.006	http://dx.doi.org/10.1016/j.immuni.2013.02.006			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521876	Green Accepted, Bronze			2022-12-18	WOS:000330941500001
J	Kang, YH; Biswas, SK				Kang, Yu Hui; Biswas, Subhra K.			Basophil-Macrophage Dialog in Allergic Inflammation	IMMUNITY			English	Editorial Material							MONOCYTES; SUBSETS	Monocyte-macrophage differentiation under pathological conditions is poorly understood. In the present issue of Immunity, Egawa et al. (2013) report how basophils drive the differentiation of inflammatory monocytes into M2 macrophages, thereby regulating allergic skin inflammation.	[Kang, Yu Hui; Biswas, Subhra K.] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Biswas, SK (corresponding author), ASTAR, Singapore Immunol Network SIgN, 04-01 Immunos,8A Biomed Grove, Singapore 138648, Singapore.	subhra_biswas@immunol.a-star.edu.sg		Kang, Yu Hui/0000-0001-9081-3969				Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Frankenberger M, 2012, EUR J IMMUNOL, V42, P957, DOI 10.1002/eji.201141907; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Han HW, 2013, J IMMUNOL, V190, P904, DOI 10.4049/jimmunol.1201808; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sokol CL, 2010, MUCOSAL IMMUNOL, V3, P129, DOI 10.1038/mi.2009.137	10	5	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					408	410		10.1016/j.immuni.2013.02.015	http://dx.doi.org/10.1016/j.immuni.2013.02.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521881	Bronze			2022-12-18	WOS:000330941500006
J	Delgoffe, GM; Bettini, ML; Vignali, DAA				Delgoffe, Greg M.; Bettini, Matthew L.; Vignali, Dario A. A.			Identity Crisis: It's Not Just Foxp3 Anymore	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; TRANSCRIPTIONAL SIGNATURE; DIFFERENTIATION	What does it take to make a regulatory T (Treg) cell? In this issue of Immunity, Ohkura et al. show that Treg-cell-specific CpG hypomethylation and Foxp3 expression are independent events required for Treg cell development, stability, and full suppressive activity.	[Delgoffe, Greg M.; Bettini, Matthew L.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vignali.lab@stjude.org	Delgoffe, Greg M./HCH-2805-2022	Delgoffe, Greg M./0000-0002-2957-8135	NIAID NIH HHS [F32 AI098383] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI098383] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Ziegler SF, 2009, MICROBES INFECT, V11, P594, DOI 10.1016/j.micinf.2009.04.002	10	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 16	2012	37	5					759	761		10.1016/j.immuni.2012.10.012	http://dx.doi.org/10.1016/j.immuni.2012.10.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23159220	Bronze, Green Accepted			2022-12-18	WOS:000311460000001
J	Ohkura, N; Sakaguchi, S				Ohkura, Naganari; Sakaguchi, Shimon			Treg Cells Acquire New Directions, Cytokines Navigate	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; RESPONSES	Foxp3(+) Treg cells express transcription factors normally expressed by specific T helper cells at sites of inflammation. In this issue of Immunity, Koch et al. (2012) and Hall et al. (2012) demonstrate that IFN-gamma and IL-27 distinctly induces T-bet(+) Treg cells via STAT-1 transcription factor activation.	[Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Osaka University	Sakaguchi, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	shimon@ifrec.osaka-u.ac.jp	Sakaguchi, Shimon/C-9535-2009					Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	9	5	5	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					443	444		10.1016/j.immuni.2012.09.004	http://dx.doi.org/10.1016/j.immuni.2012.09.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22999950	Bronze			2022-12-18	WOS:000309199000007
J	Bonneville, M				Bonneville, Marc			Semaphorins: New Cues for Skin Healing by gamma delta T Cells	IMMUNITY			English	Editorial Material							ACTIVATION	In this issue of Immunity, Witherden et al. (2012) demonstrate a crucial role for CD100-plexin B2 interactions in the wound healing response mediated by murine gamma delta T cells and in the T cell morphological changes associated with this process.	[Bonneville, Marc] Univ Nantes, Ctr Rech Canc Nantes Angers, F-44007 Nantes, France; [Bonneville, Marc] INSERM, UMR892, F-44007 Nantes, France; [Bonneville, Marc] CNRS, UMR6299, F-44007 Nantes, France	Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Bonneville, M (corresponding author), Univ Nantes, Ctr Rech Canc Nantes Angers, F-44007 Nantes, France.	marc.bonneville@inserm.fr						Elhabazi A, 1997, J BIOL CHEM, V272, P23515, DOI 10.1074/jbc.272.38.23515; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Klemke M, 2010, EMBO J, V29, P2915, DOI 10.1038/emboj.2010.153; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; MacLeod AS, 2011, CELL MOL LIFE SCI, V68, P2399, DOI 10.1007/s00018-011-0702-x; SAMSTAG Y, 1992, INT IMMUNOL, V4, P1255, DOI 10.1093/intimm/4.11.1255; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Witherden DA, 2012, IMMUNITY, V37, P314, DOI 10.1016/j.immuni.2012.05.026; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698	10	5	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					194	196		10.1016/j.immuni.2012.08.003	http://dx.doi.org/10.1016/j.immuni.2012.08.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22921116	Bronze			2022-12-18	WOS:000308261800004
J	Diefenbach, A				Diefenbach, Andreas			Interleukin-22, the Guardian of the Intestinal Stem Cell Niche?	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; HOMEOSTASIS	Our molecular understanding of how immune cells protect epithelial cells against damage is limited. In this issue of Immunity, Hanash et al. (2012) report that interleukin-22 produced by innate lymphoid cells provides protection to the stem cell niche of the intestinal epithelium.	[Diefenbach, Andreas] Univ Freiburg, Inst Med Microbiol & Hyg, IMMH, D-79104 Freiburg, Germany; [Diefenbach, Andreas] Univ Freiburg, Ctr Biol Signaling Studies, BIOSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Diefenbach, A (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, IMMH, Hermann Herder Str 11, D-79104 Freiburg, Germany.	andreas.diefenbach@uniklinik-freiburg.de	Diefenbach, Andreas/T-2589-2018	Diefenbach, Andreas/0000-0002-9176-9530				Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	10	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					196	198		10.1016/j.immuni.2012.08.007	http://dx.doi.org/10.1016/j.immuni.2012.08.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22921117	Bronze			2022-12-18	WOS:000308261800005
J	Collins, M				Collins, Mary			Regulating with Reg Proteins: A New Role in Th17 Cell-Mediated Skin inflammation	IMMUNITY			English	Editorial Material							T-CELLS; PSORIASIS; MECHANISMS; ANTIBODY; IL-22		Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Collins, M (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	mcollins.immunology@verizon.net						Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Parikh Abhirath, 2012, Biomol Concepts, V3, P57; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	9	5	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					5	7		10.1016/j.immuni.2012.07.005	http://dx.doi.org/10.1016/j.immuni.2012.07.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22840837	Bronze			2022-12-18	WOS:000307133200003
J	Pascual, V; Banchereau, J				Pascual, Virginia; Banchereau, Jacques			Tracking Interferon in Autoimmunity	IMMUNITY			English	Editorial Material							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DENDRITIC CELLS; DISEASES	Type I interferon is a family of antiviral cytokines linked to human autoimmune diseases. In this issue of Immunity, Gall et al. (2012) characterize, in a murine model of autoimmunity, the origin and progression of the type I interferon response leading to disease.	[Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Pascual, Virginia] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Banchereau, Jacques] Hoffmann La Roche Inc, Pharma Res & Early Dev, Nutley, NJ 07110 USA	Baylor Scott & White Health; Texas Scottish Rite Hospital for Children; Roche Holding	Pascual, V (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.	virginip@baylorhealth.edu	Pascual, Virginia/ABD-3099-2020		NIAID NIH HHS [U19 AI082715] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082715] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Richards KH, 2011, MICROBES INFECT, V13, P291, DOI 10.1016/j.micinf.2010.12.007; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	11	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 27	2012	36	1					7	9		10.1016/j.immuni.2012.01.007	http://dx.doi.org/10.1016/j.immuni.2012.01.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22284415	Green Accepted, Bronze			2022-12-18	WOS:000299766000004
J	Kumagai, Y; Akira, S				Kumagai, Yutaro; Akira, Shizuo			Mind Bomb Proteins in the Antiviral Arsenal	IMMUNITY			English	Editorial Material							INTERACTOME; MAP	In this issue of Immunity, Li et al. (2011) reported a dynamic protein interactome network underlying antiviral innate immune response and established the role of Mind Bomb proteins in the anti-RNA viral innate immune response.	[Kumagai, Yutaro; Akira, Shizuo] Osaka Univ, Immunol Frontier Res Ctr, Host Def Lab, Osaka, Japan; [Kumagai, Yutaro; Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan	Osaka University; Osaka University	Akira, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Host Def Lab, Osaka, Japan.	sakira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Kumagai, Yutaro/L-7732-2018	Kumagai, Yutaro/0000-0002-5039-3979				Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742	8	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 23	2011	35	3					320	322		10.1016/j.immuni.2011.09.003	http://dx.doi.org/10.1016/j.immuni.2011.09.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21943487	Bronze			2022-12-18	WOS:000295748100004
J	Reizis, B				Reizis, Boris			Intracellular Pathogens and CD8(+) Dendritic Cells: Dangerous Liaisons	IMMUNITY			English	Editorial Material							TOXOPLASMA-GONDII; IMMUNITY; ENTRY		Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	bvr2101@columbia.edu		Reizis, Boris/0000-0003-1140-7853				Alaniz RC, 2004, J IMMUNOL, V172, P3725, DOI 10.4049/jimmunol.172.6.3725; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819	11	5	5	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 26	2011	35	2					153	155		10.1016/j.immuni.2011.08.003	http://dx.doi.org/10.1016/j.immuni.2011.08.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21867923	Bronze			2022-12-18	WOS:000294387900004
J	Bowie, AG				Bowie, Andrew G.			TRAF3: Uncovering the Real but Restricted Role in Human	IMMUNITY			English	Editorial Material							DEFICIENCY; RESPONSES		Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373				de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	9	5	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 24	2010	33	3					293	295		10.1016/j.immuni.2010.09.008	http://dx.doi.org/10.1016/j.immuni.2010.09.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20870170	Green Submitted, Bronze			2022-12-18	WOS:000282798500003
J	Merad, M				Merad, Miriam			PU.1 Takes Control of the Dendritic Cell Lineage	IMMUNITY			English	Editorial Material							COMMITMENT	Despite the importance of the cytokine receptor flt3 in dendritic cell (DC) homeostasis, little is known about its regulation during DC development. In this issue of Immunity, Carotta et al. (2010) reveal that the transcription factor PU.1 controls Flt3 expression in hematopoietic progenitors in a dose-dependent manner.	[Merad, Miriam] Tisch Canc Inst, Dept Gene & Cell Med, New York, NY 10128 USA; [Merad, Miriam] Inst Immunol, New York, NY 10128 USA; [Merad, Miriam] Mt Sinai Sch Med, New York, NY 10128 USA	Icahn School of Medicine at Mount Sinai	Merad, M (corresponding author), Tisch Canc Inst, Dept Gene & Cell Med, 1425 Madison Ave, New York, NY 10128 USA.	miriam.merad@mssm.edu						Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Dakic A, 2007, TRENDS IMMUNOL, V28, P108, DOI 10.1016/j.it.2007.01.006; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175	9	5	5	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 28	2010	32	5					583	585		10.1016/j.immuni.2010.05.006	http://dx.doi.org/10.1016/j.immuni.2010.05.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20510866	Bronze			2022-12-18	WOS:000278280500002
J	Jung, S				Jung, Steffen			Dendritic Cells: A Question of Upbringing	IMMUNITY			English	Editorial Material							BLOOD MONOCYTES	Dendritic cells (DCs) arise from dedicated precursors and monocytes; however, the impact of these differential origins remain unclear. In this issue of Immunity, Siddiqui et al. (2010) describe a population of colitogenic monocyte-derived DCs that propagate intestinal inflammation.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.		Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716				Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90	10	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 23	2010	32	4					502	504		10.1016/j.immuni.2010.04.007	http://dx.doi.org/10.1016/j.immuni.2010.04.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20412761	Bronze			2022-12-18	WOS:000277171900008
J	Desjardins, M				Desjardins, Michel			The Good Fat: A Link between Lipid Bodies and Antigen Cross-presentation	IMMUNITY			English	Editorial Material								Antigen cross-presentation enables an efficient CD8(+) T cell response against antigens from exogenous sources. In this issue of Immunity, Bougneres et al. (2009) identify lipid bodies as an unexpected new player involved in this complex cellular pathway.	[Desjardins, Michel] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Desjardins, Michel] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Desjardins, M (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada.	michel.desjardins@umontreal.ca		Desjardins, Michel/0000-0002-5684-5980				Bertholet S, 2006, J IMMUNOL, V177, P3525, DOI 10.4049/jimmunol.177.6.3525; Bougneres L, 2009, IMMUNITY, V31, P232, DOI 10.1016/j.immuni.2009.06.022; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; van Manen HJ, 2005, P NATL ACAD SCI USA, V102, P10159, DOI 10.1073/pnas.0502746102; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x	8	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 21	2009	31	2					176	178		10.1016/j.immuni.2009.08.003	http://dx.doi.org/10.1016/j.immuni.2009.08.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19699167	Bronze			2022-12-18	WOS:000269338600003
J	Fitzgerald, KA				Fitzgerald, Katherine A.			Integr-ating IL-1 alpha in Antiviral Host Defenses	IMMUNITY			English	Editorial Material							INNATE IMMUNE-RESPONSE; ADENOVIRUS VECTORS; INFLAMMASOME; DISEASE	Adenoviral vectors used in gene therapy induce inflammation, although the underlying mechanisms are currently unknown. In this issue of Immunity, Di Paolo et al. (2009) implicate interleukin-1 alpha (IL-1 alpha) in virus-induced inflammation and identify the beta 3 integrin as the key receptor regulating IL-1 alpha activity.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X				Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Raper SE, 2002, HUM GENE THER, V13, P163, DOI 10.1089/10430340152712719; Schnell MA, 2001, MOL THER, V3, P708, DOI 10.1006/mthe.2001.0330; Shayakhmetov DM, 2005, J IMMUNOL, V174, P7310, DOI 10.4049/jimmunol.174.11.7310	10	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 17	2009	31	1					7	9		10.1016/j.immuni.2009.07.001	http://dx.doi.org/10.1016/j.immuni.2009.07.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604487	Bronze			2022-12-18	WOS:000268219900005
J	Girardin, SE				Girardin, Stephen E.			Knocking In the NLRP3 Inflammasome	IMMUNITY			English	Editorial Material							DISEASE	Mutations in the human NLRP3 gene cause interleukin-1 beta-related autoinflammatory syndromes. In this issue of Immunity, Brydges et al. (2009) and Meng et al. (2009) report the characterization of Nlrp3 gene-targeted mice harboring mutations mimicking those causing disease in humans.	Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Girardin, SE (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	stephen.girardin@utoronto.ca						Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788	7	5	5	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					761	763		10.1016/j.immuni.2009.06.001	http://dx.doi.org/10.1016/j.immuni.2009.06.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19538926	Bronze			2022-12-18	WOS:000267270700004
J	Durum, SK; Mazzucchelli, RI				Durum, Scott K.; Mazzucchelli, Renata I.			Live from the Liver: Hepatocyte IL-7	IMMUNITY			English	Editorial Material							INTERLEUKIN-7; EXPRESSION; CELLS	Interleukin 7 (IL-7), which is required for T cell survival, was previously found in lymphoid tissues. In this issue of Immunity, Sawa et al. (2009) have identified the liver as a new source of IL-7.	[Durum, Scott K.] NCI, Lab Immunoregulat Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Mazzucchelli, Renata I.] San Raffaele Telethon Inst Gene Therapy, Lab Gene Therapy & Primary Immunodeficiency, I-20132 Milan, Italy	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget)	Durum, SK (corresponding author), NCI, Lab Immunoregulat Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA.	durums@mail.nih.gov		durum, scott/0000-0003-1307-9582	Intramural NIH HHS [Z99 CA999999, Z01 BC009287-23] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC009287] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARIIZUMI K, 1995, J IMMUNOL, V154, P6031; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Min DL, 2002, BLOOD, V99, P4592, DOI 10.1182/blood.V99.12.4592; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Sawa S, 2006, J EXP MED, V203, P1459, DOI 10.1084/jem.20052187; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Traggiai E, 2001, J NEUROIMMUNOL, V121, P111, DOI 10.1016/S0165-5728(01)00433-7; Weitzmann MN, 2000, BLOOD, V96, P1873, DOI 10.1182/blood.V96.5.1873.h8001873_1873_1878	8	5	5	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 20	2009	30	3					320	321		10.1016/j.immuni.2009.03.001	http://dx.doi.org/10.1016/j.immuni.2009.03.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19303385	Green Accepted, Bronze			2022-12-18	WOS:000264405500004
J	Lane, PJL				Lane, Peter J. L.			The architects of B and T cell immune responses	IMMUNITY			English	Editorial Material							LYMPHOID-TISSUES	Published work links adult lymphoidtissue-inducer cells (LTi) with Tcell-dependent antibody responses. In this issue of Immunity, Tsuji et al. (2008) associate LTi with T cell-independent IgA antibody responses in the gut.	Univ Birmingham Sch Med, Inst Biomed Res, Med Res Council Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Lane, PJL (corresponding author), Univ Birmingham Sch Med, Inst Biomed Res, Med Res Council Ctr Immune Regulat, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	p.j.l.lane@bham.ac.uk			Medical Research Council [G9818340B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bekiaris V, 2007, J IMMUNOL, V179, P7535, DOI 10.4049/jimmunol.179.11.7535; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Glenney GW, 2007, J IMMUNOL, V178, P7955, DOI 10.4049/jimmunol.178.12.7955; Hayday A, 2008, MUCOSAL IMMUNOL, V1, P172, DOI 10.1038/mi.2008.8; Lane PJL, 2005, NAT REV IMMUNOL, V5, P655, DOI 10.1038/nri1665; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014	10	5	6	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 15	2008	29	2					171	172		10.1016/j.immuni.2008.07.005	http://dx.doi.org/10.1016/j.immuni.2008.07.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18701078	Bronze			2022-12-18	WOS:000258610800003
J	Murphy, KM				Murphy, Kenneth M.			Permission to proceed: Jak3 and STAT5 signaling molecules give the green light for T helper 1 cell differentiation	IMMUNITY			English	Editorial Material							T-BET; HISTONE ACETYLATION; GENE-EXPRESSION; NK	In this issue of Immunity, Shi et al. (2008) identify a previously unknown requirement in T helper cell differentiation, showing that Jak3 and STAT5 are needed to generate chromatin that is permissive to the activating effects of T-bet.	[Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu			Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI076427] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076427] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7	10	5	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					725	727		10.1016/j.immuni.2008.05.004	http://dx.doi.org/10.1016/j.immuni.2008.05.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549792	Green Accepted, Bronze			2022-12-18	WOS:000256760200001
J	Oltz, EM; Osipovich, O				Oltz, Eugene M.; Osipovich, Oleg			Targeting V(D)J recombinase: Putting a PHD to work	IMMUNITY			English	Editorial Material							RAG2 C-TERMINUS; RECOMBINATION; HISTONE-H3; LYSINE-4	In this issue of Immunity, Liu et al. (2007) show that V(D)J recombinase binds chromatin marked by H3K4 trimethylation. Because this mark associates with active promoters, the finding forges a new link between transcription, epigenetics, and recombinase targeting during lymphocyte development.	Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Oltz, EM (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, 1161 21st Ave S,Room A4203, Nashville, TN 37232 USA.	eugene.oltz@vanderbilt.edu						Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Oestreich KJ, 2006, IMMUNITY, V24, P381, DOI 10.1016/j.immuni.2006.02.009; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; West KL, 2005, IMMUNITY, V23, P203, DOI 10.1016/j.immuni.2005.07.004	10	5	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					539	541		10.1016/j.immuni.2007.10.001	http://dx.doi.org/10.1016/j.immuni.2007.10.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17967406	Bronze			2022-12-18	WOS:000250490700003
J	Doherty, PC; Turner, SJ				Doherty, Peter C.; Turner, Stephen J.			The challenge of viral immunity	IMMUNITY			English	Article							CELL; REVEALS; MICE	Bringing together discussion of innate immunity, B cell and T cell responses, vaccine design and efficacy, and the genetics of HIV and AIDS resistance allows us to access the extraordinary complexity of viral immunity and host responsiveness.	Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	University of Melbourne; St Jude Children's Research Hospital	Doherty, PC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	peter.doherty@stjude.org; sjtum@unimelb.edu.au	Turner, Stephen/GXM-4654-2022; Doherty, Peter Charles/C-4185-2013	Doherty, Peter Charles/0000-0002-5028-3489; Turner, Stephen/0000-0002-1002-0000				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Doherty PC, 2001, PHILOS T R SOC B, V356, P581, DOI 10.1098/rstb.2000.0786; IP YT, 1994, CURR OPIN GENET DEV, V4, P672, DOI 10.1016/0959-437X(94)90133-N; Johnson BJ, 2003, P NATL ACAD SCI USA, V100, P2657, DOI 10.1073/pnas.0538056100; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P1, DOI 10.1016/j.coi.2006.11.018; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Knipe DM., 2006, FIELDS VIROLOGY, V5th ed; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Liu XS, 1998, VIROLOGY, V252, P39, DOI 10.1006/viro.1998.9442; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; SALOMON R, 2007, CELL CYCLE; Silverstein AM, 2005, NAT IMMUNOL, V6, P639, DOI 10.1038/ni0705-639; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977	17	5	5	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					363	365		10.1016/j.immuni.2007.08.011	http://dx.doi.org/10.1016/j.immuni.2007.08.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892844	Green Published, Bronze			2022-12-18	WOS:000249843400001
J	Petrie, HT				Petrie, Howard T.			Early commitment: T cell progenitors in the blood	IMMUNITY			English	Editorial Material							BONE-MARROW; LINEAGE; THYMUS; MICE; PRECURSORS; KINETICS	Thymic lymphopoiesis depends on blood-borne, marrow-derived progenitors, but characterization of these cells, and their lineage potentials, has been difficult. In this issue, Krueger and von Boehmer (2007) show some blood cells that are already T lineage restricted, suggesting that T lineage commitment can occur prethymically.	Scripps Florida Res Inst, Jupiter, FL USA	State University System of Florida; University of Florida	Petrie, HT (corresponding author), Scripps Florida Res Inst, 5353 Parkside Dr,RF-1, Jupiter, FL USA.	hpetrie@scripps.edu						Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004; Lu M, 2005, J IMMUNOL, V175, P5848, DOI 10.4049/jimmunol.175.9.5848; Mori S, 2001, BLOOD, V98, P696, DOI 10.1182/blood.V98.3.696; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; WALLIS VJ, 1975, TRANSPLANTATION, V19, P2, DOI 10.1097/00007890-197501000-00002	10	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2007	26	1					7	8		10.1016/j.immuni.2007.01.003	http://dx.doi.org/10.1016/j.immuni.2007.01.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17241955	Bronze			2022-12-18	WOS:000243959000003
J	Collins, A; Littman, DR				Collins, A; Littman, DR			Selection and lineage specification in the thymus: Commitment 4-stalled	IMMUNITY			English	Editorial Material							POSITIVE SELECTION; DECISION; CD4	How CD4(+)CD8(+) thymocytes commit to CD4 helper versus CD8 cytotoxic lineages is a central unresolved question in developmental immunology. In this issue, Sarafova et al. (2005) show that engineering CD4 for shutoff immediately after positive selection misdirects cells to the cytotoxic lineage. The result highlights the distinction between positive selection and lineage commitment and provides new impetus for re-examining lineage models.	NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program,Howard Hughes Med Inst, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Collins, A (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program,Howard Hughes Med Inst, 550 1St Ave, New York, NY 10016 USA.							Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Robey E, 2005, IMMUNITY, V22, P533, DOI 10.1016/j.immuni.2005.04.005; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183	8	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2005	23	1					4	5		10.1016/j.immuni.2005.07.003	http://dx.doi.org/10.1016/j.immuni.2005.07.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039574	Bronze			2022-12-18	WOS:000231024800003
J	Xavier, R; Seed, B				Xavier, R; Seed, B			PDZ domains and the politics of polarity in lymphocytes	IMMUNITY			English	Editorial Material							CELL POLARITY	In this issue of Immunity, Ludford-Menting et al. (2005) show that scaffold proteins previously implicated in the control of epithelial cell polarity also play an important role in determining the macroscopic organization of the engaged T cell.	Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Xavier, R (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.							Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158	10	5	5	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					655	656		10.1016/j.immuni.2005.06.003	http://dx.doi.org/10.1016/j.immuni.2005.06.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963778	Bronze			2022-12-18	WOS:000230180300001
J	Smale, ST				Smale, ST			A Th2 cytokine LCR: Adding a new piece to the regulatory puzzle	IMMUNITY			English	Article							COORDINATE REGULATOR; GENE-EXPRESSION; TRANSCRIPTION; REGION; CELLS	DNase I hypersensitivity assays and phylogenetic analyses previously led to the identification of multiple enhancers in the Th2 cytokine cluster. As described in this issue of Immunity, Lee et al. have now used a transgenic mouse assay to identify a locus control region (LCR) that supports integration site-independent, copy number-dependent transcription of II4 and II13.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Smale, ST (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.							Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981	9	5	5	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					1	2		10.1016/S1074-7613(03)00180-8	http://dx.doi.org/10.1016/S1074-7613(03)00180-8			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871632	Bronze			2022-12-18	WOS:000184260400001
J	Allen, PM; Murphy, KM; Schreiber, RD; Unanue, ER				Allen, PM; Murphy, KM; Schreiber, RD; Unanue, ER			Immunology at 2000	IMMUNITY			English	Editorial Material									Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.		Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341					0	5	5	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					649	651		10.1016/S1074-7613(00)80139-9	http://dx.doi.org/10.1016/S1074-7613(00)80139-9			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626887	Bronze			2022-12-18	WOS:000084612900001
J	Straten, KV; Guerra, D; Gils, MJV; Bontjer, I; Caniels, TG; Willigen, HDGV; Wynberg, E; Poniman, M; Burger, JA; Bouhuijs, JH; van Rijswijk, J; Olijhoek, W; Liesdek, MH; Lavell, AHA; Appelman, B; Sikkens, JJ; Bomers, MK; Han, AX; Nichols, BE; Prins, M; Vennema, H; Reusken, C; Jong, MMDD; Bree, GJD; Russell, CA; Eggink, D; Sanders, RW				Straten, Karlijn van der; Guerra, Denise; Gils, Marit J. van; Bontjer, Ilja; Caniels, Tom G.; Willigen, Hugo D. G. van; Wynberg, Elke; Poniman, Meliawati; Burger, Judith A.; Bouhuijs, Joey H.; van Rijswijk, Jacqueline; Olijhoek, Wouter; Liesdek, Marinus H.; Lavell, A. H. Ayesha; Appelman, Brent; Sikkens, Jonne J.; Bomers, Marije K.; Han, Alvin X.; Nichols, Brooke E.; Prins, Maria; Vennema, Harry; Reusken, Chantal; Jong, Marije Menno D. de; Bree, Godelieve J. de; Russell, Colin A.; Eggink, Dirk; Sanders, Rogier W.			Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron	IMMUNITY			English	Article								Large-scale vaccination campaigns have prevented countless hospitalizations and deaths due to COVID-19. However, the emergence of SARS-CoV-2 variants that escape from immunity challenges the effectiveness of current vaccines. Given this continuing evolution, an important question is when and how to update SARS-CoV-2 vaccines to antigenically match circulating variants, similarly to seasonal influenza viruses where anti-genic drift necessitates periodic vaccine updates. Here, we studied SARS-CoV-2 antigenic drift by assessing neutralizing activity against variants of concern (VOCs) in a set of sera from patients infected with viral sequence-confirmed VOCs. Infections with D614G or Alpha strains induced the broadest immunity, whereas individuals infected with other VOCs had more strain-specific responses. Omicron BA.1 and BA.2 were sub-stantially resistant to neutralization by sera elicited by all other variants. Antigenic cartography revealed that Omicron BA.1 and BA.2 were antigenically most distinct from D614G, associated with immune escape, and possibly will require vaccine updates to ensure vaccine effectiveness.	[Straten, Karlijn van der; Guerra, Denise; Gils, Marit J. van; Bontjer, Ilja; Caniels, Tom G.; Willigen, Hugo D. G. van; Wynberg, Elke; Poniman, Meliawati; Burger, Judith A.; Bouhuijs, Joey H.; van Rijswijk, Jacqueline; Olijhoek, Wouter; Liesdek, Marinus H.; Han, Alvin X.; Nichols, Brooke E.; Russell, Colin A.; Eggink, Dirk; Sanders, Rogier W.] Amsterdam UMC Locat Univ Amsterdam, Dept Med Microbiol & Infect Prevent, Lab Expt Virol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Straten, Karlijn van der; Guerra, Denise; Gils, Marit J. van; Bontjer, Ilja; Caniels, Tom G.; Willigen, Hugo D. G. van; Wynberg, Elke; Poniman, Meliawati; Burger, Judith A.; Bouhuijs, Joey H.; van Rijswijk, Jacqueline; Olijhoek, Wouter; Liesdek, Marinus H.; Lavell, A. H. Ayesha; Sikkens, Jonne J.; Bomers, Marije K.; Han, Alvin X.; Nichols, Brooke E.; Russell, Colin A.; Eggink, Dirk; Sanders, Rogier W.] Amsterdam Inst Infect & Immun, Infect Dis, Amsterdam, Netherlands; [Straten, Karlijn van der; Liesdek, Marinus H.; Prins, Maria] Amsterdam UMC Locat Univ Amsterdam, Dept Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Prins, Maria] Dept Infect Dis, Publ Hlth Serv Amsterdam, GGD, NL-1018 WT Amsterdam, Netherlands; [Lavell, A. H. Ayesha; Sikkens, Jonne J.; Bomers, Marije K.] Univ Amsterdam, Amsterdam UMC Locat VU, Dept Internal Med, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Appelman, Brent] Univ Amsterdam, Amsterdam UMC Locat, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Nichols, Brooke E.; Vennema, Harry] Boston Univ Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Vennema, Harry; Eggink, Dirk] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3721 MA Bilthoven, Netherlands; [Sanders, Rogier W.] Weill Med Coll Cornell Univ, Dept Microbiol & Immunol, New York, NY 10065 USA	Public Health Service Amsterdam; University of Amsterdam; University of Amsterdam; Boston University; Netherlands National Institute for Public Health & the Environment; Cornell University	Straten, KV; Russell, CA; Eggink, D; Sanders, RW (corresponding author), Amsterdam UMC Locat Univ Amsterdam, Dept Med Microbiol & Infect Prevent, Lab Expt Virol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Straten, KV; Russell, CA; Eggink, D; Sanders, RW (corresponding author), Amsterdam Inst Infect & Immun, Infect Dis, Amsterdam, Netherlands.; Straten, KV (corresponding author), Amsterdam UMC Locat Univ Amsterdam, Dept Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Eggink, D (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3721 MA Bilthoven, Netherlands.; Sanders, RW (corresponding author), Weill Med Coll Cornell Univ, Dept Microbiol & Immunol, New York, NY 10065 USA.	c.a.russell@amsterdamumc.nl; dirk.eggink@rivm.nl; r.w.sanders@amsterdamumc.nl			Netherlands Organization for Scientific Research (NWO) [91818627, 09150182010027]; ERC Consolidator Award [818353]; NWO ZonMw [10150062010002, 10430072110003]; Public Health Service of Amsterdam Research Development [21-14]; NWO [10430022010023, 10430022010030]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERC Consolidator Award; NWO ZonMw(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Public Health Service of Amsterdam Research Development; NWO(Netherlands Organization for Scientific Research (NWO))	We thank all public health services (GGD) in the Netherlands for their help in contacting participants. We are also thankful to the study personnel and the participants of the COSCA, RECoVERED and the S3 -study for their contribu- tion to this research. Funding: R.W.S. and C.A.R. are recipients of Vici grants from the Netherlands Organization for Scientific Research (NWO no. 91818627 to R.W.S, no. 09150182010027 to C.A.R.) . C.A.R. and A.X.H. are also sup- ported by an ERC Consolidator Award no. 818353. This work was supported by the NWO ZonMw (grant agreement no. 10150062010002 to M.D.d.J. and no. 10430072110003 to G.J.d.B.) and the Public Health Service of Amsterdam Research & Development grant no. 21-14 to M. Prins (RECoVERED) . J.J.S. and M.K.B. are recipients of the NWO grant agreement nos. 10430022010023 and 10430022010030, respectively.	Asvold B. O, 2021, MEDRXIV, DOI [10.1101/2021, DOI 10.1101/2021]; Barr IG, 2014, VACCINE, V32, P4713, DOI 10.1016/j.vaccine.2014.02.014; Caniels TG, 2021, SCI ADV, V7, DOI [10.1126/sciadv.abj5365, 10.1101/2021.05.26.21257441]; Cele S, 2022, CELL HOST MICROBE, V30, P154, DOI 10.1016/j.chom.2022.01.005; Center for Disease Control and Prevention, 2021, ANT CHAR; Eggink Dirk, 2022, Euro Surveill, V27, DOI 10.2807/1560-7917.ES.2022.27.4.2101196; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Garcia-Beltran W.F., 2021, PREPRINT; Grobben M, 2021, ELIFE, V10, DOI [10.7554/eLife.70330, 10.7554/eLife.70330.sa0, 10.7554/eLife.70330.sa1, 10.7554/eLife.70330.sa2]; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kristiansen PA, 2021, LANCET, V397, P1347, DOI 10.1016/S0140-6736(21)00527-4; Liu C, 2021, CELL, V184, P4220, DOI 10.1016/j.cell.2021.06.020; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Mykytyn Anna Z, 2022, Sci Immunol, V7, peabq4450, DOI 10.1126/sciimmunol.abq4450; Rijksinstituut voor Volksgezondheid en Milieu (RIVM), 2022, RES KIEM SURV; Rossler A, 2022, NEW ENGL J MED, V386, P698, DOI 10.1056/NEJMc2119236; Wilks SH, 2022, bioRxiv, DOI 10.1101/2022.01.28.477987; Schmidt F, 2020, J EXP MED, V217, DOI 10.1084/jem.20201181; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; van Gils MJ, 2022, PLOS MED, V19, DOI 10.1371/journal.pmed.1003991; World Health Organization, 2022, TRACK SARS COV 2 VAR; Wynberg E, 2022, CLIN INFECT DIS, V75, pE482, DOI 10.1093/cid/ciab759	22	4	5	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1725	+		10.1016/j.immuni.2022.07.018	http://dx.doi.org/10.1016/j.immuni.2022.07.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4X1ZN	35973428	hybrid, Green Published			2022-12-18	WOS:000860648000001
J	Koutsakos, M; Lee, WS; Reynaldi, A; Tan, HX; Gare, G; Kinsella, P; Liew, KC; Taiaroa, G; Williamson, DA; Kent, HE; Stadler, E; Cromer, D; Khoury, DS; Wheatley, AK; Juno, JA; Davenport, MP; Kent, SJ				Koutsakos, Marios; Lee, Wen Shi; Reynaldi, Arnold; Tan, Hyon-Xhi; Gare, Grace; Kinsella, Paul; Liew, Kwee Chin; Taiaroa, George; Williamson, Deborah A.; Kent, Helen E.; Stadler, Eva; Cromer, Deborah; Khoury, David S.; Wheatley, Adam K.; Juno, Jennifer A.; Davenport, Miles P.; Kent, Stephen J.			The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants	IMMUNITY			English	Article								Vaccination against SARS-CoV-2 protects from infection and improves clinical outcomes in breakthrough in-fections, likely reflecting residual vaccine-elicited immunity and recall of immunological memory. Here, we define the early kinetics of spike-specific humoral and cellular immunity after vaccination of seropositive individuals and after Delta or Omicron breakthrough infection in vaccinated individuals. Early longitudinal sampling revealed the timing and magnitude of recall, with the phenotypic activation of B cells preceding an increase in neutralizing antibody titers. While vaccination of seropositive individuals resulted in robust recall of humoral and T cell immunity, recall of vaccine-elicited responses was delayed and variable in magni-tude during breakthrough infections and depended on the infecting variant of concern. While the delayed kinetics of immune recall provides a potential mechanism for the lack of early control of viral replication, the recall of antibodies coincided with viral clearance and likely underpins the protective effects of vaccina-tion against severe COVID-19.	[Koutsakos, Marios; Lee, Wen Shi; Tan, Hyon-Xhi; Gare, Grace; Kent, Helen E.; Wheatley, Adam K.; Juno, Jennifer A.; Kent, Stephen J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Reynaldi, Arnold; Stadler, Eva; Cromer, Deborah; Khoury, David S.; Davenport, Miles P.] Univ New South Wales, Kirby Inst, Kensington, NSW, Australia; [Kinsella, Paul; Liew, Kwee Chin; Taiaroa, George; Williamson, Deborah A.] Royal Melbourne Hosp, Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Williamson, Deborah A.] Univ Melbourne, Dept Infect Dis, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia; [Kent, Stephen J.] Monash Univ, Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Kent, Stephen J.] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Kent, Stephen J.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	University of Melbourne; University of New South Wales Sydney; Kirby Institute; Royal Melbourne Hospital; Victorian Infectious Diseases Reference Laboratory; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University	Wheatley, AK; Juno, JA; Kent, SJ (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Davenport, MP (corresponding author), Univ New South Wales, Kirby Inst, Kensington, NSW, Australia.; Kent, SJ (corresponding author), Monash Univ, Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Kent, SJ (corresponding author), Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia.; Kent, SJ (corresponding author), Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia.	a.wheatley@unimelb.edu.au; jennifer.juno@unimelb.edu.au; m.davenport@unsw.edu.au; skent@unimelb.edu.au		Stadler, Eva Maria/0000-0002-5129-8180	Australian National Health and Medical Research Council [1149990, 1162760, 2004398]; Australian Medical Research Future Fund [2005544, 2013870]; Victorian Government; Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Medical Research Future Fund(Medical Research Future Fund (MRFF)); Victorian Government; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank the participants for the generous involvement and provision of sam- ples. We thank T. Amarasena, R. Esterbauer, K. Wragg, P. Konstandopoulos, K. Field, and A. Kelly (University of Melbourne) for excellent technical assis- tance. We thank molecular staff at the Victorian Infectious Diseases Reference Laboratory for performing RT-PCR. We thank Dr. Julian Druce and Dr. Leon Caly at the Victorian Infectious Diseases Reference Laboratory for isolating and distributing SARS-CoV-2 virus isolates. We acknowledge the Melbourne Cytometry Platform for provision of flow cytometry services. This study was supported by the Australian National Health and Medical Research Council grants 1149990, 1162760, and 2004398; Australian Medical Research Future Fund grants 2005544 and 2013870; The Victorian Government; and Australian National Health and Medical Research Council Investigator or Fellowship grants (M.K., A.K.W., J.A.J., H.-X.T., D.A.W., M.P.D., and S.J.K.) .	Backer JA, 2022, EUROSURVEILLANCE, V27, DOI 10.2807/1560-7917.ES.2022.27.6.2200042; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1101/2021.12.12.472269, 10.1038/s41586-021-04386-2]; Carreno JM, 2022, NATURE, V602, P682, DOI 10.1038/s41586-022-04399-5; Chan JFW, 2020, J CLIN MICROBIOL, V58, DOI [10.1128/JCM.00310-20, 10.1128/JCM.00310-20.]; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Chia PY, 2022, CLIN MICROBIOL INFEC, V28, DOI 10.1016/j.cmi.2021.11.010; Chung H, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1943; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Cromer D, 2022, LANCET MICROBE, V3, pE52, DOI 10.1016/S2666-5247(21)00267-6; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Ferdinands JM, 2021, VACCINE, V39, P3678, DOI 10.1016/j.vaccine.2021.05.011; Francica JR, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abi4547; Gagne M, 2022, CELL, V185, P113, DOI 10.1016/j.cell.2021.12.002; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Joyner MJ, 2021, NEW ENGL J MED, V384, P1015, DOI 10.1056/NEJMoa2031893; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Kared H., 2022, PREPRINT, DOI [10.1101/2022.01.13, DOI 10.1101/2022.01.13]; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kissler SM, 2021, NEW ENGL J MED, V385, P2489, DOI 10.1056/NEJMc2102507; Koutsakos M, 2022, J LEUKOCYTE BIOL, V111, P355, DOI 10.1002/JLB.5MR0821-464R; Nguyen THO, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23018-x; Nyberg T, 2022, LANCET, V399, P1303, DOI 10.1016/S0140-6736(22)00462-7; Patel MM, 2021, LANCET MICROBE, V2, pE715, DOI 10.1016/S2666-5247(21)00180-4; Rahil Z, 2020, J CLIN INVEST, V130, P5800, DOI 10.1172/JCI137265; Rossler A., 2021, NEW ENGL J MED, DOI [10.1101/2021.12.08.21267491, DOI 10.1101/2021.12.08.21267491]; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; Shamier MC, 2021, VIROLOGICAL CHARACTE, DOI [10.1101/2021.08.20.21262158, DOI 10.1101/2021.08.20.21262158]; Singanayagam A, 2022, LANCET INFECT DIS, V22, P183, DOI 10.1016/S1473-3099(21)00648-4; Stadler E., 2022, PREPRINT, DOI [10.1101/2022.03.21.22272672, DOI 10.1101/2022.03.21.22272672]; Tang P, 2021, NAT MED, V27, P2136, DOI 10.1038/s41591-021-01583-4; Tenforde MW, 2021, JAMA-J AM MED ASSOC, V326, P2043, DOI 10.1001/jama.2021.19499; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Wheatley AK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21444-5; Wragg KM, 2022, NAT IMMUNOL, V23, P768, DOI 10.1038/s41590-022-01175-5	36	4	4	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1316	+		10.1016/j.immuni.2022.05.018	http://dx.doi.org/10.1016/j.immuni.2022.05.018			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3D3AD	35690062	Bronze, Green Published			2022-12-18	WOS:000829177900006
J	Gruell, H; Vanshylla, K; Weber, T; Barnes, CO; Kreer, C; Klein, F				Gruell, Henning; Vanshylla, Kanika; Weber, Timm; Barnes, Christopher O.; Kreer, Christoph; Klein, Florian			Antibody-mediated neutralization of SARS-CoV-2	IMMUNITY			English	Review							MESSENGER-RNA VACCINATION; RECEPTOR-BINDING DOMAIN; B-CELL MEMORY; HUMORAL IMMUNITY; COVID-19; SPIKE; INFECTION; POTENT; MATURATION; PROTECTION	Neutralizing antibodies can block infection, clear pathogens, and are essential to provide long-term immunity. Since the onset of the pandemic, SARS-CoV-2 neutralizing antibodies have been comprehensively investigated and critical information on their development, function, and potential use to prevent and treat COVID-19 have been revealed. With the emergence of SARS-CoV-2 immune escape variants, humoral immunity is being challenged, and a detailed understanding of neutralizing antibodies is essential to guide vaccine design strategies as well as antibody-mediated therapies. In this review, we summarize some of the key findings on SARS-CoV-2 neutralizing antibodies, with a focus on their clinical application.	[Gruell, Henning; Vanshylla, Kanika; Weber, Timm; Kreer, Christoph; Klein, Florian] Univ Cologne, Fac Med, Inst Virol, Lab Expt Immunol, D-50931 Cologne, Germany; [Gruell, Henning; Vanshylla, Kanika; Weber, Timm; Kreer, Christoph; Klein, Florian] Univ Cologne, Univ Hosp Cologne, D-50931 Cologne, Germany; [Barnes, Christopher O.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Barnes, Christopher O.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Klein, Florian] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, D-50931 Cologne, Germany; [Klein, Florian] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany	University of Cologne; University of Cologne; Stanford University; German Center for Infection Research; University of Cologne; University of Cologne	Klein, F (corresponding author), Univ Cologne, Fac Med, Inst Virol, Lab Expt Immunol, D-50931 Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, Univ Hosp Cologne, D-50931 Cologne, Germany.; Klein, F (corresponding author), German Ctr Infect Res DZIF, Partner Site Bonn Cologne, D-50931 Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.	florian.klein@uk-koeln.de		Grull, Henning/0000-0002-0725-7138; Vanshylla, Kanika/0000-0003-4552-9170	Howard Hughes Medical Institute Hanna Gray Fellowship; German Research Foundation [CRC 1310]; German Center for Infection Research; COVIM: NaFoUniMedCovid19 [FKZ: 01KX2021]	Howard Hughes Medical Institute Hanna Gray Fellowship; German Research Foundation(German Research Foundation (DFG)); German Center for Infection Research; COVIM: NaFoUniMedCovid19	We thank all laboratories making SARS-CoV-2 sequence information available through GISAID for facilitating rapid analyses of global variant distributions and we acknowledge outbreak.info for aggregating the data. C.O.B. is supported by the Howard Hughes Medical Institute Hanna Gray Fellowship and is a Chan Zuckerberg Biohub investigator. This work was supported by grants from COVIM: NaFoUniMedCovid19 (FKZ: 01KX2021) (to F.K.) , the German Research Foundation (CRC 1310, to C.K. and F.K.) , and the German Center for Infection Research (to F.K.) .	A. L. Cathcart, 2021, bioRxiv, DOI 10.1101/2021.03.09.434607; Abu-Raddad LJ, 2022, NEW ENGL J MED, V386, P1804, DOI 10.1056/NEJMoa2200797; Abu-Raddad LJ, 2022, NEW ENGL J MED, V386, P1091, DOI 10.1056/NEJMc2119432; ACTIV-3 TICO LY-CoV555 Study Grp, 2021, NEW ENGL J MED, V384, P905, DOI 10.1056/NEJMoa2033130; Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Amanat F, 2021, CELL, V184, P3936, DOI 10.1016/j.cell.2021.06.005; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Anderson EM, 2021, CELL, V184, P1858, DOI 10.1016/j.cell.2021.02.010; Andreano E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103154118; Andreano E, 2021, CELL, V184, P1821, DOI 10.1016/j.cell.2021.02.035; Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI 10.1056/NEJMoa2119451; Andrews N, 2022, NEW ENGL J MED, V386, P340, DOI 10.1056/NEJMoa2115481; Apostolidis SA, 2021, NAT MED, V27, P1990, DOI 10.1038/s41591-021-01507-2; Arvin AM, 2020, NATURE, V584, P353, DOI 10.1038/s41586-020-2538-8; Azzi L, 2022, EBIOMEDICINE, V75, DOI 10.1016/j.ebiom.2021.103788; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Barros-Martins J, 2021, NAT MED, V27, P1525, DOI 10.1038/s41591-021-01449-9; Bates TA, 2022, JAMA-J AM MED ASSOC, V327, P179, DOI 10.1001/jama.2021.22898; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Begin P, 2021, NAT MED, V27, P2012, DOI 10.1038/s41591-021-01488-2; Benton DJ, 2020, NATURE, V588, DOI 10.1038/s41586-020-2772-0; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Bertoglio F, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109433; Borobia AM, 2021, LANCET, V398, P121, DOI 10.1016/S0140-6736(21)01420-3; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; C.Ono, 2020, bioRxiv, DOI 10.1101/2020.11.05.369264; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1002/nla.2362, 10.1038/s41586-021-04385-3]; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Carreno JM, 2022, NATURE, V602, P682, DOI 10.1038/s41586-022-04399-5; Cerutti G, 2021, CELL REP, V37, DOI [10.1101/2021.06.29.450397, 10.1016/j.celrep.2021.109928]; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Chan CEZ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253487; Chen EC, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109604; Chen P, 2021, CLIN PHARMACOL THER, V110, P1467, DOI 10.1002/cpt.2405; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Chen RE, 2021, NATURE, V596, P103, DOI 10.1038/s41586-021-03720-y; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Chen YZ, 2020, CELL, V183, P1496, DOI 10.1016/j.cell.2020.10.051; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Chia WN, 2021, LANCET MICROBE, V2, pE240, DOI 10.1016/S2666-5247(21)00025-2; Cho A, 2021, NATURE, V600, P517, DOI 10.1038/s41586-021-04060-7; Choi A, 2021, NAT MED, V27, P2025, DOI 10.1038/s41591-021-01527-y; Cobb RR, 2022, MED-CAMBRIDGE, V3, P188, DOI 10.1016/j.medj.2022.01.004; Cohen MS, 2021, JAMA-J AM MED ASSOC, V326, P46, DOI [10.1001/jama.2021.8828, 10.1001/jama.2021.88282021.]; Copin R, 2021, CELL, V184, P3949, DOI 10.1016/j.cell.2021.06.002; Corbett KS, 2021, SCIENCE, V374, P1343, DOI 10.1126/science.abl8912; Corbett KS, 2021, SCIENCE, V373, P1325, DOI 10.1126/science.abj0299; Corti D, 2021, CELL, V184, P3086, DOI [10.1016/j.cell.2021.07.027, 10.1016/j.cell.2021.05.005]; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Dejnirattisai W, 2022, CELL, V185, P467, DOI 10.1016/j.cell.2021.12.046; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Dong JH, 2021, NAT MICROBIOL, V6, P1233, DOI 10.1038/s41564-021-00972-2; Doria-Rose N, 2021, NEW ENGL J MED, V384, P2259, DOI 10.1056/NEJMc2103916; Dougan M, 2021, NEW ENGL J MED, V385, P1382, DOI 10.1056/NEJMoa2102685; Du S, 2020, CELL, V183, P1013, DOI 10.1016/j.cell.2020.09.035; Earle KA, 2021, VACCINE, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; Edridge AWD, 2020, NAT MED, V26, P1691, DOI 10.1038/s41591-020-1083-1; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Elsner RA, 2020, IMMUNITY, V53, P1136, DOI 10.1016/j.immuni.2020.11.006; Ercanoglu MS, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2022.103951; Escalera A, 2022, CELL HOST MICROBE, V30, P373, DOI 10.1016/j.chom.2022.01.006; Fan XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17371-6; Feldman J, 2021, SCI IMMUNOL, V6, DOI [10.1126/sciimmunol.abl5842, 10.1101/2021.02.02.429458]; Feng S, 2021, NAT MED, V27, P2032, DOI [DOI 10.1038/s41591-021-01540-1, 10.1038/s41591-021-01540-1]; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Froberg J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25949-x; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gagne M, 2022, CELL, V185, P1556, DOI 10.1016/j.cell.2022.03.038; Garcia-Beltran WF, 2022, CELL, V185, P457, DOI [10.1016/j.cell.2021.12.033, 10.1101/2021.12.14.21267755]; Garcia-Beltran WF, 2021, CELL, V184, P476, DOI 10.1016/j.cell.2020.12.015; Gieselmann L, 2021, NAT PROTOC, V16, P3639, DOI 10.1038/s41596-021-00554-w; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Greaney AJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24435-8; Greaney AJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abi9915; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Gruell H, 2022, NAT MED, V28, P477, DOI 10.1038/s41591-021-01676-0; Gu CY, 2021, MABS-AUSTIN, V13, DOI 10.1080/19420862.2021.1930636; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Guo Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22926-2; Gupta A, 2022, JAMA-J AM MED ASSOC, V327, P1236, DOI 10.1001/jama.2022.2832; Gupta A, 2021, NEW ENGL J MED, V385, P1941, DOI 10.1056/NEJMoa2107934; Haagmans BL, 2021, J INFECT DIS, V223, P2020, DOI 10.1093/infdis/jiab289; Hall V, 2022, NEW ENGL J MED, V386, P1207, DOI 10.1056/NEJMoa2118691; Hall VG, 2022, NAT IMMUNOL, V23, P380, DOI 10.1038/s41590-021-01126-6; Halwe S, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13081498; Hammitt LL, 2022, NEW ENGL J MED, V386, P837, DOI 10.1056/NEJMoa2110275; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hastie KM, 2021, SCIENCE, V374, P472, DOI 10.1126/science.abh2315; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Hillus D, 2021, LANCET RESP MED, V9, P1255, DOI 10.1016/S2213-2600(21)00357-X; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Horby PW, 2022, LANCET, V399, P665, DOI 10.1016/S0140-6736(22)00163-5; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Huo JD, 2020, CELL HOST MICROBE, V28, P497, DOI 10.1016/j.chom.2020.07.002; Iketani S, 2022, NATURE, V604, P553, DOI 10.1038/s41586-022-04594-4; Imkeller K, 2018, IMMUNOL REV, V284, P51, DOI 10.1111/imr.12670; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jensen B, 2021, LANCET REG HEALTH-EU, V8, DOI 10.1016/j.lanepe.2021.100164; Jette CA, 2021, CELL REP, V36, DOI [10.1016/j.celrep.2021.109760, 10.1101/2021.04.23.441195]; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Joyner MJ, 2021, NEW ENGL J MED, V384, P1015, DOI 10.1056/NEJMoa2031893; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Junqueira C, 2022, NATURE, V606, P576, DOI 10.1038/s41586-022-04702-4; Kaneko N., 2020, CELL; Kaplonek P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj2901; Ke ZL, 2020, NATURE, V588, P498, DOI 10.1038/s41586-020-2665-2; Keeton R, 2021, CELL HOST MICROBE, V29, P1611, DOI 10.1016/j.chom.2021.10.003; Ketas Thomas J, 2021, Pathog Immun, V6, P116, DOI [10.1101/2021.03.11.434841, 10.20411/pai.v6i1.441]; Khare S, 2021, CHINA CDC WEEKLY, V3, P1049, DOI 10.46234/ccdcw2021.255; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Khoury DS, 2020, NAT REV IMMUNOL, V20, P727, DOI 10.1038/s41577-020-00471-1; Kim C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20602-5; Kim JY, 2021, CLIN THER, V43, P1706, DOI 10.1016/j.clinthera.2021.08.009; Kim SI, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd6990; Kim W, 2022, NATURE, V604, P141, DOI 10.1038/s41586-022-04527-1; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Korley FK, 2021, NEW ENGL J MED, V385, P1951, DOI 10.1056/NEJMoa2103784; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Kreye J, 2020, CELL, V183, P1058, DOI 10.1016/j.cell.2020.09.049; Kristiansen PA, 2021, LANCET, V397, P1347, DOI 10.1016/S0140-6736(21)00527-4; Kuhlmann C, 2022, LANCET, V399, P625, DOI 10.1016/S0140-6736(22)00090-3; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lederer K, 2022, CELL, V185, P1008, DOI 10.1016/j.cell.2022.01.027; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Lempp FA, 2021, NATURE, V598, P342, DOI 10.1038/s41586-021-03925-1; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Levin MJ, 2022, NEW ENGL J MED, V386, P2188, DOI 10.1056/NEJMoa2116620; Li DP, 2021, CELL, V184, P4203, DOI 10.1016/j.cell.2021.06.021; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Li YJ, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.01063-21; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Lilly, 2020, PRESS REL LILL BEG W; Liu C, 2021, CELL, V184, P4220, DOI 10.1016/j.cell.2021.06.020; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu ZM, 2021, CELL HOST MICROBE, V29, P477, DOI 10.1016/j.chom.2021.01.014; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Loo YM, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abl8124; Lucas C, 2021, NAT MED, V27, P1178, DOI 10.1038/s41591-021-01355-0; Luchsinger LL, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02005-20; Lundgren JD, 2022, ANN INTERN MED, V175, P234, DOI 10.7326/M21-3507; M. C. Choudhary, 2021, medRxiv, DOI 10.1101/2021.09.03.21263105; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Martinez DR, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abj7125; Martinez DR, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109450; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; McCarthy KR, 2021, SCIENCE, V371, P1139, DOI 10.1126/science.abf6950; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Meng XM, 2021, EMERG MICROBES INFEC, V10, P1638, DOI 10.1080/22221751.2021.1960900; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Moriyama S, 2021, IMMUNITY, V54, P1841, DOI 10.1016/j.immuni.2021.06.015; Mudd PA, 2022, CELL, V185, P603, DOI 10.1016/j.cell.2021.12.026; Muecksch F, 2022, NATURE, V607, P128, DOI 10.1038/s41586-022-04778-y; Muecksch F, 2021, IMMUNITY, V54, P1853, DOI 10.1016/j.immuni.2021.07.008; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Mullen J.L., 2020, OUTBREAKINFO; Munro APS, 2021, LANCET, V398, P2258, DOI 10.1016/S0140-6736(21)02717-3; Nabel KG, 2022, SCIENCE, V375, P282, DOI 10.1126/science.abl6251; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; O'Brien MP, 2021, NEW ENGL J MED, V385, P1184, DOI 10.1056/NEJMoa2109682; O'Brien MP, 2022, JAMA-J AM MED ASSOC, V327, P432, DOI 10.1001/jama.2021.24939; Pajon R, 2022, NEW ENGL J MED, V386, P1088, DOI 10.1056/NEJMc2119912; Perez-Then E, 2022, NAT MED, V28, P481, DOI 10.1038/s41591-022-01705-6; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2021, SCIENCE, V373, P1109, DOI 10.1126/science.abj3321; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Planas D, 2022, NATURE, V602, P671, DOI 10.1038/s41586-021-04389-z; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Poston D, 2021, CLIN INFECT DIS, V73, pE1208, DOI [10.1093/cid/ciaa1803, 10.1101/2020.10.08.20209650]; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Razonable RR, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101102; Reynolds CJ, 2021, SCIENCE, V372, P1418, DOI 10.1126/science.abh1282; Ripperger TJ, 2020, IMMUNITY, V53, P925, DOI 10.1016/j.immuni.2020.10.004; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rockett R, 2022, NEW ENGL J MED, V386, DOI 10.1056/NEJMc2120219; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Roltgen K, 2022, CELL, V185, P1025, DOI 10.1016/j.cell.2022.01.018; Roltgen K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0240; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Scheid JF, 2021, CELL, V184, P3205, DOI 10.1016/j.cell.2021.04.032; Schmidt F, 2022, NEW ENGL J MED, V386, P599, DOI 10.1056/NEJMc2119641; Schmidt F, 2021, NATURE, V600, P512, DOI 10.1038/s41586-021-04005-0; Schmitz AJ, 2021, IMMUNITY, V54, P2159, DOI [10.1016/j.immuni.2021.08.013, 10.1101/2021.03.24.436864]; Self WH, 2022, LANCET INFECT DIS, V22, P622, DOI 10.1016/S1473-3099(21)00751-9; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Seydoux E, 2020, IMMUNITY, V53, P98, DOI 10.1016/j.immuni.2020.06.001; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Sholukh AM, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00527-21; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Singh S, 2021, LANCET, V398, P2109, DOI 10.1016/S0140-6736(21)01897-3; Smith N, 2021, NAT IMMUNOL, V22, P1428, DOI 10.1038/s41590-021-01028-7; Sokal A, 2021, CELL, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Song G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23074-3; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Stephenson KE, 2021, JAMA-J AM MED ASSOC, V325, P1535, DOI 10.1001/jama.2021.3645; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Stuart ASV, 2022, LANCET, V399, P36, DOI 10.1016/S0140-6736(21)02718-5; Su W, 2021, MBIO, V12, DOI 10.1128/mBio.02395-21; Suryadevara N, 2021, CELL, V184, P2316, DOI 10.1016/j.cell.2021.03.029; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Tai LH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2112703118; Takashita E, 2022, NEW ENGL J MED, V386, P995, DOI 10.1056/NEJMc2119407; Tan TJC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24123-7; Tauzin A, 2022, CELL HOST MICROBE, V30, P97, DOI 10.1016/j.chom.2021.12.004; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; The ITAC (INSIGHT 013) Study Group, 2022, Lancet (British edition), V399, P530, DOI 10.1016/S0140-6736(22)00101-5; Tober-Lau P, 2022, EMERG INFECT DIS, V28, P1050, DOI 10.3201/eid2805.220271; Tober-Lau P, 2021, LANCET RESP MED, V9, pE104, DOI 10.1016/S2213-2600(21)00456-2; Tong P, 2021, CELL, V184, P4969, DOI [10.1016/j.cell.2021.07.025, 10.1101/2021.03.10.434840]; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Tseng HF, 2022, NAT MED, V28, P1063, DOI 10.1038/s41591-022-01753-y; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Turner JS, 2021, NATURE, V595, P421, DOI 10.1038/s41586-021-03647-4; Ullah I, 2021, IMMUNITY, V54, P2143, DOI 10.1016/j.immuni.2021.08.015; Uriu K, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMc2114706; VanBlargan LA, 2022, NAT MED, V28, P490, DOI 10.1038/s41591-021-01678-y; Vanshylla K, 2022, LANCET INFECT DIS, V22, P445, DOI 10.1016/S1473-3099(22)00135-9; Vanshylla K, 2022, CELL HOST MICROBE, V30, P69, DOI 10.1016/j.chom.2021.12.010; Vanshylla K, 2021, CELL HOST MICROBE, V29, P917, DOI 10.1016/j.chom.2021.04.015; Verma A, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109942; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Voss WN, 2021, SCIENCE, V372, P1108, DOI 10.1126/science.abg5268; Walls AC, 2022, CELL, V185, P872, DOI 10.1016/j.cell.2022.01.011; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19568-1; Wang Z., 2022, IMMUNITY, DOI [10.1016/j.im- muni.2022.04.003, DOI 10.1016/J.IM-MUNI.2022.04.003]; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312; Westendorf K, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110812; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wratil PR, 2022, NAT MED, V28, P496, DOI 10.1038/s41591-022-01715-4; Wrobel AG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19146-5; Wu NC, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108274; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yamin R, 2021, NATURE, V599, P465, DOI 10.1038/s41586-021-04017-w; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang Y, 2022, NAT MICROBIOL, V7, P423, DOI 10.1038/s41564-021-01051-2; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Yuan M, 2021, BIOCHEM BIOPH RES CO, V538, P192, DOI 10.1016/j.bbrc.2020.10.012; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zhang YJ, 2021, LANCET INFECT DIS, V21, P181, DOI 10.1016/S1473-3099(20)30843-4; Zhang YH., 2021, MEDRXIV, DOI [10.1101/2021.07.21.21260964, DOI 10.1101/2021.07.21.21260964]; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhou PP, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abi9215; Zhou YJ, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108699; Zhu L, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwaa297; Zohar T, 2020, CELL, V183, P1508, DOI 10.1016/j.cell.2020.10.052; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	293	4	4	16	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					925	944		10.1016/j.immuni.2022.05.005	http://dx.doi.org/10.1016/j.immuni.2022.05.005			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35623355	Bronze, Green Published			2022-12-18	WOS:000823293900001
J	Jiang, SZ; Chan, CN; Rovira-Clave, X; Chen, H; Bai, YH; Zhu, BK; McCaffrey, E; Greenwald, NF; Liu, C; Barlow, GL; Weirather, JL; Oliveria, JP; Nakayama, T; Lee, IT; Matter, MS; Carlisle, AE; Philips, D; Vazquez, G; Mukherjee, N; Busman-Sahay, K; Nekorchuk, M; Terry, M; Younger, S; Bosse, M; Demeter, J; Rodig, SJ; Tzankov, A; Goltsev, Y; McIlwain, DR; Angelo, M; Estes, JD; Nolan, GP				Jiang, Sizun; Chan, Chi Ngai; Rovira-Clave, Xavier; Chen, Han; Bai, Yunhao; Zhu, Bokai; McCaffrey, Erin; Greenwald, Noah F.; Liu, Candace; Barlow, Graham L.; Weirather, Jason L.; Oliveria, John Paul; Nakayama, Tsuguhisa; Lee, Ivan T.; Matter, Matthias S.; Carlisle, Anne E.; Philips, Darci; Vazquez, Gustavo; Mukherjee, Nilanjan; Busman-Sahay, Kathleen; Nekorchuk, Michael; Terry, Margaret; Younger, Skyler; Bosse, Marc; Demeter, Janos; Rodig, Scott J.; Tzankov, Alexandar; Goltsev, Yury; McIlwain, David Robert; Angelo, Michael; Estes, Jacob D.; Nolan, Garry P.			Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironments	IMMUNITY			English	Article							CD4(+) T-CELLS; SUBCELLULAR RESOLUTION; RHESUS MACAQUES; RNA; INFECTION; IL-10; HIV-1; ARCHITECTURE; CONTRIBUTES; CYTOMETRY	Understanding the mechanisms of HIV tissue persistence necessitates the ability to visualize tissue microenvironments where infected cells reside; however, technological barriers limit our ability to dissect the cellular components of these HIV reservoirs. Here, we developed protein and nucleic acid in situ imaging (PANINI) to simultaneously quantify DNA, RNA, and protein levels within these tissue compartments. By coupling PANINI with multiplexed ion beam imaging (MIBI), we measured over 30 parameters simultaneously across archival lymphoid tissues from healthy or simian immunodeficiency virus (SIV)-infected nonhuman primates. PANINI enabled the spatial dissection of cellular phenotypes, functional markers, and viral events resulting from infection. SIV infection induced IL-10 expression in lymphoid B cells, which correlated with local macrophage M2 polarization. This highlights a potential viral mechanism for conditioning an immunosuppressive tissue environment for virion production. The spatial multimodal framework here can be extended to decipher tissue responses in other infectious diseases and tumor biology.	[Jiang, Sizun; Rovira-Clave, Xavier; Chen, Han; Bai, Yunhao; Zhu, Bokai; McCaffrey, Erin; Greenwald, Noah F.; Liu, Candace; Barlow, Graham L.; Oliveria, John Paul; Nakayama, Tsuguhisa; Lee, Ivan T.; Philips, Darci; Vazquez, Gustavo; Mukherjee, Nilanjan; Bosse, Marc; Demeter, Janos; Goltsev, Yury; McIlwain, David Robert; Angelo, Michael; Nolan, Garry P.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Chan, Chi Ngai; Busman-Sahay, Kathleen; Nekorchuk, Michael; Terry, Margaret; Younger, Skyler; Estes, Jacob D.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Oliveria, John Paul] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Nakayama, Tsuguhisa] Jikei Univ, Dept Otorhinolaryngol, Sch Med, Tokyo, Japan; [Lee, Ivan T.] Stanford Univ, Sch Med, Dept Pediat, Div Allergy Immunol & Rheumatol, Stanford, CA 94305 USA; [Matter, Matthias S.; Tzankov, Alexandar] Univ Basel, Univ Hosp Basel, Inst Med Genet & Pathol, Pathol, Basel, Switzerland; [Weirather, Jason L.; Carlisle, Anne E.] Dana Faber Canc Inst, Ctr Immunooncol, Boston, MA USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Estes, Jacob D.] Oregon Hlth & Sci Univ, Div Pathobiol & Immunol, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Jiang, Sizun] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Stanford University; Oregon Health & Science University; McMaster University; Jikei University; Stanford University; University of Basel; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Oregon Health & Science University; Oregon National Primate Research Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Jiang, SZ; Nolan, GP (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Estes, JD (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.; Estes, JD (corresponding author), Oregon Hlth & Sci Univ, Div Pathobiol & Immunol, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA.; Jiang, SZ (corresponding author), Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	sjiang3@bidmc.harvard.edu; estesja@ohsu.edu; gnolan@stanford.edu	Tzankov, Alexandar/H-5656-2019; Greenwald, Noah/GNH-3982-2022	Tzankov, Alexandar/0000-0002-1100-3819; Greenwald, Noah/0000-0002-7836-4379; Barlow, Graham/0000-0001-9335-5414; Zhu, Bokai/0000-0003-3599-9419; Nolan, Garry/0000-0002-8862-9043; Phillips, Darci/0000-0002-0804-3342	Leukemia & Lymphoma Society Career Development Program; Stanford Dean's Fellowship; EMBO postdoctoral fellowship [ALTF 300-2017]; Stanford Graduate Fellowship; NCI [CA246880-01]; Canadian Institutes of Health Research Postdoctoral Fellowship; Banting Postdoctoral Fellowship; NIH [R01AI149672]; Bill & Melinda Gates Foundation [INV-002704, OPP1113682, P51OD011092]; COVID-19 Pilot Award; Fast Grant Funding for COVID-19 Science; Botnar Research Centre for Child Health Emergency Response to COVID-19 grant; US Food and Drug Administration Medical Countermeasures Initiative contracts [HHSF223201610018C, 75F40120C00176]; Parker Institute for Cancer Immunotherapy; Rachford and Carlota A. Harris Endowed Professorship	Leukemia & Lymphoma Society Career Development Program; Stanford Dean's Fellowship; EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Stanford Graduate Fellowship(Stanford University); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Banting Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); COVID-19 Pilot Award; Fast Grant Funding for COVID-19 Science; Botnar Research Centre for Child Health Emergency Response to COVID-19 grant; US Food and Drug Administration Medical Countermeasures Initiative contracts; Parker Institute for Cancer Immunotherapy; Rachford and Carlota A. Harris Endowed Professorship	The authors thank previous and current members of Ionpath Inc., including Matthew Newgren and Maciej Zerkowski, for their unwavering technical support. We thank Drs. Xiao-jun Ma and Bingqing Zhang from ACDBio for reagent support and discussions. We thank members of the Nolan, Estes, Angelo, and Jiang labs for helpful discussions. This study was supported by the Leukemia & Lymphoma Society Career Development Program (S.J.), Stanford Dean's Fellowship (S.J.), EMBO postdoctoral fellowship ALTF 300-2017 (X.R.-C.), Stanford Graduate Fellowship (B.Z.), NCI CA246880-01 (N.F.G.), Stanford Graduate Fellowship (N.F.G.), Canadian Institutes of Health Research Postdoctoral Fellowship (J.P.O.), Banting Postdoctoral Fellowship (J.P.O.), NIH R01AI149672 (S.J., G.P.N., and J.D.E.), Bill & Melinda Gates Foundation INV-002704 (S.J., G.P.N., and J.D.E.), OPP1113682 (G.P.N.), P51OD011092 (J.D.E.), COVID-19 Pilot Award (S.J., D.R.M., and G.P.N.), Fast Grant Funding for COVID-19 Science (G.P.N.), Botnar Research Centre for Child Health Emergency Response to COVID-19 grant (S.J., D.R.M., G.P.N., M.S.M., and A.T.), US Food and Drug Administration Medical Countermeasures Initiative contracts HHSF223201610018C and 75F40120C00176 (G.P.N.), Parker Institute for Cancer Immunotherapy (G.P.N.), and a Rachford and Carlota A. Harris Endowed Professorship (G.P.N.). This article reflects the views of the authors and should not be construed as representing the views or policies of the FDA, NIH, BMGF or other institutions that provided funding.	Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Baranski A, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008887; Baxter AE, 2017, NAT PROTOC, V12, P2029, DOI 10.1038/nprot.2017.079; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Black S, 2021, NAT PROTOC, V16, P3802, DOI 10.1038/s41596-021-00556-8; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Burton GF, 2002, SEMIN IMMUNOL, V14, P275, DOI 10.1016/S1044-5323(02)00060-X; Chevrier S, 2018, CELL SYST, V6, P612, DOI 10.1016/j.cels.2018.02.010; Chung S, 2015, J LEUKOCYTE BIOL, V97, P327, DOI 10.1189/jlb.3A0514-251R; Deleage Claire, 2016, Pathog Immun, V1, P68; Diggins KE, 2017, NAT METHODS, V14, P275, DOI [10.1038/NMETH.4149, 10.1038/nmeth.4149]; Estes JD, 2008, SEMIN IMMUNOL, V20, P181, DOI 10.1016/j.smim.2008.04.002; Estes JD, 2017, NAT MED, V23, P1271, DOI 10.1038/nm.4411; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Frei AP, 2016, NAT METHODS, V13, P269, DOI [10.1038/NMETH.3742, 10.1038/nmeth.3742]; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/nmeth.2869, 10.1038/NMETH.2869]; Glass M.C., 2021, BIORXIV; Goltsev Y, 2018, CELL, V174, P968, DOI 10.1016/j.cell.2018.07.010; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Greenwald NF, 2022, NAT BIOTECHNOL, V40, P555, DOI 10.1038/s41587-021-01094-0; Han GJ, 2018, NAT PROTOC, V13, P2121, DOI 10.1038/s41596-018-0016-7; Harper J, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI155251; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hickey JW, 2022, NAT METHODS, V19, P284, DOI 10.1038/s41592-021-01316-y; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hollandi R, 2020, CELL SYST, V10, P453, DOI 10.1016/j.cels.2020.04.003; Hoyt CC, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.674747; Ji AL, 2020, CELL, V182, P497, DOI 10.1016/j.cell.2020.05.039; Jiang SZ, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.729845; Kazer SW, 2020, NAT MED, V26, P511, DOI 10.1038/s41591-020-0799-2; Keren L, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5851; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Kishi JY, 2019, NAT METHODS, V16, P533, DOI 10.1038/s41592-019-0404-0; Lee IT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19145-6; Lin JR, 2018, ELIFE, V7, DOI 10.7554/eLife.31657; Lin JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9390; Liu CC, 2022, LAB INVEST, V102, P762, DOI 10.1038/s41374-022-00778-8; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McCaffrey EF, 2022, NAT IMMUNOL, V23, P318, DOI 10.1038/s41590-021-01121-x; Merritt CR, 2020, NAT BIOTECHNOL, V38, P586, DOI 10.1038/s41587-020-0472-9; Moen E, 2019, NAT METHODS, V16, P1233, DOI 10.1038/s41592-019-0403-1; Mudd JC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05528-3; Nishimura Y, 2009, P NATL ACAD SCI USA, V106, P8015, DOI 10.1073/pnas.0903022106; Ouyang WJ, 2019, IMMUNITY, V50, P871, DOI 10.1016/j.immuni.2019.03.020; Patel SS, 2019, BLOOD, V134, P2059, DOI 10.1182/blood.2019002206; Phillips D, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.687673; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; Ribeiro S.P., 2021, BIORXIV; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rojas JM, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6104054; Saka SK, 2019, NAT BIOTECHNOL, V37, P1080, DOI 10.1038/s41587-019-0207-y; Schulz D, 2018, CELL SYST, V6, P25, DOI 10.1016/j.cels.2017.12.001; Schurch CM, 2020, CELL, V182, P1341, DOI 10.1016/j.cell.2020.07.005; Sun RC, 2021, CELL METAB, V33, P1404, DOI 10.1016/j.cmet.2021.05.003; Tabb B, 2013, J INFECT DIS, V207, P880, DOI 10.1093/infdis/jis643; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Van Valen DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005177; Venables W.N., 2002, MODERN APPL STAT S, V4th; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	66	4	4	6	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1118	+		10.1016/j.immuni.2022.03.020	http://dx.doi.org/10.1016/j.immuni.2022.03.020			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F2TY	35447093	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000830524400006
J	Agaronyan, K; Sharma, L; Vaidyanathan, B; Glenn, K; Yu, S; Annicelli, C; Wiggen, TD; Penningroth, MR; Hunter, RC; Dela Cruz, CS; Medzhitov, R				Agaronyan, Karen; Sharma, Lokesh; Vaidyanathan, Bharat; Glenn, Keith; Yu, Shuang; Annicelli, Charles; Wiggen, Talia D.; Penningroth, Mitchell R.; Hunter, Ryan C.; Dela Cruz, Charles S.; Medzhitov, Ruslan			Tissue remodeling by an opportunistic pathogen triggers allergic inflammation	IMMUNITY			English	Article							FATTY-ACID INCORPORATION; EPIDERMAL-GROWTH-FACTOR; PSEUDOMONAS-AERUGINOSA; IMMUNE-RESPONSE; TYPE-2 IMMUNITY; GUT MICROBIOTA; DIETARY FIBER; HOST-DEFENSE; T-CELLS; IN-VIVO	Different effector arms of the immune system are optimized to protect from different classes of pathogens. In some cases, pathogens manipulate the host immune system to promote the wrong type of effector response???a phenomenon known as immune deviation. Typically, immune deviation helps pathogens to avoid destructive immune responses. Here, we report on a type of immune deviation whereby an opportunistic pathogen, Pseudomonas aeruginosa (P. aeruginosa), induces the type 2 immune response resulting in mucin production that is used as an energy source by the pathogen. Specifically, P. aeruginosa-secreted toxin, LasB, processed and activated epithelial amphiregulin to induce type 2 inflammation and mucin production. This ???niche remodeling???by P. aeruginosa promoted colonization and, as a by-product, allergic sensitization. Our study thus reveals a type of bacterial immune deviation by increasing nutrient supply. It also uncovers a mechanism of allergic sensitization by a bacterial virulence factor.	[Agaronyan, Karen; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Agaronyan, Karen; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Sharma, Lokesh; Glenn, Keith; Dela Cruz, Charles S.] Yale Sch Med, Dept Internal Med Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA; [Vaidyanathan, Bharat] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Wiggen, Talia D.; Penningroth, Mitchell R.; Hunter, Ryan C.] Univ Minnesota, Med Sch, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA; [Vaidyanathan, Bharat] EMD Serono Res & Dev Inst, Billerica, MA 01821 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; University of Minnesota System; University of Minnesota Twin Cities	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.; Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Hunter, Ryan/0000-0003-3841-1676	Howard Hughes Medical Institute; Blavatnik Family Foundation; Food Allergy Science Initiative; NIH [HL136919, AI144152-01, HL126094]; Department of Defense grant; Veterans Affairs merit grant; American Lung Association Catalyst Award; Yale Brown-Coxe Post-Doctoral Fellowship; Francis B Parker Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Blavatnik Family Foundation; Food Allergy Science Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense grant(United States Department of Defense); Veterans Affairs merit grant(US Department of Veterans Affairs); American Lung Association Catalyst Award; Yale Brown-Coxe Post-Doctoral Fellowship; Francis B Parker Fellowship	We thank Dr. B. Kazmerciak for providing P. aeruginosa gDNA. We would like to thank all current and former members of Medzhitov lab for helpful discus-sions. DLasB and DLasR PA01 strains were obtained from PA01 Mutant Li-brary (NIH P30 DK089507) . Work in the R.M. lab was supported by the Howard Hughes Medical Institute, the Blavatnik Family Foundation, the Food Allergy Science Initiative, and a grant from NIH (AI144152-01) . C.S.D.C. is supported by NIH HL126094, a Department of Defense grant, and a Veterans Affairs merit grant. L.S. is supported by Francis B Parker Fellowship and American Lung As-sociation Catalyst Award. R.C.H. is supported by NIH HL136919. K.A. was supported by the Yale Brown-Coxe Post-Doctoral Fellowship and is a Howard Hughes Medical Institute fellow of the Life Sciences Research Foundation. Im-ages were created with BioRender.com .	Abebe F, 2019, INT REV IMMUNOL, V38, P172, DOI 10.1080/08830185.2019.1632842; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Annunziato F, 2015, J ALLERGY CLIN IMMUN, V135, P626, DOI 10.1016/j.jaci.2014.11.001; Arabyan N, 2016, SCI REP-UK, V6, DOI 10.1038/srep29525; Aristoteli LP, 2003, INFECT IMMUN, V71, P5565, DOI 10.1128/IAI.71.10.5565-5575.2003; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Benmerzoug S, 2019, CELL REP, V27, P2649, DOI 10.1016/j.celrep.2019.04.110; Berasain C, 2014, SEMIN CELL DEV BIOL, V28, P31, DOI 10.1016/j.semcdb.2014.01.005; BEVER RA, 1988, J BACTERIOL, V170, P4309, DOI 10.1128/jb.170.9.4309-4314.1988; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borah K, 2019, CELL REP, V29, P3580, DOI 10.1016/j.celrep.2019.11.037; Broaddus VC, 2015, MURRAY NADELS TXB RE; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Cheng LE, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016352; Chong J, 2020, NAT PROTOC, V15, P799, DOI 10.1038/s41596-019-0264-1; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cronan MR, 2021, CELL, V184, P1757, DOI 10.1016/j.cell.2021.02.046; Davis MF, 2015, J ALLERGY CLIN IMMUN, V135, P811, DOI 10.1016/j.jaci.2014.10.052; Delekta PC, 2018, J BACTERIOL, V200, DOI [10.1123/JB.00728-17, 10.1128/JB.00728-17]; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Dmitrijeva M, 2021, MBIO, V12, DOI 10.1128/mBio.02863-20; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ehrt S, 2018, NAT REV MICROBIOL, V16, P496, DOI 10.1038/s41579-018-0013-4; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Esther CR, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav3488; Fischer NL, 2020, NAT MICROBIOL, V5, P14, DOI 10.1038/s41564-019-0623-2; Florsheim EB, 2021, CELL, V184, P1440, DOI 10.1016/j.cell.2020.12.007; Flynn JM, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00182-17; Flynn JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005846; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; GAMBELLO MJ, 1991, J BACTERIOL, V173, P3000, DOI 10.1128/JB.173.9.3000-3009.1991; Ge ZM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25927-2; Geoghegan JA, 2018, TRENDS MICROBIOL, V26, P484, DOI 10.1016/j.tim.2017.11.008; Giacomin P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36797; Grayczyk JP, 2017, CELL HOST MICROBE, V22, P678, DOI 10.1016/j.chom.2017.09.004; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Hoffman CL, 2020, MBIO, V11, DOI 10.1128/mBio.00060-20; Howard NC, 2020, TRENDS MICROBIOL, V28, P832, DOI 10.1016/j.tim.2020.04.010; Hur GY, 2007, EXP MOL MED, V39, P367, DOI 10.1038/emm.2007.41; Jaramillo AM, 2018, ANN AM THORAC SOC, V15, pS164, DOI 10.1513/AnnalsATS.201806-371AW; Jensen PO, 2010, FEMS IMMUNOL MED MIC, V59, P292, DOI 10.1111/j.1574-695X.2010.00706.x; Jia ZR, 2021, MUCOSAL IMMUNOL, V14, P125, DOI 10.1038/s41385-020-0272-z; Kenanian G, 2019, CELL REP, V29, P3974, DOI 10.1016/j.celrep.2019.11.071; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lan F, 2018, AM J RESP CRIT CARE, V198, P452, DOI 10.1164/rccm.201710-2112OC; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lopez MS, 2017, P NATL ACAD SCI USA, V114, P11223, DOI 10.1073/pnas.1700627114; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012; Manzo ND, 2012, AM J RESP CELL MOL, V47, P349, DOI 10.1165/rcmb.2011-0257OC; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Marrero J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003116; Martens EC, 2018, NAT REV MICROBIOL, V16, P457, DOI 10.1038/s41579-018-0036-x; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Minutti CM, 2017, IMMUNITY, V47, P710, DOI 10.1016/j.immuni.2017.09.013; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; MORIHARA K, 1978, JPN J EXP MED, V48, P81; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Mukherjee S, 2019, NAT REV MICROBIOL, V17, P371, DOI 10.1038/s41579-019-0186-5; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Newton JL, 1998, GUT, V43, P470, DOI 10.1136/gut.43.4.470; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Oldak E, 2005, ANTIMICROB AGENTS CH, V49, P3281, DOI 10.1128/AAC.49.8.3281-3288.2005; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quinnell RJ, 2004, J INFECT DIS, V190, P430, DOI 10.1086/422256; Ravimohan S, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0077-2017; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Rosa BA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0416-5; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sharpe C, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12517; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shi LB, 2015, SCI REP-UK, V5, DOI 10.1038/srep18176; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Starkl P, 2020, IMMUNITY, V53, P793, DOI 10.1016/j.immuni.2020.08.002; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Tan X, 2020, TRENDS MICROBIOL, V28, P6, DOI 10.1016/j.tim.2019.10.013; Tropini C, 2017, CELL HOST MICROBE, V21, P433, DOI 10.1016/j.chom.2017.03.010; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; von Moltke J, 2014, CURR OPIN IMMUNOL, V31, P58, DOI 10.1016/j.coi.2014.09.009; Wu JX, 2020, NAT IMMUNOL, V21, P671, DOI 10.1038/s41590-020-0688-3; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020	108	4	4	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					895	+		10.1016/j.immuni.2022.04.001	http://dx.doi.org/10.1016/j.immuni.2022.04.001			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35483356				2022-12-18	WOS:000802171100013
J	Cucolo, L; Chen, QZ; Qiu, JY; Yu, YJ; Klapholz, M; Budinich, KA; Zhang, ZJ; Shao, Y; Brodsky, IE; Jordan, MS; Gilliland, DG; Zhang, NR; Shi, JW; Minn, AJ				Cucolo, Lisa; Chen, Qingzhou; Qiu, Jingya; Yu, Yongjun; Klapholz, Max; Budinich, Krista A.; Zhang, Zhaojun; Shao, Yue; Brodsky, Igor E.; Jordan, Martha S.; Gilliland, D. Gary; Zhang, Nancy R.; Shi, Junwei; Minn, Andy J.			The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade	IMMUNITY			English	Article							NECROSIS-FACTOR-ALPHA; ACQUIRED-RESISTANCE; KINASE-ACTIVITY; RECEPTOR; UBIQUITINATION; DEATH; SEQ; IMMUNOTHERAPY; MODULATION; ACTIVATION	Interferon-gamma (IFN-gamma) has pleiotropic effects on cancer immune checkpoint blockade (ICB), including roles in ICB resistance. We analyzed gene expression in ICB-sensitive versus ICB-resistant tumor cells and identified a strong association between interferon-mediated resistance and expression of Ripk1, a regulator of tumor necrosis factor (TNF) superfamily receptors. Genetic interaction screening revealed that in cancer cells, RIPK1 diverted TNF signaling through NF-kappa B and away from its role in cell death. This promoted an immunosuppressive chemokine program by cancer cells, enhanced cancer cell survival, and decreased infiltration of T and NK cells expressing TNF superfamily ligands. Deletion of RIPK1 in cancer cells compromised chemokine secretion, decreased ARG1(+) suppressive myeloid cells linked to ICB failure in mice and humans, and improved ICB response driven by CASP8-killing and dependent on T and NK cells. RIPK1-mediated resistance required its ubiquitin scaffolding but not kinase function. Thus, cancer cells co-opt RIPK1 to promote cell-intrinsic and cell-extrinsic resistance to immunotherapy.	[Cucolo, Lisa; Qiu, Jingya; Yu, Yongjun; Klapholz, Max; Shao, Yue; Minn, Andy J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Chen, Qingzhou; Budinich, Krista A.; Shi, Junwei] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Jordan, Martha S.] Univ Penn, Perelman Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA; [Cucolo, Lisa; Chen, Qingzhou; Qiu, Jingya; Yu, Yongjun; Klapholz, Max; Shao, Yue; Shi, Junwei; Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Minn, Andy J.] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Brodsky, Igor E.; Zhang, Nancy R.; Shi, Junwei; Minn, Andy J.] Univ Penn, Mark Fdn Ctr Immunotherapy Immune Signaling & Rad, Perelman Sch Med, Philadelphia, PA 19104 USA; [Brodsky, Igor E.] Univ Penn, Dept Pathobiol, Sch Vet Med, Philadelphia, PA 19104 USA; [Zhang, Zhaojun; Zhang, Nancy R.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Gilliland, D. Gary] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Fred Hutchinson Cancer Center	Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Mark Fdn Ctr Immunotherapy Immune Signaling & Rad, Perelman Sch Med, Philadelphia, PA 19104 USA.	andyminn@upenn.edu		Klapholz, Max/0000-0001-6527-8722; SHAO, YUE/0000-0001-9055-5437	Breast Cancer Research Foundation; Mark Foundation for Cancer Research; Parker Institute for Cancer Immunotherapy; NIH [1P01CA210944-01]	Breast Cancer Research Foundation; Mark Foundation for Cancer Research; Parker Institute for Cancer Immunotherapy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.J.M. and L.C. are supported by the Breast Cancer Research Foundation. A.J.M., J.S., Q.C., Y.Y, M.K., K.A.B., Y.S., I.E.B., and N.R.Z. are supported by The Mark Foundation for Cancer Research. A.J.M. and J.Q. are supported by the Parker Institute for Cancer Immunotherapy and by a program project grant from the NIH (1P01CA210944-01).	Aaes TL, 2016, CELL REP, V15, P274, DOI 10.1016/j.celrep.2016.03.037; Annibaldi A, 2018, TRENDS MOL MED, V24, P49, DOI 10.1016/j.molmed.2017.11.002; Beck RJ, 2019, CANCER RES, V79, P3406, DOI 10.1158/0008-5472.CAN-18-3147; Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Cunha LD, 2018, CELL, V175, P429, DOI 10.1016/j.cell.2018.08.061; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y., 2015, NF KB INDEPENDENT RO; Donovan KA, 2020, CELL, V183, P1714, DOI 10.1016/j.cell.2020.10.038; Dufva O, 2020, BLOOD, V135, P597, DOI 10.1182/blood.2019002121; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feng MY, 2019, NAT REV CANCER, V19, P568, DOI 10.1038/s41568-019-0183-z; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Gier RA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17209-1; Grevet JD, 2018, SCIENCE, V361, P285, DOI 10.1126/science.aao0932; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoekstra ME, 2020, NAT CANCER, V1, P749, DOI 10.1038/s43018-020-0092-9; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Huang M, 2018, NAT METHODS, V15, P539, DOI 10.1038/s41592-018-0033-z; I.Nikaido, 2019, bioRxiv, DOI 10.1101/566182; Ishwaran Hemant, 2011, Statistical Analysis and Data Mining, V4, P115, DOI 10.1002/sam.10103; Jahchan NS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01611; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Katzenelenbogen Y, 2020, CELL, V182, P872, DOI 10.1016/j.cell.2020.06.032; Kearney CJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3451; Kearney CJ, 2017, CELL DEATH DIFFER, V24, P1705, DOI 10.1038/cdd.2017.94; Kim JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9687; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; M.Huang, 2020, bioRxiv, DOI 10.1101/2020.08.03.234765; MACIEJEWSKI J, 1995, BLOOD, V85, P3183, DOI 10.1182/blood.V85.11.3183.bloodjournal85113183; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Montfort A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01818; Patel SA, 2018, IMMUNITY, V48, P417, DOI 10.1016/j.immuni.2018.03.007; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sedger LM, 1999, J IMMUNOL, V163, P920; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Singh N, 2020, CANCER DISCOV, V10, P552, DOI 10.1158/2159-8290.CD-19-0813; Snyder AG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw2004; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12033-8; Tarumoto Y, 2018, MOL CELL, V69, P1017, DOI 10.1016/j.molcel.2018.02.011; Therneau T., 2021, PACKAGE SURVIVAL ANA; Therneau T.M., 2000, MODELING SURVIVAL DA, P1; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Vredevoogd DW, 2019, CELL, V178, P585, DOI 10.1016/j.cell.2019.06.014; Wang JS, 2018, P NATL ACAD SCI USA, V115, pE6437, DOI 10.1073/pnas.1721085115; Wang W, 2018, CANCER CELL, V34, P757, DOI 10.1016/j.ccell.2018.10.006; Wegner KW, 2017, TRENDS PHARMACOL SCI, V38, P202, DOI 10.1016/j.tips.2016.12.005; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zhang XX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11839-w; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	71	4	4	6	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					671	+		10.1016/j.immuni.2022.03.007	http://dx.doi.org/10.1016/j.immuni.2022.03.007			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z9WH	35417675				2022-12-18	WOS:000791419000002
J	Giles, JR; Manne, S; Freilich, E; Oldridge, DA; Baxter, AE; George, S; Chen, ZY; Huang, H; Chilukuri, L; Carberry, M; Giles, L; Weng, NP; Young, RM; June, CH; Schuchter, LM; Amaravadi, RK; Xu, XW; Karakousis, GC; Mitchell, TC; Huang, AC; Shi, JW; Wherry, EJ				Giles, Josephine R.; Manne, Sasikanth; Freilich, Elizabeth; Oldridge, Derek A.; Baxter, Amy E.; George, Sangeeth; Chen, Zeyu; Huang, Hua; Chilukuri, Lakshmi; Carberry, Mary; Giles, Lydia; Weng, Nan-Ping P.; Young, Regina M.; June, Carl H.; Schuchter, Lynn M.; Amaravadi, Ravi K.; Xu, Xiaowei; Karakousis, Giorgos C.; Mitchell, Tara C.; Huang, Alexander C.; Shi, Junwei; Wherry, E. John			Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers	IMMUNITY			English	Article							LINEAGE RELATIONSHIP; REGULATORY ELEMENTS; MEMORY; EFFECTOR; CHROMATIN; SUBSETS; LANDSCAPE; INFECTION; PROLIFERATION; EXHAUSTION	The clinical benefit of T cell immunotherapies remains limited by incomplete understanding of T cell differentiation and dysfunction. We generated an epigenetic and transcriptional atlas of T cell differentiation from healthy humans that included exhausted CD8 T cells and applied this resource in three ways. First, we identified modules of gene expression and chromatin accessibility, revealing molecular coordination of differentiation after activation and between central memory and effector memory. Second, we applied this healthy molecular framework to three settings-a neoadjuvant anti-PD1 melanoma trial, a basal cell carcinoma scATAC-seq dataset, and autoimmune disease-associated SNPs-yielding insights into disease specific biology. Third, we predicted genome-wide cis-regulatory elements and validated this approach for key effector genes using CRISPR interference, providing functional annotation and demonstrating the ability to identify targets for non-coding cellular engineering. These studies define epigenetic and transcriptional regulation of human T cells and illustrate the utility of interrogating disease in the context of a healthy T cell atlas.	[Giles, Josephine R.; Manne, Sasikanth; Baxter, Amy E.; George, Sangeeth; Chen, Zeyu; Huang, Hua; Chilukuri, Lakshmi; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Giles, Josephine R.; Manne, Sasikanth; Oldridge, Derek A.; Baxter, Amy E.; Chen, Zeyu; Huang, Hua; Huang, Alexander C.; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Giles, Josephine R.; June, Carl H.; Huang, Alexander C.; Wherry, E. John] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Carberry, Mary; Giles, Lydia; Schuchter, Lynn M.; Amaravadi, Ravi K.; Mitchell, Tara C.; Huang, Alexander C.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Freilich, Elizabeth; Shi, Junwei] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Oldridge, Derek A.; June, Carl H.; Xu, Xiaowei] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Huang, Hua] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Carberry, Mary; Giles, Lydia; Schuchter, Lynn M.; Amaravadi, Ravi K.; Xu, Xiaowei; Karakousis, Giorgos C.; Mitchell, Tara C.; Huang, Alexander C.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Karakousis, Giorgos C.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weng, Nan-Ping P.] NIA, Lab Immunol, NIH, Baltimore, MD 21224 USA; [Oldridge, Derek A.; Young, Regina M.; June, Carl H.; Xu, Xiaowei] Univ Penn, Ctr Cellular Immunotherapies, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [George, Sangeeth] Bristol Myers Squibb, Lawrenceville, NJ USA; [Chen, Zeyu] Dana Farber Canc Inst, Boston, MA 02115 USA; [Wherry, E. John] Prostate Canc Clin Trials Consortium, New York, NY 10065 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Pennsylvania Medicine; Bristol-Myers Squibb; Harvard University; Dana-Farber Cancer Institute	Wherry, EJ (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Prostate Canc Clin Trials Consortium, New York, NY 10065 USA.	wherry@pennmedicine.upenn.edu	Chen, Zeyu/HGF-2358-2022; Chen, Zeyu/HGE-0239-2022		Cancer Research Institute-Mark Foundation Fellowship; NIH [CA234842, CA230157, AI155577, AI115712, AI117950, AI108545, AI082630, CA210944, U19AI149680]; NHLBI [1R38HL143613]; Tara Miller Award; Parker Institute Bridge Scholar Award; Parker Institute for Cancer Immunotherapy; Allen Institute for Immunology; Stand up to Cancer; Penn Center for AIDS Research/Human Immunology Core [P30-AI045008/P30-CA016520];  [P50-CA174523];  [T32 CA009140]	Cancer Research Institute-Mark Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Tara Miller Award; Parker Institute Bridge Scholar Award; Parker Institute for Cancer Immunotherapy; Allen Institute for Immunology; Stand up to Cancer; Penn Center for AIDS Research/Human Immunology Core; ; 	We thank the members of the Wherry Lab, especiallyA. Greenplate and J. Wu. Emily Duffner assisted in cloning. Tumor collection was supported by P50-CA174523. This work was supported by T32 CA009140 and a Cancer Research Institute-Mark Foundation Fellowship (J.R.G.) , NIH grant CA234842 (Z.C.) , NHLBI grant 1R38HL143613 (D.A.O.) , NIH CA230157, the Tara Miller Award, the Parker Institute Bridge Scholar Award (A.C.H.) , and the Parker Institute for Cancer Immunotherapy, the Allen Institute for Immu-nology, and Stand up to Cancer and NIH grants AI155577, AI115712, AI117950, AI108545, AI082630, CA210944, and U19AI149680 (to E.J.W.) . We also thank the Penn Center for AIDS Research/Human Immunology Core (P30-AI045008/P30-CA016520) . Work in the Wherry Lab was supported by the Parker Institute for Cancer Immunotherapy.	Abdelsamed HA, 2017, J EXP MED, V214, P1593, DOI 10.1084/jem.20161760; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Canale FP, 2018, CANCER RES, V78, P115, DOI 10.1158/0008-5472.CAN-16-2684; Chen ZY, 2021, CELL, V184, P1262, DOI 10.1016/j.cell.2021.02.019; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Croft M, 2014, SEMIN IMMUNOL, V26, P183, DOI 10.1016/j.smim.2014.02.005; Crompton JG, 2016, CELL MOL IMMUNOL, V13, P502, DOI 10.1038/cmi.2015.32; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gasperini M, 2019, CELL, V176, P377, DOI 10.1016/j.cell.2018.11.029; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goronzy JJ, 2019, NAT REV IMMUNOL, V19, P573, DOI 10.1038/s41577-019-0180-1; Gromping U., 2006, J STAT SOFTW, V17, DOI DOI 10.18637/JSS.V017.I01; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Gupta PK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005177; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Haider S, 2019, **DATA OBJECT**; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; He B, 2016, IMMUNITY, V45, P1341, DOI 10.1016/j.immuni.2016.11.009; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Johnnidis JB, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe3702; Jung YS, 2020, EXP MOL MED, V52, P183, DOI 10.1038/s12276-020-0380-6; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kassambara A., 2020, R PACKAGE VERSION 06; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Kolde Raivo, 2019, CRAN; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Kulinskaya E., 2008, ARXIV08102124; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li X, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02293; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luke JJ, 2019, CLIN CANCER RES, V25, P3074, DOI 10.1158/1078-0432.CCR-18-1942; Lun, 2019, SINGLECELLEXPERIMENT; Mathewson ND, 2021, CELL, V184, P1281, DOI 10.1016/j.cell.2021.01.022; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Neuwirth Erich, 2014, RCOLORBREWER COLORBR; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107827; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Qu K, 2015, CELL SYST, V1, P51, DOI 10.1016/j.cels.2015.06.003; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Rome KS, 2020, J EXP MED, V217, DOI 10.1084/jem.20190888; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Scharer CD, 2017, J IMMUNOL, V198, P2238, DOI 10.4049/jimmunol.1602086; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Scrucca L, 2016, R J, V8, P289; Sekine T, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba7918; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Seumois G, 2014, NAT IMMUNOL, V15, P777, DOI 10.1038/ni.2937; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Tarumoto Y, 2018, MOL CELL, V69, P1017, DOI 10.1016/j.molcel.2018.02.011; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Ucar D, 2017, J EXP MED, V214, P3123, DOI 10.1084/jem.20170416; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vella LA, 2019, J CLIN INVEST, V129, P3185, DOI 10.1172/JCI125628; Venables W.N., 2002, MODERN APPL STAT S, V4, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Wang YQ, 2013, NAT IMMUNOL, V14, P714, DOI 10.1038/ni.2623; Wei HR, 2016, J IMMUNOL, V196, P3537, DOI 10.4049/jimmunol.1501896; Wickham H, 2007, J STAT SOFTW, V21, P1; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhang K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3262; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zhu X, 2004, Pac Symp Biocomput, P152	111	4	4	6	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					557	+		10.1016/j.immuni.2022.02.004	http://dx.doi.org/10.1016/j.immuni.2022.02.004			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ5WU	35263570				2022-12-18	WOS:000767175700005
J	Formaglio, P; Alabdullah, M; Siokis, A; Handschuh, J; Sauerland, I; Fu, Y; Krone, A; Gintschel, P; Stettin, J; Heyde, S; Mohr, J; Philipsen, L; Schroder, A; Robert, PA; Zhao, G; Khailaie, S; Dudeck, A; Bertrand, J; Spath, GF; Kahlfuss, S; Bousso, P; Schraven, B; Huehn, J; Binder, S; Meyer-Hermann, M; Muller, AJ				Formaglio, Pauline; Alabdullah, Mohamad; Siokis, Anastasios; Handschuh, Juliane; Sauerland, Ina; Fu, Yan; Krone, Anna; Gintschel, Patricia; Stettin, Juliane; Heyde, Sandrina; Mohr, Juliane; Philipsen, Lars; Schroeder, Anja; Robert, Philippe A.; Zhao, Gang; Khailaie, Sahamoddin; Dudeck, Anne; Bertrand, Jessica; Spaeth, Gerald F.; Kahlfuss, Sascha; Bousso, Philippe; Schraven, Burkhart; Huehn, Jochen; Binder, Sebastian; Meyer-Hermann, Michael; Mueller, Andreas J.			Nitric oxide controls proliferation of Leishmania major by inhibiting the recruitment of permissive host cells	IMMUNITY			English	Article							IN-VIVO; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; INTERFERON-GAMMA; INFECTION; SKIN; TUBERCULOSIS; RESPONSES; REVEALS; PROMASTIGOTES	Nitric oxide (NO) is an important antimicrobial effector but also prevents unnecessary tissue damage by shutting down the recruitment of monocyte-derived phagocytes. Intracellular pathogens such as Leishmania major can hijack these cells as a niche for replication. Thus, NO might exert containment by restricting the availability of the cellular niche required for efficient pathogen proliferation. However, such indirect modes of action remain to be established. By combining mathematical modeling with intravital 2-photon biosensors of pathogen viability and proliferation, we show that low L. major proliferation results not from direct NO impact on the pathogen but from reduced availability of proliferation-permissive host cells. Although inhibiting NO production increases recruitment of these cells, and thus pathogen proliferation, blocking cell recruitment uncouples the NO effect from pathogen proliferation. Therefore, NO fulfills two distinct functions for L. major containment: permitting direct killing and restricting the supply of proliferation-permissive host cells.	[Formaglio, Pauline; Alabdullah, Mohamad; Handschuh, Juliane; Sauerland, Ina; Fu, Yan; Krone, Anna; Gintschel, Patricia; Stettin, Juliane; Heyde, Sandrina; Mohr, Juliane; Philipsen, Lars; Dudeck, Anne; Kahlfuss, Sascha; Schraven, Burkhart; Mueller, Andreas J.] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Hlth Campus Immunol Infectiol & Inflammat GC 13, D-39120 Magdeburg, Germany; [Siokis, Anastasios; Robert, Philippe A.; Zhao, Gang; Khailaie, Sahamoddin; Binder, Sebastian; Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol & Braunschweig Integrated Ctr S, D-38124 Braunschweig, Germany; [Schroeder, Anja; Bertrand, Jessica] Otto Von Guericke Univ, Expt Orthoped, Hlth Campus Immunol Infectiol & Inflammat GC 13, D-39120 Magdeburg, Germany; [Robert, Philippe A.] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Spaeth, Gerald F.] Inst Pasteur, Mol Parasitol & Signalling Unit, F-75015 Paris, France; [Bousso, Philippe] Inst Pasteur, Dynam Immune Responses Unit, INSERM U1223, F-75015 Paris, France; [Huehn, Jochen] Helmholtz Ctr Infect Res, Dept Expt Immunol, D-38124 Braunschweig, Germany; [Huehn, Jochen] Hannover Med Sch, Cluster Excellence Resist EXC 2155, D-30625 Hannover, Germany; [Meyer-Hermann, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Mueller, Andreas J.] Helmholtz Ctr Infect Res, Intravital Microscopy Infect & Immun, D-38124 Braunschweig, Germany	Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; University of Oslo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Formaglio, P; Muller, AJ (corresponding author), Otto Von Guericke Univ, Inst Mol & Clin Immunol, Hlth Campus Immunol Infectiol & Inflammat GC 13, D-39120 Magdeburg, Germany.; Muller, AJ (corresponding author), Helmholtz Ctr Infect Res, Intravital Microscopy Infect & Immun, D-38124 Braunschweig, Germany.	pauline.formaglio@pasteur.fr; andreas.mueller@med.ovgu.de	Robert, Philippe A./Z-2816-2019	Robert, Philippe A./0000-0003-1345-5015; Siokis, Anastasios/0000-0003-4695-0354; Sauerland, Ina/0000-0002-1830-418X; zhao, gang/0000-0002-2897-6633; Formaglio, Pauline/0000-0002-9612-3157; Alabdullah, Mohamad/0000-0001-9579-0807	European Research Council (ERC) under the European Union [714233]; German Research Foundation (DFG) [SFB854-Z01, SFB854-B31, MU 3744/2-1, MU3744/4-1, SPP2225 [MU3744/5-1], KA 4514/2-1]; federal state of Saxony-Anhalt; European Regional Development Fund	European Research Council (ERC) under the European Union(European Research Council (ERC)); German Research Foundation (DFG)(German Research Foundation (DFG)); federal state of Saxony-Anhalt; European Regional Development Fund(European Commission)	Invaluable discussions with Tatjana Ruhl, Christa Zellweger, Toni Aebischer, David Kilias, Thomas TuEuroting, and all members of the MuEuroller lab are gratefully acknowledged. We also thank Ute Bank and Thomas SchuEuroler for reagentsand Jan Dudeck, Roland Hartig, Guido Hobbel, the MPBIC platform, and ZTL of the Medical Faculty OvGU for excellent technical support. This work was supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (StG ImmProDynamics, grant agreement 714233 to A.J.M.) , the German Research Foundation (DFG) (SFB854-Z01, SFB854-B31, MU 3744/2-1, MU3744/4-1, and SPP2225 [MU3744/5-1] to A.J.M. and KA 4514/2-1 to S. Kahlfu ss) , and the federal state of Saxony-Anhalt and the European Regional Development Fund (project NeutrEat to A.J.M.) .	Abidin BM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006422; Antoine JC, 1998, TRENDS MICROBIOL, V6, P392, DOI 10.1016/S0966-842X(98)01324-9; Beisiegel M, 2009, J INFECT DIS, V199, P1222, DOI 10.1086/597421; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Binder SC, 2015, COMPUT PHYS COMMUN, V190, P15, DOI 10.1016/j.cpc.2015.01.001; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Bonneville M, 2007, J INVEST DERMATOL, V127, P1430, DOI 10.1038/sj.jid.5700726; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Carneiro MB, 2020, CELL HOST MICROBE, V27, P752, DOI 10.1016/j.chom.2020.03.011; Chandrasekar B, 2013, J INFECT DIS, V207, P1556, DOI 10.1093/infdis/jit067; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Fromm PD, 2012, J IMMUNOL, V188, P6258, DOI 10.4049/jimmunol.1100977; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; HANDMAN E, 1983, MOL BIOCHEM PARASIT, V7, P111, DOI 10.1016/0166-6851(83)90039-7; Hasenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017314; Heyde S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007374; Hopkins N, 2006, J PATHOL, V209, P198, DOI 10.1002/path.1963; Hurrell BP, 2017, J LEUKOCYTE BIOL, V102, P1187, DOI [10.1189/jlb.4hi0417-158r, 10.1189/jlb.4HI0417-158R]; Janssen JJE, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81217-4; Jara M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55486-z; Johnson DE, 2009, J BIOL CHEM, V284, P20499, DOI 10.1074/jbc.M109.019042; Kerr A, 2009, BRIT J DERMATOL, V161, P202, DOI 10.1111/j.1365-2133.2009.09201.x; Kloehn J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004683; Kobayashi Y, 2010, J LEUKOCYTE BIOL, V88, P1157, DOI 10.1189/jlb.0310149; Lacey CA, 2019, J LEUKOCYTE BIOL, V106, P27, DOI 10.1002/JLB.4MIA1018-409R; Lemesre JL, 1997, EXP PARASITOL, V86, P58, DOI 10.1006/expr.1997.4151; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; LIEW FY, 1990, J IMMUNOL, V144, P4794; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mandell MA, 2017, P NATL ACAD SCI USA, V114, pE801, DOI 10.1073/pnas.1619265114; Minodier P, 2003, FUND CLIN PHARMACOL, V17, P183, DOI 10.1046/j.1472-8206.2003.00168.x; Mishra BB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.72; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Moreau HD, 2012, IMMUNITY, V37, P351, DOI 10.1016/j.immuni.2012.05.014; Muller AJ, 2013, CELL HOST MICROBE, V14, P460, DOI 10.1016/j.chom.2013.09.008; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; Norman MU, 2008, EUR J IMMUNOL, V38, P1368, DOI 10.1002/eji.200737847; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Okwor I, 2008, IMMUNOL RES, V41, P123, DOI 10.1007/s12026-008-8016-2; Olekhnovitch R, 2014, J CLIN INVEST, V124, P1711, DOI 10.1172/JCI72058; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Postat J, 2018, IMMUNITY, V49, P654, DOI 10.1016/j.immuni.2018.07.014; RAB MA, 1992, T ROY SOC TROP MED H, V86, P620, DOI 10.1016/0035-9203(92)90152-3; Robert P.A., 2018, MOONFIT MINIMAL INTE, DOI [10.1101/281188, DOI 10.1101/281188]; Rocha FJS, 2007, INFECT IMMUN, V75, P3823, DOI 10.1128/IAI.01335-06; Romano A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006479; Runarsson T, 2003, INT SER OPER RES MAN, V48, P87; Scorza BM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061296; Scott P, 2016, NAT REV IMMUNOL, V16, P581, DOI 10.1038/nri.2016.72; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Solomon M, 2011, J EUR ACAD DERMATOL, V25, P973, DOI 10.1111/j.1468-3083.2010.03908.x; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Terrazas C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14935-3; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Walker DM, 2014, CELL MOL LIFE SCI, V71, P1245, DOI 10.1007/s00018-013-1491-1; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; Zhao G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01627-9	69	4	4	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2724	+		10.1016/j.immuni.2021.09.021	http://dx.doi.org/10.1016/j.immuni.2021.09.021		DEC 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34687607	hybrid, Green Published			2022-12-18	WOS:000731645300012
J	Roy, R; Ramamoorthy, S; Shapiro, BD; Kaileh, M; Hernandez, D; Sarantopoulou, D; Arepalli, S; Boller, S; Singh, A; Bektas, A; Kim, J; Moore, AZ; Tanaka, T; McKelvey, J; Zukley, L; Nguyen, C; Wallace, T; Dunn, C; Wersto, R; Wood, W; Piao, Y; Becker, KG; Coletta, C; De, S; Sen, JM; Battle, A; Weng, NP; Grosschedl, R; Ferrucci, L; Sen, RJ				Roy, Roshni; Ramamoorthy, Senthilkumar; Shapiro, Benjamin D.; Kaileh, Mary; Hernandez, Dena; Sarantopoulou, Dimitra; Arepalli, Sampath; Boller, Soeren; Singh, Amit; Bektas, Arsun; Kim, Jaekwan; Moore, Ann Zenobia; Tanaka, Toshiko; McKelvey, Julia; Zukley, Linda; Cuong Nguyen; Wallace, Tonya; Dunn, Christopher; Wersto, Robert; Wood, William; Piao, Yulan; Becker, Kevin G.; Coletta, Christopher; De, Supriyo; Sen, Jyoti Misra; Battle, Alexis; Weng, Nan-ping; Grosschedl, Rudolf; Ferrucci, Luigi; Sen, Ranjan			DNA methylation signatures reveal that distinct combinations of transcription factors specify human immune cell epigenetic identity	IMMUNITY			English	Article							INNATE; LANDSCAPE; PACKAGE; LINEAGE; MATURATION; PATHWAY	Epigenetic reprogramming underlies specification of immune cell lineages, but patterns that uniquely define immune cell types and the mechanisms by which they are established remain unclear. Here, we identified lineage-specific DNA methylation signatures of six immune cell types from human peripheral blood and determined their relationship to other epigenetic and transcriptomic patterns. Sites of lineage-specific hypomethylation were associated with distinct combinations of transcription factors in each cell type. By contrast, sites of lineage-specific hypermethylation were restricted mostly to adaptive immune cells. PU.1 binding sites were associated with lineage-specific hypoand hypermethylation in different cell types, suggesting that it regulates DNA methylation in a context-dependent manner. These observations indicate that innate and adaptive immune lineages are specified by distinct epigenetic mechanisms via combinatorial and context-dependent use of key transcription factors. The cell-specific epigenomics and transcriptional patterns identified serve as a foundation for future studies on immune dysregulation in diseases and aging.	[Roy, Roshni; Kaileh, Mary; Sarantopoulou, Dimitra; Singh, Amit; Kim, Jaekwan; Weng, Nan-ping; Sen, Ranjan] NIA, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA; [Ramamoorthy, Senthilkumar; Boller, Soeren; Grosschedl, Rudolf] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Shapiro, Benjamin D.; Battle, Alexis] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Shapiro, Benjamin D.; Battle, Alexis] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Hernandez, Dena; Arepalli, Sampath] Natl Inst Aging, Lab Neurogenet, Baltimore, MD USA; [Bektas, Arsun; Moore, Ann Zenobia; Tanaka, Toshiko; Ferrucci, Luigi] NIA, Translat Gerontol Branch, Baltimore, MD USA; [McKelvey, Julia; Zukley, Linda] NIA, Clin Res Core, Baltimore, MD USA; [Cuong Nguyen; Wallace, Tonya; Dunn, Christopher; Wersto, Robert] NIA, Flow Cytometry Unit, Baltimore, MD USA; [Wood, William; Piao, Yulan; Becker, Kevin G.; Coletta, Christopher; De, Supriyo] NIA, Lab Genet & Genom, Baltimore, MD USA; [Sen, Jyoti Misra] NIA, Lab Clin Invest, Baltimore, MD USA; [Ramamoorthy, Senthilkumar] Univ Freiburg, Med Ctr, Inst Med Bioinformat & Syst Med, Div Pediat Hematol & Oncol, Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Max Planck Society; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Freiburg	Sen, RJ (corresponding author), NIA, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA.	senranja@grc.nia.nih.gov	Ramamoorthy, Senthilkumar/E-9325-2017	Ramamoorthy, Senthilkumar/0000-0003-3468-4247; Singh, Amit/0000-0001-9782-306X; Sarantopoulou, Dimitra/0000-0002-1972-8865; Dunn, Christopher/0000-0001-7899-0110	Intramural Research Program of the National Institute on Aging; Max Planck Society	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Intramural Research Program of the National Institute on Aging and funds from the Max Planck Society (S.R., S.B., and R.G.) . We are grateful to the Genetic and Epigenetic Signatures of Transla-tional Aging Laboratory Testing (GESTALT) participants and the GESTALT Study Team at Harbor Hospital and NIA. We thank Drs. Anjana Rao and Yehu-dit Bergman for their valuable comments and feedback on the paper.	Andrews S., 2010, FASTQC QUALITY CONTR; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barndt R, 1999, J IMMUNOL, V163, P3331; Benner C, 2015, P NATL ACAD SCI USA, V112, P12776, DOI 10.1073/pnas.1512995112; Bestor TH, 2015, P NATL ACAD SCI USA, V112, P6796, DOI 10.1073/pnas.1415301111; Bonin M., 2014, ANN RHEUM DIS, V73, pA84; Brillantes M, 2019, IMMUNOLOGY, V156, P111, DOI 10.1111/imm.13017; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Farlik M, 2016, CELL STEM CELL, V19, P808, DOI 10.1016/j.stem.2016.10.019; Fortin JP, 2017, BIOINFORMATICS, V33, P558, DOI 10.1093/bioinformatics/btw691; Geiger TL, 2016, CURR OPIN IMMUNOL, V39, P82, DOI 10.1016/j.coi.2016.01.007; Ginno PA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16354-x; Hachiya T, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0016-5; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hosokawa H, 2021, NAT REV IMMUNOL, V21, P162, DOI 10.1038/s41577-020-00426-6; Izzo F, 2020, NAT GENET, V52, P378, DOI 10.1038/s41588-020-0595-4; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Kurioka A, 2018, IMMUNOLOGY, V154, P547, DOI 10.1111/imm.12925; Li R, 2018, GENE DEV, V32, P96, DOI 10.1101/gad.309583.117; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Lio CWJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00210; Liu J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2819-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Mallona I, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-11; Mayran A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11791-9; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Orlanski S, 2016, P NATL ACAD SCI USA, V113, P5018, DOI 10.1073/pnas.1604365113; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Tejedor JR, 2018, EPIGENOMICS-UK, V10, P903, DOI 10.2217/epi-2017-0163; Rolink AG, 2006, IMMUNOL LETT, V107, P50, DOI 10.1016/j.imlet.2006.07.005; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Schuyler RP, 2016, CELL REP, V17, P2101, DOI 10.1016/j.celrep.2016.10.054; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Ubaida-Mohien C, 2019, ELIFE, V8, DOI 10.7554/eLife.49874; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhong C, 2017, PROTEIN CELL, V8, P242, DOI 10.1007/s13238-017-0369-7; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	55	4	4	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2465	+		10.1016/j.immuni.2021.10.001	http://dx.doi.org/10.1016/j.immuni.2021.10.001		NOV 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34706222	Bronze, Green Accepted			2022-12-18	WOS:000718366000007
J	Velegraki, M; Salem, M; Ansa-Addo, EA; Wu, BX; Li, ZH				Velegraki, Maria; Salem, Mohammad; Ansa-Addo, Ephraim A.; Wu, Bill X.; Li, Zihai			Autocrine transforming growth factor beta 1 in regulatory T cell biology-gone but not missed	IMMUNITY			English	Letter							RECOMBINATION; GENERATION; SITES		[Velegraki, Maria; Ansa-Addo, Ephraim A.; Wu, Bill X.; Li, Zihai] Ohio State Univ, Ctr Comprehens Canc, Pelotonia Inst Immunooncol, Columbus, OH 43210 USA; [Salem, Mohammad] Med Univ South Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Medical University of South Carolina	Velegraki, M; Li, ZH (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Pelotonia Inst Immunooncol, Columbus, OH 43210 USA.	maria.velegraki@osumc.edu; zihai.li@osumc.edu	Velegraki, Maria/HDZ-6889-2022		NIH [R01AI077283, R01CA213290]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by NIH grants to Z.L. (R01AI077283 and R01CA213290). We would like to thank Dr. Bruce Beutler for his insightful comments and helpful discussion.	Azhar M, 2009, GENESIS, V47, P423, DOI 10.1002/dvg.20516; Gregoire D, 2008, P NATL ACAD SCI USA, V105, P14492, DOI 10.1073/pnas.0807484105; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Titen SWA, 2020, GENETICS, V215, P923, DOI 10.1534/genetics.120.303394; Turner JA, 2020, IMMUNITY, V53, P1202, DOI [10.1016/j.immuni.2020.10.002, 10.1016/j.immuni.2020.11.011]; Zhu Y, 2010, J BIOL CHEM, V285, P26005, DOI 10.1074/jbc.M110.139196	6	4	4	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					395	396		10.1016/j.immuni.2021.02.007	http://dx.doi.org/10.1016/j.immuni.2021.02.007		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691126	Bronze			2022-12-18	WOS:000627409300004
J	Ishak, CA; Yau, HL; De Carvalho, DD				Ishak, Charles A.; Yau, Helen Loo; De Carvalho, Daniel D.			Spliceosome-Targeted Therapies Induce dsRNA Responses	IMMUNITY			English	Editorial Material								In a recent issue of Cell, Bowling et al. describe a mechanism by which spliceosome-targeted therapies result in intron-containing transcripts that form double-stranded RNAs (dsRNAs), thereby activating tumor antiviral signaling (viral mimicry) and downstream adaptive immunity.	[Ishak, Charles A.; Yau, Helen Loo; De Carvalho, Daniel D.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Yau, Helen Loo; De Carvalho, Daniel D.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	De Carvalho, DD (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; De Carvalho, DD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.	ddecarv@uhnresearch.ca						Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; Bowling EA, 2021, CELL, V184, P384, DOI 10.1016/j.cell.2020.12.031; Canadas I, 2018, NAT MED, V24, P1143, DOI 10.1038/s41591-018-0116-5; Deblois G, 2020, CANCER DISCOV, V10, P1312, DOI 10.1158/2159-8290.CD-19-1493; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Goodall GJ, 2021, NAT REV CANCER, V21, P22, DOI 10.1038/s41568-020-00306-0; Guler GD, 2017, CANCER CELL, V32, P221, DOI 10.1016/j.ccell.2017.07.002; Ishak CA, 2018, TRENDS CANCER, V4, P583, DOI 10.1016/j.trecan.2018.05.008; Mehdipour P, 2020, NATURE, V588, P169, DOI 10.1038/s41586-020-2844-1; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056	10	4	4	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					11	13		10.1016/j.immuni.2020.12.012	http://dx.doi.org/10.1016/j.immuni.2020.12.012		JAN 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33440135	Bronze			2022-12-18	WOS:000607814000005
J	Zigmond, E; Varol, C				Zigmond, Ehud; Varol, Chen			Two Roads Diverge in the Sick Liver, Monocytes Travel Both	IMMUNITY			English	Editorial Material							MACROPHAGES	Liver macrophages play critical roles in the pathogenesis of non-alcoholic steatohepatitis (NASH). In this issue of Immunity, Tran et al. and Remmerie et al. reveal that Ly6C(hi) monocytes in NASH replace dying resident Kupffer cells, while concomitantly are differentiating into distinct lipid associated macrophages.	[Zigmond, Ehud; Varol, Chen] Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-64239 Tel Aviv, Israel; [Zigmond, Ehud; Varol, Chen] Tel Aviv Univ, Sackler Sch Med, IL-64239 Tel Aviv, Israel; [Varol, Chen] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Varol, C (corresponding author), Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-64239 Tel Aviv, Israel.; Varol, C (corresponding author), Tel Aviv Univ, Sackler Sch Med, IL-64239 Tel Aviv, Israel.; Varol, C (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	chenv@tlvmc.gov.il	Varol, Chen/AAW-4202-2021; Varol, Chen/ABH-6487-2020					Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Krenkel O, 2018, HEPATOLOGY, V67, P1270, DOI 10.1002/hep.29544; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Morgantini C, 2019, NAT METAB, V1, P445, DOI 10.1038/s42255-019-0044-9; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Ratziu V, 2020, HEPATOLOGY, V72, P892, DOI 10.1002/hep.31108; Remmerie A, 2020, IMMUNITY, V53, P641, DOI 10.1016/j.immuni.2020.08.004; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Seidman JS, 2020, IMMUNITY, V52, P1057, DOI 10.1016/j.immuni.2020.04.001; Tran S, 2020, IMMUNITY, V53, P627, DOI 10.1016/j.immuni.2020.06.003	11	4	4	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					479	481		10.1016/j.immuni.2020.08.006	http://dx.doi.org/10.1016/j.immuni.2020.08.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32937148	Bronze			2022-12-18	WOS:000569806100004
J	Vande Walle, L; Lamkanfi, M				Vande Walle, Lieselotte; Lamkanfi, Mohamed			Snapshot of a Deadly Embrace: The Caspase-1-GSDMD Interface	IMMUNITY			English	Editorial Material								Proteolytic maturation of the pore-forming protein gasdermin D (GSDMD) by inflammasome-activated caspase-1 is crucial for initiating pyroptosis, a lytic form of cell death. In this issue of Immunity, Lui et al. report the X-ray structure of the caspase-1-GSDMD complex, mapping the interaction interfaces that determine recognition and cleavage of GSDMD by inflammatory caspases.	[Vande Walle, Lieselotte; Lamkanfi, Mohamed] Univ Ghent, Dept Internal Med & Pediat, Lab Med Innate Immun, B-9000 Ghent, Belgium	Ghent University	Lamkanfi, M (corresponding author), Univ Ghent, Dept Internal Med & Pediat, Lab Med Innate Immun, B-9000 Ghent, Belgium.	mohamed.lamkanfi@ugent.be						[Anonymous], TITLE ERROR, DOI 10.1016/j.bbi.2019.12.019; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Ramirez MLG, 2018, J BIOL CHEM, V293, P7058, DOI 10.1074/jbc.RA117.001329; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Van Opdenbosch N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4209; Wang K, 2020, CELL, V180, P941, DOI 10.1016/j.cell.2020.02.002	10	4	5	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					6	8		10.1016/j.immuni.2020.06.019	http://dx.doi.org/10.1016/j.immuni.2020.06.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668229	Bronze			2022-12-18	WOS:000551116800002
J	Barnett, KC; Ting, JPY				Barnett, Katherine C.; Ting, Jenny P. -Y.			Mitochondrial GSDMD Pores DAMPen Pyroptosis	IMMUNITY			English	Editorial Material							UPSTREAM	Noncanoncial inflammasome activation by cytosolic lipopolysaccharide (LPS) causes pyroptotic cell death facilitated by gasdermin D (GSDMD) pore formation. In this issue of Immunity, Huang et al. describe how cytosolic LPS in endothelial cells does not cause cell death but restrains endothelial cell proliferation.	[Barnett, Katherine C.; Ting, Jenny P. -Y.] Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	jenny_ting@med.unc.edu			NCI NIH HHS [T32 CA009156, T32 CA071341] Funding Source: Medline; NIAID NIH HHS [R01 AI029564] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banerjee I, 2018, IMMUNITY, V49, P413, DOI 10.1016/j.immuni.2018.07.006; Barnett KC, 2020, INNATE IMMUN-LONDON, V26, P4, DOI 10.1177/1753425919852695; Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Huang LS, 2020, IMMUNITY, V52, P475, DOI 10.1016/j.immuni.2020.02.002; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Platnich JM, 2018, CELL REP, V25, P1525, DOI 10.1016/j.celrep.2018.09.071; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Swanson KV, 2017, J EXP MED, V214, P3611, DOI 10.1084/jem.20171749; Zanconato F, 2019, NAT REV CANCER, V19, P454, DOI 10.1038/s41568-019-0168-y	10	4	5	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					424	426		10.1016/j.immuni.2020.02.012	http://dx.doi.org/10.1016/j.immuni.2020.02.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187511	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000520600200003
J	Li, CF; Zhu, BB; Son, YM; Wang, Z; Jiang, L; Xiang, M; Ye, ZQ; Beckermann, KE; Wu, Y; Jenkins, JW; Siska, PJ; Vincent, BG; Prakash, YS; Peikert, T; Edelson, BT; Taneja, R; Kaplan, MH; Rathmell, JC; Dong, HD; Hitosugi, T; Sun, J				Li, Chaofan; Zhu, Bibo; Son, Young Min; Wang, Zheng; Jiang, Li; Xiang, Min; Ye, Zhenqing; Beckermann, Kathryn E.; Wu, Yue; Jenkins, James W.; Siska, Peter J.; Vincent, Benjamin G.; Prakash, Y. S.; Peikert, Tobias; Edelson, Brian T.; Taneja, Reshma; Kaplan, Mark H.; Rathmell, Jeffrey C.; Dong, Haidong; Hitosugi, Taro; Sun, Jie			The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8(+) T Cell Fitness and Functionality (vol 51, pg 491.e1, 2019)	IMMUNITY			English	Correction												sun.jie@mayo.edu	Ye, Zhenqing/ABF-1433-2020		NCI NIH HHS [R01 CA217987] Funding Source: Medline; NHLBI NIH HHS [R01 HL126647, R01 HL136664] Funding Source: Medline; NIAID NIH HHS [R01 AI057459, R01 AI112844] Funding Source: Medline; NIA NIH HHS [R01 AG047156] Funding Source: Medline; NIDDK NIH HHS [R01 DK105550] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Li CF, 2019, IMMUNITY, V51, P491, DOI 10.1016/j.immuni.2019.08.013	1	4	4	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					201	202		10.1016/j.immuni.2019.12.008	http://dx.doi.org/10.1016/j.immuni.2019.12.008			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31940270	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000507384600019
J	Varanasi, SK; Ma, SX; Kaech, SM				Varanasi, Siva Karthik; Ma, Shixin; Kaech, Susan M.			T Cell Metabolism in a State of Flux	IMMUNITY			English	Editorial Material								Our knowledge of T cell metabolism relies primarily on studies performed in vitro that may not fully recapitulate physiological conditions in vivo. In this issue of Immunity, Ma et al. find that the in vivo environment dictates the metabolic phenotype of effector CD8+ T cells-particularly their glucose utilization.	[Varanasi, Siva Karthik; Ma, Shixin; Kaech, Susan M.] Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Kaech, SM (corresponding author), Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	skaech@salk.edu						Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Chapman N. M., 2019, NAT REV IMMUNOL, V20, P55, DOI DOI 10.1038/S41577-019-0203-Y; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519	8	4	4	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					783	+		10.1016/j.immuni.2019.10.012	http://dx.doi.org/10.1016/j.immuni.2019.10.012			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31747577	Bronze			2022-12-18	WOS:000497811300002
J	Acharya, N; Anderson, AC				Acharya, Nandini; Anderson, Ana C.			New Clones on the Block	IMMUNITY			English	Editorial Material								Although immune checkpoint blockade (ICB) has yielded striking clinical responses in subsets of cancer patients, the mechanism of action is still unclear. In a recent issue of Nature Medicine, Yost et al., 2019 report that the T cell clones that dominate the intra-tumoral T cell landscape after ICB are distinct from those prior to treatment, a phenomenon referred to by the authors as "clonal replacement.''	[Acharya, Nandini; Anderson, Ana C.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Acharya, Nandini; Anderson, Ana C.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Acharya, Nandini; Anderson, Ana C.] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Anderson, AC (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Anderson, AC (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Anderson, AC (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.	acanderson@bwh.harvard.edu	Anderson, Ana C/ABD-6829-2021	Anderson, Ana C/0000-0002-0877-2932	National Institutes of Health [P01AI073748, R01CA229400, R01CA187975]; NATIONAL CANCER INSTITUTE [R01CA229400, R01CA187975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in the authors' laboratory is supported by grants from the National Institutes of Health (P01AI073748, R01CA229400, R01CA187975).	Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Garris CS, 2018, IMMUNITY, V49, P1148, DOI 10.1016/j.immuni.2018.09.024; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3	10	4	4	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					606	608		10.1016/j.immuni.2019.09.018	http://dx.doi.org/10.1016/j.immuni.2019.09.018			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31618653	Bronze			2022-12-18	WOS:000490141700008
J	Casazza, RL; Lazear, HM				Casazza, Rebecca L.; Lazear, Helen M.			Why Is IFN-lambda Less Inflammatory? One IRF Decides	IMMUNITY			English	Editorial Material								Type I and type III interferons (IFNs) activate similar antiviral transcriptional programs, but the type I IFN response is more inflammatory. In this issue of Immunity, Forero et al. find that selective induction of the transcription factor IRF1 promotes proinflammatory chemokine expression downstream of type I IFN signaling.	[Casazza, Rebecca L.; Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lazear, HM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	helen.lazear@med.unc.edu		Casazza, Rebecca/0000-0002-8271-6947				Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821; Espinosa V, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5357; Forero A, 2019, IMMUNITY, V51, P451, DOI 10.1016/j.immuni.2019.07.007; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Hemann EA, 2019, NAT IMMUNOL, V20, P1035, DOI 10.1038/s41590-019-0408-z; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Yamane D, 2019, NAT MICROBIOL, V4, P1096, DOI 10.1038/s41564-019-0425-6; Ye L., 2019, NAT REV IMMUNOL	10	4	4	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					415	417		10.1016/j.immuni.2019.08.019	http://dx.doi.org/10.1016/j.immuni.2019.08.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31533051	Bronze, Green Published			2022-12-18	WOS:000486184600002
J	Greving, CNA; Towne, JE				Greving, Carrie N. Arnold; Towne, Jennifer E.			A Role for IL-12 in IBD after All?	IMMUNITY			English	Editorial Material							INTERLEUKIN-23; INNATE; IL-23	The interplay between intestinal epithelial barrier function, the intestinal microbiota, and cytokine signaling in the pathogenesis of inflammatory bowel disease is not completely understood. In this issue of Immunity, Eftychi et al. examined the cell types and cytokines that drive colitis in mice with an intestinal epithelial barrier defect and uncovered a surprising role for IL-12 in initiation of disease.	[Greving, Carrie N. Arnold; Towne, Jennifer E.] Janssen Res & Dev, Immunol Discovery, 3210 Merryfield Row, San Diego, CA 92121 USA		Towne, JE (corresponding author), Janssen Res & Dev, Immunol Discovery, 3210 Merryfield Row, San Diego, CA 92121 USA.	jtowne1@its.jnj.com						Feagan BG, 2017, LANCET, V389, P1699, DOI 10.1016/S0140-6736(17)30570-6; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Imamura E, 2018, EUR J PHARMACOL, V824, P163, DOI 10.1016/j.ejphar.2018.01.045; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Vlantis K, 2016, IMMUNITY, V44, P553, DOI 10.1016/j.immuni.2016.02.020	8	4	4	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					209	211		10.1016/j.immuni.2019.07.008	http://dx.doi.org/10.1016/j.immuni.2019.07.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31433967	Bronze			2022-12-18	WOS:000482088500005
J	Kennedy, R; Klein, U				Kennedy, Ruth; Klein, Ulf			A T Cell-B Cell Tumor-Suppressive Axis in the Germinal Center	IMMUNITY			English	Editorial Material							FOLLICULAR LYMPHOMA; PATHOGENESIS	TNFRSF14, encoding the receptor HVEM, is frequently mutated in germinal center (GC)-derived B cell lymphomas. In this issue, Mintz et al. demonstrate that the HVEM-BTLA axis restrains T cell help to GC B cells. Mutation-associated loss of this interaction promotes B cell proliferation through exaggerated T cell help, explaining how HVEM loss contributes to GC lymphomagenesis and revealing a cell-extrinsic tumor-suppressor role for BTLA.	[Kennedy, Ruth; Klein, Ulf] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Med Res, Div Haematol & Immunol, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Klein, U (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Med Res, Div Haematol & Immunol, Leeds LS9 7TF, W Yorkshire, England.	u.p.klein@leeds.ac.uk						Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Boice M, 2016, CELL, V167, P405, DOI 10.1016/j.cell.2016.08.032; Cheung KJJ, 2010, CANCER RES, V70, P9166, DOI 10.1158/0008-5472.CAN-10-2460; Dustin M. L., 2007, CURR PROTOC IMMUNOL, V13; Launay E, 2012, LEUKEMIA, V26, P559, DOI 10.1038/leu.2011.266; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Mintz MA, 2019, IMMUNITY, V51, P310, DOI 10.1016/j.immuni.2019.05.022; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380	10	4	4	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					204	206		10.1016/j.immuni.2019.07.006	http://dx.doi.org/10.1016/j.immuni.2019.07.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31433965	Bronze			2022-12-18	WOS:000482088500003
J	Dorman, LC; Molofsky, AV				Dorman, Leah C.; Molofsky, Anna V.			Demystifying Microglia: And Now the Work Begins	IMMUNITY			English	Editorial Material								Microglia actively shape the developing brain, but their transcriptional diversity is not well understood. Complementary studies by Hammond et al. (2018) and Li et al. (2019) characterize the microglial transcriptome at single cell resolution, highlighting their diversity during development, aging, and pathology.	[Dorman, Leah C.; Molofsky, Anna V.] Univ Calif San Francisco, Dept Psychiat, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA; [Dorman, Leah C.; Molofsky, Anna V.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Molofsky, AV (corresponding author), Univ Calif San Francisco, Dept Psychiat, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA.; Molofsky, AV (corresponding author), Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA.	anna.molofsky@ucsf.edu		Dorman, Leah/0000-0002-5511-887X				Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615	10	4	4	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					11	13		10.1016/j.immuni.2018.12.025	http://dx.doi.org/10.1016/j.immuni.2018.12.025			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650371	Bronze			2022-12-18	WOS:000455661600005
J	Ford, ML				Ford, Mandy L.			Coronin-1, King of Alloimmunity	IMMUNITY			English	Editorial Material							CD40 EXPRESSION; CUTTING EDGE; MEMORY	Defining pathways that differentially regulate graft-reactive versus anti-microbial T cell responses could facilitate more precise manipulation of immune responses in the context of organ and tissue transplantation. Here, Jayachandran et al. (2019) identify a coronin-1-PDE4-cAMP axis that, when perturbed, results in the induction of transplantation tolerance while maintaining anti-microbial immunity.	[Ford, Mandy L.] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Ford, Mandy L.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA	Emory University; Emory University	Ford, ML (corresponding author), Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA.; Ford, ML (corresponding author), Emory Univ, Dept Surg, Atlanta, GA 30322 USA.	mandy.ford@emory.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104699, R01AI073707] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI104699, R01 AI073707] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Ferrer IR, 2010, J IMMUNOL, V185, P2004, DOI 10.4049/jimmunol.1001176; Ford ML, 2014, NAT REV NEPHROL, V10, P14, DOI 10.1038/nrneph.2013.183; Jayachandran R, 2019, IMMUNITY, V50, P152, DOI 10.1016/j.immuni.2018.12.011; Lam AJ, 2017, TRANSPLANTATION, V101, P2277, DOI 10.1097/TP.0000000000001757; Moshous D, 2013, J ALLERGY CLIN IMMUN, V131, P1594, DOI 10.1016/j.jaci.2013.01.042; Scott PH, 1998, J BIOL CHEM, V273, P34496, DOI 10.1074/jbc.273.51.34496; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385	9	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					3	5		10.1016/j.immuni.2018.12.030	http://dx.doi.org/10.1016/j.immuni.2018.12.030			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650379	Bronze			2022-12-18	WOS:000455661600002
J	Qiu, Y; Xu, YP; Zhang, Y; Zhou, H; Deng, YQ; Li, XF; Miao, M; Zhang, Q; Zhong, B; Hu, YY; Zhang, FC; Wu, LG; Qin, CF; Zhou, X				Qiu, Yang; Xu, Yanpeng; Zhang, Yao; Zhou, Hui; Deng, Yong-Qiang; Li, Xiao-Feng; Miao, Meng; Zhang, Qiang; Zhong, Bo; Hu, Yuanyang; Zhang, Fu-Chun; Wu, Ligang; Qin, Cheng-Feng; Zhou, Xi			Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals (vol 46, pg 992, 2017)	IMMUNITY			English	Correction												qincf@bmi.ac.cn; zhouxi@wh.iov.cn	li, xiao/GSN-6181-2022; Qin, Cheng-Feng/I-6839-2019; li, xiaofeng/GXF-9442-2022	Qin, Cheng-Feng/0000-0002-0632-2807; 				Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006	1	4	4	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					780	781		10.1016/j.immuni.2018.10.003	http://dx.doi.org/10.1016/j.immuni.2018.10.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332633	hybrid, Green Published			2022-12-18	WOS:000447386700021
J	Randolph, HE; Barreiro, LB				Randolph, Haley E.; Barreiro, Luis B.			Holy Immune Tolerance, Batman!	IMMUNITY			English	Editorial Material							BATS; VIRUSES; CELLS	Bats are reservoir hosts of numerous viruses that cause severe pathology in humans. How bats cope with such pathogens remains elusive. In a recent issue of Cell, Pavlovich et al. (2018) describe several key adaptations in innate immune-related genes that suggest that the Egyptian rousette fruit bat relies on immune tolerance mechanisms to manage viral infections.	[Randolph, Haley E.] Univ Montreal, Dept Biochem, Fac Med, Montreal, PQ H3T 1J4, Canada; [Randolph, Haley E.; Barreiro, Luis B.] CHU St Justine Res Ctr, Dept Genet, Montreal, PQ H3T 1C5, Canada; [Barreiro, Luis B.] Univ Montreal, Dept Pediat, Fac Med, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Barreiro, LB (corresponding author), CHU St Justine Res Ctr, Dept Genet, Montreal, PQ H3T 1C5, Canada.; Barreiro, LB (corresponding author), Univ Montreal, Dept Pediat, Fac Med, Montreal, PQ H3T 1C5, Canada.	luis.barreiro@umontreal.ca	Barreiro, Luis/I-7772-2015	Barreiro, Luis/0000-0001-9456-367X; Randolph, Haley/0000-0003-2044-1180				Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Jones MEB, 2015, VIRUSES-BASEL, V7, P3420, DOI 10.3390/v7072779; Kikuchi-Maki A, 2005, J IMMUNOL, V174, P3859, DOI 10.4049/jimmunol.174.7.3859; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Pavlovich SS, 2018, CELL, V173, P1098, DOI 10.1016/j.cell.2018.03.070; Rapaport AS, 2015, IMMUNITY, V43, P1112, DOI 10.1016/j.immuni.2015.11.005; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Totura AL, 2012, CURR OPIN VIROL, V2, P264, DOI 10.1016/j.coviro.2012.04.004; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhou P, 2016, P NATL ACAD SCI USA, V113, P2696, DOI 10.1073/pnas.1518240113	10	4	5	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1074	1076		10.1016/j.immuni.2018.05.016	http://dx.doi.org/10.1016/j.immuni.2018.05.016			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924972	Green Published, Bronze			2022-12-18	WOS:000436456900007
J	Guerrini, MM; Vogelzang, A; Fagarasan, S				Guerrini, Matteo M.; Vogelzang, Alexis; Fagarasan, Sidonia			A Hen in the Wolf Den: A Pathobiont Tale	IMMUNITY			English	Editorial Material							MICROBIOTA; HUMANS; MICE	Disruption of the gut microbiota is thought to contribute to disease onset in individuals with a genetic predisposition to autoimmunity. In a recent issue of Science, Manfredo Vieira et al. (2018) identify translocation of the gut commensal Enterococcus gallinarum into the liver as a trigger for the autoimmune disease systemic lupus erythematous.	[Guerrini, Matteo M.; Vogelzang, Alexis; Fagarasan, Sidonia] RIKEN Yokohama Inst, Ctr Integrat Med Sci, Lab Mucosal Immun, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	RIKEN	Fagarasan, S (corresponding author), RIKEN Yokohama Inst, Ctr Integrat Med Sci, Lab Mucosal Immun, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	sidonia.fagarasan@riken.jp	Fagarasan, Sidonia/A-5258-2016	Fagarasan, Sidonia/0000-0003-2086-6402; Vogelzang, Alexis/0000-0002-2921-1755	RIKEN Special Postdoctoral Researcher program (SPDR)	RIKEN Special Postdoctoral Researcher program (SPDR)	We thank N. Minato for comments. Supported by RIKEN Special Postdoctoral Researcher program (SPDR) (A.V.) and intramural grant (S.F. and M.M.G).	Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Chervonsky A. V., 2013, COLD SPRING HARB PER, V5; Lebreton F., 2014, ENTEROCOCCI COMMENSA; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Mu QH, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0300-8; Rojo D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08310; Theriot CM, 2015, ANNU REV MICROBIOL, V69, P445, DOI 10.1146/annurev-micro-091014-104115; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201; Zhang HS, 2014, APPL ENVIRON MICROB, V80, P7551, DOI 10.1128/AEM.02676-14	10	4	4	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					628	631		10.1016/j.immuni.2018.04.003	http://dx.doi.org/10.1016/j.immuni.2018.04.003			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669247	Bronze			2022-12-18	WOS:000430198900011
J	Meyer, MA; DeNardo, DG				Meyer, Melissa A.; DeNardo, David G.			Better Together: B7S1 Checkpoint Blockade Synergizes with anti-PD1	IMMUNITY			English	Editorial Material							B7-H4	T cell checkpoint blockades can produce durable clinical responses, but only some patients and cancer types respond. In this issue of Immunity, Li et al. (2018) show B7S1-B7S1R signaling additionally regulates CD8(+) T cell responses by working with the PD1-PDL1 checkpoint to block anti-tumor immunity.	[Meyer, Melissa A.; DeNardo, David G.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [DeNardo, David G.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [DeNardo, David G.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	DeNardo, DG (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; DeNardo, DG (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; DeNardo, DG (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA.	ddenardo@wustl.edu		Meyer, Melissa/0000-0003-3050-4819; DeNardo, David/0000-0002-3655-5783	NATIONAL CANCER INSTITUTE [R01CA203890, R01CA177670, P50CA196510] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA196510, R01 CA177670, R01 CA203890] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Li J, 2018, IMMUNITY, V48, P773, DOI 10.1016/j.immuni.2018.03.018; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Podojil JR, 2017, IMMUNOL REV, V276, P40, DOI 10.1111/imr.12530; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	10	4	5	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					621	623		10.1016/j.immuni.2018.03.029	http://dx.doi.org/10.1016/j.immuni.2018.03.029			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669244	Bronze			2022-12-18	WOS:000430198900008
J	Libby, P; Vrooman, A				Libby, Peter; Vrooman, Amelie			Swell, or Not Too Swell: Cytokines Regulate Arterial Aneurysm Formation	IMMUNITY			English	Editorial Material							SMOOTH-MUSCLE CELLS; INTERLEUKIN-1 GENE-EXPRESSION; MICE	Arterial remodeling participates pivotally in many diseases including arterial aneurysms. In this issue of Immunity, Da Ros et al. (2017) report that, in experimental aortic aneurysm formation, neutralization of inter-leukin-1 beta reduced arterial wall stiffness and hampered aneurysm development.	[Libby, Peter; Vrooman, Amelie] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Libby, P (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA.	plibby@bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X				Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; Da Ros F, 2017, IMMUNITY, V47, P959, DOI 10.1016/j.immuni.2017.10.016; LIBBY P, 1986, J CLIN INVEST, V78, P1432, DOI 10.1172/JCI112732; Libby P, 2017, CARDIOVASC RES, V113, P1279, DOI 10.1093/cvr/cvx140; MacFarlane EG, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022269; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rohde LEP, 1999, ARTERIOSCL THROM VAS, V19, P1695, DOI 10.1161/01.ATV.19.7.1695; WARNER SJC, 1987, J EXP MED, V165, P1316, DOI 10.1084/jem.165.5.1316	10	4	4	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					814	816		10.1016/j.immuni.2017.11.011	http://dx.doi.org/10.1016/j.immuni.2017.11.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166584	Bronze			2022-12-18	WOS:000416483700006
J	Li, A; Jacks, T				Li, Amy; Jacks, Tyler			Driving Rel-iant Tregs toward an Identity Crisis	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; ANTITUMOR IMMUNITY	Inhibiting Treg cell function in tumors is an attractive strategy to improve anti-cancer immunity. In a pair of papers in Immunity and Cell, Ghosh and colleagues show that the canonical NF-kappa B subunits p65 and c-Rel have non-redundant, critical roles in promoting Treg cell development and function (Oh et al., 2017). Targeting c-Rel blunts Treg cell immunosuppressive activity in the tumor microenvironment and enhances anti-tumor T cell responses (Grinberg-Bleyer et al., 2017).	[Li, Amy; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Li, Amy; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02142 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.; Jacks, T (corresponding author), MIT, Dept Biol, Cambridge, MA 02142 USA.; Jacks, T (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA.	tjacks@mit.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Grinberg-Bleyer Y, 2017, CELL, V170, P1096, DOI 10.1016/j.cell.2017.08.004; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Messina N, 2016, J AUTOIMMUN, V70, P52, DOI 10.1016/j.jaut.2016.03.017; Nakagawa H, 2016, P NATL ACAD SCI USA, V113, P6248, DOI 10.1073/pnas.1604765113; Oh H, 2017, IMMUNITY, V47, P450, DOI 10.1016/j.immuni.2017.08.010; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Shang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15179; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151	11	4	4	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					391	393		10.1016/j.immuni.2017.08.014	http://dx.doi.org/10.1016/j.immuni.2017.08.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930651	Bronze			2022-12-18	WOS:000411128200002
J	Friedrich, C; Gasteiger, G				Friedrich, Christin; Gasteiger, Georg			ILCs and T Cells Competing for Space: More Than a Numbers Game	IMMUNITY			English	Editorial Material							INTERLEUKIN-7 RECEPTOR; MECHANISM; SURVIVAL	T cell homeostasis critically depends on interleukin-7 (IL-7). In this issue of Immunity, Martin et al. (2017) provide evidence that IL-7 availability is regulated through a "cytokine sink'' involving innate lymphoid cells that compete for and consume IL-7 and thereby restrict T cell homeostasis in lymphoid organs.	[Friedrich, Christin; Gasteiger, Georg] Univ Freiburg, Freiburg Med Ctr, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Friedrich, Christin; Gasteiger, Georg] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Gasteiger, Georg] Univ Wurzburg, Inst Syst Immunol, D-97078 Wurzburg, Germany	University of Freiburg; Johannes Gutenberg University of Mainz; University of Wurzburg	Gasteiger, G (corresponding author), Univ Freiburg, Freiburg Med Ctr, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany.; Gasteiger, G (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany.; Gasteiger, G (corresponding author), Univ Wurzburg, Inst Syst Immunol, D-97078 Wurzburg, Germany.	georg.gasteiger@uni-wuerzburg.de		Gasteiger, Georg/0000-0001-6986-127X				Bank U, 2016, J IMMUNOL, V196, P3532, DOI 10.4049/jimmunol.1501643; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim Grace Yoonhee, 2011, Immune Netw, V11, P1, DOI 10.4110/in.2011.11.1.1; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Martin CE, 2017, IMMUNITY, V47, P171, DOI 10.1016/j.immuni.2017.07.005; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Oyler-Yaniv A, 2017, IMMUNITY, V46, P609, DOI 10.1016/j.immuni.2017.03.011; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551	11	4	5	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					8	10		10.1016/j.immuni.2017.07.003	http://dx.doi.org/10.1016/j.immuni.2017.07.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723555	Bronze			2022-12-18	WOS:000405712800004
J	Maelfait, J; Rehwinkel, J				Maelfait, Jonathan; Rehwinkel, Jan			RECONsidering Sensing of Cyclic Dinucleotides	IMMUNITY			English	Editorial Material							C-DI-AMP; I INTERFERON; PATHWAY; ACTIVATE		[Maelfait, Jonathan; Rehwinkel, Jan] Univ Oxford, Med Res Council Human Immunol Unit, Radcliffe Dept Med, Med Res Council Weatherall Inst Mol, Oxford OX3 9DS, England	University of Oxford	Rehwinkel, J (corresponding author), Univ Oxford, Med Res Council Human Immunol Unit, Radcliffe Dept Med, Med Res Council Weatherall Inst Mol, Oxford OX3 9DS, England.	jan.rehwinkel@imm.ox.ac.uk	Maelfait, Jonathan/AAE-7827-2021; Rehwinkel, Jan/CAG-1436-2022	Maelfait, Jonathan/0000-0002-1476-0583; Rehwinkel, Jan/0000-0003-3841-835X	MRC [MC_UU_12010/8, MC_UU_00008/8] Funding Source: UKRI; Medical Research Council [MC_UU_12010/8, MC_UU_00008/8] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Boxx GM, 2016, CELL HOST MICROBE, V19, P760, DOI 10.1016/j.chom.2016.05.016; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Crimmins GT, 2008, P NATL ACAD SCI USA, V105, P10191, DOI 10.1073/pnas.0804170105; Hansen K, 2014, EMBO J, V33, P1654, DOI 10.15252/embj.201488029; McFarland AP, 2017, IMMUNITY, V46, P433, DOI 10.1016/j.immuni.2017.02.014; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	10	4	4	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					337	339		10.1016/j.immuni.2017.03.005	http://dx.doi.org/10.1016/j.immuni.2017.03.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329697	Green Submitted, Bronze			2022-12-18	WOS:000396818100004
J	Kondo, M				Kondo, Motonari			One Niche to Rule Both Maintenance and Loss of Stemness in HSCs	IMMUNITY			English	Editorial Material							BONE-MARROW; CELLS; LYMPHOCYTE	Hemato-lymphopoiesis initiated by hematopoietic stem cells (HSCs) is tightly regulated by factors present in the bone marrow (BM) niche. Using genetically modified mice, Gomes et al. (2016) show that IL-7 is produced by HSC niche-forming cells and find that the same niche that controls HSC self-renewal can also support differentiation.	[Kondo, Motonari] Toho Univ, Dept Mol Immunol, Sch Med, Tokyo 1438540, Japan	Toho University	Kondo, M (corresponding author), Toho Univ, Dept Mol Immunol, Sch Med, Tokyo 1438540, Japan.	motonari.kondo@med.toho-u.ac.jp						Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Lai AY, 2008, SEMIN IMMUNOL, V20, P207, DOI 10.1016/j.smim.2008.05.002; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	8	4	4	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1177	1179		10.1016/j.immuni.2016.12.003	http://dx.doi.org/10.1016/j.immuni.2016.12.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002722	Bronze			2022-12-18	WOS:000392918100001
J	Martin, MD; Badovinac, VP				Martin, Matthew D.; Badovinac, Vladimir P.			Sifting through CD8(+) T Cell Memory	IMMUNITY			English	Editorial Material							SUBSETS	In this issue of Immunity, Gerlach et al. (2016) describe three distinct memory CD8(+) T cell subsets based upon expression of the fractalkine receptor CX3CR1. Their findings revise the paradigm of effector and central memory T cells by revealing a subset of CD8(+) memory T cells defined by intermediate levels of expression of CX3CR1 that conducts tissue surveillance.	[Martin, Matthew D.; Badovinac, Vladimir P.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Badovinac, Vladimir P.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Badovinac, VP (corresponding author), Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.; Badovinac, VP (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.	vladimir-badovinac@uiowa.edu		Badovinac, Vladimir/0000-0003-3180-2439	NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113961] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM113961] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Eberlein J, 2016, J CLIN INVEST, V126, P3942, DOI 10.1172/JCI88546; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Martin MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005219; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889	9	4	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1184	1186		10.1016/j.immuni.2016.12.005	http://dx.doi.org/10.1016/j.immuni.2016.12.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002725	Bronze			2022-12-18	WOS:000392918100004
J	Monahan, A; Kleino, A; Silverman, N				Monahan, Amanda; Kleino, Anni; Silverman, Neal			ReaDAPting the Role of PGRP-SD in Bacterial Sensing and Immune Activation	IMMUNITY			English	Editorial Material							PEPTIDOGLYCAN RECOGNITION PROTEIN; GRAM-POSITIVE BACTERIA; DROSOPHILA TOLL; PATHWAY	Contradictory to previous reports, Iatsenko et al. (2016) reveal that PGRP-SD regulates the Imd signaling pathway rather than the Toll pathway in Drosophila and shed light on a decade-old mystery of conflicting structural and phenotypic data.	[Monahan, Amanda; Kleino, Anni; Silverman, Neal] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Silverman, N (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	neal.silverman@umassmed.edu		Silverman, Neal/0000-0002-4259-456X; Kleino, Anni/0000-0001-8919-9404				Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Iatsenko I, 2016, IMMUNITY, V45, P1013, DOI 10.1016/j.immuni.2016.10.029; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Wang L, 2008, P NATL ACAD SCI USA, V105, P11881, DOI 10.1073/pnas.0710092105	9	4	4	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					951	953		10.1016/j.immuni.2016.11.002	http://dx.doi.org/10.1016/j.immuni.2016.11.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851920	Bronze			2022-12-18	WOS:000389473500004
J	Cooper, MA				Cooper, Megan A.			Teach Your NK Cells Well	IMMUNITY			English	Editorial Material							NATURAL-KILLER-CELLS; MHC CLASS-I; INHIBITORY RECEPTORS; MOLECULES; ENVIRONMENT; SELF	Natural killer cells readily kill target cells, and education ensures tolerance to self. In this issue of Immunity, Boudreau et al. (2016) and Chen et al. (2016) report new mechanisms of human and mouse natural killer cell education by inhibitory and activating receptors.	[Cooper, Megan A.] Washington Univ, Div Rheumatol, Dept Pediat, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Cooper, MA (corresponding author), Washington Univ, Div Rheumatol, Dept Pediat, Sch Med, St Louis, MO 63110 USA.	cooper_m@kids.wustl.edu		Cooper, Megan/0000-0002-5696-172X				Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Boudreau JE, 2016, IMMUNITY, V45, P280, DOI 10.1016/j.immuni.2016.07.005; Chen SS, 2016, IMMUNITY, V45, P292, DOI 10.1016/j.immuni.2016.07.013; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Kadri N, 2016, CURR TOP MICROBIOL, V395, P95, DOI 10.1007/82_2015_485; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Wu N, 2016, CURR OPIN IMMUNOL, V38, P45, DOI 10.1016/j.coi.2015.11.003	11	4	4	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					229	231		10.1016/j.immuni.2016.07.020	http://dx.doi.org/10.1016/j.immuni.2016.07.020			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533007	Bronze			2022-12-18	WOS:000382267300003
J	Barthel, SR; Schatton, T				Barthel, Steven R.; Schatton, Tobias			Homing in on the Sweet Side of Immune Checkpoint Biology	IMMUNITY			English	Editorial Material							T-CELLS; PSGL-1; CANCER	P-selectin glycoprotein ligand-1 (PSGL-1) and its glycostructural determinants facilitate responses to infection and cancer by promoting immune effector-cell trafficking into inflamed tissue. In this issue of Immunity, Tinoco et al. (2016) report homing-independent functions of PSGL-1 in immune checkpoint regulation and T cell effector activity, in models of chronic viral infection and melanoma.	[Barthel, Steven R.; Schatton, Tobias] Harvard Univ, Sch Med, Dept Dermatol, Harvard Skin Dis Res Ctr,Brigham & Womens Hosp, Boston, MA 02115 USA; [Schatton, Tobias] Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Schatton, T (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Harvard Skin Dis Res Ctr,Brigham & Womens Hosp, Boston, MA 02115 USA.; Schatton, T (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp, Boston, MA 02115 USA.	tschatton@bwh.harvard.edu	Schatton, Tobias/N-9898-2018	Schatton, Tobias/0000-0003-1386-680X				Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Baumeister SH, 2016, ANN REV IMMUNOL; Carlow DA, 2009, IMMUNOL REV, V230, P75, DOI 10.1111/j.1600-065X.2009.00797.x; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Matsumoto M, 2009, J IMMUNOL, V183, P7204, DOI 10.4049/jimmunol.0902173; Tinoco R, 2016, IMMUNITY, V44, P1190, DOI 10.1016/j.immuni.2016.04.015; Veerman KM, 2007, NAT IMMUNOL, V8, P532, DOI 10.1038/ni1456; Veerman KM, 2012, J IMMUNOL, V188, P1638, DOI 10.4049/jimmunol.1103026; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	9	4	4	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1083	1085		10.1016/j.immuni.2016.05.003	http://dx.doi.org/10.1016/j.immuni.2016.05.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192573	Bronze			2022-12-18	WOS:000376478500011
J	Berraondo, P; Teijeira, A; Melero, I				Berraondo, Pedro; Teijeira, Alvaro; Melero, Ignacio			Cancer Immunosurveillance Caught in the Act	IMMUNITY			English	Editorial Material							BLOCKADE; CELLS	The role of the immune system in the control of cancer formation and progression has been a matter of considerable debate over many years. In this issue of Immunity, Mlecnik et al. ( 2016) show the importance of immunosurveillance in controlling tumors in a series of microsatellite-instable human colon carcinomas.	[Berraondo, Pedro; Teijeira, Alvaro; Melero, Ignacio] Univ Navarra Clin, Ctr Appl Med Res CIMA, Program Immunol & Immunotherapy, Navarra 31008, Spain; [Berraondo, Pedro; Teijeira, Alvaro; Melero, Ignacio] Navarra Inst Hlth Res IdiSNA, Navarra 31008, Spain	University of Navarra	Melero, I (corresponding author), Univ Navarra Clin, Ctr Appl Med Res CIMA, Program Immunol & Immunotherapy, Navarra 31008, Spain.; Melero, I (corresponding author), Navarra Inst Hlth Res IdiSNA, Navarra 31008, Spain.	imelero@unav.es	Teijeira, Alvaro/I-6903-2017; Berraondo, Pedro/J-3154-2012; Melero, Ignacio/T-7600-2019	Teijeira, Alvaro/0000-0002-7339-4464; Berraondo, Pedro/0000-0001-7410-1865; Melero, Ignacio/0000-0002-1360-348X				BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Ngiow SF, 2015, CANCER RES, V75, P3800, DOI 10.1158/0008-5472.CAN-15-1082; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	10	4	4	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					525	526		10.1016/j.immuni.2016.03.004	http://dx.doi.org/10.1016/j.immuni.2016.03.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982362	Bronze			2022-12-18	WOS:000372784200011
J	Neu, KE; Wilson, PC				Neu, Karlynn E.; Wilson, Patrick C.			Taking the Broad View on B Cell Affinity Maturation	IMMUNITY			English	Editorial Material							INFLUENZA-VIRUS HEMAGGLUTININ; ANTIBODY-RESPONSE; DIVERSITY	Germinal center (GC) responses are required for the generation of high-affinity antigen-specific B cells. Kuraoka et al. (2016) explore the importance of inter-clonal competition in GC affinity maturation through the use of complex immunizing antigens and discover an unexpected increase in clonal diversity over the course of the response.	[Neu, Karlynn E.; Wilson, Patrick C.] Univ Chicago, Comm Immunol, Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Wilson, Patrick C.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Wilson, PC (corresponding author), Univ Chicago, Comm Immunol, Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA.; Wilson, PC (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	wilsonp@uchicago.edu	Wilson, Patrick/HGC-3157-2022		NIAID NIH HHS [P01 AI097092, U19 AI109946] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109946, P01AI097092] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; CLARKE SH, 1990, J IMMUNOL, V144, P2795; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	9	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					518	520		10.1016/j.immuni.2016.03.001	http://dx.doi.org/10.1016/j.immuni.2016.03.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982359	Bronze			2022-12-18	WOS:000372784200008
J	Reynolds, LA; Finlay, BB				Reynolds, Lisa A.; Finlay, B. Brett			Worming Their Way into the Picture: Microbiota Help Helminths Modulate Host Immunity	IMMUNITY			English	Editorial Material							IMMUNOMODULATION; PARASITES; DISEASE		[Reynolds, Lisa A.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.	bfinlay@msl.ubc.ca		Reynolds, Lisa/0000-0002-2969-2296				Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; McCoy KD, 2015, CLIN IMMUNOL, V159, P170, DOI 10.1016/j.clim.2015.05.007; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reynolds LA, 2015, J IMMUNOL, V195, P4059, DOI 10.4049/jimmunol.1501432; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012	10	4	5	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					840	842		10.1016/j.immuni.2015.10.025	http://dx.doi.org/10.1016/j.immuni.2015.10.025			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588776	Bronze			2022-12-18	WOS:000366846000005
J	Hor, JL; Whitney, PG; Zaid, A; Brooks, AG; Heath, WR; Mueller, SN				Hor, Jyh Liang; Whitney, Paul G.; Zaid, Ali; Brooks, Andrew G.; Heath, William R.; Mueller, Scott N.			Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4(+) and CD8(+) T Cell Activation to Localized Viral Infection (vol 43, pg 554, 2015)	IMMUNITY			English	Correction												smue@unimelb.edu.au	Mueller, Scott N/B-1918-2012	Mueller, Scott N/0000-0002-3838-3989; Whitney, Paul/0000-0003-3836-7601				Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020	1	4	4	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					615	615		10.1016/j.immuni.2015.08.018	http://dx.doi.org/10.1016/j.immuni.2015.08.018			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE		Bronze			2022-12-18	WOS:000361575300013
J	Wolf, D; Li, J; Ley, K				Wolf, Dennis; Li, Jie; Ley, Klaus			HGF Guides T Cells into the Heart	IMMUNITY			English	Editorial Material							RECEPTOR EXPRESSION; LYMPHOCYTES; REJECTION	Expression of distinct homing receptors guides adaptive immune cells to antigen-rich tissue. In this issue of Immunity, Komarowska et al. (2015) describe an autocrine loop that is initiated by cardiac-expressed hepatocyte growth factor to direct T cells into the heart during inflammation and cardiac transplant rejection.	[Wolf, Dennis; Li, Jie; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Ley, K (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.	klaus@liai.org	Wolf, Dennis/S-9217-2018	Wolf, Dennis/0000-0003-1525-4348				Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Huser N, 2005, EUR J IMMUNOL, V35, P128, DOI 10.1002/eji.200324745; Komarowska I, 2015, IMMUNITY, V42, P1087, DOI 10.1016/j.immuni.2015.05.014; Ley Klaus, 2014, F1000Res, V3, P37, DOI 10.12688/f1000research.3-37.v1; Li J, 2015, ARTERIOSCL THROM VAS, V35, P40, DOI 10.1161/ATVBAHA.114.303227; McCully ML, 2012, BLOOD, V120, P4591, DOI 10.1182/blood-2012-05-433037; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	9	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					979	981		10.1016/j.immuni.2015.06.001	http://dx.doi.org/10.1016/j.immuni.2015.06.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084015	Bronze			2022-12-18	WOS:000356362800002
J	Allen, CDC				Allen, Christopher D. C.			Germinal Center Quality Control: Death by Fas	IMMUNITY			English	Editorial Material							B-CELLS; REVEALS; LUPUS	Fas is a cell surface death receptor critical for immune regulation. In this issue of Immunity, Butt et al. (2015) show that Fas eliminates B cells that have become uncoupled from positive and negative selection in the germinal center.	[Allen, Christopher D. C.] Univ Calif San Francisco, Dept Anat, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Allen, Christopher D. C.] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Allen, CDC (corresponding author), Univ Calif San Francisco, Dept Anat, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	chris.allen@ucsf.edu		Allen, Christopher/0000-0002-1879-9047				Butt D, 2015, IMMUNITY, V42, P890, DOI 10.1016/j.immuni.2015.04.010; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Futatsugi-Yumikura S, 2014, INT IMMUNOL, V26, P221, DOI 10.1093/intimm/dxt070; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Kim YJ, 2007, AM J HEMATOL, V82, P615, DOI 10.1002/ajh.20851; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009	10	4	4	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					783	785		10.1016/j.immuni.2015.05.005	http://dx.doi.org/10.1016/j.immuni.2015.05.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992852	Bronze			2022-12-18	WOS:000354827400003
J	Thaiss, CA; Elinav, E				Thaiss, Christoph A.; Elinav, Eran			NF-kappa B Regulation by NLRs: T Cells Join the Club	IMMUNITY			English	Editorial Material							COLON INFLAMMATION; NLRP12; TUMORIGENESIS		[Thaiss, Christoph A.; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Elinav, E (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	eran.elinav@weizmann.ac.il	Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110				Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022	9	4	5	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					595	597		10.1016/j.immuni.2015.03.010	http://dx.doi.org/10.1016/j.immuni.2015.03.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902475	Bronze			2022-12-18	WOS:000353347500003
J	Woo, SR; Fuertes, MB; Corrales, L; Spranger, S; Furdyna, MJ; Leung, MYK; Duggan, R; Wang, Y; Barber, GN; Fitzgerald, KA; Alegre, ML; Gajewski, TF				Woo, Seng-Ryong; Fuertes, Mercedes B.; Corrales, Leticia; Spranger, Stefani; Furdyna, Michael J.; Leung, Michael Y. K.; Duggan, Ryan; Wang, Ying; Barber, Glen N.; Fitzgerald, Katherine A.; Alegre, Maria-Luisa; Gajewski, Thomas F.			STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors (vol 41, pg 830, 2014)	IMMUNITY			English	Correction												tgajewsk@medicine.bsd.uchicago.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X; Fuertes, Mercedes Beatriz/0000-0002-2734-1468				Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017	1	4	4	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					199	199		10.1016/j.immuni.2014.12.015	http://dx.doi.org/10.1016/j.immuni.2014.12.015			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC		Bronze, Green Published			2022-12-18	WOS:000348197500022
J	Soares, MP				Soares, Miguel P.			"Nuts and Bolts" of Disease Tolerance	IMMUNITY			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR; PROTECTION	Disease tolerance describes the ability of an infected host to limit disease severity without negatively impacting the causative pathogen. Bessede et al. (2014) show that the aryl hydrocarbon receptor is an essential component of disease tolerance during bacterial infection in mice.	Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal	Instituto Gulbenkian de Ciencia	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt		Soares, Miguel/0000-0002-9314-4833				Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Figueiredo N, 2013, IMMUNITY, V39, P874, DOI 10.1016/j.immuni.2013.08.039; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pa.35.040195.001515; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; SCHAFER JF, 1971, ANNU REV PHYTOPATHOL, V9, P235, DOI 10.1146/annurev.py.09.090171.001315; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245	10	4	4	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					176	178		10.1016/j.immuni.2014.07.011	http://dx.doi.org/10.1016/j.immuni.2014.07.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148020	Bronze			2022-12-18	WOS:000341455300005
J	Onai, N; Ohteki, T				Onai, Nobuyuki; Ohteki, Toshiaki			Bipotent or Oligopotent? A Macrophage and DC Progenitor Revisited	IMMUNITY			English	Editorial Material							DENDRITIC CELL-DEVELOPMENT; IN-VIVO; BONE-MARROW; HOMEOSTASIS	Macrophage and dendritic cell (DC) progenitors (MDPs) produce macrophages and DCs but not other hematopoietic lineages. In this issue of Immunity, Sathe et al. (2014) show that isolated MDP populations hardly contain such bipotent progenitors at clonal levels, arguing against the existence of MDPs.	[Onai, Nobuyuki; Ohteki, Toshiaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Ohteki, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1138510, Japan.	ohteki.bre@mri.tmd.ac.jp		Onai, Nobuyuki/0000-0003-2246-4917				Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615	10	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					5	7		10.1016/j.immuni.2014.07.004	http://dx.doi.org/10.1016/j.immuni.2014.07.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035946	Bronze			2022-12-18	WOS:000341444200003
J	Tiller, GR; Garsin, DA				Tiller, George R.; Garsin, Danielle A.			Of Worms and Men: HLH-30 and TFEB Regulate Tolerance to Infection	IMMUNITY			English	Editorial Material							IMMUNITY	In this issue of Immunity, Visvikis et al. (2014) use the model host Caenorhabditis elegans to discover a role in innate immunity for the basic helix-loop-helix transcription factor, HLH-30. The finding inspires study of the mammalian ortholog TFEB, in which a similar role in immune response is ascertained.	[Tiller, George R.; Garsin, Danielle A.] Univ Texas Hlth Sci Ctr Houston, Houston Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Garsin, DA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Houston Dept Microbiol & Mol Genet, 6431 Fannin St,MSB 1-168, Houston, TX 77030 USA.	danielle.a.garsin@uth.tmc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076406, R56AI110432] Funding Source: NIH RePORTER; NIAID NIH HHS [R56 AI110432, R01 AI076406] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Visvikis O, 2014, IMMUNITY, V40, P896, DOI 10.1016/j.immuni.2014.05.002	9	4	4	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					857	858		10.1016/j.immuni.2014.06.002	http://dx.doi.org/10.1016/j.immuni.2014.06.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24950206	Green Accepted, Bronze			2022-12-18	WOS:000341440200006
J	Todd, JA				Todd, John A.			Constitutive Antiviral Immunity at the Expense of Autoimmunity	IMMUNITY			English	Editorial Material							IFIH1	In this issue of Immunity, Funabiki et al. (2014) have identified in mice a mutation of the IFIH1 gene, encoding the viral receptor MDA5 that causes constitutive IFN production and fatal autoimmune disease. The authors show that the autoimmune disease-associated variant of human MDA5 is permanently switched on.	Univ Cambridge, JDRF Wellcome Trust Diabet & Inflammat Lab, NIHR Biomed Res Ctr, Dept Med Genet,Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Todd, JA (corresponding author), Univ Cambridge, JDRF Wellcome Trust Diabet & Inflammat Lab, NIHR Biomed Res Ctr, Dept Med Genet,Cambridge Inst Med Res, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Todd, John/A-3542-2010	Todd, John/0000-0003-2740-8148	Wellcome Trust [091157, 100140] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646; Ferreira R. C., 2014, DIABETES, V63; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Molineros JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003222; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	10	4	5	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					167	169		10.1016/j.immuni.2014.01.009	http://dx.doi.org/10.1016/j.immuni.2014.01.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24560191	Bronze			2022-12-18	WOS:000331637600001
J	Lajoie, S; Wills-Karp, M				Lajoie, Stephane; Wills-Karp, Marsha			New Twist on an Ancient Innate Immune Pathway	IMMUNITY			English	Editorial Material							T-CELLS; ALLERGIC-ASTHMA; COMPLEMENT; C3A; C5A	Activation of the complement system has long been known to be regulated by a series of steps involving fluid-phase convertases. In this issue of Immunity, Liszewski et al. (2013) report the discovery of an intracellular cathepsin-L-dependent C3 activation pathway.	[Lajoie, Stephane; Wills-Karp, Marsha] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wills-Karp, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.	mwkarp@jhsph.edu		Lajoie, Stephane/0000-0002-0514-1801	NIAID NIH HHS [U19 AI070235, R01 AI083315] Funding Source: Medline; NIEHS NIH HHS [T32 ES007141] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083315, U19AI070235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Le Friec G, 2012, NAT IMMUNOL, V13, P1213, DOI 10.1038/ni.2454; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; van der Touw W, 2013, J IMMUNOL, V190, P5921, DOI 10.4049/jimmunol.1300847; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84	9	4	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1000	1002		10.1016/j.immuni.2013.11.015	http://dx.doi.org/10.1016/j.immuni.2013.11.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332028	Bronze, Green Accepted			2022-12-18	WOS:000330951000007
J	Gutierrez, DA; Rodewald, HR				Gutierrez, Dario A.; Rodewald, Hans-Reimer			A Sting in the Tale of Th2 Immunity	IMMUNITY			English	Editorial Material							DEFENSE; SNAKE		[Gutierrez, Dario A.; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Rodewald, HR (corresponding author), German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany.	hr.rodewald@dkfz.de						Artis D, 2012, NATURE, V484, P458, DOI 10.1038/484458a; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Portier P, 1902, CR SEANC SOC BIOL, V54, P170; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250	10	4	5	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					803	805		10.1016/j.immuni.2013.10.015	http://dx.doi.org/10.1016/j.immuni.2013.10.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238337	Bronze			2022-12-18	WOS:000330950600004
J	Brodsky, IE				Brodsky, Igor E.			RNA Helicase DHX33 Puts a New Twist on NLRP3 Inflammasome Activation	IMMUNITY			English	Editorial Material								The mechanisms by which NLRP3 senses inflammasome-activating stimuli remain poorly defined. In this issue of Immunity, Mitoma et al. (2013) demonstrate that the RNA helicase DHX33 binds to cytosolic dsRNAs to trigger NLRP3 inflammasome activation.	Univ Penn, Sch Vet Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Brodsky, IE (corresponding author), Univ Penn, Sch Vet Med, Dept Pathol, Philadelphia, PA 19104 USA.	ibrodsky@vet.upenn.edu						Broz P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003144; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Zhang YD, 2011, MOL CELL BIOL, V31, P4676, DOI 10.1128/MCB.05832-11	10	4	4	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					94	96		10.1016/j.immuni.2013.07.010	http://dx.doi.org/10.1016/j.immuni.2013.07.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890068	Bronze			2022-12-18	WOS:000330948300010
J	Rieder, SA; Shevach, EM				Rieder, Sadiye Amcaoglu; Shevach, Ethan M.			Eos, Goddess of Treg Cell Reprogramming	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS	Under certain conditions, Sharma et al. (2013) show in this issue of Immunity that a subpopulation of Foxp3(+) regulatory T cells loses expression of the transcription factor Eos and develops into Foxp3(+) T helper cells that facilitate priming of naive CD8(+) T cells.	[Rieder, Sadiye Amcaoglu; Shevach, Ethan M.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shevach, EM (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	eshevach@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000959] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; GERSHON RK, 1976, COLD SPRING HARB SYM, V41, P85, DOI 10.1101/SQB.1977.041.01.012; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354	7	4	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					849	850		10.1016/j.immuni.2013.05.001	http://dx.doi.org/10.1016/j.immuni.2013.05.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23706664	Bronze			2022-12-18	WOS:000330942500003
J	Shortman, K; Sathe, P				Shortman, Ken; Sathe, Priyanka			Another Heritage for Plasmacytoid Dendritic Cells	IMMUNITY			English	Editorial Material							PROGENITORS	Plasmacytoid dendritic cell (pDC) development has been linked to that of conventional dendritic cells via a common dendritic cell precursor (CDP). In this issue of Immunity, Onai et al. (2013) outline a parallel but more effective pathway to pDCs that proceeds via a novel CDP-like precursor.	[Shortman, Ken; Sathe, Priyanka] Walter & Eliza Hall Inst Med Res, IG Royal Parade, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute	Shortman, K (corresponding author), Walter & Eliza Hall Inst Med Res, IG Royal Parade, Parkville, Vic 3052, Australia.	shortman@wehi.edu.au						Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011	8	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					845	846		10.1016/j.immuni.2013.05.002	http://dx.doi.org/10.1016/j.immuni.2013.05.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23706662	Bronze			2022-12-18	WOS:000330942500001
J	Vacchio, MS; Bosselut, R				Vacchio, Melanie S.; Bosselut, Remy			T Cell Metabolism: MicroRNAs Cap PTEN to Feed the Expanding Crowd	IMMUNITY			English	Editorial Material							SELECTION	Cell proliferation during T cell development and effector responses require the resetting of metabolic activity to fit energy and anabolic needs. Henao-Mejia et al., (2013) show a critical role for a specific microRNA family in this process.	[Vacchio, Melanie S.; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	bosselur@helix.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010671] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; Finlay D, 2010, ANN NY ACAD SCI, V1183, P149, DOI 10.1111/j.1749-6632.2009.05134.x; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110	10	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					847	848		10.1016/j.immuni.2013.05.006	http://dx.doi.org/10.1016/j.immuni.2013.05.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23706663	Bronze			2022-12-18	WOS:000330942500002
J	Infantino, S; Tarlinton, DM				Infantino, Simona; Tarlinton, David M.			Feeling a Little SYK after Mixing BAFF with BCR	IMMUNITY			English	Editorial Material							SURVIVAL; RECEPTOR; SIGNALS; AKT	In this issue of Immunity, Schweighoffer et al. (2013) report that full BAFF responsiveness in B cells requires the tyrosine kinase Syk and that BAFF may co-opt components of the B cell receptor in transmitting its survival signal.	[Infantino, Simona; Tarlinton, David M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute	Infantino, S (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	infantino@wehi.edu.au; tarlinton@wehi.edu.au		Tarlinton, David/0000-0001-9928-686X				Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041	6	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					406	408		10.1016/j.immuni.2013.03.001	http://dx.doi.org/10.1016/j.immuni.2013.03.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521880	Bronze			2022-12-18	WOS:000330941500005
J	Romani, N; Tripp, CH; Stoitzner, P				Romani, Nikolaus; Tripp, Christoph H.; Stoitzner, Patrizia			Langerhans Cells Come in Waves	IMMUNITY			English	Editorial Material							SKIN	It is unclear how the Langerhans cell (LC) network is maintained in adult epidermis. In this issue of Immunity, Sere et al. (2012) show that LCs are replenished in two waves. Monocyte-derived, short-lived LCs come first. A second wave follows, and these LCs of nonmonocytic origin are long-lived.	[Romani, Nikolaus; Tripp, Christoph H.; Stoitzner, Patrizia] Innsbruck Med Univ, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Romani, N (corresponding author), Innsbruck Med Univ, Dept Dermatol & Venereol, Anichstr 35, A-6020 Innsbruck, Austria.	nikolaus.romani@i-med.ac.at		Romani, Nikolaus/0000-0003-1614-9128; Tripp, Christoph/0000-0001-5502-7241; stoitzner, patrizia/0000-0002-8488-6704	Austrian Science Fund FWF [P 21487] Funding Source: Medline; Austrian Science Fund (FWF) [P 21487] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Kanitakis J, 2011, EXP DERMATOL, V20, P145, DOI 10.1111/j.1600-0625.2010.01146.x; KRUEGER GG, 1983, P NATL ACAD SCI-BIOL, V80, P1650, DOI 10.1073/pnas.80.6.1650; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Schuster C, 2009, J EXP MED, V206, P169, DOI 10.1084/jem.20081747	9	4	4	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 16	2012	37	5					766	768		10.1016/j.immuni.2012.10.013	http://dx.doi.org/10.1016/j.immuni.2012.10.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23159223	Green Accepted, Bronze			2022-12-18	WOS:000311460000004
J	Muller, WA				Muller, William A.			Regulate Globally, Act Locally: Adrenergic Nerves Promote Leukocyte Recruitment	IMMUNITY			English	Editorial Material							INFLAMMATION; CELLS	In this issue of Immunity, Scheiermann et al. (2012) demonstrate that circadian regulation of the expression of endothelial cell adhesion molecules via adrenergic innervation of local vasculature promotes clinically significant changes in leukocyte homing and bone marrow engraftment.	Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Muller, WA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA.	wamuller@northwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046849, R37HL064774] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL064774, R01 HL046849] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; BERTOUCH JV, 1983, BRIT MED J, V286, P1171, DOI 10.1136/bmj.286.6372.1171; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Luyer MD, 2005, J EXP MED, V202, P1023, DOI 10.1084/jem.20042397; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X	10	4	4	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 24	2012	37	2					189	191		10.1016/j.immuni.2012.08.004	http://dx.doi.org/10.1016/j.immuni.2012.08.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22921114	Green Accepted, Bronze			2022-12-18	WOS:000308261800002
J	Bogdan, C				Bogdan, Christian			Listeria monocytogenes: No Spreading without NO	IMMUNITY			English	Editorial Material							MACROPHAGES; OXIDASE		[Bogdan, Christian] Univ Erlangen Nurnberg, Inst Mikrobiol, Klin Mikrobiol Immunol & Hyg, D-91054 Erlangen, Germany; [Bogdan, Christian] Univ Klinikum Erlangen, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Bogdan, C (corresponding author), Univ Erlangen Nurnberg, Inst Mikrobiol, Klin Mikrobiol Immunol & Hyg, D-91054 Erlangen, Germany.	christian.bogdan@uk-erlangen.de		Bogdan, Christian/0000-0002-2300-0631				Bogdan C, 1997, Behring Inst Mitt, P58; Bogdan C, 2011, METHODS MOL BIOL, V677, P375, DOI 10.1007/978-1-60761-869-0_24; Cole C, 2012, IMMUNITY, V36, P807, DOI 10.1016/j.immuni.2012.03.011; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Lam GY, 2011, CELL HOST MICROBE, V10, P627, DOI 10.1016/j.chom.2011.11.005; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6	10	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					697	699		10.1016/j.immuni.2012.05.009	http://dx.doi.org/10.1016/j.immuni.2012.05.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22633455	Bronze			2022-12-18	WOS:000304976000003
J	Spits, H; Mjosberg, J				Spits, Hergen; Mjosberg, Jenny			The Aryl Hydrocarbon Receptor: A Sentinel Safeguarding the Survival of Immune Cells in the Gut	IMMUNITY			English	Editorial Material								Innate lymphoid cells (ILCs) regulate the epithelial barrier function and immunity in the gut. How ILC numbers are maintained is unknown. In this issue of Immunity, Qiu et al. (2012) report that the transcription factor aryl hydrocarbon receptor controls survival and function of gut-residing ILCs.	[Spits, Hergen; Mjosberg, Jenny] Acad Med Ctr, Tytgat Inst Intestinal & Liver Res, NL-1105 BK Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Spits, H (corresponding author), Acad Med Ctr, Tytgat Inst Intestinal & Liver Res, NL-1105 BK Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338				Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2010, CURR OPIN IMMUNOL, V22, P747, DOI 10.1016/j.coi.2010.09.001	9	4	4	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 27	2012	36	1					5	7		10.1016/j.immuni.2012.01.004	http://dx.doi.org/10.1016/j.immuni.2012.01.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22284414	Bronze			2022-12-18	WOS:000299766000003
J	Hanabuchi, S; Liu, YJ				Hanabuchi, Shino; Liu, Yong-Jun			In Vivo Role of pDCs in Regulating Adaptive Immunity	IMMUNITY			English	Editorial Material							PLASMACYTOID DENDRITIC CELLS; LISTERIA-MONOCYTOGENES; SIGLEC-H; INFECTION; RECEPTOR; PRECURSORS; IPC		[Hanabuchi, Shino; Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Liu, Yong-Jun] Baylor Inst Immunol Res, Dallas, TX 75204 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor Scott & White Health	Hanabuchi, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	shanabuc@mdanderson.org	Hanabuchi, Shino/AAI-8676-2021					Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Efron PA, 2004, J IMMUNOL, V173, P3035, DOI 10.4049/jimmunol.173.5.3035; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	10	4	5	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 23	2011	35	6					851	853		10.1016/j.immuni.2011.12.005	http://dx.doi.org/10.1016/j.immuni.2011.12.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195741	Bronze			2022-12-18	WOS:000298777300004
J	Wang, JH; Reinherz, EL				Wang, Jia-huai; Reinherz, Ellis L.			A New Angle on TCR Activation	IMMUNITY			English	Editorial Material							T-CELL-RECEPTOR; COMPLEX	Functional cognate T cell recognition is mediated via the interaction of a T cell receptor complex with its pMHC ligand. Adams et al. (2011) in this issue of Immunity provide evidence that docking geometry may impact 2D binding and T cell activation.	[Wang, Jia-huai; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Reinherz, Ellis L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Reinherz, EL (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, 44 Binney St, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu			NHLBI NIH HHS [P01 HL103526] Funding Source: Medline; NIAID NIH HHS [R37 AI019807, U01 AI090043] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019807, U01AI090043] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10	10	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					658	660		10.1016/j.immuni.2011.11.008	http://dx.doi.org/10.1016/j.immuni.2011.11.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118519	Bronze, Green Accepted			2022-12-18	WOS:000297390800003
J	Campbell, DJ				Campbell, Daniel J.			Regulatory T Cells GATA Have It	IMMUNITY			English	Editorial Material							DIFFERENTIATION	The factors that control regulatory T (Treg) cell homeostasis and function are still being defined. In this issue of Immunity, Wang et al. (2011) demonstrate that the Th2 cell-associated transcription factor GATA-3 helps control Foxp3 expression in Treg cells and is required for their proper functional activity in vivo.	[Campbell, Daniel J.] Benaroya Res Inst, Seattle, WA 98101 USA; [Campbell, Daniel J.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Benaroya Research Institute; University of Washington; University of Washington Seattle	Campbell, DJ (corresponding author), Benaroya Res Inst, Seattle, WA 98101 USA.	campbell@benaroyaresearch.org						Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	9	4	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 23	2011	35	3					313	315		10.1016/j.immuni.2011.09.002	http://dx.doi.org/10.1016/j.immuni.2011.09.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21943484	Bronze			2022-12-18	WOS:000295748100001
J	Kool, M; Willart, MAM; van Nimwegen, M; Bergen, I; Pouliot, P; Virchow, JC; Rogers, N; Osorio, F; Reis e Sousa, C; Hammad, H; Lambrecht, BN				Kool, Mirjam; Willart, Monique A. M.; van Nimwegen, Menno; Bergen, Ingrid; Pouliot, Philippe; Virchow, J. Christian; Rogers, Neil; Osorio, Fabiola; Reis e Sousa, Caetano; Hammad, Hamida; Lambrecht, Bart N.			An Unexpected Role for Uric Acid as an Inducer of T Helper 2 Cell Immunity to Inhaled Antigens and Inflammatory Mediator of Allergic Asthma (vol 34, pg 527, 2011)	IMMUNITY			English	Correction												hamida.hammad@ugent.be; bart.lambrecht@ugent.be	Osorio, Fabiola/H-4529-2014	Osorio, Fabiola/0000-0001-5306-7856				Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015	1	4	4	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					627	627		10.1016/j.immuni.2011.04.012	http://dx.doi.org/10.1016/j.immuni.2011.04.012			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ		Bronze			2022-12-18	WOS:000290367300021
J	De Libero, G; Mori, L				De Libero, Gennaro; Mori, Lucia			The Easy Virtue of CD1c	IMMUNITY			English	Editorial Material							ANTIGEN	CD1 molecules present lipid antigens to T cells. In this issue of Immunity, Scharf et al. (2010) solve the structure of CD1c, which has binding pockets suited for insertion of a variety of lipid antigens.	[De Libero, Gennaro; Mori, Lucia] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Mori, Lucia] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore	University of Basel; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	De Libero, G (corresponding author), Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.	gennaro.delibero@unibas.ch	De Libero, Gennaro/P-2694-2017	De Libero, Gennaro/0000-0003-0853-7868				de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; Geho DH, 2000, J IMMUNOL, V165, P1272, DOI 10.4049/jimmunol.165.3.1272; Guiard J, 2009, J IMMUNOL, V182, P7030, DOI 10.4049/jimmunol.0804044; KEFFORD RF, 1984, NATURE, V308, P641, DOI 10.1038/308641a0; Manolova V, 2006, EUR J IMMUNOL, V36, P1083, DOI 10.1002/eji.200535544; Relloso M, 2008, IMMUNITY, V28, P774, DOI 10.1016/j.immuni.2008.04.017; Scharf L, 2010, IMMUNITY, V33, P853, DOI 10.1016/j.immuni.2010.11.026; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Van Rhijn I, 2009, J EXP MED, V206, P1409, DOI 10.1084/jem.20082480	10	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 22	2010	33	6					831	833		10.1016/j.immuni.2010.12.001	http://dx.doi.org/10.1016/j.immuni.2010.12.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21168772	Bronze			2022-12-18	WOS:000286293900001
J	Alon, R				Alon, Ronen			Trapped versus Soluble Chemokines: Functions in Leukocyte Adhesion and Motility	IMMUNITY			English	Editorial Material							TRAFFICKING; MIGRATION; CELLS	In this issue of Immunity, Bao et al. (2010) provide in vivo evidence that heparan sulfate glycosaminoglycans (GAGs) are indispensable for immobilization and function of major chemokines required for leukocyte adhesion to and crossing through blood and lymphatic vessels.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022	Alon, Ronen/0000-0001-9161-6369				Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233	10	4	4	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 24	2010	33	5					654	656		10.1016/j.immuni.2010.11.012	http://dx.doi.org/10.1016/j.immuni.2010.11.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21094462	Bronze			2022-12-18	WOS:000286082600005
J	Kincade, PW				Kincade, Paul W.			Plasticity of Supporting Cells in a Stem Cell Factory	IMMUNITY			English	Editorial Material							MICROENVIRONMENT; NICHES		Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu						Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Ichii M, 2010, IMMUNOL REV, V237, P10, DOI 10.1111/j.1600-065X.2010.00933.x; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Yao LB, 2005, BLOOD, V106, P4093, DOI 10.1182/blood-2005-02-0671; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200	10	4	4	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 24	2010	33	3					291	293		10.1016/j.immuni.2010.09.003	http://dx.doi.org/10.1016/j.immuni.2010.09.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20870169	Bronze			2022-12-18	WOS:000282798500002
J	Van Kaer, L; Joyce, S				Van Kaer, Luc; Joyce, Sebastian			The Hunt for iNKT Cell Antigens: alpha-Galactosidase-Deficient Mice to the Rescue?	IMMUNITY			English	Editorial Material							NKT CELLS; CD1D	The endogenous lipids that control the functions of invariant natural killer T (iNKT) cells remain enigmatic. In this issue of Immunity, Darmoise et al. (2010) report that lysosomal a-galactosidase A destroys self-antigens recognized by iNKT cells.	[Van Kaer, Luc; Joyce, Sebastian] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Van Kaer, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA.	luc.van.kaer@vanderbilt.edu	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; JOYCE, Sebastian/0000-0002-3183-1451				Chen XX, 2007, J IMMUNOL, V178, P6181, DOI 10.4049/jimmunol.178.10.6181; Darmoise A, 2010, IMMUNITY, V33, P216, DOI 10.1016/j.immuni.2010.08.003; Gadola SD, 2006, J EXP MED, V203, P2293, DOI 10.1084/jem.20060921; Gapin L, 2010, NAT REV IMMUNOL, V10, P272, DOI 10.1038/nri2743; Li YS, 2009, J PROTEOME RES, V8, P2740, DOI 10.1021/pr801040h; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Muindi K, 2010, P NATL ACAD SCI USA, V107, P3052, DOI 10.1073/pnas.0915056107; Stanic AK, 2003, P NATL ACAD SCI USA, V100, P1849, DOI 10.1073/pnas.0430327100; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	9	4	4	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 27	2010	33	2					143	145		10.1016/j.immuni.2010.08.009	http://dx.doi.org/10.1016/j.immuni.2010.08.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20732635	Bronze			2022-12-18	WOS:000281654900002
J	Shevach, EM				Shevach, Ethan M.			TGF-beta to the Rescue	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS	Is transforming growth factor-beta (TGF-beta) required for induction of the transcription factor Foxp3 in developing thymocytes? Ouyang et al. (2010) demonstrate that TGF-beta in the thymus prevents deletion of Foxp3(+) regulatory T cells.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shevach, EM (corresponding author), NIAID, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	eshevach@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000959] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen WJ, 2001, J EXP MED, V194, P439, DOI 10.1084/jem.194.4.439; Golstein P, 2001, J EXP MED, V194, pF19, DOI 10.1084/jem.194.4.F19; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106	7	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 28	2010	32	5					585	587		10.1016/j.immuni.2010.04.014	http://dx.doi.org/10.1016/j.immuni.2010.04.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20510867	Bronze			2022-12-18	WOS:000278280500003
J	Buschow, SI; Figdor, CG				Buschow, Sonja I.; Figdor, Carl G.			Dendritic Cell Subsets Digested: RNA Sensing Makes the Difference!	IMMUNITY			English	Editorial Material							RECOGNITION		[Buschow, Sonja I.; Figdor, Carl G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Figdor, CG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands.	c.figdor@ncmls.ru.nl	Buschow, Sonja/AAD-3567-2020; Figdor, Carl G/A-4232-2010; Buschow, Sonja I/F-3777-2010	Figdor, Carl G/0000-0002-2366-9212; Buschow, Sonja/0000-0002-7907-8315				Beltrame L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004128; Buschow SI, 2010, J PROTEOME RES, V9, P1727, DOI 10.1021/pr9008546; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kumagai Y, 2009, J IMMUNOL, V182, P3960, DOI 10.4049/jimmunol.0804315; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Shortman K, 2009, EXP MOL MED, V41, P61, DOI 10.3858/emm.2009.41.2.008	9	4	4	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					149	151		10.1016/j.immuni.2010.02.006	http://dx.doi.org/10.1016/j.immuni.2010.02.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20189479	Bronze			2022-12-18	WOS:000275346000005
J	Malefyt, RD				Malefyt, Rene de Waal			Interieukin-17 Kick-Starts T Helper 1 Cell Differentiation	IMMUNITY			English	Editorial Material							INFLAMMATION; IL-23	In this issue of Immunity, Lin et al. (2009) implicate interleukin-17 in the regulation of T helper 1 (Th1) cell immunity against Francisella tularensis. These findings add a unique twist to the cytokine regulation of T cell differentiation and function.	Schering Plough Biopharma, Dept Immunol, Palo Alto, CA 94304 USA	Merck & Company	Malefyt, RD (corresponding author), Schering Plough Biopharma, Dept Immunol, Palo Alto, CA 94304 USA.	rene.de.waal.malefyt@spcorp.com						Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4	5	4	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 20	2009	31	5					700	702		10.1016/j.immuni.2009.11.002	http://dx.doi.org/10.1016/j.immuni.2009.11.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ		Bronze			2022-12-18	WOS:000272097900004
J	van Endert, P				van Endert, Peter			Toll-like Receptor 9: AEP Takes Control	IMMUNITY			English	Editorial Material							ASPARAGINYL ENDOPEPTIDASE; COMPARTMENT; CATHEPSINS; MICE	Toll-like receptor 9 (TLR9) requires proteolytic maturation to acquire signaling capacity; however, the involved protease(s) is unclear. In this issue of Immunity, Sepulveda et al. (2009) demonstrate that in dendritic cells, asparaginyl endopeptidase is a key protease that controls TLR9 maturation.	[van Endert, Peter] INSERM, U580, F-75015 Paris, France; [van Endert, Peter] Univ Paris 05, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	van Endert, P (corresponding author), INSERM, U580, F-75015 Paris, France.	peter.van-endert@inserm.fr	van Endert, Peter/R-4606-2017	van Endert, Peter/0000-0003-3782-0750				Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Watts C, 2005, IMMUNOL REV, V207, P218, DOI 10.1111/j.0105-2896.2005.00312.x	10	4	4	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					696	698		10.1016/j.immuni.2009.10.004	http://dx.doi.org/10.1016/j.immuni.2009.10.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19932067	Bronze			2022-12-18	WOS:000272097900002
J	Ma, CS; Tangye, SG				Ma, Cindy S.; Tangye, Stuart G.			Helping the Helpers!	IMMUNITY			English	Editorial Material							T-CELLS; DIFFERENTIATION	T follicular helper (Tfh) cells are crucial for generating humoral immune responses. In this issue of Immunity, Schmitt et al. (2009) reveal the differentiation of human Tfh cells is dependent on dendritic cell-derived interleukin-12.	[Ma, Cindy S.; Tangye, Stuart G.] St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia; [Tangye, Stuart G.] Univ New S Wales, St Vincents Clin Sch, Kensington, NSW 2052, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Tangye, SG (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia.	s.tangye@garvan.org.au	Tangye, Stuart G/H-4023-2014; S, Cindy/B-2340-2012	Tangye, Stuart G/0000-0002-5360-5180; S, Cindy/0000-0001-5387-8413				Annunziato F, 2008, INT IMMUNOL, V20, P1361, DOI 10.1093/intimm/dxn106; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Marodi L, 2007, NAT REV IMMUNOL, V7, P851, DOI 10.1038/nri2195; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Robertson MJ, 2005, BLOOD, V106, P963, DOI 10.1182/blood-2005-01-0201; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	10	4	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					12	14		10.1016/j.immuni.2009.06.009	http://dx.doi.org/10.1016/j.immuni.2009.06.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604489	Bronze			2022-12-18	WOS:000268219900007
J	Ho, IC				Ho, I-Cheng			m(en)TOR(ing) Differentiating T Helper Cells	IMMUNITY			English	Editorial Material							MTOR; AKT	The decision of naive Th cells to assume the fate of effector or regulator Th cells heavily influences the outcome of adaptive immune responses. In this issue of Immunity, Delgoffe et al. (2009) use genetic approaches and demonstrate that mTOR kinase plays a critical role in this decision-making process.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ho, IC (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	iho@partners.org						Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	7	4	4	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					759	761		10.1016/j.immuni.2009.06.002	http://dx.doi.org/10.1016/j.immuni.2009.06.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19538925	Bronze			2022-12-18	WOS:000267270700003
J	Boothby, M				Boothby, Mark			The Calculus of Integrating Differentiation: Timing Control of T-Bet	IMMUNITY			English	Editorial Material							TRANSCRIPTION; COMMITMENT; RESPONSES; CELLS	In this issue of Immunity, Schulz et al. (2009) use mathematical modeling to elucidate a signaling network controlling Ifng gene expression, thereby showing the importance of an Interleukin-12-dependent, Interferon-gamma-independent second phase of inducing the transcription factor T-bet.	[Boothby, Mark] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Boothby, Mark] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Boothby, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, 1161 21st Ave S, Nashville, TN 37232 USA.	mark.boothby@vanderbiIt.edu						Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tomlin CJ, 2007, NAT REV GENET, V8, P331, DOI 10.1038/nrg2098; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8	10	4	4	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 22	2009	30	5					666	668		10.1016/j.immuni.2009.04.008	http://dx.doi.org/10.1016/j.immuni.2009.04.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19464989	Bronze			2022-12-18	WOS:000266356900007
J	Alugupalli, KR; Abraham, D				Alugupalli, Kishore R.; Abraham, David			B Cell Multitasking Is Required to Control Nematode Infection	IMMUNITY			English	Editorial Material							HELMINTH INFECTION; LYMPHOCYTES; RESPONSES; IMMUNITY	In this issue of Immunity, Wojciechowski et al. (2009) demonstrate that in addition to producing antibodies, B cells play pivotal roles in specific-antigen presentation and cytokine production for optimal T helper 2 responses required for protection against Heligmosomoides polygyrus.	[Alugupalli, Kishore R.; Abraham, David] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Alugupalli, KR (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	kishore.alugupalli@mail.jci.tju.edu						Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Artis D, 1999, J EXP MED, V190, P953, DOI 10.1084/jem.190.7.953; Chen XJ, 2008, ARCH IMMUNOL THER EX, V56, P77, DOI 10.1007/s00005-008-0014-5; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Mccoy KD, 2008, CELL HOST MICROBE, V4, P362, DOI 10.1016/j.chom.2008.08.014; URBAN JF, 1995, J IMMUNOL, V154, P4675; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006	8	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 20	2009	30	3					317	319		10.1016/j.immuni.2009.02.004	http://dx.doi.org/10.1016/j.immuni.2009.02.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19303384	Bronze			2022-12-18	WOS:000264405500003
J	von Boehmer, H				von Boehmer, Harald			Notch 1 Keeps Pro-T Cells on Track	IMMUNITY			English	Editorial Material							DELTA-LIKE 4	In this issue of Immunity, Feyerabend et al. (2009) report that Delta-like 4, acting on Notch 1, prevents pro-T cells from differentiating into dendritic cells and B cells. In addition, in the absence of Notch 1, B cells in the thymus arose from a cell-extrinsic pathway.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu						Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; FEYERABEND T, 2009, IMMUNITY, V30; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486	9	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 16	2009	30	1					5	7		10.1016/j.immuni.2008.12.008	http://dx.doi.org/10.1016/j.immuni.2008.12.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144311	Bronze			2022-12-18	WOS:000262769900003
J	DeFranco, AL				DeFranco, Anthony L.			"Dangerous Crystals"	IMMUNITY			English	Editorial Material							NALP3 INFLAMMASOME; ACTIVATION	Uric acid (UA) crystals are a potent stimulator of inflammation, but how they activate immune cells is not known. In this issue of Immunity, Ng et al. (2008) provide evidence suggesting that UA activates the Syk kinase via membrane cholesterol.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	DeFranco, AL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	anthony.defranco@ucsf.edu						Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013	6	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					670	671		10.1016/j.immuni.2008.10.005	http://dx.doi.org/10.1016/j.immuni.2008.10.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006690	Bronze			2022-12-18	WOS:000261036000004
J	Kronenberg, M; Sullivan, BA				Kronenberg, Mitchell; Sullivan, Barbara A.			Acid test: Lipid antigens get into the groove	IMMUNITY			English	Editorial Material							CD1; BIOLOGY; CELLS	How do CD1 molecules load lipid antigens? In this issue of Immunity, Relloso et al. (2008) uncover how lysosomal pH targets amino acids in CD1b, causing it to open and attain a conformation more receptive to lipid antigens.	[Kronenberg, Mitchell; Sullivan, Barbara A.] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	mitch@liai.org	Kronenberg, Mitchell/AAT-6078-2021		NIAID NIH HHS [R01 AI040617, R37 AI071922] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040617, R37AI071922] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Cheng TY, 2006, EMBO J, V25, P2989, DOI 10.1038/SJ.EMBOJ.7601185; Dascher CC, 2007, CURR TOP MICROBIOL, V314, P3; De Libero G, 2008, CURR OPIN IMMUNOL, V20, P96, DOI 10.1016/j.coi.2007.10.008; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Garcia-Alles LF, 2006, EMBO J, V25, P3684, DOI 10.1038/sj.emboj.7601244; Im JS, 2004, J BIOL CHEM, V279, P299, DOI 10.1074/jbc.M308803200; Relloso M, 2008, IMMUNITY, V28, P774, DOI 10.1016/j.immuni.2008.04.017; Zajonc DM, 2007, CURR OPIN STRUC BIOL, V17, P521, DOI 10.1016/j.sbi.2007.09.010	10	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					727	729		10.1016/j.immuni.2008.05.003	http://dx.doi.org/10.1016/j.immuni.2008.05.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549793	Bronze			2022-12-18	WOS:000256760200002
J	Walker, JM; Slifka, MK				Walker, Joshua M.; Slifka, Mark K.			The immunostimulatory power of acute viral infection	IMMUNITY			English	Editorial Material							SMALLPOX VACCINATION; RESPONSES; EPITOPES; MEMORY		[Walker, Joshua M.; Slifka, Mark K.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA	Oregon Health & Science University	Slifka, MK (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, 505 NW 185th Ave, Beaverton, OR 97006 USA.	slifkam@ohsu.edu		Walker, Joshua/0000-0002-0810-4969	NIAID NIH HHS [R01 AI054458, R41 AI063675] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054458, R41AI063675] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Dasgupta A, 2007, J IMMUNOL, V178, P1654, DOI 10.4049/jimmunol.178.3.1654; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Terajima M, 2003, J EXP MED, V197, P927, DOI 10.1084/jem.20022222	8	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY	2008	28	5					604	606		10.1016/j.immuni.2008.04.009	http://dx.doi.org/10.1016/j.immuni.2008.04.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18482565	Bronze			2022-12-18	WOS:000256003900006
J	Ferrandon, D				Ferrandon, Dominique			Ubiquitin-proteasome: Pallbearer carries the deceased to the grave	IMMUNITY			English	Editorial Material							APOPTOTIC CELLS; PHAGOCYTOSIS; REQUIREMENT	Phagocytosis is a complex process that involves multiple cellular functions. In this issue of Immunity, Silva et al. (2007) report that a protein ubiquitylation, complex and the proteasome are required for the clearance of apoptotic cells in Drosophila. Phagocytosis is a complex process that involves multiple cellular functions. In this issue of Immunity, Silva et al. (2007) report that a protein ubiquitylation, complex and the proteasome are required for the clearance of apoptotic cells in Drosophila.	Inst Biol Mol & Cellulaire, CNRS, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ferrandon, D (corresponding author), Inst Biol Mol & Cellulaire, CNRS, 15 Rue Descartes, F-67084 Strasbourg, France.	d.ferrandon@ibmc.u-strasbg.fr		FERRANDON, Dominique/0000-0001-7680-7773				Ayres JS, 2006, TRENDS MICROBIOL, V14, P101, DOI 10.1016/j.tim.2006.01.008; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Lee WL, 2005, MOL BIOL CELL, V16, P2077, DOI 10.1091/mbc.E04-06-0464; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007	10	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					541	544		10.1016/j.immuni.2007.10.003	http://dx.doi.org/10.1016/j.immuni.2007.10.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17967407	Bronze			2022-12-18	WOS:000250490700004
J	Davis, MM				Davis, Mark M.			The alpha beta T cell repertoire comes into focus	IMMUNITY			English	Editorial Material							DIVERSITY	The size of the lymphocyte repertoire is of great interest, but direct information has been elusive. Moon et al. (2007) report the enumeration and isolation of naive CD4(+) T cells and show their numbers could predict the size and diversity of the primary immune response.	Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	mmdavis@stanford.edu		Davis, Mark/0000-0001-6868-657X				Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; CANCRO MP, 1978, J EXP MED, V147, P776, DOI 10.1084/jem.147.3.776; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; KINDT TJ, 1984, ANTIBODY ENLGMA; Mallet-Designe VI, 2003, J IMMUNOL, V170, P123, DOI 10.4049/jimmunol.170.1.123; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476	10	4	4	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					179	180		10.1016/j.immuni.2007.08.005	http://dx.doi.org/10.1016/j.immuni.2007.08.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723209	Bronze			2022-12-18	WOS:000249056300002
J	van Kooyk, Y; Geijtenbeek, TBH				van Kooyk, Yvette; Geijtenbeek, Teunis B. H.			Toll-like receptors keep antigen sorting on the right track	IMMUNITY			English	Editorial Material							DENDRITIC CELLS	In this issue of Immunity, Yarovinsky et al. (2006) provide new in vivo insights into the concept that antigen recognition by TLR is more than APC costimulation and regulates antigen processing and presentation to create specific microbial immunity.	Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands		van Kooyk, Y (corresponding author), Dept Mol Cell Biol & Immunol, Van Der Boechorststr 7,POB 7057, NL-1007 MB Amsterdam, Netherlands.		Geijtenbeek, Teunis/C-2229-2009	Van Kooyk, Yvette/0000-0001-5997-3665				Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015	9	4	4	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					525	527		10.1016/j.immuni.2006.09.006	http://dx.doi.org/10.1016/j.immuni.2006.09.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17046679	Bronze			2022-12-18	WOS:000241481500003
J	Stadanlick, JE; Cancro, MP				Stadanlick, Jason E.; Cancro, Michael P.			Unraveling the warp and weft of B cell fate	IMMUNITY			English	Editorial Material								Two recent Immunity articles (Enzler et al., 2006; Sasaki et al., 2006) probe the roles of Nuclear Factor K-B (NF-kappa B) pathways in survival and differentiation mediated by B cell activation factor of the TNF family (BAFF).	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Stadanlick, JE (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 284 John Morgan, Philadelphia, PA 19104 USA.			Cancro, Michael/0000-0002-8659-3227				Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Harless SM, 2001, CURR BIOL, V11, P1986, DOI 10.1016/S0960-9822(01)00598-X; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010	7	4	4	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2006	25	3					395	396		10.1016/j.immuni.2006.09.001	http://dx.doi.org/10.1016/j.immuni.2006.09.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16979572	Bronze			2022-12-18	WOS:000240862200007
J	Holl, TM; Kelsoe, G				Holl, TM; Kelsoe, G			Outside influence: TLRs direct hematopoietic cell fates	IMMUNITY			English	Editorial Material							TOLL-LIKE RECEPTORS; BONE-MARROW; INFLAMMATION	Toll-like receptors (TLRs) modulate immune responses indirectly by promoting the efficacy of antigen presentation. In this issue of Immunity, Nagai et al. (2006) demonstrate that TLR signals also bias hematopoietic progenitor cells toward myelopoiesis directly by replacing cytokine and differentiative cues.	Duke Univ, Dept Immunol, Durham, NC 27710 USA	Duke University	Holl, TM (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27710 USA.							Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Ferrandon D, 2004, SEMIN IMMUNOL, V16, P43, DOI 10.1016/j.smim.2003.10.008; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Pasare C, 2006, NATURE, V441, pE4, DOI 10.1038/nature04876; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779	11	4	4	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2006	24	6					667	669		10.1016/j.immuni.2006.06.007	http://dx.doi.org/10.1016/j.immuni.2006.06.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782021	Bronze			2022-12-18	WOS:000238592200003
J	Lineberry, N; Fathman, CG				Lineberry, N; Fathman, CG			T cell anergy: Where it's LAT	IMMUNITY			English	Editorial Material							LINKER	T cell receptor engagement activates selective signaling pathways in T lymphocytes under different conditions. In this issue of Immunity, Hundt et al. (2006) demonstrate that anergic T cells are selectively defective in LAT activation.	Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA	Stanford University	Lineberry, N (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007290] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Borde M, 2006, IMMUNOL REV, V210, P105, DOI 10.1111/j.0105-2896.2006.00370.x; Brignatz C, 2005, BBA-MOL CELL RES, V1746, P108, DOI 10.1016/j.bbamcr.2005.08.009; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Houtman JCD, 2005, FEBS J, V272, P5426, DOI 10.1111/j.1742-4658.2005.04972.x; Hundt M, 2006, IMMUNITY, V24, P513, DOI 10.1016/j.immuni.2006.03.011; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110	9	4	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					501	503		10.1016/j.immuni.2006.05.002	http://dx.doi.org/10.1016/j.immuni.2006.05.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713965	Bronze			2022-12-18	WOS:000237970100004
J	Harrison, JM; Ramshaw, IA				Harrison, JM; Ramshaw, IA			Cytokines, skin, and smallpox - A new link to an antimicrobial peptide	IMMUNITY			English	Editorial Material							ATOPIC-DERMATITIS; IMMUNITY; VIRUS; LL-37	Patients with atopic dermatitis (AD) have an increased risk of infection with several viruses compared to patients with other inflammatory skin disorders such as psoriasis. In this issue of Immunity, Howell et al. (2006) find that the cytokine milieu in the skin of AD patients profoundly affects the innate response to vaccinia virus (VV) by blocking production of the antimicrobial peptide LL-37.	Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Harrison, JM (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.							Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Steinstraesser L, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-2; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	10	4	4	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2006	24	3					245	247		10.1016/j.immuni.2006.03.003	http://dx.doi.org/10.1016/j.immuni.2006.03.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546093	Bronze			2022-12-18	WOS:000236504500005
J	Lee, PT; Stacey, J				Lee, PT; Stacey, J			Fostering an immunology community	IMMUNITY			English	Editorial Material																			0	4	4	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2006	24	1					1	1		10.1016/j.immuni.2005.12.010	http://dx.doi.org/10.1016/j.immuni.2005.12.010			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT		Bronze			2022-12-18	WOS:000234850200001
J	Robey, E				Robey, E			The alpha beta versus gamma delta T cell fate decision: When less is more	IMMUNITY			English	Editorial Material							LINEAGE DECISION; COMMITMENT; SELECTION; PRE	How does signaling through receptors with very similar signaling pathways promote distinct cell fates? For the up alpha beta versus gamma delta T cell fate, quantitative differences in T cell antigen receptor signaling appear to be crucial.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Robey, E (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 471 Life Sci Addict, Berkeley, CA 94720 USA.							Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Robey E, 1998, CURR OPIN IMMUNOL, V10, P181, DOI 10.1016/S0952-7915(98)80247-1; Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; von Boehmer H, 1998, IMMUNOL REV, V165, P111; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7	12	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2005	22	5					533	534		10.1016/j.immuni.2005.04.005	http://dx.doi.org/10.1016/j.immuni.2005.04.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894269	Bronze			2022-12-18	WOS:000229447200001
J	Amin, RH; Schlissel, MS				Amin, RH; Schlissel, MS			NF-kappa B comes home	IMMUNITY			English	Editorial Material							IMMUNOGLOBULIN; ENHANCER; CELLS		Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Amin, RH (corresponding author), Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, 439 Life Sci Addit, Berkeley, CA 94720 USA.							Ait-Azzouzene D, 2005, J EXP MED, V201, P817, DOI 10.1084/jem.20041854; Diamant E, 2005, BLOOD, V105, P3247, DOI 10.1182/blood-2004-08-3165; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907	9	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2005	22	4					401	402		10.1016/j.immuni.2005.04.002	http://dx.doi.org/10.1016/j.immuni.2005.04.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845445	Bronze			2022-12-18	WOS:000228909600002
J	Reiner, SL				Reiner, SL			Immunity and the animation of the genome	IMMUNITY			English	Article							T-CELL DIFFERENTIATION; GENE-EXPRESSION; CHROMATIN; LYMPHOCYTE; MEMORY; HETEROCHROMATIN; PATTERNS; SELF		Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu						Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Greenwald RJ, 2002, CURR OPIN IMMUNOL, V14, P391, DOI 10.1016/S0952-7915(02)00341-2; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Murray James A. H., 2002, Developmental Cell, V2, P21, DOI 10.1016/S1534-5807(01)00115-0; PIRROTTA V, 1994, BIOESSAYS, V16, P549, DOI 10.1002/bies.950160808; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Reiner SL, 2001, CURR OPIN IMMUNOL, V13, P351, DOI 10.1016/S0952-7915(00)00226-0; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Smale ST, 2003, IMMUNITY, V19, P1, DOI 10.1016/S1074-7613(03)00180-8; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Tanaka EM, 2003, CELL, V113, P559, DOI 10.1016/S0092-8674(03)00395-7; Theise ND, 2003, NATURE, V425, P21, DOI 10.1038/425021a; WEINTRAUB H, 1977, COLD SPRING HARB SYM, V42, P401, DOI 10.1101/SQB.1978.042.01.042; Zamoyska R, 2003, CURR BIOL, V13, pR189, DOI 10.1016/S0960-9822(03)00121-0; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2003	19	6					775	780		10.1016/S1074-7613(03)00333-9	http://dx.doi.org/10.1016/S1074-7613(03)00333-9			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670295	Bronze			2022-12-18	WOS:000187230700003
J	Malissen, B				Malissen, B			Glimpses at TCR trans-species crossreactivity	IMMUNITY			English	Editorial Material							T-CELL-RECEPTOR; STRUCTURAL BASIS; ALLOREACTIVITY; RECOGNITION; RESTRICTION; MOLECULE; PEPTIDE		Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Malissen, B (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, Parc Sci Luminy,Case 906, F-13288 Marseille 9, France.		Malissen, Bernard/AAK-4659-2020	Malissen, Bernard/0000-0003-1340-9342				Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Firat H, 2002, INT IMMUNOL, V14, P925, DOI 10.1093/intimm/dxf056; Guimezanes A, 2001, EUR J IMMUNOL, V31, P421, DOI 10.1002/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942	10	4	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2003	19	4					463	464		10.1016/S1074-7613(03)00271-1	http://dx.doi.org/10.1016/S1074-7613(03)00271-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563309	Bronze			2022-12-18	WOS:000186051900001
J	Unanue, ER				Unanue, ER			Intracellular pathogens and antigen presentation - New challenges with Legionella pneumophila	IMMUNITY			English	Editorial Material							HUMAN-MONOCYTES; PHAGOSOMES; VACUOLES		Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Unanue, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.							ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BHARDWAJ N, 1986, J IMMUNOL, V137, P2662; DiPaolo RJ, 2002, J IMMUNOL, V169, P1; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261	7	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2003	18	6					722	724		10.1016/S1074-7613(03)00145-6	http://dx.doi.org/10.1016/S1074-7613(03)00145-6			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818153	Bronze			2022-12-18	WOS:000183767700002
J	Carbone, FR; Speck, PG				Carbone, FR; Speck, PG			Hide and seek: The immunology of HSV persistence	IMMUNITY			English	Article							HERPES-SIMPLEX VIRUS; INFECTED NEURONS; SENSORY NEURONS; TYPE-1; REACTIVATION; LATENCY	Herpes simplex virus (HSV) has been thought to persist as a latent infection by completely extinguishing antigen expression. In this issue of Immunity, Khanna et al. challenge this view by showing that CTL specific for antigens normally associated with active viral replication are crucial participants in regulating virus latency.	Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3050, Australia; Inst Med & Vet Sci, Infect Dis Labs, Adelaide, SA 5000, Australia	University of Melbourne; Institute Medical & Veterinary Science Australia	Carbone, FR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3050, Australia.		Carbone, Francis/ABF-2141-2020	Speck, Peter/0000-0001-9087-258X				Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; GESSER RM, 1994, VIROLOGY, V200, P791, DOI 10.1006/viro.1994.1243; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Sawtell NM, 2003, J VIROL, V77, P4127, DOI 10.1128/JVI.77.7.4127-4138.2003; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; SPECK PG, 1991, J VIROL, V65, P4001, DOI 10.1128/JVI.65.8.4001-4005.1991; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993	10	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					583	584		10.1016/S1074-7613(03)00121-3	http://dx.doi.org/10.1016/S1074-7613(03)00121-3			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753733	Bronze			2022-12-18	WOS:000182962200001
J	Silvin, A; Uderhardt, S; Piot, C; Da Mesquita, S; Yang, KTRE; Geirsdottir, L; Mulder, K; Eyal, D; Liu, ZY; Bridlance, C; Thion, MS; Zhang, XM; Kong, WT; Deloger, M; Fontes, V; Weiner, A; Ee, R; Dress, R; Hang, JW; Balachander, A; Chakarov, S; Malleret, B; Dunsmore, G; Cexus, O; Chen, JM; Garel, S; Dutertre, CA; Amit, I; Kipnis, J; Ginhoux, F				Silvin, Aymeric; Uderhardt, Stefan; Piot, Cecile; Da Mesquita, Sandro; Yang, Katharine; Geirsdottir, Laufey; Mulder, Kevin; Eyal, David; Liu, Zhaoyuan; Bridlance, Cecile; Thion, Morgane Sonia; Zhang, Xiao Meng; Kong, Wan Ting; Deloger, Marc; Fontes, Vasco; Weiner, Assaf; Ee, Rachel; Dress, Regine; Hang, Jing Wen; Balachander, Akhila; Chakarov, Svetoslav; Malleret, Benoit; Dunsmore, Garett; Cexus, Olivier; Chen, Jinmiao; Garel, Sonia; Dutertre, Charles Antoine; Amit, Ido; Kipnis, Jonathan; Ginhoux, Florent			Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration	IMMUNITY			English	Article							ALZHEIMERS-DISEASE; RNA-SEQ; CELLS; FATE; REVEALS; MYELINOGENESIS; PATHOLOGY; IDENTITY; PACKAGE; ORIGIN	Brain macrophage populations include parenchymal microglia, border-associated macrophages, and recruited monocyte-derived cells; together, they control brain development and homeostasis but are also implicated in aging pathogenesis and neurodegeneration. The phenotypes, localization, and functions of each population in different contexts have yet to be resolved. We generated a murine brain myeloid scRNA-seq integration to systematically delineate brain macrophage populations. We show that the previ-ously identified disease-associated microglia (DAM) population detected in murine Alzheimer's disease models actually comprises two ontogenetically and functionally distinct cell lineages: embryonically derived triggering receptor expressed on myeloid cells 2 (TREM2)-dependent DAM expressing a neuroprotective signature and monocyte-derived TREM2-expressing disease inflammatory macrophages (DIMs) accumu-lating in the brain during aging. These two distinct populations appear to also be conserved in the human brain. Herein, we generate an ontogeny-resolved model of brain myeloid cell heterogeneity in development, homeostasis, and disease and identify cellular targets for the treatment of neurodegeneration.	[Silvin, Aymeric; Piot, Cecile; Yang, Katharine; Zhang, Xiao Meng; Kong, Wan Ting; Ee, Rachel; Dress, Regine; Balachander, Akhila; Chakarov, Svetoslav; Malleret, Benoit; Chen, Jinmiao; Dutertre, Charles Antoine; Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore; [Silvin, Aymeric; Mulder, Kevin; Dunsmore, Garett; Cexus, Olivier; Dutertre, Charles Antoine; Ginhoux, Florent] INSERM, U1015, Gustave Roussy Canc Campus, F-94800 Villejuif, France; [Uderhardt, Stefan; Fontes, Vasco] Friedrich Alexander Univ Erlangen Nuernberg FAU, Dept Med Rheumatol & Immunol 3, D-91054 Erlangen, Germany; [Uderhardt, Stefan; Fontes, Vasco] Univ Klinikum Erlangen, D-91054 Erlangen, Germany; [Uderhardt, Stefan; Fontes, Vasco] FAU, Deutsch Zent Immuntherapie, D-91054 Erlangen, Germany; [Uderhardt, Stefan; Fontes, Vasco] FAU, Opt Imaging Ctr Erlangen, Exploratory Res Unit, D-91058 Erlangen, Germany; [Da Mesquita, Sandro; Kipnis, Jonathan] Univ Virginia, Ctr Brain Immunol & Glia, Dept Neurosci, Charlottesville, VA 22908 USA; [Da Mesquita, Sandro] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Geirsdottir, Laufey; Eyal, David; Weiner, Assaf; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Liu, Zhaoyuan; Chakarov, Svetoslav; Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai 200025, Peoples R China; [Bridlance, Cecile; Thion, Morgane Sonia; Garel, Sonia] PSL Res Univ, Inst Biol Ecole Normale Super IBENS, Ecole Normale Super, CNRS,INSERM, F-75005 Paris, France; [Deloger, Marc] CNRS, INSERM, Gustave Roussy Canc Campus, UMS 3655,US23, F-94800 Villejuif, France; [Hang, Jing Wen; Malleret, Benoit] Natl Univ Singapore, Life Sci Inst, Yong Loo Lin Sch Med, Dept Microbiol & Immunol,Immunol Translat Res Prog, Singapore 117543, Singapore; [Cexus, Olivier] Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Guildford GU2 7XH, England; [Kipnis, Jonathan] Washington Univ, Ctr Brain Immunol & Glia, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Virginia; Mayo Clinic; Weizmann Institute of Science; Chinese Academy of Sciences; Shanghai Jiao Tong University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; National University of Singapore; University of Surrey; Washington University (WUSTL)	Ginhoux, F (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore.; Ginhoux, F (corresponding author), INSERM, U1015, Gustave Roussy Canc Campus, F-94800 Villejuif, France.; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai 200025, Peoples R China.	florent_ginhoux@immunol.a-star.edu.sg	Garel, Sonia/P-4538-2017; Kipnis, Jonathan/AGG-9735-2022	Garel, Sonia/0000-0003-2984-3645; Kipnis, Jonathan/0000-0002-3714-517X; Bridlance, Cecile/0000-0001-8245-3457; Fontes, Vasco/0000-0001-8566-724X; Mulder, Kevin/0000-0002-1568-6581	A*STAR Singapore [IAF311006, H16/99/b0/011]; DFG [448121430, 448121523, 405969122]; ERC [101039438]; EMBO YIP; Singapore NRF Senior Investigatorship [NRFI2017-02]; NUHS Start-up grant [NUHSRO/2018/006/SU/01]; SIgN/A*STAR	A*STAR Singapore(Agency for Science Technology & Research (A*STAR)); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); EMBO YIP(European Molecular Biology Organization (EMBO)); Singapore NRF Senior Investigatorship(National Research Foundation, Singapore); NUHS Start-up grant; SIgN/A*STAR	We thank all the laboratory?s members for helpful discussions. Flow cytometry, cell sorting, and RNA library preparation were carried out on SIgN platformsestablished by A*STAR Singapore. SIgN platforms are supported by a BMRC IAF311006 grant and BMRC transition funds #H16/99/b0/011 from A*STAR. S.U. is supported by DFG (448121430, 448121523, and 405969122) and by ERC starting grant (101039438) . F.G. is supported by EMBO YIP, SIgN core funding (A*STAR) and Singapore NRF Senior Investigatorship (NRFI2017-02) . B.M. was funded by NUHS Start-up grant (NUHSRO/2018/006/SU/01) and core funds from SIgN/A*STAR. We also thank the Electron Microscopy Unit, National University of Singapore and the Research Support Centre A*STAR Microscopy Platform for Electron Microscopy and Analysis. We thank Insight Editing London for their help.	Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Butchart J, 2015, NEUROLOGY, V84, P2161, DOI 10.1212/WNL.0000000000001617; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Chou RC, 2016, CNS DRUGS, V30, P1111, DOI 10.1007/s40263-016-0374-z; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Da Mesquita S, 2021, NATURE, V593, P255, DOI 10.1038/s41586-021-03489-0; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Frigerio CS, 2019, CELL REP, V27, P1293, DOI 10.1016/j.celrep.2019.03.099; Gabande-Rodriguez E, 2019, EMBO J, V38, DOI 10.15252/embj.201899553; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hu YL, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109228; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jia JP, 2005, NEUROSCI LETT, V383, P12, DOI 10.1016/j.neulet.2005.03.051; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kracht L, 2020, SCIENCE, V369, P530, DOI 10.1126/science.aba5906; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kusnadi A, 2019, IMMUNITY, V51, P241, DOI 10.1016/j.immuni.2019.06.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee MO, 2012, ARTERIOSCL THROM VAS, V32, P343, DOI 10.1161/ATVBAHA.111.237651; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Low D, 2018, CELL IMMUNOL, V330, P68, DOI 10.1016/j.cellimm.2018.01.004; Lund H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07295-7; Marschallinger J, 2020, NAT NEUROSCI, V23, P194, DOI 10.1038/s41593-019-0566-1; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Mrdjen D, 2018, IMMUNITY, V48, P599, DOI 10.1016/j.immuni.2018.02.014; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Paouri E, 2017, J NEUROSCI, V37, P5155, DOI 10.1523/JNEUROSCI.2484-16.2017; Parihar VK, 2015, BRAIN STRUCT FUNCT, V220, P1161, DOI 10.1007/s00429-014-0709-9; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rustenhoven J, 2019, SCIENCE, V366, P1448, DOI 10.1126/science.aay0479; Shemer A, 2020, IMMUNITY, V53, P1033, DOI 10.1016/j.immuni.2020.09.018; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Thrupp N, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108189; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Vieth B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12266-7; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	69	3	3	8	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 9	2022	55	8					1448	+		10.1016/j.immuni.2022.07.004	http://dx.doi.org/10.1016/j.immuni.2022.07.004			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W7VU	35931085				2022-12-18	WOS:000860366700001
J	Yang, XG; Chen, J; Wang, J; Ma, S; Feng, WX; Wu, ZH; Guo, YY; Zhou, H; Mi, WL; Chen, W; Yin, B; Lin, YL				Yang, Xuguang; Chen, Jie; Wang, Jun; Ma, Shuai; Feng, Wenxue; Wu, Zhihao; Guo, Yangyang; Zhou, Hong; Mi, Wenli; Chen, Wei; Yin, Bo; Lin, Yuli			Very-low-density lipoprotein receptor-enhanced lipid metabolism in pancreatic stellate cells promotes pancreatic fibrosis	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; TRIGLYCERIDE-RICH LIPOPROTEINS; ENDOPLASMIC-RETICULUM STRESS; VLDL RECEPTOR; MATRIX SYNTHESIS; INTERLEUKIN 33; MOUSE MODEL; CYTOKINE; IL-33; EXPRESSION	Lipoprotein disorder is a common feature of chronic pancreatitis (CP); however, the relationship between lipoprotein disorder and pancreatic fibrotic environment is unclear. Here, we investigated the occurrence and mechanism of pancreatic stellate cell (PSC) activation by lipoprotein metabolites and the subsequent regulation of type 2 immune responses, as well as the driving force of fibrotic aggressiveness in CP. Single-cell RNA sequencing revealed the heterogeneity of PSCs and identified very-low-density lipoprotein receptor (VLDLR)(+) PSCs that were characterized by a higher lipid metabolism. VLDLR promoted intracellular lipid accumulation, followed by interleukin-33 (IL-33) expression and release in PSCs. PSC-derived IL-33 strongly induced pancreatic group 2 innate lymphoid cells (ILC2s) to trigger a type 2 immune response accompanied by the activation of PSCs, eventually leading to fibrosis during pancreatitis. Our findings indicate that VLDLR-enhanced lipoprotein metabolism in PSCs promotes pancreatic fibrosis and highlight a dominant role of IL-33 in this pro-fibrotic cascade.	[Yang, Xuguang; Chen, Wei] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Clin Res Ctr, Shanghai 200032, Peoples R China; [Yang, Xuguang; Guo, Yangyang; Lin, Yuli] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China; [Yang, Xuguang; Lin, Yuli] Fudan Univ, Shanghai Pudong Hosp, Shanghai 201399, Peoples R China; [Chen, Jie; Wu, Zhihao] Shanghai Jiao Tong Univ, Dept Pediat Surg, Xinhua Hosp, Sch Med, Shanghai 200032, Peoples R China; [Chen, Jie] Jiaxing Univ, Dept Pediat Surg, Jiaxing Matern & Child Hlth Care Hosp, Jiaxing 314000, Peoples R China; [Wang, Jun] Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200032, Peoples R China; [Ma, Shuai] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Div Nephrol, Sch Med, Shanghai 200032, Peoples R China; [Feng, Wenxue; Yin, Bo] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200032, Peoples R China; [Zhou, Hong] Anhui Med Univ, Dept Immunol, An Hui 230031, Peoples R China; [Mi, Wenli] Fudan Univ, Sch Basic Med Sci, Inst Integrat Med, Dept Integrat Med & Neurobiol, Shanghai 200032, Peoples R China	Shanghai University of Traditional Chinese Medicine; Fudan University; Fudan University; Shanghai Jiao Tong University; Jiaxing University; Fudan University; Shanghai Jiao Tong University; Fudan University; Anhui Medical University; Fudan University	Yang, XG (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Clin Res Ctr, Shanghai 200032, Peoples R China.; Yang, XG; Lin, YL (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China.; Yang, XG; Lin, YL (corresponding author), Fudan Univ, Shanghai Pudong Hosp, Shanghai 201399, Peoples R China.; Yin, B (corresponding author), Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200032, Peoples R China.	xuguangyang11@fudan.edu.cn; yinbo7@163.com; yulilin@fudan.edu.cn	Yang, Xuguang/GNP-2847-2022; Lin, Yuli/GNP-4999-2022	Yang, Xuguang/0000-0002-6198-6008; Lin, Yuli/0000-0002-8779-2471; Guo, Yangyang/0000-0002-4765-885X	National Natural Science Foundation of China [91942313, 81900591]; innovative research team of high-level local universities in Shanghai-Clinical and basic research; Clinical Research Project of Health Industry of Shanghai Municipal Health Commission [201940508]; Medical Heath Science and Technology Project of Zhejiang Provincial Heath Commission [2022KY390, 2022RC271]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); innovative research team of high-level local universities in Shanghai-Clinical and basic research; Clinical Research Project of Health Industry of Shanghai Municipal Health Commission; Medical Heath Science and Technology Project of Zhejiang Provincial Heath Commission	This work was supported by National Natural Science Foundation of China (81900591), National Natural Science Foundation of China major research project (91942313), an innovative research team of high-level local universities in Shanghai-Clinical and basic research, Clinical Research Project of Health Industry of Shanghai Municipal Health Commission (201940508), and The Medical Heath Science and Technology Project of Zhejiang Provincial Heath Commission (2022KY390; 2022RC271).	Ahmadi A, 2016, CENT EUR J IMMUNOL, V41, P54, DOI 10.5114/ceji.2016.58816; Albrengues J, 2014, CELL REP, V7, P1664, DOI 10.1016/j.celrep.2014.04.036; Apte MV, 2000, GASTROENTEROLOGY, V118, P780, DOI 10.1016/S0016-5085(00)70148-X; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bellin MD, 2017, AM J GASTROENTEROL, V112, P1457, DOI 10.1038/ajg.2017.181; Beyer G, 2020, LANCET, V396, P499, DOI 10.1016/S0140-6736(20)31318-0; Biczo G, 2018, GASTROENTEROLOGY, V154, P689, DOI 10.1053/j.gastro.2017.10.012; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chu SG, 2019, AM J RESP CELL MOL, V61, P737, DOI 10.1165/rcmb.2018-0324OC; Cote GA, 2011, CLIN GASTROENTEROL H, V9, P266, DOI 10.1016/j.cgh.2010.10.015; Dalmas E, 2017, IMMUNITY, V47, P928, DOI 10.1016/j.immuni.2017.10.015; de Oliveira C, 2020, J CLIN INVEST, V130, P1931, DOI 10.1172/JCI132767; DOMINGUEZMUNOZ JE, 1995, INT J PANCREATOL, V18, P101; Esrefoglu M, 2012, WORLD J GASTROENTERO, V18, P5533, DOI 10.3748/wjg.v18.i39.5533; Ewald N, 2009, CURR OPIN LIPIDOL, V20, P497, DOI 10.1097/MOL.0b013e3283319a1d; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Goudriaan JR, 2004, J LIPID RES, V45, P1475, DOI 10.1194/jlr.M400009-JLR200; Hong YP, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8172714; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kempuraj D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056866; Klop B, 2013, CURR OPIN LIPIDOL, V24, P321, DOI 10.1097/MOL.0b013e3283606845; Kotsiou OS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02432; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Liu TJ, 2016, FASEB J, V30; Luttenberger T, 2000, LAB INVEST, V80, P47, DOI 10.1038/labinvest.3780007; Masamune A, 2010, AM J PHYSIOL-GASTR L, V299, pG821, DOI 10.1152/ajpgi.00178.2010; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Nguyen HN, 2017, IMMUNITY, V46, P220, DOI 10.1016/j.immuni.2017.01.004; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nishida A, 2010, GUT, V59, P531, DOI 10.1136/gut.2009.193599; Ouziel R, 2012, AM J PATHOL, V180, P2330, DOI 10.1016/j.ajpath.2012.03.009; Perides G, 2005, GUT, V54, P1461, DOI 10.1136/gut.2004.062919; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Phillips PA, 2003, GUT, V52, P275, DOI 10.1136/gut.52.2.275; Sankaran SJ, 2015, GASTROENTEROLOGY, V149, P1490, DOI 10.1053/j.gastro.2015.07.066; Santo SMSE, 2005, J LIPID RES, V46, P1097, DOI 10.1194/jlr.C500007-JLR200; Sesti-Costa R, 2013, J IMMUNOL, V191, P283, DOI 10.4049/jimmunol.1202806; Sherman MH, 2018, ANNU REV CELL DEV BI, V34, P333, DOI 10.1146/annurev-cellbio-100617-062855; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; TASKINEN MR, 1987, AM HEART J, V113, P458, DOI 10.1016/0002-8703(87)90614-4; Teratani T, 2019, HEPATOL COMMUN, V3, P1098, DOI 10.1002/hep4.1383; Teratani T, 2012, GASTROENTEROLOGY, V142, P152, DOI 10.1053/j.gastro.2011.09.049; TOSKES PP, 1990, GASTROENTEROL CLIN N, V19, P783; Watanabe T, 2017, MUCOSAL IMMUNOL, V10, P283, DOI 10.1038/mi.2016.101; Watanabe T, 2017, J IMMUNOL, V198, P3886, DOI 10.4049/jimmunol.1700060; Zhang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1969-3	53	3	3	9	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1185	+		10.1016/j.immuni.2022.06.001	http://dx.doi.org/10.1016/j.immuni.2022.06.001			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35738281				2022-12-18	WOS:000831554100011
J	Bhattacharya, D				Bhattacharya, Deepta			Instructing durable humoral immunity for COVID-19 and other vaccinable diseases	IMMUNITY			English	Review							MEMORY B-CELLS; LIVED PLASMA-CELLS; NEUTRALIZING ANTIBODY-RESPONSES; MESSENGER-RNA VACCINATION; GERMINAL CENTER; BONE-MARROW; HUMAN-PAPILLOMAVIRUS; AFFINITY MATURATION; SEROLOGICAL MEMORY; INFLUENZA VACCINE	Many aspects of SARS-CoV-2 have fully conformed with the principles established by decades of viral immunology research, ultimately leading to the crowning achievement of highly effective COVID-19 vaccines. Nonetheless, the pandemic has also exposed areas where our fundamental knowledge is thinner. Some key unknowns are the duration of humoral immunity post-primary infection or vaccination and how long booster shots confer protection. As a corollary, if protection does not last as long as desired, what are some ways it can be improved? Here, I discuss lessons from other infections and vaccines that point to several key features that influence durable antibody production and the perseverance of immunity. These include (1) the specific innate sensors that are initially triggered, (2) the kinetics of antigen delivery and persistence, (3) the starting B cell receptor (BCR) avidity and antigen valency, and (4) the memory B cell subsets that are recalled by boosters. I further highlight the fundamental B cell-intrinsic and B cellextrinsic pathways that, if understood better, would provide a rational framework for vaccines to reliably provide durable immunity.	[Bhattacharya, Deepta] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA	University of Arizona	Bhattacharya, D (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA.	deeptab@arizona.edu			National Institutes of Health [R01AI099108, R01AI129945]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants R01AI099108 and R01AI129945 from the National Institutes of Health (D.B.). Figures were created with Biorender.com.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Alameh MG, 2021, IMMUNITY, V54, P2877, DOI 10.1016/j.immuni.2021.11.001; Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Alu A, 2022, EBIOMEDICINE, V76, DOI 10.1016/j.ebiom.2022.103841; Amanat F, 2021, CELL, V184, P3936, DOI 10.1016/j.cell.2021.06.005; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Anghelina D, 2016, J VIROL, V90, P5915, DOI 10.1128/JVI.00500-16; Antunes RD, 2021, J INFECT DIS, V224, P70, DOI 10.1093/infdis/jiab176; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bangaru S, 2020, SCIENCE, V370, P1089, DOI 10.1126/science.abe1502; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Barda N, 2021, LANCET, V398, P2093, DOI 10.1016/S0140-6736(21)02249-2; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Behring E. v, 1913, DEUT MED WOCHENSCHR, V39, P873, DOI [10.1055/s-0028-1128380, DOI 10.1055/S-0028-1128380]; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Bemark M, 2011, J IMMUNOL, V186, P1399, DOI 10.4049/jimmunol.1002881; Benet Z, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108733; BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bharat Biotech International Limited, 2021, PHAS 1 RAND DOUBL BL; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Bohannon C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11826; Bortnick A, 2018, EUR J IMMUNOL, V48, P815, DOI 10.1002/eji.201747229; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Brynjolfsson SF, 2017, BLOOD ADV, V1, P835, DOI 10.1182/bloodadvances.2017004481; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Chakraborty S, 2021, NAT IMMUNOL, V22, P67, DOI [10.1038/s41590-020-00828-7, 10.1101/2020.05.15.20103341]; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chatterjee D, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110429; Chernova I, 2014, J IMMUNOL, V193, P4971, DOI 10.4049/jimmunol.1401264; Chevrier S, 2009, P NATL ACAD SCI USA, V106, P3895, DOI 10.1073/pnas.0809736106; Chia PY, 2022, CLIN MICROBIOL INFEC, V28, DOI 10.1016/j.cmi.2021.11.010; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Cocco M, 2012, J IMMUNOL, V189, P5773, DOI 10.4049/jimmunol.1103720; Cohen AA, 2021, SCIENCE, V371, P735, DOI 10.1126/science.abf6840; Collie S, 2022, NEW ENGL J MED, V386, P494, DOI 10.1056/NEJMc2119270; Cortes M, 2004, J EXP MED, V199, P209, DOI 10.1084/jem.20031571; Cravedi P, 2013, AM J TRANSPLANT, V13, P2696, DOI 10.1111/ajt.12404; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Crotty S, 2021, SCIENCE, V372, P1392, DOI 10.1126/science.abj2258; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Davis CW, 2020, SCIENCE, V370, P237, DOI 10.1126/science.aaz8432; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dolgin E, 2022, NAT REV DRUG DISCOV, V21, P324, DOI 10.1038/d41573-022-00074-6; Domeier PP, 2017, AUTOIMMUNITY, V50, P4, DOI 10.1080/08916934.2017.1280671; Edara VV, 2021, CELL HOST MICROBE, V29, P516, DOI 10.1016/j.chom.2021.03.009; Edridge AWD, 2020, NAT MED, V26, P1691, DOI 10.1038/s41591-020-1083-1; Eguia RT, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009453; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Einstein MH, 2014, HUM VACC IMMUNOTHER, V10, P3455, DOI 10.4161/hv.36117; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; El Sahly HM, 2021, NEW ENGL J MED, V385, P1774, DOI 10.1056/NEJMoa2113017; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; FAGRAEUS A, 1948, J IMMUNOL, V58, P1; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; Flaxman A, 2021, LANCET, V398, P981, DOI 10.1016/S0140-6736(21)01699-8; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; G. Regev, 2022, medRxiv, DOI 10.1101/2021.08.01.21261297; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006]; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Geers D, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1750; GeurtsvanKessel CH, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abo2202; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Goel RR, 2022, CELL, V185, P1875, DOI 10.1016/j.cell.2022.04.009; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Greaney AJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24435-8; Greaney AJ, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100257; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; HAN SH, 1995, J IMMUNOL, V155, P556; HANNA MG, 1968, J IMMUNOL, V101, P949; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Israel A, 2022, VACCINES-BASEL, V10, DOI [10.3390/vaccines10010064, 10.1101/2021.08.19.21262111]; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Jacobsen JT, 2021, SCIENCE, V373, DOI 10.1126/science.abe5146; Jash A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51860-z; Jash A, 2016, J IMMUNOL, V197, P1159, DOI 10.4049/jimmunol.1600882; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Johnson S, 2022, J INFECT DIS, V225, P34, DOI 10.1093/infdis/jiab561; Jourdan M, 2014, LEUKEMIA, V28, P1647, DOI 10.1038/leu.2014.61; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Kang M., 2021, MEDRXIV, DOI [10.1101/2021.08.12.21261991, DOI 10.1101/2021.08.12.21261991]; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kato Y, 2020, IMMUNITY, V53, P548, DOI 10.1016/j.immuni.2020.08.001; Ke ZL, 2020, NATURE, V588, P498, DOI 10.1038/s41586-020-2665-2; Keitany GJ, 2016, CELL REP, V17, P3193, DOI 10.1016/j.celrep.2016.11.060; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kim EH, 2020, ELIFE, V9, DOI 10.7554/eLife.52687; Kim W, 2022, NATURE, V604, P141, DOI 10.1038/s41586-022-04527-1; King HAD, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106433118; Knox JJ, 2019, IMMUNOL REV, V288, P149, DOI 10.1111/imr.12736; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Lam WY, 2018, CELL REP, V24, P2479, DOI 10.1016/j.celrep.2018.07.084; Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011; Landsverk OJB, 2017, J EXP MED, V214, P309, DOI 10.1084/jem.20161590; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lederer K, 2022, CELL, V185, P1008, DOI 10.1016/j.cell.2022.01.027; Lee J.H., 2021, BIORXIV, DOI [10.1101/2021.12.20.473537, DOI 10.1101/2021.12.20.473537]; Li CF, 2022, NAT IMMUNOL, V23, P543, DOI 10.1038/s41590-022-01163-9; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lightman SM, 2021, IMMUNITY, V54, P2772, DOI 10.1016/j.immuni.2021.10.005; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Lipsitch M, 2020, SCIENCE, V370, P763, DOI 10.1126/science.abe5938; Lipsitch M, 2020, NAT REV IMMUNOL, V20, P709, DOI 10.1038/s41577-020-00460-4; Liu FL, 2017, J IMMUNOL, V199, P3293, DOI 10.4049/jimmunol.1700698; Liu XX, 2022, J INFECTION, V84, P795, DOI 10.1016/j.jinf.2022.04.018; Loyal L, 2021, SCIENCE, V374, P171, DOI 10.1126/science.abh1823; M. Jergovic, 2022, medRxiv, DOI 10.1101/2022.01.16.22269361; M. Koutsakos, 2021, medRxiv, DOI 10.1101/2021.12.23.21268285; Mahevas M, 2013, J CLIN INVEST, V123, P432, DOI 10.1172/JCI65689; Malherbe L, 2008, IMMUNITY, V28, P698, DOI 10.1016/j.immuni.2008.03.014; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Mao T., 2022, BIORXIV, DOI [10.1101/2022.01.24.477597v1., DOI 10.1101/2022.01.24.477597, 10.1101/2022.01.24.477597]; Marcandalli J, 2019, CELL, V176, P1420, DOI 10.1016/j.cell.2019.01.046; Martinez DR, 2021, SCIENCE, V373, P991, DOI [10.1126/science.abi4506, 10.1101/2021.03.11.434872]; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Mei HE, 2015, BLOOD, V125, P1739, DOI 10.1182/blood-2014-02-555169; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Muecksch F., 2022, BIORXIV, DOI [10.1101/2022.02.14.480394, DOI 10.1101/2022.02.14.480394]; Muecksch F, 2022, NATURE, V607, P128, DOI 10.1038/s41586-022-04778-y; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Muik A, 2022, SCIENCE, V375, P678, DOI 10.1126/science.abn7591; Munro APS, 2021, LANCET, V398, P2258, DOI 10.1016/S0140-6736(21)02717-3; Nahass GR., 2021, MEDRXIV, DOI [10.1101/2021.08.22.21262168, DOI 10.1101/2021.08.22.21262168V1, DOI 10.1101/2021.08.22.21262168]; Nelson D. L., 2000, LEHNINGER PRINCIPLES, V3; Nguyen DC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05853-7; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Obeng-Adjei N, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006576; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Pape KA, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109823; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Paulke-Korinek M, 2015, VACCINE, V33, P3600, DOI 10.1016/j.vaccine.2015.05.037; Payne RP, 2021, CELL, V184, P5699, DOI 10.1016/j.cell.2021.10.011; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Perez-Mazliah D, 2018, ELIFE, V7, DOI 10.7554/eLife.39800; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Popescu M, 2019, J IMMUNOL, V203, P2415, DOI 10.4049/jimmunol.1900484; Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218; Pracht K, 2017, EUR J IMMUNOL, V47, P1389, DOI 10.1002/eji.201747019; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; REED SE, 1984, J MED VIROL, V13, P179, DOI 10.1002/jmv.1890130208; Richard K, 2008, J IMMUNOL, V181, P1746, DOI 10.4049/jimmunol.181.3.1746; Ripperger TJ, 2021, ANNU REV IMMUNOL, V39, P345, DOI 10.1146/annurev-immunol-093019-125603; Ripperger TJ, 2020, IMMUNITY, V53, P925, DOI 10.1016/j.immuni.2020.10.004; Rodda LB, 2022, CELL, V185, P1588, DOI 10.1016/j.cell.2022.03.018; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.21203/rs.3.rs-57112/v1, 10.1101/2020.08.11.20171843]; Roltgen K, 2022, CELL, V185, P1025, DOI 10.1016/j.cell.2022.01.018; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Ryg-Cornejo V, 2016, CELL REP, V14, P68, DOI 10.1016/j.celrep.2015.12.006; Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Sagar M, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143380; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skowronski DM, MEDRXIV, V2021, DOI [10.26.21265397, 10.1101/2021.10.26.21265397, DOI 10.1101/2021.10.26.21265397]; Slifka MK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00956; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Sokal A, 2021, CELL, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Soresina A, 2020, PEDIAT ALLERG IMM-UK, V31, P565, DOI 10.1111/pai.13263; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tan CW, 2021, NEW ENGL J MED, V385, P1401, DOI 10.1056/NEJMoa2108453; Tanriover MD, 2021, LANCET, V398, P213, DOI 10.1016/S0140-6736(21)01429-X; Tarke A, 2022, CELL, V185, P847, DOI 10.1016/j.cell.2022.01.015; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100355; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Tauzin A, 2022, CELL HOST MICROBE, V30, P97, DOI 10.1016/j.chom.2021.12.004; Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; Thompson Mark G, 2022, MMWR Morb Mortal Wkly Rep, V71, P139, DOI 10.15585/mmwr.mm7104e3; Tian MJ, 2018, J IMMUNOL, V200, P937, DOI 10.4049/jimmunol.1701067; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Tooze RM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00460; Tso FY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247640; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Turner JS, 2020, NATURE, V586, P127, DOI 10.1038/s41586-020-2711-0; Ubelhart R, 2015, NAT IMMUNOL, V16, P534, DOI 10.1038/ni.3141; Utley A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107815; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; WAGNER DK, 1987, J CLIN MICROBIOL, V25, P559, DOI 10.1128/JCM.25.3.559-562.1987; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Walls AC, 2020, CELL, V183, P1367, DOI 10.1016/j.cell.2020.10.043; Wang HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18028-z; Wang YN, 2014, J EXP MED, V211, P841, DOI 10.1084/jem.20131821; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; Wilmore JR, 2017, J IMMUNOL, V199, P839, DOI 10.4049/jimmunol.1700461; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Wong R, 2020, IMMUNITY, V53, P1078, DOI 10.1016/j.immuni.2020.09.001; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Wu F, 2020, NATURE, V580, pE7; Xia SL, 2021, LANCET INFECT DIS, V21, P39, DOI 10.1016/S1473-3099(20)30831-8; Yewdell JW, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009509; Yewdell WT, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109961; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313; Zhang HX, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2005191118; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	276	3	3	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					945	964		10.1016/j.immuni.2022.05.004	http://dx.doi.org/10.1016/j.immuni.2022.05.004			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35637104	Bronze, Green Published			2022-12-18	WOS:000823293900002
J	Gargaro, M; Scalisi, G; Manni, G; Briseno, CG; Bagadia, P; Durai, V; Theisen, DJ; Kim, S; Castelli, M; Xu, CLA; zu Horste, GM; Servillo, G; Della Fazia, MA; Mencarelli, G; Ricciuti, D; Padiglioni, E; Giacche, N; Colliva, C; Pellicciari, R; Calvitti, M; Zelante, T; Fuchs, D; Orabona, C; Boon, L; Bessede, A; Colonna, M; Puccetti, P; Murphy, TL; Murphy, KM; Fallarino, F				Gargaro, Marco; Scalisi, Giulia; Manni, Giorgia; Briseno, Carlos G.; Bagadia, Prachi; Durai, Vivek; Theisen, Derek J.; Kim, Sunkyung; Castelli, Marilena; Xu, Chenling A.; zu Horste, Gerd Meyer; Servillo, Giuseppe; Della Fazia, Maria A.; Mencarelli, Giulia; Ricciuti, Doriana; Padiglioni, Eleonora; Giacche, Nicola; Colliva, Carolina; Pellicciari, Roberto; Calvitti, Mario; Zelante, Teresa; Fuchs, Dietmar; Orabona, Ciriana; Boon, Louis; Bessede, Alban; Colonna, Marco; Puccetti, Paolo; Murphy, Theresa L.; Murphy, Kenneth M.; Fallarino, Francesca			Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication	IMMUNITY			English	Article							ARYL-HYDROCARBON RECEPTOR; REGULATORY T-CELLS; DENDRITIC CELLS; TRYPTOPHAN CATABOLITES; ANTIGEN PRESENTATION; IDO; EXPRESSION; TOLERANCE; IRF8; KYNURENINE	Conventional dendritic cells (cDCs), cDC1 and cDC2, act both to initiate immunity and maintain self-tolerance. The tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) is used by cDCs in maintaining tolerance, but its role in different subsets remains unclear At homeostasis, only mature CCR7(+) cDC1 expressed IDO1 that was dependent on IRF8. Lipopolysaccharide treatment induced maturation and IDO1-dependent tolerogenic activity in isolated immature cDC1, but not isolated cDC2. However, both human and mouse cDC2 could induce IDO1 and acquire tolerogenic function when co-cultured with mature cDC1 through the action of cDC1-derived L-kynurenine. Accordingly, cDC1-specific inactivation of IDO1 in vivo exacerbated disease in experimental autoimmune encephalomyelitis. This study identifies a previously unrecognized metabolic communication in which IDO1-expressing cDC1 cells extend their immunoregulatory capacity to the cDC2 subset through their production of tryptophan metabolite L-kynurenine. This metabolic axis represents a potential therapeutic target in treating autoimmune demyelinating diseases.	[Gargaro, Marco; Scalisi, Giulia; Manni, Giorgia; Castelli, Marilena; Servillo, Giuseppe; Della Fazia, Maria A.; Mencarelli, Giulia; Ricciuti, Doriana; Padiglioni, Eleonora; Calvitti, Mario; Zelante, Teresa; Orabona, Ciriana; Puccetti, Paolo; Fallarino, Francesca] Univ Perugia, Dept Med & Surg, Perugia, Italy; [Gargaro, Marco; Briseno, Carlos G.; Bagadia, Prachi; Durai, Vivek; Theisen, Derek J.; Kim, Sunkyung; Colonna, Marco; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Xu, Chenling A.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Ctr Computat Biol, Berkeley, CA 94720 USA; [zu Horste, Gerd Meyer] Univ Hosp Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany; [Servillo, Giuseppe; Puccetti, Paolo; Fallarino, Francesca] Univ Perugia, Univ Res Ctr Funct Genom Curgef, Perugia, Italy; [Giacche, Nicola; Colliva, Carolina; Pellicciari, Roberto] TES Pharma, Loc Taverne, Corciano, Italy; [Fuchs, Dietmar] Innsbruck Med Univ, Div Biol Chem, Bioctr, Innsbruck, Austria; [Boon, Louis] Bioceros, Utrecht, Netherlands; [Bessede, Alban] Immusmol, Bordeaux, France; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	University of Perugia; Washington University (WUSTL); University of California System; University of California Berkeley; University of Munster; University of Perugia; Medical University of Innsbruck; Howard Hughes Medical Institute; Washington University (WUSTL)	Fallarino, F (corresponding author), Univ Perugia, Dept Med & Surg, Perugia, Italy.; Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Fallarino, F (corresponding author), Univ Perugia, Univ Res Ctr Funct Genom Curgef, Perugia, Italy.; Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	kmurphy@wustl.edu; francesca.fallarino@unipg.it	Boon, Laurence/HCI-3629-2022; Fallarino, Francesca/O-3358-2013; Gargaro, Marco/K-7077-2016	Fallarino, Francesca/0000-0002-8501-2136; Boon, Louis/0000-0002-0937-9171; Gargaro, Marco/0000-0003-0645-9800; Scalisi, Giulia/0000-0002-8128-0336; Servillo, Giuseppe/0000-0001-7960-7689	Italian Foundation for Cancer Research [AIRC 19903]; Telethon [GGP17094]; Prin [2017BZEREZ]; Italian Multiple Sclerosis Foundation [FISM 2019/R-single/012]; US National Institutes of Health [R01AI150297]	Italian Foundation for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); Prin(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Multiple Sclerosis Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supporting fundings: Italian Foundation for Cancer Research (AIRC 19903), Telethon (GGP17094), Prin 2017BZEREZ, and Italian Multiple Sclerosis Foundation (FISM 2019/R-single/012) to F.F; US National Institutes of Health (R01AI150297) to K.M.M.	Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; Askew D, 2008, IMMUNOLOGY, V123, P447, DOI 10.1111/j.1365-2567.2007.02711.x; Bacsi SG, 1996, J BIOL CHEM, V271, P8843, DOI 10.1074/jbc.271.15.8843; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bishnupuri KS, 2019, CANCER RES, V79, P1138, DOI 10.1158/0008-5472.CAN-18-0668; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Bottcher C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55852-x; Bosnjak B, 2022, IMMUNOL REV, V306, P137, DOI 10.1111/imr.13050; Breton G, 2016, J EXP MED, V213, P2861, DOI 10.1084/jem.20161135; Briseno CG, 2017, P NATL ACAD SCI USA, V114, P3957, DOI 10.1073/pnas.1619863114; Castelli M, 2020, EMBO REP, V21, DOI 10.15252/embr.201948073; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Deng MH, 2016, J INFECT DIS, V213, P1280, DOI 10.1093/infdis/jiv562; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Duarte JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079819; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Ferris ST, 2020, NATURE, V584, P624, DOI 10.1038/s41586-020-2611-3; FREI K, 1991, J NEUROIMMUNOL, V31, P147; Gaetani L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00157; Gao WX, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0499-0; Gomes P, 1999, BRAIN RES, V829, P143, DOI 10.1016/S0006-8993(99)01387-6; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Guyot E, 2013, DRUG DISCOV TODAY, V18, P479, DOI 10.1016/j.drudis.2012.11.014; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Kim S, 2020, IMMUNITY, V53, P759, DOI 10.1016/j.immuni.2020.07.018; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kowal J, 2019, INT REV CEL MOL BIO, V349, P213, DOI 10.1016/bs.ircmb.2019.08.005; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Lindenbergh MFS, 2018, ANNU REV IMMUNOL, V36, P435, DOI 10.1146/annurev-immunol-041015-055700; Manni G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00292; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Minarrieta L, 2017, SEMIN IMMUNOPATHOL, V39, P177, DOI 10.1007/s00281-016-0609-6; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Nuti R, 2014, J CHEM INF MODEL, V54, P3373, DOI 10.1021/ci5005459; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pallotta MT, 2014, J CELL MOL MED, V18, P2082, DOI 10.1111/jcmm.12360; Pasqual G, 2018, NATURE, V553, P496, DOI 10.1038/nature25442; Paterka M, 2017, J AUTOIMMUN, V76, P108, DOI 10.1016/j.jaut.2016.09.008; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Pulendran B, 2000, J IMMUNOL, V165, P566, DOI 10.4049/jimmunol.165.1.566; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Robertson H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.733231; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Schafflick D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14118-w; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Sharma MD, 2021, IMMUNITY, V54, P2354, DOI 10.1016/j.immuni.2021.09.005; Sinclair LV, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-04366-7, 10.1038/S41467-018-04366-7]; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sundaram G, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01844-y; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Takenaka MC, 2019, NAT NEUROSCI, V22, P729, DOI 10.1038/s41593-019-0370-y; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Theisen DJ, 2019, CANCER IMMUNOL RES, V7, P29, DOI 10.1158/2326-6066.CIR-18-0138; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; Torralba D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05077-9; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Uehori J, 2005, J IMMUNOL, V174, P7096, DOI 10.4049/jimmunol.174.11.7096; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vogel CFA, 2013, IMMUNOL CELL BIOL, V91, P568, DOI 10.1038/icb.2013.43; Von Bubnoff D, 2011, J IMMUNOL, V186, P6701, DOI 10.4049/jimmunol.1003151; Wohn C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba1896; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	87	3	3	12	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1032	+		10.1016/j.immuni.2022.05.013	http://dx.doi.org/10.1016/j.immuni.2022.05.013			34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35704993	hybrid, Green Published			2022-12-18	WOS:000823293900012
J	Emoto, T; Lu, J; Sivasubramaniyam, T; Maan, H; Khan, AB; Abow, AA; Schroer, SA; Hyduk, SJ; Althagafi, MG; McKee, TD; Fu, F; Shabro, S; Ulndreaj, A; Chiu, F; Paneda, E; Pacheco, S; Wang, T; Li, A; Jiang, JX; Libby, P; Husain, M; Wang, B; Rubin, BB; Cybulsky, MI; Robbins, CS				Emoto, Takuo; Lu, Jessie; Sivasubramaniyam, Tharini; Maan, Hassaan; Khan, Aniqa B.; Abow, Amina A.; Schroer, Stephanie A.; Hyduk, Sharon J.; Althagafi, Marwan G.; McKee, Trevor D.; Fu, Fred; Shabro, Shiva; Ulndreaj, Antigona; Chiu, Felix; Paneda, Elvira; Pacheco, Shaun; Wang, Tao; Li, Angela; Jiang, Jean X.; Libby, Peter; Husain, Mansoor; Wang, Bo; Rubin, Barry B.; Cybulsky, Myron I.; Robbins, Clinton S.			Colony stimulating factor-1 producing endothelial cells and mesenchymal stromal cells maintain monocytes within a perivascular bone marrow niche	IMMUNITY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; EXTRAMEDULLARY HEMATOPOIESIS; LISTERIA-MONOCYTOGENES; POSTNATAL-DEVELOPMENT; TISSUE MACROPHAGES; VASCULAR NICHES; STEM-CELLS; C/EBP-BETA; CSF-1; DIFFERENTIATION	Macrophage colony stimulating factor-1 (CSF-1) plays a critical role in maintaining myeloid lineage cells. However, congenital global deficiency of CSF-1 (Csf1(op/op)) causes severe musculoskeletal defects that may indirectly affect hematopoiesis. Indeed, we show here that osteolineage-derived Csf1 prevented developmental abnormalities but had no effect on monopoiesis in adulthood. However, ubiquitous deletion of Csf1 conditionally in adulthood decreased monocyte survival, differentiation, and migration, independent of its effects on bone development. Bone histology revealed that monocytes reside near sinusoidal endothelial cells (ECs) and leptin receptor (Lepr)-expressing perivascular mesenchymal stromal cells (MSCs). Targeted deletion of Csf1 from sinusoidal ECs selectively reduced Ly6C(-) monocytes, whereas combined depletion of Csf1 from ECs and MSCs further decreased Ly6C(hi) cells. Moreover, EC-derived CSF-1 facilitated recovery of Ly6C(-) monocytes and protected mice from weight loss following induction of polymicrobial sepsis. Thus, monocytes are supported by distinct cellular sources of CSF-1 within a perivascular BM niche.	[Emoto, Takuo; Sivasubramaniyam, Tharini; Schroer, Stephanie A.; Hyduk, Sharon J.; Ulndreaj, Antigona; Paneda, Elvira; Pacheco, Shaun; Husain, Mansoor; Cybulsky, Myron I.; Robbins, Clinton S.] Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Emoto, Takuo] Kobe Univ, Div Cardiovasc Med, Dept Internal Med, Grad Sch Med, Kobe, Hyogo, Japan; [Lu, Jessie; Abow, Amina A.; Althagafi, Marwan G.; Chiu, Felix; Cybulsky, Myron I.; Robbins, Clinton S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Maan, Hassaan] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Maan, Hassaan; Wang, Bo] Vector Inst Artificial Intelligence, Toronto, ON, Canada; [Khan, Aniqa B.; Li, Angela; Robbins, Clinton S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [McKee, Trevor D.; Fu, Fred; Shabro, Shiva] Univ Hlth Network, STTARR Innovat Ctr, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Wang, Tao] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Jiang, Jean X.] Univ Texas Hlth Sci Ctr, Dept Biochem & Struct Biol, San Antonio, TX USA; [Libby, Peter] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Husain, Mansoor] Ted Rogers Ctr Heart Res, Toronto, ON, Canada; [Husain, Mansoor; Wang, Bo; Rubin, Barry B.; Cybulsky, Myron I.; Robbins, Clinton S.] Peter Munk Cardiac Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Kobe University; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Texas System; University of Texas Health San Antonio; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; Peter Munk Cardiac Centre	Robbins, CS (corresponding author), Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada.; Robbins, CS (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Robbins, CS (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Robbins, CS (corresponding author), Peter Munk Cardiac Ctr, Toronto, ON, Canada.	clint.robbins@utoronto.ca	Wang, Bo/HDO-6738-2022	Wang, Bo/0000-0002-9620-3413; Hyduk, Sharon J./0000-0003-2862-0300; Emoto, Takuo/0000-0001-7425-4087	CIHR [376108, 426699, 463387]; Canada First Research Excellence Fund (CFREF); Toronto General Research Institute; SENSHIN Medical Research Foundation; US National Institutes of Health [AG045040]; Welch Foundation [AQ-1507]; Peter Munk Chair in Aortic Disease Research; Ontario Graduate Scholarship	CIHR(Canadian Institutes of Health Research (CIHR)); Canada First Research Excellence Fund (CFREF); Toronto General Research Institute; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Peter Munk Chair in Aortic Disease Research; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	We would like to acknowledge the administrative assistance of Bani Bali. This work was supported by CIHR awards (376108, 426699, 463387) and the Peter Munk Chair in Aortic Disease Research (C.S.R.) . This research is part of the University of Toronto?s Medicine by Design initiative, which receives funding from the Canada First Research Excellence Fund (CFREF) . T.E. and T.S. were supported by post-doctoral research scholarships awarded by the Tor-onto General Research Institute. T.E. was also supported by a scholarship from SENSHIN Medical Research Foundation. J.L. was supported by an On-tario Graduate Scholarship. J.X.J. was supported by US National Institutes of Health grant AG045040 and Welch Foundation grant AQ-1507.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Amezquita RA, 2020, NAT METHODS, V17, P137, DOI 10.1038/s41592-019-0654-x; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; BECKER S, 1987, J IMMUNOL, V139, P3703; BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237; Bettina A, 2016, J IMMUNOL, V196, P5047, DOI 10.4049/jimmunol.1600306; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chong SZ, 2016, J EXP MED, V213, P2293, DOI 10.1084/jem.20160800; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ehling M, 2013, DEVELOPMENT, V140, P3051, DOI 10.1242/dev.093351; Gamrekelashvili J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12597; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Germain PL, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02136-7; Gow DJ, 2010, J LEUKOCYTE BIOL, V88, P475, DOI 10.1189/jlb.0310158; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Guleria I, 2001, INFECT IMMUN, V69, P1795, DOI 10.1128/IAI.69.3.1795-1807.2001; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jassal B, 2020, NUCLEIC ACIDS RES, V48, pD498, DOI 10.1093/nar/gkz1031; Jenkins SJ, 2014, TRENDS IMMUNOL, V35, P358, DOI 10.1016/j.it.2014.06.006; Jin YX, 2002, INFECT IMMUN, V70, P4682, DOI 10.1128/IAI.70.8.4682-4686.2002; Kawamoto T, 2014, METHODS MOL BIOL, V1130, P149, DOI 10.1007/978-1-62703-989-5_11; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Lun Aaron T L, 2016, F1000Res, V5, P2122; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; McAlpine CS, 2019, NATURE, V566, P383, DOI 10.1038/s41586-019-0948-2; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Menke J, 2011, J AM SOC NEPHROL, V22, P1821, DOI 10.1681/ASN.2011010038; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Ogiku M, 2011, J SURG RES, V169, P106, DOI 10.1016/j.jss.2009.10.023; Paczkowska M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13983-9; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; PIERCE JH, 1990, P NATL ACAD SCI USA, V87, P5613, DOI 10.1073/pnas.87.15.5613; Pinho S., 2019, BLOOD, V20, P303, DOI DOI 10.1182/BLOOD.V90.4.1345.1345_1345_1364; Radi ZA, 2011, AM J PATHOL, V179, P240, DOI 10.1016/j.ajpath.2011.03.029; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Sauter KA, 2014, J LEUKOCYTE BIOL, V96, P265, DOI 10.1189/jlb.2A0114-006R; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sinha SK, 2021, ARTERIOSCL THROM VAS, V41, P220, DOI 10.1161/ATVBAHA.120.315255; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sudo T, 1995, ONCOGENE, V11, P2469; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tamura A, 2017, BLOOD, V130, P1809, DOI 10.1182/blood-2017-03-772962; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wei S, 2005, IMMUNOBIOLOGY, V210, P109, DOI 10.1016/j.imbio.2005.05.005; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; WIKTORJEDRZEJCZAK W, 1992, EXP HEMATOL, V20, P1004; Yao GQ, 2012, J BONE MINER METAB, V30, P408, DOI 10.1007/s00774-011-0336-y; Yao GQ, 2002, CALCIFIED TISSUE INT, V70, P339, DOI 10.1007/s00223-001-1079-x; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zhang JZ, 2021, NATURE, V590, P457, DOI 10.1038/s41586-021-03201-2; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024	86	3	3	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					862	+		10.1016/j.immuni.2022.04.005	http://dx.doi.org/10.1016/j.immuni.2022.04.005			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35508166				2022-12-18	WOS:000802171100011
J	Lockhart, A; Mucida, D; Parsa, R				Lockhart, Ainsley; Mucida, Daniel; Parsa, Roham			Immunity to enteric viruses	IMMUNITY			English	Review							ORAL POLIOVIRUS VACCINE; HUMAN ROTAVIRUS VACCINE; INTESTINAL HOMING RECEPTOR; MURINE NOROVIRUS INFECTION; LUNG DENDRITIC CELLS; CD8(+) T-CELLS; B-CELLS; ADENOVIRUS INFECTION; MUCOSAL IMMUNITY; RETINOIC ACID	Pathogenic enteric viruses are a major cause of morbidity and mortality, particularly among children in developing countries. The host response to enteric viruses occurs primarily within the mucosa, where the intestinal immune system must balance protection against pathogens with tissue protection and tolerance to harmless commensal bacteria and food. Here, we summarize current knowledge in natural immunity to enteric viruses, highlighting specialized features of the intestinal immune system. We further discuss how knowledge of intestinal anti-viral mechanisms can be translated into vaccine development with particular focus on immunization in the oral route. Research reveals that the intestine is a complex interface between enteric viruses and the host where environmental factors influence susceptibility and immunity to infection, while viral infections can have lasting implications for host health. A deeper mechanistic understanding of enteric anti-viral immunity with this broader context can ultimately lead to better vaccines for existing and emerging viruses.	[Lockhart, Ainsley; Mucida, Daniel; Parsa, Roham] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Mucida, Daniel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Mucida, D; Parsa, R (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA.; Mucida, D (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	mucida@rockefeller.edu; rparsa@rockefeller.edu	Parsa, Roham/AHA-7145-2022	Parsa, Roham/0000-0002-0864-6098; Mucida, Daniel/0000-0002-0000-0452	FASI/FARE Consortium; National Institute of Health [R01DK113375, R01DK093674]; Howard Hughes Medical Institute	FASI/FARE Consortium; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Y. Alvarez, B. Aydin, A. Bilate, G. Donaldson, and B. Reis for critical reading and discussion of the manuscript. This work was supported by the FASI/FARE Consortium and National Institute of Health grants R01DK113375 and R01DK093674 and the Howard Hughes Medical Institute (D.M.) . The un-published SARS-CoV-2 experiment described in Box 2 was done by R. Parsa, H.H. Hoffmann and M.C. Campos Canesso. Figures and tables were created with BioRender.com .	Alexander LN, 2004, JAMA-J AM MED ASSOC, V292, P1696, DOI 10.1001/jama.292.14.1696; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Angel J, 2012, CURR OPIN VIROL, V2, P419, DOI 10.1016/j.coviro.2012.05.003; [Anonymous], 1997, SCIENCE, DOI [DOI 10.1126/SCIENCE.275.5304.1320, 10.1126/science, 10.1126/science.275, DOI 10.1126/SCIENCE.275]; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Baldridge MT, 2017, J VIROL, V91, DOI 10.1128/JVI.02079-16; Baldridge MT, 2016, TRENDS MOL MED, V22, P1047, DOI 10.1016/j.molmed.2016.10.003; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Bandyopadhyay AS, 2015, FUTURE MICROBIOL, V10, P791, DOI [10.2217/FMB.15.19, 10.2217/fmb.15.19]; Banyai K, 2018, LANCET, V392, P175, DOI 10.1016/S0140-6736(18)31128-0; Barry MA, 2020, FEBS LETT, V594, P1918, DOI 10.1002/1873-3468.13731; Becker-Dreps S, 2015, PEDIATR INFECT DIS J, V34, P115, DOI 10.1097/INF.0000000000000481; Bein A, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.718484; Bhandari N, 2014, VACCINE, V32, pA110, DOI 10.1016/j.vaccine.2014.04.079; Bianchi FP, 2021, VACCINE, V39, P2989, DOI 10.1016/j.vaccine.2021.04.005; Bilate AM, 2020, IMMUNITY, V53, P1001, DOI 10.1016/j.immuni.2020.09.003; BISHOP RF, 1973, LANCET, V2, P1281, DOI 10.1016/s0140-6736(73)92867-5; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Blutt SE, 2012, MUCOSAL IMMUNOL, V5, P712, DOI 10.1038/mi.2012.51; Bouziat R, 2018, CELL HOST MICROBE, V24, P677, DOI 10.1016/j.chom.2018.10.004; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Brickley EB, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001613; Burke RM, 2020, J INFECT DIS, V222, P1076, DOI 10.1093/infdis/jiaa168; Burnett E, 2020, LANCET GLOB HEALTH, V8, pE1195, DOI 10.1016/S2214-109X(20)30262-X; Bushman FD, 2019, NAT MICROBIOL, V4, P1778, DOI 10.1038/s41564-019-0523-5; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Carty M, 2021, BIOCHEM PHARMACOL, V183, DOI 10.1016/j.bcp.2020.114316; Chachu KA, 2008, J VIROL, V82, P6610, DOI 10.1128/JVI.00141-08; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chard AN, 2020, MMWR-MORBID MORTAL W, V69, P784, DOI 10.15585/mmwr.mm6925a4; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Cheuvart B, 2014, HUM VACC IMMUNOTHER, V10, P505, DOI 10.4161/hv.27097; Ciabattini A, 2010, VACCINE, V28, P1226, DOI 10.1016/j.vaccine.2009.11.021; Coffey JW, 2021, ANNU REV PHARMACOL, V61, P517, DOI 10.1146/annurev-pharmtox-030320-092348; Collins ND, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030411; Connor RI, 2022, MUCOSAL IMMUNOL, V15, P1, DOI 10.1038/s41385-021-00428-0; Cunliffe N, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0295-2; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Declercq J, 2022, ALLERGY, V77, P304, DOI 10.1111/all.15101; Delorme-Axford E, 2011, VIRUSES-BASEL, V3, P2462, DOI 10.3390/v3122462; DHARAKUL T, 1990, J VIROL, V64, P4375, DOI 10.1128/JVI.64.9.4375-4382.1990; Di Niro R, 2010, J IMMUNOL, V185, P5377, DOI 10.4049/jimmunol.1001587; Dillon A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01499; DOMOK I, 1984, REV INFECT DIS, V6, pS413; Eggers HJ, 1999, J VIROL, V73, P4533, DOI 10.1128/JVI.73.6.4533-4535.1999; Elftman MD, 2013, J GEN VIROL, V94, P1761, DOI 10.1099/vir.0.052134-0; Emperador DM, 2016, CLIN INFECT DIS, V62, P150, DOI 10.1093/cid/civ807; Eriksson K, 1998, INFECT IMMUN, V66, P5889, DOI 10.1128/IAI.66.12.5889-5896.1998; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; FADEN H, 1990, J INFECT DIS, V162, P1291, DOI 10.1093/infdis/162.6.1291; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Faria AMC, 2017, J EXP MED, V214, P1211, DOI 10.1084/jem.20162014; Fejer G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000208; FLEWETT TH, 1973, LANCET, V2, P1497; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Franco MA, 1997, J VIROL, V71, P479, DOI 10.1128/JVI.71.1.479-486.1997; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; FRANCO MA, 1995, J VIROL, V69, P7800, DOI 10.1128/JVI.69.12.7800-7806.1995; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; GBD, 2019, GBD 2019 CAUS RISK; Gilbert SC, 2012, IMMUNOLOGY, V135, P19, DOI 10.1111/j.1365-2567.2011.03517.x; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Gomez-Rial J, 2020, J INFECTION, V81, P183, DOI 10.1016/j.jinf.2020.04.041; Gonzalez-Hernandez MB, 2014, J VIROL, V88, P6934, DOI 10.1128/JVI.00204-14; Gonzalez-Hernandez MB, 2013, J VIROL, V87, P12685, DOI 10.1128/JVI.02378-13; Grau KR, 2017, NAT MICROBIOL, V2, P1586, DOI 10.1038/s41564-017-0057-7; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Greber UF, 2019, ANNU REV VIROL, V6, P177, DOI 10.1146/annurev-virology-092818-015550; GRIMWOOD K, 1988, J CLIN MICROBIOL, V26, P732, DOI 10.1128/JCM.26.4.732-738.1988; Groome MJ, 2017, LANCET INFECT DIS, V17, P843, DOI [10.1016/S1473-3099(17)30242-6, 10.1016/s1473-3099(17)30242-6]; Guo M, 2021, NAT REV GASTRO HEPAT, V18, P269, DOI [10.1038/s41575-021-00416-6, 10.1080/14786419.2021.2011271]; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; Hagbom M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002115; Hallander HO, 2002, VACCINE, V21, P138, DOI 10.1016/S0264-410X(02)00348-1; Hallowell BD, 2022, J PEDIAT INF DIS SOC, V11, P149, DOI 10.1093/jpids/piab114; Hammerschmidt SI, 2011, J CLIN INVEST, V121, P3051, DOI 10.1172/JCI44262; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; HASHIMOTO K, 1966, JPN J MICROBIOL, V10, P115, DOI 10.1111/j.1348-0421.1966.tb00298.x; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; HILLEMAN MR, 1954, P SOC EXP BIOL MED, V85, P183, DOI 10.3181/00379727-85-20825; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; HoLmann M, 2020, CELL, V181, DOI [10.1016/ j.cell.2020.02.052, 10.1016/j.cell.2020.02.052, DOI 10.1016/J.CELL.2020.02.052]; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; HOLSHUE ML, 2020, NEW ENGL J MED, V382, P929, DOI [DOI 10.1056/NEJM0A2001191, 10.1056/NEJMoa2001191, DOI 10.1056/NEJMOA2001191]; HORNQUIST CE, 1995, J IMMUNOL, V155, P2877; Howley P.M.K., 2020, FIELDS VIROLOGY, VSeventh; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Ingle H, 2019, NAT MICROBIOL, V4, P1120, DOI 10.1038/s41564-019-0416-7; Ingle H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010046; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jertborn M, 2001, INFECT IMMUN, V69, P4125, DOI 10.1128/IAI.69.6.4125-4128.2001; Jiang JQ, 2008, J VIROL, V82, P6812, DOI 10.1128/JVI.00450-08; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Jiao L, 2021, GASTROENTEROLOGY, V160, P1647, DOI 10.1053/j.gastro.2020.12.001; Johansen FE, 2005, BLOOD, V106, P593, DOI 10.1182/blood-2004-12-4630; Johansson EL, 2004, VACCINE, V22, P984, DOI 10.1016/j.vaccine.2003.09.002; JOHN TJ, 1976, BRIT MED J, V1, P812, DOI 10.1136/bmj.1.6013.812; Johnson S, 2022, J INFECT DIS, V225, P34, DOI 10.1093/infdis/jiab561; Kang J, 2020, CLADISTICS, V36, P358, DOI 10.1111/cla.12422; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Karst S.M., 2003, SCIENCE, V299, P1575, DOI [10.1126/science.1077905, DOI 10.1126/SCIENCE.1077905]; Karst SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004626; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; KELLEY PW, 1991, JAMA-J AM MED ASSOC, V266, P2724, DOI 10.1001/jama.266.19.2724; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Khan S, 2014, J GEN VIROL, V95, P1668, DOI 10.1099/vir.0.064535-0; Kim L, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121077; Kim L, 2016, SCI REP-UK, V6, DOI 10.1038/srep37295; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P951, DOI 10.1073/pnas.88.3.951; Koutsakos M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01158; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Kuklin NA, 2000, J CLIN INVEST, V106, P1541, DOI 10.1172/JCI10927; Kuschner RA, 2013, VACCINE, V31, P2963, DOI 10.1016/j.vaccine.2013.04.035; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Kuss SK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000082; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Larsen SB, 2020, CURR OPIN IMMUNOL, V62, P45, DOI 10.1016/j.coi.2019.11.004; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lavelle EC, 2022, NAT REV IMMUNOL, V22, P236, DOI 10.1038/s41577-021-00583-2; Lee JM, 2016, CELL MOL IMMUNOL, V13, P862, DOI 10.1038/cmi.2015.73; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Liebowitz D, 2020, LANCET INFECT DIS, V20, P435, DOI 10.1016/S1473-3099(19)30584-5; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13; Lisulo MM, 2014, CLIN EXP IMMUNOL, V175, P468, DOI 10.1111/cei.12238; LITTLE LM, 1982, INFECT IMMUN, V38, P755, DOI 10.1128/IAI.38.2.755-763.1982; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; London M, 2021, NAT IMMUNOL, V22, P449, DOI 10.1038/s41590-021-00883-8; Lundgren O, 2001, MICROBES INFECT, V3, P1145, DOI 10.1016/S1286-4579(01)01475-7; LUSSIER G, 1987, LAB ANIM SCI, V37, P55; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Margolis R, 2010, ADV LIFE COURSE RES, V15, P132, DOI 10.1016/j.alcr.2010.10.001; Marshall JK, 2007, CLIN GASTROENTEROL H, V5, P457, DOI 10.1016/j.cgh.2006.11.025; Mayassi T, 2018, MUCOSAL IMMUNOL, V11, P1281, DOI 10.1038/s41385-018-0016-5; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; MCBEAN AM, 1988, AM J EPIDEMIOL, V128, P615, DOI 10.1093/oxfordjournals.aje.a115009; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; MCNEAL MM, 1995, VIROLOGY, V211, P474, DOI 10.1006/viro.1995.1429; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Merkenschlager J, 2021, NATURE, V591, P458, DOI 10.1038/s41586-021-03187-x; Modlin JF, 1997, J INFECT DIS, V175, pS228, DOI 10.1093/infdis/175.Supplement_1.S228; Moon SS, 2016, CLIN INFECT DIS, V62, P157, DOI 10.1093/cid/civ828; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Mwanza-Lisulo M, 2018, VACCINE, V36, P4134, DOI 10.1016/j.vaccine.2018.04.083; Nahass GR., 2021, MEDRXIV, DOI [10.1101/2021.08.22.21262168, DOI 10.1101/2021.08.22.21262168V1, DOI 10.1101/2021.08.22.21262168]; Nair N, 2016, MUCOSAL IMMUNOL, V9, P68, DOI 10.1038/mi.2015.36; Nathanson N, 2008, ADV VIRUS RES, V71, P1, DOI 10.1016/S0065-3527(08)00001-8; Neil JA, 2018, J IMMUNOL, V201, P1615, DOI 10.4049/jimmunol.1800631; Nelson AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048224; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newman KL, 2015, EUR J IMMUNOL, V45, P2742, DOI 10.1002/eji.201545512; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; NISHIO O, 1990, MICROBIOL IMMUNOL, V34, P683, DOI 10.1111/j.1348-0421.1990.tb01044.x; NISHIO O, 1992, MICROBIOL IMMUNOL, V36, P623, DOI 10.1111/j.1348-0421.1992.tb02062.x; Niu JL, 2019, CYTOKINE, V120, P115, DOI 10.1016/j.cyto.2019.04.019; Nomoto A, 2007, P JPN ACAD B-PHYS, V83, P266, DOI [10.2183/pjab.83.266, 10.2183/pjab/83.266]; O'Ryan M, 2009, EXPERT REV VACCINES, V8, P1627, DOI 10.1586/ERV.09.136; Ogier A, 2005, EUR J IMMUNOL, V35, P2122, DOI 10.1002/eji.200526059; OGRA PL, 1995, ANN NY ACAD SCI, V754, P97, DOI 10.1111/j.1749-6632.1995.tb44442.x; Olivares-Villagomez D, 2018, TRENDS IMMUNOL, V39, P264, DOI 10.1016/j.it.2017.11.003; Parker EPK, 2018, FUTURE MICROBIOL, V13, P97, DOI 10.2217/fmb-2017-0128; Parker EPK, 2014, J INFECT DIS, V210, P853, DOI 10.1093/infdis/jiu182; Parra M, 2014, VIROLOGY, V452, P191, DOI 10.1016/j.virol.2014.01.014; Parsa R., 2021, PREPRINT, DOI [10.1101/2021.11.10.468106, DOI 10.1101/2021.11.10.468106]; Pedersen R.M., 2022, CLIN MICROBIOL INFEC; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Platt LR, 2014, J INFECT DIS, V210, pS380, DOI 10.1093/infdis/jiu184; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; QuidingJarbrink M, 1997, J CLIN INVEST, V99, P1281, DOI 10.1172/JCI119286; Ramani S, 2015, J INFECT DIS, V212, P397, DOI 10.1093/infdis/jiv053; Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022; Velazguez FR, 2009, PEDIATR INFECT DIS J, V28, pS54, DOI 10.1097/INF.0b013e3181967c03; Razum O, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001633; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Rennels MB, 1996, J INFECT DIS, V174, pS107, DOI 10.1093/infdis/174.Supplement_1.S107; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Rodriguez-Diaz J, 2017, SCI REP-UK, V7, DOI 10.1038/srep45559; Rongsen-Chandola T, 2014, VACCINE, V32, pA134, DOI 10.1016/j.vaccine.2014.04.078; Roth AN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16798-1; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Ruane D, 2016, J EXP MED, V213, P53, DOI 10.1084/jem.20150567; Ruane D, 2013, J EXP MED, V210, P1871, DOI 10.1084/jem.20122762; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; SABIN AB, 1963, PEDIATRICS, V31, P623; De Jesus MCS, 2020, EXPERT REV VACCINES, V19, P585, DOI 10.1080/14760584.2020.1775081; Savy M, 2009, J NUTR, V139, p2154S, DOI 10.3945/jn.109.105312; Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15; Scallan CD, 2013, CLIN VACCINE IMMUNOL, V20, P85, DOI 10.1128/CVI.00552-12; Schlaudecker EP, 2011, CURR OPIN INFECT DIS, V24, P496, DOI 10.1097/QCO.0b013e328349287d; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; Shah MP, 2017, EXPERT REV VACCINES, V16, P987, DOI 10.1080/14760584.2017.1371595; SHERIDAN JF, 1983, INFECT IMMUN, V39, P917, DOI 10.1128/IAI.39.2.917-927.1983; Shi ZD, 2019, CELL, V179, P644, DOI 10.1016/j.cell.2019.09.028; Shulman LM, 2015, CLIN INFECT DIS, V60, P1057, DOI 10.1093/cid/ciu1136; Simmons K, 2013, EMERG INFECT DIS, V19, P1260, DOI 10.3201/eid1908.130472; Simonsen L, 2021, ELIFE, V10, DOI 10.7554/eLife.71974; SIVAK JG, 1978, INVEST OPHTH VIS SCI, V17, P705; Slifka MK, 1996, TRENDS MICROBIOL, V4, P394, DOI 10.1016/0966-842X(96)10059-7; Snider DP, 1999, INT IMMUNOL, V11, P191, DOI 10.1093/intimm/11.2.191; Stadnytskyi V, 2020, P NATL ACAD SCI USA, V117, P11875, DOI 10.1073/pnas.2006874117; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Svennerholm AM, 2021, J INFECT DIS, V224, pS821, DOI 10.1093/infdis/jiab475; Swamy M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8090; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Tan M, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.2; Tan XF, 2011, J VIROL, V85, P8316, DOI 10.1128/JVI.00781-11; Taniuchi M, 2016, VACCINE, V34, P3068, DOI 10.1016/j.vaccine.2016.04.080; Thackray LB, 2012, J VIROL, V86, P13515, DOI 10.1128/JVI.01824-12; Tickell KD, 2020, LANCET GLOB HEALTH, V8, pE215, DOI 10.1016/S2214-109X(19)30498-X; Tomov VT, 2017, IMMUNITY, V47, P723, DOI 10.1016/j.immuni.2017.09.017; Tomov VT, 2013, J VIROL, V87, P7015, DOI 10.1128/JVI.03389-12; Troeger C, 2018, LANCET INFECT DIS, V18, P1211, DOI 10.1016/S1473-3099(18)30362-1; Uchiyama R, 2015, INNATE IMMUN-LONDON, V21, P416, DOI 10.1177/1753425914547435; Uchiyama R, 2014, J INFECT DIS, V210, P171, DOI 10.1093/infdis/jiu037; UMEHARA K, 1984, MICROBIOL IMMUNOL, V28, P679, DOI 10.1111/j.1348-0421.1984.tb00722.x; Unicomb LE, 1996, MICROBIOL IMMUNOL, V40, P161, DOI 10.1111/j.1348-0421.1996.tb03320.x; van Konijnenburg DPH, 2017, CELL, V171, P783, DOI 10.1016/j.cell.2017.08.046; van Montfoort N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00182; van Splunter M, 2018, MUCOSAL IMMUNOL, V11, P1254, DOI 10.1038/s41385-018-0006-7; Van Winkle J.A., 2022, ELIFE, V11, P74072; Vekemans J, 2002, CLIN EXP IMMUNOL, V127, P495, DOI 10.1046/j.1365-2249.2002.01788.x; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Velazquez FR, 2000, J INFECT DIS, V182, P1602, DOI 10.1086/317619; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Wahid R, 2005, J VIROL, V79, P5988, DOI 10.1128/JVI.79.10.5988-5995.2005; Wang DW, 2020, J COASTAL RES, P1, DOI [10.1001/jama.2020.1585, 10.2112/JCR-SI109-001.1]; Wang ZJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1555; Wei J, 2006, J GEN VIROL, V87, P3393, DOI 10.1099/vir.0.82031-0; Wei J, 2009, VIRAL IMMUNOL, V22, P189, DOI 10.1089/vim.2008.0091; Williams MB, 1998, J IMMUNOL, V161, P4227; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wright PF, 2016, LANCET INFECT DIS, V16, P1377, DOI 10.1016/S1473-3099(16)30169-4; Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2; Ye L, 2019, NAT REV IMMUNOL, V19, P614, DOI 10.1038/s41577-019-0182-z; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Youngman KR, 2002, J IMMUNOL, V168, P2173, DOI 10.4049/jimmunol.168.5.2173; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999; Zhao CY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00211; ZHAORI G, 1988, J INFECT DIS, V158, P160, DOI 10.1093/infdis/158.1.160; Zhou L, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1605; Zhu S, 2016, MUCOSAL IMMUNOL, V9, P1559, DOI 10.1038/mi.2016.15; Zhu S, 2017, NATURE, V546, P667, DOI 10.1038/nature22967; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592; Zimmermann M, 2020, J INFECT DIS, V221, P561, DOI 10.1093/infdis/jiz488	270	3	3	11	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					800	818		10.1016/j.immuni.2022.04.007	http://dx.doi.org/10.1016/j.immuni.2022.04.007			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35545029				2022-12-18	WOS:000802171100005
J	Nathan, C				Nathan, Carl			Nonresolving inflammation redux	IMMUNITY			English	Review							NITRIC-OXIDE SYNTHASE; REGULATORY T-CELLS; NEUTROPHIL RECRUITMENT; CLONAL HEMATOPOIESIS; IMMUNE-RESPONSE; AIR-POLLUTION; I INTERFERON; ACTIVATION; RECEPTOR; INNATE	Nonresolving inflammation contributes to many diseases, including COVID-19 in its fatal and long forms. Our understanding of inflammation is rapidly evolving. Like the immune system of which it is a part, inflammation can now be seen as an interactive component of a homeostatic network with the endocrine and nervous systems. This review samples emerging insights regarding inflammatory memory, inflammatory aging, inflammatory cell death, inflammatory DNA, inflammation-regulating cells and metabolites, approaches to resolving or modulating inflammation, and inflammatory inequity.	[Nathan, Carl] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University	Nathan, C (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA.	cnathan@med.cornell.edu			Abby and Howard P. Milstein Program in Chemical Biology and Translational Medicine; Randolph Hearst Trust	Abby and Howard P. Milstein Program in Chemical Biology and Translational Medicine; Randolph Hearst Trust	Preparation of this review was supported by the Abby and Howard P. Milstein Program in Chemical Biology and Translational Medicine. The Department of Microbiology & Immunology is supported by the Randolph Hearst Trust.	Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Agirman G, 2021, SCIENCE, V374, P1087, DOI 10.1126/science.abi6087; Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Ma Lina, 2021, bioRxiv, DOI [10.1126/sciimmunol.abh2259, 10.1101/2021.02.22.432177]; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Avagyan S, 2021, SCIENCE, V374, P768, DOI 10.1126/science.aba9304; Balestrini A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201637; Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bhatnagar A, 2022, ANNU REV MED, V73, P393, DOI 10.1146/annurev-med-042220-011549; Bjornevik K, 2022, SCIENCE, V375, P296, DOI 10.1126/science.abj8222; Blacher E, 2022, NAT IMMUNOL, V23, P229, DOI 10.1038/s41590-021-01083-0; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Boothby IC, 2021, NATURE, V599, P667, DOI 10.1038/s41586-021-04044-7; Brandmaier A, 2020, SEMIN RADIAT ONCOL, V30, P139, DOI 10.1016/j.semradonc.2019.12.005; Braza MS, 2018, IMMUNITY, V49, P819, DOI 10.1016/j.immuni.2018.09.008; Caiado F, 2021, J EXP MED, V218, DOI 10.1084/jem.20201541; Caielli S, 2021, CELL, V184, P4464, DOI 10.1016/j.cell.2021.07.021; Cao W, 2022, J ENVIRON SCI, V111, P429, DOI 10.1016/j.jes.2021.04.021; Casanova JL, 2021, SCIENCE, V374, P1080, DOI 10.1126/science.abj7965; Chavakis T, 2019, NAT IMMUNOL, V20, P802, DOI 10.1038/s41590-019-0402-5; Chen MA, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.788351; Chen X, 2021, J EXP MED, V218, DOI 10.1084/jem.20210518; Chen YE, 2018, NATURE, V553, P427, DOI 10.1038/nature25177; Choudhury SR, 2019, CELL, V178, P1205, DOI 10.1016/j.cell.2019.07.017; Chung AW, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abj5070; Clark IC, 2021, SCIENCE, V372, P360, DOI 10.1126/science.abf1230; Cox MA, 2019, SCIENCE, V363, P639, DOI 10.1126/science.aau9072; Crainiciuc G, 2022, NATURE, V601, P415, DOI 10.1038/s41586-021-04263-y; Crow YJ, 2022, NAT REV IMMUNOL, V22, P471, DOI 10.1038/s41577-021-00633-9; De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9; De Miguel Z, 2021, NATURE, V600, P494, DOI 10.1038/s41586-021-04183-x; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Del Poggetto E, 2021, SCIENCE, V373, P1326, DOI 10.1126/science.abj0486; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1101/2020.05.28.20115758, 10.1038/s41591-020-1051-9]; Desdin-Mico G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860; Dey T, 2021, CHEM RES TOXICOL, V34, P669, DOI 10.1021/acs.chemrestox.0c00432; Di Domizio J, 2022, NATURE, V603, P145, DOI 10.1038/s41586-022-04421-w; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; DING AH, 1990, SCIENCE, V248, P370, DOI 10.1126/science.1970196; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; El-Gayar S, 2003, J IMMUNOL, V171, P4561, DOI 10.4049/jimmunol.171.9.4561; Faas M, 2021, IMMUNITY, V54, P2531, DOI 10.1016/j.immuni.2021.09.010; Frontera A, 2020, J INFECTION, V81, P255, DOI 10.1016/j.jinf.2020.05.031; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Goldfine AB, 2017, J CLIN INVEST, V127, P83, DOI 10.1172/JCI88884; Goldstein I., 1988, INFLAMMATION BASIC P; Gruber Conor, 2020, medRxiv, DOI [10.1016/j.cell.2020.09.034, 10.1101/2020.07.04.20142752]; Grunewald M, 2021, SCIENCE, V373, P533, DOI 10.1126/science.abc8479; He YM, 2018, NAT MED, V24, P224, DOI 10.1038/nm.4467; Henderson NC, 2020, NATURE, V587, P555, DOI 10.1038/s41586-020-2938-9; Hezaveh K, 2022, IMMUNITY, V55, P324, DOI 10.1016/j.immuni.2022.01.006; Hoang TN, 2021, CELL, V184, P460, DOI 10.1016/j.cell.2020.11.007; Hu W, 2021, NAT IMMUNOL, V22, P1163, DOI 10.1038/s41590-021-01001-4; Humphries F, 2020, SCIENCE, V369, P1633, DOI 10.1126/science.abb9818; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jaynes JM, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax6337; Kabata H, 2019, J CLIN INVEST, V129, P1475, DOI 10.1172/JCI124609; Kamerkar S, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abj7002; Kang YT, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141588; Karki Rajendra, 2021, Cell, V184, P149, DOI [10.1101/2020.10.29.361048, 10.1016/j.cell.2020.11.025]; Kayagaki N, 2021, NATURE, V591, P131, DOI 10.1038/s41586-021-03218-7; Kerur N, 2018, NAT MED, V24, P50, DOI 10.1038/nm.4450; Kim D, 2020, IMMUNITY, V53, P581, DOI 10.1016/j.immuni.2020.07.002; Kim E, 2022, IMMUNITY, V55, P145, DOI 10.1016/j.immuni.2021.11.005; Kioon MDA, 2021, J IMMUNOL, V206, P1631, DOI 10.4049/jimmunol.2000951; Kirk CJ, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11010009; Klein Robyn, 2021, Res Sq, DOI 10.21203/rs.3.rs-1031824/v1; Koeken VACM, 2020, J CLIN INVEST, V130, P5591, DOI 10.1172/JCI133935; Korner A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017527118; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kokosi T, 2021, PSYCHONEUROENDOCRINO, V123, DOI 10.1016/j.psyneuen.2020.105040; Koprivica I, 2022, INFLAMM RES, V71, P169, DOI 10.1007/s00011-021-01529-z; Koren T, 2021, CELL, V184, P5902, DOI 10.1016/j.cell.2021.10.013; Kosaka A, 2021, J EXP MED, V218, DOI 10.1084/jem.20200792; Kourtzelis I, 2019, NAT IMMUNOL, V20, P40, DOI 10.1038/s41590-018-0249-1; Krautkramer KA, 2021, NAT REV MICROBIOL, V19, P77, DOI 10.1038/s41579-020-0438-4; Lai JJ, 2020, IMMUNITY, V52, P123, DOI 10.1016/j.immuni.2019.11.013; Lam KC, 2021, CELL, V184, P5338, DOI 10.1016/j.cell.2021.09.019; Lamas B, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba0624; Li HZ, 2022, CANCER CELL, V40, P36, DOI 10.1016/j.ccell.2021.11.002; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Libby P, 2018, CIRCULATION, V138, P666, DOI 10.1161/CIRCULATIONAHA.118.034392; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Lim AI, 2021, SCIENCE, V373, DOI 10.1126/science.abf3002; Lima DS, 2021, CELL, V184, P3794, DOI 10.1016/j.cell.2021.05.020; Linden JR, 2015, MBIO, V6, DOI 10.1128/mBio.02513-14; Liu ZY, 2021, AUTOIMMUN REV, V20, DOI 10.1016/j.autrev.2021.102826; Lorenzo C, 2021, NATURE, V589, P287, DOI 10.1038/s41586-020-2993-2; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Mao CY, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.735590; Masetti M, 2021, J EXP MED, V219, DOI 10.1084/jem.20210564; Medzhitov R, 2021, SCIENCE, V374, P1070, DOI 10.1126/science.abi5200; Megli CJ, 2022, NAT REV MICROBIOL, V20, P67, DOI 10.1038/s41579-021-00610-y; Mendy A, 2021, RESP MED, V178, DOI 10.1016/j.rmed.2021.106313; Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005; Moreau JM, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg2329; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Nagashima H, 2019, IMMUNITY, V51, P682, DOI 10.1016/j.immuni.2019.06.009; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nathan C, 2021, SCIENCE, V373, P276, DOI 10.1126/science.abj5637; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Netea MG, 2017, NAT IMMUNOL, V18, P826, DOI 10.1038/ni.3790; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; Newton K, 2021, SCIENCE, V374, P1076, DOI 10.1126/science.abi5934; Niec RE, 2021, CELL, V184, P3361, DOI 10.1016/j.cell.2021.05.036; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; Orning P, 2019, J EXP MED, V216, P2453, DOI 10.1084/jem.20190545; Paccoud R, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abe2587; Patel DF, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax7006; Patriki D, 2022, CURR MED CHEM, V29, P251, DOI 10.2174/0929867328666210707192625; Pavlov VA, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a034140; Pavlov VA, 2018, ANNU REV IMMUNOL, V36, P783, DOI 10.1146/annurev-immunol-042617-053158; Peace CG, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI148548; Perry CJ, 2018, J EXP MED, V215, P877, DOI 10.1084/jem.20171435; Phetsouphanh C, 2022, NAT IMMUNOL, V23, P210, DOI 10.1038/s41590-021-01113-x; Plant T, 2020, J CLIN INVEST, V130, P3221, DOI 10.1172/JCI130834; Podstawka J, 2021, J EXP MED, V218, DOI 10.1084/jem.20210409; Pozzer A, 2020, CARDIOVASC RES, V116, P2247, DOI 10.1093/cvr/cvaa288; Priem B, 2020, CELL, V183, P786, DOI 10.1016/j.cell.2020.09.059; Qing H, 2020, CELL, V182, P372, DOI 10.1016/j.cell.2020.05.054; Rodrigues TS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201707; Rohm TV, 2022, IMMUNITY, V55, P31, DOI 10.1016/j.immuni.2021.12.013; Roquilly A, 2020, NAT IMMUNOL, V21, P636, DOI 10.1038/s41590-020-0673-x; Rosen DA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5266; Rossaint J, 2021, J EXP MED, V218, DOI 10.1084/jem.20201353; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Russo AJ, 2021, NAT IMMUNOL, V22, P154, DOI 10.1038/s41590-020-00844-7; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sanmarco LM, 2021, NATURE, V590, P473, DOI 10.1038/s41586-020-03116-4; Schaafsma W, 2017, NEUROBIOL DIS, V106, P291, DOI 10.1016/j.nbd.2017.07.017; Schlegel M, 2019, J CLIN INVEST, V129, P2165, DOI 10.1172/JCI128681; Shichita T, 2017, NAT MED, V23, P723, DOI 10.1038/nm.4312; Silvestre-Roig C, 2019, NATURE, V569, P236, DOI 10.1038/s41586-019-1167-6; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Spadaro O, 2022, SCIENCE, V375, P671, DOI 10.1126/science.abg7292; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Sun LJ, 2021, CANCER CELL, V39, P1361, DOI 10.1016/j.ccell.2021.08.005; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Temba GS, 2021, NAT IMMUNOL, V22, P287, DOI 10.1038/s41590-021-00867-8; Thompson DJ, 2019, NATURE, V575, P652, DOI 10.1038/s41586-019-1765-3; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Trowbridge JJ, 2021, J EXP MED, V218, DOI 10.1084/jem.20201544; Tyler PM, 2021, NAT IMMUNOL, V22, P1118, DOI 10.1038/s41590-021-00984-4; Veras FP, 2020, J EXP MED, V217, DOI 10.1084/jem.20201129; Victora CG, 2021, LANCET, V397, P1388, DOI 10.1016/S0140-6736(21)00394-9; Virtue AT, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav1892; Visnes T, 2018, SCIENCE, V362, P834, DOI 10.1126/science.aar8048; Vitek L, 2020, NEW ENGL J MED, V383, P684, DOI 10.1056/NEJMcibr2013250; von Hundelshausen P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6650; Vora SM, 2021, NAT REV IMMUNOL, V21, P694, DOI 10.1038/s41577-021-00588-x; Wang EY, 2021, NATURE, V595, P283, DOI [10.1038/s41586-021-03631-y, 10.1101/2020.12.10.20247205]; Wang L, 2022, J EXP MED, V219, DOI 10.1084/jem.20211147; Wang RC, 2020, NATURE, V580, P386, DOI 10.1038/s41586-020-2127-x; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0; Wypych TP, 2021, NAT IMMUNOL, V22, P279, DOI 10.1038/s41590-020-00856-3; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Xie Y, 2022, NAT MED, V28, P583, DOI 10.1038/s41591-022-01689-3; Yang H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102034118; Yim YS, 2017, NATURE, V549, P482, DOI 10.1038/nature23909; Yin CJ, 2019, NAT MED, V25, P496, DOI 10.1038/s41591-018-0336-8; Ytterberg SR, 2022, NEW ENGL J MED, V386, P316, DOI 10.1056/NEJMoa2109927; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang XL, 2018, J EXP MED, V215, P1365, DOI 10.1084/jem.20171417; Zheng RX, 2018, ECOTOX ENVIRON SAFE, V163, P612, DOI 10.1016/j.ecoenv.2018.07.076; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhu WF, 2021, CELL HOST MICROBE, V29, P1199, DOI 10.1016/j.chom.2021.05.002; Zweifach BW, 2014, INFLAMMATORY PROCESS	173	3	3	11	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					592	605		10.1016/j.immuni.2022.03.016	http://dx.doi.org/10.1016/j.immuni.2022.03.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35417674	Bronze, Green Published			2022-12-18	WOS:000788864600007
J	Peuker, K; Strigli, A; Tauriello, DVF; Hendricks, A; von Schonfels, W; Burmeister, G; Brosch, M; Herrmann, A; Kruger, S; Nitsche, J; Juznic, L; Geissler, MM; Hiergeist, A; Gessner, A; Wirbel, J; Ponnudurai, RP; Tunger, A; Wehner, R; Stange, DE; Weitz, J; Aust, DE; Baretton, GB; Schmitz, M; Rocken, C; Hampe, J; Hinz, S; Zeller, G; Chavakis, T; Schafmayer, C; Batlle, E; Zeissig, S				Peuker, Kenneth; Strigli, Anne; Tauriello, Daniele V. F.; Hendricks, Alexander; von Schonfels, Witigo; Burmeister, Greta; Brosch, Mario; Herrmann, Alexander; Krueger, Sandra; Nitsche, Jessica; Juznic, Lea; Geissler, Marc Marius; Hiergeist, Andreas; Gessner, Andre; Wirbel, Jakob; Ponnudurai, Ruby Priyadarshini; Tunger, Antje; Wehner, Rebekka; Stange, Daniel E.; Weitz, Juergen; Aust, Daniela E.; Baretton, Gustavo B.; Schmitz, Marc; Rocken, Christoph; Hampe, Jochen; Hinz, Sebastian; Zeller, Georg; Chavakis, Triantafyllos; Schafmayer, Clemens; Batlle, Eduard; Zeissig, Sebastian			Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3-and B7H4-dependent anti-tumor immunity in colorectal cancer	IMMUNITY			English	Article							B7 FAMILY-MEMBER; T-CELLS; EXPRESSION ANALYSIS; NUCLEAR FACTOR; MACROPHAGES; SELECTION; PACKAGE; B7-H4; TRANSPLANTATION; INFLAMMATION	Bacterial sensing by intestinal tumor cells contributes to tumor growth through cell-intrinsic activation of the calcineurin-NFAT axis, but the role of this pathway in other intestinal cells remains unclear Here, we found that myeloid-specific deletion of calcineurin in mice activated protective CD8(+) T cell responses and inhibited colorectal cancer (CRC) growth. Microbial sensing by myeloid cells promoted calcineurin- and NFAT-dependent interleukin 6 (IL-6) release, expression of the co-inhibitory molecules B7H3 and B7H4 by tumor cells, and inhibition of CD8(+) T cell-dependent anti-tumor immunity. Accordingly, targeting members of this pathway activated protective CD8(+) T cell responses and inhibited primary and metastatic CRC growth. B7H3 and B7H4 were expressed by the majority of human primary CRCs and metastases, which was associated with low numbers of tumor-infiltrating CD8(+) T cells and poor survival. Therefore, a microbiota-, calcineurin-, and B7H3/B7H4-dependent pathway controls anti-tumor immunity, revealing additional targets for immune checkpoint inhibition in microsatellite-stable CRC.	[Peuker, Kenneth; Strigli, Anne; Brosch, Mario; Herrmann, Alexander; Nitsche, Jessica; Juznic, Lea; Geissler, Marc Marius; Zeissig, Sebastian] Tech Univ TU Dresden, Univ Med Ctr Dresden, Dept Med 1, D-01307 Dresden, Germany; [Peuker, Kenneth; Strigli, Anne; Brosch, Mario; Herrmann, Alexander; Nitsche, Jessica; Juznic, Lea; Geissler, Marc Marius; Zeissig, Sebastian] Tech Univ TU Dresden, Ctr Regenerat Therapies Dresden CRTD, D-01307 Dresden, Germany; [Tauriello, Daniele V. F.; Batlle, Eduard] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Baldiri I Reixac 10, Barcelona 08028, Spain; [Tauriello, Daniele V. F.; Batlle, Eduard] Ctr Invest Biomed Red Canc CIBERONC, Barcelona 08028, Spain; [Hendricks, Alexander; von Schonfels, Witigo; Burmeister, Greta; Hinz, Sebastian; Schafmayer, Clemens] Univ Med Ctr Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; [Hendricks, Alexander; Burmeister, Greta; Hinz, Sebastian; Schafmayer, Clemens] Univ Med Rostock, Dept Gen Surg, D-18507 Rostock, Germany; [Krueger, Sandra; Rocken, Christoph] Univ Med Ctr Schleswig Holstein, Inst Pathol, D-24105 Kiel, Germany; [Hiergeist, Andreas; Gessner, Andre] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, D-93042 Regensburg, Germany; [Wirbel, Jakob; Ponnudurai, Ruby Priyadarshini; Zeller, Georg] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Tunger, Antje; Wehner, Rebekka; Schmitz, Marc] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Immunol, D-01307 Dresden, Germany; [Tunger, Antje; Wehner, Rebekka; Stange, Daniel E.; Weitz, Juergen; Schmitz, Marc] Natl Ctr Tumor Dis NCT, Partner Site Dresden, D-01307 Dresden, Germany; [Stange, Daniel E.; Weitz, Juergen; Hampe, Jochen] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Med Fac, Dept Visceral Thorac & Vasc Surg, D-01307 Dresden, Germany; [Stange, Daniel E.; Weitz, Juergen; Schmitz, Marc] German Canc Consortium DKTK, Partner Site Dresden, Dresden, Germany; [Stange, Daniel E.; Weitz, Juergen; Schmitz, Marc] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Aust, Daniela E.; Baretton, Gustavo B.] Tech Univ TU Dresden, Univ Med Ctr Dresden, Inst Pathol, Dresden, Germany; [Aust, Daniela E.] Tech Univ TU Dresden, Univ Med Ctr Dresden, Univ Canc Ctr UCC, Tumor & Normal Tissue Bank, Dresden, Germany; [Chavakis, Triantafyllos] Tech Univ TU Dresden, Univ Med Ctr Dresden, Inst Clin Chem & Lab Med, D-01307 Dresden, Germany; [Batlle, Eduard] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain; [Tauriello, Daniele V. F.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Cell Biol, POB 9101, NL-6500 HB Nijmegen, Netherlands	Technische Universitat Dresden; Technische Universitat Dresden; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Kiel; Schleswig Holstein University Hospital; University of Rostock; University of Kiel; Schleswig Holstein University Hospital; University of Regensburg; European Molecular Biology Laboratory (EMBL); Technische Universitat Dresden; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; ICREA; Radboud University Nijmegen	Zeissig, S (corresponding author), Tech Univ TU Dresden, Univ Med Ctr Dresden, Dept Med 1, D-01307 Dresden, Germany.; Zeissig, S (corresponding author), Tech Univ TU Dresden, Ctr Regenerat Therapies Dresden CRTD, D-01307 Dresden, Germany.	sebastian.zeissig@tu-dresden.de	Tauriello, Daniele/H-4644-2018; Zeissig, Sebastian/B-6297-2012	Tauriello, Daniele/0000-0003-1522-3496; Zeissig, Sebastian/0000-0001-5124-0897; Wirbel, Jakob/0000-0002-4073-3562	CMCB Technology Platform at TU Dresden; Deutsche Forschungsgemeinschaft (DFG) [ZE814/5-1, ZE814/8-1]; European Research Council (ERC Starting Grant) [336528]; BMBF consortium MiEOCRC; DFG Excellence Cluster "Center for Regenerative Therapies Dresden"; AECC [PROYE18046BATL]	CMCB Technology Platform at TU Dresden; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council (ERC Starting Grant)(European Research Council (ERC)); BMBF consortium MiEOCRC(Federal Ministry of Education & Research (BMBF)); DFG Excellence Cluster "Center for Regenerative Therapies Dresden"(German Research Foundation (DFG)); AECC	The authors thank Richard S. Blumberg (Boston, MA, USA) for helpful discussions; B. Bazylak-Kaps (Dresden, Germany), A. Caldarelli (Dresden, Germany), B. Lobel (Dresden, Germany), and Julia Wilking (Kiel, Germany) for excellent technical assistance; K. Anastassiadis (Dresden, Germany) for Flpo deleter mice; R. Behrendt, R. Naumann (Dresden, Germany), and the Transgenic Core Facility of the Max Planck Institute of Molecular Cell Biology and Genetics for the generation of Villin-Cre Cd276fl/fl mice, Villin-Cre Vtcn1fl/fl mice, and VIVITLSL/LSL mice; C.G.P. Voogdt (Heidelberg, Germany) for assistance with microbiota-dependent in vitro studies; and S. Rose-John (Kiel, Germany) for hyper-IL-6. This work was supported by the Flow Cytometry Facility, the Histology Facility, and the Light Microscopy Facility of the CMCB Technology Platform at TU Dresden. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through the DFG Collaborative Research Center 1371 and DFG ZE814/5-1 and ZE814/8-1; the European Research Council (ERC Starting Grant agreement number 336528); the BMBF consortium MiEOCRC; and the DFG Excellence Cluster ``Center for Regenerative Therapies Dresden.'' E.B. is supported by AECC (grant number PROYE18046BATL).	Abbott KL, 2000, MOL PHARMACOL, V58, P946, DOI 10.1124/mol.58.5.946; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Allen J, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0621-2; Angell HK, 2020, CLIN CANCER RES, V26, P332, DOI 10.1158/1078-0432.CCR-18-1851; Angelova M., 2015, GENOME; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollrath J., 2009, GP130 MEDIATED STAT3; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brennan CA, 2016, ANNU REV MICROBIOL, V70, P395, DOI 10.1146/annurev-micro-102215-095513; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Cante-Barrett K, 2007, J IMMUNOL, V179, P103, DOI 10.4049/jimmunol.179.1.103; Chapoval A.I., 2001, B7 H3 COSTIMULATORY; Che FY, 2017, CANCER IMMUNOL IMMUN, V66, P717, DOI 10.1007/s00262-017-1961-7; Choi IH, 2003, J IMMUNOL, V171, P4650, DOI 10.4049/jimmunol.171.9.4650; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dohlman AB, 2021, CELL HOST MICROBE, V29, P281, DOI 10.1016/j.chom.2020.12.001; Dong H., 2004, B7 H3 ENHANCES TUMOR; Eide PW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16747-x; Elinav E, 2019, NAT REV CANCER, V19, P371, DOI 10.1038/s41568-019-0155-3; Enquist IB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4530; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fumagalli A, 2017, P NATL ACAD SCI USA, V114, pE2357, DOI 10.1073/pnas.1701219114; Ganesh K, 2019, NAT REV GASTRO HEPAT, V16, P361, DOI 10.1038/s41575-019-0126-x; Gerlach K, 2012, CANCER RES, V72, P4340, DOI 10.1158/0008-5472.CAN-11-4155; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Grivennikov S., 2009, IL 6 STAT3 ARE REQUI; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jeon H, 2014, CELL REP, V9, P1089, DOI 10.1016/j.celrep.2014.09.053; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kang FB, 2015, ONCOL REP, V33, P274, DOI 10.3892/or.2014.3587; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee YH, 2017, CELL RES, V27, P1034, DOI 10.1038/cr.2017.90; Leitner J., 2009, B7 H3 IS POTENT INHI; Li J, 2018, IMMUNITY, V48, P773, DOI 10.1016/j.immuni.2018.03.018; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; O'Rourke KP, 2017, NAT BIOTECHNOL, V35, P577, DOI 10.1038/nbt.3837; Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150; Park YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00195; Peuker K, 2016, NAT MED, V22, P506, DOI 10.1038/nm.4072; Poore GD, 2020, NATURE, V579, P567, DOI 10.1038/s41586-020-2095-1; Prasad D.V., 2004, MURINE B7 H3 IS NEGA; Prasad DVR, 2003, IMMUNITY, V18, P863, DOI 10.1016/S1074-7613(03)00147-X; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Schumacher TN, 2019, ANNU REV IMMUNOL, V37, P173, DOI 10.1146/annurev-immunol-042617-053402; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Soncin I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02834-8; Suh W.K., 2003, B7 FAMILY MEMBER B7; Sun X., 2003, MOUSE B7 H3 INDUCES; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van den Bulk J, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0697-8; Veenstra RG, 2015, BLOOD, V125, P3335, DOI 10.1182/blood-2014-09-603357; Wei S., 2006, B7H4 EXPRESSION IDEN; Yao Y, 2016, CLIN CANCER RES, V22, P2778, DOI 10.1158/1078-0432.CCR-15-0858; Yonesaka K, 2018, CLIN CANCER RES, V24, P2653, DOI 10.1158/1078-0432.CCR-17-2852; Zang XX, 2003, P NATL ACAD SCI USA, V100, P10388, DOI 10.1073/pnas.1434299100; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118	80	3	3	21	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					701	+		10.1016/j.immuni.2022.03.008	http://dx.doi.org/10.1016/j.immuni.2022.03.008			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z9WH	35364006				2022-12-18	WOS:000791419000004
J	Fueyo-Gonzalez, F; McGinty, M; Ningoo, M; Anderson, L; Cantarelli, C; Angeletti, A; Demir, M; Llaudo, I; Purroy, C; Marjanovic, N; Heja, D; Sealfon, SC; Heeger, PS; Cravedi, P; Fribourg, M				Fueyo-Gonzalez, Francisco; McGinty, Mitchell; Ningoo, Mehek; Anderson, Lisa; Cantarelli, Chiara; Angeletti, Andrea; Demir, Markus; Llaudo, Ines; Purroy, Carolina; Marjanovic, Nada; Heja, David; Sealfon, Stuart C.; Heeger, Peter S.; Cravedi, Paolo; Fribourg, Miguel			Interferon-beta acts directly on T cells to prolong allograft survival by enhancing regulatory T cell induction through Foxp3 acetylation	IMMUNITY			English	Article							INDUCIBLE GENE-EXPRESSION; CHRONIC HEPATITIS-C; I INTERFERON; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; CUTTING EDGE; TARGET GENES; NK CELLS; REJECTION; RESPONSES	Type I interferons (IFNs) are pleiotropic cytokines with potent antiviral properties that also promote protective T cell and humoral immunity. Paradoxically, type I IFNs, including the widely expressed IFN beta, also have immunosuppressive properties, including promoting persistent viral infections and treating T-cell-driven, remitting-relapsing multiple sclerosis. Although associative evidence suggests that IFN beta mediates these immunosuppressive effects by impacting regulatory T (Treg) cells, mechanistic links remain elusive. Here, we found that IFN beta enhanced graft survival in a Treg-cell-dependent murine transplant model. Genetic conditional deletion models revealed that the extended allograft survival was Treg cell-mediated and required IFN beta signaling on T cells. Using an in silico computational model and analysis of human immune cells, we found that IFN beta directly promoted Treg cell induction via STAT1- and P300-dependent Foxp3 acetylation. These findings identify a mechanistic connection between the immunosuppressive effects of IFN beta and Treg cells, with therapeutic implications for transplantation, autoimmunity, and malignancy.	[Fueyo-Gonzalez, Francisco; Ningoo, Mehek; Anderson, Lisa; Llaudo, Ines; Heja, David; Heeger, Peter S.; Cravedi, Paolo; Fribourg, Miguel] Icahn Sch Med Mt Sinai, Translat Transplant Res Ctr, Dept Med, Div Nephrol, New York, NY 10029 USA; [Fueyo-Gonzalez, Francisco; Ningoo, Mehek; Anderson, Lisa; Llaudo, Ines; Marjanovic, Nada; Heja, David; Sealfon, Stuart C.; Heeger, Peter S.; Cravedi, Paolo; Fribourg, Miguel] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [McGinty, Mitchell] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA; [Cantarelli, Chiara] UO Nefrol Azienda Osped Univ Parma, Parma, Italy; [Angeletti, Andrea] IRCCS Giannina Gaslini, Div Nephrol Dialysis Transplantat, Genoa, Italy; [Demir, Markus] Univ Cologne, Dept Anesthesiol, Cologne, Germany; [Purroy, Carolina] Complejo Hosp Navarra, Dept Nephrol, Navarra, Spain; [Marjanovic, Nada; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Virginia; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Cologne; Servicio Navarro de Salud - Osasunbidea; Icahn School of Medicine at Mount Sinai	Fribourg, M (corresponding author), Icahn Sch Med Mt Sinai, Translat Transplant Res Ctr, Dept Med, Div Nephrol, New York, NY 10029 USA.; Fribourg, M (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.	miguel.fribourg@mssm.edu		Anderson, Lisa/0000-0002-0006-0308; Ningoo, Mehek/0000-0001-8318-3508	NIH [AI141710]; PRiME (Program for Research on Immune Modeling and Experimentation), an NIAID [U19 AI117873]; NIAID [R01 AI 132949]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PRiME (Program for Research on Immune Modeling and Experimentation), an NIAID; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge the contributions of Ana Fernandez-Sesma, Irene Ramos, and Uma Potla for their help with buffy coat preparation; Ciriyam Jayaprakash for insightful discussions on the computational model; Cijiang He, Irene Ramos, Guillermo Vilanova, and Jeremy Leventhal for their important feedback on the manuscript; Aana Hahn and Nancy Francoeur for their guidance with the RNA-seq transcriptional dataset; Silvio Streddi for his work and expertise on the illustrations; and Ethan M. Shevach for providing an additional Ifnar1<SUP>fl/fl</SUP> x Foxp3-YFP-Cre mouse line to confirm our results. Mi-croscopy images were obtained at Microscopy CoRE and Advanced Bio-imaging Center at the Icahn School of Medicine at Mount Sinai. Sequencing for the RNA-seq transcriptomic dataset was performed at the Genomics Core Facility at the Icahn School of Medicine at Mount Sinai. The study was funded by NIH AI141710 awarded to M.F. and supported by the PRiME (Pro-gram for Research on Immune Modeling and Experimentation) , an NIAID-funded Modeling Immunity for Biodefense center (grant U19 AI117873 to S.C.S.) . P.C. is supported by the NIAID grant R01 AI 132949.	Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Bendtzen K, 2010, J INTERF CYTOK RES, V30, P759, DOI 10.1089/jir.2010.0091; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Borderia AV, 2008, J IMMUNOL, V181, P6872, DOI 10.4049/jimmunol.181.10.6872; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896; Chewning JH, 2007, J IMMUNOL, V179, P854, DOI 10.4049/jimmunol.179.2.854; Christopher K, 2002, J IMMUNOL, V169, P522, DOI 10.4049/jimmunol.169.1.522; Conde P, 2015, IMMUNITY, V42, P1143, DOI 10.1016/j.immuni.2015.05.009; Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806; Dag F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003962; Dahiya S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57294-x; de Andres C., 2007, J; de Zoeten EF, 2009, J BIOL CHEM, V284, P5709, DOI 10.1074/jbc.M807322200; Delbue S, 2007, J NEUROVIROL, V13, P73, DOI 10.1080/13550280601094563; Diaz GA, 2006, J VIROL, V80, P8271, DOI 10.1128/JVI.00656-06; Donadei C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127428; Fabritius C, 2017, AM J TRANSPLANT, V17, P3199, DOI 10.1111/ajt.14467; Floris S, 2002, J NEUROIMMUNOL, V127, P69, DOI 10.1016/S0165-5728(02)00098-X; Furusyo N, 1999, DIGEST DIS SCI, V44, P608, DOI 10.1023/A:1026625928117; Graham R.R., 2007, Proc. Natl. Acad. Sci; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hall BM, 2016, TRANSPLANTATION, V100, P2533, DOI 10.1097/TP.0000000000001436; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Hirohashi T, 2012, AM J TRANSPLANT, V12, P313, DOI 10.1111/j.1600-6143.2011.03836.x; Holzki JK, 2015, J VIROL, V89, P9886, DOI 10.1128/JVI.01459-15; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jiao J, 2017, METHODS MOL BIOL, V1510, P287, DOI 10.1007/978-1-4939-6527-4_21; Kawano Y, 2018, J CLIN INVEST, V128, P2487, DOI 10.1172/JCI88169; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kindler E, 2016, ADV VIRUS RES, V96, P219, DOI 10.1016/bs.aivir.2016.08.006; Korporal M, 2008, ARCH NEUROL-CHICAGO, V65, P1434, DOI 10.1001/archneur.65.11.1434; La Mantia L., 2016, Cochrane Database Syst. Rev., V11; Lampl C, 2013, J NEUROL, V260, P1838, DOI 10.1007/s00415-013-6888-0; Liu YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029035; Llaudo I, 2019, AM J TRANSPLANT, V19, P633, DOI 10.1111/ajt.15072; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Namdar A, 2010, J NEUROIMMUNOL, V218, P120, DOI 10.1016/j.jneuroim.2009.10.013; Ng CT, 2016, CELL, V164, P349, DOI 10.1016/j.cell.2015.12.027; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; O'Hara BA, 2008, VIRUS RES, V132, P97, DOI 10.1016/j.virusres.2007.11.002; Oberbarnscheidt MH, 2010, AM J TRANSPLANT, V10, P162, DOI 10.1111/j.1600-6143.2009.02871.x; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; PEREZ R, 1995, J VIRAL HEPATITIS, V2, P103, DOI 10.1111/j.1365-2893.1995.tb00014.x; Purroy C, 2017, J AM SOC NEPHROL, V28, P2377, DOI 10.1681/ASN.2016101100; Qin QS, 2016, J VIROL, V90, P5187, DOI 10.1128/JVI.00199-16; Rothstein DM, 2015, CURR OPIN ORGAN TRAN, V20, P376, DOI 10.1097/MOT.0000000000000212; Rudick RA, 1996, ANN NEUROL, V40, P618, DOI 10.1002/ana.410400412; Schoggins JW, 2019, ANNU REV VIROL, V6, P567, DOI 10.1146/annurev-virology-092818-015756; Shevach EM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01048; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; Stewart CA, 2013, J CLIN INVEST, V123, P4859, DOI 10.1172/JCI65180; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Teige I, 2006, J IMMUNOL, V177, P3542, DOI 10.4049/jimmunol.177.6.3542; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Toka FN, 2004, J VIROL, V78, P13082, DOI 10.1128/JVI.78.23.13082-13089.2004; Ubani A., 2020, MEDRXIV, DOI [10.1101/2020, DOI 10.1101/2020, 10.1101/2020.]; Vallin H, 1999, J IMMUNOL, V163, P6306; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; van der Touw W, 2013, J IMMUNOL, V190, P5921, DOI 10.4049/jimmunol.1300847; van Loosdregt J, 2014, TRENDS IMMUNOL, V35, P368, DOI 10.1016/j.it.2014.06.005; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Vandenbark AA, 2009, J NEUROIMMUNOL, V215, P125, DOI 10.1016/j.jneuroim.2009.08.007; Walsh RJ, 2007, ARTHRITIS RHEUM, V56, P3784, DOI 10.1002/art.22928; Wang DC, 2016, J IMMUNOL, V197, P2992, DOI 10.4049/jimmunol.1500411; Wang HZ, 2011, J IMMUNOL, V186, P675, DOI 10.4049/jimmunol.1001473; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Ward SM, 2007, J HEPATOL, V47, P316, DOI 10.1016/j.jhep.2007.03.023; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Xiao Y, 2014, CELL REP, V7, P1471, DOI 10.1016/j.celrep.2014.04.021; Xie X, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005251; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	86	3	3	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					459	+		10.1016/j.immuni.2022.01.011	http://dx.doi.org/10.1016/j.immuni.2022.01.011			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35148827				2022-12-18	WOS:000791044400011
J	Poli, V; Di Gioia, M; Sola-Visner, M; Granucci, F; Frelinger, AL; Michelson, AD; Zanoni, I				Poli, Valentina; Di Gioia, Marco; Sola-Visner, Martha; Granucci, Francesca; Frelinger, Andrew L.; Michelson, Alan D.; Zanoni, Ivan			Inhibition of transcription factor NFAT activity in activated platelets enhances their aggregation and exacerbates gram-negative bacterial septicemia	IMMUNITY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; T-CELLS; NUCLEAR FACTOR; INFLAMMASOME ACTIVATION; GASDERMIN D; CYCLOSPORINE; MEGAKARYOCYTES; COAGULATION; RECEPTORS; MEDIATORS	During gram-negative septicemia, interactions between platelets and neutrophils initiate a detrimental feedback loop that sustains neutrophil extracellular trap (NET) induction, disseminated intravascular coagulation, and inflammation. Understanding intracellular pathways that control platelet-neutrophil interactions is essential for identifying new therapeutic targets. Here, we found that thrombin signaling induced activation of the transcription factor NFAT in platelets. Using genetic and pharmacologic approaches, as well as iNFATuation, a newly developed mouse model in which NFAT activation can be abrogated in a cell-specific manner, we demonstrated that NFAT inhibition in activated murine and human platelets enhanced their activation and aggregation, as well as their interactions with neutrophils and NET induction. During gram-negative septicemia, NFAT inhibition in platelets promoted disease severity by increasing disseminated coagulation and NETosis. NFAT inhibition also partially restored coagulation ex vivo in patients with hypoactive platelets. Our results define non-transcriptional roles for NFAT that could be harnessed to address pressing clinical needs.	[Poli, Valentina; Di Gioia, Marco; Zanoni, Ivan] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Sola-Visner, Martha] Harvard Med Sch, Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Granucci, Francesca] Univ Milano Bicocca, INGM Natl Inst Mol Genet Romeo Enr Invernizzi, Dept Biotechnol & Biosci, Milan, Italy; [Frelinger, Andrew L.; Michelson, Alan D.] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Ctr Platelet Res Studies, Boston, MA 02115 USA; [Zanoni, Ivan] Harvard Med Sch, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Milano-Bicocca; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Zanoni, I (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Zanoni, I (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA.	ivan.zanoni@childrens.harvard.edu	Di Gioia, Marco/AAC-4192-2019; GRANUCCI, Francesca/K-6150-2019	Di Gioia, Marco/0000-0001-9499-5771; Zanoni, Ivan/0000-0002-3423-7474	NIH [R01AI121066, R01DK115217, R01AI165505, NIAID-DAIT-NIHAI201700100]; Lloyd J. Old STAR Program [CRI3888]; Burroughs Wellcome Fund; AIRC [23512]; Fondazione regionale per la ricerca Biomedica, FRRB [IANG-CRC CP2_12/2018]; Ministero della Salute [RF-2018-12367072]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lloyd J. Old STAR Program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione regionale per la ricerca Biomedica, FRRB(Regione Lombardia); Ministero della Salute(Ministry of Health, Italy)	I.Z. is supported by NIH grants R01AI121066, R01DK115217, R01AI165505, and NIAID-DAIT-NIHAI201700100; Lloyd J. Old STAR Program CRI3888; and holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. F.G. is supported by AIRC (IG 2019Id.23512) , Fondazione regionale per la ricerca Biomedica, FRRB (IANG-CRC CP2_12/2018) , and Ministero della Salute, Ricerca Finalizzata (RF-2018-12367072) .	Adrover JM, 2020, NAT IMMUNOL, V21, P135, DOI 10.1038/s41590-019-0571-2; Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Arabanian LS, 2012, BRIT J HAEMATOL, V156, P523, DOI 10.1111/j.1365-2141.2011.08970.x; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Azzi JR, 2013, J IMMUNOL, V191, P5785, DOI 10.4049/jimmunol.1390055; Bahou WF, 2004, J BIOL CHEM, V279, P22571, DOI 10.1074/jbc.M402561200; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carestia A, 2016, J LEUKOCYTE BIOL, V99, P153, DOI 10.1189/jlb.3A0415-161R; Cattaneo M, 2013, PLATELETS, P261; Cattaneo M., 2013, PLATELETS, P1019; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Crist SA, 2013, J BIOL CHEM, V288, P33985, DOI 10.1074/jbc.M113.511881; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Deppermann C, 2018, INNATE IMMUN-LONDON, V24, P335, DOI 10.1177/1753425918789255; Dinkla S, 2016, BLOOD, V127, P1976, DOI 10.1182/blood-2015-04-640300; Elaskalani O, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0235-0; Etulain J, 2015, BLOOD, V126, P242, DOI 10.1182/blood-2015-01-624023; Feng LJ, 2000, GENOMICS, V69, P370, DOI 10.1006/geno.2000.6350; GRACE AA, 1987, KIDNEY INT, V32, P889, DOI 10.1038/ki.1987.291; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Han P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1580; Jackson SP, 2019, BLOOD, V133, P906, DOI 10.1182/blood-2018-11-882993; Jimenez-Alcazar M, 2017, SCIENCE, V358, P1202, DOI 10.1126/science.aam8897; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Khatlani T, 2014, J THROMB HAEMOST, V12, P2089, DOI 10.1111/jth.12761; Lannan KL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00048; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lisman T, 2018, CELL TISSUE RES, V371, P567, DOI 10.1007/s00441-017-2727-4; Liu SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep37252; Lizio M, 2019, NUCLEIC ACIDS RES, V47, pD752, DOI 10.1093/nar/gky1099; Malaver E, 2009, J THROMB HAEMOST, V7, P1333, DOI 10.1111/j.1538-7836.2009.03492.x; McDonald B, 2017, BLOOD, V129, P1357, DOI 10.1182/blood-2016-09-741298; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Nicolai L, 2019, TRENDS IMMUNOL, V40, P922, DOI 10.1016/j.it.2019.08.004; Poli V, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103256; Rivera J, 2009, HAEMATOL-HEMATOL J, V94, P700, DOI 10.3324/haematol.2008.003178; Rolfes V, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107615; Rossaint J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13464; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Steele BM, 2009, P NATL ACAD SCI USA, V106, P19836, DOI 10.1073/pnas.0906268106; Tang YT, 2021, IMMUNITY, V54, P454, DOI 10.1016/j.immuni.2021.01.007; Thiam HR, 2020, ANNU REV CELL DEV BI, V36, P191, DOI 10.1146/annurev-cellbio-020520-111016; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tomasiak M, 2007, NEPHROL DIAL TRANSPL, V22, P1750, DOI 10.1093/ndt/gfl836; Williams SCP, 2012, NAT MED, V18, P1001, DOI 10.1038/nm0712-1001; Wu CQ, 2019, IMMUNITY, V50, P1401, DOI 10.1016/j.immuni.2019.04.003; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yang XY, 2019, IMMUNITY, V51, P983, DOI 10.1016/j.immuni.2019.11.005; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Yost CC, 2016, J CLIN INVEST, V126, P3783, DOI 10.1172/JCI83873; Zanoni I, 2012, EUR J IMMUNOL, V42, P1924, DOI 10.1002/eji.201242580; Zaslavsky A, 2013, BLOOD, V121, P3205, DOI 10.1182/blood-2012-04-421172	60	3	3	7	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					224	+		10.1016/j.immuni.2021.12.002	http://dx.doi.org/10.1016/j.immuni.2021.12.002			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	34995475				2022-12-18	WOS:000754308000009
J	Weber, T; Potthoff, J; Bizu, S; Labuhn, M; Dold, L; Schoofs, T; Horning, M; Ercanoglu, MS; Kreer, C; Gieselmann, L; Vanshylla, K; Langhans, B; Janicki, H; Stroh, LJ; Knops, E; Nierhoff, D; Spengler, U; Kaiser, R; Bjorkman, PJ; Krey, T; Bankwitz, D; Pfeifer, N; Pietschmann, T; Flyak, AI; Klein, F				Weber, Timm; Potthoff, Julian; Bizu, Sven; Labuhn, Maurice; Dold, Leona; Schoofs, Till; Horning, Marcel; Ercanoglu, Meryem S.; Kreer, Christoph; Gieselmann, Lutz; Vanshylla, Kanika; Langhans, Bettina; Janicki, Hanna; Stroeh, Luisa J.; Knops, Elena; Nierhoff, Dirk; Spengler, Ulrich; Kaiser, Rolf; Bjorkman, Pamela J.; Krey, Thomas; Bankwitz, Dorothea; Pfeifer, Nico; Pietschmann, Thomas; Flyak, Andrew, I; Klein, Florian			Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization	IMMUNITY			English	Article							HEPATITIS-C VIRUS; MONOCLONAL-ANTIBODIES; B-CELLS; INFECTION; HIV-1; IMMUNOGLOBULIN; RECEPTOR; CHIMPANZEES; CLEARANCE; FUSION	The high genetic diversity of hepatitis C virus (HCV) complicates effective vaccine development. We screened a cohort of 435 HCV-infected individuals and found that 2%-5% demonstrated outstanding HCV-neutralizing activity. From four of these patients, we isolated 310 HCV antibodies, including neutralizing antibodies with exceptional breadth and potency. High neutralizing activity was enabled by the use of the VH1-69 heavy chain gene segment, somatic mutations within CDRH1, and CDRH2 hydrophobicity. Structural and mutational analyses revealed an important role for mutations replacing the serines at positions 30 and 31, as well as the presence of neutral and hydrophobic residues at the tip of the CDRH3. Based on these characteristics, we computationally created a de novo antibody with a fully synthetic VH1-69 heavy chain that efficiently neutralized multiple HCV genotypes. Our findings provide a deep understanding of the generation of broadly HCV-neutralizing antibodies that can guide the design of effective vaccine candidates.	[Weber, Timm; Potthoff, Julian; Dold, Leona; Schoofs, Till; Horning, Marcel; Ercanoglu, Meryem S.; Kreer, Christoph; Gieselmann, Lutz; Vanshylla, Kanika; Janicki, Hanna; Klein, Florian] Univ Cologne, Inst Virol, Lab Expt Immunol, Fac Med, D-50931 Cologne, Germany; [Weber, Timm; Potthoff, Julian; Dold, Leona; Schoofs, Till; Horning, Marcel; Ercanoglu, Meryem S.; Kreer, Christoph; Gieselmann, Lutz; Vanshylla, Kanika; Janicki, Hanna; Knops, Elena; Kaiser, Rolf; Klein, Florian] Univ Cologne, Univ Hosp Cologne, D-50931 Cologne, Germany; [Bizu, Sven; Pfeifer, Nico] Univ Tubingen, Dept Comp Sci, Methods Med Informat, D-72076 Tubingen, Germany; [Labuhn, Maurice; Bankwitz, Dorothea; Pietschmann, Thomas] Inst Expt Virol, Twincore, Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany; [Dold, Leona; Langhans, Bettina; Spengler, Ulrich] Univ Hosp Bonn, Dept Internal Med 1, D-53127 Bonn, Germany; [Dold, Leona; Gieselmann, Lutz; Langhans, Bettina; Spengler, Ulrich; Kaiser, Rolf; Klein, Florian] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, D-50931 Cologne, Germany; [Knops, Elena; Kaiser, Rolf; Klein, Florian] Univ Cologne, Inst Virol, Fac Med, D-50931 Cologne, Germany; [Nierhoff, Dirk] Fac Med, Dept Gastroenterol & Hepatol, D-50931 Cologne, Germany; [Nierhoff, Dirk] Univ Hosp Cologne, D-50931 Cologne, Germany; [Bjorkman, Pamela J.; Flyak, Andrew, I] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Stroeh, Luisa J.; Krey, Thomas] Hannover Med Sch, Inst Virol, D-30625 Hannover, Germany; [Krey, Thomas] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, D-23562 Lubeck, Germany; [Krey, Thomas] Ctr Struct Syst Biol CSSB, D-22607 Hamburg, Germany; [Krey, Thomas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel Riems, D-23562 Lubeck, Germany; [Krey, Thomas; Pietschmann, Thomas] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, D-30625 Hannover, Germany; [Pietschmann, Thomas] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, D-30625 Hannover, Germany; [Klein, Florian] Fac Med, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Klein, Florian] Univ Cologne, D-50931 Cologne, Germany; [Schoofs, Till] GlaxoSmithKline Vaccines, B-1300 Wavre, Belgium	University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bonn; German Center for Infection Research; University of Cologne; University of Cologne; University of Cologne; University of Cologne; California Institute of Technology; Hannover Medical School; University of Lubeck; German Center for Infection Research; Hannover Medical School; German Center for Infection Research; University of Cologne; University of Cologne; GlaxoSmithKline	Klein, F (corresponding author), Univ Cologne, Inst Virol, Lab Expt Immunol, Fac Med, D-50931 Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, Univ Hosp Cologne, D-50931 Cologne, Germany.; Klein, F (corresponding author), German Ctr Infect Res DZIF, Partner Site Bonn Cologne, D-50931 Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, Inst Virol, Fac Med, D-50931 Cologne, Germany.; Klein, F (corresponding author), Fac Med, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, D-50931 Cologne, Germany.	florian.klein@uk-koeln.de	Kreer, Christoph/ABG-7275-2021	Kreer, Christoph/0000-0002-9140-9850; Horning, Marcel/0000-0003-1468-4645; Bizu, Sven/0000-0003-4839-2472; Gieselmann, Lutz/0000-0003-3699-3318; Pfeifer, Nico/0000-0002-4647-8566; Weber, Timm/0000-0003-2079-842X; Vanshylla, Kanika/0000-0003-4552-9170	European Research Council [ERC-STG-639961]; German Center for Infection Research (DZIF) [TTU 05.817, TTU 05.821]; German Research Foundation (DFG) [CRC 1310]; DFG un-der Germany's Excellence Strategy [39087428]; U.S. National Institutes of Health (NIH) [R01 AI127469, K99 AI153465]; Gordon and Betty Moore Founda-tion; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIHGMS [P41GM103393]	European Research Council(European Research Council (ERC)European Commission); German Center for Infection Research (DZIF); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG un-der Germany's Excellence Strategy(German Research Foundation (DFG)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Founda-tion(Gordon and Betty Moore Foundation); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all study participants who devoted time to our research; members of the Klein, Pietschmann, Pfeifer, Krey, and Bjorkman Laboratories for contin-uous support and helpful discussions, Maike Schlotz and Carola Ruping for help with sample processing, and Henning Gruell for valuable discussions. We thank the Caltech Protein Expression Center for help with protein expres-sion and the Caltech Molecular Observatory for assistance with structural studies. This work was funded by grants from the European Research Council (ERC-STG-639961 to F.K.) , the German Center for Infection Research (DZIF TTU 05.817 and TTU 05.821 to F.K., T.P., T.K., and T.W.) and the German Research Foundation (DFG) (CRC 1310 to F.K.) . T.P. and T.K. are funded by the DFG un-der Germany's Excellence Strategy (EXC 2155 "RESIST"-project ID 39087428) . This research was also supported by the U.S. National Institutes of Health (NIH) (NIH grant R01 AI127469 to P.J.B.) and (NIH grant K99 AI153465 to A.I.F.) (content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH) and the Molecular Observatory at Caltech supported by the Gordon and Betty Moore Founda-tion. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (contract no DE-AC02-76SF00515) . The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIHGMS (P41GM103393) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bailey JR, 2019, GASTROENTEROLOGY, V156, P418, DOI 10.1053/j.gastro.2018.08.060; Bailey JR, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92872; Bankwitz D, 2021, GUT, V70, P1734, DOI 10.1136/gutjnl-2020-321190; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chen F, 2021, IMMUNITY, V54, P781, DOI 10.1016/j.immuni.2021.02.013; Chen F, 2020, GASTROENTEROLOGY, V158, P1058, DOI 10.1053/j.gastro.2019.11.282; Chen F, 2019, CURR OPIN VIROL, V34, P149, DOI 10.1016/j.coviro.2019.02.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Colbert MD, 2019, J VIROL, V93, DOI 10.1128/JVI.02070-18; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Jong YP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009512; Ehrhardt SA, 2019, NAT MED, V25, P1589, DOI 10.1038/s41591-019-0602-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Flyak AI, 2020, ELIFE, V9, DOI 10.7554/eLife.53169; Flyak AI, 2018, CELL HOST MICROBE, V24, P703, DOI 10.1016/j.chom.2018.10.009; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Gieselmann L, 2021, NAT PROTOC, V16, P3639, DOI 10.1038/s41596-021-00554-w; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Irimia A, 2016, IMMUNITY, V44, P21, DOI 10.1016/j.immuni.2015.12.001; Kabat EA, 1991, SEQUENCES PROTEINS I; Keck ZY, 2016, HEPATOLOGY, V64, P1922, DOI 10.1002/hep.28850; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck Z, 2013, J VIROL, V87, P37, DOI 10.1128/JVI.01941-12; Kelsoe G, 2017, IMMUNOL REV, V275, P79, DOI 10.1111/imr.12508; Kinchen VJ, 2018, CELL HOST MICROBE, V24, P717, DOI 10.1016/j.chom.2018.10.012; Kinchen VJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01703; Kinchen VJ, 2018, TRENDS MICROBIOL, V26, P854, DOI 10.1016/j.tim.2018.04.002; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Kreer Christoph, 2020, J Immunol Methods, V480, P112752, DOI 10.1016/j.jim.2020.112752; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Luna JM, 2019, CURR OPIN VIROL, V35, P27, DOI 10.1016/j.coviro.2019.02.008; Merat SJ, 2019, J HEPATOL, V71, P14, DOI 10.1016/j.jhep.2019.02.013; Merat SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165047; Morin TJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002895; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Perin PM, 2016, HEPATOLOGY, V63, P49, DOI 10.1002/hep.28111; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Roingeard P, 2020, HEPATOLOGY, V71, P1845, DOI 10.1002/hep.31182; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schommers P, 2020, CELL, V180, P471, DOI 10.1016/j.cell.2020.01.010; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sirkoski AM, 2013, J HEPATOL, V58, pS489, DOI 10.1016/S0168-8278(13)61205-2; Stroh LJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186781; Suryadevara N, 2021, CELL, V184, P2316, DOI 10.1016/j.cell.2021.03.029; Thomas DL, 2019, NEW ENGL J MED, V380, P2041, DOI 10.1056/NEJMra1810477; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tzarum N, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1882; Tzarum N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01315; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wrensch F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01436; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	78	3	3	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					341	+		10.1016/j.immuni.2021.12.003	http://dx.doi.org/10.1016/j.immuni.2021.12.003			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX8WB	34990590				2022-12-18	WOS:000754375200003
J	He, DY; Xu, HP; Zhang, HY; Tang, RH; Lan, YN; Xing, RX; Li, SM; Christian, E; Hou, Y; Lorello, P; Caldarone, B; Ding, JR; Nguyen, L; Dionne, D; Thakore, P; Schnell, A; Huh, JR; Rozenblatt-Rosen, O; Regev, A; Kuchroo, VK				He, Danyang; Xu, Heping; Zhang, Huiyuan; Tang, Ruihan; Lan, Yangning; Xing, Ruxiao; Li, Shaomin; Christian, Elena; Hou, Yu; Lorello, Paul; Caldarone, Barbara; Ding, Jiarui; Nguyen, Lan; Dionne, Danielle; Thakore, Pratiksha; Schnell, Alexandra; Huh, Jun R.; Rozenblatt-Rosen, Orit; Regev, Aviv; Kuchroo, Vijay K.			Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function	IMMUNITY			English	Article							PTEN TUMOR-SUPPRESSOR; GENE; DISEASE; IL-33; PATHWAYS; MEMORY; HEALTH; CELLS; TREM2	To accommodate the changing needs of the developing brain, microglia must undergo substantial morphological, phenotypic, and functional reprogramming. Here, we examined whether cellular metabolism regulates microglial function during neurodevelopment. Microglial mitochondria bioenergetics correlated with and were functionally coupled to phagocytic activity in the developing brain. Transcriptional profiling of microglia with diverse metabolic profiles revealed an activation signature wherein the interleukin (IL)-33 signaling axis is associated with phagocytic activity. Genetic perturbation of IL-33 or its receptor ST2 led to microglial dystrophy, impaired synaptic function, and behavioral abnormalities. Conditional deletion of Il33 from astrocytes or Il1rl1, encoding ST2, in microglia increased susceptibility to seizures. Mechanistically, IL-33 promoted mitochondrial activity and phagocytosis in an AKT-dependent manner. Mitochondrial metabolism and AKT activity were temporally regulated in vivo. Thus, a microglia-astrocyte circuit mediated by the IL-33-ST2-AKT signaling axis supports microglial metabolic adaptation and phagocytic function during early development, with implications for neurodevelopmental and neuropsychiatric disorders.	[He, Danyang; Zhang, Huiyuan; Tang, Ruihan; Hou, Yu; Schnell, Alexandra; Huh, Jun R.; Kuchroo, Vijay K.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [He, Danyang; Zhang, Huiyuan; Tang, Ruihan; Hou, Yu; Schnell, Alexandra; Huh, Jun R.; Kuchroo, Vijay K.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [He, Danyang; Xu, Heping; Lan, Yangning; Xing, Ruxiao] Westlake Univ, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China; [He, Danyang; Xu, Heping; Lan, Yangning; Xing, Ruxiao] Westlake Lab Life Sci & Biomed, Hangzhou, Zhejiang, Peoples R China; [He, Danyang; Xu, Heping; Lan, Yangning; Xing, Ruxiao] Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [He, Danyang; Zhang, Huiyuan; Tang, Ruihan; Li, Shaomin; Hou, Yu; Schnell, Alexandra; Kuchroo, Vijay K.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA; [Xu, Heping; Christian, Elena; Hou, Yu; Ding, Jiarui; Nguyen, Lan; Dionne, Danielle; Thakore, Pratiksha; Rozenblatt-Rosen, Orit; Regev, Aviv; Kuchroo, Vijay K.] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Lorello, Paul; Caldarone, Barbara] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Mouse Behav Core, Boston, MA 02115 USA; [Huh, Jun R.] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Rozenblatt-Rosen, Orit; Regev, Aviv] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Westlake University; Westlake University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Roche Holding; Genentech	He, DY; Kuchroo, VK (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; He, DY; Kuchroo, VK (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; He, DY (corresponding author), Westlake Univ, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China.; He, DY (corresponding author), Westlake Lab Life Sci & Biomed, Hangzhou, Zhejiang, Peoples R China.; He, DY (corresponding author), Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou, Zhejiang, Peoples R China.; He, DY; Kuchroo, VK (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA.; Regev, A; Kuchroo, VK (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Regev, A (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Regev, A (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	hedanyang@westlake.edu.cn; aregev@broadinstitute.org; vkuchroo@rics.bwh.harvard.edu	Thakore, Pratiksha I./HDM-5197-2022; Rozenblatt-Rosen, Orit/HDN-4182-2022; Tang, Ruihan/K-6908-2015	Schnell, Alexandra/0000-0003-3442-7750; Li, Shaomin/0000-0001-9451-2151; He, Danyang/0000-0002-3613-4188; Zhang, Huiyuan/0000-0003-0763-6856; Tang, Ruihan/0000-0001-5250-6239	NIH; Klarman Cell Observatory; National Natural Science Foundation of China [32070953]; National Key R&D Program of China [2020YFA0804200]; Education Foun-dation of Westlake University; Crohn's & Colitis Foun-dation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Education Foun-dation of Westlake University; Crohn's & Colitis Foun-dation	We thank I. Chiu, T. Hammond, and A. walker for discussion, D. Kozoriz, J. Shi, A.R. Bialas, and J. Presumey for technical advice, W. Zhu and J. Xia for mouse genotyping, O. Butovsky and M. Collins for careful reading of the manuscript, and S. Riesenfeld for computational advice. This work was supported by NIH grants (to V.K.K.) , the Klarman Cell Observatory (to A.R.) , the National Natural Science Foundation of China (grant 32070953 to D.H.) , the National Key R&D Program of China (grant 2020YFA0804200 to D.H.) , and the Education Foun-dation of Westlake University (to D.H.) . A.R. was an investigator of the Howard Hughes Medical Institute. D.H. was supported by the Crohn's & Colitis Foun-dation post-doctoral research fellowship.	Baik SH, 2019, CELL METAB, V30, P493, DOI 10.1016/j.cmet.2019.06.005; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Borst K, 2019, NEUROCHEM INT, V130, DOI 10.1016/j.neuint.2018.11.006; Bouffi C, 2013, J IMMUNOL, V191, P4317, DOI 10.4049/jimmunol.1301465; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Chamoto K, 2017, P NATL ACAD SCI USA, V114, pE761, DOI 10.1073/pnas.1620433114; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Deczkowska A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00769-0; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Druart M, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00573; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Dykens JA, 2001, METHOD CELL BIOL, V65, P285, DOI 10.1016/S0091-679X(01)65018-0; Edmonson CA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00009; Elali A, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00072; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Friedman BA, 2018, CELL REP, V22, P832, DOI 10.1016/j.celrep.2017.12.066; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Gandal MJ, 2018, SCIENCE, V362, P1265, DOI 10.1126/science.aat8127; Gao YQ, 2017, CELL REP, V20, P3034, DOI 10.1016/j.celrep.2017.09.008; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hammond TR, 2018, ANNU REV CELL DEV BI, V34, P523, DOI 10.1146/annurev-cellbio-100616-060509; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Linke M, 2017, FEBS LETT, V591, P3089, DOI 10.1002/1873-3468.12711; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Montoya D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009546; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; Nguyen PT, 2020, CELL, V182, P388, DOI 10.1016/j.cell.2020.05.050; Nugent AA, 2020, NEURON, V105, P837, DOI 10.1016/j.neuron.2019.12.007; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rajasekaran A, 2015, NEUROSCI BIOBEHAV R, V48, P10, DOI 10.1016/j.neubiorev.2014.11.005; Reid IC, 1997, SEIZURE, V6, P351, DOI 10.1016/S1059-1311(97)80034-9; Risher WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107591; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rock RB, 2005, GENES IMMUN, V6, P712, DOI 10.1038/sj.gene.6364246; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Salvatore G, 2015, J LIPID RES, V56, P1110, DOI 10.1194/jlr.M054874; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schafer DP, 2014, JOVE-J VIS EXP, DOI 10.3791/51482; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thion MS, 2018, SCIENCE, V362, P185, DOI 10.1126/science.aat0474; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	66	3	3	18	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					159	+		10.1016/j.immuni.2021.12.001	http://dx.doi.org/10.1016/j.immuni.2021.12.001			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI5DT	34982959				2022-12-18	WOS:000743868800004
J	Newman, R; Tolar, P				Newman, Rebecca; Tolar, Pavel			Chronic calcium signaling in IgE(+) B cells limits plasma cell differentiation and survival	IMMUNITY			English	Article							CLASS-SWITCH RECOMBINATION; ANTIGEN RECEPTOR; GENE-FUNCTION; EXPRESSION; ACTIVATION; INTERACTS; SELECTION; MODEL; IGG	In contrast to other antibody isotypes, B cells switched to IgE respond transiently and do not give rise to long-lived plasma cells (PCs) or memory B cells. To better understand IgE-BCR-mediated control of IgE responses, we developed whole-genome CRISPR screening that enabled comparison of IgE(+) and IgG1(+) B cell requirements for proliferation, survival, and differentiation into PCs. IgE(+) PCs exhibited dependency on the PI3K-mTOR axis that increased protein amounts of the transcription factor IRF4. In contrast, loss of components of the calcium-calcineurin-NFAT pathway promoted IgE(+) PC differentiation. Mice bearing a B cell-specific deletion of calcineurin B1 exhibited increased production of IgE(+) PCs. Mechanistically, sustained elevation of intracellular calcium in IgE(+) PCs downstream of the IgE-BCR promoted BCL2L11-dependent apoptosis. Thus, chronic calcium signaling downstream of the IgE-BCR controls the self-limiting character of IgE responses and may be relevant to the accumulation of IgE-producing cells in allergic disease.	[Newman, Rebecca; Tolar, Pavel] Francis Crick Inst, Immune Receptor Activat Lab, 1 Midland Rd, London NW1 1AT, England; [Tolar, Pavel] UCL, Inst Immun & Transplantat, Div Infect & Immun, London NW3 2PF, England	Francis Crick Institute; University of London; University College London	Tolar, P (corresponding author), Francis Crick Inst, Immune Receptor Activat Lab, 1 Midland Rd, London NW1 1AT, England.; Tolar, P (corresponding author), UCL, Inst Immun & Transplantat, Div Infect & Immun, London NW3 2PF, England.	p.tolar@ucl.ac.uk			Francis Crick Institute; Cancer Research UK [FC001185]; UK Medical Research Council [FC001185]; Wellcome Trust [FC001185]	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	This work was supported by the Francis Crick Institute, which receives its core funding from the Cancer Research UK (FC001185) , the UK Medical Research Council (FC001185) , and the Wellcome Trust (FC001185) . This research was funded in whole, or in part, by the Wellcome Trust (grant number FC001185) . For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. We thank the Francis Crick Institute Science Technology Platforms for their help with cell sorting and next-generation sequencing and Harshil Patel from the Bioinformatics and Biostatistics Science Technology Platform at the Francis Crick Institute for performing the bioinformatics anal-ysis of the RNA-seq data. We also thank Daisuke Kitamura for the 40LB cells and Lars Nitschke and Richard Cornall for sharing the Grb2fl/flCd79acre/+ mice. We also thank Edina Schweighoffer and Victor Tybulewicz for providing the Brie CRISPR library and the Syk inhibitor BAY 61-3606. We thank Martin Turner for critical reading of the manuscript.	Achatz G, 1997, SCIENCE, V276, P409, DOI 10.1126/science.276.5311.409; Akkaya M, 2018, NAT IMMUNOL, V19, P871, DOI 10.1038/s41590-018-0156-5; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; [Anonymous], NUCLEIC ACIDS RES, V47, pD607; AsanteKorang A, 1996, J HEART LUNG TRANSPL, V15, P415; Asrat S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aav8402; Cante-Barrett K, 2007, J IMMUNOL, V179, P103, DOI 10.4049/jimmunol.179.1.103; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Crawford G, 2018, NAT IMMUNOL, V19, P859, DOI 10.1038/s41590-018-0161-8; Croote D, 2018, SCIENCE, V362, P1306, DOI 10.1126/science.aau2599; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Engels N, 2018, IMMUNOL REV, V283, P150, DOI 10.1111/imr.12651; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Fitzsimmons CM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00061; Haniuda K, 2016, NAT IMMUNOL, V17, P1109, DOI 10.1038/ni.3508; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; He JS, 2013, J EXP MED, V210, P2755, DOI 10.1084/jem.20131539; Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Kar P, 2016, MOL CELL, V64, P746, DOI 10.1016/j.molcel.2016.11.011; Kawamura N, 1997, INT ARCH ALLERGY IMM, V112, P422, DOI 10.1159/000237491; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Laffleur B, 2015, CELL REP, V10, P900, DOI 10.1016/j.celrep.2015.01.023; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li SS, 2016, P NATL ACAD SCI USA, V113, pE5108, DOI 10.1073/pnas.1609709113; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lin WHW, 2015, CELL REP, V13, P2203, DOI 10.1016/j.celrep.2015.10.072; Liu WL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002820; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Low MSY, 2019, CELL REP, V29, P2634, DOI 10.1016/j.celrep.2019.10.097; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Milner JD, 2020, ANNU REV IMMUNOL, V38, P785, DOI 10.1146/annurev-immunol-042718-041553; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Oberndorfer I, 2006, J IMMUNOL, V177, P1139, DOI 10.4049/jimmunol.177.2.1139; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; R Development Core Team, 2016, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Ramadani F, 2017, ALLERGY, V72, P66, DOI 10.1111/all.12911; Ramadani F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00402; Roca FJ, 2019, CELL, V178, P1344, DOI 10.1016/j.cell.2019.08.004; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Satpathy S, 2015, MOL SYST BIOL, V11; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitt MER, 2020, J ALLERGY CLIN IMMUN, V146, P642, DOI 10.1016/j.jaci.2020.02.015; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shindo Y, 2010, CHEM SENSES, V35, P171, DOI 10.1093/chemse/bjp097; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; SoRelle JA, 2021, ALLERGY, V76, P1095, DOI 10.1111/all.14564; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Starkl P, 2016, J ALLERGY CLIN IMMUN, V137, P246, DOI 10.1016/j.jaci.2015.08.005; Szklarczyk D., 2019, STRING V11 PROTEIN P; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Wang J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005392; Wang Tim, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot090811; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Winslow MM, 2006, IMMUNITY, V24, P141, DOI 10.1016/j.immuni.2005.12.013; Yang ZY, 2020, J EXP MED, V217, DOI 10.1084/jem.20190472; Yang ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.21238; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009	74	3	3	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2756	+		10.1016/j.immuni.2021.11.006	http://dx.doi.org/10.1016/j.immuni.2021.11.006		DEC 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34879220	Green Published, hybrid			2022-12-18	WOS:000731645300014
J	Saluzzo, S; Pandey, RV; Gail, LM; Dingelmaier-Hovorka, R; Kleissl, L; Shaw, L; Reininger, B; Atzmuller, D; Strobl, J; Touzeau-Romer, V; Beer, A; Staud, C; Rieger, A; Farlik, M; Weninger, W; Stingl, G; Stary, G				Saluzzo, Simona; Pandey, Ram Vinay; Gail, Laura Marie; Dingelmaier-Hovorka, Ruth; Kleissl, Lisa; Shaw, Lisa; Reininger, Barbel; Atzmueller, Denise; Strobl, Johanna; Touzeau-Roemer, Veronique; Beer, Andrea; Staud, Clement; Rieger, Armin; Farlik, Matthias; Weninger, Wolfgang; Stingl, Georg; Stary, Georg			Delayed antiretroviral therapy in HIV-infected individuals leads to irreversible depletion of skin- and mucosa-resident memory T cells	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; DENDRITIC CELLS; LATENT RESERVOIR; RNA-SEQ; DISEASE; PEOPLE; CXCR3; IMMUNOLOGY; IMMUNITY; CANCERS	People living with HIV (PLWH) are at increased risk for developing skin and mucosal malignancies despite systemic reconstitution of CD4(+) T cells upon antiretroviral therapy (ART). The underlying mechanism of chronic tissue-related immunodeficiency in HIV is unclear. We found that skin CD4(+) tissue-resident memory T (Trm) cells were depleted after HIV infection and replenished only upon early ART initiation. TCR clonal analysis following early ART suggested a systemic origin for reconstituting CD4(+) Trm cells. Single-cell RNA sequencing in PLWH that received late ART treatment revealed a loss of CXCR3(+) Trm cells and a tolerogenic skin immune environment. Human papilloma virus-induced precancerous lesion biopsies showed reduced CXCR3(+) Trm cell frequencies in the mucosa in PLWH versus HIV- individuals. These results reveal an irreversible loss of CXCR3(+) Trm cells confined to skin and mucosa in PLWH who received late ART treatment, which may be a precipitating factor in the development of HPV-related cancer.	[Saluzzo, Simona; Pandey, Ram Vinay; Gail, Laura Marie; Dingelmaier-Hovorka, Ruth; Kleissl, Lisa; Shaw, Lisa; Reininger, Barbel; Atzmueller, Denise; Strobl, Johanna; Touzeau-Roemer, Veronique; Rieger, Armin; Farlik, Matthias; Weninger, Wolfgang; Stingl, Georg; Stary, Georg] Med Univ Vienna, Dept Dermatol, A-1090 Vienna, Austria; [Gail, Laura Marie; Kleissl, Lisa; Atzmueller, Denise; Stary, Georg] LBI RUD Ludwig Boltzmann Inst Rare & Undiagnosed, A-1090 Vienna, Austria; [Gail, Laura Marie; Strobl, Johanna; Stary, Georg] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Beer, Andrea] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Staud, Clement] Med Univ Vienna, Dept Plast Reconstruct & Aesthet Surg, A-1090 Vienna, Austria	Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Medical University of Vienna	Saluzzo, S; Stary, G (corresponding author), Med Univ Vienna, Dept Dermatol, A-1090 Vienna, Austria.; Stary, G (corresponding author), LBI RUD Ludwig Boltzmann Inst Rare & Undiagnosed, A-1090 Vienna, Austria.	simona.saluzzo@meduniwien.ac.at; georg.stary@meduniwien.ac.at	Pandey, Ram Vinay/AAA-3544-2022	Strobl, Johanna/0000-0003-3606-2185; Gail, Laura Marie/0000-0002-2525-9399; Saluzzo, Simona/0000-0003-2675-4014; Kleissl, Lisa/0000-0001-8011-796X	Clinician Scientist Grant of the Austrian Society of Dermatology and Venereology [AP00871OFF]; Medical Scientific Fund of the Mayor of the City of Vienna [18127]; Oesterreichische Nationalbank (Austrian Central Bank) [17872]; Oesterreichische Nationalbank (Anniversary Fund) [17872]; Austrian Science Fund [P31494]	Clinician Scientist Grant of the Austrian Society of Dermatology and Venereology; Medical Scientific Fund of the Mayor of the City of Vienna; Oesterreichische Nationalbank (Austrian Central Bank); Oesterreichische Nationalbank (Anniversary Fund); Austrian Science Fund(Austrian Science Fund (FWF))	We thank the Biomedical Sequencing Facility (BSF) at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences for assis-tance with next-generation sequencing. We acknowledge the Core Facilities of the Medical University of Vienna, a member of Vienna Life-Science Instru-ments (VLSI) . This research was funded in part by the Clinician Scientist Grant of the Austrian Society of Dermatology and Venereology (AP00871OFF) and by the Medical Scientific Fund of the Mayor of the City of Vienna (project number 18127) . This work was further supported by funds from Oesterreichische Na-tionalbank (Austrian Central Bank, Anniversary Fund, project number 17872) and by the Austrian Science Fund (FWF; P31494) .	[Anonymous], 2011, CSH PERSPECT MED, DOI DOI 10.1101/cshperspect.a007096; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Arunachalam PS, 2020, NAT MED, V26, P932, DOI 10.1038/s41591-020-0858-8; Beachler DC, 2013, CURR OPIN ONCOL, V25, P503, DOI 10.1097/CCO.0b013e32836242b4; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bedognetti D, 2013, BRIT J CANCER, V109, P2412, DOI 10.1038/bjc.2013.557; BERGER R, 1992, J INVEST DERMATOL, V99, P271, DOI 10.1111/1523-1747.ep12616619; Bianchi ME, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02109; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; BRAATHEN LR, 1991, RES VIROLOGY, V142, P119, DOI 10.1016/0923-2516(91)90047-7; Buggert M, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar4526; Cantero-Perez J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12732-2; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cedeno-Laurent F, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-5; Chang AY, 2017, CURR OPIN HIV AIDS, V12, P57, DOI 10.1097/COH.0000000000000338; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Davis ASW, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8718; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doitsh G, 2016, CELL HOST MICROBE, V19, P280, DOI 10.1016/j.chom.2016.02.012; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dumauthioz N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02076; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; Faber MT, 2020, CANCER EPIDEM BIOMAR, V29, P185, DOI 10.1158/1055-9965.EPI-19-0601; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gantner P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17898-8; Gebhardt T, 2018, IMMUNOL REV, V283, P54, DOI 10.1111/imr.12650; Gomez-Sanchez D, 2018, MOL ECOL RESOUR, V18, P676, DOI 10.1111/1755-0998.12741; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Kazer SW, 2020, IMMUNITY, V53, P908, DOI 10.1016/j.immuni.2020.10.015; Kelly H, 2020, LANCET HIV, V7, pE262, DOI 10.1016/S2352-3018(19)30434-5; Kelly H, 2018, LANCET HIV, V5, pE45, DOI 10.1016/S2352-3018(17)30149-2; Kiniry BE, 2018, MUCOSAL IMMUNOL, V11, P909, DOI 10.1038/mi.2017.96; Klicznik MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav8995; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Kok L, 2022, NAT REV IMMUNOL, V22, P283, DOI 10.1038/s41577-021-00590-3; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kuo P, 2018, J INVEST DERMATOL, V138, P1348, DOI 10.1016/j.jid.2017.12.021; Kuo PT, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00271; Kurd NS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz6894; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2016, EMBO REP, V17, P178, DOI 10.15252/embr.201540946; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Malik BT, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6346; May MT, 2017, LANCET PUBLIC HEALTH, V2, pE6, DOI 10.1016/S2468-2667(16)30038-X; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Menares E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12319-x; Molodtsov A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02810; Mudd JC, 2016, J INFECT DIS, V214, pS58, DOI 10.1093/infdis/jiw258; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Munoz-Arias I, 2015, CELL HOST MICROBE, V18, P463, DOI 10.1016/j.chom.2015.09.010; Nguyen QP, 2019, IMMUNOLOGY, V157, P3, DOI 10.1111/imm.13059; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Olsen CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095096; Onodera A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02929; Palefsky J, 2009, CURR OPIN HIV AIDS, V4, P52, DOI 10.1097/COH.0b013e32831a7246; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Park SL, 2019, NATURE, V565, P366, DOI 10.1038/s41586-018-0812-9; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Poljak M, 2017, EXPERT REV ANTI-INFE, V15, P987, DOI 10.1080/14787210.2017.1392854; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rahimi RA, 2018, ADV IMMUNOL, V138, P71, DOI 10.1016/bs.ai.2018.02.002; Sengupta S, 2018, IMMUNITY, V48, P872, DOI 10.1016/j.immuni.2018.04.030; Shacklett BL, 2020, CURR HIV-AIDS REP, V17, P109, DOI 10.1007/s11904-020-00481-7; Shacklett Barbara L, 2010, Curr Infect Dis Rep, V12, P19, DOI 10.1007/s11908-009-0072-9; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Simonitsch I, 2000, MODERN PATHOL, V13, P1232, DOI 10.1038/modpathol.3880227; Sparber F, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00198; Stary G, 2009, BLOOD, V114, P3854, DOI 10.1182/blood-2009-04-217927; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Strobl J, 2021, J EXP MED, V218, DOI 10.1084/jem.20210417; Strobl J, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb7028; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun YY, 2016, CLIN CANCER RES, V22, P657, DOI 10.1158/1078-0432.CCR-15-0234; Trickey A, 2017, LANCET HIV, V4, pE349, DOI 10.1016/S2352-3018(17)30066-8; Tschachler E, 1996, LANCET, V348, P659, DOI 10.1016/S0140-6736(96)01032-X; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Wenzel J, 2005, AM J CLIN PATHOL, V124, P37, DOI 10.1309/4EJ9KL7CGDENWLE; Wijeyesinghe S, 2021, NATURE, V592, P457, DOI 10.1038/s41586-021-03351-3; Willemsen M, 2019, PIGM CELL MELANOMA R, V32, P612, DOI 10.1111/pcmr.12803; Williams JB, 2020, ADV EXP MED BIOL, V1273, P39, DOI 10.1007/978-3-030-49270-0_3; Xu HB, 2013, IMMUNOL REV, V254, P10, DOI 10.1111/imr.12072; Yu CI, 2013, IMMUNITY, V38, P818, DOI 10.1016/j.immuni.2013.03.004; Zhang W, 2020, BIOINFORMATICS, V36, P897, DOI 10.1093/bioinformatics/btz614; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	99	3	3	5	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2842	+		10.1016/j.immuni.2021.10.021	http://dx.doi.org/10.1016/j.immuni.2021.10.021		DEC 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6LX	34813775				2022-12-18	WOS:000731658800004
J	Muschaweck, M; Kopplin, L; Ticconi, F; Schippers, A; Iljazovic, A; Galvez, EJC; Abdallah, AT; Wagner, N; Costa, IG; Strowig, T; Pabst, O				Muschaweck, Moritz; Kopplin, Lydia; Ticconi, Fabio; Schippers, Angela; Iljazovic, Aida; Galvez, Eric J. C.; Abdallah, Ali T.; Wagner, Norbert; Costa, Ivan G.; Strowig, Till; Pabst, Oliver			Cognate recognition of microbial antigens defines constricted CD4(+) T cell receptor repertoires in the inflamed colon	IMMUNITY			English	Article							COLITIS; MICE; INDUCTION; SEQUENCES; MODEL; SPECIFICITY; BACTEROIDES; REACTIVITY; TOLERANCE; RESPONSES	Key aspects of intestinal T cells, including their antigen specificity and their selection by the microbiota and other intestinal antigens, as well as the contribution of individual T cell clones to regulatory and effector functions, remain unresolved. Here we tracked adoptively transferred T cell populations to specify the interrelation of T cell receptor repertoire and the gut antigenic environment. We show that dominant TCR alpha clonotypes were shared between interferon -gamma- and interleukin-17-producing but not regulatory Foxp3(+) T cells. Identical TCR alpha clonotypes accumulated in the colon of different individuals, whereas antibiotics or defined colonization correlated with the expansion of distinct expanded T cell clonotypes. Our results demonstrate key aspects of intestinal CD4(+) T cell activation and suggest that few microbial species exert a dominant effect on the intestinal T cell repertoire during colitis. We speculate that dominant proinflammatory T cell clones might provide a therapeutic target in human inflammatory bowel disease.	[Muschaweck, Moritz; Kopplin, Lydia; Ticconi, Fabio; Pabst, Oliver] Rhein Westfal TH Aachen, Inst Mol Med, Aachen, Germany; [Muschaweck, Moritz; Schippers, Angela; Wagner, Norbert] Rhein Westfal TH Aachen, Dept Pediat, Aachen, Germany; [Ticconi, Fabio; Costa, Ivan G.] Rhein Westfal TH Aachen, Inst Computat Genom, Aachen, Germany; [Iljazovic, Aida; Galvez, Eric J. C.; Strowig, Till] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Galvez, Eric J. C.; Strowig, Till] Hannover Med Sch, Hannover, Germany; [Abdallah, Ali T.] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res IZKF, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; RWTH Aachen University	Muschaweck, M; Pabst, O (corresponding author), Rhein Westfal TH Aachen, Inst Mol Med, Aachen, Germany.; Muschaweck, M (corresponding author), Rhein Westfal TH Aachen, Dept Pediat, Aachen, Germany.	mmuschaweck@ukaachen.de; opabst@ukaachen.de	Costa, Ivan G./D-5335-2014	Costa, Ivan G./0000-0003-2890-8697; Kopplin, Lydia/0000-0001-8048-599X; Ticconi, Fabio/0000-0001-8905-6657	Flow Cytometry Facility, a core unit of the Interdisciplinary Center for Clinical Research (IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University; German research foundation (DFG) [403224013 - SFB 1382, 418004173 (PA921/8-1)]; IZKF starting grant	Flow Cytometry Facility, a core unit of the Interdisciplinary Center for Clinical Research (IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University; German research foundation (DFG)(German Research Foundation (DFG)); IZKF starting grant	We thank Ana Izcue, Vuk Cerovic, Emma Slack, and Andreas Krueger for help-ful discussion and editorial contributions. Christoph von Oy created R scripts to visualize tree-maps and circos plots. Kerstin Esser provided histomicro-graphs. The work was supported by the Flow Cytometry Facility, a core unit of the Interdisciplinary Center for Clinical Research (IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University and the German research foundation (DFG) Project-ID 403224013 - SFB 1382 (B06 to O.P.) , Project-ID 418004173 (PA921/8-1 to O.P.) , and IZKF starting grant to M.M.	Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Beutner U, 1998, INT IMMUNOL, V10, P305, DOI 10.1093/intimm/10.3.305; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Britton GJ, 2019, IMMUNITY, V50, P212, DOI 10.1016/j.immuni.2018.12.015; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Calderon-Gomez E, 2016, GASTROENTEROLOGY, V151, P489, DOI 10.1053/j.gastro.2016.05.050; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Duchmann R, 1999, GUT, V44, P812, DOI 10.1136/gut.44.6.812; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fang HM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8941340; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Iljazovic A, 2021, MUCOSAL IMMUNOL, V14, P113, DOI 10.1038/s41385-020-0296-4; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Khatun A, 2021, J EXP MED, V218, DOI 10.1084/jem.20200650; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Mamedov IZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00456; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nutsch K, 2016, CELL REP, V17, P206, DOI 10.1016/j.celrep.2016.08.092; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; POWRIE F, 1994, RES IMMUNOL, V145, P347, DOI 10.1016/S0923-2494(94)80198-3; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rosati E, 2020, J CROHNS COLITIS, V14, P778, DOI 10.1093/ecco-jcc/jjz179; Schippers A, 2016, MUCOSAL IMMUNOL, V9, P527, DOI 10.1038/mi.2015.82; Shapiro JM, 2021, CELL HOST MICROBE, V29, P83, DOI 10.1016/j.chom.2020.12.003; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/nmeth.2960, 10.1038/NMETH.2960]; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Thiemann S, 2017, CELL HOST MICROBE, V21, P682, DOI 10.1016/j.chom.2017.05.005; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wardernann, J EXP MED, V717; Webb CR, 2018, INFLAMM BOWEL DIS, V24, P361, DOI 10.1093/ibd/izx014; Wegorzewska MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9079; Xiang LY, 2020, MICROB BIOTECHNOL, V13, P760, DOI 10.1111/1751-7915.13536; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	52	3	3	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2565	+		10.1016/j.immuni.2021.08.014	http://dx.doi.org/10.1016/j.immuni.2021.08.014		NOV 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LN	34582747	hybrid			2022-12-18	WOS:000718365500001
J	Liu, SS; Liu, C; Lv, XX; Cui, B; Yan, J; Li, YX; Li, K; Hua, F; Zhang, XW; Yu, JJ; Yu, JM; Wang, F; Shang, S; Li, PP; Zhou, ZG; Xiao, Y; Hu, ZW				Liu, Shan-shan; Liu, Chang; Lv, Xiao-xi; Cui, Bing; Yan, Jun; Li, Yun-xuan; Li, Ke; Hua, Fang; Zhang, Xiao-wei; Yu, Jiao-jiao; Yu, Jin-mei; Wang, Feng; Shang, Shuang; Li, Ping-ping; Zhou, Zhi-guang; Xiao, Yang; Hu, Zhuo-wei			The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis (vol 54, pg 2042, 2021)	IMMUNITY			English	Correction												xiaoyang29@csu.edu.cn; huzhuowei@csu.edu.cn	Li, Ping/GYV-4914-2022; zhang, xiaowei/GQH-5387-2022					Liu SS, 2021, IMMUNITY, V54, P2042, DOI 10.1016/j.immuni.2021.06.008	1	3	3	4	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2433	2435		10.1016/j.immuni.2021.09.009	http://dx.doi.org/10.1016/j.immuni.2021.09.009		OCT 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644559	Bronze			2022-12-18	WOS:000706854100025
J	Song, B; Chen, Y; Liu, X; Yuan, F; Tan, EYJ; Lei, YX; Song, N; Han, YQ; Pascal, BD; Griffin, PR; Luo, C; Wu, B; Luo, DH; Zheng, J				Song, Bin; Chen, Yun; Liu, Xin; Yuan, Fei; Tan, Eddie Yong Jun; Lei, Yixuan; Song, Ning; Han, Yinqi; Pascal, Bruce D.; Griffin, Patrick R.; Luo, Cheng; Wu, Bin; Luo, Dahai; Zheng, Jie			Ordered assembly of the cytosolic RNA-sensing MDA5-MAVS signaling complex via binding to unanchored K63-linked poly-ubiquitin chains	IMMUNITY			English	Article							RIG-I; STRUCTURAL BASIS; ACTIVATION; RECOGNITION; ADAR1; MDA5; SELF; MUTATIONS; RESPONSES; IMMUNITY	The RNA sensor MDA5 recruits the signaling adaptor MAVS to initiate type I interferon signaling and downstream antiviral responses, a process that requires K63-linked polyubiquitin chains. Here, we examined the mechanisms whereby K63-polyUb chain regulate MDA5 activation. Only long unanchored K63-polyUb(n) (n >= 8) could mediate tetramerization of the caspase activation and recruitment domains of MDA5 (MDA5CARDs). Cryoelectron microscopy structures of a polyUb(13)-bound (MDA5)CARDs tetramer and a polyUb(11)-bound (MDA5)CARDs-(MAVS)CARD assembly revealed a tower-like formation, wherein eight Ubs tethered along the outer rim of the helical shell, bridging (MDA5)CARDs and (MAVS)CARD tetramers into proximity. ATP binding and hydrolysis promoted the stabilization of RNA-bound MDA5 prior to MAVS activation via allosteric effects on CARDs-polyUb complex. Abundant ATP prevented basal activation of apo MDA5. Our findings reveal the ordered assembly of aMDA5 signaling complex competent to recruit and activate MAVS and highlight differences with RIG-I in terms of CARD orientation and Ub sensing that suggest different abilities to induce antiviral responses.	[Song, Bin; Liu, Xin; Yuan, Fei; Lei, Yixuan; Song, Ning; Han, Yinqi; Luo, Cheng; Zheng, Jie] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Luo, Cheng; Zheng, Jie] UCAS, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 310024, Peoples R China; [Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore; [Tan, Eddie Yong Jun; Wu, Bin; Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore; [Tan, Eddie Yong Jun; Wu, Bin; Luo, Dahai] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 636921, Singapore; [Luo, Cheng] Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, State Key Lab Drug Res,Ctr Chem Biol, Shanghai 201203, Peoples R China; [Chen, Yun] NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA; [Griffin, Patrick R.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Pascal, Bruce D.] Omics Informat LLC, Honolulu, HI 96813 USA; [Chen, Yun] BeiGene Shanghai Co Ltd, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Scripps Research Institute	Zheng, J (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.; Zheng, J (corresponding author), UCAS, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 310024, Peoples R China.	jzheng@simm.ac.cn		Song, Bin/0000-0002-5327-5839	Shanghai Institute of Material Medica; 100 Talents program of the Chinese Academy of Sciences, National Natural Science Foundation of China [81971538]; Shanghai PuJiang Talent program [PJ20190001389]; Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 1 [2018-T1-002-010]; Singapore Ministry of Health's National Medical Research Council [NMRC/OFIRG/0075/2018]	Shanghai Institute of Material Medica; 100 Talents program of the Chinese Academy of Sciences, National Natural Science Foundation of China; Shanghai PuJiang Talent program; Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 1(Ministry of Education, Singapore); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	We thank Dr. Naixia Zhang for providing key reagents of Ub, E1, E2 plasmids. We are grateful to Qingxia Wang and Yue Zhou to collect the cryo-EM data at Cryo-Electron Microscopy Research Center, Shanghai Institute of Material Medica; to Dr. Xiang Zhang and Dr. Zhanyu Ding from Shanghai YueXin LifeScience Information Technology Co. for computation support and cryoEM data analysis; to Jiahang Xu from Special preTreatment Solution (STS) (Shanghai) Analytical Instrument Co., LTD for assistance of HDX LEAP-Pal maintenance; and Bowen Ying for coordinating experimental reagents. This research was supported in part by start-funding from the Shanghai Institute of Material Medica, 100 Talents program of the Chinese Academy of Sciences, National Natural Science Foundation of China (81971538), and Shanghai PuJiang Talent program (PJ20190001389). This research is also supported by the Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 1 (2018-T1-002-010) and by the Singapore Ministry of Health's National Medical Research Council under its Open Fund-Individual Research Grant (OF-IRG) (NMRC/OFIRG/0075/2018).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; Blount JR, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.582361; Cadena C, 2019, CELL, V177, P1187, DOI 10.1016/j.cell.2019.03.017; Catici DAM, 2015, J BIOL CHEM, V290, P14130, DOI 10.1074/jbc.M115.640417; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113; Dias AG, 2019, TRENDS MICROBIOL, V27, P75, DOI 10.1016/j.tim.2018.08.007; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng Q, 2012, CELL REP, V2, P1187, DOI 10.1016/j.celrep.2012.10.005; Fernandez-Leiro R, 2017, ACTA CRYSTALLOGR D, V73, P496, DOI 10.1107/S2059798316019276; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hayman TJ, 2019, IMMUNOL CELL BIOL, V97, P840, DOI 10.1111/imcb.12284; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Hu MM, 2017, J EXP MED, V214, P973, DOI 10.1084/jem.20161015; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lang XT, 2017, J EXP MED, V214, P459, DOI 10.1084/jem.20160592; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu G., 2020, ISG15 DEPENDENT ACTI; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lutz J, 2020, ANGEW CHEM INT EDIT, V59, P12371, DOI 10.1002/anie.202003058; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Martinez A, 2008, ANN RHEUM DIS, V67, P137, DOI 10.1136/ard.2007.073213; Molineros JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003222; Mu X, 2016, ADV IMMUNOL, V132, P47, DOI 10.1016/bs.ai.2016.07.001; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nguyen NTH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23377; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Patel A, 2017, SCIENCE, V356, P753, DOI 10.1126/science.aaf6846; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Rebendenne A, 2021, J VIROL, V95, DOI 10.1128/JVI.02415-20; Rehwinkel J, 2020, NAT REV IMMUNOL, V20, P537, DOI 10.1038/s41577-020-0288-3; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Swint-Kruse L, 2005, BIOINFORMATICS, V21, P3327, DOI 10.1093/bioinformatics/bti511; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yin X, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108628; Yu Q, 2018, MOL CELL, V72, P999, DOI 10.1016/j.molcel.2018.10.012; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07780-z; Zheng J, 2015, NUCLEIC ACIDS RES, V43, P1216, DOI 10.1093/nar/gku1329; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	60	3	3	10	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2218	+		10.1016/j.immuni.2021.09.008	http://dx.doi.org/10.1016/j.immuni.2021.09.008		OCT 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644557	Bronze			2022-12-18	WOS:000706854100011
J	Arnett, E; Schlesinger, LS				Arnett, Eusondia; Schlesinger, Larry S.			Live and let die: TB control by enhancing apoptosis	IMMUNITY			English	Editorial Material								The impact of cellular apoptosis in controlling M. tuberculosis during tuberculosis (TB) infection remains unresolved. In this issue of Immunity, Stutz et al. provide compelling evidence that apoptosis controls M. tuberculosis infection in vivo and compounds that induce apoptosis limit M. tuberculosis growth in mice.	[Arnett, Eusondia; Schlesinger, Larry S.] Texas Biomed Res Inst, San Antonio, TX 78227 USA	Texas Biomedical Research Institute	Schlesinger, LS (corresponding author), Texas Biomed Res Inst, San Antonio, TX 78227 USA.	lschlesinger@txbiomed.org			NIH [AI136831, AG051428, AI145539]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	L.S.S. and E.A. are supported by NIH grants AI136831 (L.S.S. and E.A.), AG051428 (L.S.S.), and AI145539 (L.S.S. and E.A.).	Amaral EP, 2019, J EXP MED, V216, P556, DOI 10.1084/jem.20181776; Arnett E, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007100; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Philchenkov Alex, 2016, Critical Reviews in Oncogenesis, V21, P185, DOI 10.1615/CritRevOncog.2016017032; Stutz MD, 2021, IMMUNITY, V54, P1758, DOI 10.1016/j.immuni.2021.06.009; Wei AH, 2020, BLOOD REV, V44, DOI 10.1016/j.blre.2020.100672; Xue YS, 2019, TRENDS IMMUNOL, V40, P1035, DOI 10.1016/j.it.2019.09.005	10	3	3	3	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1625	1627		10.1016/j.immuni.2021.07.010	http://dx.doi.org/10.1016/j.immuni.2021.07.010		AUG 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34380059	Bronze			2022-12-18	WOS:000684589700002
J	Tomac, J; Mazor, M; Lisnic, B; Golemac, M; Kvestak, D; Bralic, M; Zulle, LB; Brinkmann, MM; Dolken, L; Reinert, LS; Paludan, SR; Krmpotic, A; Jonjic, S; Lisnic, VJ				Tomac, Jelena; Mazor, Marija; Lisnic, Berislav; Golemac, Mijo; Kvestak, Daria; Bralic, Marina; Zulle, Lidija Bilic; Brinkmann, Melanie M.; Doelken, Lars; Reinert, Line S.; Paludan, Soren R.; Krmpotic, Astrid; Jonjic, Stipan; Lisnic, Vanda Juranic			Viral infection of the ovaries compromises pregnancy and reveals innate immune mechanisms protecting fertility	IMMUNITY			English	Article							CYTOSOLIC DNA SENSOR; KAPPA-B ACTIVATION; DIFFERENTIAL MODULATION; MURINE CYTOMEGALOVIRUS; MOUSE CYTOMEGALOVIRUS; INTERFERON-BETA; VACCINIA VIRUS; GAP-JUNCTIONS; PROGESTERONE; CELLS	Viral infections during pregnancy are a considerable cause of adverse outcomes and birth defects, and the underlying mechanisms are poorly understood. Among those, cytomegalovirus (CMV) infection stands out as the most common intrauterine infection in humans, putatively causing early pregnancy loss. We employed murine CMV as a model to study the consequences of viral infection on pregnancy outcome and fertility maintenance. Even though pregnant mice successfully controlled CMV infection, we observed highly selective, strong infection of corpus luteum (CL) cells in their ovaries. High infection densities indicated complete failure of immune control in CL cells, resulting in progesterone insufficiency and pregnancy loss. An abundance of gap junctions, absence of vasculature, strong type I interferon (IFN) responses, and interaction of innate immune cells fully protected the ovarian follicles from viral infection. Our work provides fundamental insights into the effect of CMV infection on pregnancy loss and mechanisms protecting fertility.	[Tomac, Jelena; Lisnic, Berislav; Golemac, Mijo; Kvestak, Daria; Bralic, Marina; Krmpotic, Astrid; Jonjic, Stipan; Lisnic, Vanda Juranic] Univ Rijeka, Fac Med, Dept Histol & Embryol, B Branchetta 20, Rijeka 51000, Croatia; [Mazor, Marija; Lisnic, Berislav; Jonjic, Stipan; Lisnic, Vanda Juranic] Univ Rijeka, Fac Med, Ctr Prote, B Branchetta 20, Rijeka 51000, Croatia; [Zulle, Lidija Bilic] Univ Rijeka, Clin Hosp Rijeka, B Branchetta 20, Rijeka 51000, Croatia; [Brinkmann, Melanie M.] Helmholtz Ctr Infect Res, Viral Immune Modulat Res Grp, D-38124 Braunschweig, Germany; [Brinkmann, Melanie M.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, D-38106 Braunschweig, Germany; [Doelken, Lars] Julius Maximilians Univ Wurzburg, Inst Virol & Immunobiol, D-97080 Wurzburg, Germany; [Doelken, Lars] Helmholtz Ctr Infect Res, Helmholtz Inst RNA Based Infect Res HIRI, D-97080 Wurzburg, Germany; [Reinert, Line S.; Paludan, Soren R.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	University of Rijeka; University of Rijeka; University of Rijeka; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Aarhus University	Jonjic, S; Lisnic, VJ (corresponding author), Univ Rijeka, Fac Med, Dept Histol & Embryol, B Branchetta 20, Rijeka 51000, Croatia.; Jonjic, S; Lisnic, VJ (corresponding author), Univ Rijeka, Fac Med, Ctr Prote, B Branchetta 20, Rijeka 51000, Croatia.	stipan.jonjic@uniri.hr; vanda.juranic@uniri.hr	Bralic, Marina/AFM-0513-2022; Mazor, Marija/S-5544-2018; Tomac, Jelena/S-7331-2018; Kvestak, Daria/S-5481-2018; Bralic, Marina/AAH-2886-2022; Juranic Lisnic, Vanda/P-1176-2018; Jonjic, Stipan/C-5657-2016	Mazor, Marija/0000-0002-3670-6334; Tomac, Jelena/0000-0002-7672-9311; Kvestak, Daria/0000-0001-5280-827X; Juranic Lisnic, Vanda/0000-0002-7182-8927; Jonjic, Stipan/0000-0001-5003-3108; Reinert, Line/0000-0002-8317-0886	Croatian Science Foundation [IP-2016-06-5980, KK.01.1.1.01.0006]; European Regional Development Fund; Ministry of Science and Culture (MWK) of Lower Saxony, Germany; Helmholtz Association [W2/W3-090]; Leibniz Universit_at Hannover - Ministry of Science and Culture (MWK) of Lower Saxony, Germany	Croatian Science Foundation; European Regional Development Fund(European Commission); Ministry of Science and Culture (MWK) of Lower Saxony, Germany; Helmholtz Association(Helmholtz Association); Leibniz Universit_at Hannover - Ministry of Science and Culture (MWK) of Lower Saxony, Germany	We thank our laboratory engineers and administrative staff for excellent support. This work has been supported in part by the Croatian Science Foundation under project IP-2016-06-5980 (to V.J.L.) and grant KK.01.1.1.01.0006 awarded to the Scientific Centre of Excellence for Virus Immunology and Vaccines and co-financed by the European Regional Development Fund (to S.J.). M.M.B. was funded by the SMART BIOTECS alliance between Ministry of Science and Culture (MWK) of Lower Saxony, Germany and Leibniz Universit_at Hannover, an initiative supported by the Ministry of Science and Culture (MWK) of Lower Saxony, Germany, and the Helmholtz Association (W2/W3-090).	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; An JQ, 2018, ONCOTARGET, V9, P4475, DOI 10.18632/oncotarget.23381; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Arck P, 2007, AM J REPROD IMMUNOL, V58, P268, DOI 10.1111/j.1600-0897.2007.00512.x; Bachelot A, 2005, CURR TOP DEV BIOL, V68, P49, DOI 10.1016/S0070-2153(05)68003-9; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; BRAUTIGAM AR, 1980, AM J PATHOL, V98, P213; Britt W, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P737; Britt WJ, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL II, P119; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butts CL, 2010, MUCOSAL IMMUNOL, V3, P496, DOI 10.1038/mi.2010.28; Caine EA, 2019, J INFECT DIS, V220, P1904, DOI 10.1093/infdis/jiz239; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Cekinovic D, 2014, METHODS MOL BIOL, V1119, P289, DOI 10.1007/978-1-62703-788-4_16; Christenson Lane K, 2003, Reprod Biol Endocrinol, V1, P90, DOI 10.1186/1477-7827-1-90; Clarke LM, 1997, J INFECT DIS, V176, P286, DOI 10.1086/517268; DAVIDSON JS, 1986, BIOCHEM BIOPH RES CO, V134, P29, DOI 10.1016/0006-291X(86)90522-X; Day SL, 2008, J IMMUNOL, V180, P7158, DOI 10.4049/jimmunol.180.11.7158; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gershon E, 2008, MOL CELL ENDOCRINOL, V282, P18, DOI 10.1016/j.mce.2007.11.001; Grammatikopoulou I, 2012, CLIN EXP OBSTET GYN, V39, P96; Grandi G, 2016, AM J REPROD IMMUNOL, V76, P292, DOI 10.1111/aji.12552; Grooms DL, 1998, J VET DIAGN INVEST, V10, P125, DOI 10.1177/104063879801000201; Hall OJ, 2017, MUCOSAL IMMUNOL, V10, P1097, DOI 10.1038/mi.2017.35; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; IWASAKI T, 1988, ACTA PATHOL JAPON, V38, P1069; Iwasenko JM, 2011, J INFECT DIS, V203, P1526, DOI 10.1093/infdis/jir121; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones LA, 2010, J IMMUNOL, V185, P4525, DOI 10.4049/jimmunol.0901155; KARUPIAH G, 1990, IMMUNOL CELL BIOL, V68, P325, DOI 10.1038/icb.1990.44; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; KEIL GM, 1987, J VIROL, V61, P526, DOI 10.1128/JVI.61.2.526-533.1987; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Kwon JY, 2014, AM J REPROD IMMUNOL, V71, P387, DOI 10.1111/aji.12243; Labarta E, 2020, BEST PRACT RES CL OB, V69, P74, DOI 10.1016/j.bpobgyn.2020.05.005; Labarta E, 2020, J ASSIST REPROD GEN, V37, P2047, DOI 10.1007/s10815-020-01862-y; LARSEN WJ, 1981, BIOL REPROD, V25, P1119, DOI 10.1095/biolreprod25.5.1119; LARSEN WJ, 1987, DEV BIOL, V122, P61, DOI 10.1016/0012-1606(87)90332-0; Lio CWJ, 2016, J VIROL, V90, P7789, DOI 10.1128/JVI.01040-16; Mak JSM, 2020, J VIRAL HEPATITIS, V27, P110, DOI 10.1111/jvh.13210; Martin-Coello J, 2008, THERIOGENOLOGY, V70, P1004, DOI 10.1016/j.theriogenology.2008.06.002; Mathys S, 2003, J INFECT DIS, V187, P988, DOI 10.1086/368094; McGowan MR, 2003, THERIOGENOLOGY, V59, P1051, DOI 10.1016/S0093-691X(02)01136-6; Michel T, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00403; Mizutani T, 1997, BIOCHEM BIOPH RES CO, V234, P499, DOI 10.1006/bbrc.1997.6646; MORRISON JC, 1975, FERTIL STERIL, V26, P655; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pathak S., 2020, CANCERS BASEL, V12, P12; Pereira L, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P814; Piekorz RP, 2005, MOL ENDOCRINOL, V19, P431, DOI 10.1210/me.2004-0302; PRINZ W, 1969, GYNAECOLOGIA, V167, P23, DOI 10.1159/000302156; Rahim MMA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00145; Reddehase MJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120693; Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348; RUBINSTEIN L, 1963, P SOC EXP BIOL MED, V113, P1043; SHARMA TM, 1994, ACTA OBSTET GYN SCAN, V73, P429, DOI 10.3109/00016349409006258; Shim HM, 2015, EXP ANIM TOKYO, V64, P343, DOI 10.1538/expanim.14-0097; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Siu MKY, 2013, ADV EXP MED BIOL, V763, P186; Stempel M, 2019, MED MICROBIOL IMMUN, V208, P495, DOI 10.1007/s00430-019-00582-0; Stempel M, 2019, EMBO J, V38, DOI 10.15252/embj.2018100983; Stocco C, 2003, ENDOCRINOLOGY, V144, P3301, DOI 10.1210/en.2003-0420; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Stocco DM, 1997, STEROIDS, V62, P29, DOI 10.1016/S0039-128X(96)00155-9; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; Virant-Klun I, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0350-1; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114; Wang Q, 2016, MOL CELL ENDOCRINOL, V436, P183, DOI 10.1016/j.mce.2016.07.033; Watson S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-130; Yan KQ, 2017, REPRODUCTION, V153, P821, DOI 10.1530/REP-16-0674; Yang ZY, 2011, INT IMMUNOPHARMACOL, V11, P1442, DOI 10.1016/j.intimp.2011.04.024; Zeligs KP, 2016, CLIN CANCER RES, V22, P4302, DOI 10.1158/1078-0432.CCR-15-1374; Zhao Y, 2011, VIRAL IMMUNOL, V24, P387, DOI 10.1089/vim.2011.0020; Zuhair M, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2034	85	3	3	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1478	+		10.1016/j.immuni.2021.04.020	http://dx.doi.org/10.1016/j.immuni.2021.04.020		JUL 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34015257	Bronze			2022-12-18	WOS:000672812100013
J	Pan, YG; Aiamkitsumrit, B; Bartolo, L; Wang, YF; Lavery, C; Marc, A; Holec, PV; Rappazzo, CG; Eilola, T; Gimotty, PA; Hensley, SE; Antia, R; Zarnitsyna, VI; Birnbaum, ME; Su, LF				Pan, Yi-Gen; Aiamkitsumrit, Benjamas; Bartolo, Laurent; Wang, Yifeng; Lavery, Criswell; Marc, Adam; Holec, Patrick, V; Rappazzo, C. Garrett; Eilola, Theresa; Gimotty, Phyllis A.; Hensley, Scott E.; Antia, Rustom; Zarnitsyna, Veronika, I; Birnbaum, Michael E.; Su, Laura F.			Vaccination reshapes the virus-specific T cell repertoire in unexposed adults	IMMUNITY			English	Article							ANTIGEN; NAIVE; RESPONSES; PHENOTYPE; FREQUENCY; DIFFERENTIATION; VALIDATION; DIVERSITY; THRESHOLD; AVIDITY	We examined how baseline CD4(+) T cell repertoire and precursor states impact responses to pathogen infection in humans using primary immunization with yellow fever virus (YFV) vaccine. YFV-specific T cells in unexposed individuals were identified by peptide-MHC tetramer staining and tracked pre- and post-vaccination by tetramers and TCR sequencing. A substantial number of YFV-reactive T cells expressed memory phenotype markers and contained expanded clones in the absence of exposure to YFV. After vaccination, pre-existing YFV-specific T cell populations with low clonal diversity underwent limited expansion, but rare populations with a reservoir of unexpanded TCRs generated robust responses. These altered dynamics reorganized the immunodominance hierarchy and resulted in an overall increase in higher avidity T cells. Thus, instead of further increasing the representation of dominant clones, YFV vaccination recruits rare and more responsive T cells. Our findings illustrate the impact of vaccines in prioritizing T cell responses and reveal repertoire reorganization as a key component of effective vaccination.	[Pan, Yi-Gen; Aiamkitsumrit, Benjamas; Bartolo, Laurent; Wang, Yifeng; Lavery, Criswell; Marc, Adam; Su, Laura F.] Univ Penn, Perelman Sch Med, Inst Immunol, Dept Med,Div Rheumatol, Philadelphia, PA 19104 USA; [Lavery, Criswell; Marc, Adam; Su, Laura F.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA 19104 USA; [Eilola, Theresa; Hensley, Scott E.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Gimotty, Phyllis A.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Holec, Patrick, V; Rappazzo, C. Garrett; Birnbaum, Michael E.] MIT, Koch Inst Integrat Canc Res, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Zarnitsyna, Veronika, I] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Massachusetts Institute of Technology (MIT); Emory University; Emory University	Su, LF (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Dept Med,Div Rheumatol, Philadelphia, PA 19104 USA.; Su, LF (corresponding author), Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA 19104 USA.	laurasu@upenn.edu	Gimotty, Phyllis/GWZ-4136-2022	Gimotty, Phyllis/0000-0002-3850-9799; Birnbaum, Michael/0000-0002-2281-3518; Lavery, Criswell/0000-0001-5498-0209; Pan, Yi-Gen/0000-0003-2427-2759	NIH [R01AI134879]; VA Merit Award [IMMA-020-15F]; National Cancer Institute [P30-CA14051]; Schmidt Futures; V Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Schmidt Futures; V Foundation	We thank Lea Williams, Tammy Ruozhang Xu, and Ning Jiang for helpful discussions. We thank our study subjects for their participation. Funding was provided from NIH R01AI134879 (L.F.S.), VA Merit Award IMMA-020-15F (L.F.S.), National Cancer Institute P30-CA14051 (M.E.B.), and Schmidt Futures, the V Foundation (M.E.B.).	Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Bacher P, 2020, IMMUNITY, V53, P1258, DOI 10.1016/j.immuni.2020.11.016; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Davis BH, 2013, CYTOM PART B-CLIN CY, V84, P286, DOI 10.1002/cyto.b.21105; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; de Melo AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001938; Del Alcazar D, 2019, CELL REP, V28, P3047, DOI 10.1016/j.celrep.2019.08.037; Fraser KA, 2013, IMMUNITY, V39, P171, DOI 10.1016/j.immuni.2013.07.003; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13; Kawabe T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9304; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Martin MD, 2012, J IMMUNOL, V188, P1255, DOI 10.4049/jimmunol.1101579; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McCurley N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011949; Mehlhop-Williams ER, 2014, J EXP MED, V211, P345, DOI 10.1084/jem.20131271; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Nelson RW, 2015, IMMUNITY, V42, P95, DOI 10.1016/j.immuni.2014.12.022; Paul S, 2015, J IMMUNOL METHODS, V422, P28, DOI 10.1016/j.jim.2015.03.022; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Smith A, 2000, IMMUNITY, V13, P783, DOI 10.1016/S1074-7613(00)00076-5; Su LF, 2016, P NATL ACAD SCI USA, V113, pE6192, DOI 10.1073/pnas.1611723113; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; T Stock A, 2006, J IMMUNOL, V177, P1411, DOI 10.4049/jimmunol.177.3.1411; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wendel BS, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan8884; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	50	3	3	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1245	+	e5	10.1016/j.immuni.2021.04.023	http://dx.doi.org/10.1016/j.immuni.2021.04.023		JUN 2021	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34004140	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000659882900015
J	Maghzi, AH; Weiner, HL				Maghzi, Amir-Hadi; Weiner, Howard L.			A One-Two Punch in the Gut May Trigger Multiple Sclerosis	IMMUNITY			English	Editorial Material							MICROBIOTA	The microbiome plays an important role in multiple sclerosis. In a recent issue of Nature, Miyauchi et al. report that gut microbial molecular mimicry in concert with gut microbes that enhance Th17 cells act synergistically to worsen CNS autoimmunity.	[Maghzi, Amir-Hadi; Weiner, Howard L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Brigham MS Ctr,Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Weiner, HL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Brigham MS Ctr,Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu			Clinician-Scientist development award from the National MS Society	Clinician-Scientist development award from the National MS Society	A.H.M. is supported by a Clinician-Scientist development award from the National MS Society.	Arrieta MC, 2016, CELL HOST MICROBE, V19, P575, DOI 10.1016/j.chom.2016.04.014; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; He BK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00385; Mirza A, 2020, MULT SCLER RELAT DIS, V37, DOI 10.1016/j.msard.2019.101427; Miyauchi E, 2020, NATURE, V585, P102, DOI 10.1038/s41586-020-2634-9; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Tankou SK, 2018, ANN NEUROL, V83, P1147, DOI 10.1002/ana.25244; Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651	10	3	3	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					707	709		10.1016/j.immuni.2020.09.016	http://dx.doi.org/10.1016/j.immuni.2020.09.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053328	Bronze			2022-12-18	WOS:000581062800005
J	Finney, J; Kelsoe, G				Finney, Joel; Kelsoe, Garnett			Ideal Vaccines: Balancing B Cell Recruitment and Differentiation	IMMUNITY			English	Editorial Material							GERMINAL CENTER B; PLASMA-CELL; MEMORY B; SELECTION	In this issue of Immunity, Kato et al. show that high-affinity vaccines targeting rare B cells capable of broadly protective antibody responses are not hindered by promotion of terminal plasmacytic differentiation. These findings provide new understanding into vaccine design and offer important insight into B cell fate decisions.	[Finney, Joel; Kelsoe, Garnett] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA; [Kelsoe, Garnett] Duke Univ, Sch Med, Dept Surg, Durham, NC 27710 USA; [Kelsoe, Garnett] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Finney, J; Kelsoe, G (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA.; Kelsoe, G (corresponding author), Duke Univ, Sch Med, Dept Surg, Durham, NC 27710 USA.; Kelsoe, G (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.	joel.finney@duke.edu; ghkelsoe@duke.edu	Finney, Joel/AAD-3773-2021	Finney, Joel/0000-0002-3755-8425	NIAID NIH HHS [T32 AI052077] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; [Anonymous], TITLE ERROR, DOI 10.1016/j.bbi.2019.12.019; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Shinnakasu R, 2017, CURR OPIN IMMUNOL, V45, P126, DOI 10.1016/j.coi.2017.03.003; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Yeh CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03382-x	10	3	3	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					473	475		10.1016/j.immuni.2020.08.008	http://dx.doi.org/10.1016/j.immuni.2020.08.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32937146	Bronze			2022-12-18	WOS:000569806100002
J	Tussiwand, R; Rodrigues, PF				Tussiwand, Roxane; Rodrigues, Patrick F.			Where's Waldo: Identifying DCs within Mononuclear Phagocytes during Inflammation	IMMUNITY			English	Editorial Material							DENDRITIC CELLS	Dendritic cells (DCs) are antigen-presenting cells subdivided in specialized subsets. In this issue, Bosteels et al. challenge this concept, identifying a unique subset of inflammatory DCs characterized by hybrid myeloid features, capable of efficiently priming CD4(+) as well as CD8(+) T cells.	[Tussiwand, Roxane; Rodrigues, Patrick F.] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Tussiwand, Roxane] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	University of Basel; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Tussiwand, R (corresponding author), Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.; Tussiwand, R (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	roxane.tussiwand@nih.gov		Rodrigues, Patrick/0000-0002-0214-0627				Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Bosteels C, 2020, IMMUNITY, V52, P1039, DOI 10.1016/j.immuni.2020.04.005; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030	10	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					892	894		10.1016/j.immuni.2020.05.006	http://dx.doi.org/10.1016/j.immuni.2020.05.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32553175	Bronze			2022-12-18	WOS:000541890000003
J	Oherle, K; Acker, E; Bonfield, M; Wang, T; Gray, J; Lang, I; Bridges, J; Lewkowich, I; Xu, Y; Ahlfeld, S; Zacharias, W; Alenghat, T; Deshmukh, H				Oherle, Katherine; Acker, Elizabeth; Bonfield, Madeline; Wang, Timothy; Gray, Jerilyn; Lang, Ian; Bridges, James; Lewkowich, Ian; Xu, Yan; Ahlfeld, Shawn; Zacharias, William; Alenghat, Theresa; Deshmukh, Hitesh			Insulin-like Growth Factor 1 Supports a Pulmonary Niche that Promotes Type 3 Innate Lymphoid Cell Development in Newborn Lungs (vol 52, pg 275, 2020)	IMMUNITY			English	Correction												hitesh.deshmukh@cchmc.org			NHLBI NIH HHS [R01 HL131634, K08 HL140178, R01 HL142708, R01 HL122300] Funding Source: Medline; NICHD NIH HHS [K08 HD084686] Funding Source: Medline; NIDDK NIH HHS [R01 DK114123, R01 DK116868] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Oherle K, 2020, IMMUNITY, V52, P275, DOI [10.1016/j.immuni.7020.01.005, 10.1016/j.immuni.2020.01.005]	1	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					716	718		10.1016/j.immuni.2020.03.018	http://dx.doi.org/10.1016/j.immuni.2020.03.018			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294410	Bronze, Green Accepted			2022-12-18	WOS:000526782600014
J	Evans, SS; Appenheimer, MM				Evans, Sharon S.; Appenheimer, Michelle M.			A Fever-Th17 Cell Immune Axis: Some SMADs Like It Hot	IMMUNITY			English	Editorial Material							TRAFFICKING	Fever has beneficial effects on immune responses; however, its impact on T cell polarization is poorly understood. In this issue of Immunity, Wang et al. show that fever acts through a T cell-intrinsic SMAD4-dependent mechanism that selectively drives Th17 cell differentiation and pathogenicity in autoimmunity.	[Evans, Sharon S.; Appenheimer, Michelle M.] Roswell Pk Comprehens Canc Ctr, Dept Immunol, Buffalo, NY 14203 USA		Evans, SS (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Immunol, Buffalo, NY 14203 USA.	sharon.evans@roswellpark.org						Capitano ML, 2012, BLOOD, V120, P2600, DOI 10.1182/blood-2012-02-409805; Chen Q, 2004, IMMUNITY, V20, P59, DOI 10.1016/S1074-7613(03)00358-3; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Lin CD, 2019, IMMUNITY, V50, P137, DOI 10.1016/j.immuni.2018.11.013; Mikucki ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8458; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhang S, 2017, NATURE, V551, P105, DOI 10.1038/nature24283	9	3	3	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					209	211		10.1016/j.immuni.2020.01.010	http://dx.doi.org/10.1016/j.immuni.2020.01.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32075722	Bronze			2022-12-18	WOS:000515082000003
J	Nimmerjahn, F				Nimmerjahn, Falk			Keeping T-he Killers at Bay via Fc gamma RIIb	IMMUNITY			English	Editorial Material							RECEPTORS	Understanding how cytotoxic T cells are regulated is key for enhancing or suppressing their activity in tumor or transplantation settings. A study by Morris et al. (2020) in this issue of Immunity shows that crosslinking of inhibitory Fc receptor Fc gamma RIIb by the suppressive cytokine Fgl2 limits cytotoxic CD8(+) T cell responses by inducing T cell apoptosis.	[Nimmerjahn, Falk] Univ Erlangen Nurnberg, Dept Biol, Inst Genet, Erwin Rommelstr 3, D-91054 Erlangen, Germany; [Nimmerjahn, Falk] Univ Erlangen Nurnberg, Med Immunol Campus Erlangen, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Nimmerjahn, F (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Inst Genet, Erwin Rommelstr 3, D-91054 Erlangen, Germany.; Nimmerjahn, F (corresponding author), Univ Erlangen Nurnberg, Med Immunol Campus Erlangen, D-91054 Erlangen, Germany.	falk.nimmerjahn@fau.de						Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Descours B, 2017, NATURE, V543, P564, DOI 10.1038/nature21710; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; Hudrisier D, 2009, J IMMUNOL, V183, P6102, DOI 10.4049/jimmunol.0900821; LEE ST, 1978, CELL IMMUNOL, V40, P141, DOI 10.1016/0008-8749(78)90322-2; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Morris AB, 2020, IMMUNITY, V52, P136, DOI 10.1016/j.immuni.2019.12.006; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Smith KGC, 2010, NAT REV IMMUNOL, V10, P328, DOI 10.1038/nri2762; Starbeck-Miller GR, 2014, J IMMUNOL, V192, P35, DOI 10.4049/jimmunol.1302232	10	3	3	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					9	11		10.1016/j.immuni.2019.12.012	http://dx.doi.org/10.1016/j.immuni.2019.12.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31951551	Bronze			2022-12-18	WOS:000507384600004
J	Nishio, A; Rehermann, B				Nishio, Akira; Rehermann, Barbara			Virus-Induced Interferon Regulates the Urea Cycle	IMMUNITY			English	Editorial Material							CELLS	Integrating transcriptomic, proteomic, and metabolomic data, Lercher et al. show in a mouse model of LCMV infection that type I interferon alters the expression and function of key enzymes of the urea cycle in hepato-cytes. This results in altered systemic metabolism, attenuating antiviral T cell responses and ameliorating liver injury.	[Nishio, Akira; Rehermann, Barbara] NIDDK, Immunol Sect, Liver Dis Branch, NIH,DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rehermann, B (corresponding author), NIDDK, Immunol Sect, Liver Dis Branch, NIH,DHHS, Bethesda, MD 20892 USA.	rehermann@nih.gov		Rehermann, Barbara/0000-0001-6832-9951	intramural research program of NIDDK, NIH	intramural research program of NIDDK, NIH	This work was supported by the intramural research program of NIDDK, NIH.	De Chiara F, 2018, J HEPATOL, V69, P905, DOI 10.1016/j.jhep.2018.06.023; Hamdane N, 2019, GASTROENTEROLOGY, V156, P2313, DOI 10.1053/j.gastro.2019.02.038; Jalan R, 2016, J HEPATOL, V64, P823, DOI 10.1016/j.jhep.2015.11.019; Kim DJ, 2019, CANCERS, V11, DOI 10.3390/cancers11101497; Lauber C, 2017, CELL HOST MICROBE, V22, P387, DOI 10.1016/j.chom.2017.07.019; Lercher A, 2019, IMMUNITY, V51, P1074, DOI 10.1016/j.immuni.2019.10.014; Lupberger J, 2019, GASTROENTEROLOGY, V157, P537, DOI 10.1053/j.gastro.2019.04.003; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Shen TCD, 2015, J CLIN INVEST, V125, P2841, DOI 10.1172/JCI79214	10	3	3	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					975	977		10.1016/j.immuni.2019.11.012	http://dx.doi.org/10.1016/j.immuni.2019.11.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31951542	Bronze			2022-12-18	WOS:000503162900004
J	Motomura, Y; Kobayashi, T; Moro, K				Motomura, Yasutaka; Kobayashi, Tetsuro; Moro, Kazuyo			The Neuropeptide CGRP Induces Bipolar Syndrome in Group 2 Innate Lymphoid Cells	IMMUNITY			English	Editorial Material								In this issue of Immunity, Nagashima et al., Wallrapp et al., and Xu et al. demonstrate that the neuropeptide calcitonin gene-related peptide (CGRP) fine tunes type 2 innate immune response via suppressing group 2 innate lymphoid cells (ILC2s).	[Motomura, Yasutaka; Moro, Kazuyo] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Innate Immune Syst, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Kobayashi, Tetsuro; Moro, Kazuyo] RIKEN Ctr Integrat Med Sci IMS, Lab Innate Immune Syst, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Moro, Kazuyo] Osaka Univ, Immunol Frontier Res Ctr iFReC, Lab Innate Immune Syst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University; RIKEN; Osaka University	Moro, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Innate Immune Syst, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Moro, K (corresponding author), RIKEN Ctr Integrat Med Sci IMS, Lab Innate Immune Syst, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Moro, K (corresponding author), Osaka Univ, Immunol Frontier Res Ctr iFReC, Lab Innate Immune Syst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	moro@ilc.med.osaka-u.ac.jp		Kobayashi, Tetsuro/0000-0003-2316-4748; Moro, Kazuyo/0000-0002-7377-1303				Assas BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00023; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kabata H, 2018, IMMUNOL REV, V286, P37, DOI 10.1111/imr.12706; Klose CSN, 2019, CURR OPIN IMMUNOL, V56, P94, DOI 10.1016/j.coi.2018.11.002; Nagashima H, 2019, IMMUNITY, V51, P682, DOI 10.1016/j.immuni.2019.06.009; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Sonnenberg GE, 2019, NAT REV IMMUNOL, V19, P599, DOI 10.1038/s41577-019-0194-8; Sui P., 2018, SCIENCE, V360; Wallrapp A, 2019, IMMUNITY, V51, P709, DOI 10.1016/j.immuni.2019.09.005; Xu HP, 2019, IMMUNITY, V51, P696, DOI 10.1016/j.immuni.2019.09.004	10	3	4	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					598	600		10.1016/j.immuni.2019.09.015	http://dx.doi.org/10.1016/j.immuni.2019.09.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31618650	Bronze			2022-12-18	WOS:000490141700005
J	Kroemer, G; Zitvogel, L				Kroemer, Guido; Zitvogel, Laurence			Leptin-Producing Oncolytic Virus Makes Tumor-Infiltrating T Cells Fit, Not Fat	IMMUNITY			English	Editorial Material							CHEMOTHERAPY	Effective anticancer immunosurveillance after oncolytic viral infection is often hindered by the defective metabolic function of tumor-infiltrating lymphocytes (TILs). A recent paper by Rivadeneira et al. demonstrates that intratumoral delivery of leptin by a recombinant oncolytic vaccinia virus can metabolically enhance TIL effector and memory functions through improved mitochondrial oxidative phosphorylation, thereby enhancing therapeutic efficacy.	[Kroemer, Guido] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc,INSERM,U1138, Paris, France; [Kroemer, Guido] Inst Gustave Roussy, Metabol & Cell Biol Platforms, Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido; Zitvogel, Laurence] Chinese Acad Med Sci, Suzhou Inst Syst Med, Suzhou, Peoples R China; [Kroemer, Guido] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Zitvogel, Laurence] Paris Sud Paris XI Univ, Fac Med, Le Kremlin Bicetre, France; [Zitvogel, Laurence] Gustave Roussy Comprehens Canc Inst, Villejuif, France; [Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Medical Sciences - Peking Union Medical College; Karolinska Institutet; Karolinska University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Kroemer, G (corresponding author), Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc,INSERM,U1138, Paris, France.; Kroemer, G (corresponding author), Inst Gustave Roussy, Metabol & Cell Biol Platforms, Villejuif, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France.; Kroemer, G (corresponding author), Chinese Acad Med Sci, Suzhou Inst Syst Med, Suzhou, Peoples R China.; Kroemer, G (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	kroemer@orange.fr	KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020	KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR)-Projets Blancs, ANR; Association pour la Recherche sur le Cancer (ARC); Canceropole Ile-de-France; Fondation pour la Recherche Medicale (FRM); European Research Area Network on Cardiovascular Diseases; Gustave Roussy Odyssea; European Union; Fondation Carrefour, High-End Foreign Expert Program in China [GDW20171100085]; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; LabEx Immuno-Oncology [ANR-18-IDEX-0001]; RHU Torino Lumiere; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM)	Ligue contre le Cancer (equipe labelisee)(Ligue nationale contre le cancer); Agence National de la Recherche (ANR)-Projets Blancs, ANR(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Research Area Network on Cardiovascular Diseases; Gustave Roussy Odyssea; European Union(European Commission); Fondation Carrefour, High-End Foreign Expert Program in China; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; RHU Torino Lumiere; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM)	G.K. and L.Z. are supported by the Ligue contre le Cancer (equipe labelisee), Agence National de la Recherche (ANR)-Projets Blancs, ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases, Association pour la Recherche sur le Cancer (ARC), Canceropole Ile-de-France, Chancelerie des Universites de Paris (Legs Poix), Fondation pour la Recherche Medicale (FRM), a donation by Elior; European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea, the European Union Horizon 2020 Project Oncobiome, Fondation Carrefour, High-End Foreign Expert Program in China (GDW20171100085), Institut National du Cancer (INCa), Inserm (HTE), Institut Universitaire de France, LeDucq Foundation, the LabEx Immuno-Oncology (ANR-18-IDEX-0001), the RHU Torino Lumiere, the Seerave Foundation, the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE), and the SIRIC Cancer Research and Personalized Medicine (CARPEM).	Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Fend L, 2017, CANCER RES, V77, P4146, DOI 10.1158/0008-5472.CAN-16-2165; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; McQuade JL, 2018, LANCET ONCOL, V19, P310, DOI 10.1016/S1470-2045(18)30078-0; Menk AV, 2018, J EXP MED, V215, P1091, DOI 10.1084/jem.20171068; Ribas A, 2018, CELL, V174, P1031, DOI 10.1016/j.cell.2018.07.035; Rivadeneira DB, 2019, IMMUNITY, V51, P548, DOI 10.1016/j.immuni.2019.07.003; Scharping NE, 2016, IMMUNITY, V45, P701, DOI 10.1016/j.immuni.2016.08.009; Wang ZM, 2019, NAT MED, V25, P141, DOI 10.1038/s41591-018-0221-5	9	3	3	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					423	425		10.1016/j.immuni.2019.08.010	http://dx.doi.org/10.1016/j.immuni.2019.08.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31533054	Bronze, Green Published			2022-12-18	WOS:000486184600005
J	Dikiy, S; Rudensky, AY				Dikiy, Stanislav; Rudensky, Alexander Y.			Mouse Watch: A Cautionary Tale	IMMUNITY			English	Editorial Material							CONGENIC MICE; STRAINS; GENES	In this issue of Immunity, Chisolm et al. (2019) issue a "three-alarm fire'' warning to the immunology research community of unexpectedly widespread genetic variation in widely used congenic mouse strains and provide a simple method to identify such a variation through a re-analysis of existing RNA-seq and ChIP-seq datasets.	[Dikiy, Stanislav; Rudensky, Alexander Y.] Howard Hughes Med Inst, New York, NY 10065 USA; [Dikiy, Stanislav; Rudensky, Alexander Y.] Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA; [Dikiy, Stanislav; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Dikiy, Stanislav] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Dikiy, S; Rudensky, AY (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.; Dikiy, S; Rudensky, AY (corresponding author), Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA.; Dikiy, S; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA.; Dikiy, S (corresponding author), Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA.	dikiys@mskcc.org; rudenska@mskcc.org	Dikiy, Stanislav/GWR-2104-2022	Dikiy, Stanislav/0000-0002-8287-6561	General Atlantic Fellowship; NIH/NCI Cancer Center Support Grant (CCSG) [P30 CA008748]; Ludwig Center at Memorial Sloan Kettering; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	General Atlantic Fellowship; NIH/NCI Cancer Center Support Grant (CCSG); Ludwig Center at Memorial Sloan Kettering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	A.Y.R. is an investigator with the Howard Hughes Medical Institute. S.D. is supported by the General Atlantic Fellowship. This work was supported by the NIH/NCI Cancer Center Support Grant (CCSG) P30 CA008748 and the Ludwig Center at Memorial Sloan Kettering.	ADA G, 1994, IMMUNOL CELL BIOL, V72, P447, DOI 10.1038/icb.1994.68; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Casellas J, 2011, ANIMAL, V5, P1, DOI 10.1017/S1751731110001667; Chisolm DA, 2019, IMMUNITY, V51, P155, DOI 10.1016/j.immuni.2019.05.006; Jang Y, 2018, J IMMUNOL, V200, P1982, DOI 10.4049/jimmunol.1701676; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lathrop AEC, 1914, J EXP MED, V22, P646, DOI 10.1084/jem.22.5.646; LAWLOR DA, 1990, ANNU REV IMMUNOL, V8, P23, DOI 10.1146/annurev.iy.08.040190.000323; SNELL GD, 1981, SCIENCE, V213, P172, DOI 10.1126/science.7017931; Waterstrat A, 2010, BLOOD, V115, P408, DOI 10.1182/blood-2008-03-143370	10	3	3	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					10	12		10.1016/j.immuni.2019.06.019	http://dx.doi.org/10.1016/j.immuni.2019.06.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31315029	Bronze			2022-12-18	WOS:000475561000005
J	Lien, EC; Lau, AN; Vander Heiden, MG				Lien, Evan C.; Lau, Allison N.; Vander Heiden, Matthew G.			Putting the K+ in K+ aloric Restriction	IMMUNITY			English	Editorial Material							TUMOR MICROENVIRONMENT	Metabolic changes affect T lymphocyte function, and understanding this phenomenon could improve immunotherapy. In a recent paper in Science, Vodnala et al. (2019) report that tumor microenvironmental potassium impairs T cell nutrient uptake and thus causes functional caloric restriction and allows improved anti-tumor immune responses.	[Lien, Evan C.; Lau, Allison N.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lien, Evan C.; Lau, Allison N.; Vander Heiden, Matthew G.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Lau, AN; Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lau, AN; Vander Heiden, MG (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	anlau@mit.edu; mvh@mit.edu			NCI NIH HHS [K99 CA234221] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K99CA234221] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kishton RJ, 2017, CELL METAB, V26, P94, DOI 10.1016/j.cmet.2017.06.016; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Sullivan LF, 2019, ELIFE, V8, DOI 10.7554/eLife.43482; Vande Voorde J., 2019, SCI ADV, V5, pu7314; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135	10	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1129	1131		10.1016/j.immuni.2019.04.016	http://dx.doi.org/10.1016/j.immuni.2019.04.016			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31117009	Bronze			2022-12-18	WOS:000468429500006
J	Voisin, T; Chiu, IM				Voisin, Tiphaine; Chiu, Isaac M.			Mast Cells Get on Your Nerves in Itch	IMMUNITY			English	Editorial Material								Mast-cell-nerve interactions play an integral role in itch and inflammation. Meixiong et al. (2019) show that the receptors MRGPRB2 and Fc epsilon RI mediate distinct types of mast cell activation and nerve interactions and that mast cell activation through MRGPRB2 drives itch in allergic contact dermatitis.	[Voisin, Tiphaine; Chiu, Isaac M.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Chiu, IM (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.	isaac_chiu@hms.harvard.edu		Voisin, Tiphaine/0000-0003-0643-5948	National Institutes of Health (NIH) [R01AI30019, DP2AT009499]; Chan-Zuckerberg Initiative; Harvard Stem Cell Institute; National Center for Complementary & Integrative Health [DP2AT009499] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chan-Zuckerberg Initiative; Harvard Stem Cell Institute; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors receive funding from National Institutes of Health (NIH) under grants R01AI30019 and DP2AT009499, the Chan-Zuckerberg Initiative, and the Harvard Stem Cell Institute.	Akiyama T, 2015, HANDB EXP PHARMACOL, V226, P219, DOI 10.1007/978-3-662-44605-8_13; Forsythe P, 2012, CHEM IMMUNOL ALLERGY, V98, P196, DOI 10.1159/000336523; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; LEON A, 1994, P NATL ACAD SCI USA, V91, P3739, DOI 10.1073/pnas.91.9.3739; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meixiong J, 2019, IMMUNITY, V50, P1163, DOI 10.1016/j.immuni.2019.03.013; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; 2005, BIOCHEM BIOPH RES CO, V330, P1146, DOI DOI 10.1016/J.BBRC.2005.03.008	10	3	5	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1117	1119		10.1016/j.immuni.2019.04.007	http://dx.doi.org/10.1016/j.immuni.2019.04.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31117004	Bronze			2022-12-18	WOS:000468429500001
J	Wu, D; Levings, MK				Wu, Dan; Levings, Megan K.			A New Mechanism of Action in Human and Mouse Treg Cells: The Ke(y)to Suppression	IMMUNITY			English	Editorial Material								Little is known about how Treg cells mediate suppression, especially in tissues. In this issue of Immunity, Schmidleithner et al. report that Treg cells catabolize PGE(2) into 15-keto-PGE(2), a T cell-inhibitory metabolite, and that this mechanism controls inflammation in adipose tissue.	[Wu, Dan; Levings, Megan K.] British Columbia Childrens Hosp Res Inst, Vancouver, BC, Canada; [Wu, Dan; Levings, Megan K.] Univ British Columbia, Dept Surg, Vancouver, BC, Canada; [Levings, Megan K.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Levings, MK (corresponding author), British Columbia Childrens Hosp Res Inst, Vancouver, BC, Canada.; Levings, MK (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC, Canada.; Levings, MK (corresponding author), Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada.	mlevings@bcchr.ca		Wu, Dan/0000-0002-9040-4337; Levings, Megan/0000-0002-0305-5790				Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Hoeppli RE, 2019, AM J TRANSPLANT, V19, P62, DOI 10.1111/ajt.14936; Hou TZ, 2019, METHODS MOL BIOL, V1899, P87, DOI 10.1007/978-1-4939-8938-6_7; Markovic T, 2017, DRUG DISCOV TODAY, V22, P57, DOI 10.1016/j.drudis.2016.08.003; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schmidleithner L, 2019, IMMUNITY, V50, P1232, DOI 10.1016/j.immuni.2019.03.014; Stockis J, 2017, P NATL ACAD SCI USA, V114, pE10161, DOI 10.1073/pnas.1710680114; 2018, FREE RADIC BIOL MED, V115, P113, DOI DOI 10.1016/J.FREERADBIOMED.2017.11.016; 2009, J EXP MED, V206, P535, DOI DOI 10.1084/JEM.20082293	10	3	3	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1122	1124		10.1016/j.immuni.2019.04.008	http://dx.doi.org/10.1016/j.immuni.2019.04.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31117006	Bronze			2022-12-18	WOS:000468429500003
J	Chen, HH; Simmons, A				Chen, Hannah H.; Simmons, Alison			Becalming Type 17 Inflammation in Ulcerative Colitis	IMMUNITY			English	Editorial Material							MODEL	Genome-wide association studies in ulcerative colitis point to a role for Fc gamma RIIA, a receptor for IgG. Castro-Dopico et al. (2019) find a profound induction of anti-commensal IgG in the colonic mucosa of UC patients and outline a pathway whereby Fc gamma R activation by IgG triggers IL-1 beta production, type 17 immunity, and the exacerbation of inflammation.	[Chen, Hannah H.; Simmons, Alison] John Radcliffe Hosp, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Chen, Hannah H.; Simmons, Alison] John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England	University of Oxford; University of Oxford	Simmons, A (corresponding author), John Radcliffe Hosp, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.; Simmons, A (corresponding author), John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England.	alison.simmons@imm.ox.ac.uk		Simmons, Alison/0000-0003-3454-0710	MRC [MC_UU_00008/7, MC_UU_12010/7, MR/S036377/1] Funding Source: UKRI; Medical Research Council [MC_UU_12010/7, MC_UU_00008/7, MR/S036377/1] Funding Source: Medline; Department of Health [NIHR-RP-R3-12-026] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Brownlie RJ, 2008, J EXP MED, V205, P883, DOI 10.1084/jem.20072565; Castro-Dopico T, 2019, IMMUNITY, V50, P1099, DOI 10.1016/j.immuni.2019.02.006; Grootjans J, 2019, SCIENCE, V363, P993, DOI 10.1126/science.aat7186; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; McRae BL, 2016, J CROHNS COLITIS, V10, P69, DOI 10.1093/ecco-jcc/jjv179; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Olson TS, 2004, J CLIN INVEST, V114, P389, DOI 10.1172/jci200420855; Verstockt B, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1001	10	3	4	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1029	1031		10.1016/j.immuni.2019.03.019	http://dx.doi.org/10.1016/j.immuni.2019.03.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995495	Bronze			2022-12-18	WOS:000464660800019
J	Giogha, C; Lawlor, KE				Giogha, Cristina; Lawlor, Kate E.			Sugar Fix Keeps RIPK3 at Bay	IMMUNITY			English	Editorial Material							CELL-DEATH; INFLAMMATION; CASPASE-8	Immunometabolism is emerging as an important modulator of immune responses. In this issue of Immunity, Li et al. (2019) examine the link between lipopolysaccharide (LPS)-induced glucose metabolism and innate immune signaling and identify how beta-N-acetylglucosamine (O-GlcNAc) modification of the RIPK3 RHIM domain limits inflammation and necroptosis.	[Giogha, Cristina; Lawlor, Kate E.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Lawlor, Kate E.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia	Hudson Institute of Medical Research; Monash University	Giogha, C; Lawlor, KE (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia.; Lawlor, KE (corresponding author), Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia.	cristina.giogha@hudson.org.au; kate.lawlor@hudson.org.au		Giogha, Cristina/0000-0002-9075-9840				de Jesus T, 2018, CELL IMMUNOL, V333, P85, DOI 10.1016/j.cellimm.2018.05.010; Feltham R, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2016.83; Kang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8515; Li XH, 2019, IMMUNITY, V50, P576, DOI 10.1016/j.immuni.2019.01.007; Liu X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.197; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Orozco S, 2017, IMMUNOL REV, V277, P102, DOI 10.1111/imr.12536; Pearson JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.258; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019	10	3	3	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					539	541		10.1016/j.immuni.2019.02.018	http://dx.doi.org/10.1016/j.immuni.2019.02.018			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30893581	Bronze			2022-12-18	WOS:000461660500003
J	Olsen, LR; Pedersen, CB; Leipold, MD; Maecker, HT				Olsen, Lars R.; Pedersen, Christina B.; Leipold, Michael D.; Maecker, Holden T.			Getting the Most from Your High-Dimensional Cytometry Data	IMMUNITY			English	Letter									[Olsen, Lars R.; Pedersen, Christina B.] Tech Univ Denmark, Dept Hlth Technol, Lyngby, Denmark; [Olsen, Lars R.; Pedersen, Christina B.] Copenhagen Univ Hosp, Ctr Genom Med, Copenhagen, Denmark; [Leipold, Michael D.; Maecker, Holden T.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA	Technical University of Denmark; University of Copenhagen; Stanford University	Maecker, HT (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	maecker@stanford.edu	Leipold, Michael/A-9452-2013	Leipold, Michael/0000-0001-5389-0906; Pedersen, Christina Bligaard/0000-0002-9895-0930; Olsen, Lars Ronn/0000-0002-6725-7850				Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Chevrier S, 2018, CELL SYST, V6, P612, DOI 10.1016/j.cels.2018.02.010; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Leipold MD, 2018, J IMMUNOL METHODS, V453, P37, DOI 10.1016/j.jim.2017.11.008; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; Olsen L. R, 2018, CYTOMETRY, V95, P156; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Takahashi C, 2017, CYTOM PART A, V91A, P39, DOI 10.1002/cyto.a.22977	10	3	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					535	536		10.1016/j.immuni.2019.02.015	http://dx.doi.org/10.1016/j.immuni.2019.02.015			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30893579	Green Submitted, Bronze			2022-12-18	WOS:000461660500001
J	Page, N; Klimek, B; De Roo, M; Steinbach, K; Soldati, H; Lemeille, S; Wagner, I; Kreutzfeldt, M; Di Liberto, G; Vincenti, I; Lingner, T; Salinas, G; Bruck, W; Simons, M; Murr, R; Kaye, J; Zehn, D; Pinschewer, DD; Merkler, D				Page, Nicolas; Klimek, Bogna; De Roo, Mathias; Steinbach, Karin; Soldati, Hadrien; Lemeille, Sylvain; Wagner, Ingrid; Kreutzfeldt, Mario; Di Liberto, Giovanni; Vincenti, Ilena; Lingner, Thomas; Salinas, Gabriela; Bruck, Wolfgang; Simons, Mikael; Murr, Rabih; Kaye, Jonathan; Zehn, Dietmar; Pinschewer, Daniel D.; Merkler, Doron			Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8(+) T Cells (vol 48, pg 937, 2018)	IMMUNITY			English	Correction												doron.merkler@unige.ch	; Merkler, Doron/N-9157-2016	Kreutzfeldt, Mario/0000-0003-0335-2733; De Roo, Mathias/0000-0001-9912-6954; Vincenti, Ilena/0000-0003-1061-6071; Kaye, Jonathan/0000-0002-1634-9069; Simons, Mikael/0000-0001-5329-192X; Merkler, Doron/0000-0002-0247-2007; Pinschewer, Daniel/0000-0002-1594-3189				Page N, 2018, IMMUNITY, V48, P937, DOI 10.1016/j.immuni.2018.04.005	1	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					763	763		10.1016/j.immuni.2019.02.011	http://dx.doi.org/10.1016/j.immuni.2019.02.011			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30893589	Bronze			2022-12-18	WOS:000461660500024
J	Begka, C; Marsland, BJ				Begka, Christina; Marsland, Benjamin J.			Make (No) Bones about Butyrate	IMMUNITY			English	Editorial Material								In this issue of Immunity, Tyagi et al. (2018) report that the microbial metabolite butyrate orchestrates the interplay between regulatory T cells and CD8(+) T cells, increasing Wnt signaling, and promoting bone formation in young mice.	[Begka, Christina; Marsland, Benjamin J.] Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic 3004, Australia	Monash University	Marsland, BJ (corresponding author), Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic 3004, Australia.	benjamin.marsland@monash.edu						Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Lucas S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02490-4; Roser-Page S, 2014, ARTHRITIS RHEUMATOL, V66, P990, DOI 10.1002/art.38319; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tyagi AM, 2018, IMMUNITY, V49, P1116, DOI 10.1016/j.immuni.2018.10.013; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774	10	3	3	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					994	996		10.1016/j.immuni.2018.12.005	http://dx.doi.org/10.1016/j.immuni.2018.12.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566888	Bronze			2022-12-18	WOS:000453556500004
J	Vella, G; Bergers, G				Vella, Gerlanda; Bergers, Gabriele			Where Have All the T Cells Gone?	IMMUNITY			English	Editorial Material							RECEPTOR	Glioblastoma are highly immunosuppressive brain tumors that are known for their T cell paucity. In a recent issue of Nature Medicine, Chongsathidkiet et al. (2018) discovered a brain-specific mechanism of tumors to escape immunosurveillance by trapping T cells in the bone marrow through the loss of sphingosine-1-phosphate (S1P) receptor on the T cell surface.	[Vella, Gerlanda; Bergers, Gabriele] Katholieke Univ Leuven, Dept Oncol, VIB Ctr Canc Biol, B-3000 Leuven, Belgium; [Bergers, Gabriele] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Neurol Surg, Brain Tumor Res Ctr, San Francisco, CA 94158 USA	Flanders Institute for Biotechnology (VIB); KU Leuven; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Bergers, G (corresponding author), Katholieke Univ Leuven, Dept Oncol, VIB Ctr Canc Biol, B-3000 Leuven, Belgium.; Bergers, G (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Neurol Surg, Brain Tumor Res Ctr, San Francisco, CA 94158 USA.	gabriele.bergers@kuleuven.vib.be	Bergers, Gabriele/AAJ-5535-2020	Vella, Gerlanda/0000-0001-7175-3120; Bergers, Gabriele/0000-0003-3545-5171	NATIONAL CANCER INSTITUTE [R01CA201537] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA201537] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chongsathidkiet P, 2018, NAT MED, V24, P1459, DOI 10.1038/s41591-018-0135-2; Jackson CM, 2016, CLIN CANCER RES, V22, P1161, DOI 10.1158/1078-0432.CCR-15-1516; Maeda Y, 2010, INT IMMUNOL, V22, P515, DOI 10.1093/intimm/dxq036; Tiper IV, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw063; Vinay DS, 2014, BMB REP, V47, P122, DOI 10.5483/BMBRep.2014.47.3.283	5	3	3	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					592	594		10.1016/j.immuni.2018.10.006	http://dx.doi.org/10.1016/j.immuni.2018.10.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332627	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000447386700007
J	Rankin, LC; Arpaia, N				Rankin, Lucille C.; Arpaia, Nicholas			Treg Cells: A LAGging Hand Holds the Double-Edged Sword of the IL-23 Axis	IMMUNITY			English	Editorial Material							T-CELLS; LAG-3	Intestinal Treg cells suppress colitis; yet the mechanisms behind the intricate pathways involved in this process remain largely unknown. In this issue of Immunity, Bauche et al. (2018) show that Treg cells engage MHCII on CX(3)CR1(+) macrophages via LAG3. This indirectly reduces IL-22 mediated colonic inflammation.	[Rankin, Lucille C.; Arpaia, Nicholas] Columbia Univ, Irving Med Ctr, Dept Microbiol & Immunol, New York, NY 10027 USA	Columbia University; NewYork-Presbyterian Hospital	Arpaia, N (corresponding author), Columbia Univ, Irving Med Ctr, Dept Microbiol & Immunol, New York, NY 10027 USA.	na2697@cumc.columbia.edu	Arpaia, Nicholas/R-2549-2018	Arpaia, Nicholas/0000-0002-0657-0528	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI127847] Funding Source: NIH RePORTER; NIAID NIH HHS [K22 AI127847] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauche D, 2018, IMMUNITY, V49, P342, DOI 10.1016/j.immuni.2018.07.007; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Hemon P, 2011, J IMMUNOL, V186, P5173, DOI 10.4049/jimmunol.1002050; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	9	3	3	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					201	203		10.1016/j.immuni.2018.08.008	http://dx.doi.org/10.1016/j.immuni.2018.08.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30134197	Bronze			2022-12-18	WOS:000442354500004
J	Zakovic, S; Levashina, EA				Zakovic, Suzana; Levashina, Elena A.			Insects Go on a STING Operation to Tackle Intracellular Invaders	IMMUNITY			English	Editorial Material							DROSOPHILA; PATHWAY	Insect immunity to extracellular microbes relies largely on the TOLL and IMD pathways. In this issue of Immunity, Goto et al. (2018) report that the IKK beta-Relish module of the IMD pathway hitches up the intracellular sensor STING to activate antiviral responses in Drosophila.	[Zakovic, Suzana; Levashina, Elena A.] Max Planck Inst Infect Biol, Vector Biol Unit, D-10117 Berlin, Germany	Max Planck Society	Levashina, EA (corresponding author), Max Planck Inst Infect Biol, Vector Biol Unit, D-10117 Berlin, Germany.	levashina@mpiib-berlin.mpg.de		Levashina, Elena/0000-0003-4605-906X	Max Planck Society; German Research Foundation (DFG) [GRK 2046]	Max Planck Society(Max Planck Society); German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by Max Planck Society. S.Z. is a PhD fellow of GRK 2046 funded by the German Research Foundation (DFG).	Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Goto A, 2018, IMMUNITY, V49, P225, DOI 10.1016/j.immuni.2018.07.013; Hua XT, 2018, J BIOL CHEM, V293, P11878, DOI 10.1074/jbc.RA117.000194; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Lamiable O, 2016, P NATL ACAD SCI USA, V113, P698, DOI 10.1073/pnas.1516122113; Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022; Severo MS, 2018, P NATL ACAD SCI USA, V115, pE7568, DOI 10.1073/pnas.1803062115	9	3	3	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					195	197		10.1016/j.immuni.2018.08.003	http://dx.doi.org/10.1016/j.immuni.2018.08.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30134194	Bronze			2022-12-18	WOS:000442354500001
J	van Gils, MJ; Sanders, RW				van Gils, Marit J.; Sanders, Rogier W.			Hitting HIV's Harpoon	IMMUNITY			English	Editorial Material							VACCINE; ANTIBODIES	The HIV-1 fusion peptide is a target for broadly neutralizing antibodies. In a recent issue of Nature Medicine, Xu et al. (2018) provide proof-of-concept that vaccination with fusion peptide followed by vaccination with an envelope glycoprotein trimer can induce antibodies in animal models that neutralize diverse HIV-1 viruses.	[van Gils, Marit J.; Sanders, Rogier W.] Univ Amsterdam, Amsterdam UMC, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Amsterdam; Cornell University	van Gils, MJ; Sanders, RW (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.; Sanders, RW (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	m.j.vangils@amc.uva.nl; r.w.sanders@amc.uva.nl	van Gils, Marit J./H-4791-2019	van Gils, Marit J./0000-0003-3422-8161				Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; van Gils MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.199; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507; Xu K, 2018, NAT MED, V24, P857, DOI 10.1038/s41591-018-0042-6	10	3	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					14	15		10.1016/j.immuni.2018.07.003	http://dx.doi.org/10.1016/j.immuni.2018.07.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30021141	Bronze			2022-12-18	WOS:000438949100006
J	Murphy, AG; Maloy, KJ				Murphy, Alison G.; Maloy, Kevin J.			Defens-IN! Human alpha-Defensin 5 Acts as an Unwitting Double Agent to Promote Shigella Infection	IMMUNITY			English	Editorial Material							INVASION	Shigella pathogenesis has confounded researchers for years because of its narrow host selectivity and extraordinary infectious capability. In this issue of Immunity, Xu et al. (2018) identify a cunning mechanism whereby Shigella hijacks human alpha-defensin 5 to enhance its adhesion and subsequent invasion.	[Murphy, Alison G.; Maloy, Kevin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Maloy, KJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England.	kevin.maloy@path.ox.ac.uk		Murphy, Alison/0000-0001-8241-1660				Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Eilers B, 2010, CELL MICROBIOL, V12, P1134, DOI 10.1111/j.1462-5822.2010.01459.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Wilson SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006446; Xu D, 2018, IMMUNITY, V48, P1233, DOI 10.1016/j.immuni.2018.04.014	9	3	3	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1070	1072		10.1016/j.immuni.2018.05.015	http://dx.doi.org/10.1016/j.immuni.2018.05.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924970	Bronze			2022-12-18	WOS:000436456900005
J	Lok, SM				Lok, Shee-Mei			Inhibiting EBV: The Key to Carefree Smooching	IMMUNITY			English	Editorial Material							EPSTEIN-BARR-VIRUS; EPITHELIAL-CELLS; RECEPTOR; INFECTION; BINDING; FUSION	There are no vaccines or therapies to treat Epstein-Barr virus (EBV). Snijder et al. (2018) isolated a potent human antibody against EBV that blocks infection of both B cells and epithelial cells. Structural analysis of the antibody complexed with a viral surface protein complex identified a site that may be useful in vaccine development.	[Lok, Shee-Mei] Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore; [Lok, Shee-Mei] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Lok, SM (corresponding author), Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore.; Lok, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	sheemei.lok@duke-nus.edu.sg		Lok, Shee-Mei/0000-0003-4631-8041	Singapore Ministry of Education Tier 3 grant [MOE2012-T3-1-008]; National Research Foundation Investigatorship award [NRF-NRFI2016-01]; National Research Foundation competitive Research Project grant [NRF2016NRF-CRP001-063]	Singapore Ministry of Education Tier 3 grant(Ministry of Education, Singapore); National Research Foundation Investigatorship award; National Research Foundation competitive Research Project grant	S.-M.L. acknowledges support by the Singapore Ministry of Education Tier 3 grant (MOE2012-T3-1-008), the National Research Foundation Investigatorship award (NRF-NRFI2016-01), and the National Research Foundation competitive Research Project grant (NRF2016NRF-CRP001-063).	Chen J, 2018, NAT MICROBIOL, V3, P172, DOI 10.1038/s41564-017-0081-7; Chen J, 2012, MBIO, V3, DOI 10.1128/mBio.00290-11; Chesnokova LS, 2014, CHIN J CANCER, V33, P545, DOI 10.5732/cjc.014.10168; Chesnokova LS, 2011, J VIROL, V85, P13214, DOI 10.1128/JVI.05580-11; Mohl BS, 2016, MOL CELLS, V39, P286, DOI 10.14348/molcells.2016.0066; Ogembo JG, 2013, CELL REP, V3, P371, DOI 10.1016/j.celrep.2013.01.023; Omerovic J, 2005, J VIROL, V79, P12408, DOI 10.1128/JVI.79.19.12408-12415.2005; Snijder J, 2018, IMMUNITY, V48, P799, DOI 10.1016/j.immuni.2018.03.026; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Turk SM, 2006, J VIROL, V80, P9628, DOI 10.1128/JVI.00622-06	11	3	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					623	625		10.1016/j.immuni.2018.03.036	http://dx.doi.org/10.1016/j.immuni.2018.03.036			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669245	Bronze			2022-12-18	WOS:000430198900009
J	Delmas, C; Dalmas, E				Delmas, Charlene; Dalmas, Elise			IL-33 Deals with the Gray Matter	IMMUNITY			English	Editorial Material							INJURY; RECOVERY	The central nervous system undergoes extensive postnatal synapse remodeling that is critical for the formation of mature neural circuits. In a recent issue of Science, Vainchtein et al. (2018) describe an additional role for astrocyte-derived interleukin-33 (IL-33) in promoting synapse refinement by microglia in the developing brain.	[Delmas, Charlene; Dalmas, Elise] INSERM, Cordeliers Res Ctr, Paris, France; [Delmas, Charlene; Dalmas, Elise] Sorbonne Paris Cite, Paris, France; [Delmas, Charlene; Dalmas, Elise] Paris Diderot Univ, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Dalmas, E (corresponding author), INSERM, Cordeliers Res Ctr, Paris, France.; Dalmas, E (corresponding author), Sorbonne Paris Cite, Paris, France.; Dalmas, E (corresponding author), Paris Diderot Univ, Paris, France.	edalmas@hotmail.fr		Dalmas, Elise/0000-0003-0959-5648				Dalmas E, 2017, IMMUNITY, V47, P928, DOI 10.1016/j.immuni.2017.10.015; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Luo Y, 2015, BRAIN RES, V1597, P86, DOI 10.1016/j.brainres.2014.12.005; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Vainchtein I.D., 2018, SCIENCE; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045	10	3	3	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					484	486		10.1016/j.immuni.2018.03.005	http://dx.doi.org/10.1016/j.immuni.2018.03.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562200	Bronze			2022-12-18	WOS:000427916900009
J	Fontana, MF; Pepper, M				Fontana, Mary F.; Pepper, Marion			NKTeeing Up B Cell Responses to Viral Infection	IMMUNITY			English	Editorial Material							COGNATE HELP; NKT CELLS; ACTIVATION; INNATE; MECHANISM; SIGNALS	Activated B cells mature in germinal centers (GCs), but GC initiation during infection is poorly understood. Gaya et al. (2018) show that NKT cells, activated by CD169(+) macrophages, produce an early wave of interleukin-4 (IL-4) that promotes GC formation during viral infection.	[Fontana, Mary F.; Pepper, Marion] Univ Washington, Sch Med, Dept Immunol, 750 Republican St, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle	Pepper, M (corresponding author), Univ Washington, Sch Med, Dept Immunol, 750 Republican St, Seattle, WA 98109 USA.	mpepper@uw.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118803] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI118803] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Gaya M, 2018, CELL, V172, P517, DOI 10.1016/j.cell.2017.11.036; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Sagoo P, 2016, NAT MED, V22, P64, DOI 10.1038/nm.4016; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452	10	3	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					198	200		10.1016/j.immuni.2018.02.008	http://dx.doi.org/10.1016/j.immuni.2018.02.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466751	Green Accepted, Bronze			2022-12-18	WOS:000425507800006
J	Villacampa, N; Heneka, MT				Villacampa, Nadia; Heneka, Michael T.			Microglia: You'll Never Walk Alone!	IMMUNITY			English	Editorial Material							MULTIPLE-SCLEROSIS; DENDRITIC CELLS; MACROPHAGES; DISEASE; CNS	In this issue of Immunity, Mrdjen et al. (2018) use high-dimensional single-cell proteomics and high parametric mass cytometry to provide insight into the long-lasting issue of how to identify and characterize both resident and recruited leukocyte populations in healthy, aged, and diseased CNS.	[Villacampa, Nadia; Heneka, Michael T.] Univ Bonn, Dept Neurodegenerat Dis & Gerontopsychiat, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Heneka, Michael T.] DZNE, D-53127 Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Heneka, MT (corresponding author), Univ Bonn, Dept Neurodegenerat Dis & Gerontopsychiat, Sigmund Freud Str 25, D-53127 Bonn, Germany.; Heneka, MT (corresponding author), DZNE, D-53127 Bonn, Germany.	michael.heneka@ukbonn.de	Heneka, Michael/AAE-8011-2019; Villacampa, Dr Nàdia/K-5304-2014; Heneka, Michael/E-8072-2015	Villacampa, Dr Nàdia/0000-0001-6513-0250; Heneka, Michael/0000-0003-4996-1630				Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bechmann I, 2001, EUR J NEUROSCI, V14, P1651, DOI 10.1046/j.0953-816x.2001.01793.x; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Kipp M, 2017, BRAIN PATHOL, V27, P123, DOI 10.1111/bpa.12454; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606; Sie C, 2017, SEMIN IMMUNOPATHOL, V39, P99, DOI 10.1007/s00281-016-0608-7	10	3	3	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					195	197		10.1016/j.immuni.2018.02.009	http://dx.doi.org/10.1016/j.immuni.2018.02.009			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466750	Bronze			2022-12-18	WOS:000425507800005
J	Chen, YG; Chang, HY				Chen, Y. Grace; Chang, Howard Y.			LncRNA Seduction of GOT2 Goes Viral	IMMUNITY			English	Editorial Material							LONG NONCODING RNAS	Mechanisms of viral infection are active areas of investigation. In a recent issue of Science, Wang et al. (2017) reveal an additional function of a host-encoded long non-coding RNA (lncRNA) in regulating viral expression by binding a host metabolic enzyme to enhance its catalytic activity.	[Chen, Y. Grace; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA	Stanford University	Chang, HY (corresponding author), Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.	howchang@stanford.edu						Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Fitzgerald KA, 2014, CURR OPIN IMMUNOL, V26, P140, DOI 10.1016/j.coi.2013.12.001; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Sztuba-Solinska J, 2017, NUCLEIC ACIDS RES, V45, P6805, DOI 10.1093/nar/gkx241; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456	10	3	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1021	+		10.1016/j.immuni.2017.12.006	http://dx.doi.org/10.1016/j.immuni.2017.12.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262346	Bronze			2022-12-18	WOS:000418486500008
J	Erttmann, SF; Hartlova, A; Sloniecka, M; Raffi, FAM; Hosseinzadeh, A; Edgren, T; Rofougaran, R; Resch, U; Fallman, M; Ek, T; Gekara, NO				Erttmann, Saskia F.; Hartlova, Anetta; Sloniecka, Marta; Raffi, Faizal A. M.; Hosseinzadeh, Ava; Edgren, Tomas; Rofougaran, Reza; Resch, Ulrike; Fallman, Maria; Ek, Torben; Gekara, Nelson O.			Loss of the DNA Damage Repair Kinase ATM Impairs Inflammasome-Dependent Anti-Bacterial Innate Immunity (vol 45, pg 106, 2016)	IMMUNITY			English	Correction												nelson.gekara@mims.umu.se	Gekara, Nelson/AAG-7944-2020; Ek, Torben/GWN-2839-2022	Gekara, Nelson O./0000-0002-1269-8288; Hartlova, Anetta/0000-0002-8152-4361; Ek, Torben/0000-0002-0518-983X				Erttmann SF, 2016, IMMUNITY, V45, P106, DOI 10.1016/j.immuni.2016.06.018	1	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1210	1211		10.1016/j.immuni.2017.11.014	http://dx.doi.org/10.1016/j.immuni.2017.11.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262353	Bronze			2022-12-18	WOS:000418486500023
J	Lobel, L; Garrett, WS				Lobel, Lior; Garrett, Wendy S.			Take DAT, Flu!	IMMUNITY			English	Editorial Material							I INTERFERON; INFLUENZA; MICROBIOME; IMMUNITY	Some microbial metabolites can be immunomodulatory, but there is limited understanding of how these contribute to inter-individual variation in response to infection. In a recent study in Science, Steed et al. (2017) show that the bacterial metabolite desaminotyrosine (DAT) increases type I interferon expression, resulting in an improved immune response to influenza infection.	[Lobel, Lior; Garrett, Wendy S.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lobel, Lior; Garrett, Wendy S.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Garrett, Wendy S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Garrett, Wendy S.] Dana Farber Canc Inst, Dept & Div Med Oncol, Boston, MA 02215 USA; [Garrett, Wendy S.] Harvard Med Sch, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Garrett, WS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Garrett, WS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.; Garrett, WS (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Garrett, WS (corresponding author), Dana Farber Canc Inst, Dept & Div Med Oncol, Boston, MA 02215 USA.; Garrett, WS (corresponding author), Harvard Med Sch, Boston, MA 02215 USA.	wgarrett@hsph.harvard.edu	Lobel, Lior/AAW-4055-2021	Lobel, Lior/0000-0001-9146-5839; Garrett, Wendy/0000-0002-5092-0150				Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Cassidy A, 2017, AM J CLIN NUTR, V105, P10, DOI 10.3945/ajcn.116.136051; Deriu E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005572; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796; Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	10	3	3	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					400	402		10.1016/j.immuni.2017.09.002	http://dx.doi.org/10.1016/j.immuni.2017.09.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930655	Bronze			2022-12-18	WOS:000411128200006
J	Zheng, Y				Zheng, Ye			A Rogue Foxp3 Mutant Undermines Treg Cell Function	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; COOPERATION; BATF	Hayatsu et al. (2017) reveal that a FOXP3 mutant found in some patients afflicted with the autoimmune disease IPEX has broadened DNA-recognition specificity, directly repressing the expression of the gene encoding the transcription factor Batf. Their findings identify Batf as critical to tissue regulatory T cell function and suggest that polymorphisms that impact FOXP3 DNA-binding specificity may contribute susceptibility to autoimmune disease.	[Zheng, Ye] Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Zheng, Y (corresponding author), Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yzheng@salk.edu			NIH [AI107027, CA014195]; Nomis Foundation; Leona M. and Harry B. Helmsley Charitable Trust; CCFA [402451]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nomis Foundation; Leona M. and Harry B. Helmsley Charitable Trust; CCFA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Y.Z. is supported by NIH (AI107027, CA014195), the Nomis Foundation, the Leona M. and Harry B. Helmsley Charitable Trust, and CCFA (402451).	Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Hayatsu N., 2017, IMMUNITY, P47; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042	10	3	4	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					211	214		10.1016/j.immuni.2017.07.024	http://dx.doi.org/10.1016/j.immuni.2017.07.024			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813651	Bronze			2022-12-18	WOS:000407788300005
J	Reyes, NJ; Saban, DR				Reyes, Nancy J.; Saban, Daniel R.			A Commencement for Eye Commensals	IMMUNITY			English	Editorial Material							DELTA T-CELLS; IMMUNE PRIVILEGE	"Paucibacterial'' levels of the normal eye surface have left immunologists wondering whether a true microbiome exists there. In this issue of Immunity, St. Leger et al. (2017) address this head-on, discovering a naturally existing commensal in mice that induces gamma delta T cell-mediated protection from opportunistic infection.	[Reyes, Nancy J.; Saban, Daniel R.] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27708 USA; [Saban, Daniel R.] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27708 USA	Duke University; Duke University	Saban, DR (corresponding author), Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27708 USA.; Saban, DR (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC 27708 USA.	daniel.saban@duke.edu			 [R01EY021798];  [F32EY025557]; NATIONAL EYE INSTITUTE [F32EY025557, P30EY005722, R01EY021798] Funding Source: NIH RePORTER	; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Grant support is as follows: R01EY021798 (D.R.S.); F32EY025557 (N.J.R.).	Ahadome SD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87012; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Chien YH, 2013, TRENDS IMMUNOL, V34, P151, DOI 10.1016/j.it.2012.11.004; Doan T, 2016, INVEST OPHTH VIS SCI, V57, P5116, DOI 10.1167/iovs.16-19803; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Leger AJ, 2017, IMMUNITY, V47, P148, DOI DOI 10.1016/j.immuni.2017.06.014; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; Papotto PH, 2017, NAT IMMUNOL, V18, P604, DOI 10.1038/ni.3726; Reyes NJ, 2017, NAT REV IMMUNOL, V17, P322, DOI 10.1038/nri.2017.13; Streilein JW, 1996, INVEST OPHTH VIS SCI, V37, P1940	10	3	3	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					6	8		10.1016/j.immuni.2017.07.006	http://dx.doi.org/10.1016/j.immuni.2017.07.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723553	Green Accepted, Bronze			2022-12-18	WOS:000405712800003
J	Robinson, BA; Nice, TJ				Robinson, Bridget A.; Nice, Timothy J.			You Can Breathe Easy: IFN lambda Handles Flu without Triggering a Damaging Inflammatory Response	IMMUNITY			English	Editorial Material								Type III interferon (IFN lambda) and type I IFN (IFN alpha/beta) have overlapping antiviral activities in the lung. In this issue of Immunity, Galani et al. (2017) identify a critical early role for IFN lambda, not shared by IFN alpha/beta, in protection of the lung following influenza virus infection.	[Robinson, Bridget A.; Nice, Timothy J.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA	Oregon Health & Science University	Nice, TJ (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97239 USA.	nice@ohsu.edu	Nice, Timothy/X-9114-2019	Nice, Timothy/0000-0002-4471-7666				Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108	8	3	3	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					768	770		10.1016/j.immuni.2017.04.027	http://dx.doi.org/10.1016/j.immuni.2017.04.027			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514682	Bronze			2022-12-18	WOS:000401316300011
J	Mouquet, H				Mouquet, Hugo			Hunting Down the HIV-1 Reservoir: A Starring Role for Antibodies?	IMMUNITY			English	Editorial Material							BROADLY NEUTRALIZING ANTIBODIES; THERAPY; 3BNC117; VIREMIA; SHIV	The persistence of viruses "hidden" in a reservoir of latently infected CD4(+)T cells under antiretroviral therapy is the major obstacle to an HIV-1 cure. Recently published in Nature, two seminal studies from Descours et al. (2017) and Nishimura et al. (2017) bring hope for tracking and possibly eradicating the HIV-1 reservoir.	[Mouquet, Hugo] Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, F-75015 Paris, France; [Mouquet, Hugo] INSERM U1222, F-75015 Paris, France; [Mouquet, Hugo] Vaccine Res Inst, F-94028 Creteil, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mouquet, H (corresponding author), Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, F-75015 Paris, France.; Mouquet, H (corresponding author), INSERM U1222, F-75015 Paris, France.; Mouquet, H (corresponding author), Vaccine Res Inst, F-94028 Creteil, France.	hugo.mouquet@pasteur.fr	Mouquet, Hugo/M-2750-2014	Mouquet, Hugo/0000-0002-4230-610X				Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bruel T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10844; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Descours B, 2017, NATURE, V543, P564, DOI 10.1038/nature21710; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Nishimura Y, 2017, NATURE, V543, P559, DOI 10.1038/nature21435; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972	11	3	3	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					527	529		10.1016/j.immuni.2017.04.001	http://dx.doi.org/10.1016/j.immuni.2017.04.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423333	Bronze			2022-12-18	WOS:000399451100006
J	Aden, K; Rosenstiel, P				Aden, Konrad; Rosenstiel, Philip			The Dark Age(ing) of the Inflammasome	IMMUNITY			English	Editorial Material							NLRP3 INFLAMMASOME; IL-1-BETA PRODUCTION; AUTOPHAGY	Mechanisms that contribute to healthy aging remain obscure. In a recent issue of Nature Medicine, Furman et al. (2017) describe that dietary caffeine inhibits the NLRC4 inflammasome, which is associated with disease-free aging.	[Aden, Konrad; Rosenstiel, Philip] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany	University of Kiel	Rosenstiel, P (corresponding author), Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany.	p.rosenstiel@mucosa.de	Rosenstiel, Philip/A-5137-2009; Aden, Konrad/H-1477-2014; Aden, Konrad/AAG-3290-2020	Rosenstiel, Philip/0000-0002-9692-8828; Aden, Konrad/0000-0003-3482-7316; 				Eisenberg T., 2017, AUTOPHAGY; Furman D, 2017, NAT MED; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Murthy P, 2017, BIOCHEM BIOPH RES CO, V483, P230, DOI 10.1016/j.bbrc.2016.12.161; Rosenstiel P, 2008, GENES IMMUN, V9, P103, DOI 10.1038/sj.gene.6364454; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010	10	3	3	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					173	175		10.1016/j.immuni.2017.02.009	http://dx.doi.org/10.1016/j.immuni.2017.02.009			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228276	Bronze			2022-12-18	WOS:000396410900006
J	Silva-Sanchez, A; Randall, TD				Silva-Sanchez, Aaron; Randall, Troy D.			Fugue G Minor: Getting the Lymph Node Ensemble Together with Circadian Rhythm	IMMUNITY			English	Editorial Material							CLOCK; DIFFERENTIATION; INFLAMMATION	A fugue is characterized by the systematic repetition of a principal theme in simultaneous melodic lines. In this issue of Immunity, Druzd et al. (2017) show that a similar phenomenon occurs in lymph nodes (LNs), in which lymphocyte entry and exit is governed by repetitive circadian rhythms.	[Silva-Sanchez, Aaron; Randall, Troy D.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Randall, TD (corresponding author), Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA.	randallt@uab.edu	Silva-Sanchez, Aaron/AAI-8572-2021	Silva-Sanchez, Aaron/0000-0002-1882-2534				Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; HALBERG F, 1963, P ROY SOC MED, V56, P253, DOI 10.1177/003591576305600404; Haspel JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5753; Hemmers S, 2015, CELL REP, V11, P1339, DOI 10.1016/j.celrep.2015.04.058; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884	10	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					6	8		10.1016/j.immuni.2017.01.001	http://dx.doi.org/10.1016/j.immuni.2017.01.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28099865	Bronze			2022-12-18	WOS:000392918300003
J	Veldhoen, M				Veldhoen, Marc			Th17 Cells Require You to Chew before You Swallow	IMMUNITY			English	Editorial Material							T-CELLS; MICROBIOTA; RESPONSES	How immunity is regulated at distinct epithelial tissues that vary in microbial occupancy and environmental and tissue specific cues isn't clear. Dutzan et al. (2017) report that mechanical-derived signals, not those from micro-organisms, are key to maintaining interleukin-17-expressing T helper (Th17) cells at the oral epithelia.	[Veldhoen, Marc] Univ Lisbon, Fac Med, Inst Mol Med, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal	Universidade de Lisboa	Veldhoen, M (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.	marc.veldhoen@medicina.ulisboa.pt	Veldhoen, Marc/AAM-5357-2021	Veldhoen, Marc/0000-0002-1478-9562	Biotechnology and Biological Sciences Research Council [BB/E021638/1, BBS/E/B/000C0409] Funding Source: Medline; BBSRC [BB/E021638/1, BBS/E/B/000C0409] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Dutzan N, 2017, IMMUNITY, V46, P133, DOI 10.1016/j.immuni.2016.12.010; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783	9	3	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					8	10		10.1016/j.immuni.2016.12.016	http://dx.doi.org/10.1016/j.immuni.2016.12.016			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28099867	Bronze			2022-12-18	WOS:000392918300004
J	Delgoffe, GM				Delgoffe, Greg M.			VHL Brings Warburg into the Memory Spotlight	IMMUNITY			English	Editorial Material							CD8(+) T-CELLS; EFFECTOR FUNCTION; METABOLISM	Previous studies suggest mitochondrial metabolic pathways are essential for the generation of memory T cells. In this issue of Immunity, Phan et al. (2016) describe the formation of memory in T cells with constitutive glycolytic metabolism, suggesting that fuel does not necessarily dictate function.	[Delgoffe, Greg M.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15262 USA; [Delgoffe, Greg M.] Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Delgoffe, GM (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15262 USA.; Delgoffe, GM (corresponding author), Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.	gdelgoffe@pitt.edu	Delgoffe, Greg M./HCH-2805-2022	Delgoffe, Greg M./0000-0002-2957-8135				Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; ROOS D, 1970, BIOCHIM BIOPHYS ACTA, V222, P565, DOI 10.1016/0304-4165(70)90182-0; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007	10	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					953	955		10.1016/j.immuni.2016.11.001	http://dx.doi.org/10.1016/j.immuni.2016.11.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851921	Bronze			2022-12-18	WOS:000389473500005
J	Crompton, PD; Pierce, SK				Crompton, Peter D.; Pierce, Susan K.			PD-L2 Elbows out PD-L1 to Rescue T Cell Immunity to Malaria	IMMUNITY			English	Editorial Material								How early interactions between innate and adaptive immune cells influence outcomes of acute infections is incompletely understood. In this issue of Immunity, Karunarathne et al. (2016) show that dendritic cells help CD4(+) T helper 1 cell immunity against malaria through PD-L2' s competition with PD-L1.	[Crompton, Peter D.] NIAID, Malaria Infect Biol & Immun Unit, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Pierce, Susan K.] NIAID, Lymphocyte Activat Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pierce, SK (corresponding author), NIAID, Lymphocyte Activat Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	spierce@nih.gov	Crompton, Peter/N-1130-2016		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001155] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Hafalla JCR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002504; Karunarathne DS, 2016, IMMUNITY, V45, P333, DOI 10.1016/j.immuni.2016.07.017; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Van Braeckel-Budimir N, 2016, CURR OPIN IMMUNOL, V42, P91, DOI 10.1016/j.coi.2016.06.008; Velu V, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0144-x; WHO, 2015, WORLD MAL REP 2015	10	3	3	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					231	233		10.1016/j.immuni.2016.08.001	http://dx.doi.org/10.1016/j.immuni.2016.08.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533008	Bronze			2022-12-18	WOS:000382267300004
J	Stone, SL; Lund, FE				Stone, Sara L.; Lund, Frances E.			IgM Memory Cells: First Responders in Malaria	IMMUNITY			English	Editorial Material							B-CELLS; SUBSETS	Following the fate of antigen-specific memory B cells has been difficult. In this issue of Immunity, Krishnamurty et al. (2016) use a novel B cell tetramer to define Plasmodium-specific memory B cells in parasite-infected mice and demonstrate that after re-infection, somatically mutated IgM(+) memory B cells function as first responders by rapidly differentiating into T-cell-dependent plasmablasts and T-cell-independent plasma cells.	[Stone, Sara L.; Lund, Frances E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Lund, FE (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	flund@uab.edu						Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Arama C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv118; Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	9	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					235	237		10.1016/j.immuni.2016.08.005	http://dx.doi.org/10.1016/j.immuni.2016.08.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533010	Bronze			2022-12-18	WOS:000382267300006
J	Nguyen, TTT; Baumgarth, N				Nguyen, Trang T. T.; Baumgarth, Nicole			Innate B Cells Tell ILC How It's Done	IMMUNITY			English	Editorial Material							IMMUNITY	Innate lymphoid cells (ILCs) are known as first responders to infections and as instructors of subsequent CD4(+) T cell cytokine profiles. In this issue of Immunity, Fan and colleagues now demonstrate that even earlier responding innate-like B cells (NKB) induce these protective ILC responses.	[Nguyen, Trang T. T.; Baumgarth, Nicole] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Nguyen, Trang T. T.; Baumgarth, Nicole] Univ Calif Davis, Grad Grp Immunol, Davis, CA 95616 USA; [Baumgarth, Nicole] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Baumgarth, N (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.; Baumgarth, N (corresponding author), Univ Calif Davis, Grad Grp Immunol, Davis, CA 95616 USA.; Baumgarth, N (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	nbaumgarth@ucdavis.edu	Baumgarth, Nicole/AAI-6949-2020	Nguyen, Trang/0000-0003-0488-5590				Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Hardy RR, 2015, EUR J IMMUNOL, V45, P2978, DOI 10.1002/eji.201445146; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; O'Donnell H, 2014, IMMUNITY, V40, P213, DOI 10.1016/j.immuni.2013.12.013; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Shtrichman R, 2001, CURR OPIN MICROBIOL, V4, P251, DOI 10.1016/S1369-5274(00)00199-5; Wang S, 2016, IMMUNITY, V45, P131, DOI 10.1016/j.immuni.2016.06.019	10	3	3	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					8	10		10.1016/j.immuni.2016.06.030	http://dx.doi.org/10.1016/j.immuni.2016.06.030			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438761	Bronze			2022-12-18	WOS:000380749000004
J	Berod, L; Sparwasser, T				Berod, Luciana; Sparwasser, Tim			pDCs Take a Deep Breath to Fight Viruses	IMMUNITY			English	Editorial Material							PLASMACYTOID DENDRITIC CELLS; INTERFERON	Conventional dendritic cells (cDCs) and plasmacytoid dendritic cells (pDCs) serve non-overlapping functions in immune responses. In this issue of Immunity, Pearce and colleagues (2016) report that pDCs use different metabolic pathways from cDCs to support their specialized function.	[Berod, Luciana; Sparwasser, Tim] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Feodor Lynen Str 7, D-30625 Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Berod, L; Sparwasser, T (corresponding author), Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Feodor Lynen Str 7, D-30625 Hannover, Germany.	luciana.berod@twincore.de; sparwasser.tim@mh-hannover.de	Sparwasser, Tim D/AAA-4306-2022; Berod, Luciana/AAG-8095-2019; Sparwasser, Tim/AAF-7085-2019	Berod, Luciana/0000-0002-9677-3483; Sparwasser, Tim/0000-0001-5645-902X				Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Lochner M, 2015, TRENDS IMMUNOL, V36, P81, DOI 10.1016/j.it.2014.12.005; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006	10	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1246	1248		10.1016/j.immuni.2016.06.005	http://dx.doi.org/10.1016/j.immuni.2016.06.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332726	Bronze			2022-12-18	WOS:000378341200003
J	Julg, B; Alter, G				Julg, Boris; Alter, Galit			Broadly Neutralizing Antibodies: Magic Bullets against HIV?	IMMUNITY			English	Editorial Material							IN-VIVO; PROTECTION; EFFICACY; 3BNC117	Broadly neutralizing antibodies (bNAbs) offer new avenues for HIV prevention and cure strategies. Three recent papers, published in Science and Nature, highlight the broad applicability of bNAbs in HIV cure and prevention and in boosting immunity against HIV.	[Julg, Boris; Alter, Galit] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Alter, G (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.	galter@partners.org	Juelg, Boris/ABA-1955-2020	Juelg, Boris/0000-0002-4687-9626	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI106408] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI106408] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Platzer B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00140; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972	12	3	3	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1253	1254		10.1016/j.immuni.2016.06.012	http://dx.doi.org/10.1016/j.immuni.2016.06.012			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332729	Bronze			2022-12-18	WOS:000378341200006
J	Kinder, JM; Jiang, TT; Way, SS				Kinder, Jeremy M.; Jiang, Tony T.; Way, Sing Sing			Offspring's Tolerance of Mother Goes Viral	IMMUNITY			English	Editorial Material							HEPATITIS-B	Pregnancy uniquely allows genetically discordant tissues of the mother and child to intimately coexist in harmony. In this issue of Immunity, Ou and colleagues show that hepatitis B virus exploits these naturally occurring immune tolerance pathways to establish persistent postnatal infection in offspring.	[Kinder, Jeremy M.; Jiang, Tony T.; Way, Sing Sing] Cincinnati Childrens Hosp, Div Infect Dis, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Kinder, Jeremy M.; Jiang, Tony T.; Way, Sing Sing] Cincinnati Childrens Hosp, Perinatal Inst, 3333 Burnet Ave, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Way, SS (corresponding author), Cincinnati Childrens Hosp, Div Infect Dis, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Way, SS (corresponding author), Cincinnati Childrens Hosp, Perinatal Inst, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	singsing.way@cchmc.org		Way, Sing Sing/0000-0001-8948-1952; Kinder, Jeremy/0000-0001-5145-1344	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Kinder JM, 2015, CELL, V162, P505, DOI 10.1016/j.cell.2015.07.006; Levy O, 2014, NEONATOLOGY, V105, P136, DOI 10.1159/000356035; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2012, ADV IMMUNOL, V115, P73, DOI 10.1016/B978-0-12-394299-9.00003-5; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Tian YJ, 2016, IMMUNITY, V44, P1204, DOI 10.1016/j.immuni.2016.04.008	10	3	3	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1085	1087		10.1016/j.immuni.2016.04.021	http://dx.doi.org/10.1016/j.immuni.2016.04.021			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192574	Bronze, Green Accepted			2022-12-18	WOS:000376478500012
J	Mudd, JC; Brenchley, JM				Mudd, Joseph C.; Brenchley, Jason M.			ILC You Later: Early and Irreparable Loss of Innate Lymphocytes in HIV Infection	IMMUNITY			English	Editorial Material							LYMPHOID-CELLS	Loss of IL-17-producing cells in the gut during HIV infection is linked to GI barrier damage. Kloverpris et al. (2016) find that circulating ILCs are lost early and irreversibly during HIV infection. Early ART administration protects against the ILC loss, and this might be clinically beneficial to HIV-infected individuals.	[Mudd, Joseph C.; Brenchley, Jason M.] NIAID, Immunopathogenesis Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20874 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Brenchley, JM (corresponding author), NIAID, Immunopathogenesis Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20874 USA.	jbrenchl@niaid.nih.gov	Brenchley, Jason/AAC-5085-2019	Brenchley, Jason/0000-0001-8357-2984	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001029] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Li HY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004551; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Reeves RK, 2011, BLOOD, V118, P3321, DOI 10.1182/blood-2011-04-347260; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Zhang Z, 2015, J CLIN INVEST, V125, P3692, DOI 10.1172/JCI82124	10	3	5	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					216	218		10.1016/j.immuni.2016.01.022	http://dx.doi.org/10.1016/j.immuni.2016.01.022			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885853	Bronze			2022-12-18	WOS:000370294000005
J	Nolz, JC; Hill, AB				Nolz, Jeffrey C.; Hill, Ann B.			Strength in Numbers: Visualizing CTL-Mediated Killing In Vivo	IMMUNITY			English	Editorial Material							CYTOTOXIC T-LYMPHOCYTES; CELLS	Cytotoxic CD8(+) T lymphocytes (CTLs) have long been believed to be extremely efficient killers. Forster and colleagues (Halle et al., 2016) used in vivo imaging to tell a different story, in which each CTL killed only 2-16 targets a day, and several CTLs per target were needed to get the job done.	[Nolz, Jeffrey C.; Hill, Ann B.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA	Oregon Health & Science University	Hill, AB (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA.	hillan@ohsu.edu						Bartholdy C, 2000, J VIROL, V74, P10304, DOI 10.1128/JVI.74.22.10304-10311.2000; Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004; Holtappels R, 2004, J EXP MED, V199, P131, DOI 10.1084/jem.20031582; ISAAZ S, 1995, EUR J IMMUNOL, V25, P1071, DOI 10.1002/eji.1830250432; Pinto AK, 2006, J IMMUNOL, V177, P3225, DOI 10.4049/jimmunol.177.5.3225; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104	7	3	3	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					207	208		10.1016/j.immuni.2016.01.026	http://dx.doi.org/10.1016/j.immuni.2016.01.026			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885849	Bronze			2022-12-18	WOS:000370294000001
J	Lloyd, CM; Harker, JA				Lloyd, Clare M.; Harker, James A.			Location, Location, Location: Localized Memory Cells Take Residence in the Allergic Lung	IMMUNITY			English	Editorial Material							HOUSE-DUST MITES; ANTIGEN CHALLENGE; T-CELLS; CHEMOKINE; IMMUNITY	Understanding the localization of cells is important as local environmental cues influence both phenotype and effector function. In this issue of Immunity, Pepper and colleagues find that allergen-specific tissue-resident memory T cells are maintained by IL-2 and are key drivers of allergic pathology.	[Lloyd, Clare M.; Harker, James A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London SW7 2AZ, England	Imperial College London	Lloyd, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	c.lloyd@imperial.ac.uk		Lloyd, Clare/0000-0001-8977-6726; Harker, James/0000-0002-0301-6898	Wellcome Trust [101372] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Mathie SA, 2015, ALLERGY, V70, P80, DOI 10.1111/all.12536; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; VERVLOET D, 1982, J ALLERGY CLIN IMMUN, V69, P290, DOI 10.1016/S0091-6749(82)80006-7	10	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					13	15		10.1016/j.immuni.2015.12.012	http://dx.doi.org/10.1016/j.immuni.2015.12.012			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789918	Bronze			2022-12-18	WOS:000368347000007
J	Helbig, C; Amsen, D				Helbig, Christina; Amsen, Derk			Notch Signaling: Piercing a Harness of Simplicity	IMMUNITY			English	Editorial Material							RECEPTORS		[Helbig, Christina; Amsen, Derk] Sanquin & Landsteiner Lab Blood Res, Dept Hematopoiesis, NL-1066 CX Amsterdam, Netherlands		Amsen, D (corresponding author), Sanquin & Landsteiner Lab Blood Res, Dept Hematopoiesis, NL-1066 CX Amsterdam, Netherlands.	d.amsen@sanquin.nl						He Y., 2015, ONCOGENE; Pinnell N, 2015, IMMUNITY, V43, P870, DOI 10.1016/j.immuni.2015.10.007; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Rakowski LA, 2013, CANCER RES, V73, P930, DOI 10.1158/0008-5472.CAN-12-1389; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Wang HF, 2015, J CELL PHYSIOL, V230, P982, DOI 10.1002/jcp.24872; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022	9	3	3	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					831	833		10.1016/j.immuni.2015.10.022	http://dx.doi.org/10.1016/j.immuni.2015.10.022			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588772	Bronze			2022-12-18	WOS:000366846000001
J	Barrett, NA; Austen, KF				Barrett, Nora A.; Austen, K. Frank			Licensed to III: IL-9 Generation in Immature Mast Cells Permits Food-Elicited Anaphylaxis	IMMUNITY			English	Editorial Material							PROGENITORS; ALLERGY	Food-specific IgE is central to the pathobiology of food allergy, but not sufficient to induce disease. Chen et al. (2015) demonstrate that food-elicited reactions require an immature mast cell that generates IL-9 to induce its own maturation.	[Barrett, Nora A.; Austen, K. Frank] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Barrett, Nora A.; Austen, K. Frank] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Austen, KF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	fausten@research.bwh.harvard.edu						Abonia JP, 2006, BLOOD, V108, P1588, DOI 10.1182/blood-2005-12-012781; Bankova LG, 2015, MUCOSAL IMMUNOL, V8, P596, DOI 10.1038/mi.2014.91; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Liu AY, 2013, J IMMUNOL, V190, P1758, DOI 10.4049/jimmunol.1202567; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; Oyoshi MK, 2014, J ALLERGY CLIN IMMUN, V133, P309, DOI 10.1016/j.jaci.2013.12.1045; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026	10	3	3	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					626	628		10.1016/j.immuni.2015.09.011	http://dx.doi.org/10.1016/j.immuni.2015.09.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26488812	Bronze			2022-12-18	WOS:000363478700005
J	Farkas, AM; Ivanov, II				Farkas, Adam M.; Ivanov, Ivaylo I.			Escaping Negative Selection: ILC You in the Gut	IMMUNITY			English	Editorial Material							CELLS; IGA	How commensal-specific T cells are controlled in the periphery is poorly understood. In a recent issue of Science, Hepworth et al. (2015) show that ILC3s induce apoptosis of microbiota-specific CD4 T cells in a form of extrathymic negative selection.	[Farkas, Adam M.; Ivanov, Ivaylo I.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University	Ivanov, II (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	ii2137@cumc.columbia.edu		Farkas, Adam/0000-0002-5813-9473	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098378] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK098378] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Grainger JR, 2014, IMMUNOL REV, V259, P75, DOI 10.1111/imr.12167; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288	10	3	5	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					12	14		10.1016/j.immuni.2015.07.006	http://dx.doi.org/10.1016/j.immuni.2015.07.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200009	Green Accepted, Bronze			2022-12-18	WOS:000360101100006
J	Schneider, C; Kopf, M				Schneider, Christoph; Kopf, Manfred			tEMPting Fate MaYBe the Solution	IMMUNITY			English	Editorial Material							ALVEOLAR MACROPHAGES; FETAL MONOCYTES; GM-CSF; CELLS; DERIVE		[Schneider, Christoph; Kopf, Manfred] ETH, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Schneider, C (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	christoph.schneider@ucsf.edu; manfred.kopf@ethz.ch	Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140; Schneider, Christoph/0000-0002-0452-2960	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179	9	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					597	599		10.1016/j.immuni.2015.04.001	http://dx.doi.org/10.1016/j.immuni.2015.04.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902476	Bronze			2022-12-18	WOS:000353347500004
J	Zhong, C; Zhu, JF				Zhong, Chao; Zhu, Jinfang			Tet2: Breaking Down Barriers to T Cell Cytokine Expression	IMMUNITY			English	Editorial Material							EPIGENETIC CONTROL; DIFFERENTIATION; PLASTICITY		[Zhong, Chao; Zhu, Jinfang] NIAID, Mol & Cellular Immunoregulat Unit, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhu, JF (corresponding author), NIAID, Mol & Cellular Immunoregulat Unit, Immunol Lab, NIH, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov	Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AI001169-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Jiang S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004824; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Koh KP, 2013, CURR OPIN CELL BIOL, V25, P152, DOI 10.1016/j.ceb.2013.02.014; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	9	3	3	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					593	595		10.1016/j.immuni.2015.04.003	http://dx.doi.org/10.1016/j.immuni.2015.04.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902474	Bronze			2022-12-18	WOS:000353347500002
B	Paul, WE				Paul, WE			Immunity	IMMUNITY			English	Book																			0	3	3	0	0	JOHNS HOPKINS UNIV PRESS	BALTIMORE	2715 N CHARLES ST, BALTIMORE, MD 21218-4319 USA			978-1-4214-1802-5; 978-1-4214-1801-8				2015							1	260						275	Immunology	Book Citation Index – Science (BKCI-S)	Immunology	BD7YP					2022-12-18	WOS:000363697400035
J	Eyre, S; Worthington, J				Eyre, Stephen; Worthington, Jane			Take Your PICS: Moving from GWAS to Immune Function	IMMUNITY			English	Editorial Material							CELL-TYPES; DISEASE; DNA		[Eyre, Stephen; Worthington, Jane] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Ctr Musculoskeletal Res,Arthrit Res UK Ctr Genet, Manchester M13 9PT, Lancs, England; [Eyre, Stephen; Worthington, Jane] Cent Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Worthington, J (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Ctr Musculoskeletal Res,Arthrit Res UK Ctr Genet, Oxford Rd, Manchester M13 9PT, Lancs, England.	jane.worthington@manchester.ac.uk	eyre, stephen/K-3776-2017	eyre, stephen/0000-0002-1251-6974				Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KK- H, 2014, NATURE; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Martens JHA, 2013, HAEMATOLOGICA, V98, P1487, DOI 10.3324/haematol.2013.094243; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504	8	3	3	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					883	885		10.1016/j.immuni.2014.12.014	http://dx.doi.org/10.1016/j.immuni.2014.12.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526303	Bronze			2022-12-18	WOS:000346654100007
J	Friedl, P; Weigelin, B				Friedl, Peter; Weigelin, Bettina			A Swiss Army Knife for CTLs	IMMUNITY			English	Editorial Material							TRANSMIGRATION; MIGRATION; CELLS		[Friedl, Peter; Weigelin, Bettina] Radboudumc, Radboud Inst Mol Life Sci, Dept Cell Biol 283, NL-6525 GA Nijmegen, Netherlands; [Friedl, Peter] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77030 USA; [Friedl, Peter] Univ Med Ctr Utrecht, Dept Mol Canc Res, Canc Genom Ctr Netherlands CGC Nl, NL-3584 CG Utrecht, Netherlands	Radboud University Nijmegen; University of Texas System; UTMD Anderson Cancer Center; Utrecht University; Utrecht University Medical Center	Friedl, P (corresponding author), Radboudumc, Radboud Inst Mol Life Sci, Dept Cell Biol 283, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	peter.friedl@radboudumc.nl	Weigelin, Bettina/H-8604-2015; Friedl, Peter/A-8961-2010	Friedl, Peter/0000-0002-0119-4041; Weigelin, Bettina/0000-0003-4460-3113				Boivin WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033163; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Prakash MD, 2014, IMMUNITY, V41, P960, DOI 10.1016/j.immuni.2014.11.012; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Wang SJ, 2005, J CELL SCI, V118, P2067, DOI 10.1242/jcs.02340; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791	10	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					873	875		10.1016/j.immuni.2014.12.008	http://dx.doi.org/10.1016/j.immuni.2014.12.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526299	Bronze			2022-12-18	WOS:000346654100003
J	Van Kaer, L; Algood, HMS; Singh, K; Parekh, VV; Greer, MJ; Piazuelo, MB; Weitkamp, JH; Matta, P; Chaturvedi, R; Wilson, KT; Olivares-Villagomez, D				Van Kaer, Luc; Algood, Holly M. Scott; Singh, Kshipra; Parekh, Vrajesh V.; Greer, Michael J.; Piazuelo, M. Blanca; Weitkamp, Joern-Hendrik; Matta, Pranathi; Chaturvedi, Rupesh; Wilson, Keith T.; Olivares-Villagomez, Danyvid			CD8 alpha alpha(+) Innate-Type Lymphocytes in the Intestinal Epithelium Mediate Mucosal Immunity (vol 41, pg 451, 2014)	IMMUNITY			English	Correction												luc.van.kaer@vanderbilt.edu; danyvid.olivares-villagomez@vanderbilt.edu	Weitkamp, Joern-Hendrik/AAZ-8272-2020	Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Wilson, Keith/0000-0003-4421-1830				Van Kaer L, 2014, IMMUNITY, V41, P451, DOI 10.1016/j.immuni.2014.08.010	1	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					1064	1064		10.1016/j.immuni.2014.12.012	http://dx.doi.org/10.1016/j.immuni.2014.12.012			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM		Bronze			2022-12-18	WOS:000346654100022
